pmid,year,mesh,meshTreeNumber
17197173,2007-01-02T00:00:00,Animals,B01.050
17203016,2007-01-03T00:00:00,Adult,M01.060.116
17203016,2007-01-03T00:00:00,Bipolar Disorder,F03.600.150.150
17203016,2007-01-03T00:00:00,Brain,A08.186.211
17203016,2007-01-03T00:00:00,Brain Mapping,E01.370.350.086
17203016,2007-01-03T00:00:00,Brain Mapping,E01.370.376.149
17203016,2007-01-03T00:00:00,Brain Mapping,E05.132
17203016,2007-01-03T00:00:00,Double-Blind Method,E05.318.780.300
17203016,2007-01-03T00:00:00,Double-Blind Method,E05.581.500.300
17203016,2007-01-03T00:00:00,Double-Blind Method,N05.715.360.780.320
17203016,2007-01-03T00:00:00,Double-Blind Method,N06.850.520.445.300
17203016,2007-01-03T00:00:00,Electric Stimulation Therapy,E02.342
17203016,2007-01-03T00:00:00,Electric Stimulation Therapy,E02.779.468
17203016,2007-01-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17203016,2007-01-03T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
17203016,2007-01-03T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17203016,2007-01-03T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17203016,2007-01-03T00:00:00,Middle Aged,M01.060.116.630
17203016,2007-01-03T00:00:00,Oxygen,D01.268.185.550
17203016,2007-01-03T00:00:00,Oxygen,D01.362.670
17204516,2007-01-04T00:00:00,Adult,M01.060.116
17204516,2007-01-04T00:00:00,Aged,M01.060.116.100
17204516,2007-01-04T00:00:00,Environmental Exposure,N06.850.460.350
17204516,2007-01-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17204516,2007-01-04T00:00:00,Incidence,E05.318.308.985.525.375
17204516,2007-01-04T00:00:00,Incidence,L01.280.975.525.375
17204516,2007-01-04T00:00:00,Incidence,N01.224.935.597.500
17204516,2007-01-04T00:00:00,Incidence,N06.850.505.400.975.525.375
17204516,2007-01-04T00:00:00,Incidence,N06.850.520.308.985.525.375
17204516,2007-01-04T00:00:00,Middle Aged,M01.060.116.630
17204516,2007-01-04T00:00:00,Population Surveillance,E05.318.308.250.700
17204516,2007-01-04T00:00:00,Population Surveillance,N05.715.360.300.375.625
17204516,2007-01-04T00:00:00,Population Surveillance,N06.850.520.308.250.700
17204516,2007-01-04T00:00:00,Population Surveillance,N06.850.780.675
17204516,2007-01-04T00:00:00,Questionnaires,E05.318.308.750
17204516,2007-01-04T00:00:00,Questionnaires,L01.280.800
17204516,2007-01-04T00:00:00,Questionnaires,N05.715.360.300.695
17204516,2007-01-04T00:00:00,Questionnaires,N06.850.520.308.750
17204516,2007-01-04T00:00:00,Regression Analysis,E05.318.740.750
17204516,2007-01-04T00:00:00,Regression Analysis,N05.715.360.750.695
17204516,2007-01-04T00:00:00,Regression Analysis,N06.850.520.830.750
17204516,2007-01-04T00:00:00,Smoking,F01.145.466.753
17204516,2007-01-04T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
17204516,2007-01-04T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
17204516,2007-01-04T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
17204516,2007-01-04T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
17204516,2007-01-04T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
17204516,2007-01-04T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
17204516,2007-01-04T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
17204545,2007-01-04T00:00:00,Adenocarcinoma,C04.557.470.200.025
17204545,2007-01-04T00:00:00,Epithelial Cells,A11.436
17204545,2007-01-04T00:00:00,Gastric Mucosa,A03.556.875.875.440
17204545,2007-01-04T00:00:00,Gastric Mucosa,A10.615.550.291
17204545,2007-01-04T00:00:00,H(+)-K(+)-Exchanging ATPase,D08.811.277.040.025.325.625
17204545,2007-01-04T00:00:00,H(+)-K(+)-Exchanging ATPase,D12.776.157.530.450.250.875.500.625
17204545,2007-01-04T00:00:00,H(+)-K(+)-Exchanging ATPase,D12.776.543.585.450.250.875.500.625
17204545,2007-01-04T00:00:00,Helicobacter Infections,C01.252.400.466
17204545,2007-01-04T00:00:00,Helicobacter pylori,B03.440.500.550
17204545,2007-01-04T00:00:00,Helicobacter pylori,B03.660.150.280.550
17204545,2007-01-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17204545,2007-01-04T00:00:00,Interleukin-1beta,D12.644.276.374.465.501.600
17204545,2007-01-04T00:00:00,Interleukin-1beta,D12.644.276.374.500.400.600
17204545,2007-01-04T00:00:00,Interleukin-1beta,D12.776.467.374.465.501.600
17204545,2007-01-04T00:00:00,Interleukin-1beta,D12.776.467.374.500.400.600
17204545,2007-01-04T00:00:00,Interleukin-1beta,D23.529.374.465.501.600
17204545,2007-01-04T00:00:00,Interleukin-1beta,D23.529.374.500.400.600
17204545,2007-01-04T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
17204545,2007-01-04T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
17204545,2007-01-04T00:00:00,MAP Kinase Signaling System,G03.495.553.560
17204545,2007-01-04T00:00:00,MAP Kinase Signaling System,G04.299.880.560
17204545,2007-01-04T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
17204545,2007-01-04T00:00:00,"RNA, Messenger",D13.444.735.544
17204545,2007-01-04T00:00:00,Stomach Neoplasms,C04.588.274.476.767
17204545,2007-01-04T00:00:00,Stomach Neoplasms,C06.301.371.767
17204545,2007-01-04T00:00:00,Stomach Neoplasms,C06.405.249.767
17204545,2007-01-04T00:00:00,Stomach Neoplasms,C06.405.748.789
17204545,2007-01-04T00:00:00,Time Factors,G01.910.857
17204545,2007-01-04T00:00:00,"Transcription, Genetic",G02.111.087.847
17204545,2007-01-04T00:00:00,"Transcription, Genetic",G02.149.115.847
17204545,2007-01-04T00:00:00,"Transcription, Genetic",G05.355.310.700
17204668,2007-01-04T00:00:00,Clinical Trials as Topic,E05.318.760.535
17204668,2007-01-04T00:00:00,Clinical Trials as Topic,E05.337.250
17204668,2007-01-04T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
17204668,2007-01-04T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
17204668,2007-01-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17204668,2007-01-04T00:00:00,Stroke,C10.228.140.300.775
17204668,2007-01-04T00:00:00,Stroke,C14.907.253.855
17204668,2007-01-04T00:00:00,Treatment Outcome,E01.789.800
17204668,2007-01-04T00:00:00,Treatment Outcome,N04.761.559.590.800
17204668,2007-01-04T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17204668,2007-01-04T00:00:00,Virginia,Z01.107.567.875.075.837
17204668,2007-01-04T00:00:00,Virginia,Z01.107.567.875.750.870
17229066,2007-01-04T00:00:00,Aged,M01.060.116.100
17229066,2007-01-04T00:00:00,Graft Rejection,G12.425.901.545.328
17229066,2007-01-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17229066,2007-01-04T00:00:00,Immunosuppression,E02.095.465.425.450
17229066,2007-01-04T00:00:00,Immunosuppression,E05.478.610
17229066,2007-01-04T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
17229066,2007-01-04T00:00:00,Kidney Transplantation,E02.870.500
17229066,2007-01-04T00:00:00,Kidney Transplantation,E04.936.450.485
17229066,2007-01-04T00:00:00,Kidney Transplantation,E04.950.774.400
17229066,2007-01-04T00:00:00,Middle Aged,M01.060.116.630
17229066,2007-01-04T00:00:00,Treatment Outcome,E01.789.800
17229066,2007-01-04T00:00:00,Treatment Outcome,N04.761.559.590.800
17229066,2007-01-04T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17274963,2007-01-04T00:00:00,Age Factors,N05.715.350.075
17274963,2007-01-04T00:00:00,Age Factors,N06.850.490.250
17274963,2007-01-04T00:00:00,Animals,B01.050
17274963,2007-01-04T00:00:00,Association Learning,F02.463.425.069.296
17274963,2007-01-04T00:00:00,Central Nervous System Stimulants,D27.505.696.282
17274963,2007-01-04T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
17274963,2007-01-04T00:00:00,Methylphenidate,D02.241.223.601.600
17274963,2007-01-04T00:00:00,Methylphenidate,D03.383.621.460
17274963,2007-01-04T00:00:00,Morphine,D03.132.577.249.547
17274963,2007-01-04T00:00:00,Morphine,D03.549.686.575
17274963,2007-01-04T00:00:00,Morphine,D03.605.497.575
17274963,2007-01-04T00:00:00,Morphine,D04.615.723.795.547
17274963,2007-01-04T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
17274963,2007-01-04T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17274963,2007-01-04T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17274963,2007-01-04T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.070.300.400.500
17274963,2007-01-04T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.100.150.400.500
17274963,2007-01-04T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.720.300.300.400.500
17317356,2007-01-04T00:00:00,Aged,M01.060.116.100
17317356,2007-01-04T00:00:00,Coronary Disease,C14.280.647.250
17317356,2007-01-04T00:00:00,Coronary Disease,C14.907.585.250
17317356,2007-01-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17317356,2007-01-04T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
17317356,2007-01-04T00:00:00,Middle Aged,M01.060.116.630
17317356,2007-01-04T00:00:00,Stents,E07.695.750
17317356,2007-01-04T00:00:00,Treatment Outcome,E01.789.800
17317356,2007-01-04T00:00:00,Treatment Outcome,N04.761.559.590.800
17317356,2007-01-04T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17208980,2007-01-05T00:00:00,Binding Sites,G02.111.570.120
17208980,2007-01-05T00:00:00,Computer Simulation,L01.224.160
17208980,2007-01-05T00:00:00,"Models, Chemical",E05.599.495
17208980,2007-01-05T00:00:00,"Models, Molecular",E05.599.595
17208980,2007-01-05T00:00:00,Multiprotein Complexes,D05.500
17208980,2007-01-05T00:00:00,Proteins,D12.776
17208980,2007-01-05T00:00:00,Static Electricity,G01.201.249.820
17217414,2007-01-08T00:00:00,Animals,B01.050
17217414,2007-01-08T00:00:00,Blood-Brain Barrier,A07.035
17217414,2007-01-08T00:00:00,Blood-Brain Barrier,A08.186.211.035
17217414,2007-01-08T00:00:00,Cytokines,D12.644.276.374
17217414,2007-01-08T00:00:00,Cytokines,D12.776.467.374
17217414,2007-01-08T00:00:00,Cytokines,D23.529.374
17217414,2007-01-08T00:00:00,Down-Regulation,G02.111.087.225
17217414,2007-01-08T00:00:00,Down-Regulation,G02.149.115.225
17217414,2007-01-08T00:00:00,Down-Regulation,G05.355.315.200
17217414,2007-01-08T00:00:00,Down-Regulation,G07.690.812.230
17217414,2007-01-08T00:00:00,Down-Regulation,G07.700.680.230
17217414,2007-01-08T00:00:00,Endothelial Cells,A11.436.275
17217414,2007-01-08T00:00:00,"Gait Disorders, Neurologic",C10.597.404
17217414,2007-01-08T00:00:00,"Gait Disorders, Neurologic",C23.888.592.413
17217414,2007-01-08T00:00:00,Heptanoic Acids,D10.251.450
17217414,2007-01-08T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.205.360
17217414,2007-01-08T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.252.445
17217414,2007-01-08T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.525.700.350
17217414,2007-01-08T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.205.360
17217414,2007-01-08T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.252.445
17217414,2007-01-08T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.525.700.350
17217414,2007-01-08T00:00:00,Neuroprotective Agents,D27.505.696.706.548
17217414,2007-01-08T00:00:00,Neuroprotective Agents,D27.505.954.427.575
17217414,2007-01-08T00:00:00,Pyrroles,D03.383.129.578
17217414,2007-01-08T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17217414,2007-01-08T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17217414,2007-01-08T00:00:00,Recovery of Function,G16.757
17217414,2007-01-08T00:00:00,Spinal Cord,A08.186.854
17217414,2007-01-08T00:00:00,Spinal Cord Injuries,C10.228.854.770
17217414,2007-01-08T00:00:00,Spinal Cord Injuries,C10.900.850
17217414,2007-01-08T00:00:00,Spinal Cord Injuries,C21.866.819
17217414,2007-01-08T00:00:00,Treatment Outcome,E01.789.800
17217414,2007-01-08T00:00:00,Treatment Outcome,N04.761.559.590.800
17217414,2007-01-08T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17211573,2007-01-09T00:00:00,Adult,M01.060.116
17211573,2007-01-09T00:00:00,Aged,M01.060.116.100
17211573,2007-01-09T00:00:00,"Carcinoma, Renal Cell",C04.557.470.200.025.390
17211573,2007-01-09T00:00:00,"Carcinoma, Renal Cell",C04.588.945.947.535.160
17211573,2007-01-09T00:00:00,"Carcinoma, Renal Cell",C12.758.820.750.160
17211573,2007-01-09T00:00:00,"Carcinoma, Renal Cell",C12.777.419.473.160
17211573,2007-01-09T00:00:00,"Carcinoma, Renal Cell",C13.351.937.820.535.160
17211573,2007-01-09T00:00:00,"Carcinoma, Renal Cell",C13.351.968.419.473.160
17211573,2007-01-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17211573,2007-01-09T00:00:00,Kidney Neoplasms,C04.588.945.947.535
17211573,2007-01-09T00:00:00,Kidney Neoplasms,C12.758.820.750
17211573,2007-01-09T00:00:00,Kidney Neoplasms,C12.777.419.473
17211573,2007-01-09T00:00:00,Kidney Neoplasms,C13.351.937.820.535
17211573,2007-01-09T00:00:00,Kidney Neoplasms,C13.351.968.419.473
17211573,2007-01-09T00:00:00,Middle Aged,M01.060.116.630
17211573,2007-01-09T00:00:00,Skin Neoplasms,C04.588.805
17211573,2007-01-09T00:00:00,Skin Neoplasms,C17.800.882
17211573,2007-01-09T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17211573,2007-01-09T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17211573,2007-01-09T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17211573,2007-01-09T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17211573,2007-01-09T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17213201,2007-01-09T00:00:00,Antineoplastic Agents,D27.505.954.248
17213201,2007-01-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17213201,2007-01-09T00:00:00,Mitochondria,A11.284.430.214.190.875.564
17213201,2007-01-09T00:00:00,Mitochondria,A11.284.835.626
17213201,2007-01-09T00:00:00,Oxygen Consumption,G03.730
17213201,2007-01-09T00:00:00,Reactive Oxygen Species,D01.339.431
17213201,2007-01-09T00:00:00,Reactive Oxygen Species,D01.650.775
17213201,2007-01-09T00:00:00,Superoxides,D01.248.497.158.685.750.850
17213201,2007-01-09T00:00:00,Superoxides,D01.339.431.374.850
17213201,2007-01-09T00:00:00,Superoxides,D01.339.431.750
17213201,2007-01-09T00:00:00,Superoxides,D01.650.550.750.800
17216332,2007-01-10T00:00:00,Attention,F02.830.104.214
17216332,2007-01-10T00:00:00,Autistic Disorder,F03.550.325.125
17216332,2007-01-10T00:00:00,"Child, Preschool",M01.060.406.448
17216332,2007-01-10T00:00:00,Communication,F01.145.209
17216332,2007-01-10T00:00:00,Communication,L01.143
17216332,2007-01-10T00:00:00,Cooperative Behavior,F01.145.813.115
17216332,2007-01-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17216332,2007-01-10T00:00:00,Interpersonal Relations,F01.829.401
17216332,2007-01-10T00:00:00,Phenotype,G05.695
17216332,2007-01-10T00:00:00,Questionnaires,E05.318.308.750
17216332,2007-01-10T00:00:00,Questionnaires,L01.280.800
17216332,2007-01-10T00:00:00,Questionnaires,N05.715.360.300.695
17216332,2007-01-10T00:00:00,Questionnaires,N06.850.520.308.750
17216332,2007-01-10T00:00:00,Risk Factors,E05.318.740.600.800.725
17216332,2007-01-10T00:00:00,Risk Factors,N05.715.350.200.700
17216332,2007-01-10T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17216332,2007-01-10T00:00:00,Risk Factors,N06.850.490.625.750
17216332,2007-01-10T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17218096,2007-01-10T00:00:00,Cholecalciferol,D04.808.247.222.159
17218096,2007-01-10T00:00:00,Cholecalciferol,D04.808.247.808.146
17218096,2007-01-10T00:00:00,Cholecalciferol,D04.808.812.768.196
17218096,2007-01-10T00:00:00,Cholecalciferol,D10.570.938.146
17218096,2007-01-10T00:00:00,Diet,E05.272
17218096,2007-01-10T00:00:00,Diet,G07.610.240
17218096,2007-01-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17218096,2007-01-10T00:00:00,Vitamin D,D04.808.812.768
17292928,2007-01-10T00:00:00,Adult,M01.060.116
17292928,2007-01-10T00:00:00,Brain Mapping,E01.370.350.086
17292928,2007-01-10T00:00:00,Brain Mapping,E01.370.376.149
17292928,2007-01-10T00:00:00,Brain Mapping,E05.132
17292928,2007-01-10T00:00:00,Case-Control Studies,E05.318.760.500.500
17292928,2007-01-10T00:00:00,Case-Control Studies,N05.715.360.775.175.200
17292928,2007-01-10T00:00:00,Case-Control Studies,N06.850.520.450.500.500
17292928,2007-01-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17292928,2007-01-10T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
17292928,2007-01-10T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17292928,2007-01-10T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17292928,2007-01-10T00:00:00,Middle Aged,M01.060.116.630
17292928,2007-01-10T00:00:00,Oxygen,D01.268.185.550
17292928,2007-01-10T00:00:00,Oxygen,D01.362.670
17292928,2007-01-10T00:00:00,Semantics,L01.143.506.598.745
17292928,2007-01-10T00:00:00,Treatment Outcome,E01.789.800
17292928,2007-01-10T00:00:00,Treatment Outcome,N04.761.559.590.800
17292928,2007-01-10T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17218638,2007-01-11T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
17218638,2007-01-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17218638,2007-01-11T00:00:00,Phenotype,G05.695
17218638,2007-01-11T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
17218638,2007-01-11T00:00:00,Prostatic Neoplasms,C12.294.260.750
17218638,2007-01-11T00:00:00,Prostatic Neoplasms,C12.294.565.625
17218638,2007-01-11T00:00:00,Prostatic Neoplasms,C12.758.409.750
17218638,2007-01-11T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
17218638,2007-01-11T00:00:00,"Protein Structure, Secondary",G02.111.570.790.709.600
17218638,2007-01-11T00:00:00,Proto-Oncogene Proteins c-pim-1,D08.811.913.696.620.682.700.776
17218638,2007-01-11T00:00:00,Proto-Oncogene Proteins c-pim-1,D12.776.624.664.700.191
17275198,2007-01-11T00:00:00,Adolescent,M01.060.057
17275198,2007-01-11T00:00:00,Adult,M01.060.116
17275198,2007-01-11T00:00:00,Alcoholism,C21.739.100.250
17275198,2007-01-11T00:00:00,Alcoholism,F03.900.100.350
17275198,2007-01-11T00:00:00,"Child Abuse, Sexual",I01.198.240.748.300
17275198,2007-01-11T00:00:00,"Child Abuse, Sexual",I01.198.240.856.350.250.255
17275198,2007-01-11T00:00:00,"Child Abuse, Sexual",I01.880.735.900.350.250.255
17275198,2007-01-11T00:00:00,"Child Abuse, Sexual",I01.880.787.293.292.325
17275198,2007-01-11T00:00:00,Crime Victims,M01.135
17275198,2007-01-11T00:00:00,Forensic Medicine,H02.403.330
17275198,2007-01-11T00:00:00,Forensic Medicine,I01.198.780.937
17275198,2007-01-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17275198,2007-01-11T00:00:00,Informed Consent,I01.880.604.473.650.718
17275198,2007-01-11T00:00:00,Informed Consent,I01.880.604.583.427
17275198,2007-01-11T00:00:00,Informed Consent,N03.706.437.650.312
17275198,2007-01-11T00:00:00,Informed Consent,N03.706.535.489
17275198,2007-01-11T00:00:00,"Interview, Psychological",F04.669.599
17275198,2007-01-11T00:00:00,Marijuana Abuse,C21.739.635
17275198,2007-01-11T00:00:00,Marijuana Abuse,F03.900.635
17275198,2007-01-11T00:00:00,Psychotherapy,F04.754
17275198,2007-01-11T00:00:00,Rape,I01.198.240.748.640
17275198,2007-01-11T00:00:00,Regression Analysis,E05.318.740.750
17275198,2007-01-11T00:00:00,Regression Analysis,N05.715.360.750.695
17275198,2007-01-11T00:00:00,Regression Analysis,N06.850.520.830.750
17275198,2007-01-11T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17275198,2007-01-11T00:00:00,Substance-Related Disorders,C21.739
17275198,2007-01-11T00:00:00,Substance-Related Disorders,F03.900
17275198,2007-01-11T00:00:00,Video Recording,L01.240.960
17223551,2007-01-12T00:00:00,Aged,M01.060.116.100
17223551,2007-01-12T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
17223551,2007-01-12T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
17223551,2007-01-12T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
17223551,2007-01-12T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
17223551,2007-01-12T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
17223551,2007-01-12T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
17223551,2007-01-12T00:00:00,Diet,E05.272
17223551,2007-01-12T00:00:00,Diet,G07.610.240
17223551,2007-01-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17223551,2007-01-12T00:00:00,Vitamin D,D04.808.812.768
17225294,2007-01-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17225294,2007-01-12T00:00:00,Risk Assessment,E05.318.740.600.800.715
17225294,2007-01-12T00:00:00,Risk Assessment,N04.452.871.715
17225294,2007-01-12T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17225294,2007-01-12T00:00:00,Risk Assessment,N06.850.505.715
17225294,2007-01-12T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17225294,2007-01-12T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17225294,2007-01-12T00:00:00,United States,Z01.107.567.875
17225294,2007-01-12T00:00:00,Veterans,M01.930
17320076,2007-01-12T00:00:00,Animals,B01.050
17320076,2007-01-12T00:00:00,Cytomegalovirus,B04.280.382.150.150
17320076,2007-01-12T00:00:00,Cytomegalovirus,B04.909.204.382.150.150
17320076,2007-01-12T00:00:00,"Disease Models, Animal",C22.232
17320076,2007-01-12T00:00:00,"Disease Models, Animal",E05.598.500
17320076,2007-01-12T00:00:00,"Disease Models, Animal",E05.599.395.080
17320076,2007-01-12T00:00:00,Liver Diseases,C06.552
17320076,2007-01-12T00:00:00,Viremia,C02.937
17320076,2007-01-12T00:00:00,Viremia,C23.550.470.790.500.900
17224468,2007-01-15T00:00:00,Adult,M01.060.116
17224468,2007-01-15T00:00:00,Aged,M01.060.116.100
17224468,2007-01-15T00:00:00,Aortic Valve,A07.541.510.110
17224468,2007-01-15T00:00:00,Calcinosis,C18.452.174.130
17224468,2007-01-15T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17224468,2007-01-15T00:00:00,Genetic Predisposition to Disease,G05.380.355
17224468,2007-01-15T00:00:00,Genetic Testing,E01.370.427
17224468,2007-01-15T00:00:00,Genetic Testing,E05.393.435
17224468,2007-01-15T00:00:00,Genetic Testing,N02.421.143.827.233.221
17224468,2007-01-15T00:00:00,Genetic Testing,N02.421.308.430
17224468,2007-01-15T00:00:00,Heart Valve Diseases,C14.280.484
17224468,2007-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17224468,2007-01-15T00:00:00,Hypertension,C14.907.489
17224468,2007-01-15T00:00:00,Middle Aged,M01.060.116.630
17224468,2007-01-15T00:00:00,Mitral Valve,A07.541.510.507
17224475,2007-01-15T00:00:00,Animals,B01.050
17224475,2007-01-15T00:00:00,Apoptosis,G04.299.139.160
17224475,2007-01-15T00:00:00,Bradykinin,D12.644.276.812.169
17224475,2007-01-15T00:00:00,Bradykinin,D12.644.400.090
17224475,2007-01-15T00:00:00,Bradykinin,D12.644.456.193
17224475,2007-01-15T00:00:00,Bradykinin,D12.776.467.812.169
17224475,2007-01-15T00:00:00,Bradykinin,D12.776.641.650.090
17224475,2007-01-15T00:00:00,Bradykinin,D23.469.050.375.110
17224475,2007-01-15T00:00:00,Bradykinin,D23.529.812.169
17224475,2007-01-15T00:00:00,Fibrosis,C23.550.355
17224475,2007-01-15T00:00:00,Kidney Diseases,C12.777.419
17224475,2007-01-15T00:00:00,Kidney Diseases,C13.351.968.419
17224475,2007-01-15T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567
17224475,2007-01-15T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750
17224475,2007-01-15T00:00:00,Mitogen-Activated Protein Kinases,D12.644.360.450
17224475,2007-01-15T00:00:00,Mitogen-Activated Protein Kinases,D12.776.476.450
17224475,2007-01-15T00:00:00,Oxidative Stress,G03.495.710
17224475,2007-01-15T00:00:00,Oxidative Stress,G07.700.830.750
17224475,2007-01-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17224475,2007-01-15T00:00:00,Transforming Growth Factor beta1,D12.644.276.374.687.100
17224475,2007-01-15T00:00:00,Transforming Growth Factor beta1,D12.644.276.954.800.720.100
17224475,2007-01-15T00:00:00,Transforming Growth Factor beta1,D12.644.276.963.720.100
17224475,2007-01-15T00:00:00,Transforming Growth Factor beta1,D12.776.467.374.687.100
17224475,2007-01-15T00:00:00,Transforming Growth Factor beta1,D12.776.467.942.800.720.100
17224475,2007-01-15T00:00:00,Transforming Growth Factor beta1,D12.776.467.960.720.100
17224475,2007-01-15T00:00:00,Transforming Growth Factor beta1,D23.529.374.687.100
17224475,2007-01-15T00:00:00,Transforming Growth Factor beta1,D23.529.942.800.720.100
17224475,2007-01-15T00:00:00,Transforming Growth Factor beta1,D23.529.960.720.100
17224475,2007-01-15T00:00:00,Vasodilator Agents,D27.505.954.411.918
17234763,2007-01-15T00:00:00,Adolescent,M01.060.057
17234763,2007-01-15T00:00:00,Adult,M01.060.116
17234763,2007-01-15T00:00:00,Animals,B01.050
17234763,2007-01-15T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
17234763,2007-01-15T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
17234763,2007-01-15T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
17234763,2007-01-15T00:00:00,Bone Marrow,A15.382.216
17234763,2007-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17234763,2007-01-15T00:00:00,Middle Aged,M01.060.116.630
17234763,2007-01-15T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
17234763,2007-01-15T00:00:00,Prostatic Neoplasms,C12.294.260.750
17234763,2007-01-15T00:00:00,Prostatic Neoplasms,C12.294.565.625
17234763,2007-01-15T00:00:00,Prostatic Neoplasms,C12.758.409.750
17234763,2007-01-15T00:00:00,"Receptor, Platelet-Derived Growth Factor alpha",D08.811.913.696.620.682.725.400.900.500
17234763,2007-01-15T00:00:00,"Receptor, Platelet-Derived Growth Factor alpha",D12.776.543.750.060.625.300
17234763,2007-01-15T00:00:00,"Receptor, Platelet-Derived Growth Factor alpha",D12.776.543.750.750.400.630.300
17234763,2007-01-15T00:00:00,Signal Transduction,G02.111.087.800
17234763,2007-01-15T00:00:00,Signal Transduction,G02.149.115.800
17234763,2007-01-15T00:00:00,Signal Transduction,G04.299.880
17209554,2007-01-16T00:00:00,Bacterial Proteins,D12.776.097
17209554,2007-01-16T00:00:00,Binding Sites,G02.111.570.120
17209554,2007-01-16T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
17209554,2007-01-16T00:00:00,Metals,D01.552
17209554,2007-01-16T00:00:00,"Models, Molecular",E05.599.595
17209554,2007-01-16T00:00:00,Mycobacterium tuberculosis,B03.510.024.049.525.500.702
17209554,2007-01-16T00:00:00,Mycobacterium tuberculosis,B03.510.460.400.410.552.552.702
17209554,2007-01-16T00:00:00,Nucleic Acid Conformation,G02.111.570.790.486
17209554,2007-01-16T00:00:00,Nucleic Acid Conformation,G05.360.580
17209554,2007-01-16T00:00:00,Recombinant Proteins,D12.776.828
17209554,2007-01-16T00:00:00,Repressor Proteins,D12.776.260.703
17209554,2007-01-16T00:00:00,Repressor Proteins,D12.776.930.700
17228174,2007-01-16T00:00:00,Adult,M01.060.116
17228174,2007-01-16T00:00:00,Aged,M01.060.116.100
17228174,2007-01-16T00:00:00,GTP-Binding Proteins,D08.811.277.040.330.300
17228174,2007-01-16T00:00:00,GTP-Binding Proteins,D12.776.157.325
17228174,2007-01-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17228174,2007-01-16T00:00:00,Kidney,A05.810.453
17228174,2007-01-16T00:00:00,Middle Aged,M01.060.116.630
17228174,2007-01-16T00:00:00,Transglutaminases,D08.811.913.050.200.800
17228358,2007-01-16T00:00:00,Adolescent,M01.060.057
17228358,2007-01-16T00:00:00,Adult,M01.060.116
17228358,2007-01-16T00:00:00,Aged,M01.060.116.100
17228358,2007-01-16T00:00:00,Electromyography,E01.370.405.255
17228358,2007-01-16T00:00:00,Electromyography,E01.370.530.255
17228358,2007-01-16T00:00:00,Exercise,G11.427.590.237
17228358,2007-01-16T00:00:00,Exercise,I03.350
17228358,2007-01-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17228358,2007-01-16T00:00:00,Isometric Contraction,G11.427.590.540.472
17228358,2007-01-16T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17228358,2007-01-16T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17228358,2007-01-16T00:00:00,Middle Aged,M01.060.116.630
17228358,2007-01-16T00:00:00,Motor Activity,F01.145.632
17228358,2007-01-16T00:00:00,Motor Activity,G11.427.590.530.698
17228358,2007-01-16T00:00:00,"Muscle, Skeletal",A02.633.567
17228358,2007-01-16T00:00:00,"Muscle, Skeletal",A10.690.552.500
17228358,2007-01-16T00:00:00,Recovery of Function,G16.757
17228358,2007-01-16T00:00:00,Spinal Cord Injuries,C10.228.854.770
17228358,2007-01-16T00:00:00,Spinal Cord Injuries,C10.900.850
17228358,2007-01-16T00:00:00,Spinal Cord Injuries,C21.866.819
17303494,2007-01-16T00:00:00,"Abortion, Induced",E04.520.050
17303494,2007-01-16T00:00:00,Adult,M01.060.116
17303494,2007-01-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17303494,2007-01-16T00:00:00,Pain,C10.597.617
17303494,2007-01-16T00:00:00,Pain,C23.888.592.612
17303494,2007-01-16T00:00:00,Pain,C23.888.646
17303494,2007-01-16T00:00:00,Pain,F02.830.816.444
17303494,2007-01-16T00:00:00,Pain,G11.561.600.810.444
17303494,2007-01-16T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
17303494,2007-01-16T00:00:00,Pregnancy,G08.686.785.760.769
17303497,2007-01-16T00:00:00,"Abortion, Induced",E04.520.050
17303497,2007-01-16T00:00:00,Adolescent,M01.060.057
17303497,2007-01-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17303497,2007-01-16T00:00:00,Pregnancy,G08.686.785.760.769
17303497,2007-01-16T00:00:00,Treatment Outcome,E01.789.800
17303497,2007-01-16T00:00:00,Treatment Outcome,N04.761.559.590.800
17303497,2007-01-16T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17303497,2007-01-16T00:00:00,Uterus,A05.360.319.679
17239508,2007-01-18T00:00:00,Adolescent,M01.060.057
17239508,2007-01-18T00:00:00,Adult,M01.060.116
17239508,2007-01-18T00:00:00,Gait,E01.370.600.250
17239508,2007-01-18T00:00:00,Gait,G11.427.590.530.389
17239508,2007-01-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17239508,2007-01-18T00:00:00,Middle Aged,M01.060.116.630
17316778,2007-01-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17316778,2007-01-18T00:00:00,Motivation,F01.658
17316778,2007-01-18T00:00:00,Motivation,F01.752.543.500.750
17316778,2007-01-18T00:00:00,Risk-Taking,F01.145.722
17316778,2007-01-18T00:00:00,Smoking Cessation,F01.145.940.700
17316778,2007-01-18T00:00:00,Weight Gain,C23.888.144.243.926
17316778,2007-01-18T00:00:00,Weight Gain,G07.700.320.249.314.120.200.926
17235686,2007-01-19T00:00:00,Animals,B01.050
17235686,2007-01-19T00:00:00,Cell Differentiation,G04.299.151
17235686,2007-01-19T00:00:00,Oligodendroglia,A08.637.600
17235686,2007-01-19T00:00:00,Oligodendroglia,A11.650.600
17235686,2007-01-19T00:00:00,Phosphorylation,G02.111.087.677
17235686,2007-01-19T00:00:00,Phosphorylation,G02.149.115.677
17235686,2007-01-19T00:00:00,Phosphorylation,G02.149.465.700
17235686,2007-01-19T00:00:00,Phosphorylation,G02.607.750.700
17235686,2007-01-19T00:00:00,Phosphorylation,G03.495.790
17235686,2007-01-19T00:00:00,Pyridines,D03.383.725
17235686,2007-01-19T00:00:00,"RNA, Messenger",D13.444.735.544
17235686,2007-01-19T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17235686,2007-01-19T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
17235686,2007-01-19T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
17235686,2007-01-19T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
17235686,2007-01-19T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
17244384,2007-01-23T00:00:00,"Anastomosis, Surgical",E04.035
17244384,2007-01-23T00:00:00,Cardiac Surgical Procedures,E04.100.376
17244384,2007-01-23T00:00:00,Cardiac Surgical Procedures,E04.928.220
17244384,2007-01-23T00:00:00,Diastole,G09.330.190.541.295
17244384,2007-01-23T00:00:00,Diastole,G11.427.590.540.554.250
17244384,2007-01-23T00:00:00,Diastole,G11.427.590.540.570.295
17244384,2007-01-23T00:00:00,"Echocardiography, Doppler, Color",E01.370.350.850.220.220.220
17244384,2007-01-23T00:00:00,"Echocardiography, Doppler, Color",E01.370.350.850.850.220.220
17244384,2007-01-23T00:00:00,"Echocardiography, Doppler, Color",E01.370.350.850.850.850.850.220
17244384,2007-01-23T00:00:00,"Echocardiography, Doppler, Color",E01.370.370.380.220.220.220
17244384,2007-01-23T00:00:00,Heart Ventricles,A07.541.560
17244384,2007-01-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17244384,2007-01-23T00:00:00,Hypoplastic Left Heart Syndrome,C14.240.400.625
17244384,2007-01-23T00:00:00,Hypoplastic Left Heart Syndrome,C14.280.400.625
17244384,2007-01-23T00:00:00,Hypoplastic Left Heart Syndrome,C16.131.240.400.625
17244384,2007-01-23T00:00:00,Infant,M01.060.703
17244384,2007-01-23T00:00:00,Palliative Care,E02.760.666
17244384,2007-01-23T00:00:00,Palliative Care,N02.421.585.666
17244384,2007-01-23T00:00:00,Pulmonary Artery,A07.231.114.715
17244384,2007-01-23T00:00:00,Treatment Outcome,E01.789.800
17244384,2007-01-23T00:00:00,Treatment Outcome,N04.761.559.590.800
17244384,2007-01-23T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17244384,2007-01-23T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
17244384,2007-01-23T00:00:00,Ventricular Pressure,G09.330.190.962.950
17244384,2007-01-23T00:00:00,Ventricular Pressure,G09.330.380.937
17244694,2007-01-23T00:00:00,Adult,M01.060.116
17244694,2007-01-23T00:00:00,Aged,M01.060.116.100
17244694,2007-01-23T00:00:00,Disability Evaluation,E01.370.400
17244694,2007-01-23T00:00:00,Exercise Therapy,E02.779.483
17244694,2007-01-23T00:00:00,Exercise Therapy,E02.831.387
17244694,2007-01-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17244694,2007-01-23T00:00:00,Middle Aged,M01.060.116.630
17244694,2007-01-23T00:00:00,Neuropsychological Tests,F04.711.513
17244694,2007-01-23T00:00:00,Recovery of Function,G16.757
17244694,2007-01-23T00:00:00,Regression Analysis,E05.318.740.750
17244694,2007-01-23T00:00:00,Regression Analysis,N05.715.360.750.695
17244694,2007-01-23T00:00:00,Regression Analysis,N06.850.520.830.750
17244694,2007-01-23T00:00:00,Stroke,C10.228.140.300.775
17244694,2007-01-23T00:00:00,Stroke,C14.907.253.855
17244694,2007-01-23T00:00:00,Treatment Outcome,E01.789.800
17244694,2007-01-23T00:00:00,Treatment Outcome,N04.761.559.590.800
17244694,2007-01-23T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17250948,2007-01-23T00:00:00,Age Factors,N05.715.350.075
17250948,2007-01-23T00:00:00,Age Factors,N06.850.490.250
17250948,2007-01-23T00:00:00,Diabetes Mellitus,C18.452.394.750
17250948,2007-01-23T00:00:00,Diabetes Mellitus,C19.246
17250948,2007-01-23T00:00:00,Electric Countershock,E02.342.287
17250948,2007-01-23T00:00:00,Heart Arrest,C14.280.383
17250948,2007-01-23T00:00:00,Hospitalization,E02.760.400
17250948,2007-01-23T00:00:00,Hospitalization,N02.421.585.400
17250948,2007-01-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17250948,2007-01-23T00:00:00,Quality of Health Care,N04.761
17250948,2007-01-23T00:00:00,Quality of Health Care,N05.715
17250948,2007-01-23T00:00:00,"Tachycardia, Ventricular",C14.280.067.845.940
17250948,2007-01-23T00:00:00,"Tachycardia, Ventricular",C23.550.073.845.940
17250948,2007-01-23T00:00:00,Time Factors,G01.910.857
17250948,2007-01-23T00:00:00,Ventricular Fibrillation,C14.280.067.922
17250948,2007-01-23T00:00:00,Ventricular Fibrillation,C23.550.073.922
17262720,2007-01-23T00:00:00,Adult,M01.060.116
17262720,2007-01-23T00:00:00,Aged,M01.060.116.100
17262720,2007-01-23T00:00:00,Cryptococcosis,C01.703.248
17262720,2007-01-23T00:00:00,Cryptococcus neoformans,B01.300.381.258.366
17262720,2007-01-23T00:00:00,Cryptococcus neoformans,B01.300.930.316.366
17262720,2007-01-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17262720,2007-01-23T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
17262720,2007-01-23T00:00:00,Middle Aged,M01.060.116.630
17262720,2007-01-23T00:00:00,Organ Transplantation,E04.936.450
17262720,2007-01-23T00:00:00,Treatment Outcome,E01.789.800
17262720,2007-01-23T00:00:00,Treatment Outcome,N04.761.559.590.800
17262720,2007-01-23T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17291572,2007-01-23T00:00:00,Adolescent,M01.060.057
17291572,2007-01-23T00:00:00,Alcohol Drinking,F01.145.317.269
17291572,2007-01-23T00:00:00,Alcoholism,C21.739.100.250
17291572,2007-01-23T00:00:00,Alcoholism,F03.900.100.350
17291572,2007-01-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17291572,2007-01-23T00:00:00,Learning,F02.463.425
17291572,2007-01-23T00:00:00,Learning,F02.784.629.529
17291572,2007-01-23T00:00:00,Neuronal Plasticity,G11.561.600.635
17291572,2007-01-23T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
17291572,2007-01-23T00:00:00,Synaptic Transmission,G02.111.087.800.850
17291572,2007-01-23T00:00:00,Synaptic Transmission,G02.149.115.800.850
17291572,2007-01-23T00:00:00,Synaptic Transmission,G04.299.880.850
17291572,2007-01-23T00:00:00,Synaptic Transmission,G07.265.337.900
17291572,2007-01-23T00:00:00,Synaptic Transmission,G07.700.240.900
17291572,2007-01-23T00:00:00,Synaptic Transmission,G11.561.600.835
17321219,2007-01-23T00:00:00,Bias (Epidemiology),N05.715.350.150
17321219,2007-01-23T00:00:00,Bias (Epidemiology),N06.850.490.500
17321219,2007-01-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17321219,2007-01-23T00:00:00,Probability,E05.318.740.600
17321219,2007-01-23T00:00:00,Probability,G17.680
17321219,2007-01-23T00:00:00,Probability,N05.715.360.750.625
17321219,2007-01-23T00:00:00,Probability,N06.850.520.830.600
17321219,2007-01-23T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
17321219,2007-01-23T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
17321219,2007-01-23T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
17321219,2007-01-23T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
17321219,2007-01-23T00:00:00,Treatment Outcome,E01.789.800
17321219,2007-01-23T00:00:00,Treatment Outcome,N04.761.559.590.800
17321219,2007-01-23T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17251395,2007-01-24T00:00:00,5' Untranslated Regions,D13.444.735.544.875.885
17251395,2007-01-24T00:00:00,5' Untranslated Regions,D13.444.735.790.878.885
17251395,2007-01-24T00:00:00,5' Untranslated Regions,G05.360.340.024.220.880.885
17251395,2007-01-24T00:00:00,5' Untranslated Regions,G05.360.340.024.340.137.910.885
17251395,2007-01-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17251395,2007-01-24T00:00:00,Molecular Diagnostic Techniques,E05.200.880
17251395,2007-01-24T00:00:00,Molecular Diagnostic Techniques,E05.393.520
17251395,2007-01-24T00:00:00,"RNA, Viral",D13.444.735.828
17251395,2007-01-24T00:00:00,"Sequence Analysis, DNA",E05.393.760.700
17251395,2007-01-24T00:00:00,Viral Proteins,D12.776.964
17314031,2007-01-24T00:00:00,Animals,B01.050
17314031,2007-01-24T00:00:00,Cell Adhesion,G04.299.117
17314031,2007-01-24T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.567.342
17314031,2007-01-24T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.646.750.249
17314031,2007-01-24T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.644.360.450.169
17314031,2007-01-24T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.776.476.450.169
17314031,2007-01-24T00:00:00,Fibroblasts,A11.329.228
17314031,2007-01-24T00:00:00,Fibroblasts,A11.872.228
17314031,2007-01-24T00:00:00,Fibronectins,D12.776.377.715.390
17314031,2007-01-24T00:00:00,Fibronectins,D12.776.395.550.350
17314031,2007-01-24T00:00:00,Fibronectins,D12.776.543.550.350
17314031,2007-01-24T00:00:00,Fibronectins,D12.776.860.300.450
17314031,2007-01-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17314031,2007-01-24T00:00:00,Phosphorylation,G02.111.087.677
17314031,2007-01-24T00:00:00,Phosphorylation,G02.149.115.677
17314031,2007-01-24T00:00:00,Phosphorylation,G02.149.465.700
17314031,2007-01-24T00:00:00,Phosphorylation,G02.607.750.700
17314031,2007-01-24T00:00:00,Phosphorylation,G03.495.790
17314031,2007-01-24T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
17314031,2007-01-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17314031,2007-01-24T00:00:00,Serine,D12.125.154.800
17314031,2007-01-24T00:00:00,Serine,D12.125.837
17255364,2007-01-25T00:00:00,Adult,M01.060.116
17255364,2007-01-25T00:00:00,Animals,B01.050
17255364,2007-01-25T00:00:00,Dogs,B01.050.150.900.649.147.153.200
17255364,2007-01-25T00:00:00,H(+)-K(+)-Exchanging ATPase,D08.811.277.040.025.325.625
17255364,2007-01-25T00:00:00,H(+)-K(+)-Exchanging ATPase,D12.776.157.530.450.250.875.500.625
17255364,2007-01-25T00:00:00,H(+)-K(+)-Exchanging ATPase,D12.776.543.585.450.250.875.500.625
17255364,2007-01-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17255364,2007-01-25T00:00:00,Middle Aged,M01.060.116.630
17255364,2007-01-25T00:00:00,"Parietal Cells, Gastric",A03.556.875.875.440.708
17255364,2007-01-25T00:00:00,"Parietal Cells, Gastric",A10.615.550.291.650
17255364,2007-01-25T00:00:00,"Parietal Cells, Gastric",A11.436.708
17255364,2007-01-25T00:00:00,Tandem Mass Spectrometry,E05.196.566.880
17255364,2007-01-25T00:00:00,rab GTP-Binding Proteins,D08.811.277.040.330.300.400.400
17255364,2007-01-25T00:00:00,rab GTP-Binding Proteins,D12.644.360.525.400
17255364,2007-01-25T00:00:00,rab GTP-Binding Proteins,D12.776.157.325.515.400
17255364,2007-01-25T00:00:00,rab GTP-Binding Proteins,D12.776.476.525.400
17255471,2007-01-25T00:00:00,Animals,B01.050
17255471,2007-01-25T00:00:00,Cell Movement,G04.299.283
17255471,2007-01-25T00:00:00,Cell Movement,G07.700.560.500.180
17255471,2007-01-25T00:00:00,Gene Silencing,G05.355.315.203.374
17255471,2007-01-25T00:00:00,Glutamic Acid,D12.125.067.750
17255471,2007-01-25T00:00:00,Glutamic Acid,D12.125.119.450
17255471,2007-01-25T00:00:00,Glutamic Acid,D12.125.427.300
17255471,2007-01-25T00:00:00,Lysophospholipids,D10.570.755.375.760.550
17255471,2007-01-25T00:00:00,Oligodendroglia,A08.637.600
17255471,2007-01-25T00:00:00,Oligodendroglia,A11.650.600
17255471,2007-01-25T00:00:00,"RNA, Messenger",D13.444.735.544
17255471,2007-01-25T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17255471,2007-01-25T00:00:00,"Receptors, Lysosphingolipid",D12.776.543.750.100.420.500
17255471,2007-01-25T00:00:00,Sphingosine,D02.033.100.700
17255471,2007-01-25T00:00:00,Sphingosine,D02.033.455.843
17255471,2007-01-25T00:00:00,Sphingosine,D02.092.063.700
17255471,2007-01-25T00:00:00,Tandem Mass Spectrometry,E05.196.566.880
17255541,2007-01-25T00:00:00,"Cholesterol, HDL",D10.532.432.400
17255541,2007-01-25T00:00:00,"Cholesterol, HDL",D10.570.938.208.270
17255541,2007-01-25T00:00:00,"Cholesterol, HDL",D12.776.521.479.470
17255541,2007-01-25T00:00:00,Drug Delivery Systems,E02.319.300
17255541,2007-01-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17255541,2007-01-25T00:00:00,Stroke,C10.228.140.300.775
17255541,2007-01-25T00:00:00,Stroke,C14.907.253.855
17320167,2007-01-25T00:00:00,Bacteria,B03
17320167,2007-01-25T00:00:00,Computer Simulation,L01.224.160
17320167,2007-01-25T00:00:00,Internet,L01.224.230.110.500
17320167,2007-01-25T00:00:00,"Models, Molecular",E05.599.595
17320167,2007-01-25T00:00:00,Static Electricity,G01.201.249.820
17344001,2007-01-25T00:00:00,Acoustic Stimulation,E02.037
17344001,2007-01-25T00:00:00,Acoustic Stimulation,E02.190.888.030
17344001,2007-01-25T00:00:00,Acoustic Stimulation,E05.723.136
17344001,2007-01-25T00:00:00,Adult,M01.060.116
17344001,2007-01-25T00:00:00,Aged,M01.060.116.100
17344001,2007-01-25T00:00:00,Aging,G07.700.320.124
17344001,2007-01-25T00:00:00,Auditory Cortex,A08.186.211.730.885.287.500.863.297
17344001,2007-01-25T00:00:00,Auditory Threshold,F02.463.593.071.173
17344001,2007-01-25T00:00:00,Auditory Threshold,F02.463.593.710.190
17344001,2007-01-25T00:00:00,"Evoked Potentials, Auditory",G07.265.500.370
17344001,2007-01-25T00:00:00,"Evoked Potentials, Auditory",G11.561.270.370
17344001,2007-01-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17344001,2007-01-25T00:00:00,Neural Inhibition,G07.265.337.615
17344001,2007-01-25T00:00:00,Neural Inhibition,G07.700.240.615
17344001,2007-01-25T00:00:00,Neural Inhibition,G11.561.600.625
17344001,2007-01-25T00:00:00,Reaction Time,F02.830.650
17344001,2007-01-25T00:00:00,Reaction Time,F04.669.817
17344001,2007-01-25T00:00:00,Reaction Time,G11.561.677
17344001,2007-01-25T00:00:00,Time Factors,G01.910.857
17391987,2007-01-25T00:00:00,Algorithms,G17.035
17391987,2007-01-25T00:00:00,Algorithms,L01.224.050
17391987,2007-01-25T00:00:00,Brain,A08.186.211
17391987,2007-01-25T00:00:00,Computer Simulation,L01.224.160
17391987,2007-01-25T00:00:00,"Data Interpretation, Statistical",E05.245.380
17391987,2007-01-25T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
17391987,2007-01-25T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
17391987,2007-01-25T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
17391987,2007-01-25T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
17391987,2007-01-25T00:00:00,"Epilepsy, Temporal Lobe",C10.228.140.490.360.290
17391987,2007-01-25T00:00:00,Hippocampus,A08.186.211.464.405
17391987,2007-01-25T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
17391987,2007-01-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17391987,2007-01-25T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
17391987,2007-01-25T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17391987,2007-01-25T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17258669,2007-01-27T00:00:00,Adult,M01.060.116
17258669,2007-01-27T00:00:00,Aged,M01.060.116.100
17258669,2007-01-27T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
17258669,2007-01-27T00:00:00,"Emergency Service, Hospital",N02.421.297.195
17258669,2007-01-27T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
17258669,2007-01-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17258669,2007-01-27T00:00:00,Intracranial Hemorrhages,C10.228.140.300.535
17258669,2007-01-27T00:00:00,Intracranial Hemorrhages,C14.907.253.573
17258669,2007-01-27T00:00:00,Intracranial Hemorrhages,C23.550.414.913
17258669,2007-01-27T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17258669,2007-01-27T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17258669,2007-01-27T00:00:00,Middle Aged,M01.060.116.630
17258669,2007-01-27T00:00:00,Myocardial Ischemia,C14.280.647
17258669,2007-01-27T00:00:00,Myocardial Ischemia,C14.907.585
17258669,2007-01-27T00:00:00,Stroke,C10.228.140.300.775
17258669,2007-01-27T00:00:00,Stroke,C14.907.253.855
17258669,2007-01-27T00:00:00,Time Factors,G01.910.857
17258669,2007-01-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17258669,2007-01-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17258669,2007-01-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17258669,2007-01-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17258669,2007-01-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17264181,2007-01-30T00:00:00,Adult,M01.060.116
17264181,2007-01-30T00:00:00,Blood Pressure,E01.370.600.875.249
17264181,2007-01-30T00:00:00,Blood Pressure,G09.330.380.076
17264181,2007-01-30T00:00:00,Child,M01.060.406
17264181,2007-01-30T00:00:00,Diet,E05.272
17264181,2007-01-30T00:00:00,Diet,G07.610.240
17264181,2007-01-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17264181,2007-01-30T00:00:00,Hydrocortisone,D04.808.745.745.654.600
17264181,2007-01-30T00:00:00,Hydrocortisone,D06.472.040.585.353.476
17264181,2007-01-30T00:00:00,Hydrocortisone,D06.472.040.585.478.392
17264181,2007-01-30T00:00:00,Hypertension,C14.907.489
17264181,2007-01-30T00:00:00,Middle Aged,M01.060.116.630
17266766,2007-01-31T00:00:00,Amino Acid Sequence,G02.111.570.060
17266766,2007-01-31T00:00:00,Amino Acid Sequence,L01.453.245.667.060
17266766,2007-01-31T00:00:00,Animals,B01.050
17266766,2007-01-31T00:00:00,B-Lymphocytes,A11.063.438
17266766,2007-01-31T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
17266766,2007-01-31T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
17266766,2007-01-31T00:00:00,B-Lymphocytes,A15.382.032.438
17266766,2007-01-31T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
17266766,2007-01-31T00:00:00,Catfishes,B01.050.150.900.493.080
17266766,2007-01-31T00:00:00,Cell Line,A11.251.210
17266766,2007-01-31T00:00:00,"Genes, Immunoglobulin",G05.360.340.024.340.335
17266766,2007-01-31T00:00:00,"Genes, Immunoglobulin",G12.500.299
17266766,2007-01-31T00:00:00,Molecular Sequence Data,L01.453.245.667
17266766,2007-01-31T00:00:00,Organic Cation Transporter 1,D12.776.157.530.450.250.812.500
17266766,2007-01-31T00:00:00,Organic Cation Transporter 1,D12.776.543.585.450.250.812.500
17266766,2007-01-31T00:00:00,Phylogeny,G05.697
17266766,2007-01-31T00:00:00,Phylogeny,G16.100.275.605
17266766,2007-01-31T00:00:00,Phylogeny,L01.100.697
17266766,2007-01-31T00:00:00,"Sequence Homology, Amino Acid",G02.111.810.200
17266766,2007-01-31T00:00:00,"Sequence Homology, Amino Acid",G05.810.200
17266766,2007-01-31T00:00:00,"Transcription, Genetic",G02.111.087.847
17266766,2007-01-31T00:00:00,"Transcription, Genetic",G02.149.115.847
17266766,2007-01-31T00:00:00,"Transcription, Genetic",G05.355.310.700
16838346,2007-02-01T00:00:00,Carbon Dioxide,D01.200.200
16838346,2007-02-01T00:00:00,Carbon Dioxide,D01.362.150
16838346,2007-02-01T00:00:00,Carbon Dioxide,D01.650.550.200
16838346,2007-02-01T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
16838346,2007-02-01T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
16838346,2007-02-01T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
16838346,2007-02-01T00:00:00,"Spores, Bacterial",A11.870.700
16838346,2007-02-01T00:00:00,"Spores, Bacterial",B05.775.700
16838346,2007-02-01T00:00:00,Temperature,G01.906.595
16838346,2007-02-01T00:00:00,Temperature,G16.500.275.063.725.710
16838346,2007-02-01T00:00:00,Temperature,G16.500.750.775.710
16838346,2007-02-01T00:00:00,Temperature,N06.230.150.450
16838346,2007-02-01T00:00:00,Temperature,N06.230.300.100.725.710
16927373,2007-02-01T00:00:00,Cell Survival,G04.299.316
16927373,2007-02-01T00:00:00,Endothelial Cells,A11.436.275
16927373,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16927373,2007-02-01T00:00:00,Ischemia,C23.550.513
16927373,2007-02-01T00:00:00,Microcirculation,G09.330.190.163.645
16927373,2007-02-01T00:00:00,"RNA, Messenger",D13.444.735.544
17091330,2007-02-01T00:00:00,Aged,M01.060.116.100
17091330,2007-02-01T00:00:00,Breast Neoplasms,C04.588.180
17091330,2007-02-01T00:00:00,Breast Neoplasms,C17.800.090.500
17091330,2007-02-01T00:00:00,"Carcinoma, Ductal, Breast",C04.557.470.200.025.232.500
17091330,2007-02-01T00:00:00,"Carcinoma, Ductal, Breast",C04.557.470.615.132.500
17091330,2007-02-01T00:00:00,"Carcinoma, Ductal, Breast",C04.588.180.390
17091330,2007-02-01T00:00:00,"Carcinoma, Ductal, Breast",C17.800.090.500.390
17091330,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17091330,2007-02-01T00:00:00,Middle Aged,M01.060.116.630
17202579,2007-02-01T00:00:00,Aged,M01.060.116.100
17202579,2007-02-01T00:00:00,Aging,G07.700.320.124
17202579,2007-02-01T00:00:00,Child,M01.060.406
17202579,2007-02-01T00:00:00,"Child Abuse, Sexual",I01.198.240.748.300
17202579,2007-02-01T00:00:00,"Child Abuse, Sexual",I01.198.240.856.350.250.255
17202579,2007-02-01T00:00:00,"Child Abuse, Sexual",I01.880.735.900.350.250.255
17202579,2007-02-01T00:00:00,"Child Abuse, Sexual",I01.880.787.293.292.325
17202579,2007-02-01T00:00:00,Crime Victims,M01.135
17202579,2007-02-01T00:00:00,Depression,F01.145.126.350
17202579,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17202579,2007-02-01T00:00:00,Life Change Events,F01.829.458.410
17202579,2007-02-01T00:00:00,Middle Aged,M01.060.116.630
17202579,2007-02-01T00:00:00,Questionnaires,E05.318.308.750
17202579,2007-02-01T00:00:00,Questionnaires,L01.280.800
17202579,2007-02-01T00:00:00,Questionnaires,N05.715.360.300.695
17202579,2007-02-01T00:00:00,Questionnaires,N06.850.520.308.750
17202579,2007-02-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17202579,2007-02-01T00:00:00,"Stress, Psychological",F01.145.126.990
17202579,2007-02-01T00:00:00,"Stress, Psychological",F02.830.900
17204895,2007-02-01T00:00:00,Adult,M01.060.116
17204895,2007-02-01T00:00:00,Auditory Perception,F02.463.593.071
17204895,2007-02-01T00:00:00,Auditory Threshold,F02.463.593.071.173
17204895,2007-02-01T00:00:00,Auditory Threshold,F02.463.593.710.190
17204895,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17204895,2007-02-01T00:00:00,Noise,G01.595.907.567
17204895,2007-02-01T00:00:00,Noise,G16.500.275.600
17204895,2007-02-01T00:00:00,Noise,N06.230.400
17204895,2007-02-01T00:00:00,Noise,N06.850.460.610
17204895,2007-02-01T00:00:00,Nonlinear Dynamics,E05.599.850
17204895,2007-02-01T00:00:00,Nonlinear Dynamics,H01.548.675
17204895,2007-02-01T00:00:00,Perceptual Masking,F02.463.593.071.594
17204895,2007-02-01T00:00:00,Perceptual Masking,F02.463.593.932.733
17204895,2007-02-01T00:00:00,Speech Perception,F02.463.593.071.875
17211180,2007-02-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C10.597.267
17211180,2007-02-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C10.900.300.153
17211180,2007-02-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C21.866.260.207
17211180,2007-02-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C21.866.915.300.300
17211180,2007-02-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C23.888.592.264
17211180,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17214637,2007-02-01T00:00:00,Cytokines,D12.644.276.374
17214637,2007-02-01T00:00:00,Cytokines,D12.776.467.374
17214637,2007-02-01T00:00:00,Cytokines,D23.529.374
17214637,2007-02-01T00:00:00,Glucose,D09.546.359.448
17214637,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17214637,2007-02-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
17214637,2007-02-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
17214637,2007-02-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
17214637,2007-02-01T00:00:00,Hypoglycemic Agents,D27.505.696.422
17214637,2007-02-01T00:00:00,Lipopolysaccharides,D09.400.500
17214637,2007-02-01T00:00:00,Lipopolysaccharides,D09.698.718.450
17214637,2007-02-01T00:00:00,Lipopolysaccharides,D10.494
17214637,2007-02-01T00:00:00,Lipopolysaccharides,D23.050.161.616.525
17214637,2007-02-01T00:00:00,Lipopolysaccharides,D23.946.123.329.500
17214637,2007-02-01T00:00:00,Nitric Oxide,D01.339.387
17214637,2007-02-01T00:00:00,Nitric Oxide,D01.625.550.500
17214637,2007-02-01T00:00:00,Nitric Oxide,D01.625.700.500
17214637,2007-02-01T00:00:00,Nitric Oxide,D01.650.550.587.600
17214637,2007-02-01T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
17214637,2007-02-01T00:00:00,Simvastatin,D02.455.426.559.847.638.400.900
17214637,2007-02-01T00:00:00,Simvastatin,D04.615.638.400.900
17214637,2007-02-01T00:00:00,Time Factors,G01.910.857
17218796,2007-02-01T00:00:00,Animals,B01.050
17218796,2007-02-01T00:00:00,Brain,A08.186.211
17218796,2007-02-01T00:00:00,Central Nervous System Stimulants,D27.505.696.282
17218796,2007-02-01T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
17218796,2007-02-01T00:00:00,Dopamine,D02.092.211.215.311.342
17218796,2007-02-01T00:00:00,Dopamine,D02.092.311.342
17218796,2007-02-01T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.450.625.124
17218796,2007-02-01T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.562.374.500.500
17218796,2007-02-01T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.450.625.124
17218796,2007-02-01T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.562.374.500.500
17218796,2007-02-01T00:00:00,Ethanol,D02.033.375
17218796,2007-02-01T00:00:00,Gas Chromatography-Mass Spectrometry,E05.196.181.349.500
17218796,2007-02-01T00:00:00,Gas Chromatography-Mass Spectrometry,E05.196.566.500
17218796,2007-02-01T00:00:00,Methylphenidate,D02.241.223.601.600
17218796,2007-02-01T00:00:00,Methylphenidate,D03.383.621.460
17218796,2007-02-01T00:00:00,"Mice, Inbred Strains",B01.050.050.157.520
17218796,2007-02-01T00:00:00,"Mice, Inbred Strains",B01.050.050.199.520.520
17218796,2007-02-01T00:00:00,"Mice, Inbred Strains",B01.050.150.900.649.865.635.505.500.400
17218796,2007-02-01T00:00:00,Motor Activity,F01.145.632
17218796,2007-02-01T00:00:00,Motor Activity,G11.427.590.530.698
17218796,2007-02-01T00:00:00,Norepinephrine,D02.033.100.291.502
17218796,2007-02-01T00:00:00,Norepinephrine,D02.092.063.480
17218796,2007-02-01T00:00:00,Norepinephrine,D02.092.211.215.311.560
17218796,2007-02-01T00:00:00,Norepinephrine,D02.092.311.461.484
17218796,2007-02-01T00:00:00,Norepinephrine Plasma Membrane Transport Proteins,D12.776.157.530.450.625.186
17218796,2007-02-01T00:00:00,Norepinephrine Plasma Membrane Transport Proteins,D12.776.157.530.562.374.500.750
17218796,2007-02-01T00:00:00,Norepinephrine Plasma Membrane Transport Proteins,D12.776.543.585.450.625.186
17218796,2007-02-01T00:00:00,Norepinephrine Plasma Membrane Transport Proteins,D12.776.543.585.562.374.500.750
17222633,2007-02-01T00:00:00,Adult,M01.060.116
17222633,2007-02-01T00:00:00,Aged,M01.060.116.100
17222633,2007-02-01T00:00:00,Biological Markers,D23.101
17222633,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17222633,2007-02-01T00:00:00,Middle Aged,M01.060.116.630
17224720,2007-02-01T00:00:00,Adult,M01.060.116
17224720,2007-02-01T00:00:00,Double-Blind Method,E05.318.780.300
17224720,2007-02-01T00:00:00,Double-Blind Method,E05.581.500.300
17224720,2007-02-01T00:00:00,Double-Blind Method,N05.715.360.780.320
17224720,2007-02-01T00:00:00,Double-Blind Method,N06.850.520.445.300
17224720,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17224720,2007-02-01T00:00:00,Middle Aged,M01.060.116.630
17224720,2007-02-01T00:00:00,Psychiatric Status Rating Scales,F04.586
17224720,2007-02-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17224720,2007-02-01T00:00:00,Treatment Outcome,E01.789.800
17224720,2007-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17224720,2007-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17234487,2007-02-01T00:00:00,Consumer Participation,N02.421.143.262
17234487,2007-02-01T00:00:00,Consumer Participation,N03.540.245.360
17234487,2007-02-01T00:00:00,Data Collection,E05.318.308
17234487,2007-02-01T00:00:00,Data Collection,L01.280
17234487,2007-02-01T00:00:00,Data Collection,N05.715.360.300
17234487,2007-02-01T00:00:00,Data Collection,N06.850.520.308
17234487,2007-02-01T00:00:00,Exercise,G11.427.590.237
17234487,2007-02-01T00:00:00,Exercise,I03.350
17234487,2007-02-01T00:00:00,Health Promotion,N02.370
17234487,2007-02-01T00:00:00,Health Promotion,N02.421.726.507
17234487,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17234487,2007-02-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17234487,2007-02-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17242220,2007-02-01T00:00:00,Cervix Uteri,A05.360.319.679.256
17242220,2007-02-01T00:00:00,Cysts,C04.182
17242220,2007-02-01T00:00:00,Cysts,C23.300.306
17242220,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17242220,2007-02-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17242220,2007-02-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17242220,2007-02-01T00:00:00,Middle Aged,M01.060.116.630
17242220,2007-02-01T00:00:00,Urethral Diseases,C12.777.767
17242220,2007-02-01T00:00:00,Urethral Diseases,C13.351.968.767
17242456,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17242456,2007-02-01T00:00:00,Middle Aged,M01.060.116.630
17242456,2007-02-01T00:00:00,Patient Care Team,N04.590.715
17242456,2007-02-01T00:00:00,Patient Selection,E05.581.500.653
17242456,2007-02-01T00:00:00,Patient Selection,N04.590.731
17242456,2007-02-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
17242456,2007-02-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
17245398,2007-02-01T00:00:00,Adult,M01.060.116
17245398,2007-02-01T00:00:00,Age Factors,N05.715.350.075
17245398,2007-02-01T00:00:00,Age Factors,N06.850.490.250
17245398,2007-02-01T00:00:00,Cardiovascular Diseases,C14
17245398,2007-02-01T00:00:00,Disease Progression,C23.550.291.656
17245398,2007-02-01T00:00:00,Forecasting,I01.320
17245398,2007-02-01T00:00:00,"Heart Defects, Congenital",C14.240.400
17245398,2007-02-01T00:00:00,"Heart Defects, Congenital",C14.280.400
17245398,2007-02-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
17245398,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17245398,2007-02-01T00:00:00,"Infant, Newborn",M01.060.703.520
17250613,2007-02-01T00:00:00,Adult,M01.060.116
17250613,2007-02-01T00:00:00,Aged,M01.060.116.100
17250613,2007-02-01T00:00:00,Alcohol-Related Disorders,C21.739.100
17250613,2007-02-01T00:00:00,Alcohol-Related Disorders,F03.900.100
17250613,2007-02-01T00:00:00,Alcoholism,C21.739.100.250
17250613,2007-02-01T00:00:00,Alcoholism,F03.900.100.350
17250613,2007-02-01T00:00:00,Amines,D02.092
17250613,2007-02-01T00:00:00,Anticonvulsants,D27.505.954.427.080
17250613,2007-02-01T00:00:00,Cyclohexanecarboxylic Acids,D02.241.223.268
17250613,2007-02-01T00:00:00,Cyclohexanecarboxylic Acids,D02.455.426.392.368.367.218
17250613,2007-02-01T00:00:00,Double-Blind Method,E05.318.780.300
17250613,2007-02-01T00:00:00,Double-Blind Method,E05.581.500.300
17250613,2007-02-01T00:00:00,Double-Blind Method,N05.715.360.780.320
17250613,2007-02-01T00:00:00,Double-Blind Method,N06.850.520.445.300
17250613,2007-02-01T00:00:00,Ethanol,D02.033.375
17250613,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17250613,2007-02-01T00:00:00,Middle Aged,M01.060.116.630
17250613,2007-02-01T00:00:00,Patient Compliance,F01.145.488.500
17250613,2007-02-01T00:00:00,Patient Compliance,N05.300.150.600.600
17250613,2007-02-01T00:00:00,Substance Withdrawal Syndrome,C21.739.835
17250613,2007-02-01T00:00:00,Substance Withdrawal Syndrome,F03.900.825
17250613,2007-02-01T00:00:00,gamma-Aminobutyric Acid,D02.241.081.160.050.350
17250613,2007-02-01T00:00:00,gamma-Aminobutyric Acid,D12.125.190.350
17258148,2007-02-01T00:00:00,Heart Transplantation,E04.100.376.475
17258148,2007-02-01T00:00:00,Heart Transplantation,E04.928.220.390
17258148,2007-02-01T00:00:00,Heart Transplantation,E04.936.450.475
17258148,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17258148,2007-02-01T00:00:00,"Hypertrophy, Left Ventricular",C14.280.195.400
17258148,2007-02-01T00:00:00,"Hypertrophy, Left Ventricular",C23.300.775.250.400
17258148,2007-02-01T00:00:00,Middle Aged,M01.060.116.630
17258148,2007-02-01T00:00:00,Time Factors,G01.910.857
17259383,2007-02-01T00:00:00,Age of Onset,N05.715.350.075.100
17259383,2007-02-01T00:00:00,Age of Onset,N06.850.490.250.100
17259383,2007-02-01T00:00:00,Alleles,G05.360.340.024.340.030
17259383,2007-02-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
17259383,2007-02-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
17259383,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17259383,2007-02-01T00:00:00,Linkage Disequilibrium,G05.540.500
17259383,2007-02-01T00:00:00,Mexican Americans,M01.686.754.441.500
17259383,2007-02-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
17259399,2007-02-01T00:00:00,Adult,M01.060.116
17259399,2007-02-01T00:00:00,Alleles,G05.360.340.024.340.030
17259399,2007-02-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
17259399,2007-02-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
17259399,2007-02-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17259399,2007-02-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
17259399,2007-02-01T00:00:00,Genetic Variation,G05.365
17259399,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17259399,2007-02-01T00:00:00,Linkage Disequilibrium,G05.540.500
17259399,2007-02-01T00:00:00,Mexican Americans,M01.686.754.441.500
17259399,2007-02-01T00:00:00,Middle Aged,M01.060.116.630
17259399,2007-02-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
17259399,2007-02-01T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
17259399,2007-02-01T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
17259399,2007-02-01T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
17261088,2007-02-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
17261088,2007-02-01T00:00:00,Alzheimer Disease,C10.574.945.249
17261088,2007-02-01T00:00:00,Alzheimer Disease,F03.087.400.100
17261088,2007-02-01T00:00:00,Animals,B01.050
17261088,2007-02-01T00:00:00,Brain,A08.186.211
17261088,2007-02-01T00:00:00,Cathepsin B,D08.811.277.656.224.125
17261088,2007-02-01T00:00:00,Cathepsin B,D08.811.277.656.262.500.133
17261088,2007-02-01T00:00:00,Cathepsin B,D08.811.277.656.300.200.133
17261088,2007-02-01T00:00:00,Molecular Weight,G02.842.580
17261088,2007-02-01T00:00:00,Synaptosomes,A11.284.835.859
17267782,2007-02-01T00:00:00,Adult,M01.060.116
17267782,2007-02-01T00:00:00,Alcohol-Related Disorders,C21.739.100
17267782,2007-02-01T00:00:00,Alcohol-Related Disorders,F03.900.100
17267782,2007-02-01T00:00:00,Anxiety Disorders,F03.080
17267782,2007-02-01T00:00:00,Combined Modality Therapy,E02.186
17267782,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17267782,2007-02-01T00:00:00,Life Change Events,F01.829.458.410
17267782,2007-02-01T00:00:00,Naltrexone,D03.132.577.249.706.550
17267782,2007-02-01T00:00:00,Naltrexone,D03.549.686.750.550
17267782,2007-02-01T00:00:00,Naltrexone,D03.605.497.750.550
17267782,2007-02-01T00:00:00,Naltrexone,D04.615.723.795.706.550
17267782,2007-02-01T00:00:00,Narcotic Antagonists,D27.505.696.543
17267782,2007-02-01T00:00:00,Narcotic Antagonists,D27.505.696.663.850.512
17267782,2007-02-01T00:00:00,Narcotic Antagonists,D27.505.954.427.550
17267782,2007-02-01T00:00:00,Personality Inventory,F04.711.647.513
17267782,2007-02-01T00:00:00,Psychotherapy,F04.754
17267782,2007-02-01T00:00:00,Questionnaires,E05.318.308.750
17267782,2007-02-01T00:00:00,Questionnaires,L01.280.800
17267782,2007-02-01T00:00:00,Questionnaires,N05.715.360.300.695
17267782,2007-02-01T00:00:00,Questionnaires,N06.850.520.308.750
17269957,2007-02-01T00:00:00,"Education, Medical, Undergraduate",I02.358.399.450
17269957,2007-02-01T00:00:00,Membrane Proteins,D12.776.543
17272402,2007-02-01T00:00:00,Animals,B01.050
17272402,2007-02-01T00:00:00,Apoptosis,G04.299.139.160
17272402,2007-02-01T00:00:00,Blood Pressure,E01.370.600.875.249
17272402,2007-02-01T00:00:00,Blood Pressure,G09.330.380.076
17272402,2007-02-01T00:00:00,"Diabetes Mellitus, Experimental",C18.452.394.750.074
17272402,2007-02-01T00:00:00,"Diabetes Mellitus, Experimental",C19.246.240
17272402,2007-02-01T00:00:00,"Diabetes Mellitus, Experimental",E05.598.500.374
17272402,2007-02-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
17272402,2007-02-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
17272402,2007-02-01T00:00:00,Diabetic Nephropathies,C12.777.419.192
17272402,2007-02-01T00:00:00,Diabetic Nephropathies,C13.351.968.419.192
17272402,2007-02-01T00:00:00,Diabetic Nephropathies,C19.246.099.875
17272402,2007-02-01T00:00:00,Gene Expression,G05.355.310
17272402,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17272402,2007-02-01T00:00:00,Insulin Resistance,C18.452.394.968.500
17272402,2007-02-01T00:00:00,Insulin Resistance,G07.690.320.617
17272402,2007-02-01T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.567.342.500
17272402,2007-02-01T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.646.750.249.500
17272402,2007-02-01T00:00:00,Mitogen-Activated Protein Kinase 1,D12.644.360.450.169.500
17272402,2007-02-01T00:00:00,Mitogen-Activated Protein Kinase 1,D12.776.476.450.169.500
17272402,2007-02-01T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.567.342.750
17272402,2007-02-01T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.646.750.249.750
17272402,2007-02-01T00:00:00,Mitogen-Activated Protein Kinase 3,D12.644.360.450.169.750
17272402,2007-02-01T00:00:00,Mitogen-Activated Protein Kinase 3,D12.776.476.450.169.750
17272402,2007-02-01T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
17272402,2007-02-01T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
17272402,2007-02-01T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
17272402,2007-02-01T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
17272402,2007-02-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17272402,2007-02-01T00:00:00,Signal Transduction,G02.111.087.800
17272402,2007-02-01T00:00:00,Signal Transduction,G02.149.115.800
17272402,2007-02-01T00:00:00,Signal Transduction,G04.299.880
17272402,2007-02-01T00:00:00,Tissue Kallikreins,D08.811.277.656.300.760.442.875
17272402,2007-02-01T00:00:00,Tissue Kallikreins,D08.811.277.656.959.350.442.875
17272402,2007-02-01T00:00:00,Tissue Kallikreins,D23.101.840.870
17272579,2007-02-01T00:00:00,Adolescent,M01.060.057
17272579,2007-02-01T00:00:00,Child,M01.060.406
17272579,2007-02-01T00:00:00,"Child, Preschool",M01.060.406.448
17272579,2007-02-01T00:00:00,Dental Care for Children,E06.170.152
17272579,2007-02-01T00:00:00,Dental Care for Children,N02.421.240.190.215
17272579,2007-02-01T00:00:00,Health Services Accessibility,N04.590.374.350
17272579,2007-02-01T00:00:00,Health Services Accessibility,N05.300.430
17272579,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17272579,2007-02-01T00:00:00,Infant,M01.060.703
17272579,2007-02-01T00:00:00,Rural Population,N01.600.725
17272579,2007-02-01T00:00:00,United States,Z01.107.567.875
17272579,2007-02-01T00:00:00,Urban Population,N01.600.900
17272588,2007-02-01T00:00:00,Adolescent,M01.060.057
17272588,2007-02-01T00:00:00,Adult,M01.060.116
17272588,2007-02-01T00:00:00,Child,M01.060.406
17272588,2007-02-01T00:00:00,"Child, Preschool",M01.060.406.448
17272588,2007-02-01T00:00:00,Ethnic Groups,M01.686.754
17272588,2007-02-01T00:00:00,Ethnic Groups,N01.224.317
17272588,2007-02-01T00:00:00,Health Surveys,E05.318.308.250
17272588,2007-02-01T00:00:00,Health Surveys,N05.715.360.300.375
17272588,2007-02-01T00:00:00,Health Surveys,N06.850.520.308.250
17272588,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17272588,2007-02-01T00:00:00,Infant,M01.060.703
17272588,2007-02-01T00:00:00,"Infant, Newborn",M01.060.703.520
17272588,2007-02-01T00:00:00,Parents,F01.829.263.500.320
17272588,2007-02-01T00:00:00,Parents,I01.880.225.500.340
17272588,2007-02-01T00:00:00,Parents,M01.620
17272588,2007-02-01T00:00:00,Rural Population,N01.600.725
17272588,2007-02-01T00:00:00,"Stress, Psychological",F01.145.126.990
17272588,2007-02-01T00:00:00,"Stress, Psychological",F02.830.900
17272588,2007-02-01T00:00:00,United States,Z01.107.567.875
17272588,2007-02-01T00:00:00,Urban Population,N01.600.900
17272769,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17272769,2007-02-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
17272769,2007-02-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
17272769,2007-02-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
17272769,2007-02-01T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
17272769,2007-02-01T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
17272769,2007-02-01T00:00:00,Stroke,C10.228.140.300.775
17272769,2007-02-01T00:00:00,Stroke,C14.907.253.855
17272781,2007-02-01T00:00:00,Aged,M01.060.116.100
17272781,2007-02-01T00:00:00,Carotid Stenosis,C10.228.140.300.200.360
17272781,2007-02-01T00:00:00,Carotid Stenosis,C14.907.137.230
17272781,2007-02-01T00:00:00,Carotid Stenosis,C14.907.253.123.360
17272781,2007-02-01T00:00:00,"Databases, Factual",L01.470.750.750
17272781,2007-02-01T00:00:00,"Databases, Factual",L01.700.508.300.188.400
17272781,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17272781,2007-02-01T00:00:00,Middle Aged,M01.060.116.630
17272781,2007-02-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17272781,2007-02-01T00:00:00,Risk Factors,N05.715.350.200.700
17272781,2007-02-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17272781,2007-02-01T00:00:00,Risk Factors,N06.850.490.625.750
17272781,2007-02-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17272781,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17272781,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17272781,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17272781,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17272781,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17273561,2007-02-01T00:00:00,Animals,B01.050
17273561,2007-02-01T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
17273561,2007-02-01T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
17273561,2007-02-01T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
17273561,2007-02-01T00:00:00,Hematopoietic Stem Cell Transplantation,E04.936.225.687.500
17273561,2007-02-01T00:00:00,Hematopoietic Stem Cells,A11.148.378
17273561,2007-02-01T00:00:00,Hematopoietic Stem Cells,A11.872.378
17273561,2007-02-01T00:00:00,Hematopoietic Stem Cells,A15.378.316.378
17273561,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17273561,2007-02-01T00:00:00,"Immunotherapy, Adoptive",E02.095.465.425.400.330.050.400
17273561,2007-02-01T00:00:00,"Immunotherapy, Adoptive",E05.478.550.520.050.400
17273561,2007-02-01T00:00:00,Membrane Glycoproteins,D12.776.395.550
17273561,2007-02-01T00:00:00,Membrane Glycoproteins,D12.776.543.550
17273561,2007-02-01T00:00:00,Transplantation Conditioning,E02.095.465.425.450.800
17273561,2007-02-01T00:00:00,Transplantation Conditioning,E05.478.610.800
17275379,2007-02-01T00:00:00,"Adrenal Hyperplasia, Congenital",C16.320.033
17275379,2007-02-01T00:00:00,"Adrenal Hyperplasia, Congenital",C16.320.565.925.249
17275379,2007-02-01T00:00:00,"Adrenal Hyperplasia, Congenital",C18.452.648.925.249
17275379,2007-02-01T00:00:00,"Adrenal Hyperplasia, Congenital",C19.053.440
17275379,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17275379,2007-02-01T00:00:00,Mutation,G05.365.590
17275379,2007-02-01T00:00:00,Phenotype,G05.695
17275379,2007-02-01T00:00:00,Steroid 21-Hydroxylase,D08.244.453.915.760
17275379,2007-02-01T00:00:00,Steroid 21-Hydroxylase,D08.811.682.690.708.170.915.760
17275379,2007-02-01T00:00:00,Steroid 21-Hydroxylase,D08.811.682.690.708.783.760
17275379,2007-02-01T00:00:00,Steroid 21-Hydroxylase,D12.776.422.220.453.915.760
17291167,2007-02-01T00:00:00,Adult,M01.060.116
17291167,2007-02-01T00:00:00,Genetic Testing,E01.370.427
17291167,2007-02-01T00:00:00,Genetic Testing,E05.393.435
17291167,2007-02-01T00:00:00,Genetic Testing,N02.421.143.827.233.221
17291167,2007-02-01T00:00:00,Genetic Testing,N02.421.308.430
17291167,2007-02-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
17291167,2007-02-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
17291167,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17291167,2007-02-01T00:00:00,Middle Aged,M01.060.116.630
17291167,2007-02-01T00:00:00,Pulmonary Emphysema,C08.381.748
17291167,2007-02-01T00:00:00,Smoking,F01.145.466.753
17291167,2007-02-01T00:00:00,Smoking Cessation,F01.145.940.700
17291167,2007-02-01T00:00:00,alpha 1-Antitrypsin Deficiency,C17.300.050
17295576,2007-02-01T00:00:00,Adolescent,M01.060.057
17295576,2007-02-01T00:00:00,Chronic Disease,C23.550.291.500
17295576,2007-02-01T00:00:00,Combined Modality Therapy,E02.186
17295576,2007-02-01T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
17295576,2007-02-01T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
17295576,2007-02-01T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
17295576,2007-02-01T00:00:00,Diabetic Ketoacidosis,C18.452.076.176.390
17295576,2007-02-01T00:00:00,Diabetic Ketoacidosis,C18.452.394.750.535
17295576,2007-02-01T00:00:00,Diabetic Ketoacidosis,C19.246.099.812
17295576,2007-02-01T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
17295576,2007-02-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
17295576,2007-02-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
17295576,2007-02-01T00:00:00,Hospitalization,E02.760.400
17295576,2007-02-01T00:00:00,Hospitalization,N02.421.585.400
17295576,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17295576,2007-02-01T00:00:00,Patient Compliance,F01.145.488.500
17295576,2007-02-01T00:00:00,Patient Compliance,N05.300.150.600.600
17295576,2007-02-01T00:00:00,Psychotherapy,F04.754
17296528,2007-02-01T00:00:00,Adolescent,M01.060.057
17296528,2007-02-01T00:00:00,Adult,M01.060.116
17296528,2007-02-01T00:00:00,Aged,M01.060.116.100
17296528,2007-02-01T00:00:00,Child,M01.060.406
17296528,2007-02-01T00:00:00,"Child, Preschool",M01.060.406.448
17296528,2007-02-01T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
17296528,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17296528,2007-02-01T00:00:00,Infant,M01.060.703
17296528,2007-02-01T00:00:00,Middle Aged,M01.060.116.630
17297067,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17297067,2007-02-01T00:00:00,Smoking,F01.145.466.753
17297067,2007-02-01T00:00:00,Tobacco,B01.650.388.100.905.900
17297067,2007-02-01T00:00:00,Tobacco Industry,J01.576.919
17297067,2007-02-01T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
17297067,2007-02-01T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
17300606,2007-02-01T00:00:00,Adult,M01.060.116
17300606,2007-02-01T00:00:00,Aged,M01.060.116.100
17300606,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17300606,2007-02-01T00:00:00,Melanocytes,A11.436.613
17300606,2007-02-01T00:00:00,Melanoma,C04.557.465.625.650.510
17300606,2007-02-01T00:00:00,Melanoma,C04.557.580.625.650.510
17300606,2007-02-01T00:00:00,Melanoma,C04.557.665.510
17300606,2007-02-01T00:00:00,Middle Aged,M01.060.116.630
17300606,2007-02-01T00:00:00,Mohs Surgery,E04.494.575
17300606,2007-02-01T00:00:00,Skin Neoplasms,C04.588.805
17300606,2007-02-01T00:00:00,Skin Neoplasms,C17.800.882
17301256,2007-02-01T00:00:00,African Americans,M01.686.508.100.100
17301256,2007-02-01T00:00:00,African Americans,M01.686.754.100
17301256,2007-02-01T00:00:00,Attitude to Health,F01.100.150
17301256,2007-02-01T00:00:00,Attitude to Health,N05.300.150
17301256,2007-02-01T00:00:00,Breast Neoplasms,C04.588.180
17301256,2007-02-01T00:00:00,Breast Neoplasms,C17.800.090.500
17301256,2007-02-01T00:00:00,"Genes, BRCA1",G05.360.340.024.340.375.249.100
17301256,2007-02-01T00:00:00,"Genes, BRCA1",G05.360.340.024.340.415.400.100
17301256,2007-02-01T00:00:00,"Genes, BRCA2",G05.360.340.024.340.375.249.105
17301256,2007-02-01T00:00:00,"Genes, BRCA2",G05.360.340.024.340.415.400.105
17301256,2007-02-01T00:00:00,Genetic Counseling,H01.158.273.343.315.384
17301256,2007-02-01T00:00:00,Genetic Counseling,N02.421.308.400
17301256,2007-02-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17301256,2007-02-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
17301256,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17301256,2007-02-01T00:00:00,Interviews as Topic,E05.318.308.420
17301256,2007-02-01T00:00:00,Interviews as Topic,L01.280.520
17301256,2007-02-01T00:00:00,Interviews as Topic,N05.715.360.300.400
17301256,2007-02-01T00:00:00,Interviews as Topic,N06.850.520.308.420
17301256,2007-02-01T00:00:00,Middle Aged,M01.060.116.630
17301256,2007-02-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17301256,2007-02-01T00:00:00,Risk Factors,N05.715.350.200.700
17301256,2007-02-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17301256,2007-02-01T00:00:00,Risk Factors,N06.850.490.625.750
17301256,2007-02-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17301256,2007-02-01T00:00:00,Survivors,M01.643.836
17301256,2007-02-01T00:00:00,Survivors,M01.860
17304496,2007-02-01T00:00:00,Nanotechnology,H01.603
17304496,2007-02-01T00:00:00,Nanotechnology,J01.897.520.600
17304496,2007-02-01T00:00:00,Pressure,G01.374.715
17304650,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17304650,2007-02-01T00:00:00,Kidney,A05.810.453
17304650,2007-02-01T00:00:00,Lupus Nephritis,C12.777.419.570.363.680
17304650,2007-02-01T00:00:00,Lupus Nephritis,C13.351.968.419.570.363.680
17304650,2007-02-01T00:00:00,Lupus Nephritis,C17.300.480.680
17304650,2007-02-01T00:00:00,Lupus Nephritis,C20.111.590.560
17304650,2007-02-01T00:00:00,Proteinuria,C12.777.934.734
17304650,2007-02-01T00:00:00,Proteinuria,C13.351.968.934.734
17304650,2007-02-01T00:00:00,Proteinuria,C23.888.942.750
17308067,2007-02-01T00:00:00,Animals,B01.050
17308067,2007-02-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
17308067,2007-02-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
17308067,2007-02-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
17308067,2007-02-01T00:00:00,Apoptosis,G04.299.139.160
17308067,2007-02-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
17308067,2007-02-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
17308067,2007-02-01T00:00:00,Caspases,D08.811.277.656.262.500.126
17308067,2007-02-01T00:00:00,Caspases,D08.811.277.656.300.200.126
17308067,2007-02-01T00:00:00,Caspases,D12.644.360.075.405
17308067,2007-02-01T00:00:00,Caspases,D12.776.476.075.405
17308067,2007-02-01T00:00:00,Ceramides,D02.065.313
17308067,2007-02-01T00:00:00,Ceramides,D09.400.410.420.525.200
17308067,2007-02-01T00:00:00,Ceramides,D10.390.470.675.200
17308067,2007-02-01T00:00:00,Ceramides,D10.570.877.360.612.200
17308067,2007-02-01T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
17308067,2007-02-01T00:00:00,Deoxycytidine,D03.383.742.680.245.500
17308067,2007-02-01T00:00:00,Deoxycytidine,D13.570.230.329
17308067,2007-02-01T00:00:00,Deoxycytidine,D13.570.685.245.500
17308067,2007-02-01T00:00:00,Doxorubicin,D02.455.426.559.847.562.050.200.175
17308067,2007-02-01T00:00:00,Doxorubicin,D04.615.562.050.200.175
17308067,2007-02-01T00:00:00,Doxorubicin,D09.408.051.059.200.175
17308067,2007-02-01T00:00:00,Head and Neck Neoplasms,C04.588.443
17308067,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17308067,2007-02-01T00:00:00,Membrane Proteins,D12.776.543
17308067,2007-02-01T00:00:00,Oxidoreductases,D08.811.682
17308067,2007-02-01T00:00:00,Plasmids,G05.360.600
17308067,2007-02-01T00:00:00,"RNA, Messenger",D13.444.735.544
17308067,2007-02-01T00:00:00,Sphingosine N-Acyltransferase,D08.811.913.050.712
17309963,2007-02-01T00:00:00,Aged,M01.060.116.100
17309963,2007-02-01T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
17309963,2007-02-01T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
17309963,2007-02-01T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
17309963,2007-02-01T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
17309963,2007-02-01T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
17309963,2007-02-01T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
17309963,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17309963,2007-02-01T00:00:00,Incidence,E05.318.308.985.525.375
17309963,2007-02-01T00:00:00,Incidence,L01.280.975.525.375
17309963,2007-02-01T00:00:00,Incidence,N01.224.935.597.500
17309963,2007-02-01T00:00:00,Incidence,N06.850.505.400.975.525.375
17309963,2007-02-01T00:00:00,Incidence,N06.850.520.308.985.525.375
17309963,2007-02-01T00:00:00,Length of Stay,E02.760.400.480
17309963,2007-02-01T00:00:00,Length of Stay,N02.421.585.400.480
17309963,2007-02-01T00:00:00,Middle Aged,M01.060.116.630
17309963,2007-02-01T00:00:00,Perioperative Care,E02.760.722
17309963,2007-02-01T00:00:00,Perioperative Care,E04.604
17309963,2007-02-01T00:00:00,Perioperative Care,N02.421.585.722
17309963,2007-02-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17309963,2007-02-01T00:00:00,Risk Factors,N05.715.350.200.700
17309963,2007-02-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17309963,2007-02-01T00:00:00,Risk Factors,N06.850.490.625.750
17309963,2007-02-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17309963,2007-02-01T00:00:00,Venous Thrombosis,C14.907.355.830.925
17316162,2007-02-01T00:00:00,Animals,B01.050
17316162,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17316162,2007-02-01T00:00:00,Neurons,A08.663
17316162,2007-02-01T00:00:00,Neurons,A11.671
17316162,2007-02-01T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
17316162,2007-02-01T00:00:00,Signal Transduction,G02.111.087.800
17316162,2007-02-01T00:00:00,Signal Transduction,G02.149.115.800
17316162,2007-02-01T00:00:00,Signal Transduction,G04.299.880
17316169,2007-02-01T00:00:00,Aged,M01.060.116.100
17316169,2007-02-01T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
17316169,2007-02-01T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
17316169,2007-02-01T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
17316169,2007-02-01T00:00:00,Dementia,C10.228.140.380
17316169,2007-02-01T00:00:00,Dementia,F03.087.400
17316169,2007-02-01T00:00:00,Dibenzothiazepines,D02.886.680.702.500
17316169,2007-02-01T00:00:00,Dibenzothiazepines,D03.494.276
17316169,2007-02-01T00:00:00,Double-Blind Method,E05.318.780.300
17316169,2007-02-01T00:00:00,Double-Blind Method,E05.581.500.300
17316169,2007-02-01T00:00:00,Double-Blind Method,N05.715.360.780.320
17316169,2007-02-01T00:00:00,Double-Blind Method,N06.850.520.445.300
17316169,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17316169,2007-02-01T00:00:00,Middle Aged,M01.060.116.630
17316169,2007-02-01T00:00:00,Psychiatric Status Rating Scales,F04.586
17316169,2007-02-01T00:00:00,Psychomotor Agitation,C10.597.350.600
17316169,2007-02-01T00:00:00,Psychomotor Agitation,C10.597.606.881.700
17316169,2007-02-01T00:00:00,Psychomotor Agitation,C23.888.592.350.600
17316169,2007-02-01T00:00:00,Psychomotor Agitation,C23.888.592.604.882.700
17316169,2007-02-01T00:00:00,Psychomotor Agitation,F01.700.875.700
17316169,2007-02-01T00:00:00,Treatment Outcome,E01.789.800
17316169,2007-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17316169,2007-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17325573,2007-02-01T00:00:00,Adult,M01.060.116
17325573,2007-02-01T00:00:00,Aged,M01.060.116.100
17325573,2007-02-01T00:00:00,Contrast Media,D27.720.259
17325573,2007-02-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
17325573,2007-02-01T00:00:00,Coronary Angiography,E01.370.370.050.200
17325573,2007-02-01T00:00:00,Coronary Angiography,E01.370.370.380.200
17325573,2007-02-01T00:00:00,Coronary Artery Disease,C14.280.647.250.260
17325573,2007-02-01T00:00:00,Coronary Artery Disease,C14.907.137.126.339
17325573,2007-02-01T00:00:00,Coronary Artery Disease,C14.907.585.250.260
17325573,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17325573,2007-02-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
17325573,2007-02-01T00:00:00,Middle Aged,M01.060.116.630
17325573,2007-02-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
17325573,2007-02-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
17325573,2007-02-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
17325573,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17325573,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17325573,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17325573,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17325573,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17325574,2007-02-01T00:00:00,Adult,M01.060.116
17325574,2007-02-01T00:00:00,Aged,M01.060.116.100
17325574,2007-02-01T00:00:00,Chest Pain,C23.888.646.215
17325574,2007-02-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
17325574,2007-02-01T00:00:00,Coronary Angiography,E01.370.370.050.200
17325574,2007-02-01T00:00:00,Coronary Angiography,E01.370.370.380.200
17325574,2007-02-01T00:00:00,Coronary Artery Disease,C14.280.647.250.260
17325574,2007-02-01T00:00:00,Coronary Artery Disease,C14.907.137.126.339
17325574,2007-02-01T00:00:00,Coronary Artery Disease,C14.907.585.250.260
17325574,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17325574,2007-02-01T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
17325574,2007-02-01T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
17325574,2007-02-01T00:00:00,Patient Selection,E05.581.500.653
17325574,2007-02-01T00:00:00,Patient Selection,N04.590.731
17325574,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17325574,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17325574,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17325574,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17325574,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17325575,2007-02-01T00:00:00,Contrast Media,D27.720.259
17325575,2007-02-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
17325575,2007-02-01T00:00:00,Coronary Angiography,E01.370.370.050.200
17325575,2007-02-01T00:00:00,Coronary Angiography,E01.370.370.380.200
17325575,2007-02-01T00:00:00,Coronary Artery Disease,C14.280.647.250.260
17325575,2007-02-01T00:00:00,Coronary Artery Disease,C14.907.137.126.339
17325575,2007-02-01T00:00:00,Coronary Artery Disease,C14.907.585.250.260
17325575,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17325575,2007-02-01T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
17325575,2007-02-01T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
17325575,2007-02-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
17325575,2007-02-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
17325575,2007-02-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
17325575,2007-02-01T00:00:00,Stents,E07.695.750
17325575,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17325575,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17325575,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17325575,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17325575,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17325579,2007-02-01T00:00:00,Heart,A07.541
17325579,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17325579,2007-02-01T00:00:00,Liver Diseases,C06.552
17325579,2007-02-01T00:00:00,Lung,A04.411
17325579,2007-02-01T00:00:00,Lung Diseases,C08.381
17325579,2007-02-01T00:00:00,"Radiography, Abdominal",E01.370.350.700.715
17325579,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17325579,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17325579,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17325579,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17325579,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17325580,2007-02-01T00:00:00,Heart Diseases,C14.280
17325580,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17325580,2007-02-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
17325580,2007-02-01T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
17325580,2007-02-01T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
17325580,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17325580,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17325580,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17325580,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17325580,2007-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17330193,2007-02-01T00:00:00,Adult,M01.060.116
17330193,2007-02-01T00:00:00,Aged,M01.060.116.100
17330193,2007-02-01T00:00:00,"Diagnosis, Differential",E01.171
17330193,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17330193,2007-02-01T00:00:00,Pulmonary Emphysema,C08.381.748
17330193,2007-02-01T00:00:00,"Sarcoidosis, Pulmonary",C08.381.483.725
17330193,2007-02-01T00:00:00,"Sarcoidosis, Pulmonary",C15.604.515.827.725
17330694,2007-02-01T00:00:00,Attention Deficit Disorder with Hyperactivity,F03.550.150.150
17330694,2007-02-01T00:00:00,Child,M01.060.406
17330694,2007-02-01T00:00:00,"Diagnosis, Differential",E01.171
17330694,2007-02-01T00:00:00,Eating,G07.610.593.260
17330694,2007-02-01T00:00:00,Eating,G07.700.620.260
17330694,2007-02-01T00:00:00,Eating,G10.261.326.240
17330694,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17351416,2007-02-01T00:00:00,Age Factors,N05.715.350.075
17351416,2007-02-01T00:00:00,Age Factors,N06.850.490.250
17351416,2007-02-01T00:00:00,Child,M01.060.406
17351416,2007-02-01T00:00:00,"Child, Preschool",M01.060.406.448
17351416,2007-02-01T00:00:00,Combined Modality Therapy,E02.186
17351416,2007-02-01T00:00:00,Hepatic Encephalopathy,C06.552.308.500.356
17351416,2007-02-01T00:00:00,Hepatic Encephalopathy,C10.228.140.163.360
17351416,2007-02-01T00:00:00,Hepatic Encephalopathy,C18.452.132.360
17351416,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17351416,2007-02-01T00:00:00,Liver Transplantation,E04.210.650
17351416,2007-02-01T00:00:00,Liver Transplantation,E04.936.450.490
17351416,2007-02-01T00:00:00,Liver Transplantation,E04.936.580.490
17351416,2007-02-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
17351416,2007-02-01T00:00:00,Risk Assessment,N04.452.871.715
17351416,2007-02-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17351416,2007-02-01T00:00:00,Risk Assessment,N06.850.505.715
17351416,2007-02-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17381399,2007-02-01T00:00:00,Adult,M01.060.116
17381399,2007-02-01T00:00:00,Aged,M01.060.116.100
17381399,2007-02-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
17381399,2007-02-01T00:00:00,Creatinine,D03.383.129.308.207
17381399,2007-02-01T00:00:00,Double-Blind Method,E05.318.780.300
17381399,2007-02-01T00:00:00,Double-Blind Method,E05.581.500.300
17381399,2007-02-01T00:00:00,Double-Blind Method,N05.715.360.780.320
17381399,2007-02-01T00:00:00,Double-Blind Method,N06.850.520.445.300
17381399,2007-02-01T00:00:00,"Hospitals, University",N02.278.020.300.310
17381399,2007-02-01T00:00:00,"Hospitals, University",N02.278.421.639.725
17381399,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17381399,2007-02-01T00:00:00,Middle Aged,M01.060.116.630
17381399,2007-02-01T00:00:00,Multiple Organ Failure,C23.550.835.525
17381399,2007-02-01T00:00:00,Pilot Projects,E05.318.760.750
17381399,2007-02-01T00:00:00,Pilot Projects,E05.337.737
17381399,2007-02-01T00:00:00,Pilot Projects,N05.715.360.775.625
17381399,2007-02-01T00:00:00,Pilot Projects,N06.850.520.450.720
17381399,2007-02-01T00:00:00,"Pneumonia, Ventilator-Associated",C01.539.248.500
17381399,2007-02-01T00:00:00,"Pneumonia, Ventilator-Associated",C08.381.520.750.750
17381399,2007-02-01T00:00:00,"Pneumonia, Ventilator-Associated",C08.381.677.800
17381399,2007-02-01T00:00:00,"Pneumonia, Ventilator-Associated",C08.730.610.750
17381399,2007-02-01T00:00:00,Pseudomonas Infections,C01.252.400.739
17381399,2007-02-01T00:00:00,Pseudomonas aeruginosa,B03.440.400.425.625.625.100
17381399,2007-02-01T00:00:00,Pseudomonas aeruginosa,B03.660.250.580.590.050
17381399,2007-02-01T00:00:00,Treatment Outcome,E01.789.800
17381399,2007-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17381399,2007-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17451038,2007-02-01T00:00:00,"Biofeedback, Psychology",E02.190.525.123
17451038,2007-02-01T00:00:00,"Biofeedback, Psychology",F02.830.131
17451038,2007-02-01T00:00:00,"Biofeedback, Psychology",F04.754.137.301
17451038,2007-02-01T00:00:00,"Biofeedback, Psychology",F04.754.308.500
17451038,2007-02-01T00:00:00,"Biofeedback, Psychology",L01.143.283.425.624.500
17451038,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17451038,2007-02-01T00:00:00,Psychotherapy,F04.754
17476870,2007-02-01T00:00:00,Bariatric Surgery,E02.065.062
17476870,2007-02-01T00:00:00,Bariatric Surgery,E04.062
17476870,2007-02-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
17476870,2007-02-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
17476870,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17476870,2007-02-01T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
17476870,2007-02-01T00:00:00,Metabolic Syndrome X,C18.452.625
17476870,2007-02-01T00:00:00,Obesity,C18.654.726.500
17476870,2007-02-01T00:00:00,Obesity,C23.888.144.699.500
17476870,2007-02-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
17476870,2007-02-01T00:00:00,Obesity,G07.100.100.160.120.699.500
17476875,2007-02-01T00:00:00,Adult,M01.060.116
17476875,2007-02-01T00:00:00,Algorithms,G17.035
17476875,2007-02-01T00:00:00,Algorithms,L01.224.050
17476875,2007-02-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
17476875,2007-02-01T00:00:00,Body Mass Index,E05.041.124.125
17476875,2007-02-01T00:00:00,Body Mass Index,G07.100.100.125
17476875,2007-02-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
17476875,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17476875,2007-02-01T00:00:00,Middle Aged,M01.060.116.630
17476875,2007-02-01T00:00:00,Obesity,C18.654.726.500
17476875,2007-02-01T00:00:00,Obesity,C23.888.144.699.500
17476875,2007-02-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
17476875,2007-02-01T00:00:00,Obesity,G07.100.100.160.120.699.500
17476875,2007-02-01T00:00:00,Weight Loss,C23.888.144.243.963
17476875,2007-02-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
17487266,2007-02-01T00:00:00,Animals,B01.050
17487266,2007-02-01T00:00:00,"Myocytes, Cardiac",A07.541.704.570
17487266,2007-02-01T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
17487266,2007-02-01T00:00:00,"Myocytes, Cardiac",A11.620.500
17487266,2007-02-01T00:00:00,Phosphorylation,G02.111.087.677
17487266,2007-02-01T00:00:00,Phosphorylation,G02.149.115.677
17487266,2007-02-01T00:00:00,Phosphorylation,G02.149.465.700
17487266,2007-02-01T00:00:00,Phosphorylation,G02.607.750.700
17487266,2007-02-01T00:00:00,Phosphorylation,G03.495.790
17487266,2007-02-01T00:00:00,Protein Kinase C,D08.811.913.696.620.682.700.725
17487266,2007-02-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17487266,2007-02-01T00:00:00,"Stress, Mechanical",G01.374.676.830
17487266,2007-02-01T00:00:00,"Stress, Mechanical",G01.595.540.830
17713213,2007-02-01T00:00:00,Geologic Sediments,G01.311.500
17713213,2007-02-01T00:00:00,Geologic Sediments,G16.500.320
17713213,2007-02-01T00:00:00,Polychlorinated Biphenyls,D02.455.426.559.389.185.698
17713213,2007-02-01T00:00:00,Polychlorinated Biphenyls,D02.455.526.439.773
17713213,2007-02-01T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
17763822,2007-02-01T00:00:00,Ethnic Groups,M01.686.754
17763822,2007-02-01T00:00:00,Ethnic Groups,N01.224.317
17763822,2007-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17763822,2007-02-01T00:00:00,Minority Groups,I01.880.371
17763822,2007-02-01T00:00:00,Quality of Health Care,N04.761
17763822,2007-02-01T00:00:00,Quality of Health Care,N05.715
17763822,2007-02-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17763822,2007-02-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17619757,2007-02-02T00:00:00,Anticoagulants,D27.505.954.502.119
17619757,2007-02-02T00:00:00,Chronic Disease,C23.550.291.500
17619757,2007-02-02T00:00:00,"Heparin, Low-Molecular-Weight",D09.698.373.400.300
17619757,2007-02-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17619757,2007-02-02T00:00:00,Middle Aged,M01.060.116.630
17619757,2007-02-02T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
17619757,2007-02-02T00:00:00,Prostatic Neoplasms,C12.294.260.750
17619757,2007-02-02T00:00:00,Prostatic Neoplasms,C12.294.565.625
17619757,2007-02-02T00:00:00,Prostatic Neoplasms,C12.758.409.750
17619757,2007-02-02T00:00:00,Treatment Outcome,E01.789.800
17619757,2007-02-02T00:00:00,Treatment Outcome,N04.761.559.590.800
17619757,2007-02-02T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17272566,2007-02-03T00:00:00,Delivery of Health Care,N04.590.374
17272566,2007-02-03T00:00:00,Delivery of Health Care,N05.300
17272566,2007-02-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17272566,2007-02-03T00:00:00,Needs Assessment,I02.594
17272566,2007-02-03T00:00:00,Needs Assessment,N03.349.380.565
17272566,2007-02-03T00:00:00,Needs Assessment,N05.300.537
17272566,2007-02-03T00:00:00,Palliative Care,E02.760.666
17272566,2007-02-03T00:00:00,Palliative Care,N02.421.585.666
17272566,2007-02-03T00:00:00,Patient Discharge,E02.760.400.610
17272566,2007-02-03T00:00:00,Patient Discharge,N02.421.585.400.610
17272566,2007-02-03T00:00:00,Terminal Care,E02.760.905
17272566,2007-02-03T00:00:00,Terminal Care,N02.421.585.905
17360126,2007-02-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17360126,2007-02-03T00:00:00,Nicotinic Agonists,D27.505.519.625.120.140.700
17360126,2007-02-03T00:00:00,Nicotinic Agonists,D27.505.696.577.120.140.700
17360126,2007-02-03T00:00:00,Smoking Cessation,F01.145.940.700
17283068,2007-02-05T00:00:00,Cell Cycle,G04.299.134
17283068,2007-02-05T00:00:00,Cell Division,G04.299.134.220
17283068,2007-02-05T00:00:00,Cell Division,G04.299.233.750.500
17283068,2007-02-05T00:00:00,Cell Division,G05.355.105
17283068,2007-02-05T00:00:00,Cell Division,G07.700.320.249.410.750.500
17283068,2007-02-05T00:00:00,Ceramides,D02.065.313
17283068,2007-02-05T00:00:00,Ceramides,D09.400.410.420.525.200
17283068,2007-02-05T00:00:00,Ceramides,D10.390.470.675.200
17283068,2007-02-05T00:00:00,Ceramides,D10.570.877.360.612.200
17283068,2007-02-05T00:00:00,Fenretinide,D02.455.326.271.665.202.495.270
17283068,2007-02-05T00:00:00,Fenretinide,D02.455.426.392.368.367.379.249.700.270
17283068,2007-02-05T00:00:00,Fenretinide,D02.455.849.131.495.270
17283068,2007-02-05T00:00:00,Fenretinide,D23.767.261.700.270
17283068,2007-02-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17283068,2007-02-05T00:00:00,Mass Spectrometry,E05.196.566
17283068,2007-02-05T00:00:00,Neuroblastoma,C04.557.465.625.600.590.650.550
17283068,2007-02-05T00:00:00,Neuroblastoma,C04.557.470.670.590.650.550
17283068,2007-02-05T00:00:00,Neuroblastoma,C04.557.580.625.600.590.650.550
17283068,2007-02-05T00:00:00,Oxidoreductases,D08.811.682
17283068,2007-02-05T00:00:00,Phosphorylation,G02.111.087.677
17283068,2007-02-05T00:00:00,Phosphorylation,G02.149.115.677
17283068,2007-02-05T00:00:00,Phosphorylation,G02.149.465.700
17283068,2007-02-05T00:00:00,Phosphorylation,G02.607.750.700
17283068,2007-02-05T00:00:00,Phosphorylation,G03.495.790
17283068,2007-02-05T00:00:00,RNA Interference,G05.355.315.203.374.790
17283076,2007-02-05T00:00:00,Animals,B01.050
17283076,2007-02-05T00:00:00,Bone Resorption,C05.116.264
17283076,2007-02-05T00:00:00,Bone Resorption,G11.427.590.195.150
17283076,2007-02-05T00:00:00,Osteoclasts,A11.329.372.700
17283076,2007-02-05T00:00:00,Osteoclasts,A11.627.482.700
17283076,2007-02-05T00:00:00,Phosphorylation,G02.111.087.677
17283076,2007-02-05T00:00:00,Phosphorylation,G02.149.115.677
17283076,2007-02-05T00:00:00,Phosphorylation,G02.149.465.700
17283076,2007-02-05T00:00:00,Phosphorylation,G02.607.750.700
17283076,2007-02-05T00:00:00,Phosphorylation,G03.495.790
17283076,2007-02-05T00:00:00,Protein-Tyrosine Kinases,D08.811.913.696.620.682.725
17283076,2007-02-05T00:00:00,Signal Transduction,G02.111.087.800
17283076,2007-02-05T00:00:00,Signal Transduction,G02.149.115.800
17283076,2007-02-05T00:00:00,Signal Transduction,G04.299.880
17283076,2007-02-05T00:00:00,src-Family Kinases,D08.811.913.696.620.682.725.800
17285296,2007-02-07T00:00:00,Calmodulin,D12.644.360.381.249
17285296,2007-02-07T00:00:00,Calmodulin,D12.776.157.125.412.249
17285296,2007-02-07T00:00:00,Calmodulin,D12.776.476.387.249
17285296,2007-02-07T00:00:00,Computer Simulation,L01.224.160
17285296,2007-02-07T00:00:00,"Models, Chemical",E05.599.495
17285296,2007-02-07T00:00:00,"Models, Molecular",E05.599.595
17285296,2007-02-07T00:00:00,Protein Conformation,G02.111.570.790.709
17285296,2007-02-07T00:00:00,Static Electricity,G01.201.249.820
17290030,2007-02-08T00:00:00,Adult,M01.060.116
17290030,2007-02-08T00:00:00,Aged,M01.060.116.100
17290030,2007-02-08T00:00:00,Blood Vessel Prosthesis Implantation,E04.100.814.200
17290030,2007-02-08T00:00:00,Blood Vessel Prosthesis Implantation,E04.650.200
17290030,2007-02-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17290030,2007-02-08T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
17290030,2007-02-08T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
17290030,2007-02-08T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
17290030,2007-02-08T00:00:00,Intraoperative Complications,C23.550.505
17290030,2007-02-08T00:00:00,Middle Aged,M01.060.116.630
17290030,2007-02-08T00:00:00,Postoperative Care,E02.760.722.700
17290030,2007-02-08T00:00:00,Postoperative Care,E04.624
17290030,2007-02-08T00:00:00,Postoperative Care,N02.421.585.722.700
17290030,2007-02-08T00:00:00,Stents,E07.695.750
17290030,2007-02-08T00:00:00,Treatment Outcome,E01.789.800
17290030,2007-02-08T00:00:00,Treatment Outcome,N04.761.559.590.800
17290030,2007-02-08T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17290030,2007-02-08T00:00:00,United States,Z01.107.567.875
17288644,2007-02-09T00:00:00,Adult,M01.060.116
17288644,2007-02-09T00:00:00,Antidepressive Agents,D27.505.954.427.700.122
17288644,2007-02-09T00:00:00,Bipolar Disorder,F03.600.150.150
17288644,2007-02-09T00:00:00,Depression,F01.145.126.350
17288644,2007-02-09T00:00:00,Electric Stimulation Therapy,E02.342
17288644,2007-02-09T00:00:00,Electric Stimulation Therapy,E02.779.468
17288644,2007-02-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17288644,2007-02-09T00:00:00,Middle Aged,M01.060.116.630
17288644,2007-02-09T00:00:00,Pilot Projects,E05.318.760.750
17288644,2007-02-09T00:00:00,Pilot Projects,E05.337.737
17288644,2007-02-09T00:00:00,Pilot Projects,N05.715.360.775.625
17288644,2007-02-09T00:00:00,Pilot Projects,N06.850.520.450.720
17288644,2007-02-09T00:00:00,Psychiatric Status Rating Scales,F04.586
17288644,2007-02-09T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
17288644,2007-02-09T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
17288644,2007-02-09T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
17288644,2007-02-09T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
17288644,2007-02-09T00:00:00,Time Factors,G01.910.857
17292415,2007-02-09T00:00:00,Animals,B01.050
17292415,2007-02-09T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
17292415,2007-02-09T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.055.239.125
17292415,2007-02-09T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.109.139.125
17292415,2007-02-09T00:00:00,Disease Progression,C23.550.291.656
17292415,2007-02-09T00:00:00,Extracellular Matrix,A11.284.295.310
17292415,2007-02-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17362949,2007-02-09T00:00:00,Animals,B01.050
17362949,2007-02-09T00:00:00,Estradiol,D04.808.365.415.248
17362949,2007-02-09T00:00:00,Estradiol,D06.472.334.851.437.500
17362949,2007-02-09T00:00:00,Fishes,B01.050.150.900.493
17362949,2007-02-09T00:00:00,Oogenesis,G04.299.151.650.249
17362949,2007-02-09T00:00:00,Oogenesis,G08.686.785.760.310.500
17362949,2007-02-09T00:00:00,Reproduction,G08.686.785.760
17290055,2007-02-10T00:00:00,Adult,M01.060.116
17290055,2007-02-10T00:00:00,Aged,M01.060.116.100
17290055,2007-02-10T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
17290055,2007-02-10T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
17290055,2007-02-10T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
17290055,2007-02-10T00:00:00,Diet,E05.272
17290055,2007-02-10T00:00:00,Diet,G07.610.240
17290055,2007-02-10T00:00:00,Dietary Supplements,J02.500.456
17290055,2007-02-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17290055,2007-02-10T00:00:00,Lung Neoplasms,C04.588.894.797.520
17290055,2007-02-10T00:00:00,Lung Neoplasms,C08.381.540
17290055,2007-02-10T00:00:00,Lung Neoplasms,C08.785.520
17290055,2007-02-10T00:00:00,Middle Aged,M01.060.116.630
17290055,2007-02-10T00:00:00,Neoplasm Staging,E01.370.550
17290055,2007-02-10T00:00:00,Time Factors,G01.910.857
17290055,2007-02-10T00:00:00,Vitamin D,D04.808.812.768
17335970,2007-02-11T00:00:00,Apoptosis,G04.299.139.160
17335970,2007-02-11T00:00:00,Apoptosis Inducing Factor,D08.811.682.608.047
17335970,2007-02-11T00:00:00,Apoptosis Inducing Factor,D12.644.360.075.311
17335970,2007-02-11T00:00:00,Apoptosis Inducing Factor,D12.776.331.161
17335970,2007-02-11T00:00:00,Apoptosis Inducing Factor,D12.776.476.075.311
17335970,2007-02-11T00:00:00,Apoptosis Regulatory Proteins,D12.644.360.075
17335970,2007-02-11T00:00:00,Apoptosis Regulatory Proteins,D12.776.476.075
17335970,2007-02-11T00:00:00,Brain Neoplasms,C04.588.614.250.195
17335970,2007-02-11T00:00:00,Brain Neoplasms,C10.228.140.211
17335970,2007-02-11T00:00:00,Brain Neoplasms,C10.551.240.250
17335970,2007-02-11T00:00:00,Calpain,D08.811.277.656.262.500.120
17335970,2007-02-11T00:00:00,Calpain,D08.811.277.656.300.200.120
17335970,2007-02-11T00:00:00,Caspases,D08.811.277.656.262.500.126
17335970,2007-02-11T00:00:00,Caspases,D08.811.277.656.300.200.126
17335970,2007-02-11T00:00:00,Caspases,D12.644.360.075.405
17335970,2007-02-11T00:00:00,Caspases,D12.776.476.075.405
17335970,2007-02-11T00:00:00,Cell Survival,G04.299.316
17335970,2007-02-11T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
17335970,2007-02-11T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
17335970,2007-02-11T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
17335970,2007-02-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17335970,2007-02-11T00:00:00,NF-kappa B,D12.776.260.600
17335970,2007-02-11T00:00:00,NF-kappa B,D12.776.660.600
17335970,2007-02-11T00:00:00,NF-kappa B,D12.776.930.600
17335970,2007-02-11T00:00:00,Photochemotherapy,E02.186.500
17335970,2007-02-11T00:00:00,Photochemotherapy,E02.319.685
17335970,2007-02-11T00:00:00,Photochemotherapy,E02.774.722
17295927,2007-02-12T00:00:00,Feedback,L01.143.283.425
17295927,2007-02-12T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
17295927,2007-02-12T00:00:00,Gene Silencing,G05.355.315.203.374
17295927,2007-02-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17295927,2007-02-12T00:00:00,Neoplasm Proteins,D12.776.624
17295927,2007-02-12T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
17295927,2007-02-12T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
17295927,2007-02-12T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
17295927,2007-02-12T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
17295927,2007-02-12T00:00:00,Prostatic Neoplasms,C12.294.260.750
17295927,2007-02-12T00:00:00,Prostatic Neoplasms,C12.294.565.625
17295927,2007-02-12T00:00:00,Prostatic Neoplasms,C12.758.409.750
17295927,2007-02-12T00:00:00,Protein Engineering,E05.393.420.601
17295927,2007-02-12T00:00:00,Transcription Factors,D12.776.930
17296283,2007-02-12T00:00:00,African Americans,M01.686.508.100.100
17296283,2007-02-12T00:00:00,African Americans,M01.686.754.100
17296283,2007-02-12T00:00:00,Aged,M01.060.116.100
17296283,2007-02-12T00:00:00,Alzheimer Disease,C10.228.140.380.100
17296283,2007-02-12T00:00:00,Alzheimer Disease,C10.574.945.249
17296283,2007-02-12T00:00:00,Alzheimer Disease,F03.087.400.100
17296283,2007-02-12T00:00:00,Cognition,F02.463.188
17296283,2007-02-12T00:00:00,Disease Progression,C23.550.291.656
17296283,2007-02-12T00:00:00,European Continental Ancestry Group,M01.686.508.400
17296283,2007-02-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17296283,2007-02-12T00:00:00,Middle Aged,M01.060.116.630
17296283,2007-02-12T00:00:00,Neuropsychological Tests,F04.711.513
17296283,2007-02-12T00:00:00,Rural Population,N01.600.725
17296283,2007-02-12T00:00:00,Social Environment,I01.880.656
17297438,2007-02-12T00:00:00,Animals,B01.050
17297438,2007-02-12T00:00:00,Cell Line,A11.251.210
17297438,2007-02-12T00:00:00,Down-Regulation,G02.111.087.225
17297438,2007-02-12T00:00:00,Down-Regulation,G02.149.115.225
17297438,2007-02-12T00:00:00,Down-Regulation,G05.355.315.200
17297438,2007-02-12T00:00:00,Down-Regulation,G07.690.812.230
17297438,2007-02-12T00:00:00,Down-Regulation,G07.700.680.230
17297438,2007-02-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17297438,2007-02-12T00:00:00,Peptidylprolyl Isomerase,D08.811.399.325.500
17297438,2007-02-12T00:00:00,Phosphoprotein Phosphatases,D08.811.277.352.650.625
17297438,2007-02-12T00:00:00,Proto-Oncogene Proteins c-pim-1,D08.811.913.696.620.682.700.776
17297438,2007-02-12T00:00:00,Proto-Oncogene Proteins c-pim-1,D12.776.624.664.700.191
17307137,2007-02-12T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
17307137,2007-02-12T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
17307137,2007-02-12T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
17307137,2007-02-12T00:00:00,Animals,B01.050
17307137,2007-02-12T00:00:00,Apoptosis,G04.299.139.160
17307137,2007-02-12T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
17307137,2007-02-12T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
17307137,2007-02-12T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
17307137,2007-02-12T00:00:00,Mitochondria,A11.284.430.214.190.875.564
17307137,2007-02-12T00:00:00,Mitochondria,A11.284.835.626
17307137,2007-02-12T00:00:00,Oxidative Stress,G03.495.710
17307137,2007-02-12T00:00:00,Oxidative Stress,G07.700.830.750
17307137,2007-02-12T00:00:00,Rabbits,B01.050.150.900.649.521.700
17307137,2007-02-12T00:00:00,Sodium,D01.268.549.750
17307137,2007-02-12T00:00:00,Sodium,D01.552.528.850
17359961,2007-02-12T00:00:00,Animals,B01.050
17359961,2007-02-12T00:00:00,Cell Differentiation,G04.299.151
17359961,2007-02-12T00:00:00,Cell Movement,G04.299.283
17359961,2007-02-12T00:00:00,Cell Movement,G07.700.560.500.180
17359961,2007-02-12T00:00:00,Chondrocytes,A11.329.171
17359961,2007-02-12T00:00:00,Cilia,A11.284.180.165
17398179,2007-02-12T00:00:00,Aged,M01.060.116.100
17398179,2007-02-12T00:00:00,Coronary Angiography,E01.370.350.700.060.200
17398179,2007-02-12T00:00:00,Coronary Angiography,E01.370.370.050.200
17398179,2007-02-12T00:00:00,Coronary Angiography,E01.370.370.380.200
17398179,2007-02-12T00:00:00,Coronary Stenosis,C14.280.647.250.285
17398179,2007-02-12T00:00:00,Coronary Stenosis,C14.907.585.250.285
17398179,2007-02-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17398179,2007-02-12T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
17398179,2007-02-12T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
17398179,2007-02-12T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
17398179,2007-02-12T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
17398179,2007-02-12T00:00:00,Middle Aged,M01.060.116.630
17398179,2007-02-12T00:00:00,Myocardial Reperfusion,E04.100.700.600
17398179,2007-02-12T00:00:00,Myocardial Reperfusion,E05.680.730.600
17398179,2007-02-12T00:00:00,Radiopharmaceuticals,D27.720.470.410.650
17398179,2007-02-12T00:00:00,Research Design,E05.581.500
17398179,2007-02-12T00:00:00,Research Design,H01.770.644.728
17398179,2007-02-12T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.350.800.800
17398179,2007-02-12T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.600.350.800.800
17398179,2007-02-12T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.710.800.800
17398179,2007-02-12T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.825.800.800
17398179,2007-02-12T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.384.730.800.800
17298030,2007-02-14T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
17298030,2007-02-14T00:00:00,Iron,D01.268.556.412
17298030,2007-02-14T00:00:00,Iron,D01.268.956.287
17298030,2007-02-14T00:00:00,Iron,D01.552.544.412
17298030,2007-02-14T00:00:00,Molecular Weight,G02.842.580
17298030,2007-02-14T00:00:00,Temperature,G01.906.595
17298030,2007-02-14T00:00:00,Temperature,G16.500.275.063.725.710
17298030,2007-02-14T00:00:00,Temperature,G16.500.750.775.710
17298030,2007-02-14T00:00:00,Temperature,N06.230.150.450
17298030,2007-02-14T00:00:00,Temperature,N06.230.300.100.725.710
17301191,2007-02-14T00:00:00,Adult,M01.060.116
17301191,2007-02-14T00:00:00,Aged,M01.060.116.100
17301191,2007-02-14T00:00:00,Algorithms,G17.035
17301191,2007-02-14T00:00:00,Algorithms,L01.224.050
17301191,2007-02-14T00:00:00,Biological Markers,D23.101
17301191,2007-02-14T00:00:00,Creatinine,D03.383.129.308.207
17301191,2007-02-14T00:00:00,Diabetic Nephropathies,C12.777.419.192
17301191,2007-02-14T00:00:00,Diabetic Nephropathies,C13.351.968.419.192
17301191,2007-02-14T00:00:00,Diabetic Nephropathies,C19.246.099.875
17301191,2007-02-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17301191,2007-02-14T00:00:00,Lupus Nephritis,C12.777.419.570.363.680
17301191,2007-02-14T00:00:00,Lupus Nephritis,C13.351.968.419.570.363.680
17301191,2007-02-14T00:00:00,Lupus Nephritis,C17.300.480.680
17301191,2007-02-14T00:00:00,Lupus Nephritis,C20.111.590.560
17301191,2007-02-14T00:00:00,Middle Aged,M01.060.116.630
17301191,2007-02-14T00:00:00,Proteinuria,C12.777.934.734
17301191,2007-02-14T00:00:00,Proteinuria,C13.351.968.934.734
17301191,2007-02-14T00:00:00,Proteinuria,C23.888.942.750
17131322,2007-02-15T00:00:00,Adult,M01.060.116
17131322,2007-02-15T00:00:00,Aged,M01.060.116.100
17131322,2007-02-15T00:00:00,"Antigens, CD147",D12.776.395.550.045
17131322,2007-02-15T00:00:00,"Antigens, CD147",D12.776.543.550.188
17131322,2007-02-15T00:00:00,"Antigens, CD147",D23.050.285.040
17131322,2007-02-15T00:00:00,"Antigens, CD147",D23.050.301.264.035.247
17131322,2007-02-15T00:00:00,"Antigens, CD147",D23.101.100.110.247
17131322,2007-02-15T00:00:00,Cell Membrane,A11.284.149
17131322,2007-02-15T00:00:00,Fibroblasts,A11.329.228
17131322,2007-02-15T00:00:00,Fibroblasts,A11.872.228
17131322,2007-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17131322,2007-02-15T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.205.352
17131322,2007-02-15T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.252.420
17131322,2007-02-15T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.525.700.150
17131322,2007-02-15T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.205.352
17131322,2007-02-15T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.252.420
17131322,2007-02-15T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.525.700.150
17131322,2007-02-15T00:00:00,Middle Aged,M01.060.116.630
17131322,2007-02-15T00:00:00,Neoplasm Invasiveness,C04.697.645
17131322,2007-02-15T00:00:00,Neoplasm Invasiveness,C23.550.727.645
17131322,2007-02-15T00:00:00,Sarcoma,C04.557.450.795
17301297,2007-02-15T00:00:00,Child,M01.060.406
17301297,2007-02-15T00:00:00,"Child, Preschool",M01.060.406.448
17301297,2007-02-15T00:00:00,Coronary Artery Disease,C14.280.647.250.260
17301297,2007-02-15T00:00:00,Coronary Artery Disease,C14.907.137.126.339
17301297,2007-02-15T00:00:00,Coronary Artery Disease,C14.907.585.250.260
17301297,2007-02-15T00:00:00,Double-Blind Method,E05.318.780.300
17301297,2007-02-15T00:00:00,Double-Blind Method,E05.581.500.300
17301297,2007-02-15T00:00:00,Double-Blind Method,N05.715.360.780.320
17301297,2007-02-15T00:00:00,Double-Blind Method,N06.850.520.445.300
17301297,2007-02-15T00:00:00,Fever,C23.888.119.344
17301297,2007-02-15T00:00:00,Glucocorticoids,D06.472.040.543
17301297,2007-02-15T00:00:00,Glucocorticoids,D27.505.696.399.472.488
17301297,2007-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17301297,2007-02-15T00:00:00,"Immunoglobulins, Intravenous",D12.776.124.486.485.114.619.393.536
17301297,2007-02-15T00:00:00,"Immunoglobulins, Intravenous",D12.776.124.486.485.114.632
17301297,2007-02-15T00:00:00,"Immunoglobulins, Intravenous",D12.776.124.790.651.114.632
17301297,2007-02-15T00:00:00,"Immunoglobulins, Intravenous",D12.776.377.715.548.114.632
17301297,2007-02-15T00:00:00,Immunologic Factors,D27.505.696.477
17301297,2007-02-15T00:00:00,Infant,M01.060.703
17301297,2007-02-15T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
17303574,2007-02-15T00:00:00,Apoptosis,G04.299.139.160
17303574,2007-02-15T00:00:00,Ceramides,D02.065.313
17303574,2007-02-15T00:00:00,Ceramides,D09.400.410.420.525.200
17303574,2007-02-15T00:00:00,Ceramides,D10.390.470.675.200
17303574,2007-02-15T00:00:00,Ceramides,D10.570.877.360.612.200
17303574,2007-02-15T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
17303574,2007-02-15T00:00:00,"Fusion Proteins, bcr-abl",D08.811.913.696.620.682.725.500.500
17303574,2007-02-15T00:00:00,"Fusion Proteins, bcr-abl",D12.776.602.500.500.100
17303574,2007-02-15T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.100
17303574,2007-02-15T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.664.500.100
17303574,2007-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17303574,2007-02-15T00:00:00,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C04.557.337.539.250
17303574,2007-02-15T00:00:00,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C15.378.190.636.370
17303574,2007-02-15T00:00:00,Lysophospholipids,D10.570.755.375.760.550
17303574,2007-02-15T00:00:00,Membrane Proteins,D12.776.543
17303574,2007-02-15T00:00:00,Piperazines,D03.383.606
17303574,2007-02-15T00:00:00,Pyrimidines,D03.383.742
17303574,2007-02-15T00:00:00,Sphingosine,D02.033.100.700
17303574,2007-02-15T00:00:00,Sphingosine,D02.033.455.843
17303574,2007-02-15T00:00:00,Sphingosine,D02.092.063.700
17303574,2007-02-15T00:00:00,Sphingosine N-Acyltransferase,D08.811.913.050.712
17303574,2007-02-15T00:00:00,Time Factors,G01.910.857
17306994,2007-02-15T00:00:00,Adolescent,M01.060.057
17306994,2007-02-15T00:00:00,Cataract Extraction,E04.540.825.249
17306994,2007-02-15T00:00:00,Child,M01.060.406
17306994,2007-02-15T00:00:00,"Child, Preschool",M01.060.406.448
17306994,2007-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17306994,2007-02-15T00:00:00,Infant,M01.060.703
17306994,2007-02-15T00:00:00,Intraoperative Complications,C23.550.505
17306994,2007-02-15T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
17306994,2007-02-15T00:00:00,Postoperative Complications,C23.550.767
17306994,2007-02-15T00:00:00,Strabismus,C10.292.562.887
17306994,2007-02-15T00:00:00,Strabismus,C11.590.810
17306994,2007-02-15T00:00:00,Treatment Outcome,E01.789.800
17306994,2007-02-15T00:00:00,Treatment Outcome,N04.761.559.590.800
17306994,2007-02-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17306994,2007-02-15T00:00:00,Vision Disorders,C10.597.751.941
17306994,2007-02-15T00:00:00,Vision Disorders,C11.966
17306994,2007-02-15T00:00:00,Vision Disorders,C23.888.592.763.941
17306994,2007-02-15T00:00:00,Visual Acuity,E01.370.380.850.950
17306994,2007-02-15T00:00:00,Visual Acuity,F02.463.593.932.901
17306994,2007-02-15T00:00:00,Visual Acuity,G14.940
17306995,2007-02-15T00:00:00,Adolescent,M01.060.057
17306995,2007-02-15T00:00:00,Cataract,C11.510.245
17306995,2007-02-15T00:00:00,Cataract Extraction,E04.540.825.249
17306995,2007-02-15T00:00:00,Child,M01.060.406
17306995,2007-02-15T00:00:00,"Child, Preschool",M01.060.406.448
17306995,2007-02-15T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
17306995,2007-02-15T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
17306995,2007-02-15T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
17306995,2007-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17306995,2007-02-15T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
17306995,2007-02-15T00:00:00,Visual Acuity,E01.370.380.850.950
17306995,2007-02-15T00:00:00,Visual Acuity,F02.463.593.932.901
17306995,2007-02-15T00:00:00,Visual Acuity,G14.940
17308102,2007-02-15T00:00:00,Actins,D05.750.078.730.250
17308102,2007-02-15T00:00:00,Actins,D12.776.210.500.100
17308102,2007-02-15T00:00:00,Actins,D12.776.220.525.255
17308102,2007-02-15T00:00:00,Breast Neoplasms,C04.588.180
17308102,2007-02-15T00:00:00,Breast Neoplasms,C17.800.090.500
17308102,2007-02-15T00:00:00,Cell Movement,G04.299.283
17308102,2007-02-15T00:00:00,Cell Movement,G07.700.560.500.180
17308102,2007-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17308102,2007-02-15T00:00:00,Proto-Oncogene Proteins c-ets,D12.776.260.665
17308102,2007-02-15T00:00:00,Proto-Oncogene Proteins c-ets,D12.776.624.664.700.175
17308102,2007-02-15T00:00:00,Proto-Oncogene Proteins c-ets,D12.776.930.635
17308119,2007-02-15T00:00:00,Animals,B01.050
17308119,2007-02-15T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
17308119,2007-02-15T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
17308119,2007-02-15T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
17308119,2007-02-15T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
17308119,2007-02-15T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
17308119,2007-02-15T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
17308119,2007-02-15T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
17308119,2007-02-15T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
17308119,2007-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17308119,2007-02-15T00:00:00,Ovarian Neoplasms,C04.588.322.455
17308119,2007-02-15T00:00:00,Ovarian Neoplasms,C13.351.500.056.630.705
17308119,2007-02-15T00:00:00,Ovarian Neoplasms,C13.351.937.418.685
17308119,2007-02-15T00:00:00,Ovarian Neoplasms,C19.344.410
17308119,2007-02-15T00:00:00,Ovarian Neoplasms,C19.391.630.705
17308119,2007-02-15T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
17308119,2007-02-15T00:00:00,Tumor Suppressor Protein p53,D12.776.260.820
17308119,2007-02-15T00:00:00,Tumor Suppressor Protein p53,D12.776.624.776.775
17308119,2007-02-15T00:00:00,Tumor Suppressor Protein p53,D12.776.660.825
17308119,2007-02-15T00:00:00,Tumor Suppressor Protein p53,D12.776.744.845
17310518,2007-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17310518,2007-02-15T00:00:00,Lung Neoplasms,C04.588.894.797.520
17310518,2007-02-15T00:00:00,Lung Neoplasms,C08.381.540
17310518,2007-02-15T00:00:00,Lung Neoplasms,C08.785.520
17310518,2007-02-15T00:00:00,Neoplasm Staging,E01.370.550
17310518,2007-02-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17310518,2007-02-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17310518,2007-02-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17310518,2007-02-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17310518,2007-02-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17323710,2007-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17323710,2007-02-15T00:00:00,Mouth Diseases,C07.465
17323710,2007-02-15T00:00:00,Risk Factors,E05.318.740.600.800.725
17323710,2007-02-15T00:00:00,Risk Factors,N05.715.350.200.700
17323710,2007-02-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17323710,2007-02-15T00:00:00,Risk Factors,N06.850.490.625.750
17323710,2007-02-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17323711,2007-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17323711,2007-02-15T00:00:00,Mouth Neoplasms,C04.588.443.591
17323711,2007-02-15T00:00:00,Mouth Neoplasms,C07.465.565
17323711,2007-02-15T00:00:00,Risk Factors,E05.318.740.600.800.725
17323711,2007-02-15T00:00:00,Risk Factors,N05.715.350.200.700
17323711,2007-02-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17323711,2007-02-15T00:00:00,Risk Factors,N06.850.490.625.750
17323711,2007-02-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17429510,2007-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17429510,2007-02-15T00:00:00,Teaching,I02.903
17557449,2007-02-15T00:00:00,Adult,M01.060.116
17557449,2007-02-15T00:00:00,Aged,M01.060.116.100
17557449,2007-02-15T00:00:00,Alcoholism,C21.739.100.250
17557449,2007-02-15T00:00:00,Alcoholism,F03.900.100.350
17557449,2007-02-15T00:00:00,Amines,D02.092
17557449,2007-02-15T00:00:00,Cyclohexanecarboxylic Acids,D02.241.223.268
17557449,2007-02-15T00:00:00,Cyclohexanecarboxylic Acids,D02.455.426.392.368.367.218
17557449,2007-02-15T00:00:00,Double-Blind Method,E05.318.780.300
17557449,2007-02-15T00:00:00,Double-Blind Method,E05.581.500.300
17557449,2007-02-15T00:00:00,Double-Blind Method,N05.715.360.780.320
17557449,2007-02-15T00:00:00,Double-Blind Method,N06.850.520.445.300
17557449,2007-02-15T00:00:00,Ethanol,D02.033.375
17557449,2007-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17557449,2007-02-15T00:00:00,Middle Aged,M01.060.116.630
17557449,2007-02-15T00:00:00,Questionnaires,E05.318.308.750
17557449,2007-02-15T00:00:00,Questionnaires,L01.280.800
17557449,2007-02-15T00:00:00,Questionnaires,N05.715.360.300.695
17557449,2007-02-15T00:00:00,Questionnaires,N06.850.520.308.750
17557449,2007-02-15T00:00:00,Substance Withdrawal Syndrome,C21.739.835
17557449,2007-02-15T00:00:00,Substance Withdrawal Syndrome,F03.900.825
17557449,2007-02-15T00:00:00,gamma-Aminobutyric Acid,D02.241.081.160.050.350
17557449,2007-02-15T00:00:00,gamma-Aminobutyric Acid,D12.125.190.350
17598275,2007-02-15T00:00:00,Animals,B01.050
17598275,2007-02-15T00:00:00,Copper,D01.268.556.195
17598275,2007-02-15T00:00:00,Copper,D01.268.956.170
17598275,2007-02-15T00:00:00,Copper,D01.552.544.195
17598275,2007-02-15T00:00:00,Iron,D01.268.556.412
17598275,2007-02-15T00:00:00,Iron,D01.268.956.287
17598275,2007-02-15T00:00:00,Iron,D01.552.544.412
17598275,2007-02-15T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
17598275,2007-02-15T00:00:00,Marine Toxins,D23.946.580
17598275,2007-02-15T00:00:00,"Models, Molecular",E05.599.595
17598275,2007-02-15T00:00:00,Pfiesteria piscicida,B01.043.214.600
17598275,2007-02-15T00:00:00,Sulfur,D01.268.185.900
17302434,2007-02-16T00:00:00,Aldehyde Dehydrogenase,D08.811.682.657.163.249
17302434,2007-02-16T00:00:00,Amino Acid Sequence,G02.111.570.060
17302434,2007-02-16T00:00:00,Amino Acid Sequence,L01.453.245.667.060
17302434,2007-02-16T00:00:00,Animals,B01.050
17302434,2007-02-16T00:00:00,Crystallization,E05.196.300
17302434,2007-02-16T00:00:00,Crystallization,G02.149.767.505
17302434,2007-02-16T00:00:00,Crystallization,G02.842.750.505
17302434,2007-02-16T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
17302434,2007-02-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17302434,2007-02-16T00:00:00,"Models, Molecular",E05.599.595
17302434,2007-02-16T00:00:00,Molecular Sequence Data,L01.453.245.667
17302434,2007-02-16T00:00:00,Oxidoreductases Acting on CH-NH Group Donors,D08.811.682.662
17302434,2007-02-16T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17307966,2007-02-16T00:00:00,Action Potentials,G04.580.100
17307966,2007-02-16T00:00:00,Action Potentials,G07.265.750.100
17307966,2007-02-16T00:00:00,Action Potentials,G11.561.570.100
17307966,2007-02-16T00:00:00,"Adaptation, Physiological",G07.700.062
17307966,2007-02-16T00:00:00,"Adaptation, Physiological",G16.100.057.500
17307966,2007-02-16T00:00:00,Animals,B01.050
17307966,2007-02-16T00:00:00,Calcium,D01.268.552.100
17307966,2007-02-16T00:00:00,Calcium,D01.552.539.288
17307966,2007-02-16T00:00:00,Calcium,D23.119.100
17307966,2007-02-16T00:00:00,Calcium Signaling,G02.111.087.800.800.100
17307966,2007-02-16T00:00:00,Calcium Signaling,G02.149.115.800.800.100
17307966,2007-02-16T00:00:00,Calcium Signaling,G03.495.166.500.100
17307966,2007-02-16T00:00:00,Calcium Signaling,G04.299.880.800.100
17307966,2007-02-16T00:00:00,Calmodulin,D12.644.360.381.249
17307966,2007-02-16T00:00:00,Calmodulin,D12.776.157.125.412.249
17307966,2007-02-16T00:00:00,Calmodulin,D12.776.476.387.249
17307966,2007-02-16T00:00:00,Myocardial Contraction,G09.330.190.541
17307966,2007-02-16T00:00:00,Myocardial Contraction,G11.427.590.540.570
17307966,2007-02-16T00:00:00,Myocardium,A02.633.580
17307966,2007-02-16T00:00:00,Myocardium,A07.541.704
17307966,2007-02-16T00:00:00,Myocardium,A10.690.552.750
17307966,2007-02-16T00:00:00,Phosphorylation,G02.111.087.677
17307966,2007-02-16T00:00:00,Phosphorylation,G02.149.115.677
17307966,2007-02-16T00:00:00,Phosphorylation,G02.149.465.700
17307966,2007-02-16T00:00:00,Phosphorylation,G02.607.750.700
17307966,2007-02-16T00:00:00,Phosphorylation,G03.495.790
17307966,2007-02-16T00:00:00,"Protein Processing, Post-Translational",G02.111.087.675.871.790.600
17307966,2007-02-16T00:00:00,"Protein Processing, Post-Translational",G02.111.087.693.600
17307966,2007-02-16T00:00:00,"Protein Processing, Post-Translational",G02.149.115.675.871.790.600
17307966,2007-02-16T00:00:00,"Protein Processing, Post-Translational",G02.149.115.693.600
17307966,2007-02-16T00:00:00,"Protein Processing, Post-Translational",G03.495.770.871.790.600
17307966,2007-02-16T00:00:00,"Protein Processing, Post-Translational",G05.355.315.670.600
17307966,2007-02-16T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17307966,2007-02-16T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.157.530.400.150.800
17307966,2007-02-16T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.210.500.800
17307966,2007-02-16T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.543.550.425.150.800
17307966,2007-02-16T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.543.585.400.150.800
17380398,2007-02-16T00:00:00,Graft Rejection,G12.425.901.545.328
17380398,2007-02-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17380398,2007-02-16T00:00:00,Postoperative Complications,C23.550.767
17380398,2007-02-16T00:00:00,Short Bowel Syndrome,C06.405.469.637.832
17380398,2007-02-16T00:00:00,Short Bowel Syndrome,C23.550.767.882
17310063,2007-02-19T00:00:00,Animals,B01.050
17310063,2007-02-19T00:00:00,CHO Cells,A11.251.210.200
17310063,2007-02-19T00:00:00,CHO Cells,A11.436.155
17310063,2007-02-19T00:00:00,Cricetinae,B01.050.150.900.649.865.635.150
17310063,2007-02-19T00:00:00,Gene Expression Regulation,G05.355.315
17310063,2007-02-19T00:00:00,Phosphorylation,G02.111.087.677
17310063,2007-02-19T00:00:00,Phosphorylation,G02.149.115.677
17310063,2007-02-19T00:00:00,Phosphorylation,G02.149.465.700
17310063,2007-02-19T00:00:00,Phosphorylation,G02.607.750.700
17310063,2007-02-19T00:00:00,Phosphorylation,G03.495.790
17310063,2007-02-19T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17310063,2007-02-19T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17310063,2007-02-19T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.157.530.450.625.311
17310063,2007-02-19T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.157.530.562.374.875
17310063,2007-02-19T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.543.585.450.625.374
17310063,2007-02-19T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.543.585.562.374.875
17310063,2007-02-19T00:00:00,Synaptosomes,A11.284.835.859
17310063,2007-02-19T00:00:00,Threonine,D12.125.142.815
17310063,2007-02-19T00:00:00,Threonine,D12.125.154.900
17310063,2007-02-19T00:00:00,Threonine,D12.125.901
17183542,2007-02-20T00:00:00,Animals,B01.050
17183542,2007-02-20T00:00:00,Brain Ischemia,C10.228.140.300.150
17183542,2007-02-20T00:00:00,Brain Ischemia,C14.907.253.092
17183542,2007-02-20T00:00:00,Cerebral Ventricles,A08.186.211.276
17183542,2007-02-20T00:00:00,"Disease Models, Animal",C22.232
17183542,2007-02-20T00:00:00,"Disease Models, Animal",E05.598.500
17183542,2007-02-20T00:00:00,"Disease Models, Animal",E05.599.395.080
17183542,2007-02-20T00:00:00,Estradiol,D04.808.365.415.248
17183542,2007-02-20T00:00:00,Estradiol,D06.472.334.851.437.500
17183542,2007-02-20T00:00:00,Estrogen Receptor alpha,D12.776.260.698.750.350.174
17183542,2007-02-20T00:00:00,Estrogen Receptor alpha,D12.776.826.750.350.174
17183542,2007-02-20T00:00:00,Estrogen Receptor alpha,D12.776.930.669.750.350.174
17183542,2007-02-20T00:00:00,Matched-Pair Analysis,E05.318.740.475
17183542,2007-02-20T00:00:00,Matched-Pair Analysis,E05.318.780.485
17183542,2007-02-20T00:00:00,Matched-Pair Analysis,N05.715.360.750.500
17183542,2007-02-20T00:00:00,Matched-Pair Analysis,N05.715.360.780.500
17183542,2007-02-20T00:00:00,Matched-Pair Analysis,N06.850.520.445.485
17183542,2007-02-20T00:00:00,Matched-Pair Analysis,N06.850.520.830.475
17183542,2007-02-20T00:00:00,Neurons,A08.663
17183542,2007-02-20T00:00:00,Neurons,A11.671
17183542,2007-02-20T00:00:00,Neuroprotective Agents,D27.505.696.706.548
17183542,2007-02-20T00:00:00,Neuroprotective Agents,D27.505.954.427.575
17183542,2007-02-20T00:00:00,Stem Cells,A11.872
17183542,2007-02-20T00:00:00,Stroke,C10.228.140.300.775
17183542,2007-02-20T00:00:00,Stroke,C14.907.253.855
17183542,2007-02-20T00:00:00,Time Factors,G01.910.857
17312185,2007-02-20T00:00:00,Animals,B01.050
17312185,2007-02-20T00:00:00,Calcium,D01.268.552.100
17312185,2007-02-20T00:00:00,Calcium,D01.552.539.288
17312185,2007-02-20T00:00:00,Calcium,D23.119.100
17312185,2007-02-20T00:00:00,Polyethylene Glycols,D02.033.455.250.700
17312185,2007-02-20T00:00:00,Polyethylene Glycols,D05.750.741
17312185,2007-02-20T00:00:00,Polyethylene Glycols,D25.720.741
17312185,2007-02-20T00:00:00,Polyethylene Glycols,J01.637.051.720.741
17312185,2007-02-20T00:00:00,Rabbits,B01.050.150.900.649.521.700
17336722,2007-02-20T00:00:00,Case-Control Studies,E05.318.760.500.500
17336722,2007-02-20T00:00:00,Case-Control Studies,N05.715.360.775.175.200
17336722,2007-02-20T00:00:00,Case-Control Studies,N06.850.520.450.500.500
17336722,2007-02-20T00:00:00,Heart Failure,C14.280.434
17336722,2007-02-20T00:00:00,Heart Ventricles,A07.541.560
17336722,2007-02-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17336722,2007-02-20T00:00:00,Hypertension,C14.907.489
17336722,2007-02-20T00:00:00,Stroke Volume,E01.370.370.380.150.700
17336722,2007-02-20T00:00:00,Stroke Volume,G09.330.380.124.882
17336722,2007-02-20T00:00:00,United States,Z01.107.567.875
17313533,2007-02-21T00:00:00,Aged,M01.060.116.100
17313533,2007-02-21T00:00:00,"Cardiac Pacing, Artificial",E02.145
17313533,2007-02-21T00:00:00,"Diagnosis, Computer-Assisted",E01.158
17313533,2007-02-21T00:00:00,"Diagnosis, Computer-Assisted",L01.700.508.100.158
17313533,2007-02-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17313533,2007-02-21T00:00:00,Middle Aged,M01.060.116.630
17313533,2007-02-21T00:00:00,"Therapy, Computer-Assisted",E02.950
17313533,2007-02-21T00:00:00,"Therapy, Computer-Assisted",L01.700.508.100.710
17313533,2007-02-21T00:00:00,Treatment Outcome,E01.789.800
17313533,2007-02-21T00:00:00,Treatment Outcome,N04.761.559.590.800
17313533,2007-02-21T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17313533,2007-02-21T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
17317093,2007-02-21T00:00:00,African Americans,M01.686.508.100.100
17317093,2007-02-21T00:00:00,African Americans,M01.686.754.100
17317093,2007-02-21T00:00:00,Aged,M01.060.116.100
17317093,2007-02-21T00:00:00,European Continental Ancestry Group,M01.686.508.400
17317093,2007-02-21T00:00:00,Geriatric Assessment,E05.318.308.225
17317093,2007-02-21T00:00:00,Geriatric Assessment,I01.240.425.350
17317093,2007-02-21T00:00:00,Geriatric Assessment,L01.280.360
17317093,2007-02-21T00:00:00,Geriatric Assessment,N01.224.425.350
17317093,2007-02-21T00:00:00,Geriatric Assessment,N05.715.360.300.360
17317093,2007-02-21T00:00:00,Geriatric Assessment,N06.850.505.400.425.350
17317093,2007-02-21T00:00:00,Geriatric Assessment,N06.850.520.308.225
17317093,2007-02-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17317093,2007-02-21T00:00:00,Neuropsychological Tests,F04.711.513
17322171,2007-02-22T00:00:00,Actins,D05.750.078.730.250
17322171,2007-02-22T00:00:00,Actins,D12.776.210.500.100
17322171,2007-02-22T00:00:00,Actins,D12.776.220.525.255
17322171,2007-02-22T00:00:00,Angiotensin II,D06.472.699.094.078
17322171,2007-02-22T00:00:00,Angiotensin II,D12.644.400.070.078
17322171,2007-02-22T00:00:00,Angiotensin II,D12.644.456.073.041
17322171,2007-02-22T00:00:00,Angiotensin II,D12.644.548.058.078
17322171,2007-02-22T00:00:00,Angiotensin II,D12.776.641.650.070.078
17322171,2007-02-22T00:00:00,Angiotensin II,D23.469.050.050.050
17322171,2007-02-22T00:00:00,Animals,B01.050
17322171,2007-02-22T00:00:00,Cell Line,A11.251.210
17322171,2007-02-22T00:00:00,Cell Movement,G04.299.283
17322171,2007-02-22T00:00:00,Cell Movement,G07.700.560.500.180
17322171,2007-02-22T00:00:00,Cytoskeletal Proteins,D12.776.220
17322171,2007-02-22T00:00:00,"Disease Models, Animal",C22.232
17322171,2007-02-22T00:00:00,"Disease Models, Animal",E05.598.500
17322171,2007-02-22T00:00:00,"Disease Models, Animal",E05.599.395.080
17322171,2007-02-22T00:00:00,Gene Expression Regulation,G05.355.315
17322171,2007-02-22T00:00:00,Gene Transfer Techniques,E05.393.350
17322171,2007-02-22T00:00:00,Homeodomain Proteins,D12.776.260.400
17322171,2007-02-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17322171,2007-02-22T00:00:00,"Muscle, Smooth, Vascular",A02.633.570.491
17322171,2007-02-22T00:00:00,"Muscle, Smooth, Vascular",A07.231.491
17322171,2007-02-22T00:00:00,"Muscle, Smooth, Vascular",A10.690.467.491
17322171,2007-02-22T00:00:00,Phosphoproteins,D12.776.744
17322171,2007-02-22T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17322171,2007-02-22T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17326795,2007-02-22T00:00:00,Adolescent,M01.060.057
17326795,2007-02-22T00:00:00,Adult,M01.060.116
17326795,2007-02-22T00:00:00,Anticonvulsants,D27.505.954.427.080
17326795,2007-02-22T00:00:00,Brain Mapping,E01.370.350.086
17326795,2007-02-22T00:00:00,Brain Mapping,E01.370.376.149
17326795,2007-02-22T00:00:00,Brain Mapping,E05.132
17326795,2007-02-22T00:00:00,Drug Resistance,G07.690.320
17326795,2007-02-22T00:00:00,"Epilepsy, Temporal Lobe",C10.228.140.490.360.290
17326795,2007-02-22T00:00:00,Hippocampus,A08.186.211.464.405
17326795,2007-02-22T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
17326795,2007-02-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17326795,2007-02-22T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
17326795,2007-02-22T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17326795,2007-02-22T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17326795,2007-02-22T00:00:00,Middle Aged,M01.060.116.630
17326795,2007-02-22T00:00:00,Neurosurgical Procedures,E04.525
17326795,2007-02-22T00:00:00,Temporal Lobe,A08.186.211.730.885.287.500.863
17326795,2007-02-22T00:00:00,Treatment Outcome,E01.789.800
17326795,2007-02-22T00:00:00,Treatment Outcome,N04.761.559.590.800
17326795,2007-02-22T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17319897,2007-02-23T00:00:00,Algorithms,G17.035
17319897,2007-02-23T00:00:00,Algorithms,L01.224.050
17319897,2007-02-23T00:00:00,Animals,B01.050
17319897,2007-02-23T00:00:00,Cell Line,A11.251.210
17319897,2007-02-23T00:00:00,Golgi Apparatus,A11.284.430.214.190.875.336
17319897,2007-02-23T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
17319897,2007-02-23T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
17319897,2007-02-23T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
17319897,2007-02-23T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
17319897,2007-02-23T00:00:00,"Microscopy, Confocal",E05.595.395
17319897,2007-02-23T00:00:00,Software,L01.224.900
17322298,2007-02-23T00:00:00,"Adaptor Proteins, Signal Transducing",D12.644.360.024
17322298,2007-02-23T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.157.057
17322298,2007-02-23T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.476.024
17322298,2007-02-23T00:00:00,Carrier Proteins,D12.776.157
17322298,2007-02-23T00:00:00,Gene Deletion,G05.355.600.800.320
17322298,2007-02-23T00:00:00,Gene Deletion,G05.365.590.762.320
17322298,2007-02-23T00:00:00,Gene Expression Regulation,G05.355.315
17322298,2007-02-23T00:00:00,"Gene Expression Regulation, Fungal",G05.355.315.330
17322298,2007-02-23T00:00:00,Hot Temperature,G01.906.595.543
17322298,2007-02-23T00:00:00,Hot Temperature,G16.500.275.063.725.710.380
17322298,2007-02-23T00:00:00,Hot Temperature,G16.500.750.775.710.380
17322298,2007-02-23T00:00:00,Hot Temperature,N06.230.300.100.725.232
17322298,2007-02-23T00:00:00,Hot Temperature,N06.230.300.100.725.710.380
17322298,2007-02-23T00:00:00,Membrane Proteins,D12.776.543
17322298,2007-02-23T00:00:00,"Models, Biological",E05.599.395
17322298,2007-02-23T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
17322298,2007-02-23T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
17322298,2007-02-23T00:00:00,Saccharomyces cerevisiae Proteins,D12.776.354.750
17322298,2007-02-23T00:00:00,Serine,D12.125.154.800
17322298,2007-02-23T00:00:00,Serine,D12.125.837
17322298,2007-02-23T00:00:00,Sphingolipids,D10.570.877
17322298,2007-02-23T00:00:00,Sphingolipids,D10.808
17322298,2007-02-23T00:00:00,Sphingosine,D02.033.100.700
17322298,2007-02-23T00:00:00,Sphingosine,D02.033.455.843
17322298,2007-02-23T00:00:00,Sphingosine,D02.092.063.700
17322298,2007-02-23T00:00:00,Time Factors,G01.910.857
17322564,2007-02-24T00:00:00,Animals,B01.050
17322564,2007-02-24T00:00:00,Lipopolysaccharides,D09.400.500
17322564,2007-02-24T00:00:00,Lipopolysaccharides,D09.698.718.450
17322564,2007-02-24T00:00:00,Lipopolysaccharides,D10.494
17322564,2007-02-24T00:00:00,Lipopolysaccharides,D23.050.161.616.525
17322564,2007-02-24T00:00:00,Lipopolysaccharides,D23.946.123.329.500
17322564,2007-02-24T00:00:00,Liver,A03.620
17322564,2007-02-24T00:00:00,Spleen,A10.549.700
17322564,2007-02-24T00:00:00,Spleen,A15.382.520.604.700
17322564,2007-02-24T00:00:00,Toll-Like Receptor 4,D12.776.543.750.705.910.500.400
17362908,2007-02-24T00:00:00,Animals,B01.050
17362908,2007-02-24T00:00:00,Avian Proteins,D12.776.093
17362908,2007-02-24T00:00:00,Cartilage,A02.165
17362908,2007-02-24T00:00:00,Cartilage,A10.165.382
17362908,2007-02-24T00:00:00,Cell Differentiation,G04.299.151
17362908,2007-02-24T00:00:00,Chick Embryo,A13.350.150
17362908,2007-02-24T00:00:00,Chick Embryo,A16.331.200
17362908,2007-02-24T00:00:00,Down-Regulation,G02.111.087.225
17362908,2007-02-24T00:00:00,Down-Regulation,G02.149.115.225
17362908,2007-02-24T00:00:00,Down-Regulation,G05.355.315.200
17362908,2007-02-24T00:00:00,Down-Regulation,G07.690.812.230
17362908,2007-02-24T00:00:00,Down-Regulation,G07.700.680.230
17362908,2007-02-24T00:00:00,Hyaluronic Acid,D09.698.373.475
17362908,2007-02-24T00:00:00,Mesoderm,A16.504.660
17362908,2007-02-24T00:00:00,Wing,A13.395.823
17368531,2007-02-25T00:00:00,Animals,B01.050
17368531,2007-02-25T00:00:00,Biocompatible Materials,D25.130
17368531,2007-02-25T00:00:00,Biocompatible Materials,D27.720.102.130
17368531,2007-02-25T00:00:00,Biocompatible Materials,J01.637.051.130
17368531,2007-02-25T00:00:00,Calcium,D01.268.552.100
17368531,2007-02-25T00:00:00,Calcium,D01.552.539.288
17368531,2007-02-25T00:00:00,Calcium,D23.119.100
17368531,2007-02-25T00:00:00,Elastin,D05.750.078.421
17368531,2007-02-25T00:00:00,Elastin,D12.776.860.300.350
17368531,2007-02-25T00:00:00,Fibroblasts,A11.329.228
17368531,2007-02-25T00:00:00,Fibroblasts,A11.872.228
17368531,2007-02-25T00:00:00,Osteogenesis,G07.700.320.500.325.377.625.100.729
17368531,2007-02-25T00:00:00,Osteogenesis,G11.427.590.560.100.729
17368531,2007-02-25T00:00:00,Prostheses and Implants,E07.695
17368531,2007-02-25T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17368531,2007-02-25T00:00:00,Sepharose,D09.698.813
17368531,2007-02-25T00:00:00,Swine,B01.050.150.900.649.077.880
17368531,2007-02-25T00:00:00,Time Factors,G01.910.857
17368531,2007-02-25T00:00:00,Tissue Engineering,E05.200.249.750
17327220,2007-02-26T00:00:00,"Adaptor Proteins, Signal Transducing",D12.644.360.024
17327220,2007-02-26T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.157.057
17327220,2007-02-26T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.476.024
17327220,2007-02-26T00:00:00,Animals,B01.050
17327220,2007-02-26T00:00:00,Antiviral Agents,D27.505.954.122.388
17327220,2007-02-26T00:00:00,Cell Line,A11.251.210
17327220,2007-02-26T00:00:00,Fibroblasts,A11.329.228
17327220,2007-02-26T00:00:00,Fibroblasts,A11.872.228
17327220,2007-02-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17327220,2007-02-26T00:00:00,"Models, Biological",E05.599.395
17327220,2007-02-26T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
17327220,2007-02-26T00:00:00,Signal Transduction,G02.111.087.800
17327220,2007-02-26T00:00:00,Signal Transduction,G02.149.115.800
17327220,2007-02-26T00:00:00,Signal Transduction,G04.299.880
17382648,2007-02-26T00:00:00,Adult,M01.060.116
17382648,2007-02-26T00:00:00,Aged,M01.060.116.100
17382648,2007-02-26T00:00:00,Aortic Valve,A07.541.510.110
17382648,2007-02-26T00:00:00,Heart Valve Diseases,C14.280.484
17382648,2007-02-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17382648,2007-02-26T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
17382648,2007-02-26T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
17382648,2007-02-26T00:00:00,Middle Aged,M01.060.116.630
17382648,2007-02-26T00:00:00,Tissue Inhibitor of Metalloproteinases,D12.776.926
17013892,2007-03-01T00:00:00,Animals,B01.050
17013892,2007-03-01T00:00:00,Cardiac Volume,G09.330.380.249
17013892,2007-03-01T00:00:00,Chick Embryo,A13.350.150
17013892,2007-03-01T00:00:00,Chick Embryo,A16.331.200
17013892,2007-03-01T00:00:00,Chickens,B01.050.150.900.248.350.150
17013892,2007-03-01T00:00:00,Chickens,B01.050.150.900.248.617.192
17013892,2007-03-01T00:00:00,Heart,A07.541
17013892,2007-03-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
17013892,2007-03-01T00:00:00,Morphogenesis,G07.700.320.500
17013892,2007-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17013892,2007-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17013892,2007-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17013892,2007-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17013892,2007-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17133345,2007-03-01T00:00:00,Alternative Splicing,G02.111.087.750.700.100
17133345,2007-03-01T00:00:00,Alternative Splicing,G02.149.115.750.700.100
17133345,2007-03-01T00:00:00,Alternative Splicing,G03.495.839.700.100
17133345,2007-03-01T00:00:00,Alternative Splicing,G05.355.315.700.700.100
17133345,2007-03-01T00:00:00,Breast Neoplasms,C04.588.180
17133345,2007-03-01T00:00:00,Breast Neoplasms,C17.800.090.500
17133345,2007-03-01T00:00:00,Cell Line,A11.251.210
17133345,2007-03-01T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
17133345,2007-03-01T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
17133345,2007-03-01T00:00:00,Epithelial Cells,A11.436
17133345,2007-03-01T00:00:00,Gene Expression Regulation,G05.355.315
17133345,2007-03-01T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
17133345,2007-03-01T00:00:00,Genetic Variation,G05.365
17133345,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17133345,2007-03-01T00:00:00,Protein Isoforms,D12.776.800
17133345,2007-03-01T00:00:00,Signal Transduction,G02.111.087.800
17133345,2007-03-01T00:00:00,Signal Transduction,G02.149.115.800
17133345,2007-03-01T00:00:00,Signal Transduction,G04.299.880
17133345,2007-03-01T00:00:00,Threonine,D12.125.142.815
17133345,2007-03-01T00:00:00,Threonine,D12.125.154.900
17133345,2007-03-01T00:00:00,Threonine,D12.125.901
17146766,2007-03-01T00:00:00,Alcoholism,C21.739.100.250
17146766,2007-03-01T00:00:00,Alcoholism,F03.900.100.350
17146766,2007-03-01T00:00:00,Animals,B01.050
17146766,2007-03-01T00:00:00,Anticonvulsants,D27.505.954.427.080
17146766,2007-03-01T00:00:00,Body Weight,C23.888.144
17146766,2007-03-01T00:00:00,Body Weight,E01.370.600.115.100.160.120
17146766,2007-03-01T00:00:00,Body Weight,E05.041.124.160.750
17146766,2007-03-01T00:00:00,Body Weight,G07.100.100.160.120
17146766,2007-03-01T00:00:00,Body Weight,G07.700.320.249.314.120
17146766,2007-03-01T00:00:00,Brain,A08.186.211
17146766,2007-03-01T00:00:00,Central Nervous System Depressants,D27.505.696.277
17146766,2007-03-01T00:00:00,Central Nervous System Depressants,D27.505.954.427.210
17146766,2007-03-01T00:00:00,"Disease Models, Animal",C22.232
17146766,2007-03-01T00:00:00,"Disease Models, Animal",E05.598.500
17146766,2007-03-01T00:00:00,"Disease Models, Animal",E05.599.395.080
17146766,2007-03-01T00:00:00,Down-Regulation,G02.111.087.225
17146766,2007-03-01T00:00:00,Down-Regulation,G02.149.115.225
17146766,2007-03-01T00:00:00,Down-Regulation,G05.355.315.200
17146766,2007-03-01T00:00:00,Down-Regulation,G07.690.812.230
17146766,2007-03-01T00:00:00,Down-Regulation,G07.700.680.230
17146766,2007-03-01T00:00:00,Drug Tolerance,G07.690.812.260
17146766,2007-03-01T00:00:00,Drug Tolerance,G07.700.680.260
17146766,2007-03-01T00:00:00,Eating,G07.610.593.260
17146766,2007-03-01T00:00:00,Eating,G07.700.620.260
17146766,2007-03-01T00:00:00,Eating,G10.261.326.240
17146766,2007-03-01T00:00:00,Ethanol,D02.033.375
17146766,2007-03-01T00:00:00,Fructose,D09.546.359.250
17146766,2007-03-01T00:00:00,Fructose,D09.546.465.354
17146766,2007-03-01T00:00:00,"Receptors, AMPA",D12.776.543.750.720.200.450.200
17146766,2007-03-01T00:00:00,Synaptic Transmission,G02.111.087.800.850
17146766,2007-03-01T00:00:00,Synaptic Transmission,G02.149.115.800.850
17146766,2007-03-01T00:00:00,Synaptic Transmission,G04.299.880.850
17146766,2007-03-01T00:00:00,Synaptic Transmission,G07.265.337.900
17146766,2007-03-01T00:00:00,Synaptic Transmission,G07.700.240.900
17146766,2007-03-01T00:00:00,Synaptic Transmission,G11.561.600.835
17146766,2007-03-01T00:00:00,Treatment Outcome,E01.789.800
17146766,2007-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17146766,2007-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17216571,2007-03-01T00:00:00,Environmental Exposure,N06.850.460.350
17216571,2007-03-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17216571,2007-03-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
17216571,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17216571,2007-03-01T00:00:00,Interdisciplinary Communication,F01.145.209.381
17216571,2007-03-01T00:00:00,Interdisciplinary Communication,F01.829.401.205.249
17216571,2007-03-01T00:00:00,Interdisciplinary Communication,L01.143.474
17216571,2007-03-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
17216571,2007-03-01T00:00:00,Lung Neoplasms,C08.381.540
17216571,2007-03-01T00:00:00,Lung Neoplasms,C08.785.520
17216571,2007-03-01T00:00:00,Systems Integration,H01.770.787
17216571,2007-03-01T00:00:00,Systems Integration,L01.906.787
17226818,2007-03-01T00:00:00,Adenoviridae,B04.280.030
17226818,2007-03-01T00:00:00,Adenoviridae,B04.909.204.097
17226818,2007-03-01T00:00:00,Animals,B01.050
17226818,2007-03-01T00:00:00,Binding Sites,G02.111.570.120
17226818,2007-03-01T00:00:00,Chick Embryo,A13.350.150
17226818,2007-03-01T00:00:00,Chick Embryo,A16.331.200
17226818,2007-03-01T00:00:00,Chickens,B01.050.150.900.248.350.150
17226818,2007-03-01T00:00:00,Chickens,B01.050.150.900.248.617.192
17226818,2007-03-01T00:00:00,Embryonic Development,G07.700.320.500.325.180
17226818,2007-03-01T00:00:00,Embryonic Development,G08.686.785.760.170.104
17226818,2007-03-01T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
17226818,2007-03-01T00:00:00,Heart,A07.541
17226818,2007-03-01T00:00:00,Hyaluronic Acid,D09.698.373.475
17226818,2007-03-01T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
17226818,2007-03-01T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
17226818,2007-03-01T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
17226818,2007-03-01T00:00:00,"Microscopy, Confocal",E05.595.395
17226818,2007-03-01T00:00:00,"Models, Genetic",E05.599.395.397
17226818,2007-03-01T00:00:00,Mutation,G05.365.590
17226818,2007-03-01T00:00:00,Myocardium,A02.633.580
17226818,2007-03-01T00:00:00,Myocardium,A07.541.704
17226818,2007-03-01T00:00:00,Myocardium,A10.690.552.750
17226818,2007-03-01T00:00:00,Versicans,D09.698.735.830.750
17226818,2007-03-01T00:00:00,Versicans,D12.776.395.650.750.750
17226818,2007-03-01T00:00:00,Versicans,D12.776.503.280.625
17288883,2007-03-01T00:00:00,Carcinoma,C04.557.470.200
17288883,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17288883,2007-03-01T00:00:00,Thyroid Neoplasms,C04.588.322.894
17288883,2007-03-01T00:00:00,Thyroid Neoplasms,C04.588.443.915
17288883,2007-03-01T00:00:00,Thyroid Neoplasms,C19.344.894
17288883,2007-03-01T00:00:00,Thyroid Neoplasms,C19.874.788
17295732,2007-03-01T00:00:00,Aged,M01.060.116.100
17295732,2007-03-01T00:00:00,Alcohol Drinking,F01.145.317.269
17295732,2007-03-01T00:00:00,Breast Neoplasms,C04.588.180
17295732,2007-03-01T00:00:00,Breast Neoplasms,C17.800.090.500
17295732,2007-03-01T00:00:00,Case-Control Studies,E05.318.760.500.500
17295732,2007-03-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
17295732,2007-03-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
17295732,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17295732,2007-03-01T00:00:00,Middle Aged,M01.060.116.630
17295732,2007-03-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
17295732,2007-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17295732,2007-03-01T00:00:00,Risk Factors,N05.715.350.200.700
17295732,2007-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17295732,2007-03-01T00:00:00,Risk Factors,N06.850.490.625.750
17295732,2007-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17295733,2007-03-01T00:00:00,Alcoholic Intoxication,C21.739.100.175
17295733,2007-03-01T00:00:00,Alcoholic Intoxication,F03.900.100.300
17295733,2007-03-01T00:00:00,Animals,B01.050
17295733,2007-03-01T00:00:00,Estrous Cycle,G08.686.195
17295733,2007-03-01T00:00:00,Ethanol,D02.033.375
17295733,2007-03-01T00:00:00,"Kindling, Neurologic",G11.561.600.480
17295733,2007-03-01T00:00:00,Sex Characteristics,G08.686.815
17296472,2007-03-01T00:00:00,Adult,M01.060.116
17296472,2007-03-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
17296472,2007-03-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
17296472,2007-03-01T00:00:00,Health Promotion,N02.370
17296472,2007-03-01T00:00:00,Health Promotion,N02.421.726.507
17296472,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17296472,2007-03-01T00:00:00,Middle Aged,M01.060.116.630
17296472,2007-03-01T00:00:00,Smoking,F01.145.466.753
17296472,2007-03-01T00:00:00,United States,Z01.107.567.875
17311951,2007-03-01T00:00:00,Animals,B01.050
17311951,2007-03-01T00:00:00,Cardiomegaly,C14.280.195
17311951,2007-03-01T00:00:00,Cardiomegaly,C23.300.775.250
17311951,2007-03-01T00:00:00,Cardiovascular Diseases,C14
17311951,2007-03-01T00:00:00,Coronary Vessels,A07.231.114.269
17311951,2007-03-01T00:00:00,Coronary Vessels,A07.231.908.194
17311951,2007-03-01T00:00:00,Dietary Supplements,J02.500.456
17311951,2007-03-01T00:00:00,Hypertension,C14.907.489
17311951,2007-03-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17311951,2007-03-01T00:00:00,"Rats, Inbred WKY",B01.050.050.157.760.390
17311951,2007-03-01T00:00:00,"Rats, Inbred WKY",B01.050.050.199.520.760.390
17311951,2007-03-01T00:00:00,"Rats, Inbred WKY",B01.050.150.900.649.865.635.505.700.400.390
17312089,2007-03-01T00:00:00,Adult,M01.060.116
17312089,2007-03-01T00:00:00,Aged,M01.060.116.100
17312089,2007-03-01T00:00:00,Gait,E01.370.600.250
17312089,2007-03-01T00:00:00,Gait,G11.427.590.530.389
17312089,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17312089,2007-03-01T00:00:00,Middle Aged,M01.060.116.630
17312089,2007-03-01T00:00:00,Motor Activity,F01.145.632
17312089,2007-03-01T00:00:00,Motor Activity,G11.427.590.530.698
17312089,2007-03-01T00:00:00,Paresis,C10.597.636
17312089,2007-03-01T00:00:00,Paresis,C23.888.592.643
17312089,2007-03-01T00:00:00,Physical Endurance,G11.427.680
17312089,2007-03-01T00:00:00,Physical Endurance,I03.450.642.845.054.600
17312089,2007-03-01T00:00:00,Physical Therapy Modalities,E02.779
17312089,2007-03-01T00:00:00,Pilot Projects,E05.318.760.750
17312089,2007-03-01T00:00:00,Pilot Projects,E05.337.737
17312089,2007-03-01T00:00:00,Pilot Projects,N05.715.360.775.625
17312089,2007-03-01T00:00:00,Pilot Projects,N06.850.520.450.720
17312089,2007-03-01T00:00:00,Recovery of Function,G16.757
17312089,2007-03-01T00:00:00,Stroke,C10.228.140.300.775
17312089,2007-03-01T00:00:00,Stroke,C14.907.253.855
17312089,2007-03-01T00:00:00,Walking,G11.427.590.530.568.900
17312089,2007-03-01T00:00:00,Walking,G11.427.590.530.698.940
17312089,2007-03-01T00:00:00,Walking,I03.450.642.845.940
17312479,2007-03-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
17312479,2007-03-01T00:00:00,Body Mass Index,E05.041.124.125
17312479,2007-03-01T00:00:00,Body Mass Index,G07.100.100.125
17312479,2007-03-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
17312479,2007-03-01T00:00:00,Body Weight,C23.888.144
17312479,2007-03-01T00:00:00,Body Weight,E01.370.600.115.100.160.120
17312479,2007-03-01T00:00:00,Body Weight,E05.041.124.160.750
17312479,2007-03-01T00:00:00,Body Weight,G07.100.100.160.120
17312479,2007-03-01T00:00:00,Body Weight,G07.700.320.249.314.120
17312479,2007-03-01T00:00:00,Breast Neoplasms,C04.588.180
17312479,2007-03-01T00:00:00,Breast Neoplasms,C17.800.090.500
17312479,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17312479,2007-03-01T00:00:00,Mammaplasty,E02.218.565
17312479,2007-03-01T00:00:00,Mammaplasty,E04.680.500
17312479,2007-03-01T00:00:00,Middle Aged,M01.060.116.630
17312479,2007-03-01T00:00:00,Obesity,C18.654.726.500
17312479,2007-03-01T00:00:00,Obesity,C23.888.144.699.500
17312479,2007-03-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
17312479,2007-03-01T00:00:00,Obesity,G07.100.100.160.120.699.500
17312479,2007-03-01T00:00:00,Postoperative Complications,C23.550.767
17312479,2007-03-01T00:00:00,Rectus Abdominis,A02.633.567.050.800
17312479,2007-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17312479,2007-03-01T00:00:00,Risk Factors,N05.715.350.200.700
17312479,2007-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17312479,2007-03-01T00:00:00,Risk Factors,N06.850.490.625.750
17312479,2007-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17312479,2007-03-01T00:00:00,Surgical Flaps,A10.850.710
17312479,2007-03-01T00:00:00,Surgical Flaps,E07.862.710
17312479,2007-03-01T00:00:00,Surgical Wound Infection,C01.539.947.692
17312479,2007-03-01T00:00:00,Surgical Wound Infection,C23.550.767.925
17312479,2007-03-01T00:00:00,Wound Healing,G16.100.856.891
17316218,2007-03-01T00:00:00,Adult,M01.060.116
17316218,2007-03-01T00:00:00,"Education, Medical",I02.358.399
17316218,2007-03-01T00:00:00,Educational Measurement,I02.399
17316218,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17316218,2007-03-01T00:00:00,Middle Aged,M01.060.116.630
17316218,2007-03-01T00:00:00,Program Development,N04.452.760
17316218,2007-03-01T00:00:00,Teaching,I02.903
17316218,2007-03-01T00:00:00,United States,Z01.107.567.875
17321254,2007-03-01T00:00:00,Animals,B01.050
17321254,2007-03-01T00:00:00,Laparoscopy,E01.370.388.250.520
17321254,2007-03-01T00:00:00,Laparoscopy,E04.800.250.520
17321254,2007-03-01T00:00:00,Swine,B01.050.150.900.649.077.880
17321257,2007-03-01T00:00:00,Animals,B01.050
17321257,2007-03-01T00:00:00,"Disease Models, Animal",C22.232
17321257,2007-03-01T00:00:00,"Disease Models, Animal",E05.598.500
17321257,2007-03-01T00:00:00,"Disease Models, Animal",E05.599.395.080
17321257,2007-03-01T00:00:00,Gastroplasty,E02.065.062.750
17321257,2007-03-01T00:00:00,Gastroplasty,E04.062.750
17321257,2007-03-01T00:00:00,Gastroplasty,E04.210.485
17321257,2007-03-01T00:00:00,"Obesity, Morbid",C18.654.726.500.700
17321257,2007-03-01T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
17321257,2007-03-01T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
17321257,2007-03-01T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
17321257,2007-03-01T00:00:00,Pilot Projects,E05.318.760.750
17321257,2007-03-01T00:00:00,Pilot Projects,E05.337.737
17321257,2007-03-01T00:00:00,Pilot Projects,N05.715.360.775.625
17321257,2007-03-01T00:00:00,Pilot Projects,N06.850.520.450.720
17321257,2007-03-01T00:00:00,Suture Techniques,E04.901
17321257,2007-03-01T00:00:00,Treatment Outcome,E01.789.800
17321257,2007-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17321257,2007-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17325468,2007-03-01T00:00:00,Adult,M01.060.116
17325468,2007-03-01T00:00:00,Aged,M01.060.116.100
17325468,2007-03-01T00:00:00,Bacteremia,C01.252.100
17325468,2007-03-01T00:00:00,Bacteremia,C01.539.757.100
17325468,2007-03-01T00:00:00,Bacteremia,C23.550.470.790.500.100
17325468,2007-03-01T00:00:00,"Death, Sudden",C23.550.260.322
17325468,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17325468,2007-03-01T00:00:00,Meningoencephalitis,C10.228.140.430.550
17325468,2007-03-01T00:00:00,Meningoencephalitis,C10.228.228.245.550
17325468,2007-03-01T00:00:00,Meningoencephalitis,C10.228.228.507.850
17325468,2007-03-01T00:00:00,Meningoencephalitis,C10.228.228.553
17325468,2007-03-01T00:00:00,Meningoencephalitis,C10.228.566.500
17325468,2007-03-01T00:00:00,Middle Aged,M01.060.116.630
17325468,2007-03-01T00:00:00,Osteomyelitis,C01.539.160.495
17325468,2007-03-01T00:00:00,Osteomyelitis,C05.116.165.495
17325468,2007-03-01T00:00:00,Sepsis,C01.539.757
17325468,2007-03-01T00:00:00,Sepsis,C23.550.470.790.500
17325468,2007-03-01T00:00:00,Streptococcal Infections,C01.252.410.890
17325468,2007-03-01T00:00:00,Streptococcus agalactiae,B03.510.400.800.872.100
17325468,2007-03-01T00:00:00,Streptococcus pyogenes,B03.510.400.800.872.575
17327715,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17327715,2007-03-01T00:00:00,Parenting,F01.829.263.370.310
17327715,2007-03-01T00:00:00,Physician-Patient Relations,F01.829.401.650.675
17327715,2007-03-01T00:00:00,Physician-Patient Relations,N05.300.660.625
17327715,2007-03-01T00:00:00,Terminal Care,E02.760.905
17327715,2007-03-01T00:00:00,Terminal Care,N02.421.585.905
17328073,2007-03-01T00:00:00,Adolescent,M01.060.057
17328073,2007-03-01T00:00:00,"Antigens, CD",D23.050.301.264.035
17328073,2007-03-01T00:00:00,"Antigens, CD",D23.101.100.110
17328073,2007-03-01T00:00:00,Cell Proliferation,G04.299.233.750
17328073,2007-03-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
17328073,2007-03-01T00:00:00,Child,M01.060.406
17328073,2007-03-01T00:00:00,"Child, Preschool",M01.060.406.448
17328073,2007-03-01T00:00:00,Ferritins,D12.776.157.427.249
17328073,2007-03-01T00:00:00,Ferritins,D12.776.556.579.249
17328073,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17328073,2007-03-01T00:00:00,Macrophages,A11.329.372
17328073,2007-03-01T00:00:00,Macrophages,A11.627.482
17328073,2007-03-01T00:00:00,Macrophages,A11.733.397
17328073,2007-03-01T00:00:00,Macrophages,A15.382.680.397
17328073,2007-03-01T00:00:00,Macrophages,A15.382.812.522
17328073,2007-03-01T00:00:00,Syndrome,C23.550.288.500
17328073,2007-03-01T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
17328073,2007-03-01T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
17328073,2007-03-01T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
17332127,2007-03-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
17332127,2007-03-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
17332127,2007-03-01T00:00:00,Electromyography,E01.370.405.255
17332127,2007-03-01T00:00:00,Electromyography,E01.370.530.255
17332127,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17335380,2007-03-01T00:00:00,Alveolar Bone Loss,C05.116.264.150
17335380,2007-03-01T00:00:00,Alveolar Bone Loss,C07.465.714.354.500
17335380,2007-03-01T00:00:00,Animals,B01.050
17335380,2007-03-01T00:00:00,Cytokines,D12.644.276.374
17335380,2007-03-01T00:00:00,Cytokines,D12.776.467.374
17335380,2007-03-01T00:00:00,Cytokines,D23.529.374
17335380,2007-03-01T00:00:00,"Disease Models, Animal",C22.232
17335380,2007-03-01T00:00:00,"Disease Models, Animal",E05.598.500
17335380,2007-03-01T00:00:00,"Disease Models, Animal",E05.599.395.080
17335380,2007-03-01T00:00:00,Interleukin-1beta,D12.644.276.374.465.501.600
17335380,2007-03-01T00:00:00,Interleukin-1beta,D12.644.276.374.500.400.600
17335380,2007-03-01T00:00:00,Interleukin-1beta,D12.776.467.374.465.501.600
17335380,2007-03-01T00:00:00,Interleukin-1beta,D12.776.467.374.500.400.600
17335380,2007-03-01T00:00:00,Interleukin-1beta,D23.529.374.465.501.600
17335380,2007-03-01T00:00:00,Interleukin-1beta,D23.529.374.500.400.600
17335380,2007-03-01T00:00:00,Interleukin-6,D12.644.276.374.465.506
17335380,2007-03-01T00:00:00,Interleukin-6,D12.776.467.374.465.506
17335380,2007-03-01T00:00:00,Interleukin-6,D23.529.374.465.506
17335380,2007-03-01T00:00:00,Lipopolysaccharides,D09.400.500
17335380,2007-03-01T00:00:00,Lipopolysaccharides,D09.698.718.450
17335380,2007-03-01T00:00:00,Lipopolysaccharides,D10.494
17335380,2007-03-01T00:00:00,Lipopolysaccharides,D23.050.161.616.525
17335380,2007-03-01T00:00:00,Lipopolysaccharides,D23.946.123.329.500
17335380,2007-03-01T00:00:00,Osteoclasts,A11.329.372.700
17335380,2007-03-01T00:00:00,Osteoclasts,A11.627.482.700
17335380,2007-03-01T00:00:00,Periodontitis,C07.465.714.533
17335380,2007-03-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17335380,2007-03-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17335380,2007-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17335380,2007-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17335380,2007-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17335380,2007-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17335380,2007-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17335380,2007-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
17335380,2007-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
17335380,2007-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
17335380,2007-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
17335380,2007-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
17335380,2007-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
17335380,2007-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
17335380,2007-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
17335380,2007-03-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
17335380,2007-03-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
17335380,2007-03-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
17336747,2007-03-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.400.200
17336747,2007-03-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.850.220.230
17336747,2007-03-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.370.380.220.230
17336747,2007-03-01T00:00:00,Forecasting,I01.320
17336747,2007-03-01T00:00:00,"Heart Defects, Congenital",C14.240.400
17336747,2007-03-01T00:00:00,"Heart Defects, Congenital",C14.280.400
17336747,2007-03-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
17336747,2007-03-01T00:00:00,Heart Valve Diseases,C14.280.484
17336747,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17336747,2007-03-01T00:00:00,Image Enhancement,E01.370.350.600.350
17336747,2007-03-01T00:00:00,Image Enhancement,L01.224.308.380
17336747,2007-03-01T00:00:00,Physician's Practice Patterns,N04.590.748
17336747,2007-03-01T00:00:00,Physician's Practice Patterns,N05.300.625
17336747,2007-03-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
17336747,2007-03-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
17336747,2007-03-01T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
17337656,2007-03-01T00:00:00,Allied Health Occupations,H02.010
17337656,2007-03-01T00:00:00,Allied Health Personnel,M01.526.485.067
17337656,2007-03-01T00:00:00,Allied Health Personnel,N02.360.067
17337656,2007-03-01T00:00:00,Professional Competence,I02.399.630
17337656,2007-03-01T00:00:00,United States,Z01.107.567.875
17339864,2007-03-01T00:00:00,Adult,M01.060.116
17339864,2007-03-01T00:00:00,Blood Pressure,E01.370.600.875.249
17339864,2007-03-01T00:00:00,Blood Pressure,G09.330.380.076
17339864,2007-03-01T00:00:00,Central Nervous System Depressants,D27.505.696.277
17339864,2007-03-01T00:00:00,Central Nervous System Depressants,D27.505.954.427.210
17339864,2007-03-01T00:00:00,Central Nervous System Stimulants,D27.505.696.282
17339864,2007-03-01T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
17339864,2007-03-01T00:00:00,Drug Interactions,G07.690.812.240
17339864,2007-03-01T00:00:00,Drug Interactions,G07.700.680.240
17339864,2007-03-01T00:00:00,Ethanol,D02.033.375
17339864,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17339864,2007-03-01T00:00:00,Methylphenidate,D02.241.223.601.600
17339864,2007-03-01T00:00:00,Methylphenidate,D03.383.621.460
17339864,2007-03-01T00:00:00,Pharmacogenetics,H01.158.273.343.750
17339864,2007-03-01T00:00:00,Pharmacogenetics,H01.158.703.052
17339864,2007-03-01T00:00:00,Pharmacogenetics,H02.628.479
17339864,2007-03-01T00:00:00,Respiratory Mechanics,G09.772.770.755.700
17339864,2007-03-01T00:00:00,Sex Characteristics,G08.686.815
17341671,2007-03-01T00:00:00,Anticoagulants,D27.505.954.502.119
17341671,2007-03-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
17341671,2007-03-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
17341671,2007-03-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
17341671,2007-03-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
17341671,2007-03-01T00:00:00,Embolism,C14.907.355.350
17341671,2007-03-01T00:00:00,"Heparin, Low-Molecular-Weight",D09.698.373.400.300
17341671,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17341671,2007-03-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
17341671,2007-03-01T00:00:00,Risk Assessment,N04.452.871.715
17341671,2007-03-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17341671,2007-03-01T00:00:00,Risk Assessment,N06.850.505.715
17341671,2007-03-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17341671,2007-03-01T00:00:00,Time Factors,G01.910.857
17341671,2007-03-01T00:00:00,Venous Thrombosis,C14.907.355.830.925
17344484,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17344484,2007-03-01T00:00:00,Vitamin D,D04.808.812.768
17344484,2007-03-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
17349465,2007-03-01T00:00:00,Arthroscopy,E01.370.388.250.070
17349465,2007-03-01T00:00:00,Arthroscopy,E04.555.113
17349465,2007-03-01T00:00:00,Arthroscopy,E04.800.250.070
17349465,2007-03-01T00:00:00,Cadaver,C23.550.260.224
17349465,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17351419,2007-03-01T00:00:00,Algorithms,G17.035
17351419,2007-03-01T00:00:00,Algorithms,L01.224.050
17351419,2007-03-01T00:00:00,Amphetamine,D02.092.471.683.152.110
17351419,2007-03-01T00:00:00,Animals,B01.050
17351419,2007-03-01T00:00:00,"Behavior, Animal",F01.145.113
17351419,2007-03-01T00:00:00,Central Nervous System Stimulants,D27.505.696.282
17351419,2007-03-01T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
17351419,2007-03-01T00:00:00,Columbidae,B01.050.150.900.248.165.150
17351419,2007-03-01T00:00:00,"Conditioning, Operant",F02.463.425.179.509
17353382,2007-03-01T00:00:00,Aged,M01.060.116.100
17353382,2007-03-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
17353382,2007-03-01T00:00:00,Body Mass Index,E05.041.124.125
17353382,2007-03-01T00:00:00,Body Mass Index,G07.100.100.125
17353382,2007-03-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
17353382,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17353382,2007-03-01T00:00:00,Middle Aged,M01.060.116.630
17353382,2007-03-01T00:00:00,Patient Discharge,E02.760.400.610
17353382,2007-03-01T00:00:00,Patient Discharge,N02.421.585.400.610
17353382,2007-03-01T00:00:00,Stroke,C10.228.140.300.775
17353382,2007-03-01T00:00:00,Stroke,C14.907.253.855
17367430,2007-03-01T00:00:00,Animals,B01.050
17367430,2007-03-01T00:00:00,"Diabetes Mellitus, Experimental",C18.452.394.750.074
17367430,2007-03-01T00:00:00,"Diabetes Mellitus, Experimental",C19.246.240
17367430,2007-03-01T00:00:00,"Diabetes Mellitus, Experimental",E05.598.500.374
17367430,2007-03-01T00:00:00,"Disease Models, Animal",C22.232
17367430,2007-03-01T00:00:00,"Disease Models, Animal",E05.598.500
17367430,2007-03-01T00:00:00,"Disease Models, Animal",E05.599.395.080
17367430,2007-03-01T00:00:00,Electric Stimulation,E05.723.402
17367430,2007-03-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
17367430,2007-03-01T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
17367430,2007-03-01T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
17367430,2007-03-01T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
17367430,2007-03-01T00:00:00,Metabolic Syndrome X,C18.452.625
17367430,2007-03-01T00:00:00,Nitric Oxide,D01.339.387
17367430,2007-03-01T00:00:00,Nitric Oxide,D01.625.550.500
17367430,2007-03-01T00:00:00,Nitric Oxide,D01.625.700.500
17367430,2007-03-01T00:00:00,Nitric Oxide,D01.650.550.587.600
17367430,2007-03-01T00:00:00,Obesity,C18.654.726.500
17367430,2007-03-01T00:00:00,Obesity,C23.888.144.699.500
17367430,2007-03-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
17367430,2007-03-01T00:00:00,Obesity,G07.100.100.160.120.699.500
17367430,2007-03-01T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
17367430,2007-03-01T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
17367430,2007-03-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17375773,2007-03-01T00:00:00,Adult,M01.060.116
17375773,2007-03-01T00:00:00,Disease Progression,C23.550.291.656
17375773,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17375773,2007-03-01T00:00:00,"Models, Statistical",E05.318.740.500
17375773,2007-03-01T00:00:00,"Models, Statistical",E05.599.835
17375773,2007-03-01T00:00:00,"Models, Statistical",N05.715.360.750.530
17375773,2007-03-01T00:00:00,"Models, Statistical",N06.850.520.830.500
17375773,2007-03-01T00:00:00,Trauma Centers,N02.278.354.422.336.500
17375773,2007-03-01T00:00:00,Trauma Centers,N02.421.297.195.480
17375773,2007-03-01T00:00:00,Trauma Centers,N04.452.442.422.336.400
17375773,2007-03-01T00:00:00,Wounds and Injuries,C21.866
17375778,2007-03-01T00:00:00,Adolescent,M01.060.057
17375778,2007-03-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.100.814.200
17375778,2007-03-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.650.200
17375778,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17375778,2007-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17375778,2007-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17375778,2007-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17375778,2007-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17375778,2007-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17375778,2007-03-01T00:00:00,"Wounds, Stab",C21.866.986.950
17382158,2007-03-01T00:00:00,Adenocarcinoma,C04.557.470.200.025
17382158,2007-03-01T00:00:00,Aged,M01.060.116.100
17382158,2007-03-01T00:00:00,Antineoplastic Agents,D27.505.954.248
17382158,2007-03-01T00:00:00,Combined Modality Therapy,E02.186
17382158,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17382158,2007-03-01T00:00:00,Middle Aged,M01.060.116.630
17382158,2007-03-01T00:00:00,Prostate-Specific Antigen,D08.811.277.656.300.760.442.750
17382158,2007-03-01T00:00:00,Prostate-Specific Antigen,D08.811.277.656.959.350.442.750
17382158,2007-03-01T00:00:00,Prostate-Specific Antigen,D12.776.866.249.500
17382158,2007-03-01T00:00:00,Prostate-Specific Antigen,D23.050.285.625
17382158,2007-03-01T00:00:00,Prostate-Specific Antigen,D23.101.840.625
17382158,2007-03-01T00:00:00,Prostatectomy,E04.950.774.860.625
17382158,2007-03-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
17382158,2007-03-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
17382158,2007-03-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
17382158,2007-03-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
17382158,2007-03-01T00:00:00,Protein-Tyrosine Kinases,D08.811.913.696.620.682.725
17382158,2007-03-01T00:00:00,Salvage Therapy,E02.186.800
17382158,2007-03-01T00:00:00,Salvage Therapy,E02.895
17382158,2007-03-01T00:00:00,Treatment Outcome,E01.789.800
17382158,2007-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17382158,2007-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17382186,2007-03-01T00:00:00,"Carcinoma, Renal Cell",C04.557.470.200.025.390
17382186,2007-03-01T00:00:00,"Carcinoma, Renal Cell",C04.588.945.947.535.160
17382186,2007-03-01T00:00:00,"Carcinoma, Renal Cell",C12.758.820.750.160
17382186,2007-03-01T00:00:00,"Carcinoma, Renal Cell",C12.777.419.473.160
17382186,2007-03-01T00:00:00,"Carcinoma, Renal Cell",C13.351.937.820.535.160
17382186,2007-03-01T00:00:00,"Carcinoma, Renal Cell",C13.351.968.419.473.160
17382186,2007-03-01T00:00:00,Cell Cycle,G04.299.134
17382186,2007-03-01T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
17382186,2007-03-01T00:00:00,Flow Cytometry,E05.200.500.386.350
17382186,2007-03-01T00:00:00,Kidney Neoplasms,C04.588.945.947.535
17382186,2007-03-01T00:00:00,Kidney Neoplasms,C12.758.820.750
17382186,2007-03-01T00:00:00,Kidney Neoplasms,C12.777.419.473
17382186,2007-03-01T00:00:00,Kidney Neoplasms,C13.351.937.820.535
17382186,2007-03-01T00:00:00,Kidney Neoplasms,C13.351.968.419.473
17382186,2007-03-01T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567
17382186,2007-03-01T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750
17382186,2007-03-01T00:00:00,Mitogen-Activated Protein Kinases,D12.644.360.450
17382186,2007-03-01T00:00:00,Mitogen-Activated Protein Kinases,D12.776.476.450
17382186,2007-03-01T00:00:00,Phosphorylation,G02.111.087.677
17382186,2007-03-01T00:00:00,Phosphorylation,G02.149.115.677
17382186,2007-03-01T00:00:00,Phosphorylation,G02.149.465.700
17382186,2007-03-01T00:00:00,Phosphorylation,G02.607.750.700
17382186,2007-03-01T00:00:00,Phosphorylation,G03.495.790
17382186,2007-03-01T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
17382186,2007-03-01T00:00:00,Protein Kinases,D08.811.913.696.620.682
17382186,2007-03-01T00:00:00,Quinazolines,D03.438.786
17382186,2007-03-01T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
17382186,2007-03-01T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
17382186,2007-03-01T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
17382186,2007-03-01T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
17388655,2007-03-01T00:00:00,Decision Making,F02.463.785.373
17388655,2007-03-01T00:00:00,Demography,I01.240
17388655,2007-03-01T00:00:00,Demography,N01.224
17388655,2007-03-01T00:00:00,Demography,N06.850.505.400
17388655,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17388655,2007-03-01T00:00:00,Mental Competency,F01.590
17388655,2007-03-01T00:00:00,Mental Competency,F02.410
17388655,2007-03-01T00:00:00,Mental Competency,I01.880.604.583.530
17388655,2007-03-01T00:00:00,Mental Competency,N03.706.535.625
17388655,2007-03-01T00:00:00,Treatment Outcome,E01.789.800
17388655,2007-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17388655,2007-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17388655,2007-03-01T00:00:00,United States,Z01.107.567.875
17388715,2007-03-01T00:00:00,Aged,M01.060.116.100
17388715,2007-03-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
17388715,2007-03-01T00:00:00,Alzheimer Disease,C10.574.945.249
17388715,2007-03-01T00:00:00,Alzheimer Disease,F03.087.400.100
17388715,2007-03-01T00:00:00,Demography,I01.240
17388715,2007-03-01T00:00:00,Demography,N01.224
17388715,2007-03-01T00:00:00,Demography,N06.850.505.400
17388715,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17388715,2007-03-01T00:00:00,Middle Aged,M01.060.116.630
17388715,2007-03-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
17388715,2007-03-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
17388715,2007-03-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
17388715,2007-03-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
17388715,2007-03-01T00:00:00,Research Design,E05.581.500
17388715,2007-03-01T00:00:00,Research Design,H01.770.644.728
17388732,2007-03-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
17388732,2007-03-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
17388732,2007-03-01T00:00:00,Health Status,I01.240.425
17388732,2007-03-01T00:00:00,Health Status,N01.224.425
17388732,2007-03-01T00:00:00,Health Status,N06.850.505.400.425
17388732,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17388732,2007-03-01T00:00:00,Patient Education as Topic,I02.233.332.500
17388732,2007-03-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
17388732,2007-03-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
17388732,2007-03-01T00:00:00,Primary Prevention,N02.421.726.758
17388732,2007-03-01T00:00:00,Primary Prevention,N06.850.780.680
17388732,2007-03-01T00:00:00,Quality of Life,I01.800
17388732,2007-03-01T00:00:00,Quality of Life,K01.752.400.750
17388732,2007-03-01T00:00:00,Substance Abuse Detection,E05.885
17388732,2007-03-01T00:00:00,Substance Abuse Detection,N06.850.780.500.765
17388732,2007-03-01T00:00:00,Substance-Related Disorders,C21.739
17388732,2007-03-01T00:00:00,Substance-Related Disorders,F03.900
17388732,2007-03-01T00:00:00,United States,Z01.107.567.875
17392385,2007-03-01T00:00:00,Breast Neoplasms,C04.588.180
17392385,2007-03-01T00:00:00,Breast Neoplasms,C17.800.090.500
17392385,2007-03-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17392385,2007-03-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
17392385,2007-03-01T00:00:00,Genetic Testing,E01.370.427
17392385,2007-03-01T00:00:00,Genetic Testing,E05.393.435
17392385,2007-03-01T00:00:00,Genetic Testing,N02.421.143.827.233.221
17392385,2007-03-01T00:00:00,Genetic Testing,N02.421.308.430
17392385,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17392385,2007-03-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17392385,2007-03-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17392385,2007-03-01T00:00:00,Mammography,E01.370.350.700.500
17392385,2007-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17392385,2007-03-01T00:00:00,Risk Factors,N05.715.350.200.700
17392385,2007-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17392385,2007-03-01T00:00:00,Risk Factors,N06.850.490.625.750
17392385,2007-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17408132,2007-03-01T00:00:00,Documentation,L01.453.245
17408132,2007-03-01T00:00:00,Family Practice,H02.403.280
17408132,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17408132,2007-03-01T00:00:00,Immunization Programs,N02.421.143.827.608
17408132,2007-03-01T00:00:00,Immunization Programs,N02.421.726.608
17408132,2007-03-01T00:00:00,United States,Z01.107.567.875
17408132,2007-03-01T00:00:00,Vaccines,D20.215.894
17414336,2007-03-01T00:00:00,Adolescent,M01.060.057
17414336,2007-03-01T00:00:00,Adult,M01.060.116
17414336,2007-03-01T00:00:00,Aged,M01.060.116.100
17414336,2007-03-01T00:00:00,Child,M01.060.406
17414336,2007-03-01T00:00:00,"Child, Preschool",M01.060.406.448
17414336,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17414336,2007-03-01T00:00:00,Infant,M01.060.703
17414336,2007-03-01T00:00:00,Middle Aged,M01.060.116.630
17414336,2007-03-01T00:00:00,Personnel Staffing and Scheduling,N04.452.677.650
17414336,2007-03-01T00:00:00,Resource Allocation,I01.261.750
17414336,2007-03-01T00:00:00,Time Factors,G01.910.857
17414336,2007-03-01T00:00:00,Trauma Centers,N02.278.354.422.336.500
17414336,2007-03-01T00:00:00,Trauma Centers,N02.421.297.195.480
17414336,2007-03-01T00:00:00,Trauma Centers,N04.452.442.422.336.400
17414336,2007-03-01T00:00:00,Wounds and Injuries,C21.866
17424881,2007-03-01T00:00:00,Adult,M01.060.116
17424881,2007-03-01T00:00:00,Endoscopy,E01.370.388.250
17424881,2007-03-01T00:00:00,Endoscopy,E04.800.250
17424881,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17424881,2007-03-01T00:00:00,Middle Aged,M01.060.116.630
17424881,2007-03-01T00:00:00,Otorhinolaryngologic Surgical Procedures,E04.580
17424881,2007-03-01T00:00:00,Postoperative Complications,C23.550.767
17426306,2007-03-01T00:00:00,Adult,M01.060.116
17426306,2007-03-01T00:00:00,Ambulatory Care,E02.760.106
17426306,2007-03-01T00:00:00,Ambulatory Care,N02.421.585.106
17426306,2007-03-01T00:00:00,Delivery of Health Care,N04.590.374
17426306,2007-03-01T00:00:00,Delivery of Health Care,N05.300
17426306,2007-03-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
17426306,2007-03-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
17426306,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17426306,2007-03-01T00:00:00,Middle Aged,M01.060.116.630
17426306,2007-03-01T00:00:00,"Physicians, Family",M01.526.485.810.770
17426306,2007-03-01T00:00:00,"Physicians, Family",N02.360.810.770
17426306,2007-03-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17426306,2007-03-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17427317,2007-03-01T00:00:00,Analgesics,D27.505.696.663.850.014
17427317,2007-03-01T00:00:00,Analgesics,D27.505.954.427.040
17427317,2007-03-01T00:00:00,Animals,B01.050
17427317,2007-03-01T00:00:00,Laboratory Animal Science,H01.158.273.368
17427317,2007-03-01T00:00:00,Pain,C10.597.617
17427317,2007-03-01T00:00:00,Pain,C23.888.592.612
17427317,2007-03-01T00:00:00,Pain,C23.888.646
17427317,2007-03-01T00:00:00,Pain,F02.830.816.444
17427317,2007-03-01T00:00:00,Pain,G11.561.600.810.444
17427317,2007-03-01T00:00:00,Pain Measurement,E01.370.376.550.600
17427317,2007-03-01T00:00:00,Rabbits,B01.050.150.900.649.521.700
17440316,2007-03-01T00:00:00,Attitude of Health Personnel,F01.100.050
17440316,2007-03-01T00:00:00,Attitude of Health Personnel,N05.300.100
17440316,2007-03-01T00:00:00,Clinical Nursing Research,H02.478.395.234
17440316,2007-03-01T00:00:00,Clinical Nursing Research,N04.590.233.508.613.234
17440316,2007-03-01T00:00:00,Diffusion of Innovation,L01.143.320
17440316,2007-03-01T00:00:00,Evidence-Based Medicine,H02.249.750
17440316,2007-03-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
17440316,2007-03-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
17440316,2007-03-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
17440316,2007-03-01T00:00:00,"Hospitals, Community",N02.278.421.306
17440316,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17440316,2007-03-01T00:00:00,Interprofessional Relations,F01.829.401.205
17440316,2007-03-01T00:00:00,Nurse Administrators,M01.526.070.670
17440316,2007-03-01T00:00:00,Nurse Administrators,M01.526.485.650.580
17440316,2007-03-01T00:00:00,Nurse Administrators,N02.360.650.580
17440316,2007-03-01T00:00:00,Nurse's Role,F01.829.316.616.625.450
17440316,2007-03-01T00:00:00,Nurse's Role,N05.300.100.337
17440316,2007-03-01T00:00:00,"Nursing Staff, Hospital",M01.526.485.680.490
17440316,2007-03-01T00:00:00,"Nursing Staff, Hospital",M01.526.485.740.523
17440316,2007-03-01T00:00:00,"Nursing Staff, Hospital",N02.360.680.490
17440316,2007-03-01T00:00:00,"Nursing Staff, Hospital",N02.360.740.523
17440316,2007-03-01T00:00:00,Social Support,I01.880.656.600
17440316,2007-03-01T00:00:00,Workload,N04.452.677.950
17446459,2007-03-01T00:00:00,Animals,B01.050
17446459,2007-03-01T00:00:00,Cardiomegaly,C14.280.195
17446459,2007-03-01T00:00:00,Cardiomegaly,C23.300.775.250
17446459,2007-03-01T00:00:00,Gene Expression Regulation,G05.355.315
17446459,2007-03-01T00:00:00,Myocardium,A02.633.580
17446459,2007-03-01T00:00:00,Myocardium,A07.541.704
17446459,2007-03-01T00:00:00,Myocardium,A10.690.552.750
17446459,2007-03-01T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
17446459,2007-03-01T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
17446459,2007-03-01T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
17446459,2007-03-01T00:00:00,Sodium-Calcium Exchanger,D12.776.157.530.450.162.442
17446459,2007-03-01T00:00:00,Sodium-Calcium Exchanger,D12.776.543.585.450.162.442
17446459,2007-03-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
17446459,2007-03-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
17446459,2007-03-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
17446459,2007-03-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
17453607,2007-03-01T00:00:00,Brain,A08.186.211
17453607,2007-03-01T00:00:00,Cocaine-Related Disorders,C21.739.300
17453607,2007-03-01T00:00:00,Cocaine-Related Disorders,F03.900.300
17453607,2007-03-01T00:00:00,Dopamine,D02.092.211.215.311.342
17453607,2007-03-01T00:00:00,Dopamine,D02.092.311.342
17453607,2007-03-01T00:00:00,Drug Therapy,E02.319
17453607,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17453607,2007-03-01T00:00:00,Learning,F02.463.425
17453607,2007-03-01T00:00:00,Learning,F02.784.629.529
17453607,2007-03-01T00:00:00,Neuronal Plasticity,G11.561.600.635
17453607,2007-03-01T00:00:00,Synaptic Transmission,G02.111.087.800.850
17453607,2007-03-01T00:00:00,Synaptic Transmission,G02.149.115.800.850
17453607,2007-03-01T00:00:00,Synaptic Transmission,G04.299.880.850
17453607,2007-03-01T00:00:00,Synaptic Transmission,G07.265.337.900
17453607,2007-03-01T00:00:00,Synaptic Transmission,G07.700.240.900
17453607,2007-03-01T00:00:00,Synaptic Transmission,G11.561.600.835
17453618,2007-03-01T00:00:00,Adult,M01.060.116
17453618,2007-03-01T00:00:00,Amines,D02.092
17453618,2007-03-01T00:00:00,Anti-Anxiety Agents,D27.505.696.277.950.015
17453618,2007-03-01T00:00:00,Anti-Anxiety Agents,D27.505.954.427.210.950.015
17453618,2007-03-01T00:00:00,Anti-Anxiety Agents,D27.505.954.427.700.872.015
17453618,2007-03-01T00:00:00,Anxiety Disorders,F03.080
17453618,2007-03-01T00:00:00,Cyclohexanecarboxylic Acids,D02.241.223.268
17453618,2007-03-01T00:00:00,Cyclohexanecarboxylic Acids,D02.455.426.392.368.367.218
17453618,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17453618,2007-03-01T00:00:00,Substance-Related Disorders,C21.739
17453618,2007-03-01T00:00:00,Substance-Related Disorders,F03.900
17453618,2007-03-01T00:00:00,gamma-Aminobutyric Acid,D02.241.081.160.050.350
17453618,2007-03-01T00:00:00,gamma-Aminobutyric Acid,D12.125.190.350
17461806,2007-03-01T00:00:00,Child,M01.060.406
17461806,2007-03-01T00:00:00,Dermatologic Agents,D27.505.954.444
17461806,2007-03-01T00:00:00,Glucocorticoids,D06.472.040.543
17461806,2007-03-01T00:00:00,Glucocorticoids,D27.505.696.399.472.488
17461806,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17472872,2007-03-01T00:00:00,Blood Proteins,D12.776.124
17472872,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17472872,2007-03-01T00:00:00,Malnutrition,C18.654.521
17472872,2007-03-01T00:00:00,Mass Screening,E01.370.500
17472872,2007-03-01T00:00:00,Mass Screening,E05.318.308.250.580
17472872,2007-03-01T00:00:00,Mass Screening,N02.421.143.827.233.443
17472872,2007-03-01T00:00:00,Mass Screening,N02.421.726.233.443
17472872,2007-03-01T00:00:00,Mass Screening,N05.715.360.300.375.500
17472872,2007-03-01T00:00:00,Mass Screening,N06.850.520.308.250.580
17472872,2007-03-01T00:00:00,Mass Screening,N06.850.780.500
17472872,2007-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17472872,2007-03-01T00:00:00,Risk Factors,N05.715.350.200.700
17472872,2007-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17472872,2007-03-01T00:00:00,Risk Factors,N06.850.490.625.750
17472872,2007-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17621505,2007-03-01T00:00:00,Adolescent,M01.060.057
17621505,2007-03-01T00:00:00,Brain,A08.186.211
17621505,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17621505,2007-03-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17621505,2007-03-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17667882,2007-03-01T00:00:00,Brain Ischemia,C10.228.140.300.150
17667882,2007-03-01T00:00:00,Brain Ischemia,C14.907.253.092
17667882,2007-03-01T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
17667882,2007-03-01T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
17667882,2007-03-01T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
17667882,2007-03-01T00:00:00,Certification,N03.706.110.120
17667882,2007-03-01T00:00:00,Certification,N05.700.200.190
17667882,2007-03-01T00:00:00,Critical Pathways,N04.590.233.624.625
17667882,2007-03-01T00:00:00,Critical Pathways,N04.590.275
17667882,2007-03-01T00:00:00,"Hospitals, Community",N02.278.421.306
17667882,2007-03-01T00:00:00,"Hospitals, University",N02.278.020.300.310
17667882,2007-03-01T00:00:00,"Hospitals, University",N02.278.421.639.725
17667882,2007-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17667882,2007-03-01T00:00:00,Intensive Care,E02.760.190.400
17667882,2007-03-01T00:00:00,Intensive Care,N02.421.585.190.400
17667882,2007-03-01T00:00:00,Referral and Consultation,N04.452.758.849
17667882,2007-03-01T00:00:00,Stroke,C10.228.140.300.775
17667882,2007-03-01T00:00:00,Stroke,C14.907.253.855
17667882,2007-03-01T00:00:00,United States,Z01.107.567.875
17334850,2007-03-02T00:00:00,Animals,B01.050
17334850,2007-03-02T00:00:00,Cochlea,A09.246.631.246
17334850,2007-03-02T00:00:00,Membrane Proteins,D12.776.543
17334850,2007-03-02T00:00:00,"RNA, Messenger",D13.444.735.544
17334850,2007-03-02T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17334850,2007-03-02T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17332540,2007-03-03T00:00:00,Certification,N03.706.110.120
17332540,2007-03-03T00:00:00,Certification,N05.700.200.190
17332540,2007-03-03T00:00:00,Health Policy,I01.880.604.825.608.400
17332540,2007-03-03T00:00:00,Health Policy,N03.706.825.608.428
17332540,2007-03-03T00:00:00,Licensure,N03.706.110.510
17332540,2007-03-03T00:00:00,Licensure,N05.700.200.450
17332540,2007-03-03T00:00:00,Physicians,M01.526.485.810
17332540,2007-03-03T00:00:00,Physicians,N02.360.810
17339335,2007-03-05T00:00:00,Animals,B01.050
17339335,2007-03-05T00:00:00,"Antigens, CD44",D12.776.395.550.200.625.144
17339335,2007-03-05T00:00:00,"Antigens, CD44",D12.776.543.550.200.625.144
17339335,2007-03-05T00:00:00,"Antigens, CD44",D12.776.543.750.705.877.144
17339335,2007-03-05T00:00:00,"Antigens, CD44",D23.050.301.264.035.850.144
17339335,2007-03-05T00:00:00,"Antigens, CD44",D23.050.301.350.625.144
17339335,2007-03-05T00:00:00,"Antigens, CD44",D23.101.100.110.850.144
17339335,2007-03-05T00:00:00,Cell Proliferation,G04.299.233.750
17339335,2007-03-05T00:00:00,Cell Proliferation,G07.700.320.249.410.750
17339335,2007-03-05T00:00:00,Cyclin-Dependent Kinase Inhibitor p16,D12.644.360.225.200
17339335,2007-03-05T00:00:00,Cyclin-Dependent Kinase Inhibitor p16,D12.776.167.187.200
17339335,2007-03-05T00:00:00,Cyclin-Dependent Kinase Inhibitor p16,D12.776.476.225.200
17339335,2007-03-05T00:00:00,Cyclin-Dependent Kinase Inhibitor p16,D12.776.624.776.355.200
17339335,2007-03-05T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.644.360.225.600
17339335,2007-03-05T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.776.167.187.600
17339335,2007-03-05T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.776.476.225.600
17339335,2007-03-05T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.776.624.776.355.600
17339335,2007-03-05T00:00:00,Gene Expression Regulation,G05.355.315
17339335,2007-03-05T00:00:00,Homeostasis,G07.700.360
17339335,2007-03-05T00:00:00,Lymphocytes,A11.118.637.555.567
17339335,2007-03-05T00:00:00,Lymphocytes,A15.145.229.637.555.567
17339335,2007-03-05T00:00:00,Lymphocytes,A15.382.490.555.567
17339335,2007-03-05T00:00:00,Molecular Sequence Data,L01.453.245.667
17339335,2007-03-05T00:00:00,Phenotype,G05.695
17339335,2007-03-05T00:00:00,Protein Isoforms,D12.776.800
17339335,2007-03-05T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.260.665.100
17339335,2007-03-05T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.624.664.700.175.100
17339335,2007-03-05T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.930.635.100
17339335,2007-03-05T00:00:00,Spleen,A10.549.700
17339335,2007-03-05T00:00:00,Spleen,A15.382.520.604.700
17339335,2007-03-05T00:00:00,Thymus Gland,A10.549.750
17339335,2007-03-05T00:00:00,Thymus Gland,A15.382.520.604.750
17339335,2007-03-05T00:00:00,"Transcription, Genetic",G02.111.087.847
17339335,2007-03-05T00:00:00,"Transcription, Genetic",G02.149.115.847
17339335,2007-03-05T00:00:00,"Transcription, Genetic",G05.355.310.700
17339043,2007-03-06T00:00:00,Age Factors,N05.715.350.075
17339043,2007-03-06T00:00:00,Age Factors,N06.850.490.250
17339043,2007-03-06T00:00:00,Child Psychology,F04.096.628.193
17339043,2007-03-06T00:00:00,Face,A01.456.505
17339043,2007-03-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17339043,2007-03-06T00:00:00,Infant,M01.060.703
17339043,2007-03-06T00:00:00,Professional Competence,I02.399.630
17339043,2007-03-06T00:00:00,Social Perception,F02.463.593.752
17339043,2007-03-06T00:00:00,Visual Perception,F02.463.593.932
17341063,2007-03-07T00:00:00,Protons,D01.248.497.300.459.700
17341063,2007-03-07T00:00:00,Protons,D01.435.550
17341063,2007-03-07T00:00:00,Protons,G01.249.765
17341729,2007-03-07T00:00:00,Adenocarcinoma,C04.557.470.200.025
17341729,2007-03-07T00:00:00,Animals,B01.050
17341729,2007-03-07T00:00:00,Antineoplastic Agents,D27.505.954.248
17341729,2007-03-07T00:00:00,Bacterial Toxins,D23.946.123
17341729,2007-03-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17341729,2007-03-07T00:00:00,Prostate-Specific Antigen,D08.811.277.656.300.760.442.750
17341729,2007-03-07T00:00:00,Prostate-Specific Antigen,D08.811.277.656.959.350.442.750
17341729,2007-03-07T00:00:00,Prostate-Specific Antigen,D12.776.866.249.500
17341729,2007-03-07T00:00:00,Prostate-Specific Antigen,D23.050.285.625
17341729,2007-03-07T00:00:00,Prostate-Specific Antigen,D23.101.840.625
17341729,2007-03-07T00:00:00,Prostatic Hyperplasia,C12.294.565.500
17341729,2007-03-07T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
17341729,2007-03-07T00:00:00,Prostatic Neoplasms,C12.294.260.750
17341729,2007-03-07T00:00:00,Prostatic Neoplasms,C12.294.565.625
17341729,2007-03-07T00:00:00,Prostatic Neoplasms,C12.758.409.750
17341729,2007-03-07T00:00:00,Research Design,E05.581.500
17341729,2007-03-07T00:00:00,Research Design,H01.770.644.728
17341729,2007-03-07T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
17341729,2007-03-07T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
17341729,2007-03-07T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
17341729,2007-03-07T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
17341729,2007-03-07T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
17344359,2007-03-07T00:00:00,Adult,M01.060.116
17344359,2007-03-07T00:00:00,Antifungal Agents,D27.505.954.122.136
17344359,2007-03-07T00:00:00,Diabetes Mellitus,C18.452.394.750
17344359,2007-03-07T00:00:00,Diabetes Mellitus,C19.246
17344359,2007-03-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17344359,2007-03-07T00:00:00,Triazoles,D03.383.129.799
17347138,2007-03-07T00:00:00,Animals,B01.050
17347138,2007-03-07T00:00:00,Anticarcinogenic Agents,D27.505.696.706.018
17347138,2007-03-07T00:00:00,Anticarcinogenic Agents,D27.505.954.248.125
17347138,2007-03-07T00:00:00,Anticarcinogenic Agents,D27.720.799.018
17347138,2007-03-07T00:00:00,Biological Markers,D23.101
17347138,2007-03-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17347138,2007-03-07T00:00:00,Isothiocyanates,D02.500.375
17347138,2007-03-07T00:00:00,Isothiocyanates,D02.886.250
17347138,2007-03-07T00:00:00,Pilot Projects,E05.318.760.750
17347138,2007-03-07T00:00:00,Pilot Projects,E05.337.737
17347138,2007-03-07T00:00:00,Pilot Projects,N05.715.360.775.625
17347138,2007-03-07T00:00:00,Pilot Projects,N06.850.520.450.720
17347138,2007-03-07T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17347138,2007-03-07T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17443369,2007-03-08T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
17443369,2007-03-08T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
17443369,2007-03-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17443369,2007-03-08T00:00:00,Middle Aged,M01.060.116.630
17443369,2007-03-08T00:00:00,Patient Compliance,F01.145.488.500
17443369,2007-03-08T00:00:00,Patient Compliance,N05.300.150.600.600
17443369,2007-03-08T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
17443369,2007-03-08T00:00:00,Practice Guidelines as Topic,N05.700.350.650
17443369,2007-03-08T00:00:00,Primary Health Care,N04.590.233.727
17350148,2007-03-09T00:00:00,Geologic Sediments,G01.311.500
17350148,2007-03-09T00:00:00,Geologic Sediments,G16.500.320
17350148,2007-03-09T00:00:00,Radiation Monitoring,E05.799.638
17350148,2007-03-09T00:00:00,Radiation Monitoring,N06.850.780.375.700
17350148,2007-03-09T00:00:00,Radiation Monitoring,N06.850.810.370
17350148,2007-03-09T00:00:00,Radium,D01.268.271.770
17350148,2007-03-09T00:00:00,Radium,D01.268.552.775
17350148,2007-03-09T00:00:00,Radium,D01.268.556.775
17350148,2007-03-09T00:00:00,Radium,D01.552.539.745
17350148,2007-03-09T00:00:00,Radium,D01.552.544.775
17350148,2007-03-09T00:00:00,Rivers,G01.311.750
17350148,2007-03-09T00:00:00,Rivers,G16.500.275.280.500
17350148,2007-03-09T00:00:00,Rivers,N06.230.232.500
17350148,2007-03-09T00:00:00,South Carolina,Z01.107.567.875.075.662
17350148,2007-03-09T00:00:00,South Carolina,Z01.107.567.875.750.700
17350148,2007-03-09T00:00:00,Uranium,D01.268.033.950
17350148,2007-03-09T00:00:00,Uranium,D01.268.271.100.950
17350148,2007-03-09T00:00:00,Uranium,D01.268.556.900
17350148,2007-03-09T00:00:00,Uranium,D01.552.020.940
17350148,2007-03-09T00:00:00,Uranium,D01.552.544.900
17350148,2007-03-09T00:00:00,"Water Pollutants, Radioactive",D20.693.903
17350148,2007-03-09T00:00:00,"Water Pollutants, Radioactive",D27.888.284.903.821
17351091,2007-03-09T00:00:00,"Biodegradation, Environmental",N06.850.460.375.500
17351091,2007-03-09T00:00:00,"Biodegradation, Environmental",N06.850.860.510.900.299
17351091,2007-03-09T00:00:00,Chlorine,D01.268.380.150
17351091,2007-03-09T00:00:00,Chlorine,D01.362.225
17351091,2007-03-09T00:00:00,Computational Biology,H01.158.273.180
17351091,2007-03-09T00:00:00,Electrophoresis,E05.196.401
17351091,2007-03-09T00:00:00,Electrophoresis,E05.301.300
17351091,2007-03-09T00:00:00,Electrophoresis,G02.149.767.570
17351091,2007-03-09T00:00:00,Electrophoresis,G02.842.750.570
17351091,2007-03-09T00:00:00,Environmental Pollutants,D27.888.284
17351091,2007-03-09T00:00:00,Geologic Sediments,G01.311.500
17351091,2007-03-09T00:00:00,Geologic Sediments,G16.500.320
17351091,2007-03-09T00:00:00,Molecular Sequence Data,L01.453.245.667
17351091,2007-03-09T00:00:00,Molecular Structure,G02.111.570
17351091,2007-03-09T00:00:00,Molecular Structure,G02.575
17351091,2007-03-09T00:00:00,Molecular Structure,G02.842.575
17351091,2007-03-09T00:00:00,"Sequence Analysis, DNA",E05.393.760.700
17503110,2007-03-09T00:00:00,Adolescent,M01.060.057
17503110,2007-03-09T00:00:00,Adult,M01.060.116
17503110,2007-03-09T00:00:00,Aged,M01.060.116.100
17503110,2007-03-09T00:00:00,Cardiovascular Diseases,C14
17503110,2007-03-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17503110,2007-03-09T00:00:00,Middle Aged,M01.060.116.630
17503110,2007-03-09T00:00:00,Obesity,C18.654.726.500
17503110,2007-03-09T00:00:00,Obesity,C23.888.144.699.500
17503110,2007-03-09T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
17503110,2007-03-09T00:00:00,Obesity,G07.100.100.160.120.699.500
17503110,2007-03-09T00:00:00,Risk Factors,E05.318.740.600.800.725
17503110,2007-03-09T00:00:00,Risk Factors,N05.715.350.200.700
17503110,2007-03-09T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17503110,2007-03-09T00:00:00,Risk Factors,N06.850.490.625.750
17503110,2007-03-09T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17503110,2007-03-09T00:00:00,Smoking,F01.145.466.753
17503110,2007-03-09T00:00:00,Time Factors,G01.910.857
17503110,2007-03-09T00:00:00,United States,Z01.107.567.875
17353195,2007-03-12T00:00:00,Amino Acid Sequence,G02.111.570.060
17353195,2007-03-12T00:00:00,Amino Acid Sequence,L01.453.245.667.060
17353195,2007-03-12T00:00:00,Animals,B01.050
17353195,2007-03-12T00:00:00,Cattle,B01.050.150.900.649.077.380.271
17353195,2007-03-12T00:00:00,GTP-Binding Protein gamma Subunits,D12.644.360.375.730
17353195,2007-03-12T00:00:00,GTP-Binding Protein gamma Subunits,D12.776.157.325.332.730
17353195,2007-03-12T00:00:00,GTP-Binding Protein gamma Subunits,D12.776.476.375.730
17353195,2007-03-12T00:00:00,GTP-Binding Protein gamma Subunits,D12.776.543.325.625
17353195,2007-03-12T00:00:00,Heterotrimeric GTP-Binding Proteins,D08.811.277.040.330.300.200
17353195,2007-03-12T00:00:00,Heterotrimeric GTP-Binding Proteins,D12.644.360.375
17353195,2007-03-12T00:00:00,Heterotrimeric GTP-Binding Proteins,D12.776.157.325.332
17353195,2007-03-12T00:00:00,Heterotrimeric GTP-Binding Proteins,D12.776.476.375
17353195,2007-03-12T00:00:00,Heterotrimeric GTP-Binding Proteins,D12.776.543.325
17353195,2007-03-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17353195,2007-03-12T00:00:00,Kidney,A05.810.453
17353195,2007-03-12T00:00:00,Molecular Sequence Data,L01.453.245.667
17353195,2007-03-12T00:00:00,Neuroblastoma,C04.557.465.625.600.590.650.550
17353195,2007-03-12T00:00:00,Neuroblastoma,C04.557.470.670.590.650.550
17353195,2007-03-12T00:00:00,Neuroblastoma,C04.557.580.625.600.590.650.550
17353195,2007-03-12T00:00:00,"Protein Processing, Post-Translational",G02.111.087.675.871.790.600
17353195,2007-03-12T00:00:00,"Protein Processing, Post-Translational",G02.111.087.693.600
17353195,2007-03-12T00:00:00,"Protein Processing, Post-Translational",G02.149.115.675.871.790.600
17353195,2007-03-12T00:00:00,"Protein Processing, Post-Translational",G02.149.115.693.600
17353195,2007-03-12T00:00:00,"Protein Processing, Post-Translational",G03.495.770.871.790.600
17353195,2007-03-12T00:00:00,"Protein Processing, Post-Translational",G05.355.315.670.600
17353195,2007-03-12T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17353195,2007-03-12T00:00:00,"Sequence Homology, Amino Acid",G02.111.810.200
17353195,2007-03-12T00:00:00,"Sequence Homology, Amino Acid",G05.810.200
17353195,2007-03-12T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
17353499,2007-03-12T00:00:00,Adult,M01.060.116
17353499,2007-03-12T00:00:00,Biological Markers,D23.101
17353499,2007-03-12T00:00:00,Blood Pressure,E01.370.600.875.249
17353499,2007-03-12T00:00:00,Blood Pressure,G09.330.380.076
17353499,2007-03-12T00:00:00,Body Mass Index,E01.370.600.115.100.125
17353499,2007-03-12T00:00:00,Body Mass Index,E05.041.124.125
17353499,2007-03-12T00:00:00,Body Mass Index,G07.100.100.125
17353499,2007-03-12T00:00:00,Body Mass Index,N06.850.505.200.100.175
17353499,2007-03-12T00:00:00,C-Reactive Protein,D12.776.034.145
17353499,2007-03-12T00:00:00,C-Reactive Protein,D12.776.124.050.120
17353499,2007-03-12T00:00:00,C-Reactive Protein,D12.776.124.486.157
17353499,2007-03-12T00:00:00,Dietary Supplements,J02.500.456
17353499,2007-03-12T00:00:00,Disease Progression,C23.550.291.656
17353499,2007-03-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17353499,2007-03-12T00:00:00,Hypertension,C14.907.489
17353499,2007-03-12T00:00:00,Treatment Outcome,E01.789.800
17353499,2007-03-12T00:00:00,Treatment Outcome,N04.761.559.590.800
17353499,2007-03-12T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17448631,2007-03-12T00:00:00,Adult,M01.060.116
17448631,2007-03-12T00:00:00,Alcohol-Related Disorders,C21.739.100
17448631,2007-03-12T00:00:00,Alcohol-Related Disorders,F03.900.100
17448631,2007-03-12T00:00:00,"Depressive Disorder, Major",F03.600.300.375
17448631,2007-03-12T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
17448631,2007-03-12T00:00:00,Double-Blind Method,E05.318.780.300
17448631,2007-03-12T00:00:00,Double-Blind Method,E05.581.500.300
17448631,2007-03-12T00:00:00,Double-Blind Method,N05.715.360.780.320
17448631,2007-03-12T00:00:00,Double-Blind Method,N06.850.520.445.300
17448631,2007-03-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17448631,2007-03-12T00:00:00,Paroxetine,D03.383.621.600
17448631,2007-03-12T00:00:00,Phobic Disorders,F03.080.725
17448631,2007-03-12T00:00:00,Psychiatric Status Rating Scales,F04.586
17448631,2007-03-12T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.600.850
17448631,2007-03-12T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.850.900
17448631,2007-03-12T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.600.850
17448631,2007-03-12T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.850.900
17448631,2007-03-12T00:00:00,Treatment Outcome,E01.789.800
17448631,2007-03-12T00:00:00,Treatment Outcome,N04.761.559.590.800
17448631,2007-03-12T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17353047,2007-03-13T00:00:00,Animals,B01.050
17353047,2007-03-13T00:00:00,Calcium,D01.268.552.100
17353047,2007-03-13T00:00:00,Calcium,D01.552.539.288
17353047,2007-03-13T00:00:00,Calcium,D23.119.100
17353047,2007-03-13T00:00:00,Collagen,D05.750.078.280
17353047,2007-03-13T00:00:00,Collagen,D12.776.860.300.250
17353047,2007-03-13T00:00:00,Electrophoresis,E05.196.401
17353047,2007-03-13T00:00:00,Electrophoresis,E05.301.300
17353047,2007-03-13T00:00:00,Electrophoresis,G02.149.767.570
17353047,2007-03-13T00:00:00,Electrophoresis,G02.842.750.570
17353047,2007-03-13T00:00:00,Glycosaminoglycans,D09.698.373
17353047,2007-03-13T00:00:00,Heart Valve Prosthesis,E07.695.310
17353047,2007-03-13T00:00:00,Neomycin,D09.408.051.623
17353047,2007-03-13T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17353047,2007-03-13T00:00:00,Swine,B01.050.150.900.649.077.880
17353047,2007-03-13T00:00:00,Temperature,G01.906.595
17353047,2007-03-13T00:00:00,Temperature,G16.500.275.063.725.710
17353047,2007-03-13T00:00:00,Temperature,G16.500.750.775.710
17353047,2007-03-13T00:00:00,Temperature,N06.230.150.450
17353047,2007-03-13T00:00:00,Temperature,N06.230.300.100.725.710
17478150,2007-03-13T00:00:00,Body Mass Index,E01.370.600.115.100.125
17478150,2007-03-13T00:00:00,Body Mass Index,E05.041.124.125
17478150,2007-03-13T00:00:00,Body Mass Index,G07.100.100.125
17478150,2007-03-13T00:00:00,Body Mass Index,N06.850.505.200.100.175
17478150,2007-03-13T00:00:00,Coronary Disease,C14.280.647.250
17478150,2007-03-13T00:00:00,Coronary Disease,C14.907.585.250
17478150,2007-03-13T00:00:00,Diabetes Complications,C19.246.099
17478150,2007-03-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17478150,2007-03-13T00:00:00,Hypercholesterolemia,C18.452.584.500.500.396
17478150,2007-03-13T00:00:00,Hypertension,C14.907.489
17478150,2007-03-13T00:00:00,Life Style,F01.829.458
17478150,2007-03-13T00:00:00,Middle Aged,M01.060.116.630
17478150,2007-03-13T00:00:00,Risk Assessment,E05.318.740.600.800.715
17478150,2007-03-13T00:00:00,Risk Assessment,N04.452.871.715
17478150,2007-03-13T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17478150,2007-03-13T00:00:00,Risk Assessment,N06.850.505.715
17478150,2007-03-13T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17478150,2007-03-13T00:00:00,Smoking,F01.145.466.753
17330279,2007-03-15T00:00:00,"Adaptation, Psychological",F01.058
17330279,2007-03-15T00:00:00,Adult,M01.060.116
17330279,2007-03-15T00:00:00,"Arthritis, Rheumatoid",C05.550.114.154
17330279,2007-03-15T00:00:00,"Arthritis, Rheumatoid",C05.799.114
17330279,2007-03-15T00:00:00,"Arthritis, Rheumatoid",C17.300.775.099
17330279,2007-03-15T00:00:00,"Arthritis, Rheumatoid",C20.111.199
17330279,2007-03-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17330279,2007-03-15T00:00:00,Middle Aged,M01.060.116.630
17330279,2007-03-15T00:00:00,Perception,F02.463.593
17330279,2007-03-15T00:00:00,Psychometrics,F04.711.780
17330279,2007-03-15T00:00:00,Self Efficacy,F01.752.747.792.700
17330279,2007-03-15T00:00:00,Spouses,F01.829.263.500.660
17330279,2007-03-15T00:00:00,Spouses,I01.880.225.500.670
17330279,2007-03-15T00:00:00,Spouses,M01.816
17361426,2007-03-15T00:00:00,Adult,M01.060.116
17361426,2007-03-15T00:00:00,Algorithms,G17.035
17361426,2007-03-15T00:00:00,Algorithms,L01.224.050
17361426,2007-03-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17361426,2007-03-15T00:00:00,Lower Extremity,A01.378.610
17361426,2007-03-15T00:00:00,Motor Cortex,A08.186.211.730.885.287.500.270.548
17361426,2007-03-15T00:00:00,Neuronal Plasticity,G11.561.600.635
17361426,2007-03-15T00:00:00,"Recruitment, Neurophysiological",G07.265.337.600.760
17361426,2007-03-15T00:00:00,"Recruitment, Neurophysiological",G07.700.240.600.760
17361426,2007-03-15T00:00:00,"Recruitment, Neurophysiological",G11.561.600.620.760
17361426,2007-03-15T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
17361426,2007-03-15T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
17390594,2007-03-15T00:00:00,Disaster Planning,N06.230.100.035
17390594,2007-03-15T00:00:00,Disasters,N06.230.100
17390594,2007-03-15T00:00:00,Emergency Medical Services,N02.421.297
17390594,2007-03-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17390594,2007-03-15T00:00:00,Mental Disorders,F03
17390594,2007-03-15T00:00:00,Mental Health Services,F04.408
17390594,2007-03-15T00:00:00,Mental Health Services,N02.421.461
17390594,2007-03-15T00:00:00,"Models, Theoretical",E05.599
17390594,2007-03-15T00:00:00,"Physicians, Family",M01.526.485.810.770
17390594,2007-03-15T00:00:00,"Physicians, Family",N02.360.810.770
17390594,2007-03-15T00:00:00,Rescue Work,N06.230.100.350
17390594,2007-03-15T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17410778,2007-03-15T00:00:00,"Biodegradation, Environmental",N06.850.460.375.500
17410778,2007-03-15T00:00:00,"Biodegradation, Environmental",N06.850.860.510.900.299
17410778,2007-03-15T00:00:00,Durapatite,D01.146.360.050.300.200
17410778,2007-03-15T00:00:00,Durapatite,D01.578.122.477.300
17410778,2007-03-15T00:00:00,Durapatite,D01.695.625.675.650.075.025.300.150
17410778,2007-03-15T00:00:00,Nickel,D01.268.556.607
17410778,2007-03-15T00:00:00,Nickel,D01.268.956.625
17410778,2007-03-15T00:00:00,Nickel,D01.552.544.607
17410778,2007-03-15T00:00:00,Trichloroethylene,D02.455.526.439.939
17410778,2007-03-15T00:00:00,Uranium,D01.268.033.950
17410778,2007-03-15T00:00:00,Uranium,D01.268.271.100.950
17410778,2007-03-15T00:00:00,Uranium,D01.268.556.900
17410778,2007-03-15T00:00:00,Uranium,D01.552.020.940
17410778,2007-03-15T00:00:00,Uranium,D01.552.544.900
17374920,2007-03-16T00:00:00,Algorithms,G17.035
17374920,2007-03-16T00:00:00,Algorithms,L01.224.050
17374920,2007-03-16T00:00:00,Artifacts,E05.047
17374920,2007-03-16T00:00:00,Carotid Arteries,A07.231.114.186
17374920,2007-03-16T00:00:00,Computer Simulation,L01.224.160
17374920,2007-03-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17374920,2007-03-16T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
17374920,2007-03-16T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17374920,2007-03-16T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17374920,2007-03-16T00:00:00,"Models, Statistical",E05.318.740.500
17374920,2007-03-16T00:00:00,"Models, Statistical",E05.599.835
17374920,2007-03-16T00:00:00,"Models, Statistical",N05.715.360.750.530
17374920,2007-03-16T00:00:00,"Models, Statistical",N06.850.520.830.500
17374920,2007-03-16T00:00:00,"Models, Theoretical",E05.599
17374920,2007-03-16T00:00:00,"Phantoms, Imaging",E07.671
17374920,2007-03-16T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
17374920,2007-03-16T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
17374920,2007-03-16T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
17374920,2007-03-16T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
17374920,2007-03-16T00:00:00,Radiography,E01.370.350.700
17374920,2007-03-16T00:00:00,"Scattering, Radiation",E05.196.822
17374920,2007-03-16T00:00:00,"Scattering, Radiation",G01.595.861
17374920,2007-03-16T00:00:00,Synchrotrons,E07.710.680.700
17374920,2007-03-16T00:00:00,X-Rays,G01.201.875.750.918
17442303,2007-03-16T00:00:00,Animals,B01.050
17442303,2007-03-16T00:00:00,"Antiretroviral Therapy, Highly Active",E02.319.310.075
17442303,2007-03-16T00:00:00,Apoptosis,G04.299.139.160
17442303,2007-03-16T00:00:00,Cognition,F02.463.188
17442303,2007-03-16T00:00:00,Cognition Disorders,F03.087.250
17442303,2007-03-16T00:00:00,"Data Interpretation, Statistical",E05.245.380
17442303,2007-03-16T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
17442303,2007-03-16T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
17442303,2007-03-16T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
17442303,2007-03-16T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
17442303,2007-03-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17442303,2007-03-16T00:00:00,Macrophages,A11.329.372
17442303,2007-03-16T00:00:00,Macrophages,A11.627.482
17442303,2007-03-16T00:00:00,Macrophages,A11.733.397
17442303,2007-03-16T00:00:00,Macrophages,A15.382.680.397
17442303,2007-03-16T00:00:00,Macrophages,A15.382.812.522
17442303,2007-03-16T00:00:00,Maze Learning,F02.463.425.507
17442303,2007-03-16T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.567.342.500
17442303,2007-03-16T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.646.750.249.500
17442303,2007-03-16T00:00:00,Mitogen-Activated Protein Kinase 1,D12.644.360.450.169.500
17442303,2007-03-16T00:00:00,Mitogen-Activated Protein Kinase 1,D12.776.476.450.169.500
17442303,2007-03-16T00:00:00,Neurons,A08.663
17442303,2007-03-16T00:00:00,Neurons,A11.671
17442303,2007-03-16T00:00:00,"RNA, Messenger",D13.444.735.544
17442303,2007-03-16T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
17442303,2007-03-16T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
17442303,2007-03-16T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
17442303,2007-03-16T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
17442303,2007-03-16T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
17442303,2007-03-16T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
17442303,2007-03-16T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
17442303,2007-03-16T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
17442303,2007-03-16T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
17442303,2007-03-16T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
17442303,2007-03-16T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
17449024,2007-03-16T00:00:00,Animals,B01.050
17449024,2007-03-16T00:00:00,"Bone Morphogenetic Protein Receptors, Type I",D08.811.913.696.620.682.700.109.500
17449024,2007-03-16T00:00:00,"Bone Morphogenetic Protein Receptors, Type I",D12.776.543.750.750.400.049.500
17449024,2007-03-16T00:00:00,Carrier Proteins,D12.776.157
17449024,2007-03-16T00:00:00,Chick Embryo,A13.350.150
17449024,2007-03-16T00:00:00,Chick Embryo,A16.331.200
17449024,2007-03-16T00:00:00,Collagen,D05.750.078.280
17449024,2007-03-16T00:00:00,Collagen,D12.776.860.300.250
17449024,2007-03-16T00:00:00,Endocardium,A07.541.207
17449024,2007-03-16T00:00:00,Heart,A07.541
17449024,2007-03-16T00:00:00,Heart Atria,A07.541.358
17449024,2007-03-16T00:00:00,Heart Ventricles,A07.541.560
17449024,2007-03-16T00:00:00,Mesoderm,A16.504.660
17449024,2007-03-16T00:00:00,Myocardium,A02.633.580
17449024,2007-03-16T00:00:00,Myocardium,A07.541.704
17449024,2007-03-16T00:00:00,Myocardium,A10.690.552.750
17449024,2007-03-16T00:00:00,Signal Transduction,G02.111.087.800
17449024,2007-03-16T00:00:00,Signal Transduction,G02.149.115.800
17449024,2007-03-16T00:00:00,Signal Transduction,G04.299.880
17370039,2007-03-17T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
17370039,2007-03-17T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
17370039,2007-03-17T00:00:00,Cell Movement,G04.299.283
17370039,2007-03-17T00:00:00,Cell Movement,G07.700.560.500.180
17370039,2007-03-17T00:00:00,Ceramides,D02.065.313
17370039,2007-03-17T00:00:00,Ceramides,D09.400.410.420.525.200
17370039,2007-03-17T00:00:00,Ceramides,D10.390.470.675.200
17370039,2007-03-17T00:00:00,Ceramides,D10.570.877.360.612.200
17370039,2007-03-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17370039,2007-03-17T00:00:00,Interleukin-10,D12.644.276.374.465.510
17370039,2007-03-17T00:00:00,Interleukin-10,D12.776.467.374.465.510
17370039,2007-03-17T00:00:00,Interleukin-10,D23.529.374.465.510
17370039,2007-03-17T00:00:00,Mouth Neoplasms,C04.588.443.591
17370039,2007-03-17T00:00:00,Mouth Neoplasms,C07.465.565
17370039,2007-03-17T00:00:00,Phosphoprotein Phosphatases,D08.811.277.352.650.625
17372168,2007-03-19T00:00:00,Animals,B01.050
17372168,2007-03-19T00:00:00,"Aortic Aneurysm, Abdominal",C14.907.055.239.075
17372168,2007-03-19T00:00:00,"Aortic Aneurysm, Abdominal",C14.907.109.139.075
17372168,2007-03-19T00:00:00,Calcinosis,C18.452.174.130
17372168,2007-03-19T00:00:00,"Disease Models, Animal",C22.232
17372168,2007-03-19T00:00:00,"Disease Models, Animal",E05.598.500
17372168,2007-03-19T00:00:00,"Disease Models, Animal",E05.599.395.080
17372168,2007-03-19T00:00:00,Disease Progression,C23.550.291.656
17372168,2007-03-19T00:00:00,Elastin,D05.750.078.421
17372168,2007-03-19T00:00:00,Elastin,D12.776.860.300.350
17372168,2007-03-19T00:00:00,Fibroblasts,A11.329.228
17372168,2007-03-19T00:00:00,Fibroblasts,A11.872.228
17372168,2007-03-19T00:00:00,Hydrolyzable Tannins,D02.241.223.100.380.350.299
17372168,2007-03-19T00:00:00,Hydrolyzable Tannins,D02.241.511.390.350.299
17372168,2007-03-19T00:00:00,Hydrolyzable Tannins,D02.755.410.350.299
17372168,2007-03-19T00:00:00,Hydrolyzable Tannins,D05.750.078.937.214
17372168,2007-03-19T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.205.352
17372168,2007-03-19T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.252.420
17372168,2007-03-19T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.525.700.150
17372168,2007-03-19T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.205.352
17372168,2007-03-19T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.252.420
17372168,2007-03-19T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.525.700.150
17372168,2007-03-19T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.205.360
17372168,2007-03-19T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.252.445
17372168,2007-03-19T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.525.700.350
17372168,2007-03-19T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.205.360
17372168,2007-03-19T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.252.445
17372168,2007-03-19T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.525.700.350
17372168,2007-03-19T00:00:00,"Muscle, Smooth, Vascular",A02.633.570.491
17372168,2007-03-19T00:00:00,"Muscle, Smooth, Vascular",A07.231.491
17372168,2007-03-19T00:00:00,"Muscle, Smooth, Vascular",A10.690.467.491
17372168,2007-03-19T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
17372168,2007-03-19T00:00:00,Protein Denaturation,G02.111.087.685
17372168,2007-03-19T00:00:00,Protein Denaturation,G02.149.115.685
17372168,2007-03-19T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17372168,2007-03-19T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17372766,2007-03-20T00:00:00,Body Mass Index,E01.370.600.115.100.125
17372766,2007-03-20T00:00:00,Body Mass Index,E05.041.124.125
17372766,2007-03-20T00:00:00,Body Mass Index,G07.100.100.125
17372766,2007-03-20T00:00:00,Body Mass Index,N06.850.505.200.100.175
17372766,2007-03-20T00:00:00,Genome,G05.360.340
17372766,2007-03-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17372766,2007-03-20T00:00:00,Hypertension,C14.907.489
17374720,2007-03-20T00:00:00,Adult,M01.060.116
17374720,2007-03-20T00:00:00,Aging,G07.700.320.124
17374720,2007-03-20T00:00:00,Animals,B01.050
17374720,2007-03-20T00:00:00,Brain Mapping,E01.370.350.086
17374720,2007-03-20T00:00:00,Brain Mapping,E01.370.376.149
17374720,2007-03-20T00:00:00,Brain Mapping,E05.132
17374720,2007-03-20T00:00:00,Dentate Gyrus,A08.186.211.464.405.200
17374720,2007-03-20T00:00:00,Dentate Gyrus,A08.186.211.730.885.287.500.345.200
17374720,2007-03-20T00:00:00,Exercise,G11.427.590.237
17374720,2007-03-20T00:00:00,Exercise,I03.350
17374720,2007-03-20T00:00:00,Hippocampus,A08.186.211.464.405
17374720,2007-03-20T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
17374720,2007-03-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17374720,2007-03-20T00:00:00,Middle Aged,M01.060.116.630
17374720,2007-03-20T00:00:00,"Neovascularization, Pathologic",C23.550.589.500
17374720,2007-03-20T00:00:00,Neurons,A08.663
17374720,2007-03-20T00:00:00,Neurons,A11.671
17375068,2007-03-20T00:00:00,Animals,B01.050
17375068,2007-03-20T00:00:00,Cancer Vaccines,D20.215.894.200
17375068,2007-03-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17375068,2007-03-20T00:00:00,"Immunotherapy, Adoptive",E02.095.465.425.400.330.050.400
17375068,2007-03-20T00:00:00,"Immunotherapy, Adoptive",E05.478.550.520.050.400
17375068,2007-03-20T00:00:00,Neoplasms,C04
17375068,2007-03-20T00:00:00,Vaccination,E02.095.465.425.400.530.890
17375068,2007-03-20T00:00:00,Vaccination,E05.478.550.600.890
17375068,2007-03-20T00:00:00,Vaccination,N02.421.726.758.310.890
17375068,2007-03-20T00:00:00,Vaccination,N06.850.780.200.425.900
17375068,2007-03-20T00:00:00,Vaccination,N06.850.780.680.310.890
17376876,2007-03-21T00:00:00,Peptides,D12.644
17376876,2007-03-21T00:00:00,Protein Conformation,G02.111.570.790.709
17376876,2007-03-21T00:00:00,Protein Engineering,E05.393.420.601
17367952,2007-03-23T00:00:00,Animals,B01.050
17367952,2007-03-23T00:00:00,Calpain,D08.811.277.656.262.500.120
17367952,2007-03-23T00:00:00,Calpain,D08.811.277.656.300.200.120
17367952,2007-03-23T00:00:00,Motor Neurons,A08.663.655.500
17367952,2007-03-23T00:00:00,Motor Neurons,A11.671.655.500
17367952,2007-03-23T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17367952,2007-03-23T00:00:00,Time Factors,G01.910.857
17367952,2007-03-23T00:00:00,Tyrosine 3-Monooxygenase,D08.811.682.690.708.923
17367952,2007-03-23T00:00:00,Tyrosine 3-Monooxygenase,D12.776.556.579.374.925
17385037,2007-03-24T00:00:00,Gastrointestinal Hemorrhage,C06.405.227
17385037,2007-03-24T00:00:00,Gastrointestinal Hemorrhage,C23.550.414.788
17385037,2007-03-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17385037,2007-03-24T00:00:00,"Hypertension, Portal",C06.552.494
17385037,2007-03-24T00:00:00,"Intubation, Intratracheal",E05.497.578
17385037,2007-03-24T00:00:00,Middle Aged,M01.060.116.630
17385037,2007-03-24T00:00:00,"Pneumonia, Aspiration",C08.381.677.529
17385037,2007-03-24T00:00:00,"Pneumonia, Aspiration",C08.730.610.529
17385037,2007-03-24T00:00:00,Preoperative Care,E02.760.795
17385037,2007-03-24T00:00:00,Preoperative Care,E04.641
17385037,2007-03-24T00:00:00,Preoperative Care,N02.421.585.795
17385037,2007-03-24T00:00:00,Treatment Outcome,E01.789.800
17385037,2007-03-24T00:00:00,Treatment Outcome,N04.761.559.590.800
17385037,2007-03-24T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17383829,2007-03-26T00:00:00,Adult,M01.060.116
17383829,2007-03-26T00:00:00,Aged,M01.060.116.100
17383829,2007-03-26T00:00:00,Brachytherapy,E02.815.150
17383829,2007-03-26T00:00:00,Breast Neoplasms,C04.588.180
17383829,2007-03-26T00:00:00,Breast Neoplasms,C17.800.090.500
17383829,2007-03-26T00:00:00,"Carcinoma, Intraductal, Noninfiltrating",C04.557.470.200.025.275
17383829,2007-03-26T00:00:00,"Carcinoma, Intraductal, Noninfiltrating",C04.557.470.615.275
17383829,2007-03-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17383829,2007-03-26T00:00:00,Middle Aged,M01.060.116.630
17383829,2007-03-26T00:00:00,Regression Analysis,E05.318.740.750
17383829,2007-03-26T00:00:00,Regression Analysis,N05.715.360.750.695
17383829,2007-03-26T00:00:00,Regression Analysis,N06.850.520.830.750
17387464,2007-03-27T00:00:00,Adult,M01.060.116
17387464,2007-03-27T00:00:00,Aged,M01.060.116.100
17387464,2007-03-27T00:00:00,"Constriction, Pathologic",C23.300.287
17387464,2007-03-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17387464,2007-03-27T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
17387464,2007-03-27T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
17387464,2007-03-27T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
17387464,2007-03-27T00:00:00,Middle Aged,M01.060.116.630
17387464,2007-03-27T00:00:00,Prosthesis Design,E05.320.550
17387464,2007-03-27T00:00:00,Prosthesis Design,E07.695.680
17387464,2007-03-27T00:00:00,Stents,E07.695.750
17389679,2007-03-27T00:00:00,Animals,B01.050
17389679,2007-03-27T00:00:00,Cell Cycle,G04.299.134
17389679,2007-03-27T00:00:00,Cell Movement,G04.299.283
17389679,2007-03-27T00:00:00,Cell Movement,G07.700.560.500.180
17389679,2007-03-27T00:00:00,Cell Proliferation,G04.299.233.750
17389679,2007-03-27T00:00:00,Cell Proliferation,G07.700.320.249.410.750
17389679,2007-03-27T00:00:00,Enzyme Inhibitors,D27.505.519.389
17389679,2007-03-27T00:00:00,"Kidney Tubules, Proximal",A05.810.453.736.560.570
17389679,2007-03-27T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567
17389679,2007-03-27T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750
17389679,2007-03-27T00:00:00,Mitogen-Activated Protein Kinases,D12.644.360.450
17389679,2007-03-27T00:00:00,Mitogen-Activated Protein Kinases,D12.776.476.450
17389679,2007-03-27T00:00:00,Quinazolines,D03.438.786
17389679,2007-03-27T00:00:00,Rabbits,B01.050.150.900.649.521.700
17389679,2007-03-27T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
17389679,2007-03-27T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
17389679,2007-03-27T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
17389679,2007-03-27T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
17389679,2007-03-27T00:00:00,Wound Healing,G16.100.856.891
17391808,2007-03-27T00:00:00,Centers for Disease Control and Prevention (U.S.),I01.409.137.500.600.650.225
17391808,2007-03-27T00:00:00,Centers for Disease Control and Prevention (U.S.),N03.540.348.500.500.600.650.225
17391808,2007-03-27T00:00:00,Continuity of Patient Care,N04.590.233.727.210
17391808,2007-03-27T00:00:00,Cost-Benefit Analysis,N03.219.151.125
17391808,2007-03-27T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
17391808,2007-03-27T00:00:00,"Emergency Service, Hospital",N02.421.297.195
17391808,2007-03-27T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
17391808,2007-03-27T00:00:00,HIV Infections,C02.782.815.616.400
17391808,2007-03-27T00:00:00,HIV Infections,C02.800.801.400
17391808,2007-03-27T00:00:00,HIV Infections,C20.673.480
17391808,2007-03-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17391808,2007-03-27T00:00:00,Mass Screening,E01.370.500
17391808,2007-03-27T00:00:00,Mass Screening,E05.318.308.250.580
17391808,2007-03-27T00:00:00,Mass Screening,N02.421.143.827.233.443
17391808,2007-03-27T00:00:00,Mass Screening,N02.421.726.233.443
17391808,2007-03-27T00:00:00,Mass Screening,N05.715.360.300.375.500
17391808,2007-03-27T00:00:00,Mass Screening,N06.850.520.308.250.580
17391808,2007-03-27T00:00:00,Mass Screening,N06.850.780.500
17391808,2007-03-27T00:00:00,Outcome and Process Assessment (Health Care),N04.761.559
17391808,2007-03-27T00:00:00,Outcome and Process Assessment (Health Care),N05.715.360.575
17391808,2007-03-27T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
17391808,2007-03-27T00:00:00,Practice Guidelines as Topic,N05.700.350.650
17391808,2007-03-27T00:00:00,Program Development,N04.452.760
17391808,2007-03-27T00:00:00,United States,Z01.107.567.875
17391930,2007-03-27T00:00:00,Adult,M01.060.116
17391930,2007-03-27T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
17391930,2007-03-27T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
17391930,2007-03-27T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
17391930,2007-03-27T00:00:00,Cholinesterase Inhibitors,D27.505.519.389.275
17391930,2007-03-27T00:00:00,Cholinesterase Inhibitors,D27.505.519.625.120.300
17391930,2007-03-27T00:00:00,Cholinesterase Inhibitors,D27.505.696.577.120.300
17391930,2007-03-27T00:00:00,Clozapine,D03.494.240.220
17391930,2007-03-27T00:00:00,Double-Blind Method,E05.318.780.300
17391930,2007-03-27T00:00:00,Double-Blind Method,E05.581.500.300
17391930,2007-03-27T00:00:00,Double-Blind Method,N05.715.360.780.320
17391930,2007-03-27T00:00:00,Double-Blind Method,N06.850.520.445.300
17391930,2007-03-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17391930,2007-03-27T00:00:00,Middle Aged,M01.060.116.630
17391930,2007-03-27T00:00:00,Piperidines,D03.383.621
17391930,2007-03-27T00:00:00,Psychiatric Status Rating Scales,F04.586
17391930,2007-03-27T00:00:00,Psychotic Disorders,F03.700.675
17391930,2007-03-27T00:00:00,Risperidone,D03.383.742.698.685
17391930,2007-03-27T00:00:00,Schizophrenia,F03.700.750
17391930,2007-03-27T00:00:00,Treatment Outcome,E01.789.800
17391930,2007-03-27T00:00:00,Treatment Outcome,N04.761.559.590.800
17391930,2007-03-27T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17392275,2007-03-28T00:00:00,Animals,B01.050
17392275,2007-03-28T00:00:00,Cations,D01.248.497.300
17392275,2007-03-28T00:00:00,Ceramides,D02.065.313
17392275,2007-03-28T00:00:00,Ceramides,D09.400.410.420.525.200
17392275,2007-03-28T00:00:00,Ceramides,D10.390.470.675.200
17392275,2007-03-28T00:00:00,Ceramides,D10.570.877.360.612.200
17392275,2007-03-28T00:00:00,Fatty Acids,D10.251
17392275,2007-03-28T00:00:00,"Fatty Acids, Unsaturated",D10.251.355
17392275,2007-03-28T00:00:00,Lipids,D10
17392275,2007-03-28T00:00:00,Phospholipids,D10.570.755
17392275,2007-03-28T00:00:00,Phospholipids,D10.695
17392275,2007-03-28T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17392275,2007-03-28T00:00:00,Spermatozoa,A05.360.490.890
17392275,2007-03-28T00:00:00,Spermatozoa,A11.497.760
17392275,2007-03-28T00:00:00,Temperature,G01.906.595
17392275,2007-03-28T00:00:00,Temperature,G16.500.275.063.725.710
17392275,2007-03-28T00:00:00,Temperature,G16.500.750.775.710
17392275,2007-03-28T00:00:00,Temperature,N06.230.150.450
17392275,2007-03-28T00:00:00,Temperature,N06.230.300.100.725.710
17392276,2007-03-28T00:00:00,Animals,B01.050
17392276,2007-03-28T00:00:00,Ceramides,D02.065.313
17392276,2007-03-28T00:00:00,Ceramides,D09.400.410.420.525.200
17392276,2007-03-28T00:00:00,Ceramides,D10.390.470.675.200
17392276,2007-03-28T00:00:00,Ceramides,D10.570.877.360.612.200
17392276,2007-03-28T00:00:00,Fatty Acids,D10.251
17392276,2007-03-28T00:00:00,"Fatty Acids, Unsaturated",D10.251.355
17392276,2007-03-28T00:00:00,Germ Cells,A05.360.490
17392276,2007-03-28T00:00:00,Germ Cells,A11.497
17392276,2007-03-28T00:00:00,Lipids,D10
17392276,2007-03-28T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17392276,2007-03-28T00:00:00,Testis,A05.360.444.849
17392276,2007-03-28T00:00:00,Testis,A05.360.576.782
17392276,2007-03-28T00:00:00,Testis,A06.407.312.782
17392276,2007-03-28T00:00:00,X-Rays,G01.201.875.750.918
17392300,2007-03-28T00:00:00,Breast Neoplasms,C04.588.180
17392300,2007-03-28T00:00:00,Breast Neoplasms,C17.800.090.500
17392300,2007-03-28T00:00:00,"Carcinoma, Ductal, Breast",C04.557.470.200.025.232.500
17392300,2007-03-28T00:00:00,"Carcinoma, Ductal, Breast",C04.557.470.615.132.500
17392300,2007-03-28T00:00:00,"Carcinoma, Ductal, Breast",C04.588.180.390
17392300,2007-03-28T00:00:00,"Carcinoma, Ductal, Breast",C17.800.090.500.390
17392300,2007-03-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17392300,2007-03-28T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17392300,2007-03-28T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17392300,2007-03-28T00:00:00,Mammography,E01.370.350.700.500
17392300,2007-03-28T00:00:00,Middle Aged,M01.060.116.630
17392478,2007-03-28T00:00:00,Animals,B01.050
17392478,2007-03-28T00:00:00,Calcium,D01.268.552.100
17392478,2007-03-28T00:00:00,Calcium,D01.552.539.288
17392478,2007-03-28T00:00:00,Calcium,D23.119.100
17392478,2007-03-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17392478,2007-03-28T00:00:00,Membrane Proteins,D12.776.543
17392478,2007-03-28T00:00:00,Monocytes,A11.118.637.555.652
17392478,2007-03-28T00:00:00,Monocytes,A11.148.580
17392478,2007-03-28T00:00:00,Monocytes,A11.627.624
17392478,2007-03-28T00:00:00,Monocytes,A11.733.547
17392478,2007-03-28T00:00:00,Monocytes,A15.145.229.637.555.652
17392478,2007-03-28T00:00:00,Monocytes,A15.378.316.580
17392478,2007-03-28T00:00:00,Monocytes,A15.382.490.555.652
17392478,2007-03-28T00:00:00,Monocytes,A15.382.680.547
17392478,2007-03-28T00:00:00,Monocytes,A15.382.812.547
17392478,2007-03-28T00:00:00,Muscle Contraction,G11.427.590.540
17392478,2007-03-28T00:00:00,"Muscle, Smooth",A02.633.570
17392478,2007-03-28T00:00:00,"Muscle, Smooth",A10.690.467
17392478,2007-03-28T00:00:00,Polymerase Chain Reaction,E05.393.620.500
17392478,2007-03-28T00:00:00,Protein Kinase C,D08.811.913.696.620.682.700.725
17392478,2007-03-28T00:00:00,Trachea,A04.889
17459354,2007-03-28T00:00:00,Animals,B01.050
17459354,2007-03-28T00:00:00,Cell Line,A11.251.210
17459354,2007-03-28T00:00:00,Genetic Vectors,G05.360.337
17459354,2007-03-28T00:00:00,Green Fluorescent Proteins,D12.776.532.265
17459354,2007-03-28T00:00:00,Hippocampus,A08.186.211.464.405
17459354,2007-03-28T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
17459354,2007-03-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17459354,2007-03-28T00:00:00,Lentivirus,B04.820.650.589
17459354,2007-03-28T00:00:00,Lentivirus,B04.909.777.731.589
17459354,2007-03-28T00:00:00,Neurons,A08.663
17459354,2007-03-28T00:00:00,Neurons,A11.671
17459354,2007-03-28T00:00:00,Peptide Fragments,D12.644.541
17459354,2007-03-28T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17459354,2007-03-28T00:00:00,"Transduction, Genetic",E05.393.350.800
17459354,2007-03-28T00:00:00,"Transduction, Genetic",G05.355.760.850
17394573,2007-03-30T00:00:00,Animals,B01.050
17394573,2007-03-30T00:00:00,Anoxia,C23.888.852.079
17394573,2007-03-30T00:00:00,Enzyme Inhibitors,D27.505.519.389
17394573,2007-03-30T00:00:00,Liver,A03.620
17394573,2007-03-30T00:00:00,"Mice, Inbred Strains",B01.050.050.157.520
17394573,2007-03-30T00:00:00,"Mice, Inbred Strains",B01.050.050.199.520.520
17394573,2007-03-30T00:00:00,"Mice, Inbred Strains",B01.050.150.900.649.865.635.505.500.400
17394573,2007-03-30T00:00:00,Oxygen,D01.268.185.550
17394573,2007-03-30T00:00:00,Oxygen,D01.362.670
17394573,2007-03-30T00:00:00,Physical Endurance,G11.427.680
17394573,2007-03-30T00:00:00,Physical Endurance,I03.450.642.845.054.600
17394573,2007-03-30T00:00:00,Procollagen-Proline Dioxygenase,D08.811.682.690.708.673
17394573,2007-03-30T00:00:00,Signal Transduction,G02.111.087.800
17394573,2007-03-30T00:00:00,Signal Transduction,G02.149.115.800
17394573,2007-03-30T00:00:00,Signal Transduction,G04.299.880
17396215,2007-03-30T00:00:00,Animals,B01.050
17396215,2007-03-30T00:00:00,Apoptosis,G04.299.139.160
17396215,2007-03-30T00:00:00,DNA Damage,C21.111
17396215,2007-03-30T00:00:00,DNA Damage,G05.355.180
17396215,2007-03-30T00:00:00,Eflornithine,D12.125.068.665.340
17396215,2007-03-30T00:00:00,Eflornithine,D12.125.095.765.340
17396215,2007-03-30T00:00:00,Glutathione,D12.644.456.448
17396215,2007-03-30T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
17396215,2007-03-30T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
17396215,2007-03-30T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
17396215,2007-03-30T00:00:00,Oxidative Stress,G03.495.710
17396215,2007-03-30T00:00:00,Oxidative Stress,G07.700.830.750
17396215,2007-03-30T00:00:00,Reactive Oxygen Species,D01.339.431
17396215,2007-03-30T00:00:00,Reactive Oxygen Species,D01.650.775
17396215,2007-03-30T00:00:00,Spermine,D02.092.211.415.701.801.821
17396215,2007-03-30T00:00:00,Spermine,D02.092.782.802
17403082,2007-03-31T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
17403082,2007-03-31T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
17403082,2007-03-31T00:00:00,"Defibrillators, Implantable",E07.695.175
17403082,2007-03-31T00:00:00,Electric Countershock,E02.342.287
17403082,2007-03-31T00:00:00,Heart Failure,C14.280.434
17403082,2007-03-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17403082,2007-03-31T00:00:00,Middle Aged,M01.060.116.630
17403082,2007-03-31T00:00:00,Risk Assessment,E05.318.740.600.800.715
17403082,2007-03-31T00:00:00,Risk Assessment,N04.452.871.715
17403082,2007-03-31T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17403082,2007-03-31T00:00:00,Risk Assessment,N06.850.505.715
17403082,2007-03-31T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17403082,2007-03-31T00:00:00,Risk Factors,E05.318.740.600.800.725
17403082,2007-03-31T00:00:00,Risk Factors,N05.715.350.200.700
17403082,2007-03-31T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17403082,2007-03-31T00:00:00,Risk Factors,N06.850.490.625.750
17403082,2007-03-31T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17403082,2007-03-31T00:00:00,Ventricular Fibrillation,C14.280.067.922
17403082,2007-03-31T00:00:00,Ventricular Fibrillation,C23.550.073.922
16395692,2007-04-01T00:00:00,Animals,B01.050
16395692,2007-04-01T00:00:00,"Animals, Newborn",B01.050.050.282
16395692,2007-04-01T00:00:00,Anti-HIV Agents,D27.505.954.122.388.077.088
16395692,2007-04-01T00:00:00,DNA Damage,C21.111
16395692,2007-04-01T00:00:00,DNA Damage,G05.355.180
16395692,2007-04-01T00:00:00,"DNA, Mitochondrial",D13.444.308.283.225
16395692,2007-04-01T00:00:00,Maternal-Fetal Exchange,G08.686.785.760.769.455
16395692,2007-04-01T00:00:00,"Mice, Inbred Strains",B01.050.050.157.520
16395692,2007-04-01T00:00:00,"Mice, Inbred Strains",B01.050.050.199.520.520
16395692,2007-04-01T00:00:00,"Mice, Inbred Strains",B01.050.150.900.649.865.635.505.500.400
16395692,2007-04-01T00:00:00,"Mitochondria, Heart",A11.284.430.214.190.875.564.627.603
16395692,2007-04-01T00:00:00,"Mitochondria, Heart",A11.284.835.626.627.603
16395692,2007-04-01T00:00:00,Mutation,G05.365.590
16395692,2007-04-01T00:00:00,Myocardium,A02.633.580
16395692,2007-04-01T00:00:00,Myocardium,A07.541.704
16395692,2007-04-01T00:00:00,Myocardium,A10.690.552.750
16395692,2007-04-01T00:00:00,Pregnancy,G08.686.785.760.769
16395692,2007-04-01T00:00:00,Reverse Transcriptase Inhibitors,D27.505.519.389.675.850
16395692,2007-04-01T00:00:00,Reverse Transcriptase Inhibitors,D27.505.954.122.388.077.750
16941600,2007-04-01T00:00:00,Amines,D02.092
16941600,2007-04-01T00:00:00,Animals,B01.050
16941600,2007-04-01T00:00:00,Cell Adhesion,G04.299.117
16941600,2007-04-01T00:00:00,"Coated Materials, Biocompatible",D25.130.420
16941600,2007-04-01T00:00:00,"Coated Materials, Biocompatible",J01.637.051.130.420
16941600,2007-04-01T00:00:00,Fibroblasts,A11.329.228
16941600,2007-04-01T00:00:00,Fibroblasts,A11.872.228
16941600,2007-04-01T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
16941600,2007-04-01T00:00:00,"Microscopy, Fluorescence",E05.595.458
16941600,2007-04-01T00:00:00,Photochemistry,H01.181.529.711
16941600,2007-04-01T00:00:00,Polyesters,D05.750.728
16941600,2007-04-01T00:00:00,Polyesters,D25.720.728
16941600,2007-04-01T00:00:00,Polyesters,J01.637.051.720.728
16941600,2007-04-01T00:00:00,Surface Properties,G02.842.850
16941600,2007-04-01T00:00:00,X-Rays,G01.201.875.750.918
17159491,2007-04-01T00:00:00,Adolescent,M01.060.057
17159491,2007-04-01T00:00:00,Adult,M01.060.116
17159491,2007-04-01T00:00:00,Child,M01.060.406
17159491,2007-04-01T00:00:00,"Child, Preschool",M01.060.406.448
17159491,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17159491,2007-04-01T00:00:00,Otologic Surgical Procedures,E04.580.450
17179226,2007-04-01T00:00:00,B-Lymphocytes,A11.063.438
17179226,2007-04-01T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
17179226,2007-04-01T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
17179226,2007-04-01T00:00:00,B-Lymphocytes,A15.382.032.438
17179226,2007-04-01T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
17179226,2007-04-01T00:00:00,Gene Expression,G05.355.310
17179226,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17179226,2007-04-01T00:00:00,Phosphoproteins,D12.776.744
17179226,2007-04-01T00:00:00,RNA Stability,G02.111.780
17179226,2007-04-01T00:00:00,"RNA, Messenger",D13.444.735.544
17179226,2007-04-01T00:00:00,RNA-Binding Proteins,D12.776.157.725
17179226,2007-04-01T00:00:00,RNA-Binding Proteins,D12.776.664.962
17179226,2007-04-01T00:00:00,Recombinant Proteins,D12.776.828
17192896,2007-04-01T00:00:00,Adult,M01.060.116
17192896,2007-04-01T00:00:00,Aged,M01.060.116.100
17192896,2007-04-01T00:00:00,"Biopsy, Fine-Needle",E01.370.388.100.100.500
17192896,2007-04-01T00:00:00,"Biopsy, Fine-Needle",E01.450.230.100.100.500
17192896,2007-04-01T00:00:00,"Biopsy, Fine-Needle",E01.450.865.100.100.500
17192896,2007-04-01T00:00:00,"Biopsy, Fine-Needle",E04.074.119.500
17192896,2007-04-01T00:00:00,"Carcinoma, Pancreatic Ductal",C04.557.470.200.025.232.750
17192896,2007-04-01T00:00:00,"Carcinoma, Pancreatic Ductal",C04.557.470.615.132.750
17192896,2007-04-01T00:00:00,"Carcinoma, Pancreatic Ductal",C04.588.274.761.750
17192896,2007-04-01T00:00:00,"Carcinoma, Pancreatic Ductal",C04.588.322.421.750
17192896,2007-04-01T00:00:00,"Carcinoma, Pancreatic Ductal",C06.301.761.750
17192896,2007-04-01T00:00:00,"Carcinoma, Pancreatic Ductal",C06.689.667.625
17192896,2007-04-01T00:00:00,"Carcinoma, Pancreatic Ductal",C19.344.421.750
17192896,2007-04-01T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
17192896,2007-04-01T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
17192896,2007-04-01T00:00:00,Cell Adhesion Molecules,D23.050.301.350
17192896,2007-04-01T00:00:00,DNA-Binding Proteins,D12.776.260
17192896,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17192896,2007-04-01T00:00:00,Membrane Glycoproteins,D12.776.395.550
17192896,2007-04-01T00:00:00,Membrane Glycoproteins,D12.776.543.550
17192896,2007-04-01T00:00:00,Middle Aged,M01.060.116.630
17192896,2007-04-01T00:00:00,Neoplasm Proteins,D12.776.624
17192896,2007-04-01T00:00:00,Pancreatic Neoplasms,C04.588.274.761
17192896,2007-04-01T00:00:00,Pancreatic Neoplasms,C04.588.322.421
17192896,2007-04-01T00:00:00,Pancreatic Neoplasms,C06.301.761
17192896,2007-04-01T00:00:00,Pancreatic Neoplasms,C06.689.667
17192896,2007-04-01T00:00:00,Pancreatic Neoplasms,C19.344.421
17192896,2007-04-01T00:00:00,"Pancreatitis, Chronic",C06.689.750.830
17192896,2007-04-01T00:00:00,Proteolipids,D10.570.780
17192896,2007-04-01T00:00:00,Proteolipids,D12.776.816
17192896,2007-04-01T00:00:00,"RNA, Messenger",D13.444.735.544
17192896,2007-04-01T00:00:00,"Surgical Procedures, Minimally Invasive",E04.800
17192896,2007-04-01T00:00:00,Transcription Factors,D12.776.930
17192896,2007-04-01T00:00:00,"Tumor Markers, Biological",D23.101.840
17192896,2007-04-01T00:00:00,Vesicular Transport Proteins,D12.776.543.990
17219050,2007-04-01T00:00:00,Anticarcinogenic Agents,D27.505.696.706.018
17219050,2007-04-01T00:00:00,Anticarcinogenic Agents,D27.505.954.248.125
17219050,2007-04-01T00:00:00,Anticarcinogenic Agents,D27.720.799.018
17219050,2007-04-01T00:00:00,Apoptosis,G04.299.139.160
17219050,2007-04-01T00:00:00,Apoptosis Regulatory Proteins,D12.644.360.075
17219050,2007-04-01T00:00:00,Apoptosis Regulatory Proteins,D12.776.476.075
17219050,2007-04-01T00:00:00,Calcium,D01.268.552.100
17219050,2007-04-01T00:00:00,Calcium,D01.552.539.288
17219050,2007-04-01T00:00:00,Calcium,D23.119.100
17219050,2007-04-01T00:00:00,Calpain,D08.811.277.656.262.500.120
17219050,2007-04-01T00:00:00,Calpain,D08.811.277.656.300.200.120
17219050,2007-04-01T00:00:00,Caspases,D08.811.277.656.262.500.126
17219050,2007-04-01T00:00:00,Caspases,D08.811.277.656.300.200.126
17219050,2007-04-01T00:00:00,Caspases,D12.644.360.075.405
17219050,2007-04-01T00:00:00,Caspases,D12.776.476.075.405
17219050,2007-04-01T00:00:00,Cell Survival,G04.299.316
17219050,2007-04-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
17219050,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17219050,2007-04-01T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
17219050,2007-04-01T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
17219050,2007-04-01T00:00:00,Mitochondrial Proteins,D12.776.575
17219050,2007-04-01T00:00:00,NF-kappa B,D12.776.260.600
17219050,2007-04-01T00:00:00,NF-kappa B,D12.776.660.600
17219050,2007-04-01T00:00:00,NF-kappa B,D12.776.930.600
17219050,2007-04-01T00:00:00,Neuroblastoma,C04.557.465.625.600.590.650.550
17219050,2007-04-01T00:00:00,Neuroblastoma,C04.557.470.670.590.650.550
17219050,2007-04-01T00:00:00,Neuroblastoma,C04.557.580.625.600.590.650.550
17219050,2007-04-01T00:00:00,Neurons,A08.663
17219050,2007-04-01T00:00:00,Neurons,A11.671
17219050,2007-04-01T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
17219050,2007-04-01T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
17219050,2007-04-01T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
17219050,2007-04-01T00:00:00,bcl-2-Associated X Protein,D12.644.360.075.718.400
17219050,2007-04-01T00:00:00,bcl-2-Associated X Protein,D12.776.476.075.718.400
17230536,2007-04-01T00:00:00,Action Potentials,G04.580.100
17230536,2007-04-01T00:00:00,Action Potentials,G07.265.750.100
17230536,2007-04-01T00:00:00,Action Potentials,G11.561.570.100
17230536,2007-04-01T00:00:00,Adult,M01.060.116
17230536,2007-04-01T00:00:00,Electric Stimulation Therapy,E02.342
17230536,2007-04-01T00:00:00,Electric Stimulation Therapy,E02.779.468
17230536,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17230536,2007-04-01T00:00:00,Muscle Contraction,G11.427.590.540
17230536,2007-04-01T00:00:00,Muscle Fatigue,G11.427.550
17230536,2007-04-01T00:00:00,"Muscle, Skeletal",A02.633.567
17230536,2007-04-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
17230536,2007-04-01T00:00:00,Pain,C10.597.617
17230536,2007-04-01T00:00:00,Pain,C23.888.592.612
17230536,2007-04-01T00:00:00,Pain,C23.888.646
17230536,2007-04-01T00:00:00,Pain,F02.830.816.444
17230536,2007-04-01T00:00:00,Pain,G11.561.600.810.444
17230536,2007-04-01T00:00:00,Pain Measurement,E01.370.376.550.600
17230536,2007-04-01T00:00:00,Pain Threshold,F02.463.593.710.560
17230536,2007-04-01T00:00:00,Pain Threshold,F02.830.816.444.700
17230536,2007-04-01T00:00:00,Pain Threshold,G11.561.600.810.444.700
17230536,2007-04-01T00:00:00,Time Factors,G01.910.857
17333408,2007-04-01T00:00:00,Adult,M01.060.116
17333408,2007-04-01T00:00:00,African Americans,M01.686.508.100.100
17333408,2007-04-01T00:00:00,African Americans,M01.686.754.100
17333408,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17333408,2007-04-01T00:00:00,Middle Aged,M01.060.116.630
17369552,2007-04-01T00:00:00,Animals,B01.050
17369552,2007-04-01T00:00:00,Chickens,B01.050.150.900.248.350.150
17369552,2007-04-01T00:00:00,Chickens,B01.050.150.900.248.617.192
17369552,2007-04-01T00:00:00,Diet,E05.272
17369552,2007-04-01T00:00:00,Diet,G07.610.240
17369552,2007-04-01T00:00:00,Dietary Supplements,J02.500.456
17369552,2007-04-01T00:00:00,Mycoplasma gallisepticum,B03.440.560.580.553.553.345
17371278,2007-04-01T00:00:00,Animals,B01.050
17371278,2007-04-01T00:00:00,Antineoplastic Agents,D27.505.954.248
17371278,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17371278,2007-04-01T00:00:00,Polyamines,D02.092.782
17371278,2007-04-01T00:00:00,Spermine,D02.092.211.415.701.801.821
17371278,2007-04-01T00:00:00,Spermine,D02.092.782.802
17371278,2007-04-01T00:00:00,Yersinia pestis,B03.440.450.425.900.600
17371278,2007-04-01T00:00:00,Yersinia pestis,B03.660.250.150.950.580
17374038,2007-04-01T00:00:00,Adult,M01.060.116
17374038,2007-04-01T00:00:00,Alcoholism,C21.739.100.250
17374038,2007-04-01T00:00:00,Alcoholism,F03.900.100.350
17374038,2007-04-01T00:00:00,Drug Monitoring,E01.370.520.200
17374038,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17374038,2007-04-01T00:00:00,Middle Aged,M01.060.116.630
17374038,2007-04-01T00:00:00,Naltrexone,D03.132.577.249.706.550
17374038,2007-04-01T00:00:00,Naltrexone,D03.549.686.750.550
17374038,2007-04-01T00:00:00,Naltrexone,D03.605.497.750.550
17374038,2007-04-01T00:00:00,Naltrexone,D04.615.723.795.706.550
17374038,2007-04-01T00:00:00,Narcotic Antagonists,D27.505.696.543
17374038,2007-04-01T00:00:00,Narcotic Antagonists,D27.505.696.663.850.512
17374038,2007-04-01T00:00:00,Narcotic Antagonists,D27.505.954.427.550
17374038,2007-04-01T00:00:00,Patient Compliance,F01.145.488.500
17374038,2007-04-01T00:00:00,Patient Compliance,N05.300.150.600.600
17374038,2007-04-01T00:00:00,Treatment Outcome,E01.789.800
17374038,2007-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17374038,2007-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17374652,2007-04-01T00:00:00,Adult,M01.060.116
17374652,2007-04-01T00:00:00,Diet,E05.272
17374652,2007-04-01T00:00:00,Diet,G07.610.240
17374652,2007-04-01T00:00:00,Glutathione Transferase,D08.811.913.225.500
17374652,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17374652,2007-04-01T00:00:00,Isothiocyanates,D02.500.375
17374652,2007-04-01T00:00:00,Isothiocyanates,D02.886.250
17374652,2007-04-01T00:00:00,Pilot Projects,E05.318.760.750
17374652,2007-04-01T00:00:00,Pilot Projects,E05.337.737
17374652,2007-04-01T00:00:00,Pilot Projects,N05.715.360.775.625
17374652,2007-04-01T00:00:00,Pilot Projects,N06.850.520.450.720
17374652,2007-04-01T00:00:00,"Polymorphism, Genetic",G05.365.795
17374652,2007-04-01T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
17374799,2007-04-01T00:00:00,Adolescent,M01.060.057
17374799,2007-04-01T00:00:00,Adult,M01.060.116
17374799,2007-04-01T00:00:00,Aged,M01.060.116.100
17374799,2007-04-01T00:00:00,Critical Illness,C23.550.291.625
17374799,2007-04-01T00:00:00,Hospital Costs,N03.219.151.400.687
17374799,2007-04-01T00:00:00,Hospital Costs,N03.219.262.500
17374799,2007-04-01T00:00:00,Hospital Costs,N05.300.375.500
17374799,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17374799,2007-04-01T00:00:00,Middle Aged,M01.060.116.630
17374799,2007-04-01T00:00:00,Parenteral Nutrition,E02.421.505
17374799,2007-04-01T00:00:00,Parenteral Nutrition,E02.642.500.505
17377020,2007-04-01T00:00:00,Adult,M01.060.116
17377020,2007-04-01T00:00:00,Career Choice,F02.463.785.373.346.400
17377020,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17377020,2007-04-01T00:00:00,Internship and Residency,I02.358.399.644
17377020,2007-04-01T00:00:00,Middle Aged,M01.060.116.630
17377020,2007-04-01T00:00:00,Questionnaires,E05.318.308.750
17377020,2007-04-01T00:00:00,Questionnaires,L01.280.800
17377020,2007-04-01T00:00:00,Questionnaires,N05.715.360.300.695
17377020,2007-04-01T00:00:00,Questionnaires,N06.850.520.308.750
17377020,2007-04-01T00:00:00,Radiology,H02.403.740
17384204,2007-04-01T00:00:00,Genetic Testing,E01.370.427
17384204,2007-04-01T00:00:00,Genetic Testing,E05.393.435
17384204,2007-04-01T00:00:00,Genetic Testing,N02.421.143.827.233.221
17384204,2007-04-01T00:00:00,Genetic Testing,N02.421.308.430
17384204,2007-04-01T00:00:00,Hematologic Diseases,C15.378
17384204,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17384204,2007-04-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.500.620.670.325.350
17384204,2007-04-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.750.600.670.325.350
17384204,2007-04-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.285.350
17384204,2007-04-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.661.475.350
17386383,2007-04-01T00:00:00,Animals,B01.050
17386383,2007-04-01T00:00:00,Catecholamines,D02.092.211.215.311
17386383,2007-04-01T00:00:00,Catecholamines,D02.092.311
17386383,2007-04-01T00:00:00,Coronary Circulation,G09.330.190.163.324
17386383,2007-04-01T00:00:00,Dogs,B01.050.150.900.649.147.153.200
17386383,2007-04-01T00:00:00,Myocardial Ischemia,C14.280.647
17386383,2007-04-01T00:00:00,Myocardial Ischemia,C14.907.585
17386383,2007-04-01T00:00:00,Treatment Outcome,E01.789.800
17386383,2007-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17386383,2007-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17386383,2007-04-01T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
17392165,2007-04-01T00:00:00,Animals,B01.050
17392165,2007-04-01T00:00:00,Bone Marrow Transplantation,E04.936.580.040
17392165,2007-04-01T00:00:00,Complement C3,D12.776.124.050.140
17392165,2007-04-01T00:00:00,Complement C3,D12.776.124.486.274.250
17392165,2007-04-01T00:00:00,Dermatitis,C17.800.174
17392165,2007-04-01T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
17392165,2007-04-01T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
17392165,2007-04-01T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
17392165,2007-04-01T00:00:00,Kidney,A05.810.453
17392165,2007-04-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
17392165,2007-04-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
17392165,2007-04-01T00:00:00,Lymph Nodes,A10.549.400
17392165,2007-04-01T00:00:00,Lymph Nodes,A15.382.520.604.412
17392165,2007-04-01T00:00:00,Signal Transduction,G02.111.087.800
17392165,2007-04-01T00:00:00,Signal Transduction,G02.149.115.800
17392165,2007-04-01T00:00:00,Signal Transduction,G04.299.880
17392494,2007-04-01T00:00:00,Animals,B01.050
17392494,2007-04-01T00:00:00,Liver Regeneration,G10.261.326.520
17392494,2007-04-01T00:00:00,Liver Regeneration,G16.100.856.468
17392494,2007-04-01T00:00:00,Liver Transplantation,E04.210.650
17392494,2007-04-01T00:00:00,Liver Transplantation,E04.936.450.490
17392494,2007-04-01T00:00:00,Liver Transplantation,E04.936.580.490
17392494,2007-04-01T00:00:00,Stem Cells,A11.872
17394900,2007-04-01T00:00:00,"Death, Sudden, Cardiac",C14.280.383.220
17394900,2007-04-01T00:00:00,"Death, Sudden, Cardiac",C23.550.260.322.250
17394900,2007-04-01T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
17394900,2007-04-01T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
17394900,2007-04-01T00:00:00,"Defibrillators, Implantable",E07.695.175
17394900,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17394900,2007-04-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
17394900,2007-04-01T00:00:00,Risk Assessment,N04.452.871.715
17394900,2007-04-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17394900,2007-04-01T00:00:00,Risk Assessment,N06.850.505.715
17394900,2007-04-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17394906,2007-04-01T00:00:00,Atrial Fibrillation,C14.280.067.198
17394906,2007-04-01T00:00:00,Atrial Fibrillation,C23.550.073.198
17394906,2007-04-01T00:00:00,Catheter Ablation,E01.370.370.380.410.200
17394906,2007-04-01T00:00:00,Catheter Ablation,E02.148.110
17394906,2007-04-01T00:00:00,Catheter Ablation,E02.148.442.110
17394906,2007-04-01T00:00:00,Catheter Ablation,E02.154.402.110
17394906,2007-04-01T00:00:00,Catheter Ablation,E04.014.170.402.110
17394906,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17394920,2007-04-01T00:00:00,Disease Outbreaks,N06.850.290
17394920,2007-04-01T00:00:00,Hot Temperature,G01.906.595.543
17394920,2007-04-01T00:00:00,Hot Temperature,G16.500.275.063.725.710.380
17394920,2007-04-01T00:00:00,Hot Temperature,G16.500.750.775.710.380
17394920,2007-04-01T00:00:00,Hot Temperature,N06.230.300.100.725.232
17394920,2007-04-01T00:00:00,Hot Temperature,N06.230.300.100.725.710.380
17394920,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17394920,2007-04-01T00:00:00,United States,Z01.107.567.875
17394922,2007-04-01T00:00:00,Bacterial Infections,C01.252
17394922,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17394922,2007-04-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17394922,2007-04-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17394922,2007-04-01T00:00:00,Musculoskeletal Diseases,C05
17394922,2007-04-01T00:00:00,Osteomyelitis,C01.539.160.495
17394922,2007-04-01T00:00:00,Osteomyelitis,C05.116.165.495
17394922,2007-04-01T00:00:00,Spinal Diseases,C05.116.900
17394922,2007-04-01T00:00:00,Staphylococcal Infections,C01.252.410.868
17394922,2007-04-01T00:00:00,Streptococcal Infections,C01.252.410.890
17394922,2007-04-01T00:00:00,Streptococcus pyogenes,B03.510.400.800.872.575
17394922,2007-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17394922,2007-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17394922,2007-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17394922,2007-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17394922,2007-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17394924,2007-04-01T00:00:00,Fluorodeoxyglucose F18,D09.254.229.500
17394924,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17394924,2007-04-01T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
17394924,2007-04-01T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
17394924,2007-04-01T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
17394924,2007-04-01T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
17394924,2007-04-01T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
17394924,2007-04-01T00:00:00,Radiopharmaceuticals,D27.720.470.410.650
17394924,2007-04-01T00:00:00,Technetium Tc 99m Exametazime,D01.632.825.562
17394924,2007-04-01T00:00:00,Technetium Tc 99m Exametazime,D02.092.570.665.810
17394924,2007-04-01T00:00:00,Technetium Tc 99m Exametazime,D02.691.825.562
17394924,2007-04-01T00:00:00,"Tomography, Emission-Computed",E01.370.350.350.800
17394924,2007-04-01T00:00:00,"Tomography, Emission-Computed",E01.370.350.600.350.800
17394924,2007-04-01T00:00:00,"Tomography, Emission-Computed",E01.370.350.710.800
17394924,2007-04-01T00:00:00,"Tomography, Emission-Computed",E01.370.350.825.800
17394924,2007-04-01T00:00:00,"Tomography, Emission-Computed",E01.370.384.730.800
17394924,2007-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17394924,2007-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17394924,2007-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17394924,2007-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17394924,2007-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17398241,2007-04-01T00:00:00,Adolescent,M01.060.057
17398241,2007-04-01T00:00:00,Adult,M01.060.116
17398241,2007-04-01T00:00:00,Aged,M01.060.116.100
17398241,2007-04-01T00:00:00,Brain Injuries,C10.228.140.199
17398241,2007-04-01T00:00:00,Brain Injuries,C10.900.300.087
17398241,2007-04-01T00:00:00,Brain Injuries,C21.866.260.118
17398241,2007-04-01T00:00:00,Brain Injuries,C21.866.915.300.200
17398241,2007-04-01T00:00:00,Hospitalization,E02.760.400
17398241,2007-04-01T00:00:00,Hospitalization,N02.421.585.400
17398241,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17398241,2007-04-01T00:00:00,Middle Aged,M01.060.116.630
17398241,2007-04-01T00:00:00,"Models, Biological",E05.599.395
17398241,2007-04-01T00:00:00,Population Surveillance,E05.318.308.250.700
17398241,2007-04-01T00:00:00,Population Surveillance,N05.715.360.300.375.625
17398241,2007-04-01T00:00:00,Population Surveillance,N06.850.520.308.250.700
17398241,2007-04-01T00:00:00,Population Surveillance,N06.850.780.675
17398241,2007-04-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17398241,2007-04-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17400124,2007-04-01T00:00:00,Anesthesiology,H02.403.066
17400124,2007-04-01T00:00:00,Echocardiography,E01.370.350.850.220
17400124,2007-04-01T00:00:00,Echocardiography,E01.370.370.380.220
17400124,2007-04-01T00:00:00,Heart Diseases,C14.280
17400124,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17400124,2007-04-01T00:00:00,Pericardium,A07.541.795
17400124,2007-04-01T00:00:00,Pericardium,A10.615.789.470
17400124,2007-04-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
17400124,2007-04-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
17400124,2007-04-01T00:00:00,Preoperative Care,E02.760.795
17400124,2007-04-01T00:00:00,Preoperative Care,E04.641
17400124,2007-04-01T00:00:00,Preoperative Care,N02.421.585.795
17400124,2007-04-01T00:00:00,United States,Z01.107.567.875
17400857,2007-04-01T00:00:00,Adult,M01.060.116
17400857,2007-04-01T00:00:00,Aged,M01.060.116.100
17400857,2007-04-01T00:00:00,Biological Markers,D23.101
17400857,2007-04-01T00:00:00,C-Reactive Protein,D12.776.034.145
17400857,2007-04-01T00:00:00,C-Reactive Protein,D12.776.124.050.120
17400857,2007-04-01T00:00:00,C-Reactive Protein,D12.776.124.486.157
17400857,2007-04-01T00:00:00,Case-Control Studies,E05.318.760.500.500
17400857,2007-04-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
17400857,2007-04-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
17400857,2007-04-01T00:00:00,"Databases, Factual",L01.470.750.750
17400857,2007-04-01T00:00:00,"Databases, Factual",L01.700.508.300.188.400
17400857,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17400857,2007-04-01T00:00:00,Inflammation,C23.550.470
17400857,2007-04-01T00:00:00,Middle Aged,M01.060.116.630
17400857,2007-04-01T00:00:00,Ovarian Neoplasms,C04.588.322.455
17400857,2007-04-01T00:00:00,Ovarian Neoplasms,C13.351.500.056.630.705
17400857,2007-04-01T00:00:00,Ovarian Neoplasms,C13.351.937.418.685
17400857,2007-04-01T00:00:00,Ovarian Neoplasms,C19.344.410
17400857,2007-04-01T00:00:00,Ovarian Neoplasms,C19.391.630.705
17400857,2007-04-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17400857,2007-04-01T00:00:00,Risk Factors,N05.715.350.200.700
17400857,2007-04-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17400857,2007-04-01T00:00:00,Risk Factors,N06.850.490.625.750
17400857,2007-04-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17404113,2007-04-01T00:00:00,Animals,B01.050
17404113,2007-04-01T00:00:00,Carcinogens,D27.888.569.100
17404113,2007-04-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
17404113,2007-04-01T00:00:00,Lung Neoplasms,C08.381.540
17404113,2007-04-01T00:00:00,Lung Neoplasms,C08.785.520
17404113,2007-04-01T00:00:00,Phenotype,G05.695
17404113,2007-04-01T00:00:00,Protein Kinases,D08.811.913.696.620.682
17404113,2007-04-01T00:00:00,Tobacco,B01.650.388.100.905.900
17407230,2007-04-01T00:00:00,Adolescent,M01.060.057
17407230,2007-04-01T00:00:00,Adult,M01.060.116
17407230,2007-04-01T00:00:00,"Antibodies, Antinuclear",D12.776.124.486.485.114.323.204
17407230,2007-04-01T00:00:00,"Antibodies, Antinuclear",D12.776.124.790.651.114.323.204
17407230,2007-04-01T00:00:00,"Antibodies, Antinuclear",D12.776.377.715.548.114.323.204
17407230,2007-04-01T00:00:00,DNA,D13.444.308
17407230,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17407230,2007-04-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
17407230,2007-04-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
17407230,2007-04-01T00:00:00,Middle Aged,M01.060.116.630
17413603,2007-04-01T00:00:00,Adult,M01.060.116
17413603,2007-04-01T00:00:00,Aged,M01.060.116.100
17413603,2007-04-01T00:00:00,Deglutition,G10.261.326.215
17413603,2007-04-01T00:00:00,Esophageal Motility Disorders,C06.405.117.119.500
17413603,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17413603,2007-04-01T00:00:00,Manometry,E05.559
17413603,2007-04-01T00:00:00,Middle Aged,M01.060.116.630
17413603,2007-04-01T00:00:00,"Muscle, Smooth",A02.633.570
17413603,2007-04-01T00:00:00,"Muscle, Smooth",A10.690.467
17416329,2007-04-01T00:00:00,Cataract,C11.510.245
17416329,2007-04-01T00:00:00,Cataract Extraction,E04.540.825.249
17416329,2007-04-01T00:00:00,"Child, Preschool",M01.060.406.448
17416329,2007-04-01T00:00:00,Disease Progression,C23.550.291.656
17416329,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17416329,2007-04-01T00:00:00,Infant,M01.060.703
17416329,2007-04-01T00:00:00,Intraocular Pressure,G14.440
17416329,2007-04-01T00:00:00,"Lens Capsule, Crystalline",A09.371.060.500.155
17416329,2007-04-01T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
17416329,2007-04-01T00:00:00,Visual Acuity,E01.370.380.850.950
17416329,2007-04-01T00:00:00,Visual Acuity,F02.463.593.932.901
17416329,2007-04-01T00:00:00,Visual Acuity,G14.940
17416771,2007-04-01T00:00:00,Adult,M01.060.116
17416771,2007-04-01T00:00:00,Case-Control Studies,E05.318.760.500.500
17416771,2007-04-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
17416771,2007-04-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
17416771,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17416771,2007-04-01T00:00:00,Incidence,E05.318.308.985.525.375
17416771,2007-04-01T00:00:00,Incidence,L01.280.975.525.375
17416771,2007-04-01T00:00:00,Incidence,N01.224.935.597.500
17416771,2007-04-01T00:00:00,Incidence,N06.850.505.400.975.525.375
17416771,2007-04-01T00:00:00,Incidence,N06.850.520.308.985.525.375
17416771,2007-04-01T00:00:00,Middle Aged,M01.060.116.630
17416771,2007-04-01T00:00:00,Ovarian Neoplasms,C04.588.322.455
17416771,2007-04-01T00:00:00,Ovarian Neoplasms,C13.351.500.056.630.705
17416771,2007-04-01T00:00:00,Ovarian Neoplasms,C13.351.937.418.685
17416771,2007-04-01T00:00:00,Ovarian Neoplasms,C19.344.410
17416771,2007-04-01T00:00:00,Ovarian Neoplasms,C19.391.630.705
17416771,2007-04-01T00:00:00,Questionnaires,E05.318.308.750
17416771,2007-04-01T00:00:00,Questionnaires,L01.280.800
17416771,2007-04-01T00:00:00,Questionnaires,N05.715.360.300.695
17416771,2007-04-01T00:00:00,Questionnaires,N06.850.520.308.750
17416771,2007-04-01T00:00:00,"Tumor Markers, Biological",D23.101.840
17416771,2007-04-01T00:00:00,Vitamin D,D04.808.812.768
17420329,2007-04-01T00:00:00,Anticoagulants,D27.505.954.502.119
17420329,2007-04-01T00:00:00,"Heparin, Low-Molecular-Weight",D09.698.373.400.300
17420329,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17420329,2007-04-01T00:00:00,Treatment Outcome,E01.789.800
17420329,2007-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17420329,2007-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17420329,2007-04-01T00:00:00,Venous Thrombosis,C14.907.355.830.925
17420329,2007-04-01T00:00:00,Warfarin,D03.438.150.446.520.914
17420329,2007-04-01T00:00:00,Warfarin,D03.830.219.446.520.914
17420377,2007-04-01T00:00:00,Cataract,C11.510.245
17420377,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17420377,2007-04-01T00:00:00,"Lens Capsule, Crystalline",A09.371.060.500.155
17420377,2007-04-01T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
17420377,2007-04-01T00:00:00,Postoperative Complications,C23.550.767
17420377,2007-04-01T00:00:00,Prostheses and Implants,E07.695
17420377,2007-04-01T00:00:00,Prosthesis Implantation,E04.650
17420377,2007-04-01T00:00:00,Visual Acuity,E01.370.380.850.950
17420377,2007-04-01T00:00:00,Visual Acuity,F02.463.593.932.901
17420377,2007-04-01T00:00:00,Visual Acuity,G14.940
17426325,2007-04-01T00:00:00,Adolescent,M01.060.057
17426325,2007-04-01T00:00:00,Adult,M01.060.116
17426325,2007-04-01T00:00:00,Aged,M01.060.116.100
17426325,2007-04-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
17426325,2007-04-01T00:00:00,Body Mass Index,E05.041.124.125
17426325,2007-04-01T00:00:00,Body Mass Index,G07.100.100.125
17426325,2007-04-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
17426325,2007-04-01T00:00:00,Cyclohexanes,D02.455.426.392.368.367
17426325,2007-04-01T00:00:00,Double-Blind Method,E05.318.780.300
17426325,2007-04-01T00:00:00,Double-Blind Method,E05.581.500.300
17426325,2007-04-01T00:00:00,Double-Blind Method,N05.715.360.780.320
17426325,2007-04-01T00:00:00,Double-Blind Method,N06.850.520.445.300
17426325,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17426325,2007-04-01T00:00:00,Middle Aged,M01.060.116.630
17426325,2007-04-01T00:00:00,Obesity,C18.654.726.500
17426325,2007-04-01T00:00:00,Obesity,C23.888.144.699.500
17426325,2007-04-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
17426325,2007-04-01T00:00:00,Obesity,G07.100.100.160.120.699.500
17426325,2007-04-01T00:00:00,Pyrazoles,D03.383.129.539
17426325,2007-04-01T00:00:00,Spiro Compounds,D02.455.426.559.847.885
17426325,2007-04-01T00:00:00,Spiro Compounds,D04.615.885
17426325,2007-04-01T00:00:00,Weight Loss,C23.888.144.243.963
17426325,2007-04-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
17438244,2007-04-01T00:00:00,Adult,M01.060.116
17438244,2007-04-01T00:00:00,Aged,M01.060.116.100
17438244,2007-04-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
17438244,2007-04-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
17438244,2007-04-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
17438244,2007-04-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
17438244,2007-04-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
17438244,2007-04-01T00:00:00,Cisplatin,D01.210.375
17438244,2007-04-01T00:00:00,Cisplatin,D01.625.125
17438244,2007-04-01T00:00:00,Cisplatin,D01.710.100
17438244,2007-04-01T00:00:00,Combined Modality Therapy,E02.186
17438244,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17438244,2007-04-01T00:00:00,Hypopharyngeal Neoplasms,C04.588.443.665.710.485
17438244,2007-04-01T00:00:00,Hypopharyngeal Neoplasms,C07.550.745.436
17438244,2007-04-01T00:00:00,Hypopharyngeal Neoplasms,C09.647.710.485
17438244,2007-04-01T00:00:00,Hypopharyngeal Neoplasms,C09.775.549.485
17438244,2007-04-01T00:00:00,Middle Aged,M01.060.116.630
17438244,2007-04-01T00:00:00,Oropharyngeal Neoplasms,C04.588.443.665.710.684
17438244,2007-04-01T00:00:00,Oropharyngeal Neoplasms,C07.550.745.671
17438244,2007-04-01T00:00:00,Oropharyngeal Neoplasms,C09.647.710.685
17438244,2007-04-01T00:00:00,Oropharyngeal Neoplasms,C09.775.549.685
17438244,2007-04-01T00:00:00,Patient Compliance,F01.145.488.500
17438244,2007-04-01T00:00:00,Patient Compliance,N05.300.150.600.600
17438244,2007-04-01T00:00:00,Treatment Outcome,E01.789.800
17438244,2007-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17438244,2007-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17445658,2007-04-01T00:00:00,Adolescent,M01.060.057
17445658,2007-04-01T00:00:00,Adult,M01.060.116
17445658,2007-04-01T00:00:00,Aged,M01.060.116.100
17445658,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17445658,2007-04-01T00:00:00,Middle Aged,M01.060.116.630
17445658,2007-04-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
17445658,2007-04-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
17445658,2007-04-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
17445658,2007-04-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
17445658,2007-04-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17445658,2007-04-01T00:00:00,Risk Factors,N05.715.350.200.700
17445658,2007-04-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17445658,2007-04-01T00:00:00,Risk Factors,N06.850.490.625.750
17445658,2007-04-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17445658,2007-04-01T00:00:00,Smoking,F01.145.466.753
17445658,2007-04-01T00:00:00,United States,Z01.107.567.875
17447185,2007-04-01T00:00:00,Adolescent,M01.060.057
17447185,2007-04-01T00:00:00,Adult,M01.060.116
17447185,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17447185,2007-04-01T00:00:00,Indomethacin,D03.438.473.420
17447185,2007-04-01T00:00:00,"Obstetric Labor, Premature",C13.703.420.491
17447185,2007-04-01T00:00:00,Pregnancy,G08.686.785.760.769
17447185,2007-04-01T00:00:00,Pregnancy Outcome,E01.789.700
17447185,2007-04-01T00:00:00,Pregnancy Outcome,G08.686.785.760.769.530
17447185,2007-04-01T00:00:00,Tocolytic Agents,D27.505.696.875.825
17447185,2007-04-01T00:00:00,Tocolytic Agents,D27.505.954.705.825
17450942,2007-04-01T00:00:00,Adsorption,G02.149.047
17450942,2007-04-01T00:00:00,Adsorption,G02.149.767.029
17450942,2007-04-01T00:00:00,Adsorption,G02.842.750.029
17450942,2007-04-01T00:00:00,Drug Delivery Systems,E02.319.300
17450942,2007-04-01T00:00:00,Enzymes,D08.811
17450942,2007-04-01T00:00:00,Graphite,D01.268.150.300
17450942,2007-04-01T00:00:00,Graphite,D01.578.300
17450942,2007-04-01T00:00:00,"Models, Chemical",E05.599.495
17450942,2007-04-01T00:00:00,Nanoparticles,J01.637.512.600
17450942,2007-04-01T00:00:00,Nanotechnology,H01.603
17450942,2007-04-01T00:00:00,Nanotechnology,J01.897.520.600
17458389,2007-04-01T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
17458389,2007-04-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
17458389,2007-04-01T00:00:00,Blood Pressure,E01.370.600.875.249
17458389,2007-04-01T00:00:00,Blood Pressure,G09.330.380.076
17458389,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17458389,2007-04-01T00:00:00,Hypertension,C14.907.489
17458389,2007-04-01T00:00:00,Middle Aged,M01.060.116.630
17458389,2007-04-01T00:00:00,Treatment Outcome,E01.789.800
17458389,2007-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17458389,2007-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17458389,2007-04-01T00:00:00,United States,Z01.107.567.875
17461008,2007-04-01T00:00:00,Adolescent,M01.060.057
17461008,2007-04-01T00:00:00,Adult,M01.060.116
17461008,2007-04-01T00:00:00,Government Regulation,I01.880.604.394
17461008,2007-04-01T00:00:00,Government Regulation,N03.706.358
17461008,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17461008,2007-04-01T00:00:00,Interviews as Topic,E05.318.308.420
17461008,2007-04-01T00:00:00,Interviews as Topic,L01.280.520
17461008,2007-04-01T00:00:00,Interviews as Topic,N05.715.360.300.400
17461008,2007-04-01T00:00:00,Interviews as Topic,N06.850.520.308.420
17461008,2007-04-01T00:00:00,Middle Aged,M01.060.116.630
17461008,2007-04-01T00:00:00,Smoking,F01.145.466.753
17461008,2007-04-01T00:00:00,Tobacco Industry,J01.576.919
17461008,2007-04-01T00:00:00,United States,Z01.107.567.875
17474853,2007-04-01T00:00:00,Adult,M01.060.116
17474853,2007-04-01T00:00:00,Attention,F02.830.104.214
17474853,2007-04-01T00:00:00,Chronic Disease,C23.550.291.500
17474853,2007-04-01T00:00:00,Combat Disorders,F03.080.931.249
17474853,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17474853,2007-04-01T00:00:00,Meditation,E02.190.525.374
17474853,2007-04-01T00:00:00,Meditation,E02.190.901.455
17474853,2007-04-01T00:00:00,Meditation,F04.754.137.750.500
17474853,2007-04-01T00:00:00,Skin Temperature,G07.110.753
17474853,2007-04-01T00:00:00,Skin Temperature,G13.750.844
17474853,2007-04-01T00:00:00,Software,L01.224.900
17474853,2007-04-01T00:00:00,User-Computer Interface,L01.224.900.910
17474853,2007-04-01T00:00:00,Video Games,I03.450.642.693.930
17474853,2007-04-01T00:00:00,Video Games,L01.224.900.930
17484690,2007-04-01T00:00:00,African Continental Ancestry Group,M01.686.508.100
17484690,2007-04-01T00:00:00,Child,M01.060.406
17484690,2007-04-01T00:00:00,Depression,F01.145.126.350
17484690,2007-04-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
17484690,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17484690,2007-04-01T00:00:00,Peer Group,F01.829.316.483
17484690,2007-04-01T00:00:00,Personality Inventory,F04.711.647.513
17484690,2007-04-01T00:00:00,Self Concept,F01.752.747.792
17484690,2007-04-01T00:00:00,Sex Factors,N05.715.350.675
17484690,2007-04-01T00:00:00,Sex Factors,N06.850.490.875
17484690,2007-04-01T00:00:00,Social Adjustment,F01.145.813.621
17484698,2007-04-01T00:00:00,"Adaptation, Psychological",F01.058
17484698,2007-04-01T00:00:00,Adolescent,M01.060.057
17484698,2007-04-01T00:00:00,Child,M01.060.406
17484698,2007-04-01T00:00:00,"Child Abuse, Sexual",I01.198.240.748.300
17484698,2007-04-01T00:00:00,"Child Abuse, Sexual",I01.198.240.856.350.250.255
17484698,2007-04-01T00:00:00,"Child Abuse, Sexual",I01.880.735.900.350.250.255
17484698,2007-04-01T00:00:00,"Child Abuse, Sexual",I01.880.787.293.292.325
17484698,2007-04-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
17484698,2007-04-01T00:00:00,Health Surveys,E05.318.308.250
17484698,2007-04-01T00:00:00,Health Surveys,N05.715.360.300.375
17484698,2007-04-01T00:00:00,Health Surveys,N06.850.520.308.250
17484698,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17484698,2007-04-01T00:00:00,Juvenile Delinquency,I01.880.735.479
17484698,2007-04-01T00:00:00,Mental Disorders,F03
17484698,2007-04-01T00:00:00,Rape,I01.198.240.748.640
17484698,2007-04-01T00:00:00,Self Disclosure,F01.752.747.792.662
17484698,2007-04-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17484698,2007-04-01T00:00:00,Substance-Related Disorders,C21.739
17484698,2007-04-01T00:00:00,Substance-Related Disorders,F03.900
17546308,2007-04-01T00:00:00,Adolescent,M01.060.057
17546308,2007-04-01T00:00:00,Adult,M01.060.116
17546308,2007-04-01T00:00:00,Aged,M01.060.116.100
17546308,2007-04-01T00:00:00,Child,M01.060.406
17546308,2007-04-01T00:00:00,"Child, Preschool",M01.060.406.448
17546308,2007-04-01T00:00:00,Data Collection,E05.318.308
17546308,2007-04-01T00:00:00,Data Collection,L01.280
17546308,2007-04-01T00:00:00,Data Collection,N05.715.360.300
17546308,2007-04-01T00:00:00,Data Collection,N06.850.520.308
17546308,2007-04-01T00:00:00,Disasters,N06.230.100
17546308,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17546308,2007-04-01T00:00:00,Infant,M01.060.703
17546308,2007-04-01T00:00:00,"Infant, Newborn",M01.060.703.520
17546308,2007-04-01T00:00:00,Middle Aged,M01.060.116.630
17569411,2007-04-01T00:00:00,Alcohol-Related Disorders,C21.739.100
17569411,2007-04-01T00:00:00,Alcohol-Related Disorders,F03.900.100
17569411,2007-04-01T00:00:00,Behavior Therapy,F04.754.137
17569411,2007-04-01T00:00:00,Cocaine-Related Disorders,C21.739.300
17569411,2007-04-01T00:00:00,Cocaine-Related Disorders,F03.900.300
17569411,2007-04-01T00:00:00,Combined Modality Therapy,E02.186
17569411,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17569411,2007-04-01T00:00:00,Marijuana Abuse,C21.739.635
17569411,2007-04-01T00:00:00,Marijuana Abuse,F03.900.635
17569411,2007-04-01T00:00:00,Opioid-Related Disorders,C21.739.675
17569411,2007-04-01T00:00:00,Opioid-Related Disorders,F03.900.675
17569411,2007-04-01T00:00:00,Pregnancy,G08.686.785.760.769
17569411,2007-04-01T00:00:00,Pregnancy Complications,C13.703
17569411,2007-04-01T00:00:00,Psychotherapy,F04.754
17569411,2007-04-01T00:00:00,Substance-Related Disorders,C21.739
17569411,2007-04-01T00:00:00,Substance-Related Disorders,F03.900
17569411,2007-04-01T00:00:00,Tobacco Use Disorder,C21.739.912
17569411,2007-04-01T00:00:00,Tobacco Use Disorder,F03.900.912
17569411,2007-04-01T00:00:00,Treatment Outcome,E01.789.800
17569411,2007-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17569411,2007-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18189078,2007-04-01T00:00:00,Child,M01.060.406
18189078,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18189078,2007-04-01T00:00:00,Lead Poisoning,C21.613.589
18189078,2007-04-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18189078,2007-04-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18193770,2007-04-01T00:00:00,Community Health Services,N02.421.143
18193770,2007-04-01T00:00:00,Cooperative Behavior,F01.145.813.115
18193770,2007-04-01T00:00:00,Government Regulation,I01.880.604.394
18193770,2007-04-01T00:00:00,Government Regulation,N03.706.358
18193770,2007-04-01T00:00:00,Health Policy,I01.880.604.825.608.400
18193770,2007-04-01T00:00:00,Health Policy,N03.706.825.608.428
18193770,2007-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18193770,2007-04-01T00:00:00,"Liability, Legal",I01.880.604.583.490
18193770,2007-04-01T00:00:00,"Liability, Legal",N03.706.535.547
18193770,2007-04-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
18193770,2007-04-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
18193770,2007-04-01T00:00:00,Private Sector,I01.791
18193770,2007-04-01T00:00:00,Private Sector,N04.452.633.390
18193770,2007-04-01T00:00:00,United States,Z01.107.567.875
17404218,2007-04-02T00:00:00,Animals,B01.050
17404218,2007-04-02T00:00:00,Antibodies,D12.776.124.486.485.114
17404218,2007-04-02T00:00:00,Antibodies,D12.776.124.790.651.114
17404218,2007-04-02T00:00:00,Antibodies,D12.776.377.715.548.114
17404218,2007-04-02T00:00:00,B-Lymphocytes,A11.063.438
17404218,2007-04-02T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
17404218,2007-04-02T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
17404218,2007-04-02T00:00:00,B-Lymphocytes,A15.382.032.438
17404218,2007-04-02T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
17404218,2007-04-02T00:00:00,Cell Differentiation,G04.299.151
17404218,2007-04-02T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
17404218,2007-04-02T00:00:00,Flow Cytometry,E05.200.500.386.350
17404218,2007-04-02T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
17404218,2007-04-02T00:00:00,Signal Transduction,G02.111.087.800
17404218,2007-04-02T00:00:00,Signal Transduction,G02.149.115.800
17404218,2007-04-02T00:00:00,Signal Transduction,G04.299.880
17406653,2007-04-04T00:00:00,Animals,B01.050
17406653,2007-04-04T00:00:00,Arachidonic Acids,D10.251.355.096
17406653,2007-04-04T00:00:00,Arachidonic Acids,D10.251.355.255.100
17406653,2007-04-04T00:00:00,Arachidonic Acids,D10.251.355.310.166
17406653,2007-04-04T00:00:00,"Behavior, Animal",F01.145.113
17406653,2007-04-04T00:00:00,Endocannabinoids,D27.505.519.625.170
17406653,2007-04-04T00:00:00,Endocannabinoids,D27.505.696.399.472.215
17406653,2007-04-04T00:00:00,Feeding Behavior,F01.145.113.547
17406653,2007-04-04T00:00:00,Feeding Behavior,F01.145.407
17406653,2007-04-04T00:00:00,Gene Expression Regulation,G05.355.315
17406653,2007-04-04T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
17406653,2007-04-04T00:00:00,Polyunsaturated Alkamides,D02.065.160
17406653,2007-04-04T00:00:00,Polyunsaturated Alkamides,D02.455.326.271.060
17406653,2007-04-04T00:00:00,Polyunsaturated Alkamides,D02.455.326.397.675
17406653,2007-04-04T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17406653,2007-04-04T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17406653,2007-04-04T00:00:00,Reaction Time,F02.830.650
17406653,2007-04-04T00:00:00,Reaction Time,F04.669.817
17406653,2007-04-04T00:00:00,Reaction Time,G11.561.677
17406653,2007-04-04T00:00:00,Sweetening Agents,D27.720.364.609
17406653,2007-04-04T00:00:00,Sweetening Agents,D27.720.888
17406653,2007-04-04T00:00:00,Sweetening Agents,J02.500.512.400.700
17409188,2007-04-04T00:00:00,Alleles,G05.360.340.024.340.030
17409188,2007-04-04T00:00:00,Animals,B01.050
17409188,2007-04-04T00:00:00,B-Lymphocytes,A11.063.438
17409188,2007-04-04T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
17409188,2007-04-04T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
17409188,2007-04-04T00:00:00,B-Lymphocytes,A15.382.032.438
17409188,2007-04-04T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
17409188,2007-04-04T00:00:00,Cell Cycle Proteins,D12.776.167
17409188,2007-04-04T00:00:00,DNA-Binding Proteins,D12.776.260
17409188,2007-04-04T00:00:00,Gene Expression Regulation,G05.355.315
17409188,2007-04-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17409188,2007-04-04T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
17409188,2007-04-04T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
17409188,2007-04-04T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
17409188,2007-04-04T00:00:00,Mutation,G05.365.590
17409188,2007-04-04T00:00:00,"RNA, Messenger",D13.444.735.544
17409188,2007-04-04T00:00:00,"Recombination, Genetic",G05.355.760
17409188,2007-04-04T00:00:00,United States,Z01.107.567.875
17409371,2007-04-04T00:00:00,Aged,M01.060.116.100
17409371,2007-04-04T00:00:00,Diagnostic Imaging,E01.370.350
17409371,2007-04-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17409371,2007-04-04T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
17409371,2007-04-04T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
17409371,2007-04-04T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
17409371,2007-04-04T00:00:00,Magnetic Resonance Angiography,E01.370.350.500.500
17409371,2007-04-04T00:00:00,Magnetic Resonance Angiography,E01.370.350.825.500.500
17409371,2007-04-04T00:00:00,Magnetic Resonance Angiography,E01.370.370.050.500
17409371,2007-04-04T00:00:00,Middle Aged,M01.060.116.630
17409371,2007-04-04T00:00:00,Stroke,C10.228.140.300.775
17409371,2007-04-04T00:00:00,Stroke,C14.907.253.855
17409371,2007-04-04T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.700.560.260.850
17409371,2007-04-04T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.260.850
17409371,2007-04-04T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.850.870
17409371,2007-04-04T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.376.560.260.850
17409371,2007-04-04T00:00:00,United States,Z01.107.567.875
17413067,2007-04-05T00:00:00,Adolescent,M01.060.057
17413067,2007-04-05T00:00:00,Adult,M01.060.116
17413067,2007-04-05T00:00:00,Anxiety Disorders,F03.080
17413067,2007-04-05T00:00:00,"Depressive Disorder, Major",F03.600.300.375
17413067,2007-04-05T00:00:00,Disasters,N06.230.100
17413067,2007-04-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17413067,2007-04-05T00:00:00,Middle Aged,M01.060.116.630
17413067,2007-04-05T00:00:00,Risk Factors,E05.318.740.600.800.725
17413067,2007-04-05T00:00:00,Risk Factors,N05.715.350.200.700
17413067,2007-04-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17413067,2007-04-05T00:00:00,Risk Factors,N06.850.490.625.750
17413067,2007-04-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17413067,2007-04-05T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17418645,2007-04-05T00:00:00,Blood Glucose,D09.546.359.448.500
17418645,2007-04-05T00:00:00,Electroencephalography,E01.370.376.300
17418645,2007-04-05T00:00:00,Electroencephalography,E01.370.405.245
17418645,2007-04-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17418645,2007-04-05T00:00:00,Hypoglycemic Agents,D27.505.696.422
17418645,2007-04-05T00:00:00,Insulin,D06.472.699.587.740.625
17418645,2007-04-05T00:00:00,Insulin,D12.644.548.586.740.625
17418645,2007-04-05T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17418645,2007-04-05T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17418645,2007-04-05T00:00:00,Middle Aged,M01.060.116.630
17418645,2007-04-05T00:00:00,Status Epilepticus,C10.228.140.490.690
17613367,2007-04-05T00:00:00,Animals,B01.050
17613367,2007-04-05T00:00:00,Carbon Dioxide,D01.200.200
17613367,2007-04-05T00:00:00,Carbon Dioxide,D01.362.150
17613367,2007-04-05T00:00:00,Carbon Dioxide,D01.650.550.200
17613367,2007-04-05T00:00:00,"Colony Count, Microbial",E05.200.875.220
17613367,2007-04-05T00:00:00,Food Preservation,J01.576.423.850.700
17613367,2007-04-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17613367,2007-04-05T00:00:00,Oxygen,D01.268.185.550
17613367,2007-04-05T00:00:00,Oxygen,D01.362.670
17613367,2007-04-05T00:00:00,Temperature,G01.906.595
17613367,2007-04-05T00:00:00,Temperature,G16.500.275.063.725.710
17613367,2007-04-05T00:00:00,Temperature,G16.500.750.775.710
17613367,2007-04-05T00:00:00,Temperature,N06.230.150.450
17613367,2007-04-05T00:00:00,Temperature,N06.230.300.100.725.710
17613367,2007-04-05T00:00:00,Time Factors,G01.910.857
17418896,2007-04-06T00:00:00,Animals,B01.050
17418896,2007-04-06T00:00:00,Arrestins,D12.776.306.090
17418896,2007-04-06T00:00:00,Arrestins,D12.776.543.090
17418896,2007-04-06T00:00:00,Gene Expression Regulation,G05.355.315
17418896,2007-04-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17418896,2007-04-06T00:00:00,Inflammation,C23.550.470
17418896,2007-04-06T00:00:00,Lipopolysaccharides,D09.400.500
17418896,2007-04-06T00:00:00,Lipopolysaccharides,D09.698.718.450
17418896,2007-04-06T00:00:00,Lipopolysaccharides,D10.494
17418896,2007-04-06T00:00:00,Lipopolysaccharides,D23.050.161.616.525
17418896,2007-04-06T00:00:00,Lipopolysaccharides,D23.946.123.329.500
17418896,2007-04-06T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.567.342.500
17418896,2007-04-06T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.646.750.249.500
17418896,2007-04-06T00:00:00,Mitogen-Activated Protein Kinase 1,D12.644.360.450.169.500
17418896,2007-04-06T00:00:00,Mitogen-Activated Protein Kinase 1,D12.776.476.450.169.500
17418896,2007-04-06T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.567.342.750
17418896,2007-04-06T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.646.750.249.750
17418896,2007-04-06T00:00:00,Mitogen-Activated Protein Kinase 3,D12.644.360.450.169.750
17418896,2007-04-06T00:00:00,Mitogen-Activated Protein Kinase 3,D12.776.476.450.169.750
17418896,2007-04-06T00:00:00,NF-kappa B,D12.776.260.600
17418896,2007-04-06T00:00:00,NF-kappa B,D12.776.660.600
17418896,2007-04-06T00:00:00,NF-kappa B,D12.776.930.600
17418896,2007-04-06T00:00:00,Signal Transduction,G02.111.087.800
17418896,2007-04-06T00:00:00,Signal Transduction,G02.149.115.800
17418896,2007-04-06T00:00:00,Signal Transduction,G04.299.880
17418932,2007-04-06T00:00:00,Animals,B01.050
17418932,2007-04-06T00:00:00,"Disease Models, Animal",C22.232
17418932,2007-04-06T00:00:00,"Disease Models, Animal",E05.598.500
17418932,2007-04-06T00:00:00,"Disease Models, Animal",E05.599.395.080
17418932,2007-04-06T00:00:00,Enzyme Inhibitors,D27.505.519.389
17418932,2007-04-06T00:00:00,Myocardial Contraction,G09.330.190.541
17418932,2007-04-06T00:00:00,Myocardial Contraction,G11.427.590.540.570
17418932,2007-04-06T00:00:00,Myocardium,A02.633.580
17418932,2007-04-06T00:00:00,Myocardium,A07.541.704
17418932,2007-04-06T00:00:00,Myocardium,A10.690.552.750
17418932,2007-04-06T00:00:00,Nitric Oxide,D01.339.387
17418932,2007-04-06T00:00:00,Nitric Oxide,D01.625.550.500
17418932,2007-04-06T00:00:00,Nitric Oxide,D01.625.700.500
17418932,2007-04-06T00:00:00,Nitric Oxide,D01.650.550.587.600
17418932,2007-04-06T00:00:00,Oxygen Consumption,G03.730
17418932,2007-04-06T00:00:00,Peroxynitrous Acid,D01.625.600.800
17418932,2007-04-06T00:00:00,Peroxynitrous Acid,D01.625.700.750
17418932,2007-04-06T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17418932,2007-04-06T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17418932,2007-04-06T00:00:00,Reactive Oxygen Species,D01.339.431
17418932,2007-04-06T00:00:00,Reactive Oxygen Species,D01.650.775
17418932,2007-04-06T00:00:00,Recovery of Function,G16.757
17418932,2007-04-06T00:00:00,Sodium-Potassium-Exchanging ATPase,D08.811.277.040.025.810
17418932,2007-04-06T00:00:00,Sodium-Potassium-Exchanging ATPase,D12.776.157.530.450.162.780
17418932,2007-04-06T00:00:00,Sodium-Potassium-Exchanging ATPase,D12.776.157.530.450.250.880
17418932,2007-04-06T00:00:00,Sodium-Potassium-Exchanging ATPase,D12.776.543.585.450.162.800
17418932,2007-04-06T00:00:00,Sodium-Potassium-Exchanging ATPase,D12.776.543.585.450.250.890
17418932,2007-04-06T00:00:00,Superoxide Dismutase,D08.811.682.881
17418932,2007-04-06T00:00:00,Treatment Outcome,E01.789.800
17418932,2007-04-06T00:00:00,Treatment Outcome,N04.761.559.590.800
17418932,2007-04-06T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17418932,2007-04-06T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
17498689,2007-04-06T00:00:00,Animals,B01.050
17498689,2007-04-06T00:00:00,Cell Cycle Proteins,D12.776.167
17498689,2007-04-06T00:00:00,Cell Division,G04.299.134.220
17498689,2007-04-06T00:00:00,Cell Division,G04.299.233.750.500
17498689,2007-04-06T00:00:00,Cell Division,G05.355.105
17498689,2007-04-06T00:00:00,Cell Division,G07.700.320.249.410.750.500
17498689,2007-04-06T00:00:00,"Chromosomal Proteins, Non-Histone",D12.776.660.235
17498689,2007-04-06T00:00:00,"Chromosomal Proteins, Non-Histone",D12.776.664.235
17498689,2007-04-06T00:00:00,DNA Replication,G02.111.087.222
17498689,2007-04-06T00:00:00,DNA Replication,G02.149.115.222
17498689,2007-04-06T00:00:00,DNA Replication,G05.355.200
17498689,2007-04-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17498689,2007-04-06T00:00:00,Mitosis,G04.299.134.220.220.781
17498689,2007-04-06T00:00:00,Mitosis,G05.355.105.220.781
17498689,2007-04-06T00:00:00,Protein Interaction Mapping,E05.601.690
17498689,2007-04-06T00:00:00,Signal Transduction,G02.111.087.800
17498689,2007-04-06T00:00:00,Signal Transduction,G02.149.115.800
17498689,2007-04-06T00:00:00,Signal Transduction,G04.299.880
17419083,2007-04-09T00:00:00,Child,M01.060.406
17419083,2007-04-09T00:00:00,"Child, Preschool",M01.060.406.448
17419083,2007-04-09T00:00:00,Esotropia,C10.292.562.887.300
17419083,2007-04-09T00:00:00,Esotropia,C11.590.810.400
17419083,2007-04-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17419083,2007-04-09T00:00:00,Infant,M01.060.703
17419083,2007-04-09T00:00:00,Oculomotor Muscles,A02.633.567.700
17419083,2007-04-09T00:00:00,Oculomotor Muscles,A09.371.613
17419083,2007-04-09T00:00:00,Ophthalmologic Surgical Procedures,E04.540
17419083,2007-04-09T00:00:00,Reoperation,E04.690
17419083,2007-04-09T00:00:00,Treatment Outcome,E01.789.800
17419083,2007-04-09T00:00:00,Treatment Outcome,N04.761.559.590.800
17419083,2007-04-09T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17420265,2007-04-09T00:00:00,Animals,B01.050
17420265,2007-04-09T00:00:00,CD4-Positive T-Lymphocytes,A11.118.637.555.567.569.200
17420265,2007-04-09T00:00:00,CD4-Positive T-Lymphocytes,A15.145.229.637.555.567.569.200
17420265,2007-04-09T00:00:00,CD4-Positive T-Lymphocytes,A15.382.490.555.567.569.200
17420265,2007-04-09T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
17420265,2007-04-09T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
17420265,2007-04-09T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
17420265,2007-04-09T00:00:00,Cell Differentiation,G04.299.151
17420265,2007-04-09T00:00:00,Cell Proliferation,G04.299.233.750
17420265,2007-04-09T00:00:00,Cell Proliferation,G07.700.320.249.410.750
17420265,2007-04-09T00:00:00,Homeostasis,G07.700.360
17420265,2007-04-09T00:00:00,Interleukin-15,D12.644.276.374.465.515
17420265,2007-04-09T00:00:00,Interleukin-15,D12.776.467.374.465.515
17420265,2007-04-09T00:00:00,Interleukin-15,D23.529.374.465.515
17420265,2007-04-09T00:00:00,Phenotype,G05.695
17426097,2007-04-10T00:00:00,Environmental Exposure,N06.850.460.350
17426097,2007-04-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17426097,2007-04-10T00:00:00,Middle Aged,M01.060.116.630
17426097,2007-04-10T00:00:00,Skin,A17.815
17426097,2007-04-10T00:00:00,Vitamin D,D04.808.812.768
17426097,2007-04-10T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
17426710,2007-04-10T00:00:00,Animals,B01.050
17426710,2007-04-10T00:00:00,Cell Survival,G04.299.316
17426710,2007-04-10T00:00:00,Ceramides,D02.065.313
17426710,2007-04-10T00:00:00,Ceramides,D09.400.410.420.525.200
17426710,2007-04-10T00:00:00,Ceramides,D10.390.470.675.200
17426710,2007-04-10T00:00:00,Ceramides,D10.570.877.360.612.200
17426710,2007-04-10T00:00:00,Down-Regulation,G02.111.087.225
17426710,2007-04-10T00:00:00,Down-Regulation,G02.149.115.225
17426710,2007-04-10T00:00:00,Down-Regulation,G05.355.315.200
17426710,2007-04-10T00:00:00,Down-Regulation,G07.690.812.230
17426710,2007-04-10T00:00:00,Down-Regulation,G07.700.680.230
17426710,2007-04-10T00:00:00,Enzyme Inhibitors,D27.505.519.389
17426710,2007-04-10T00:00:00,Fas Ligand Protein,D12.644.276.374.750.249
17426710,2007-04-10T00:00:00,Fas Ligand Protein,D12.644.276.972.249
17426710,2007-04-10T00:00:00,Fas Ligand Protein,D12.776.395.550.312
17426710,2007-04-10T00:00:00,Fas Ligand Protein,D12.776.467.374.750.249
17426710,2007-04-10T00:00:00,Fas Ligand Protein,D12.776.467.972.249
17426710,2007-04-10T00:00:00,Fas Ligand Protein,D12.776.543.550.312
17426710,2007-04-10T00:00:00,Fas Ligand Protein,D23.050.301.264.035.283
17426710,2007-04-10T00:00:00,Fas Ligand Protein,D23.101.100.110.282
17426710,2007-04-10T00:00:00,Fas Ligand Protein,D23.529.374.750.249
17426710,2007-04-10T00:00:00,Fas Ligand Protein,D23.529.972.249
17426710,2007-04-10T00:00:00,Galactosylgalactosylglucosylceramidase,D08.811.277.450.410.150
17426710,2007-04-10T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
17426710,2007-04-10T00:00:00,Head and Neck Neoplasms,C04.588.443
17426710,2007-04-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17429002,2007-04-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17429002,2007-04-11T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
17429002,2007-04-11T00:00:00,Isometric Contraction,G11.427.590.540.472
17429002,2007-04-11T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17429002,2007-04-11T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17429002,2007-04-11T00:00:00,"Muscle, Skeletal",A02.633.567
17429002,2007-04-11T00:00:00,"Muscle, Skeletal",A10.690.552.500
17429002,2007-04-11T00:00:00,Musculoskeletal Diseases,C05
17429018,2007-04-11T00:00:00,Animals,B01.050
17429018,2007-04-11T00:00:00,"Fatty Acids, Unsaturated",D10.251.355
17429018,2007-04-11T00:00:00,Germ Cells,A05.360.490
17429018,2007-04-11T00:00:00,Germ Cells,A11.497
17429018,2007-04-11T00:00:00,Phospholipids,D10.570.755
17429018,2007-04-11T00:00:00,Phospholipids,D10.695
17429018,2007-04-11T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17429018,2007-04-11T00:00:00,Testis,A05.360.444.849
17429018,2007-04-11T00:00:00,Testis,A05.360.576.782
17429018,2007-04-11T00:00:00,Testis,A06.407.312.782
17429035,2007-04-11T00:00:00,Angiotensin I,D06.472.699.094.075
17429035,2007-04-11T00:00:00,Angiotensin I,D12.644.400.070.075
17429035,2007-04-11T00:00:00,Angiotensin I,D12.644.456.073.021
17429035,2007-04-11T00:00:00,Angiotensin I,D12.644.548.058.075
17429035,2007-04-11T00:00:00,Angiotensin I,D12.776.641.650.070.075
17429035,2007-04-11T00:00:00,Angiotensin I,D23.469.050.050.025
17429035,2007-04-11T00:00:00,Angiotensin II,D06.472.699.094.078
17429035,2007-04-11T00:00:00,Angiotensin II,D12.644.400.070.078
17429035,2007-04-11T00:00:00,Angiotensin II,D12.644.456.073.041
17429035,2007-04-11T00:00:00,Angiotensin II,D12.644.548.058.078
17429035,2007-04-11T00:00:00,Angiotensin II,D12.776.641.650.070.078
17429035,2007-04-11T00:00:00,Angiotensin II,D23.469.050.050.050
17429035,2007-04-11T00:00:00,Animals,B01.050
17429035,2007-04-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17429035,2007-04-11T00:00:00,Mesangial Cells,A05.810.453.324.359.620
17429035,2007-04-11T00:00:00,Mesangial Cells,A05.810.453.736.520.620
17429035,2007-04-11T00:00:00,Mesangial Cells,A11.329.228.950
17429035,2007-04-11T00:00:00,Peptide Fragments,D12.644.541
17429035,2007-04-11T00:00:00,Podocytes,A05.810.453.324.359.720
17429035,2007-04-11T00:00:00,Podocytes,A05.810.453.736.520.720
17429035,2007-04-11T00:00:00,Podocytes,A11.436.720
17429035,2007-04-11T00:00:00,Renin,D08.811.277.656.074.500.780
17429035,2007-04-11T00:00:00,Renin,D08.811.277.656.300.048.780
17429035,2007-04-11T00:00:00,Renin,D08.811.277.656.837.750
17429035,2007-04-11T00:00:00,Renin-Angiotensin System,G03.495.805
17429035,2007-04-11T00:00:00,Renin-Angiotensin System,G09.330.190.400.750
17429035,2007-04-11T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
17429631,2007-04-12T00:00:00,Antineoplastic Agents,D27.505.954.248
17429631,2007-04-12T00:00:00,Apoptosis,G04.299.139.160
17429631,2007-04-12T00:00:00,Caspases,D08.811.277.656.262.500.126
17429631,2007-04-12T00:00:00,Caspases,D08.811.277.656.300.200.126
17429631,2007-04-12T00:00:00,Caspases,D12.644.360.075.405
17429631,2007-04-12T00:00:00,Caspases,D12.776.476.075.405
17429631,2007-04-12T00:00:00,Ceramides,D02.065.313
17429631,2007-04-12T00:00:00,Ceramides,D09.400.410.420.525.200
17429631,2007-04-12T00:00:00,Ceramides,D10.390.470.675.200
17429631,2007-04-12T00:00:00,Ceramides,D10.570.877.360.612.200
17429631,2007-04-12T00:00:00,Enzyme Inhibitors,D27.505.519.389
17429631,2007-04-12T00:00:00,Galactosylgalactosylglucosylceramidase,D08.811.277.450.410.150
17429631,2007-04-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17429631,2007-04-12T00:00:00,Lysosomes,A11.284.430.214.190.875.190.550
17429631,2007-04-12T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
17429631,2007-04-12T00:00:00,"Microscopy, Confocal",E05.595.395
17429631,2007-04-12T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
17429631,2007-04-12T00:00:00,Prostatic Neoplasms,C12.294.260.750
17429631,2007-04-12T00:00:00,Prostatic Neoplasms,C12.294.565.625
17429631,2007-04-12T00:00:00,Prostatic Neoplasms,C12.758.409.750
17429631,2007-04-12T00:00:00,Sphingolipids,D10.570.877
17429631,2007-04-12T00:00:00,Sphingolipids,D10.808
17429631,2007-04-12T00:00:00,Sphingomyelin Phosphodiesterase,D08.811.277.352.640.750
17431204,2007-04-12T00:00:00,Adult,M01.060.116
17431204,2007-04-12T00:00:00,Anticoagulants,D27.505.954.502.119
17431204,2007-04-12T00:00:00,Brain Ischemia,C10.228.140.300.150
17431204,2007-04-12T00:00:00,Brain Ischemia,C14.907.253.092
17431204,2007-04-12T00:00:00,Emergency Medical Services,N02.421.297
17431204,2007-04-12T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
17431204,2007-04-12T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
17431204,2007-04-12T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
17431204,2007-04-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17431204,2007-04-12T00:00:00,Stroke,C10.228.140.300.775
17431204,2007-04-12T00:00:00,Stroke,C14.907.253.855
17431204,2007-04-12T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
17431204,2007-04-12T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
17431204,2007-04-12T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
17431204,2007-04-12T00:00:00,Tissue Plasminogen Activator,D23.119.970
17475204,2007-04-12T00:00:00,Animals,B01.050
17475204,2007-04-12T00:00:00,Apoptosis Regulatory Proteins,D12.644.360.075
17475204,2007-04-12T00:00:00,Apoptosis Regulatory Proteins,D12.776.476.075
17475204,2007-04-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17475204,2007-04-12T00:00:00,Mitochondria,A11.284.430.214.190.875.564
17475204,2007-04-12T00:00:00,Mitochondria,A11.284.835.626
17475204,2007-04-12T00:00:00,Mitochondrial Proteins,D12.776.575
17475204,2007-04-12T00:00:00,"Models, Biological",E05.599.395
17475204,2007-04-12T00:00:00,Reactive Oxygen Species,D01.339.431
17475204,2007-04-12T00:00:00,Reactive Oxygen Species,D01.650.775
17475204,2007-04-12T00:00:00,Signal Transduction,G02.111.087.800
17475204,2007-04-12T00:00:00,Signal Transduction,G02.149.115.800
17475204,2007-04-12T00:00:00,Signal Transduction,G04.299.880
17533874,2007-04-15T00:00:00,Animals,B01.050
17533874,2007-04-15T00:00:00,Environmental Monitoring,N06.850.460.350.080
17533874,2007-04-15T00:00:00,Environmental Monitoring,N06.850.780.375
17533874,2007-04-15T00:00:00,Feeding Behavior,F01.145.113.547
17533874,2007-04-15T00:00:00,Feeding Behavior,F01.145.407
17533874,2007-04-15T00:00:00,Lipids,D10
17533874,2007-04-15T00:00:00,"Nanotubes, Carbon",D01.268.150.250.500
17533874,2007-04-15T00:00:00,"Nanotubes, Carbon",J01.637.512.850.500
17533874,2007-04-15T00:00:00,Solubility,G02.842.800
17533874,2007-04-15T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
17434579,2007-04-16T00:00:00,Adult,M01.060.116
17434579,2007-04-16T00:00:00,Aged,M01.060.116.100
17434579,2007-04-16T00:00:00,"Chemotherapy, Adjuvant",E02.186.170
17434579,2007-04-16T00:00:00,"Chemotherapy, Adjuvant",E02.319.170
17434579,2007-04-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17434579,2007-04-16T00:00:00,Middle Aged,M01.060.116.630
17434579,2007-04-16T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
17434579,2007-04-16T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
17434579,2007-04-16T00:00:00,Neoplasm Staging,E01.370.550
17434579,2007-04-16T00:00:00,"Radiotherapy, Adjuvant",E02.186.775
17434579,2007-04-16T00:00:00,"Radiotherapy, Adjuvant",E02.815.600
17434579,2007-04-16T00:00:00,Uterine Neoplasms,C04.588.945.418.948
17434579,2007-04-16T00:00:00,Uterine Neoplasms,C13.351.500.852.762
17434579,2007-04-16T00:00:00,Uterine Neoplasms,C13.351.937.418.875
17434703,2007-04-16T00:00:00,Adolescent,M01.060.057
17434703,2007-04-16T00:00:00,Adolescent Psychology,F04.096.628.065
17434703,2007-04-16T00:00:00,Attitude to Health,F01.100.150
17434703,2007-04-16T00:00:00,Attitude to Health,N05.300.150
17434703,2007-04-16T00:00:00,Cognitive Therapy,F04.754.137.428
17434703,2007-04-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17434703,2007-04-16T00:00:00,"Interview, Psychological",F04.669.599
17434703,2007-04-16T00:00:00,Motivation,F01.658
17434703,2007-04-16T00:00:00,Motivation,F01.752.543.500.750
17434703,2007-04-16T00:00:00,Substance Abuse Treatment Centers,N02.278.035.128.800
17434703,2007-04-16T00:00:00,Substance Abuse Treatment Centers,N02.278.808.930
17434703,2007-04-16T00:00:00,Substance-Related Disorders,C21.739
17434703,2007-04-16T00:00:00,Substance-Related Disorders,F03.900
17437395,2007-04-16T00:00:00,Adolescent,M01.060.057
17437395,2007-04-16T00:00:00,Adult,M01.060.116
17437395,2007-04-16T00:00:00,Asthma,C08.127.108
17437395,2007-04-16T00:00:00,Asthma,C08.381.495.108
17437395,2007-04-16T00:00:00,Asthma,C08.674.095
17437395,2007-04-16T00:00:00,Asthma,C20.543.480.680.095
17437395,2007-04-16T00:00:00,Hospitalization,E02.760.400
17437395,2007-04-16T00:00:00,Hospitalization,N02.421.585.400
17437395,2007-04-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17437395,2007-04-16T00:00:00,Middle Aged,M01.060.116.630
17437395,2007-04-16T00:00:00,"Pulmonary Disease, Chronic Obstructive",C08.381.495.389
17437395,2007-04-16T00:00:00,"Respiration, Artificial",E02.365.647.729
17437395,2007-04-16T00:00:00,"Respiration, Artificial",E02.880.820
17437550,2007-04-16T00:00:00,Animals,B01.050
17437550,2007-04-16T00:00:00,Antioxidants,D27.505.519.217
17437550,2007-04-16T00:00:00,Antioxidants,D27.505.696.706.125
17437550,2007-04-16T00:00:00,Antioxidants,D27.720.799.047
17437550,2007-04-16T00:00:00,Apoptosis,G04.299.139.160
17437550,2007-04-16T00:00:00,Apoptosis Regulatory Proteins,D12.644.360.075
17437550,2007-04-16T00:00:00,Apoptosis Regulatory Proteins,D12.776.476.075
17437550,2007-04-16T00:00:00,Biological Markers,D23.101
17437550,2007-04-16T00:00:00,"Disease Models, Animal",C22.232
17437550,2007-04-16T00:00:00,"Disease Models, Animal",E05.598.500
17437550,2007-04-16T00:00:00,"Disease Models, Animal",E05.599.395.080
17437550,2007-04-16T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
17437550,2007-04-16T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
17437550,2007-04-16T00:00:00,NF-kappa B,D12.776.260.600
17437550,2007-04-16T00:00:00,NF-kappa B,D12.776.660.600
17437550,2007-04-16T00:00:00,NF-kappa B,D12.776.930.600
17437550,2007-04-16T00:00:00,Neuroprotective Agents,D27.505.696.706.548
17437550,2007-04-16T00:00:00,Neuroprotective Agents,D27.505.954.427.575
17437550,2007-04-16T00:00:00,Nitric Oxide,D01.339.387
17437550,2007-04-16T00:00:00,Nitric Oxide,D01.625.550.500
17437550,2007-04-16T00:00:00,Nitric Oxide,D01.625.700.500
17437550,2007-04-16T00:00:00,Nitric Oxide,D01.650.550.587.600
17437550,2007-04-16T00:00:00,Oxidative Stress,G03.495.710
17437550,2007-04-16T00:00:00,Oxidative Stress,G07.700.830.750
17437550,2007-04-16T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17437550,2007-04-16T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17437550,2007-04-16T00:00:00,Reperfusion Injury,C14.907.725
17437550,2007-04-16T00:00:00,Reperfusion Injury,C23.550.767.877
17437550,2007-04-16T00:00:00,Treatment Outcome,E01.789.800
17437550,2007-04-16T00:00:00,Treatment Outcome,N04.761.559.590.800
17437550,2007-04-16T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17599425,2007-04-16T00:00:00,Antihypertensive Agents,D27.505.954.411.162
17599425,2007-04-16T00:00:00,Blood Pressure,E01.370.600.875.249
17599425,2007-04-16T00:00:00,Blood Pressure,G09.330.380.076
17599425,2007-04-16T00:00:00,Coronary Artery Disease,C14.280.647.250.260
17599425,2007-04-16T00:00:00,Coronary Artery Disease,C14.907.137.126.339
17599425,2007-04-16T00:00:00,Coronary Artery Disease,C14.907.585.250.260
17599425,2007-04-16T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
17599425,2007-04-16T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
17599425,2007-04-16T00:00:00,Diabetic Angiopathies,C14.907.320
17599425,2007-04-16T00:00:00,Diabetic Angiopathies,C19.246.099.500
17599425,2007-04-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17599425,2007-04-16T00:00:00,Hypertension,C14.907.489
17599425,2007-04-16T00:00:00,Patient Selection,E05.581.500.653
17599425,2007-04-16T00:00:00,Patient Selection,N04.590.731
17599425,2007-04-16T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
17599425,2007-04-16T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
17599425,2007-04-16T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
17599425,2007-04-16T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
17599425,2007-04-16T00:00:00,Research Design,E05.581.500
17599425,2007-04-16T00:00:00,Research Design,H01.770.644.728
17446526,2007-04-19T00:00:00,Contrast Media,D27.720.259
17446526,2007-04-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17446526,2007-04-19T00:00:00,Incidence,E05.318.308.985.525.375
17446526,2007-04-19T00:00:00,Incidence,L01.280.975.525.375
17446526,2007-04-19T00:00:00,Incidence,N01.224.935.597.500
17446526,2007-04-19T00:00:00,Incidence,N06.850.505.400.975.525.375
17446526,2007-04-19T00:00:00,Incidence,N06.850.520.308.985.525.375
17446526,2007-04-19T00:00:00,Kidney Diseases,C12.777.419
17446526,2007-04-19T00:00:00,Kidney Diseases,C13.351.968.419
17446526,2007-04-19T00:00:00,Radiopharmaceuticals,D27.720.470.410.650
17446526,2007-04-19T00:00:00,Risk Assessment,E05.318.740.600.800.715
17446526,2007-04-19T00:00:00,Risk Assessment,N04.452.871.715
17446526,2007-04-19T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17446526,2007-04-19T00:00:00,Risk Assessment,N06.850.505.715
17446526,2007-04-19T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17446526,2007-04-19T00:00:00,Risk Factors,E05.318.740.600.800.725
17446526,2007-04-19T00:00:00,Risk Factors,N05.715.350.200.700
17446526,2007-04-19T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17446526,2007-04-19T00:00:00,Risk Factors,N06.850.490.625.750
17446526,2007-04-19T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17531322,2007-04-19T00:00:00,DNA,D13.444.308
17531322,2007-04-19T00:00:00,DNA Damage,C21.111
17531322,2007-04-19T00:00:00,DNA Damage,G05.355.180
17531322,2007-04-19T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
17531322,2007-04-19T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
17531322,2007-04-19T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
17531322,2007-04-19T00:00:00,Iron,D01.268.556.412
17531322,2007-04-19T00:00:00,Iron,D01.268.956.287
17531322,2007-04-19T00:00:00,Iron,D01.552.544.412
17531322,2007-04-19T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
17531322,2007-04-19T00:00:00,Organoselenium Compounds,D02.712
17448734,2007-04-20T00:00:00,Cystic Fibrosis,C06.689.202
17448734,2007-04-20T00:00:00,Cystic Fibrosis,C08.381.187
17448734,2007-04-20T00:00:00,Cystic Fibrosis,C16.320.190
17448734,2007-04-20T00:00:00,Cystic Fibrosis,C16.614.213
17448734,2007-04-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17448734,2007-04-20T00:00:00,Intensive Care Units,N02.278.388.493
17448734,2007-04-20T00:00:00,Lung Transplantation,E04.928.600.495
17448734,2007-04-20T00:00:00,Lung Transplantation,E04.936.450.495
17451614,2007-04-23T00:00:00,Aged,M01.060.116.100
17451614,2007-04-23T00:00:00,Alzheimer Disease,C10.228.140.380.100
17451614,2007-04-23T00:00:00,Alzheimer Disease,C10.574.945.249
17451614,2007-04-23T00:00:00,Alzheimer Disease,F03.087.400.100
17451614,2007-04-23T00:00:00,Ethnic Groups,M01.686.754
17451614,2007-04-23T00:00:00,Ethnic Groups,N01.224.317
17451614,2007-04-23T00:00:00,European Continental Ancestry Group,M01.686.508.400
17451614,2007-04-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17451614,2007-04-23T00:00:00,Piperidines,D03.383.621
17451614,2007-04-23T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
17451614,2007-04-23T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
17451614,2007-04-23T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
17451614,2007-04-23T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
17451614,2007-04-23T00:00:00,Thiazoles,D02.886.675
17451614,2007-04-23T00:00:00,Thiazoles,D03.383.129.708
17452460,2007-04-23T00:00:00,Binding Sites,G02.111.570.120
17452460,2007-04-23T00:00:00,Endothelial Cells,A11.436.275
17452460,2007-04-23T00:00:00,"Endothelium, Vascular",A07.231.330
17452460,2007-04-23T00:00:00,"Endothelium, Vascular",A10.272.491.355
17452460,2007-04-23T00:00:00,Gene Expression Regulation,G05.355.315
17452460,2007-04-23T00:00:00,"Genes, Homeobox",G05.360.340.024.340.230.500
17452460,2007-04-23T00:00:00,Homeodomain Proteins,D12.776.260.400
17452460,2007-04-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17452460,2007-04-23T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
17452460,2007-04-23T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
17452460,2007-04-23T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
17452460,2007-04-23T00:00:00,Recombinant Proteins,D12.776.828
17452460,2007-04-23T00:00:00,"Transcription, Genetic",G02.111.087.847
17452460,2007-04-23T00:00:00,"Transcription, Genetic",G02.149.115.847
17452460,2007-04-23T00:00:00,"Transcription, Genetic",G05.355.310.700
17452460,2007-04-23T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
17452460,2007-04-23T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
17452460,2007-04-23T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
17452460,2007-04-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
17452460,2007-04-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
17452460,2007-04-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
17452460,2007-04-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
17452460,2007-04-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
17452460,2007-04-23T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
17452460,2007-04-23T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
17452460,2007-04-23T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
17452460,2007-04-23T00:00:00,Umbilical Veins,A07.231.908.670.874
17452460,2007-04-23T00:00:00,Umbilical Veins,A16.378.693.807
17467659,2007-04-23T00:00:00,Apoptosis,G04.299.139.160
17467659,2007-04-23T00:00:00,Ceramides,D02.065.313
17467659,2007-04-23T00:00:00,Ceramides,D09.400.410.420.525.200
17467659,2007-04-23T00:00:00,Ceramides,D10.390.470.675.200
17467659,2007-04-23T00:00:00,Ceramides,D10.570.877.360.612.200
17467659,2007-04-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17467659,2007-04-23T00:00:00,Light,G01.201.875.770.578
17467659,2007-04-23T00:00:00,Light,G01.590.540
17467659,2007-04-23T00:00:00,Membrane Proteins,D12.776.543
17467659,2007-04-23T00:00:00,Nerve Tissue Proteins,D12.776.641
17467659,2007-04-23T00:00:00,Photosensitizing Agents,D27.505.696.750.710
17467659,2007-04-23T00:00:00,Photosensitizing Agents,D27.505.954.444.600
17467659,2007-04-23T00:00:00,Sphingosine,D02.033.100.700
17467659,2007-04-23T00:00:00,Sphingosine,D02.033.455.843
17467659,2007-04-23T00:00:00,Sphingosine,D02.092.063.700
17467659,2007-04-23T00:00:00,Tandem Mass Spectrometry,E05.196.566.880
17467659,2007-04-23T00:00:00,Transferases (Other Substituted Phosphate Groups),D08.811.913.696.900
17456539,2007-04-24T00:00:00,Adult,M01.060.116
17456539,2007-04-24T00:00:00,Diphosphonates,D02.705.206
17456539,2007-04-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17456539,2007-04-24T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
17456539,2007-04-24T00:00:00,Kidney Transplantation,E02.870.500
17456539,2007-04-24T00:00:00,Kidney Transplantation,E04.936.450.485
17456539,2007-04-24T00:00:00,Kidney Transplantation,E04.950.774.400
17456539,2007-04-24T00:00:00,Middle Aged,M01.060.116.630
17456539,2007-04-24T00:00:00,Osteoporosis,C05.116.198.579
17456539,2007-04-24T00:00:00,Pancreas Transplantation,E04.210.725
17456539,2007-04-24T00:00:00,Pancreas Transplantation,E04.936.450.650
17456585,2007-04-24T00:00:00,DNA Methylation,G02.111.087.029.538.161
17456585,2007-04-24T00:00:00,DNA Methylation,G02.111.087.218
17456585,2007-04-24T00:00:00,DNA Methylation,G02.149.115.029.538.161
17456585,2007-04-24T00:00:00,DNA Methylation,G02.149.115.218
17456585,2007-04-24T00:00:00,DNA Methylation,G03.495.130.538.161
17456585,2007-04-24T00:00:00,DNA Methylation,G05.355.190
17456585,2007-04-24T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.567.342
17456585,2007-04-24T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.646.750.249
17456585,2007-04-24T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.644.360.450.169
17456585,2007-04-24T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.776.476.450.169
17456585,2007-04-24T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
17456585,2007-04-24T00:00:00,Gene Silencing,G05.355.315.203.374
17456585,2007-04-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17456585,2007-04-24T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
17456585,2007-04-24T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
17456585,2007-04-24T00:00:00,MAP Kinase Signaling System,G03.495.553.560
17456585,2007-04-24T00:00:00,MAP Kinase Signaling System,G04.299.880.560
17456585,2007-04-24T00:00:00,Mutation,G05.365.590
17456585,2007-04-24T00:00:00,Neoplastic Stem Cells,A11.872.650
17456585,2007-04-24T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
17456585,2007-04-24T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
17456585,2007-04-24T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
17456585,2007-04-24T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
17456585,2007-04-24T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
17459592,2007-04-24T00:00:00,Adult Stem Cells,A11.872.040
17459592,2007-04-24T00:00:00,Animals,B01.050
17459592,2007-04-24T00:00:00,Cell Death,G04.299.139
17459592,2007-04-24T00:00:00,Cell Differentiation,G04.299.151
17459592,2007-04-24T00:00:00,Cell Movement,G04.299.283
17459592,2007-04-24T00:00:00,Cell Movement,G07.700.560.500.180
17459592,2007-04-24T00:00:00,Cell Proliferation,G04.299.233.750
17459592,2007-04-24T00:00:00,Cell Proliferation,G07.700.320.249.410.750
17459592,2007-04-24T00:00:00,Cerebral Ventricles,A08.186.211.276
17459592,2007-04-24T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
17459592,2007-04-24T00:00:00,Genetic Vectors,G05.360.337
17459592,2007-04-24T00:00:00,Green Fluorescent Proteins,D12.776.532.265
17459592,2007-04-24T00:00:00,Nerve Tissue Proteins,D12.776.641
17459592,2007-04-24T00:00:00,Neurons,A08.663
17459592,2007-04-24T00:00:00,Neurons,A11.671
17459592,2007-04-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17459592,2007-04-24T00:00:00,Time Factors,G01.910.857
17457520,2007-04-25T00:00:00,Animals,B01.050
17457520,2007-04-25T00:00:00,"Animals, Newborn",B01.050.050.282
17457520,2007-04-25T00:00:00,Cardiomegaly,C14.280.195
17457520,2007-04-25T00:00:00,Cardiomegaly,C23.300.775.250
17457520,2007-04-25T00:00:00,Cell Cycle,G04.299.134
17457520,2007-04-25T00:00:00,Cell Cycle Proteins,D12.776.167
17457520,2007-04-25T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
17457520,2007-04-25T00:00:00,Heart,A07.541
17457520,2007-04-25T00:00:00,Myocardium,A02.633.580
17457520,2007-04-25T00:00:00,Myocardium,A07.541.704
17457520,2007-04-25T00:00:00,Myocardium,A10.690.552.750
17460071,2007-04-25T00:00:00,Adolescent,M01.060.057
17460071,2007-04-25T00:00:00,Adult,M01.060.116
17460071,2007-04-25T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
17460071,2007-04-25T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
17460071,2007-04-25T00:00:00,Decision Making,F02.463.785.373
17460071,2007-04-25T00:00:00,Frontal Lobe,A08.186.211.730.885.287.500.270
17460071,2007-04-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17460071,2007-04-25T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17460071,2007-04-25T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17460071,2007-04-25T00:00:00,Middle Aged,M01.060.116.630
17460071,2007-04-25T00:00:00,Neural Pathways,A08.612
17460071,2007-04-25T00:00:00,Risk-Taking,F01.145.722
17460089,2007-04-25T00:00:00,Animals,B01.050
17460089,2007-04-25T00:00:00,Benzazepines,D03.438.079
17460089,2007-04-25T00:00:00,Electric Stimulation,E05.723.402
17460089,2007-04-25T00:00:00,Excitatory Amino Acid Antagonists,D27.505.519.625.190.300
17460089,2007-04-25T00:00:00,Excitatory Amino Acid Antagonists,D27.505.696.577.190.300
17460089,2007-04-25T00:00:00,Hippocampus,A08.186.211.464.405
17460089,2007-04-25T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
17460089,2007-04-25T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
17460089,2007-04-25T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17460089,2007-04-25T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
17460089,2007-04-25T00:00:00,Ventral Tegmental Area,A08.186.211.132.659.822.820
17460089,2007-04-25T00:00:00,Ventral Tegmental Area,A08.186.211.653.822.820
17463086,2007-04-26T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
17463086,2007-04-26T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
17463086,2007-04-26T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
17463086,2007-04-26T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
17463086,2007-04-26T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
17463086,2007-04-26T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
17463086,2007-04-26T00:00:00,DNA Methylation,G02.111.087.029.538.161
17463086,2007-04-26T00:00:00,DNA Methylation,G02.111.087.218
17463086,2007-04-26T00:00:00,DNA Methylation,G02.149.115.029.538.161
17463086,2007-04-26T00:00:00,DNA Methylation,G02.149.115.218
17463086,2007-04-26T00:00:00,DNA Methylation,G03.495.130.538.161
17463086,2007-04-26T00:00:00,DNA Methylation,G05.355.190
17463086,2007-04-26T00:00:00,Enzyme Inhibitors,D27.505.519.389
17463086,2007-04-26T00:00:00,Gene Silencing,G05.355.315.203.374
17463086,2007-04-26T00:00:00,Histone Demethylases,D08.811.682.662.582.475
17463086,2007-04-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17463086,2007-04-26T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
17463086,2007-04-26T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
17463086,2007-04-26T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
17463086,2007-04-26T00:00:00,Membrane Proteins,D12.776.543
17463086,2007-04-26T00:00:00,Polyamines,D02.092.782
17463086,2007-04-26T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
17463086,2007-04-26T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
17463086,2007-04-26T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
17468103,2007-04-27T00:00:00,Anoxia,C23.888.852.079
17468103,2007-04-27T00:00:00,Antineoplastic Agents,D27.505.954.248
17468103,2007-04-27T00:00:00,Apoptosis,G04.299.139.160
17468103,2007-04-27T00:00:00,DNA,D13.444.308
17468103,2007-04-27T00:00:00,Glutathione,D12.644.456.448
17468103,2007-04-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17468103,2007-04-27T00:00:00,Oxidoreductases,D08.811.682
17468103,2007-04-27T00:00:00,Oxygen,D01.268.185.550
17468103,2007-04-27T00:00:00,Oxygen,D01.362.670
17468103,2007-04-27T00:00:00,Transcription Factor RelA,D12.776.260.600.249
17468103,2007-04-27T00:00:00,Transcription Factor RelA,D12.776.660.600.249
17468103,2007-04-27T00:00:00,Transcription Factor RelA,D12.776.930.600.249
17357141,2007-04-30T00:00:00,Antiparkinson Agents,D27.505.954.427.090.050
17357141,2007-04-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17357141,2007-04-30T00:00:00,Middle Aged,M01.060.116.630
17357141,2007-04-30T00:00:00,Parkinson Disease,C10.228.140.079.862.500
17357141,2007-04-30T00:00:00,Parkinson Disease,C10.228.662.600.400
17357141,2007-04-30T00:00:00,Parkinson Disease,C10.574.812
17357141,2007-04-30T00:00:00,Patient Compliance,F01.145.488.500
17357141,2007-04-30T00:00:00,Patient Compliance,N05.300.150.600.600
17357141,2007-04-30T00:00:00,Questionnaires,E05.318.308.750
17357141,2007-04-30T00:00:00,Questionnaires,L01.280.800
17357141,2007-04-30T00:00:00,Questionnaires,N05.715.360.300.695
17357141,2007-04-30T00:00:00,Questionnaires,N06.850.520.308.750
17467956,2007-04-30T00:00:00,Adult,M01.060.116
17467956,2007-04-30T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
17467956,2007-04-30T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
17467956,2007-04-30T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
17467956,2007-04-30T00:00:00,Brain,A08.186.211
17467956,2007-04-30T00:00:00,Double-Blind Method,E05.318.780.300
17467956,2007-04-30T00:00:00,Double-Blind Method,E05.581.500.300
17467956,2007-04-30T00:00:00,Double-Blind Method,N05.715.360.780.320
17467956,2007-04-30T00:00:00,Double-Blind Method,N06.850.520.445.300
17467956,2007-04-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17467956,2007-04-30T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
17467956,2007-04-30T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17467956,2007-04-30T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17467956,2007-04-30T00:00:00,"Memory, Short-Term",F02.463.425.540.407
17467956,2007-04-30T00:00:00,Middle Aged,M01.060.116.630
17467956,2007-04-30T00:00:00,Neuropsychological Tests,F04.711.513
17467956,2007-04-30T00:00:00,Oxygen,D01.268.185.550
17467956,2007-04-30T00:00:00,Oxygen,D01.362.670
17467956,2007-04-30T00:00:00,Pilot Projects,E05.318.760.750
17467956,2007-04-30T00:00:00,Pilot Projects,E05.337.737
17467956,2007-04-30T00:00:00,Pilot Projects,N05.715.360.775.625
17467956,2007-04-30T00:00:00,Pilot Projects,N06.850.520.450.720
17467956,2007-04-30T00:00:00,Psychiatric Status Rating Scales,F04.586
17467956,2007-04-30T00:00:00,Schizophrenia,F03.700.750
17467956,2007-04-30T00:00:00,Treatment Outcome,E01.789.800
17467956,2007-04-30T00:00:00,Treatment Outcome,N04.761.559.590.800
17467956,2007-04-30T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17242615,2007-05-01T00:00:00,Aged,M01.060.116.100
17242615,2007-05-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
17242615,2007-05-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
17242615,2007-05-01T00:00:00,Biocompatible Materials,D25.130
17242615,2007-05-01T00:00:00,Biocompatible Materials,D27.720.102.130
17242615,2007-05-01T00:00:00,Biocompatible Materials,J01.637.051.130
17242615,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17242615,2007-05-01T00:00:00,Knee Prosthesis,E07.695.400.410
17242615,2007-05-01T00:00:00,Materials Testing,E05.570
17242615,2007-05-01T00:00:00,Polyethylene,D02.455.326.271.665.550.500
17242615,2007-05-01T00:00:00,Polyethylene,D05.750.716.507.500
17242615,2007-05-01T00:00:00,Polyethylene,D25.720.716.507.500
17242615,2007-05-01T00:00:00,Polyethylene,J01.637.051.720.716.507.500
17242615,2007-05-01T00:00:00,Prosthesis Failure,C23.550.767.865
17242615,2007-05-01T00:00:00,Prosthesis Failure,E05.325.771
17242615,2007-05-01T00:00:00,Reoperation,E04.690
17242615,2007-05-01T00:00:00,"Stress, Mechanical",G01.374.676.830
17242615,2007-05-01T00:00:00,"Stress, Mechanical",G01.595.540.830
17242615,2007-05-01T00:00:00,Surface Properties,G02.842.850
17242615,2007-05-01T00:00:00,Weight-Bearing,G01.374.676.965
17242615,2007-05-01T00:00:00,Weight-Bearing,G01.595.540.965
17265457,2007-05-01T00:00:00,Animals,B01.050
17265457,2007-05-01T00:00:00,Apoptosis,G04.299.139.160
17265457,2007-05-01T00:00:00,Fetal Heart,A07.541.278
17265457,2007-05-01T00:00:00,Fetal Heart,A16.378.303
17265457,2007-05-01T00:00:00,"Heart Defects, Congenital",C14.240.400
17265457,2007-05-01T00:00:00,"Heart Defects, Congenital",C14.280.400
17265457,2007-05-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
17265457,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17265457,2007-05-01T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
17265457,2007-05-01T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
17265457,2007-05-01T00:00:00,Mesoderm,A16.504.660
17265457,2007-05-01T00:00:00,"Models, Cardiovascular",E05.599.395.161
17265457,2007-05-01T00:00:00,Pregnancy,G08.686.785.760.769
17365047,2007-05-01T00:00:00,Air Pollutants,D27.888.284.101
17365047,2007-05-01T00:00:00,Air Pollution,N06.850.460.100
17365047,2007-05-01T00:00:00,Animals,B01.050
17365047,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17365047,2007-05-01T00:00:00,Lung,A04.411
17365047,2007-05-01T00:00:00,Particulate Matter,D20.633
17365047,2007-05-01T00:00:00,Research Design,E05.581.500
17365047,2007-05-01T00:00:00,Research Design,H01.770.644.728
17365047,2007-05-01T00:00:00,Sulfates,D01.248.497.158.845
17365047,2007-05-01T00:00:00,Sulfates,D01.875.800.800.850
17370030,2007-05-01T00:00:00,Depressive Disorder,F03.600.300
17370030,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17370030,2007-05-01T00:00:00,"Physicians, Family",M01.526.485.810.770
17370030,2007-05-01T00:00:00,"Physicians, Family",N02.360.810.770
17370030,2007-05-01T00:00:00,Primary Health Care,N04.590.233.727
17414844,2007-05-01T00:00:00,Alcohol Drinking,F01.145.317.269
17414844,2007-05-01T00:00:00,Animals,B01.050
17414844,2007-05-01T00:00:00,Antioxidants,D27.505.519.217
17414844,2007-05-01T00:00:00,Antioxidants,D27.505.696.706.125
17414844,2007-05-01T00:00:00,Antioxidants,D27.720.799.047
17414844,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17414844,2007-05-01T00:00:00,"Liver Diseases, Alcoholic",C06.552.645
17414844,2007-05-01T00:00:00,"Liver Diseases, Alcoholic",C21.739.100.087.645
17414844,2007-05-01T00:00:00,Liver Transplantation,E04.210.650
17414844,2007-05-01T00:00:00,Liver Transplantation,E04.936.450.490
17414844,2007-05-01T00:00:00,Liver Transplantation,E04.936.580.490
17415076,2007-05-01T00:00:00,Adolescent,M01.060.057
17415076,2007-05-01T00:00:00,Cooperative Behavior,F01.145.813.115
17415076,2007-05-01T00:00:00,Crime,I01.198.240
17415076,2007-05-01T00:00:00,Crime,I01.880.735.191
17415076,2007-05-01T00:00:00,Evidence-Based Medicine,H02.249.750
17415076,2007-05-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
17415076,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17415076,2007-05-01T00:00:00,Juvenile Delinquency,I01.880.735.479
17415076,2007-05-01T00:00:00,Patient Care Team,N04.590.715
17415076,2007-05-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
17415076,2007-05-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
17415076,2007-05-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
17415076,2007-05-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
17415076,2007-05-01T00:00:00,Referral and Consultation,N04.452.758.849
17415076,2007-05-01T00:00:00,Substance-Related Disorders,C21.739
17415076,2007-05-01T00:00:00,Substance-Related Disorders,F03.900
17415076,2007-05-01T00:00:00,Treatment Outcome,E01.789.800
17415076,2007-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17415076,2007-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17415078,2007-05-01T00:00:00,Brain,A08.186.211
17415078,2007-05-01T00:00:00,Deep Brain Stimulation,E02.342.250
17415078,2007-05-01T00:00:00,Deep Brain Stimulation,E04.190
17415078,2007-05-01T00:00:00,Depressive Disorder,F03.600.300
17415078,2007-05-01T00:00:00,Electroconvulsive Therapy,F04.570.200.583
17415078,2007-05-01T00:00:00,Electroconvulsive Therapy,F04.669.224.300
17415078,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17415078,2007-05-01T00:00:00,Mental Disorders,F03
17415078,2007-05-01T00:00:00,Pain,C10.597.617
17415078,2007-05-01T00:00:00,Pain,C23.888.592.612
17415078,2007-05-01T00:00:00,Pain,C23.888.646
17415078,2007-05-01T00:00:00,Pain,F02.830.816.444
17415078,2007-05-01T00:00:00,Pain,G11.561.600.810.444
17415078,2007-05-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
17415078,2007-05-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
17415078,2007-05-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
17415078,2007-05-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
17415078,2007-05-01T00:00:00,Schizophrenia,F03.700.750
17415078,2007-05-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
17415078,2007-05-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
17430550,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17430550,2007-05-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.606.586
17430550,2007-05-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.619.393.522.400
17430550,2007-05-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.705.500.380.500
17430550,2007-05-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.606.586
17430550,2007-05-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.619.393.522.400
17430550,2007-05-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.705.500.380.500
17430550,2007-05-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.606.586
17430550,2007-05-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.619.393.522.400
17430550,2007-05-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.705.500.380.500
17430550,2007-05-01T00:00:00,Immunoglobulin Gm Allotypes,G12.500.400.586
17430550,2007-05-01T00:00:00,Linkage Disequilibrium,G05.540.500
17430550,2007-05-01T00:00:00,Malaria,C03.752.530
17430550,2007-05-01T00:00:00,Phenotype,G05.695
17434043,2007-05-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
17434043,2007-05-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
17434043,2007-05-01T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
17434043,2007-05-01T00:00:00,Antirheumatic Agents,D27.505.954.329
17434043,2007-05-01T00:00:00,"Arthritis, Rheumatoid",C05.550.114.154
17434043,2007-05-01T00:00:00,"Arthritis, Rheumatoid",C05.799.114
17434043,2007-05-01T00:00:00,"Arthritis, Rheumatoid",C17.300.775.099
17434043,2007-05-01T00:00:00,"Arthritis, Rheumatoid",C20.111.199
17434043,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17434043,2007-05-01T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
17434043,2007-05-01T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
17434043,2007-05-01T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
17434043,2007-05-01T00:00:00,Melanoma,C04.557.465.625.650.510
17434043,2007-05-01T00:00:00,Melanoma,C04.557.580.625.650.510
17434043,2007-05-01T00:00:00,Melanoma,C04.557.665.510
17434043,2007-05-01T00:00:00,Middle Aged,M01.060.116.630
17434043,2007-05-01T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
17434043,2007-05-01T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
17434043,2007-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
17434043,2007-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
17434043,2007-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
17434043,2007-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
17434043,2007-05-01T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
17434043,2007-05-01T00:00:00,Skin Neoplasms,C04.588.805
17434043,2007-05-01T00:00:00,Skin Neoplasms,C17.800.882
17434043,2007-05-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
17434043,2007-05-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
17434043,2007-05-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
17434043,2007-05-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
17434043,2007-05-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
17434043,2007-05-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
17434043,2007-05-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
17434043,2007-05-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
17434043,2007-05-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
17434043,2007-05-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
17434043,2007-05-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
17434069,2007-05-01T00:00:00,Breast Neoplasms,C04.588.180
17434069,2007-05-01T00:00:00,Breast Neoplasms,C17.800.090.500
17434069,2007-05-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
17434069,2007-05-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
17434069,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17434069,2007-05-01T00:00:00,Mammography,E01.370.350.700.500
17434069,2007-05-01T00:00:00,Mass Screening,E01.370.500
17434069,2007-05-01T00:00:00,Mass Screening,E05.318.308.250.580
17434069,2007-05-01T00:00:00,Mass Screening,N02.421.143.827.233.443
17434069,2007-05-01T00:00:00,Mass Screening,N02.421.726.233.443
17434069,2007-05-01T00:00:00,Mass Screening,N05.715.360.300.375.500
17434069,2007-05-01T00:00:00,Mass Screening,N06.850.520.308.250.580
17434069,2007-05-01T00:00:00,Mass Screening,N06.850.780.500
17434069,2007-05-01T00:00:00,Middle Aged,M01.060.116.630
17434069,2007-05-01T00:00:00,Patient Education as Topic,I02.233.332.500
17434069,2007-05-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
17434069,2007-05-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
17434069,2007-05-01T00:00:00,Questionnaires,E05.318.308.750
17434069,2007-05-01T00:00:00,Questionnaires,L01.280.800
17434069,2007-05-01T00:00:00,Questionnaires,N05.715.360.300.695
17434069,2007-05-01T00:00:00,Questionnaires,N06.850.520.308.750
17434367,2007-05-01T00:00:00,Adenocarcinoma,C04.557.470.200.025
17434367,2007-05-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
17434367,2007-05-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
17434367,2007-05-01T00:00:00,Combined Modality Therapy,E02.186
17434367,2007-05-01T00:00:00,Esophageal Neoplasms,C04.588.274.476.205
17434367,2007-05-01T00:00:00,Esophageal Neoplasms,C04.588.443.353
17434367,2007-05-01T00:00:00,Esophageal Neoplasms,C06.301.371.205
17434367,2007-05-01T00:00:00,Esophageal Neoplasms,C06.405.117.430
17434367,2007-05-01T00:00:00,Esophageal Neoplasms,C06.405.249.205
17434367,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17434367,2007-05-01T00:00:00,Middle Aged,M01.060.116.630
17435448,2007-05-01T00:00:00,Adult,M01.060.116
17435448,2007-05-01T00:00:00,Amines,D02.092
17435448,2007-05-01T00:00:00,Breast Neoplasms,C04.588.180
17435448,2007-05-01T00:00:00,Breast Neoplasms,C17.800.090.500
17435448,2007-05-01T00:00:00,Case-Control Studies,E05.318.760.500.500
17435448,2007-05-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
17435448,2007-05-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
17435448,2007-05-01T00:00:00,Heterocyclic Compounds,D03
17435448,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17435448,2007-05-01T00:00:00,Middle Aged,M01.060.116.630
17435448,2007-05-01T00:00:00,New York,Z01.107.567.875.075.437
17435448,2007-05-01T00:00:00,New York,Z01.107.567.875.350.530
17435448,2007-05-01T00:00:00,New York,Z01.107.567.875.500.530
17435448,2007-05-01T00:00:00,"Polycyclic Hydrocarbons, Aromatic",D02.455.426.559.847
17435448,2007-05-01T00:00:00,"Polycyclic Hydrocarbons, Aromatic",D04.615
17437819,2007-05-01T00:00:00,Adult,M01.060.116
17437819,2007-05-01T00:00:00,Aged,M01.060.116.100
17437819,2007-05-01T00:00:00,Antineoplastic Agents,D27.505.954.248
17437819,2007-05-01T00:00:00,"Chemotherapy, Adjuvant",E02.186.170
17437819,2007-05-01T00:00:00,"Chemotherapy, Adjuvant",E02.319.170
17437819,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17437819,2007-05-01T00:00:00,Middle Aged,M01.060.116.630
17437819,2007-05-01T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
17437819,2007-05-01T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
17437819,2007-05-01T00:00:00,Pilot Projects,E05.318.760.750
17437819,2007-05-01T00:00:00,Pilot Projects,E05.337.737
17437819,2007-05-01T00:00:00,Pilot Projects,N05.715.360.775.625
17437819,2007-05-01T00:00:00,Pilot Projects,N06.850.520.450.720
17437819,2007-05-01T00:00:00,Prostate-Specific Antigen,D08.811.277.656.300.760.442.750
17437819,2007-05-01T00:00:00,Prostate-Specific Antigen,D08.811.277.656.959.350.442.750
17437819,2007-05-01T00:00:00,Prostate-Specific Antigen,D12.776.866.249.500
17437819,2007-05-01T00:00:00,Prostate-Specific Antigen,D23.050.285.625
17437819,2007-05-01T00:00:00,Prostate-Specific Antigen,D23.101.840.625
17437819,2007-05-01T00:00:00,Prostatectomy,E04.950.774.860.625
17437819,2007-05-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
17437819,2007-05-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
17437819,2007-05-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
17437819,2007-05-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
17437819,2007-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17437819,2007-05-01T00:00:00,Risk Factors,N05.715.350.200.700
17437819,2007-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17437819,2007-05-01T00:00:00,Risk Factors,N06.850.490.625.750
17437819,2007-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17437819,2007-05-01T00:00:00,Treatment Outcome,E01.789.800
17437819,2007-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17437819,2007-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17437819,2007-05-01T00:00:00,"Tumor Markers, Biological",D23.101.840
17439501,2007-05-01T00:00:00,Ambulatory Care,E02.760.106
17439501,2007-05-01T00:00:00,Ambulatory Care,N02.421.585.106
17439501,2007-05-01T00:00:00,Cough,C08.618.248
17439501,2007-05-01T00:00:00,Cough,C23.888.852.293
17439501,2007-05-01T00:00:00,Gastric Acid,A12.200.307.603
17439501,2007-05-01T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
17439501,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17439501,2007-05-01T00:00:00,Proton Pump Inhibitors,D27.505.519.389.848
17440321,2007-05-01T00:00:00,Environmental Monitoring,N06.850.460.350.080
17440321,2007-05-01T00:00:00,Environmental Monitoring,N06.850.780.375
17440321,2007-05-01T00:00:00,"Models, Theoretical",E05.599
17440321,2007-05-01T00:00:00,Radioactive Waste,D20.693.638
17440321,2007-05-01T00:00:00,Radioactive Waste,D20.944.380.638
17440321,2007-05-01T00:00:00,Radioactive Waste,N06.850.460.710.380.638
17440321,2007-05-01T00:00:00,Radioactive Waste,N06.850.810.485
17440321,2007-05-01T00:00:00,Radioisotopes,D01.496.749
17449580,2007-05-01T00:00:00,Adult,M01.060.116
17449580,2007-05-01T00:00:00,Body Weight,C23.888.144
17449580,2007-05-01T00:00:00,Body Weight,E01.370.600.115.100.160.120
17449580,2007-05-01T00:00:00,Body Weight,E05.041.124.160.750
17449580,2007-05-01T00:00:00,Body Weight,G07.100.100.160.120
17449580,2007-05-01T00:00:00,Body Weight,G07.700.320.249.314.120
17449580,2007-05-01T00:00:00,Double-Blind Method,E05.318.780.300
17449580,2007-05-01T00:00:00,Double-Blind Method,E05.581.500.300
17449580,2007-05-01T00:00:00,Double-Blind Method,N05.715.360.780.320
17449580,2007-05-01T00:00:00,Double-Blind Method,N06.850.520.445.300
17449580,2007-05-01T00:00:00,Energy Intake,G07.610.240.340
17449580,2007-05-01T00:00:00,Energy Metabolism,G03.495.335
17449580,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17449580,2007-05-01T00:00:00,Middle Aged,M01.060.116.630
17449580,2007-05-01T00:00:00,Motor Activity,F01.145.632
17449580,2007-05-01T00:00:00,Motor Activity,G11.427.590.530.698
17449580,2007-05-01T00:00:00,Obesity,C18.654.726.500
17449580,2007-05-01T00:00:00,Obesity,C23.888.144.699.500
17449580,2007-05-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
17449580,2007-05-01T00:00:00,Obesity,G07.100.100.160.120.699.500
17451178,2007-05-01T00:00:00,Aging,G07.700.320.124
17451178,2007-05-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
17451178,2007-05-01T00:00:00,Alzheimer Disease,C10.574.945.249
17451178,2007-05-01T00:00:00,Alzheimer Disease,F03.087.400.100
17451178,2007-05-01T00:00:00,Animals,B01.050
17451178,2007-05-01T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
17451178,2007-05-01T00:00:00,"Disease Models, Animal",C22.232
17451178,2007-05-01T00:00:00,"Disease Models, Animal",E05.598.500
17451178,2007-05-01T00:00:00,"Disease Models, Animal",E05.599.395.080
17451178,2007-05-01T00:00:00,Hippocampus,A08.186.211.464.405
17451178,2007-05-01T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
17451178,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17451178,2007-05-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17451178,2007-05-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17456198,2007-05-01T00:00:00,Animals,B01.050
17456198,2007-05-01T00:00:00,Apoptosis,G04.299.139.160
17456198,2007-05-01T00:00:00,Cyclosporine,D04.345.566.235.300
17456198,2007-05-01T00:00:00,Cyclosporine,D12.644.641.235.300
17456198,2007-05-01T00:00:00,Graft Rejection,G12.425.901.545.328
17456198,2007-05-01T00:00:00,Hepatocytes,A11.436.348
17456198,2007-05-01T00:00:00,Liver Regeneration,G10.261.326.520
17456198,2007-05-01T00:00:00,Liver Regeneration,G16.100.856.468
17456198,2007-05-01T00:00:00,Liver Transplantation,E04.210.650
17456198,2007-05-01T00:00:00,Liver Transplantation,E04.936.450.490
17456198,2007-05-01T00:00:00,Liver Transplantation,E04.936.580.490
17456198,2007-05-01T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
17456198,2007-05-01T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
17456198,2007-05-01T00:00:00,Mitochondrial Proteins,D12.776.575
17456198,2007-05-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17457170,2007-05-01T00:00:00,Adenocarcinoma,C04.557.470.200.025
17457170,2007-05-01T00:00:00,Animals,B01.050
17457170,2007-05-01T00:00:00,Catheter Ablation,E01.370.370.380.410.200
17457170,2007-05-01T00:00:00,Catheter Ablation,E02.148.110
17457170,2007-05-01T00:00:00,Catheter Ablation,E02.148.442.110
17457170,2007-05-01T00:00:00,Catheter Ablation,E02.154.402.110
17457170,2007-05-01T00:00:00,Catheter Ablation,E04.014.170.402.110
17457170,2007-05-01T00:00:00,Hepatectomy,E04.210.556
17457170,2007-05-01T00:00:00,Hepatocyte Growth Factor,D12.644.276.374.420
17457170,2007-05-01T00:00:00,Hepatocyte Growth Factor,D12.776.467.374.420
17457170,2007-05-01T00:00:00,Hepatocyte Growth Factor,D23.529.374.420
17457170,2007-05-01T00:00:00,Liver Neoplasms,C04.588.274.623
17457170,2007-05-01T00:00:00,Liver Neoplasms,C06.301.623
17457170,2007-05-01T00:00:00,Liver Neoplasms,C06.552.697
17461706,2007-05-01T00:00:00,Adult,M01.060.116
17461706,2007-05-01T00:00:00,Aged,M01.060.116.100
17461706,2007-05-01T00:00:00,Anemia,C15.378.071
17461706,2007-05-01T00:00:00,"Cardiac Output, Low",C14.280.148
17461706,2007-05-01T00:00:00,"Cardiac Output, Low",C23.888.192
17461706,2007-05-01T00:00:00,Chronic Disease,C23.550.291.500
17461706,2007-05-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
17461706,2007-05-01T00:00:00,Decision Support Techniques,E05.245
17461706,2007-05-01T00:00:00,Decision Support Techniques,L01.700.508.190
17461706,2007-05-01T00:00:00,Health Care Costs,N03.219.151.400
17461706,2007-05-01T00:00:00,Health Care Costs,N05.300.375
17461706,2007-05-01T00:00:00,Hospitalization,E02.760.400
17461706,2007-05-01T00:00:00,Hospitalization,N02.421.585.400
17461706,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17461706,2007-05-01T00:00:00,Iron,D01.268.556.412
17461706,2007-05-01T00:00:00,Iron,D01.268.956.287
17461706,2007-05-01T00:00:00,Iron,D01.552.544.412
17461706,2007-05-01T00:00:00,Middle Aged,M01.060.116.630
17461706,2007-05-01T00:00:00,Recombinant Proteins,D12.776.828
17462442,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17462442,2007-05-01T00:00:00,Thoracic Surgery,H02.403.810.803
17463355,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17463355,2007-05-01T00:00:00,Program Development,N04.452.760
17463355,2007-05-01T00:00:00,Program Evaluation,E05.337.820
17463355,2007-05-01T00:00:00,Program Evaluation,N04.761.685
17463355,2007-05-01T00:00:00,Program Evaluation,N05.715.360.650
17463355,2007-05-01T00:00:00,Quality of Health Care,N04.761
17463355,2007-05-01T00:00:00,Quality of Health Care,N05.715
17463355,2007-05-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17463355,2007-05-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17463355,2007-05-01T00:00:00,Survivors,M01.643.836
17463355,2007-05-01T00:00:00,Survivors,M01.860
17463355,2007-05-01T00:00:00,Wounds and Injuries,C21.866
17466199,2007-05-01T00:00:00,Adolescent,M01.060.057
17466199,2007-05-01T00:00:00,Adult,M01.060.116
17466199,2007-05-01T00:00:00,Aged,M01.060.116.100
17466199,2007-05-01T00:00:00,Chronic Disease,C23.550.291.500
17466199,2007-05-01T00:00:00,Endosonography,E01.370.350.850.280
17466199,2007-05-01T00:00:00,Fibrosis,C23.550.355
17466199,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17466199,2007-05-01T00:00:00,Middle Aged,M01.060.116.630
17466199,2007-05-01T00:00:00,Pancreatitis,C06.689.750
17466699,2007-05-01T00:00:00,Adult,M01.060.116
17466699,2007-05-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
17466699,2007-05-01T00:00:00,Antibiotic Prophylaxis,E02.319.162.150
17466699,2007-05-01T00:00:00,Antibiotic Prophylaxis,E02.319.703.150
17466699,2007-05-01T00:00:00,Bacterial Infections,C01.252
17466699,2007-05-01T00:00:00,Cesarean Section,E04.520.252.500
17466699,2007-05-01T00:00:00,Double-Blind Method,E05.318.780.300
17466699,2007-05-01T00:00:00,Double-Blind Method,E05.581.500.300
17466699,2007-05-01T00:00:00,Double-Blind Method,N05.715.360.780.320
17466699,2007-05-01T00:00:00,Double-Blind Method,N06.850.520.445.300
17466699,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17466699,2007-05-01T00:00:00,Postoperative Complications,C23.550.767
17466699,2007-05-01T00:00:00,Pregnancy,G08.686.785.760.769
17466699,2007-05-01T00:00:00,Sepsis,C01.539.757
17466699,2007-05-01T00:00:00,Sepsis,C23.550.470.790.500
17466699,2007-05-01T00:00:00,Surgical Wound Infection,C01.539.947.692
17466699,2007-05-01T00:00:00,Surgical Wound Infection,C23.550.767.925
17466699,2007-05-01T00:00:00,Time Factors,G01.910.857
17466867,2007-05-01T00:00:00,Cataract Extraction,E04.540.825.249
17466867,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17466867,2007-05-01T00:00:00,"Lens Capsule, Crystalline",A09.371.060.500.155
17466867,2007-05-01T00:00:00,Ophthalmology,H02.403.810.468
17466867,2007-05-01T00:00:00,Physician's Practice Patterns,N04.590.748
17466867,2007-05-01T00:00:00,Physician's Practice Patterns,N05.300.625
17469162,2007-05-01T00:00:00,Adult,M01.060.116
17469162,2007-05-01T00:00:00,Antirheumatic Agents,D27.505.954.329
17469162,2007-05-01T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
17469162,2007-05-01T00:00:00,Cyclophosphamide,D02.705.670.243
17469162,2007-05-01T00:00:00,Disability Evaluation,E01.370.400
17469162,2007-05-01T00:00:00,Double-Blind Method,E05.318.780.300
17469162,2007-05-01T00:00:00,Double-Blind Method,E05.581.500.300
17469162,2007-05-01T00:00:00,Double-Blind Method,N05.715.360.780.320
17469162,2007-05-01T00:00:00,Double-Blind Method,N06.850.520.445.300
17469162,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17469162,2007-05-01T00:00:00,Lung Diseases,C08.381
17469162,2007-05-01T00:00:00,Middle Aged,M01.060.116.630
17469162,2007-05-01T00:00:00,Quality of Life,I01.800
17469162,2007-05-01T00:00:00,Quality of Life,K01.752.400.750
17469162,2007-05-01T00:00:00,"Scleroderma, Systemic",C17.300.799
17469162,2007-05-01T00:00:00,"Scleroderma, Systemic",C17.800.784
17469162,2007-05-01T00:00:00,Treatment Outcome,E01.789.800
17469162,2007-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17469162,2007-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17471598,2007-05-01T00:00:00,Aged,M01.060.116.100
17471598,2007-05-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
17471598,2007-05-01T00:00:00,Alzheimer Disease,C10.574.945.249
17471598,2007-05-01T00:00:00,Alzheimer Disease,F03.087.400.100
17471598,2007-05-01T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
17471598,2007-05-01T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
17471598,2007-05-01T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
17471598,2007-05-01T00:00:00,Dementia,C10.228.140.380
17471598,2007-05-01T00:00:00,Dementia,F03.087.400
17471598,2007-05-01T00:00:00,Double-Blind Method,E05.318.780.300
17471598,2007-05-01T00:00:00,Double-Blind Method,E05.581.500.300
17471598,2007-05-01T00:00:00,Double-Blind Method,N05.715.360.780.320
17471598,2007-05-01T00:00:00,Double-Blind Method,N06.850.520.445.300
17471598,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17471598,2007-05-01T00:00:00,Middle Aged,M01.060.116.630
17471598,2007-05-01T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
17471598,2007-05-01T00:00:00,Multicenter Studies as Topic,E05.337.250.500
17471598,2007-05-01T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
17471598,2007-05-01T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
17471598,2007-05-01T00:00:00,Psychiatric Status Rating Scales,F04.586
17471598,2007-05-01T00:00:00,Psychotic Disorders,F03.700.675
17471598,2007-05-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
17471598,2007-05-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
17471598,2007-05-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
17471598,2007-05-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
17471598,2007-05-01T00:00:00,Risperidone,D03.383.742.698.685
17471598,2007-05-01T00:00:00,Treatment Outcome,E01.789.800
17471598,2007-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17471598,2007-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17473043,2007-05-01T00:00:00,Adolescent,M01.060.057
17473043,2007-05-01T00:00:00,Adult,M01.060.116
17473043,2007-05-01T00:00:00,Aged,M01.060.116.100
17473043,2007-05-01T00:00:00,Alcohol Drinking,F01.145.317.269
17473043,2007-05-01T00:00:00,Carcinoma,C04.557.470.200
17473043,2007-05-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
17473043,2007-05-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
17473043,2007-05-01T00:00:00,"Diagnosis, Differential",E01.171
17473043,2007-05-01T00:00:00,Gingival Diseases,C07.465.714.258
17473043,2007-05-01T00:00:00,Gingival Neoplasms,C04.588.443.591.402
17473043,2007-05-01T00:00:00,Gingival Neoplasms,C07.465.565.402
17473043,2007-05-01T00:00:00,Gingival Neoplasms,C07.465.714.258.409
17473043,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17473043,2007-05-01T00:00:00,"Jaw, Edentulous, Partially",C05.500.480.450
17473043,2007-05-01T00:00:00,"Jaw, Edentulous, Partially",C07.320.480.450
17473043,2007-05-01T00:00:00,"Jaw, Edentulous, Partially",C07.465.550.425.450
17473043,2007-05-01T00:00:00,"Jaw, Edentulous, Partially",C07.793.597.425.450
17473043,2007-05-01T00:00:00,Middle Aged,M01.060.116.630
17473043,2007-05-01T00:00:00,Smoking,F01.145.466.753
17473134,2007-05-01T00:00:00,Aged,M01.060.116.100
17473134,2007-05-01T00:00:00,Ankle Injuries,C21.866.558.100
17473134,2007-05-01T00:00:00,Ankle Joint,A02.835.583.378.062
17473134,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17473134,2007-05-01T00:00:00,Middle Aged,M01.060.116.630
17475725,2007-05-01T00:00:00,Ambulatory Care,E02.760.106
17475725,2007-05-01T00:00:00,Ambulatory Care,N02.421.585.106
17475725,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17475725,2007-05-01T00:00:00,Methadone,D02.522.675
17475725,2007-05-01T00:00:00,Naltrexone,D03.132.577.249.706.550
17475725,2007-05-01T00:00:00,Naltrexone,D03.549.686.750.550
17475725,2007-05-01T00:00:00,Naltrexone,D03.605.497.750.550
17475725,2007-05-01T00:00:00,Naltrexone,D04.615.723.795.706.550
17475725,2007-05-01T00:00:00,Opioid-Related Disorders,C21.739.675
17475725,2007-05-01T00:00:00,Opioid-Related Disorders,F03.900.675
17475725,2007-05-01T00:00:00,Patient Compliance,F01.145.488.500
17475725,2007-05-01T00:00:00,Patient Compliance,N05.300.150.600.600
17475725,2007-05-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
17475725,2007-05-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
17475725,2007-05-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
17475725,2007-05-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
17475725,2007-05-01T00:00:00,Substance Abuse Detection,E05.885
17475725,2007-05-01T00:00:00,Substance Abuse Detection,N06.850.780.500.765
17475725,2007-05-01T00:00:00,Treatment Outcome,E01.789.800
17475725,2007-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17475725,2007-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17476609,2007-05-01T00:00:00,Adolescent,M01.060.057
17476609,2007-05-01T00:00:00,Adult,M01.060.116
17476609,2007-05-01T00:00:00,Diabetes Mellitus,C18.452.394.750
17476609,2007-05-01T00:00:00,Diabetes Mellitus,C19.246
17476609,2007-05-01T00:00:00,Diabetic Retinopathy,C11.768.257
17476609,2007-05-01T00:00:00,Diabetic Retinopathy,C14.907.320.382
17476609,2007-05-01T00:00:00,Diabetic Retinopathy,C19.246.099.500.382
17476609,2007-05-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
17476609,2007-05-01T00:00:00,Health Services Accessibility,N04.590.374.350
17476609,2007-05-01T00:00:00,Health Services Accessibility,N05.300.430
17476609,2007-05-01T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
17476609,2007-05-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
17476609,2007-05-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
17476609,2007-05-01T00:00:00,Hispanic Americans,M01.686.754.441
17476609,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17476609,2007-05-01T00:00:00,Middle Aged,M01.060.116.630
17476609,2007-05-01T00:00:00,Patient Education as Topic,I02.233.332.500
17476609,2007-05-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
17476609,2007-05-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
17476609,2007-05-01T00:00:00,"Quality Indicators, Health Care",N04.761.789
17476609,2007-05-01T00:00:00,Quality of Health Care,N04.761
17476609,2007-05-01T00:00:00,Quality of Health Care,N05.715
17476609,2007-05-01T00:00:00,Self Care,E02.900
17476609,2007-05-01T00:00:00,Self Care,N02.421.784.680
17476609,2007-05-01T00:00:00,United States,Z01.107.567.875
17478348,2007-05-01T00:00:00,Cholestasis,C06.130.120.135
17478348,2007-05-01T00:00:00,Endosonography,E01.370.350.850.280
17478348,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17478348,2007-05-01T00:00:00,Neoplasms,C04
17481536,2007-05-01T00:00:00,Adolescent,M01.060.057
17481536,2007-05-01T00:00:00,Adult,M01.060.116
17481536,2007-05-01T00:00:00,Aged,M01.060.116.100
17481536,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17481536,2007-05-01T00:00:00,Middle Aged,M01.060.116.630
17481536,2007-05-01T00:00:00,"Pain, Intractable",C10.597.617.788
17481536,2007-05-01T00:00:00,"Pain, Intractable",C23.888.592.612.776
17481536,2007-05-01T00:00:00,"Pain, Intractable",C23.888.646.515
17481536,2007-05-01T00:00:00,Pancreatectomy,E04.210.752
17481536,2007-05-01T00:00:00,Pancreaticoduodenectomy,E04.210.760
17481536,2007-05-01T00:00:00,"Pancreatitis, Chronic",C06.689.750.830
17481536,2007-05-01T00:00:00,Quality of Life,I01.800
17481536,2007-05-01T00:00:00,Quality of Life,K01.752.400.750
17481536,2007-05-01T00:00:00,Regression Analysis,E05.318.740.750
17481536,2007-05-01T00:00:00,Regression Analysis,N05.715.360.750.695
17481536,2007-05-01T00:00:00,Regression Analysis,N06.850.520.830.750
17481536,2007-05-01T00:00:00,Treatment Outcome,E01.789.800
17481536,2007-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17481536,2007-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17481542,2007-05-01T00:00:00,Algorithms,G17.035
17481542,2007-05-01T00:00:00,Algorithms,L01.224.050
17481542,2007-05-01T00:00:00,Blood Proteins,D12.776.124
17481542,2007-05-01T00:00:00,Breast Neoplasms,C04.588.180
17481542,2007-05-01T00:00:00,Breast Neoplasms,C17.800.090.500
17481542,2007-05-01T00:00:00,"Diagnosis, Differential",E01.171
17481542,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17481542,2007-05-01T00:00:00,Mammography,E01.370.350.700.500
17481542,2007-05-01T00:00:00,Middle Aged,M01.060.116.630
17481542,2007-05-01T00:00:00,"Tumor Markers, Biological",D23.101.840
17495195,2007-05-01T00:00:00,Adult,M01.060.116
17495195,2007-05-01T00:00:00,"Diet, Reducing",E02.642.249.285
17495195,2007-05-01T00:00:00,"Diet, Reducing",G07.610.240.285
17495195,2007-05-01T00:00:00,Gastric Bypass,E02.065.062.249
17495195,2007-05-01T00:00:00,Gastric Bypass,E04.035.398.385
17495195,2007-05-01T00:00:00,Gastric Bypass,E04.062.249
17495195,2007-05-01T00:00:00,Gastric Bypass,E04.210.457.430
17495195,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17495195,2007-05-01T00:00:00,Lactones,D02.540
17495195,2007-05-01T00:00:00,Middle Aged,M01.060.116.630
17495195,2007-05-01T00:00:00,"Muscle, Skeletal",A02.633.567
17495195,2007-05-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
17495195,2007-05-01T00:00:00,Obesity,C18.654.726.500
17495195,2007-05-01T00:00:00,Obesity,C23.888.144.699.500
17495195,2007-05-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
17495195,2007-05-01T00:00:00,Obesity,G07.100.100.160.120.699.500
17495195,2007-05-01T00:00:00,Weight Loss,C23.888.144.243.963
17495195,2007-05-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
17502465,2007-05-01T00:00:00,Adult,M01.060.116
17502465,2007-05-01T00:00:00,Aged,M01.060.116.100
17502465,2007-05-01T00:00:00,Coronary Vessels,A07.231.114.269
17502465,2007-05-01T00:00:00,Coronary Vessels,A07.231.908.194
17502465,2007-05-01T00:00:00,Embolism,C14.907.355.350
17502465,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17502465,2007-05-01T00:00:00,Middle Aged,M01.060.116.630
17502465,2007-05-01T00:00:00,Regression Analysis,E05.318.740.750
17502465,2007-05-01T00:00:00,Regression Analysis,N05.715.360.750.695
17502465,2007-05-01T00:00:00,Regression Analysis,N06.850.520.830.750
17502465,2007-05-01T00:00:00,Stroke,C10.228.140.300.775
17502465,2007-05-01T00:00:00,Stroke,C14.907.253.855
17502502,2007-05-01T00:00:00,Adolescent,M01.060.057
17502502,2007-05-01T00:00:00,Child,M01.060.406
17502502,2007-05-01T00:00:00,Eye Movements,G11.427.590.530.140
17502502,2007-05-01T00:00:00,Eye Movements,G14.640.260
17502502,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17502502,2007-05-01T00:00:00,Oculomotor Muscles,A02.633.567.700
17502502,2007-05-01T00:00:00,Oculomotor Muscles,A09.371.613
17502502,2007-05-01T00:00:00,Strabismus,C10.292.562.887
17502502,2007-05-01T00:00:00,Strabismus,C11.590.810
17502502,2007-05-01T00:00:00,Suture Techniques,E04.901
17505270,2007-05-01T00:00:00,Adolescent,M01.060.057
17505270,2007-05-01T00:00:00,Adult,M01.060.116
17505270,2007-05-01T00:00:00,Age Factors,N05.715.350.075
17505270,2007-05-01T00:00:00,Age Factors,N06.850.490.250
17505270,2007-05-01T00:00:00,Child,M01.060.406
17505270,2007-05-01T00:00:00,Cystic Fibrosis,C06.689.202
17505270,2007-05-01T00:00:00,Cystic Fibrosis,C08.381.187
17505270,2007-05-01T00:00:00,Cystic Fibrosis,C16.320.190
17505270,2007-05-01T00:00:00,Cystic Fibrosis,C16.614.213
17505270,2007-05-01T00:00:00,Data Collection,E05.318.308
17505270,2007-05-01T00:00:00,Data Collection,L01.280
17505270,2007-05-01T00:00:00,Data Collection,N05.715.360.300
17505270,2007-05-01T00:00:00,Data Collection,N06.850.520.308
17505270,2007-05-01T00:00:00,Emergency Medicine,H02.403.250
17505270,2007-05-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
17505270,2007-05-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
17505270,2007-05-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
17505270,2007-05-01T00:00:00,"Hospitals, Pediatric",N02.278.421.556.437
17505270,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17505270,2007-05-01T00:00:00,Organizational Policy,I01.880.604.825.550
17505270,2007-05-01T00:00:00,Organizational Policy,N03.706.825.550
17505270,2007-05-01T00:00:00,Pediatrics,H02.403.670
17505270,2007-05-01T00:00:00,Pregnancy,G08.686.785.760.769
17505270,2007-05-01T00:00:00,Pregnancy in Adolescence,G08.686.785.760.769.494
17505270,2007-05-01T00:00:00,United States,Z01.107.567.875
17516343,2007-05-01T00:00:00,Animals,B01.050
17516343,2007-05-01T00:00:00,"Disease Models, Animal",C22.232
17516343,2007-05-01T00:00:00,"Disease Models, Animal",E05.598.500
17516343,2007-05-01T00:00:00,"Disease Models, Animal",E05.599.395.080
17516343,2007-05-01T00:00:00,"Hernia, Abdominal",C23.300.707.374
17516343,2007-05-01T00:00:00,Swine,B01.050.150.900.649.077.880
17519670,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17534087,2007-05-01T00:00:00,Cardiovascular Diseases,C14
17534087,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17534087,2007-05-01T00:00:00,Primary Health Care,N04.590.233.727
17534087,2007-05-01T00:00:00,"Renal Insufficiency, Chronic",C12.777.419.780.750
17534087,2007-05-01T00:00:00,"Renal Insufficiency, Chronic",C13.351.968.419.780.750
17534087,2007-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17534087,2007-05-01T00:00:00,Risk Factors,N05.715.350.200.700
17534087,2007-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17534087,2007-05-01T00:00:00,Risk Factors,N06.850.490.625.750
17534087,2007-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17538318,2007-05-01T00:00:00,Animals,B01.050
17538318,2007-05-01T00:00:00,Blood Platelets,A11.118.188
17538318,2007-05-01T00:00:00,Blood Platelets,A15.145.229.188
17538318,2007-05-01T00:00:00,"Disease Models, Animal",C22.232
17538318,2007-05-01T00:00:00,"Disease Models, Animal",E05.598.500
17538318,2007-05-01T00:00:00,"Disease Models, Animal",E05.599.395.080
17538318,2007-05-01T00:00:00,Hemorrhage,C23.550.414
17538318,2007-05-01T00:00:00,Iron,D01.268.556.412
17538318,2007-05-01T00:00:00,Iron,D01.268.956.287
17538318,2007-05-01T00:00:00,Iron,D01.552.544.412
17538318,2007-05-01T00:00:00,Skin,A17.815
17538318,2007-05-01T00:00:00,Swine,B01.050.150.900.649.077.880
17538318,2007-05-01T00:00:00,Time Factors,G01.910.857
17542868,2007-05-01T00:00:00,Child,M01.060.406
17542868,2007-05-01T00:00:00,Child Welfare,I01.880.787.293
17542868,2007-05-01T00:00:00,Head Protective Devices,E07.700.380
17542868,2007-05-01T00:00:00,Head Protective Devices,J01.637.708.380
17542868,2007-05-01T00:00:00,Health Behavior,F01.145.488
17542868,2007-05-01T00:00:00,Health Education,I02.233.332
17542868,2007-05-01T00:00:00,Health Education,N02.421.143.827.407
17542868,2007-05-01T00:00:00,Health Education,N02.421.726.407
17542868,2007-05-01T00:00:00,Health Promotion,N02.370
17542868,2007-05-01T00:00:00,Health Promotion,N02.421.726.507
17542868,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17542868,2007-05-01T00:00:00,North America,Z01.107.567
17542868,2007-05-01T00:00:00,Parents,F01.829.263.500.320
17542868,2007-05-01T00:00:00,Parents,I01.880.225.500.340
17542868,2007-05-01T00:00:00,Parents,M01.620
17542868,2007-05-01T00:00:00,Program Evaluation,E05.337.820
17542868,2007-05-01T00:00:00,Program Evaluation,N04.761.685
17542868,2007-05-01T00:00:00,Program Evaluation,N05.715.360.650
17542868,2007-05-01T00:00:00,Skin Neoplasms,C04.588.805
17542868,2007-05-01T00:00:00,Skin Neoplasms,C17.800.882
17546794,2007-05-01T00:00:00,Albuminuria,C12.777.934.734.269
17546794,2007-05-01T00:00:00,Albuminuria,C13.351.968.934.734.269
17546794,2007-05-01T00:00:00,Albuminuria,C23.888.942.750.269
17546794,2007-05-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
17546794,2007-05-01T00:00:00,Blood Pressure,E01.370.600.875.249
17546794,2007-05-01T00:00:00,Blood Pressure,G09.330.380.076
17546794,2007-05-01T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.370.140.100
17546794,2007-05-01T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.520.500.100
17546794,2007-05-01T00:00:00,Diabetes Complications,C19.246.099
17546794,2007-05-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
17546794,2007-05-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
17546794,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17546794,2007-05-01T00:00:00,Hypertension,C14.907.489
17546794,2007-05-01T00:00:00,"Hypertrophy, Left Ventricular",C14.280.195.400
17546794,2007-05-01T00:00:00,"Hypertrophy, Left Ventricular",C23.300.775.250.400
17548851,2007-05-01T00:00:00,Adult,M01.060.116
17548851,2007-05-01T00:00:00,Family Practice,H02.403.280
17548851,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17548851,2007-05-01T00:00:00,Internal Medicine,H02.403.429
17548851,2007-05-01T00:00:00,"Medical Records Systems, Computerized",E05.318.308.940.968.625
17548851,2007-05-01T00:00:00,"Medical Records Systems, Computerized",L01.280.900.968.775
17548851,2007-05-01T00:00:00,"Medical Records Systems, Computerized",L01.700.508.300.695
17548851,2007-05-01T00:00:00,"Medical Records Systems, Computerized",N04.452.859.564.650
17548851,2007-05-01T00:00:00,"Medical Records Systems, Computerized",N05.715.360.300.715.500.530
17548851,2007-05-01T00:00:00,"Medical Records Systems, Computerized",N06.850.520.308.940.968.625
17548851,2007-05-01T00:00:00,Middle Aged,M01.060.116.630
17548851,2007-05-01T00:00:00,Observation,E05.581.249
17548851,2007-05-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
17548851,2007-05-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
17548851,2007-05-01T00:00:00,"Quality Indicators, Health Care",N04.761.789
17621805,2007-05-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C10.597.267
17621805,2007-05-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C10.900.300.153
17621805,2007-05-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C21.866.260.207
17621805,2007-05-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C21.866.915.300.300
17621805,2007-05-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C23.888.592.264
17621805,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17621805,2007-05-01T00:00:00,Intracranial Hypertension,C10.228.140.631
17621805,2007-05-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17621805,2007-05-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17621805,2007-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17621805,2007-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17621805,2007-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17621805,2007-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17621805,2007-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17886022,2007-05-01T00:00:00,Adolescent,M01.060.057
17886022,2007-05-01T00:00:00,Adult,M01.060.116
17886022,2007-05-01T00:00:00,Anemia,C15.378.071
17886022,2007-05-01T00:00:00,Anti-Glomerular Basement Membrane Disease,C08.381.483.156
17886022,2007-05-01T00:00:00,Anti-Glomerular Basement Membrane Disease,C12.777.419.570.363.304
17886022,2007-05-01T00:00:00,Anti-Glomerular Basement Membrane Disease,C13.351.968.419.570.363.304
17886022,2007-05-01T00:00:00,Anti-Glomerular Basement Membrane Disease,C20.111.190
17886022,2007-05-01T00:00:00,Child,M01.060.406
17886022,2007-05-01T00:00:00,Cough,C08.618.248
17886022,2007-05-01T00:00:00,Cough,C23.888.852.293
17886022,2007-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17484771,2007-05-02T00:00:00,Animals,B01.050
17484771,2007-05-02T00:00:00,Cytokines,D12.644.276.374
17484771,2007-05-02T00:00:00,Cytokines,D12.776.467.374
17484771,2007-05-02T00:00:00,Cytokines,D23.529.374
17484771,2007-05-02T00:00:00,Lipopolysaccharides,D09.400.500
17484771,2007-05-02T00:00:00,Lipopolysaccharides,D09.698.718.450
17484771,2007-05-02T00:00:00,Lipopolysaccharides,D10.494
17484771,2007-05-02T00:00:00,Lipopolysaccharides,D23.050.161.616.525
17484771,2007-05-02T00:00:00,Lipopolysaccharides,D23.946.123.329.500
17484771,2007-05-02T00:00:00,Staphylococcus aureus,B03.300.390.400.800.750.100
17484771,2007-05-02T00:00:00,Staphylococcus aureus,B03.510.100.750.750.100
17484771,2007-05-02T00:00:00,Staphylococcus aureus,B03.510.400.790.750.100
17484771,2007-05-02T00:00:00,Streptococcus agalactiae,B03.510.400.800.872.100
17505081,2007-05-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17505081,2007-05-02T00:00:00,Metals,D01.552
17505081,2007-05-02T00:00:00,"Models, Statistical",E05.318.740.500
17505081,2007-05-02T00:00:00,"Models, Statistical",E05.599.835
17505081,2007-05-02T00:00:00,"Models, Statistical",N05.715.360.750.530
17505081,2007-05-02T00:00:00,"Models, Statistical",N06.850.520.830.500
17505081,2007-05-02T00:00:00,Monte Carlo Method,E05.318.740.525
17505081,2007-05-02T00:00:00,Monte Carlo Method,L01.906.575.422
17505081,2007-05-02T00:00:00,Monte Carlo Method,N05.715.360.750.540
17505081,2007-05-02T00:00:00,Monte Carlo Method,N06.850.520.830.525
17505081,2007-05-02T00:00:00,"Phantoms, Imaging",E07.671
17505081,2007-05-02T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
17505081,2007-05-02T00:00:00,Prostatic Neoplasms,C12.294.260.750
17505081,2007-05-02T00:00:00,Prostatic Neoplasms,C12.294.565.625
17505081,2007-05-02T00:00:00,Prostatic Neoplasms,C12.758.409.750
17505081,2007-05-02T00:00:00,Protons,D01.248.497.300.459.700
17505081,2007-05-02T00:00:00,Protons,D01.435.550
17505081,2007-05-02T00:00:00,Protons,G01.249.765
17505081,2007-05-02T00:00:00,Radiation Dosage,E05.799.513
17505081,2007-05-02T00:00:00,Radiation Dosage,G01.201.875.740
17505081,2007-05-02T00:00:00,Radiation Dosage,N06.850.810.250
17505081,2007-05-02T00:00:00,Radiometry,E05.799
17505081,2007-05-02T00:00:00,Titanium,D01.268.557.800
17505081,2007-05-02T00:00:00,Titanium,D01.268.956.878
17505081,2007-05-02T00:00:00,Titanium,D01.552.547.800
17505081,2007-05-02T00:00:00,X-Rays,G01.201.875.750.918
17476115,2007-05-03T00:00:00,Amines,D02.092
17476115,2007-05-03T00:00:00,Amino Acid Sequence,G02.111.570.060
17476115,2007-05-03T00:00:00,Amino Acid Sequence,L01.453.245.667.060
17476115,2007-05-03T00:00:00,Calcium,D01.268.552.100
17476115,2007-05-03T00:00:00,Calcium,D01.552.539.288
17476115,2007-05-03T00:00:00,Calcium,D23.119.100
17476115,2007-05-03T00:00:00,Carotid Arteries,A07.231.114.186
17476115,2007-05-03T00:00:00,Carotid Stenosis,C10.228.140.300.200.360
17476115,2007-05-03T00:00:00,Carotid Stenosis,C14.907.137.230
17476115,2007-05-03T00:00:00,Carotid Stenosis,C14.907.253.123.360
17476115,2007-05-03T00:00:00,"Endarterectomy, Carotid",E04.100.814.456.250
17476115,2007-05-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17476115,2007-05-03T00:00:00,Molecular Sequence Data,L01.453.245.667
17476115,2007-05-03T00:00:00,Peptide Fragments,D12.644.541
17476115,2007-05-03T00:00:00,Serum Albumin,D12.776.034.841
17476115,2007-05-03T00:00:00,Serum Albumin,D12.776.124.050.700
17476115,2007-05-03T00:00:00,Serum Albumin,D12.776.124.727
17476115,2007-05-03T00:00:00,Transferrin,D12.776.124.050.800
17476115,2007-05-03T00:00:00,Transferrin,D12.776.124.790.223.839
17476115,2007-05-03T00:00:00,Transferrin,D12.776.157.427.500
17476115,2007-05-03T00:00:00,Transferrin,D12.776.377.715.182.839
17476115,2007-05-03T00:00:00,Transferrin,D12.776.556.579.500
17476115,2007-05-03T00:00:00,Transglutaminases,D08.811.913.050.200.800
17478728,2007-05-03T00:00:00,Animals,B01.050
17478728,2007-05-03T00:00:00,Chick Embryo,A13.350.150
17478728,2007-05-03T00:00:00,Chick Embryo,A16.331.200
17478728,2007-05-03T00:00:00,Collagen,D05.750.078.280
17478728,2007-05-03T00:00:00,Collagen,D12.776.860.300.250
17478728,2007-05-03T00:00:00,Coronary Circulation,G09.330.190.163.324
17478728,2007-05-03T00:00:00,Echocardiography,E01.370.350.850.220
17478728,2007-05-03T00:00:00,Echocardiography,E01.370.370.380.220
17478728,2007-05-03T00:00:00,Glycosaminoglycans,D09.698.373
17478728,2007-05-03T00:00:00,Heart Conduction System,A07.541.409
17478728,2007-05-03T00:00:00,Heart Valves,A07.541.510
17537583,2007-05-03T00:00:00,Adolescent,M01.060.057
17537583,2007-05-03T00:00:00,Adult,M01.060.116
17537583,2007-05-03T00:00:00,"Behavior, Addictive",F01.145.527.100.120
17537583,2007-05-03T00:00:00,Conditioning (Psychology),F02.463.425.179
17537583,2007-05-03T00:00:00,Cues,F02.463.425.234
17537583,2007-05-03T00:00:00,Ganglionic Stimulants,D27.505.696.663.050.400
17537583,2007-05-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17537583,2007-05-03T00:00:00,Nicotine,D03.132.760.570
17537583,2007-05-03T00:00:00,Nicotine,D03.383.725.518
17537583,2007-05-03T00:00:00,Smoking,F01.145.466.753
17537583,2007-05-03T00:00:00,Smoking Cessation,F01.145.940.700
17537583,2007-05-03T00:00:00,Treatment Outcome,E01.789.800
17537583,2007-05-03T00:00:00,Treatment Outcome,N04.761.559.590.800
17537583,2007-05-03T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17483439,2007-05-04T00:00:00,Animals,B01.050
17483439,2007-05-04T00:00:00,Antineoplastic Agents,D27.505.954.248
17483439,2007-05-04T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
17483439,2007-05-04T00:00:00,Pancreatic Neoplasms,C04.588.274.761
17483439,2007-05-04T00:00:00,Pancreatic Neoplasms,C04.588.322.421
17483439,2007-05-04T00:00:00,Pancreatic Neoplasms,C06.301.761
17483439,2007-05-04T00:00:00,Pancreatic Neoplasms,C06.689.667
17483439,2007-05-04T00:00:00,Pancreatic Neoplasms,C19.344.421
17483439,2007-05-04T00:00:00,Sulfur,D01.268.185.900
17483439,2007-05-04T00:00:00,Tubulin,D05.750.078.734.800
17483439,2007-05-04T00:00:00,Tubulin,D12.776.220.600.800
17483439,2007-05-04T00:00:00,Tubulin,D12.776.641.920
17483439,2007-05-04T00:00:00,tau Proteins,D12.776.220.600.450.510
17483439,2007-05-04T00:00:00,tau Proteins,D12.776.641.560.510
17561241,2007-05-05T00:00:00,Algorithms,G17.035
17561241,2007-05-05T00:00:00,Algorithms,L01.224.050
17561241,2007-05-05T00:00:00,Animals,B01.050
17561241,2007-05-05T00:00:00,Cocaine-Related Disorders,C21.739.300
17561241,2007-05-05T00:00:00,Cocaine-Related Disorders,F03.900.300
17561241,2007-05-05T00:00:00,"Conditioning, Operant",F02.463.425.179.509
17561241,2007-05-05T00:00:00,Estrous Cycle,G08.686.195
17561241,2007-05-05T00:00:00,"Models, Psychological",E05.599.695
17561241,2007-05-05T00:00:00,Self Administration,E02.319.890
17561241,2007-05-05T00:00:00,Self Administration,E02.900.890
17561241,2007-05-05T00:00:00,Sex Characteristics,G08.686.815
17485114,2007-05-07T00:00:00,Amino Acids,D12.125
17485114,2007-05-07T00:00:00,Hepacivirus,B04.450.410
17485114,2007-05-07T00:00:00,Hepacivirus,B04.820.250.475
17485114,2007-05-07T00:00:00,Hepacivirus,B04.909.777.310.475
17485114,2007-05-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17485114,2007-05-07T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
17485114,2007-05-07T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
17485114,2007-05-07T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
17485114,2007-05-07T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.606.586
17485114,2007-05-07T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.619.393.522.400
17485114,2007-05-07T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.705.500.380.500
17485114,2007-05-07T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.606.586
17485114,2007-05-07T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.619.393.522.400
17485114,2007-05-07T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.705.500.380.500
17485114,2007-05-07T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.606.586
17485114,2007-05-07T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.619.393.522.400
17485114,2007-05-07T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.705.500.380.500
17485114,2007-05-07T00:00:00,Immunoglobulin Gm Allotypes,G12.500.400.586
17485114,2007-05-07T00:00:00,"Receptors, IgG",D12.776.543.750.705.871.300
17485114,2007-05-07T00:00:00,"Receptors, IgG",D23.050.301.264.035.695
17485114,2007-05-07T00:00:00,"Receptors, IgG",D23.101.100.110.695
17485114,2007-05-07T00:00:00,Viral Core Proteins,D12.776.964.970.600.850
17485423,2007-05-07T00:00:00,Adult,M01.060.116
17485423,2007-05-07T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
17485423,2007-05-07T00:00:00,Cyclophosphamide,D02.705.670.243
17485423,2007-05-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17485423,2007-05-07T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
17485423,2007-05-07T00:00:00,Joints,A02.835.583
17485423,2007-05-07T00:00:00,Lung,A04.411
17485423,2007-05-07T00:00:00,Middle Aged,M01.060.116.630
17485423,2007-05-07T00:00:00,Pulmonary Fibrosis,C08.381.765
17485423,2007-05-07T00:00:00,"Scleroderma, Diffuse",C17.300.799.602
17485423,2007-05-07T00:00:00,"Scleroderma, Diffuse",C17.800.784.602
17485423,2007-05-07T00:00:00,"Scleroderma, Systemic",C17.300.799
17485423,2007-05-07T00:00:00,"Scleroderma, Systemic",C17.800.784
17485423,2007-05-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17485423,2007-05-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17485423,2007-05-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17485423,2007-05-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17485423,2007-05-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17488806,2007-05-08T00:00:00,Animals,B01.050
17488806,2007-05-08T00:00:00,Apoptosis,G04.299.139.160
17488806,2007-05-08T00:00:00,Body Weight,C23.888.144
17488806,2007-05-08T00:00:00,Body Weight,E01.370.600.115.100.160.120
17488806,2007-05-08T00:00:00,Body Weight,E05.041.124.160.750
17488806,2007-05-08T00:00:00,Body Weight,G07.100.100.160.120
17488806,2007-05-08T00:00:00,Body Weight,G07.700.320.249.314.120
17488806,2007-05-08T00:00:00,Bone and Bones,A02.835.232
17488806,2007-05-08T00:00:00,Bone and Bones,A10.165.265
17488806,2007-05-08T00:00:00,Eating,G07.610.593.260
17488806,2007-05-08T00:00:00,Eating,G07.700.620.260
17488806,2007-05-08T00:00:00,Eating,G10.261.326.240
17488806,2007-05-08T00:00:00,Hemoglobins,D12.776.124.400
17488806,2007-05-08T00:00:00,Hemoglobins,D12.776.422.316.762
17488806,2007-05-08T00:00:00,Prostatic Hyperplasia,C12.294.565.500
17488806,2007-05-08T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17488806,2007-05-08T00:00:00,Testosterone,D04.808.054.079.429.824
17488806,2007-05-08T00:00:00,Testosterone,D06.472.334.851.968.984
17493669,2007-05-09T00:00:00,Adult,M01.060.116
17493669,2007-05-09T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
17493669,2007-05-09T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
17493669,2007-05-09T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
17493669,2007-05-09T00:00:00,Cisplatin,D01.210.375
17493669,2007-05-09T00:00:00,Cisplatin,D01.625.125
17493669,2007-05-09T00:00:00,Cisplatin,D01.710.100
17493669,2007-05-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17493669,2007-05-09T00:00:00,Hysterectomy,E04.950.300.399
17493669,2007-05-09T00:00:00,Lymph Node Excision,E04.446
17493669,2007-05-09T00:00:00,Middle Aged,M01.060.116.630
17493669,2007-05-09T00:00:00,Neoplasm Staging,E01.370.550
17493669,2007-05-09T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
17493669,2007-05-09T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
17493669,2007-05-09T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
17493669,2007-05-09T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
17492314,2007-05-10T00:00:00,Aged,M01.060.116.100
17492314,2007-05-10T00:00:00,Angiotensinogen,D12.644.456.073.070
17492314,2007-05-10T00:00:00,Angiotensinogen,D12.644.822.750.020
17492314,2007-05-10T00:00:00,Angiotensinogen,D12.644.861.020
17492314,2007-05-10T00:00:00,Angiotensinogen,D12.776.645.750.020
17492314,2007-05-10T00:00:00,Angiotensinogen,D12.776.811.070
17492314,2007-05-10T00:00:00,Angiotensinogen,D12.776.872.020
17492314,2007-05-10T00:00:00,Antihypertensive Agents,D27.505.954.411.162
17492314,2007-05-10T00:00:00,Blood Pressure,E01.370.600.875.249
17492314,2007-05-10T00:00:00,Blood Pressure,G09.330.380.076
17492314,2007-05-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17492314,2007-05-10T00:00:00,Hypertension,C14.907.489
17492314,2007-05-10T00:00:00,Middle Aged,M01.060.116.630
17492314,2007-05-10T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
17492314,2007-05-10T00:00:00,Sex Characteristics,G08.686.815
17495176,2007-05-10T00:00:00,Contrast Media,D27.720.259
17495176,2007-05-10T00:00:00,Coronary Angiography,E01.370.350.700.060.200
17495176,2007-05-10T00:00:00,Coronary Angiography,E01.370.370.050.200
17495176,2007-05-10T00:00:00,Coronary Angiography,E01.370.370.380.200
17495176,2007-05-10T00:00:00,Heart Diseases,C14.280
17495176,2007-05-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17495176,2007-05-10T00:00:00,Patient Selection,E05.581.500.653
17495176,2007-05-10T00:00:00,Patient Selection,N04.590.731
17495176,2007-05-10T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
17495176,2007-05-10T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
17495176,2007-05-10T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
17495176,2007-05-10T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
17495176,2007-05-10T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
17495176,2007-05-10T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
17495176,2007-05-10T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
17495176,2007-05-10T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17495176,2007-05-10T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17495176,2007-05-10T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17495176,2007-05-10T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17495176,2007-05-10T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17495177,2007-05-10T00:00:00,Algorithms,G17.035
17495177,2007-05-10T00:00:00,Algorithms,L01.224.050
17495177,2007-05-10T00:00:00,Coronary Angiography,E01.370.350.700.060.200
17495177,2007-05-10T00:00:00,Coronary Angiography,E01.370.370.050.200
17495177,2007-05-10T00:00:00,Coronary Angiography,E01.370.370.380.200
17495177,2007-05-10T00:00:00,Coronary Disease,C14.280.647.250
17495177,2007-05-10T00:00:00,Coronary Disease,C14.907.585.250
17495177,2007-05-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17495177,2007-05-10T00:00:00,Middle Aged,M01.060.116.630
17495177,2007-05-10T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
17495177,2007-05-10T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
17495177,2007-05-10T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
17495177,2007-05-10T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
17495177,2007-05-10T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17495177,2007-05-10T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17495177,2007-05-10T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17495177,2007-05-10T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17495177,2007-05-10T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17564733,2007-05-12T00:00:00,Angiography,E01.370.350.700.060
17564733,2007-05-12T00:00:00,Angiography,E01.370.370.050
17564733,2007-05-12T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
17564733,2007-05-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17564733,2007-05-12T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
17564733,2007-05-12T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
17564733,2007-05-12T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
17564733,2007-05-12T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
17564733,2007-05-12T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
17564733,2007-05-12T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
17564733,2007-05-12T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17564733,2007-05-12T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17564733,2007-05-12T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17564733,2007-05-12T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17564733,2007-05-12T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17564733,2007-05-12T00:00:00,"Wounds, Nonpenetrating",C21.866.974
17585872,2007-05-13T00:00:00,Adolescent,M01.060.057
17585872,2007-05-13T00:00:00,Adult,M01.060.116
17585872,2007-05-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17585872,2007-05-13T00:00:00,Psychiatric Status Rating Scales,F04.586
17585872,2007-05-13T00:00:00,Rape,I01.198.240.748.640
17585872,2007-05-13T00:00:00,Regression Analysis,E05.318.740.750
17585872,2007-05-13T00:00:00,Regression Analysis,N05.715.360.750.695
17585872,2007-05-13T00:00:00,Regression Analysis,N06.850.520.830.750
17585872,2007-05-13T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17585872,2007-05-13T00:00:00,Video Recording,L01.240.960
17502428,2007-05-14T00:00:00,Animals,B01.050
17502428,2007-05-14T00:00:00,Cell Line,A11.251.210
17502428,2007-05-14T00:00:00,Excitatory Amino Acid Antagonists,D27.505.519.625.190.300
17502428,2007-05-14T00:00:00,Excitatory Amino Acid Antagonists,D27.505.696.577.190.300
17502428,2007-05-14T00:00:00,Glycine,D12.125.481
17502428,2007-05-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17502428,2007-05-14T00:00:00,Mutation,G05.365.590
17502428,2007-05-14T00:00:00,Pyrrolidinones,D03.383.773.812
17502428,2007-05-14T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17502428,2007-05-14T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
17520541,2007-05-14T00:00:00,Bacteremia,C01.252.100
17520541,2007-05-14T00:00:00,Bacteremia,C01.539.757.100
17520541,2007-05-14T00:00:00,Bacteremia,C23.550.470.790.500.100
17520541,2007-05-14T00:00:00,"Catheterization, Central Venous",E02.148.167
17520541,2007-05-14T00:00:00,"Catheters, Indwelling",E07.150
17520541,2007-05-14T00:00:00,Cross Infection,C01.539.248
17520541,2007-05-14T00:00:00,Disease Outbreaks,N06.850.290
17520541,2007-05-14T00:00:00,"Education, Nursing, Continuing",I02.358.212.450
17520541,2007-05-14T00:00:00,"Education, Nursing, Continuing",I02.358.462.399
17520541,2007-05-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17520541,2007-05-14T00:00:00,"Nursing Staff, Hospital",M01.526.485.680.490
17520541,2007-05-14T00:00:00,"Nursing Staff, Hospital",M01.526.485.740.523
17520541,2007-05-14T00:00:00,"Nursing Staff, Hospital",N02.360.680.490
17520541,2007-05-14T00:00:00,"Nursing Staff, Hospital",N02.360.740.523
17520541,2007-05-14T00:00:00,South Carolina,Z01.107.567.875.075.662
17520541,2007-05-14T00:00:00,South Carolina,Z01.107.567.875.750.700
17495770,2007-05-15T00:00:00,Adult,M01.060.116
17495770,2007-05-15T00:00:00,"Arthroplasty, Replacement",E04.555.110.110
17495770,2007-05-15T00:00:00,"Arthroplasty, Replacement",E04.650.110
17495770,2007-05-15T00:00:00,Disability Evaluation,E01.370.400
17495770,2007-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17495770,2007-05-15T00:00:00,Low Back Pain,C10.597.617.152.400
17495770,2007-05-15T00:00:00,Low Back Pain,C23.888.592.612.107.400
17495770,2007-05-15T00:00:00,Low Back Pain,C23.888.646.172.500
17495770,2007-05-15T00:00:00,Lumbar Vertebrae,A02.835.232.834.519
17495770,2007-05-15T00:00:00,Middle Aged,M01.060.116.630
17495770,2007-05-15T00:00:00,Pain Measurement,E01.370.376.550.600
17495770,2007-05-15T00:00:00,Patient Satisfaction,N04.452.822.360.600
17495770,2007-05-15T00:00:00,Patient Satisfaction,N05.300.150.600.630
17495770,2007-05-15T00:00:00,Patient Satisfaction,N05.715.360.600
17495770,2007-05-15T00:00:00,Prosthesis Design,E05.320.550
17495770,2007-05-15T00:00:00,Prosthesis Design,E07.695.680
17495770,2007-05-15T00:00:00,Recovery of Function,G16.757
17495770,2007-05-15T00:00:00,Spinal Diseases,C05.116.900
17495770,2007-05-15T00:00:00,Spinal Fusion,E04.555.100.700
17495770,2007-05-15T00:00:00,Time Factors,G01.910.857
17495770,2007-05-15T00:00:00,Treatment Outcome,E01.789.800
17495770,2007-05-15T00:00:00,Treatment Outcome,N04.761.559.590.800
17495770,2007-05-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17495770,2007-05-15T00:00:00,United States,Z01.107.567.875
17505042,2007-05-15T00:00:00,Adult,M01.060.116
17505042,2007-05-15T00:00:00,Aged,M01.060.116.100
17505042,2007-05-15T00:00:00,Bronchoscopy,E01.370.386.105
17505042,2007-05-15T00:00:00,Bronchoscopy,E01.370.388.250.100
17505042,2007-05-15T00:00:00,Bronchoscopy,E04.800.250.100
17505042,2007-05-15T00:00:00,Bronchoscopy,E04.928.600.080
17505042,2007-05-15T00:00:00,Diagnostic Imaging,E01.370.350
17505042,2007-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17505042,2007-05-15T00:00:00,Image Enhancement,E01.370.350.600.350
17505042,2007-05-15T00:00:00,Image Enhancement,L01.224.308.380
17505042,2007-05-15T00:00:00,Light,G01.201.875.770.578
17505042,2007-05-15T00:00:00,Light,G01.590.540
17505042,2007-05-15T00:00:00,Lung Neoplasms,C04.588.894.797.520
17505042,2007-05-15T00:00:00,Lung Neoplasms,C08.381.540
17505042,2007-05-15T00:00:00,Lung Neoplasms,C08.785.520
17505042,2007-05-15T00:00:00,Middle Aged,M01.060.116.630
17505042,2007-05-15T00:00:00,Pilot Projects,E05.318.760.750
17505042,2007-05-15T00:00:00,Pilot Projects,E05.337.737
17505042,2007-05-15T00:00:00,Pilot Projects,N05.715.360.775.625
17505042,2007-05-15T00:00:00,Pilot Projects,N06.850.520.450.720
17505042,2007-05-15T00:00:00,Respiratory System,A04
17505110,2007-05-15T00:00:00,Amino Acid Sequence,G02.111.570.060
17505110,2007-05-15T00:00:00,Amino Acid Sequence,L01.453.245.667.060
17505110,2007-05-15T00:00:00,Binding Sites,G02.111.570.120
17505110,2007-05-15T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
17505110,2007-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17505110,2007-05-15T00:00:00,"Models, Molecular",E05.599.595
17505110,2007-05-15T00:00:00,Molecular Sequence Data,L01.453.245.667
17505110,2007-05-15T00:00:00,Multiprotein Complexes,D05.500
17505110,2007-05-15T00:00:00,"Nuclear Magnetic Resonance, Biomolecular",E05.196.867.519.550
17505110,2007-05-15T00:00:00,"Protein Structure, Secondary",G02.111.570.790.709.600
17505110,2007-05-15T00:00:00,Recombinant Proteins,D12.776.828
17505110,2007-05-15T00:00:00,Static Electricity,G01.201.249.820
17516621,2007-05-15T00:00:00,Adult,M01.060.116
17516621,2007-05-15T00:00:00,African Americans,M01.686.508.100.100
17516621,2007-05-15T00:00:00,African Americans,M01.686.754.100
17516621,2007-05-15T00:00:00,African Continental Ancestry Group,M01.686.508.100
17516621,2007-05-15T00:00:00,Age Factors,N05.715.350.075
17516621,2007-05-15T00:00:00,Age Factors,N06.850.490.250
17516621,2007-05-15T00:00:00,Aged,M01.060.116.100
17516621,2007-05-15T00:00:00,Disease Progression,C23.550.291.656
17516621,2007-05-15T00:00:00,European Continental Ancestry Group,M01.686.508.400
17516621,2007-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17516621,2007-05-15T00:00:00,"Hypertension, Pulmonary",C08.381.423
17516621,2007-05-15T00:00:00,"Hypertrophy, Left Ventricular",C14.280.195.400
17516621,2007-05-15T00:00:00,"Hypertrophy, Left Ventricular",C23.300.775.250.400
17516621,2007-05-15T00:00:00,Incidence,E05.318.308.985.525.375
17516621,2007-05-15T00:00:00,Incidence,L01.280.975.525.375
17516621,2007-05-15T00:00:00,Incidence,N01.224.935.597.500
17516621,2007-05-15T00:00:00,Incidence,N06.850.505.400.975.525.375
17516621,2007-05-15T00:00:00,Incidence,N06.850.520.308.985.525.375
17516621,2007-05-15T00:00:00,Middle Aged,M01.060.116.630
17516621,2007-05-15T00:00:00,Risk Factors,E05.318.740.600.800.725
17516621,2007-05-15T00:00:00,Risk Factors,N05.715.350.200.700
17516621,2007-05-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17516621,2007-05-15T00:00:00,Risk Factors,N06.850.490.625.750
17516621,2007-05-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17516621,2007-05-15T00:00:00,"Scleroderma, Systemic",C17.300.799
17516621,2007-05-15T00:00:00,"Scleroderma, Systemic",C17.800.784
17507911,2007-05-16T00:00:00,Adult,M01.060.116
17507911,2007-05-16T00:00:00,Alcoholism,C21.739.100.250
17507911,2007-05-16T00:00:00,Alcoholism,F03.900.100.350
17507911,2007-05-16T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17507911,2007-05-16T00:00:00,Genetic Predisposition to Disease,G05.380.355
17507911,2007-05-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17507911,2007-05-16T00:00:00,Linkage Disequilibrium,G05.540.500
17507911,2007-05-16T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
17510308,2007-05-17T00:00:00,Adult,M01.060.116
17510308,2007-05-17T00:00:00,Aged,M01.060.116.100
17510308,2007-05-17T00:00:00,Anticoagulants,D27.505.954.502.119
17510308,2007-05-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17510308,2007-05-17T00:00:00,Middle Aged,M01.060.116.630
17510308,2007-05-17T00:00:00,Warfarin,D03.438.150.446.520.914
17510308,2007-05-17T00:00:00,Warfarin,D03.830.219.446.520.914
17513506,2007-05-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17513506,2007-05-18T00:00:00,Sepsis,C01.539.757
17513506,2007-05-18T00:00:00,Sepsis,C23.550.470.790.500
17513506,2007-05-18T00:00:00,Streptococcal Infections,C01.252.410.890
17513506,2007-05-18T00:00:00,Streptococcus pyogenes,B03.510.400.800.872.575
17604601,2007-05-18T00:00:00,Animals,B01.050
17604601,2007-05-18T00:00:00,Environmental Exposure,N06.850.460.350
17604601,2007-05-18T00:00:00,Environmental Monitoring,N06.850.460.350.080
17604601,2007-05-18T00:00:00,Environmental Monitoring,N06.850.780.375
17604601,2007-05-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17604601,2007-05-18T00:00:00,Reproduction,G08.686.785.760
17604601,2007-05-18T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
17515467,2007-05-21T00:00:00,Aged,M01.060.116.100
17515467,2007-05-21T00:00:00,Arterial Occlusive Diseases,C14.907.137
17515467,2007-05-21T00:00:00,Blood Pressure,E01.370.600.875.249
17515467,2007-05-21T00:00:00,Blood Pressure,G09.330.380.076
17515467,2007-05-21T00:00:00,Cerebral Arterial Diseases,C10.228.140.300.510.200
17515467,2007-05-21T00:00:00,Cerebral Arterial Diseases,C14.907.253.560.200
17515467,2007-05-21T00:00:00,Diastole,G09.330.190.541.295
17515467,2007-05-21T00:00:00,Diastole,G11.427.590.540.554.250
17515467,2007-05-21T00:00:00,Diastole,G11.427.590.540.570.295
17515467,2007-05-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17515467,2007-05-21T00:00:00,Middle Aged,M01.060.116.630
17515467,2007-05-21T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
17515467,2007-05-21T00:00:00,Practice Guidelines as Topic,N05.700.350.650
17515467,2007-05-21T00:00:00,Stroke,C10.228.140.300.775
17515467,2007-05-21T00:00:00,Stroke,C14.907.253.855
17515467,2007-05-21T00:00:00,Time Factors,G01.910.857
17515473,2007-05-22T00:00:00,Adult,M01.060.116
17515473,2007-05-22T00:00:00,Anticoagulants,D27.505.954.502.119
17515473,2007-05-22T00:00:00,Brain Ischemia,C10.228.140.300.150
17515473,2007-05-22T00:00:00,Brain Ischemia,C14.907.253.092
17515473,2007-05-22T00:00:00,Emergency Medical Services,N02.421.297
17515473,2007-05-22T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
17515473,2007-05-22T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
17515473,2007-05-22T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
17515473,2007-05-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17515473,2007-05-22T00:00:00,Stroke,C10.228.140.300.775
17515473,2007-05-22T00:00:00,Stroke,C14.907.253.855
17515473,2007-05-22T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
17515473,2007-05-22T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
17515473,2007-05-22T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
17515473,2007-05-22T00:00:00,Tissue Plasminogen Activator,D23.119.970
17516069,2007-05-22T00:00:00,Adult,M01.060.116
17516069,2007-05-22T00:00:00,Aged,M01.060.116.100
17516069,2007-05-22T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
17516069,2007-05-22T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
17516069,2007-05-22T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
17516069,2007-05-22T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
17516069,2007-05-22T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
17516069,2007-05-22T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
17516069,2007-05-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17516069,2007-05-22T00:00:00,Middle Aged,M01.060.116.630
18631895,2007-05-22T00:00:00,Bladder Exstrophy,C12.706.132
18631895,2007-05-22T00:00:00,Bladder Exstrophy,C12.777.829.132
18631895,2007-05-22T00:00:00,Bladder Exstrophy,C13.351.875.132
18631895,2007-05-22T00:00:00,Bladder Exstrophy,C13.351.968.829.132
18631895,2007-05-22T00:00:00,Bladder Exstrophy,C16.131.939.132
18631895,2007-05-22T00:00:00,Child,M01.060.406
18631895,2007-05-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18631895,2007-05-22T00:00:00,"Muscle, Skeletal",A02.633.567
18631895,2007-05-22T00:00:00,"Muscle, Skeletal",A10.690.552.500
18631895,2007-05-22T00:00:00,Pelvic Bones,A02.835.232.043.825
18631895,2007-05-22T00:00:00,Postoperative Complications,C23.550.767
18631895,2007-05-22T00:00:00,Urinary Incontinence,C12.777.934.852
18631895,2007-05-22T00:00:00,Urinary Incontinence,C13.351.968.934.814
18631895,2007-05-22T00:00:00,Urinary Incontinence,C23.888.942.800
18631895,2007-05-22T00:00:00,Urologic Surgical Procedures,E04.950.774
17522057,2007-05-23T00:00:00,Animals,B01.050
17522057,2007-05-23T00:00:00,Collagen,D05.750.078.280
17522057,2007-05-23T00:00:00,Collagen,D12.776.860.300.250
17522057,2007-05-23T00:00:00,Collagen Type I,D05.750.078.280.300.100
17522057,2007-05-23T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
17522057,2007-05-23T00:00:00,Extracellular Matrix,A11.284.295.310
17522057,2007-05-23T00:00:00,Fibroblasts,A11.329.228
17522057,2007-05-23T00:00:00,Fibroblasts,A11.872.228
17522057,2007-05-23T00:00:00,Osteonectin,D12.776.157.125.715
17522057,2007-05-23T00:00:00,Osteonectin,D12.776.395.600
17522057,2007-05-23T00:00:00,Recombinant Proteins,D12.776.828
17522263,2007-05-23T00:00:00,Albuminuria,C12.777.934.734.269
17522263,2007-05-23T00:00:00,Albuminuria,C13.351.968.934.734.269
17522263,2007-05-23T00:00:00,Albuminuria,C23.888.942.750.269
17522263,2007-05-23T00:00:00,Animals,B01.050
17522263,2007-05-23T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
17522263,2007-05-23T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
17522263,2007-05-23T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
17522263,2007-05-23T00:00:00,"Complement Pathway, Alternative",G12.425.255.695
17522263,2007-05-23T00:00:00,Doxorubicin,D02.455.426.559.847.562.050.200.175
17522263,2007-05-23T00:00:00,Doxorubicin,D04.615.562.050.200.175
17522263,2007-05-23T00:00:00,Doxorubicin,D09.408.051.059.200.175
17522263,2007-05-23T00:00:00,Kidney Diseases,C12.777.419
17522263,2007-05-23T00:00:00,Kidney Diseases,C13.351.968.419
17522263,2007-05-23T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
17522263,2007-05-23T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
17522263,2007-05-23T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
17522263,2007-05-23T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
17522263,2007-05-23T00:00:00,Kidney Glomerulus,A05.810.453.324.359
17522263,2007-05-23T00:00:00,Kidney Glomerulus,A05.810.453.736.520
17522263,2007-05-23T00:00:00,Kidney Tubules,A05.810.453.736.560
17522263,2007-05-23T00:00:00,Proteinuria,C12.777.934.734
17522263,2007-05-23T00:00:00,Proteinuria,C13.351.968.934.734
17522263,2007-05-23T00:00:00,Proteinuria,C23.888.942.750
17543647,2007-05-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17543647,2007-05-23T00:00:00,Myocardial Infarction,C14.280.647.500
17543647,2007-05-23T00:00:00,Myocardial Infarction,C14.907.585.500
17543647,2007-05-23T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
17543647,2007-05-23T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
17543647,2007-05-23T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
17543647,2007-05-23T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
17543647,2007-05-23T00:00:00,Risk Assessment,E05.318.740.600.800.715
17543647,2007-05-23T00:00:00,Risk Assessment,N04.452.871.715
17543647,2007-05-23T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17543647,2007-05-23T00:00:00,Risk Assessment,N06.850.505.715
17543647,2007-05-23T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17522977,2007-05-24T00:00:00,Animals,B01.050
17522977,2007-05-24T00:00:00,DNA,D13.444.308
17522977,2007-05-24T00:00:00,Enzyme Inhibitors,D27.505.519.389
17522977,2007-05-24T00:00:00,"Mechanotransduction, Cellular",G01.154.100.440
17522977,2007-05-24T00:00:00,"Mechanotransduction, Cellular",G01.595.100.440
17522977,2007-05-24T00:00:00,"Mechanotransduction, Cellular",G02.111.087.800.580
17522977,2007-05-24T00:00:00,"Mechanotransduction, Cellular",G02.149.115.800.580
17522977,2007-05-24T00:00:00,"Mechanotransduction, Cellular",G04.299.880.580
17522977,2007-05-24T00:00:00,"Muscle, Smooth",A02.633.570
17522977,2007-05-24T00:00:00,"Muscle, Smooth",A10.690.467
17522977,2007-05-24T00:00:00,Phosphorylation,G02.111.087.677
17522977,2007-05-24T00:00:00,Phosphorylation,G02.149.115.677
17522977,2007-05-24T00:00:00,Phosphorylation,G02.149.465.700
17522977,2007-05-24T00:00:00,Phosphorylation,G02.607.750.700
17522977,2007-05-24T00:00:00,Phosphorylation,G03.495.790
17522977,2007-05-24T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
17522977,2007-05-24T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
17522977,2007-05-24T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
17522977,2007-05-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17522977,2007-05-24T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17522977,2007-05-24T00:00:00,Urinary Bladder,A05.810.890
17582692,2007-05-24T00:00:00,Adolescent,M01.060.057
17582692,2007-05-24T00:00:00,Adult,M01.060.116
17582692,2007-05-24T00:00:00,Aged,M01.060.116.100
17582692,2007-05-24T00:00:00,Cocaine-Related Disorders,C21.739.300
17582692,2007-05-24T00:00:00,Cocaine-Related Disorders,F03.900.300
17582692,2007-05-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17582692,2007-05-24T00:00:00,Middle Aged,M01.060.116.630
17582692,2007-05-24T00:00:00,Phenotype,G05.695
17586137,2007-05-24T00:00:00,Chlamydia Infections,C01.252.400.210.210
17586137,2007-05-24T00:00:00,Chlamydia Infections,C01.252.810.301
17586137,2007-05-24T00:00:00,Chlamydia Infections,C01.539.778.281.301
17586137,2007-05-24T00:00:00,Chlamydia Infections,C12.294.668.281.301
17586137,2007-05-24T00:00:00,Chlamydia Infections,C13.351.500.711.281.301
17586137,2007-05-24T00:00:00,Chlamydia trachomatis,B03.440.190.190.190.750
17586137,2007-05-24T00:00:00,Chronic Disease,C23.550.291.500
17586137,2007-05-24T00:00:00,"Contraceptive Agents, Female",D27.505.696.875.360.276
17586137,2007-05-24T00:00:00,"Contraceptive Agents, Female",D27.505.954.705.360.276
17586137,2007-05-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17586137,2007-05-24T00:00:00,Polymerase Chain Reaction,E05.393.620.500
17586137,2007-05-24T00:00:00,South Carolina,Z01.107.567.875.075.662
17586137,2007-05-24T00:00:00,South Carolina,Z01.107.567.875.750.700
17524074,2007-05-25T00:00:00,Graft Rejection,G12.425.901.545.328
17524074,2007-05-25T00:00:00,Graft Survival,G12.425.901.545.340
17524074,2007-05-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17524074,2007-05-25T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
17524074,2007-05-25T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
17524074,2007-05-25T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
17524074,2007-05-25T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
17524074,2007-05-25T00:00:00,Kidney Transplantation,E02.870.500
17524074,2007-05-25T00:00:00,Kidney Transplantation,E04.936.450.485
17524074,2007-05-25T00:00:00,Kidney Transplantation,E04.950.774.400
17524074,2007-05-25T00:00:00,Postoperative Complications,C23.550.767
17524074,2007-05-25T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.100.047.625
17524074,2007-05-25T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.720.600.150.625
17524074,2007-05-25T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.750.130.750
17524074,2007-05-25T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.750.555.150.750
17524074,2007-05-25T00:00:00,Treatment Outcome,E01.789.800
17524074,2007-05-25T00:00:00,Treatment Outcome,N04.761.559.590.800
17524074,2007-05-25T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17644219,2007-05-25T00:00:00,Animals,B01.050
17644219,2007-05-25T00:00:00,Apoptosis,G04.299.139.160
17644219,2007-05-25T00:00:00,Heart Ventricles,A07.541.560
17644219,2007-05-25T00:00:00,"Models, Animal",E05.598
17644219,2007-05-25T00:00:00,Myocardial Infarction,C14.280.647.500
17644219,2007-05-25T00:00:00,Myocardial Infarction,C14.907.585.500
17644219,2007-05-25T00:00:00,"Myocytes, Cardiac",A07.541.704.570
17644219,2007-05-25T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
17644219,2007-05-25T00:00:00,"Myocytes, Cardiac",A11.620.500
17644219,2007-05-25T00:00:00,Phosphorylation,G02.111.087.677
17644219,2007-05-25T00:00:00,Phosphorylation,G02.149.115.677
17644219,2007-05-25T00:00:00,Phosphorylation,G02.149.465.700
17644219,2007-05-25T00:00:00,Phosphorylation,G02.607.750.700
17644219,2007-05-25T00:00:00,Phosphorylation,G03.495.790
17644219,2007-05-25T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17644219,2007-05-25T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17644219,2007-05-25T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.100.080.500
17644219,2007-05-25T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.720.600.220.500
17644219,2007-05-25T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.750.555.220.500
17644219,2007-05-25T00:00:00,Reperfusion Injury,C14.907.725
17644219,2007-05-25T00:00:00,Reperfusion Injury,C23.550.767.877
17644219,2007-05-25T00:00:00,Ventricular Remodeling,C23.300.985
17644219,2007-05-25T00:00:00,Ventricular Remodeling,G09.330.190.962.975
17603086,2007-05-26T00:00:00,Adolescent,M01.060.057
17603086,2007-05-26T00:00:00,Adult,M01.060.116
17603086,2007-05-26T00:00:00,Brain,A08.186.211
17603086,2007-05-26T00:00:00,Hippocampus,A08.186.211.464.405
17603086,2007-05-26T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
17603086,2007-05-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17603086,2007-05-26T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
17603086,2007-05-26T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17603086,2007-05-26T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17603086,2007-05-26T00:00:00,Psychomotor Performance,F02.808
17603086,2007-05-26T00:00:00,Psychomotor Performance,G11.427.700
17603086,2007-05-26T00:00:00,Psychomotor Performance,G11.561.623
17533172,2007-05-28T00:00:00,Body Mass Index,E01.370.600.115.100.125
17533172,2007-05-28T00:00:00,Body Mass Index,E05.041.124.125
17533172,2007-05-28T00:00:00,Body Mass Index,G07.100.100.125
17533172,2007-05-28T00:00:00,Body Mass Index,N06.850.505.200.100.175
17533172,2007-05-28T00:00:00,Environment Design,I01.283
17533172,2007-05-28T00:00:00,Environment Design,I01.880.709.359
17533172,2007-05-28T00:00:00,Environment Design,N06.230.200
17533172,2007-05-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17533172,2007-05-28T00:00:00,Motor Activity,F01.145.632
17533172,2007-05-28T00:00:00,Motor Activity,G11.427.590.530.698
17533172,2007-05-28T00:00:00,Obesity,C18.654.726.500
17533172,2007-05-28T00:00:00,Obesity,C23.888.144.699.500
17533172,2007-05-28T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
17533172,2007-05-28T00:00:00,Obesity,G07.100.100.160.120.699.500
17533172,2007-05-28T00:00:00,Social Environment,I01.880.656
17532240,2007-05-29T00:00:00,Cataract Extraction,E04.540.825.249
17532240,2007-05-29T00:00:00,Child,M01.060.406
17532240,2007-05-29T00:00:00,"Child, Preschool",M01.060.406.448
17532240,2007-05-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17532240,2007-05-29T00:00:00,Infant,M01.060.703
17532240,2007-05-29T00:00:00,"Infant, Newborn",M01.060.703.520
17532240,2007-05-29T00:00:00,"Lens Capsule, Crystalline",A09.371.060.500.155
17532240,2007-05-29T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
17532240,2007-05-29T00:00:00,Postoperative Complications,C23.550.767
17532240,2007-05-29T00:00:00,Treatment Outcome,E01.789.800
17532240,2007-05-29T00:00:00,Treatment Outcome,N04.761.559.590.800
17532240,2007-05-29T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17533404,2007-05-29T00:00:00,"Child, Preschool",M01.060.406.448
17533404,2007-05-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17533404,2007-05-29T00:00:00,Incidence,E05.318.308.985.525.375
17533404,2007-05-29T00:00:00,Incidence,L01.280.975.525.375
17533404,2007-05-29T00:00:00,Incidence,N01.224.935.597.500
17533404,2007-05-29T00:00:00,Incidence,N06.850.505.400.975.525.375
17533404,2007-05-29T00:00:00,Incidence,N06.850.520.308.985.525.375
17533404,2007-05-29T00:00:00,Income,N01.824.417
17533404,2007-05-29T00:00:00,Population Dynamics,I01.240.600
17533404,2007-05-29T00:00:00,Population Dynamics,N01.224.625
17533404,2007-05-29T00:00:00,Population Dynamics,N06.850.505.400.700
17533404,2007-05-29T00:00:00,Risk Factors,E05.318.740.600.800.725
17533404,2007-05-29T00:00:00,Risk Factors,N05.715.350.200.700
17533404,2007-05-29T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17533404,2007-05-29T00:00:00,Risk Factors,N06.850.490.625.750
17533404,2007-05-29T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17533404,2007-05-29T00:00:00,Sex Characteristics,G08.686.815
17533404,2007-05-29T00:00:00,United States,Z01.107.567.875
17533404,2007-05-29T00:00:00,Urban Population,N01.600.900
17535441,2007-05-29T00:00:00,Adult,M01.060.116
17535441,2007-05-29T00:00:00,Aged,M01.060.116.100
17535441,2007-05-29T00:00:00,Carcinogens,D27.888.569.100
17535441,2007-05-29T00:00:00,Case-Control Studies,E05.318.760.500.500
17535441,2007-05-29T00:00:00,Case-Control Studies,N05.715.360.775.175.200
17535441,2007-05-29T00:00:00,Case-Control Studies,N06.850.520.450.500.500
17535441,2007-05-29T00:00:00,Disinfectants,D27.505.954.122.425
17535441,2007-05-29T00:00:00,Disinfectants,D27.720.274
17535441,2007-05-29T00:00:00,Geographic Information Systems,L01.470.750.750.462
17535441,2007-05-29T00:00:00,Geographic Information Systems,L01.700.508.300.314
17535441,2007-05-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17535441,2007-05-29T00:00:00,Middle Aged,M01.060.116.630
17535441,2007-05-29T00:00:00,New York,Z01.107.567.875.075.437
17535441,2007-05-29T00:00:00,New York,Z01.107.567.875.350.530
17535441,2007-05-29T00:00:00,New York,Z01.107.567.875.500.530
17535441,2007-05-29T00:00:00,Risk Factors,E05.318.740.600.800.725
17535441,2007-05-29T00:00:00,Risk Factors,N05.715.350.200.700
17535441,2007-05-29T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17535441,2007-05-29T00:00:00,Risk Factors,N06.850.490.625.750
17535441,2007-05-29T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17535441,2007-05-29T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
17536050,2007-05-29T00:00:00,Aged,M01.060.116.100
17536050,2007-05-29T00:00:00,Biological Markers,D23.101
17536050,2007-05-29T00:00:00,Brain Infarction,C10.228.140.300.150.477
17536050,2007-05-29T00:00:00,Brain Infarction,C10.228.140.300.775.200
17536050,2007-05-29T00:00:00,Brain Infarction,C14.907.253.092.477
17536050,2007-05-29T00:00:00,Brain Infarction,C14.907.253.855.200
17536050,2007-05-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17536050,2007-05-29T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
17536050,2007-05-29T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
17536050,2007-05-29T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
17536050,2007-05-29T00:00:00,Intracranial Embolism,C10.228.140.300.525.400
17536050,2007-05-29T00:00:00,Intracranial Embolism,C14.907.253.566.300
17536050,2007-05-29T00:00:00,Intracranial Embolism,C14.907.355.590.213.300
17536050,2007-05-29T00:00:00,Intracranial Embolism,C14.907.355.830.850.213.300
17536050,2007-05-29T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
17536050,2007-05-29T00:00:00,Metabolic Syndrome X,C18.452.625
17536050,2007-05-29T00:00:00,Middle Aged,M01.060.116.630
17536050,2007-05-29T00:00:00,Risk Factors,E05.318.740.600.800.725
17536050,2007-05-29T00:00:00,Risk Factors,N05.715.350.200.700
17536050,2007-05-29T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17536050,2007-05-29T00:00:00,Risk Factors,N06.850.490.625.750
17536050,2007-05-29T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17536050,2007-05-29T00:00:00,Sex Factors,N05.715.350.675
17536050,2007-05-29T00:00:00,Sex Factors,N06.850.490.875
17536050,2007-05-29T00:00:00,Smoking,F01.145.466.753
17536059,2007-05-29T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
17536059,2007-05-29T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
17536059,2007-05-29T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
17536059,2007-05-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17536059,2007-05-29T00:00:00,Internet,L01.224.230.110.500
17536059,2007-05-29T00:00:00,Rural Population,N01.600.725
17536059,2007-05-29T00:00:00,Stroke,C10.228.140.300.775
17536059,2007-05-29T00:00:00,Stroke,C14.907.253.855
17536059,2007-05-29T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
17536059,2007-05-29T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
17536059,2007-05-29T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
17536059,2007-05-29T00:00:00,Tissue Plasminogen Activator,D23.119.970
17631078,2007-05-30T00:00:00,Aged,M01.060.116.100
17631078,2007-05-30T00:00:00,"Arrhythmias, Cardiac",C14.280.067
17631078,2007-05-30T00:00:00,"Arrhythmias, Cardiac",C23.550.073
17631078,2007-05-30T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
17631078,2007-05-30T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
17631078,2007-05-30T00:00:00,"Defibrillators, Implantable",E07.695.175
17631078,2007-05-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17540969,2007-05-31T00:00:00,Aged,M01.060.116.100
17540969,2007-05-31T00:00:00,Anticoagulants,D27.505.954.502.119
17540969,2007-05-31T00:00:00,"Constriction, Pathologic",C23.300.287
17540969,2007-05-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17540969,2007-05-31T00:00:00,Life Style,F01.829.458
17540969,2007-05-31T00:00:00,Middle Aged,M01.060.116.630
17540969,2007-05-31T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
17540969,2007-05-31T00:00:00,Risk Factors,E05.318.740.600.800.725
17540969,2007-05-31T00:00:00,Risk Factors,N05.715.350.200.700
17540969,2007-05-31T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17540969,2007-05-31T00:00:00,Risk Factors,N06.850.490.625.750
17540969,2007-05-31T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17540969,2007-05-31T00:00:00,Sex Factors,N05.715.350.675
17540969,2007-05-31T00:00:00,Sex Factors,N06.850.490.875
17540969,2007-05-31T00:00:00,Stroke,C10.228.140.300.775
17540969,2007-05-31T00:00:00,Stroke,C14.907.253.855
17540969,2007-05-31T00:00:00,Treatment Outcome,E01.789.800
17540969,2007-05-31T00:00:00,Treatment Outcome,N04.761.559.590.800
17540969,2007-05-31T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17540969,2007-05-31T00:00:00,Warfarin,D03.438.150.446.520.914
17540969,2007-05-31T00:00:00,Warfarin,D03.830.219.446.520.914
17540971,2007-05-31T00:00:00,Aged,M01.060.116.100
17540971,2007-05-31T00:00:00,Brain Ischemia,C10.228.140.300.150
17540971,2007-05-31T00:00:00,Brain Ischemia,C14.907.253.092
17540971,2007-05-31T00:00:00,"Data Interpretation, Statistical",E05.245.380
17540971,2007-05-31T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
17540971,2007-05-31T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
17540971,2007-05-31T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
17540971,2007-05-31T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
17540971,2007-05-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17540971,2007-05-31T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17540971,2007-05-31T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17540971,2007-05-31T00:00:00,Middle Aged,M01.060.116.630
17540971,2007-05-31T00:00:00,Stroke,C10.228.140.300.775
17540971,2007-05-31T00:00:00,Stroke,C14.907.253.855
17540971,2007-05-31T00:00:00,Thrombolytic Therapy,E02.319.913
17540971,2007-05-31T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17540971,2007-05-31T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17540971,2007-05-31T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17540971,2007-05-31T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17540971,2007-05-31T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17226767,2007-06-01T00:00:00,Adenoviridae,B04.280.030
17226767,2007-06-01T00:00:00,Adenoviridae,B04.909.204.097
17226767,2007-06-01T00:00:00,Animals,B01.050
17226767,2007-06-01T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
17226767,2007-06-01T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
17226767,2007-06-01T00:00:00,Cell Adhesion Molecules,D23.050.301.350
17226767,2007-06-01T00:00:00,Cell Line,A11.251.210
17226767,2007-06-01T00:00:00,Chick Embryo,A13.350.150
17226767,2007-06-01T00:00:00,Chick Embryo,A16.331.200
17226767,2007-06-01T00:00:00,Chickens,B01.050.150.900.248.350.150
17226767,2007-06-01T00:00:00,Chickens,B01.050.150.900.248.617.192
17226767,2007-06-01T00:00:00,Collagen Type I,D05.750.078.280.300.100
17226767,2007-06-01T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
17226767,2007-06-01T00:00:00,Fibrillar Collagens,D05.750.078.280.300
17226767,2007-06-01T00:00:00,Fibrillar Collagens,D12.776.860.300.250.300
17226767,2007-06-01T00:00:00,Green Fluorescent Proteins,D12.776.532.265
17226767,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17226767,2007-06-01T00:00:00,"Microscopy, Electron, Transmission",E01.370.350.515.402.580
17226767,2007-06-01T00:00:00,"Microscopy, Electron, Transmission",E05.595.402.580
17226767,2007-06-01T00:00:00,Mutation,G05.365.590
17226767,2007-06-01T00:00:00,Skin,A17.815
17345158,2007-06-01T00:00:00,African Americans,M01.686.508.100.100
17345158,2007-06-01T00:00:00,African Americans,M01.686.754.100
17345158,2007-06-01T00:00:00,Drug Prescriptions,E02.319.307
17345158,2007-06-01T00:00:00,Drug Prescriptions,N02.421.668.778.500
17345158,2007-06-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
17345158,2007-06-01T00:00:00,Health Status,I01.240.425
17345158,2007-06-01T00:00:00,Health Status,N01.224.425
17345158,2007-06-01T00:00:00,Health Status,N06.850.505.400.425
17345158,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17345158,2007-06-01T00:00:00,Life Change Events,F01.829.458.410
17345158,2007-06-01T00:00:00,Medical Records,E05.318.308.940.968
17345158,2007-06-01T00:00:00,Medical Records,L01.280.900.968
17345158,2007-06-01T00:00:00,Medical Records,N04.452.859.564
17345158,2007-06-01T00:00:00,Medical Records,N05.715.360.300.715.500
17345158,2007-06-01T00:00:00,Medical Records,N06.850.520.308.940.968
17345158,2007-06-01T00:00:00,Mental Disorders,F03
17345158,2007-06-01T00:00:00,Middle Aged,M01.060.116.630
17345158,2007-06-01T00:00:00,Psychiatric Status Rating Scales,F04.586
17345158,2007-06-01T00:00:00,Questionnaires,E05.318.308.750
17345158,2007-06-01T00:00:00,Questionnaires,L01.280.800
17345158,2007-06-01T00:00:00,Questionnaires,N05.715.360.300.695
17345158,2007-06-01T00:00:00,Questionnaires,N06.850.520.308.750
17345158,2007-06-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17345158,2007-06-01T00:00:00,Violence,I01.198.240.856
17345158,2007-06-01T00:00:00,Violence,I01.880.735.900
17380387,2007-06-01T00:00:00,"Adaptation, Psychological",F01.058
17380387,2007-06-01T00:00:00,Adult,M01.060.116
17380387,2007-06-01T00:00:00,Depressive Disorder,F03.600.300
17380387,2007-06-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
17380387,2007-06-01T00:00:00,Health Status,I01.240.425
17380387,2007-06-01T00:00:00,Health Status,N01.224.425
17380387,2007-06-01T00:00:00,Health Status,N06.850.505.400.425
17380387,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17380387,2007-06-01T00:00:00,Life Change Events,F01.829.458.410
17380387,2007-06-01T00:00:00,"Models, Psychological",E05.599.695
17380387,2007-06-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
17380387,2007-06-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
17380387,2007-06-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
17380387,2007-06-01T00:00:00,Personality Inventory,F04.711.647.513
17380387,2007-06-01T00:00:00,Psychiatric Status Rating Scales,F04.586
17380387,2007-06-01T00:00:00,Rape,I01.198.240.748.640
17380387,2007-06-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17380387,2007-06-01T00:00:00,Violence,I01.198.240.856
17380387,2007-06-01T00:00:00,Violence,I01.880.735.900
17502256,2007-06-01T00:00:00,Breast Neoplasms,C04.588.180
17502256,2007-06-01T00:00:00,Breast Neoplasms,C17.800.090.500
17502256,2007-06-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
17502256,2007-06-01T00:00:00,Clinical Trials as Topic,E05.337.250
17502256,2007-06-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
17502256,2007-06-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
17502256,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17502256,2007-06-01T00:00:00,Mammography,E01.370.350.700.500
17502256,2007-06-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
17502256,2007-06-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
17502256,2007-06-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
17502258,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17502258,2007-06-01T00:00:00,Mammography,E01.370.350.700.500
17502258,2007-06-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
17502258,2007-06-01T00:00:00,"Quality Assurance, Health Care",N05.700
17502258,2007-06-01T00:00:00,Radiation Dosage,E05.799.513
17502258,2007-06-01T00:00:00,Radiation Dosage,G01.201.875.740
17502258,2007-06-01T00:00:00,Radiation Dosage,N06.850.810.250
17502258,2007-06-01T00:00:00,United States,Z01.107.567.875
17506089,2007-06-01T00:00:00,"Adaptor Proteins, Vesicular Transport",D12.776.543.990.150
17506089,2007-06-01T00:00:00,Animals,B01.050
17506089,2007-06-01T00:00:00,Cell Differentiation,G04.299.151
17506089,2007-06-01T00:00:00,Cell Movement,G04.299.283
17506089,2007-06-01T00:00:00,Cell Movement,G07.700.560.500.180
17506089,2007-06-01T00:00:00,Embryonic Development,G07.700.320.500.325.180
17506089,2007-06-01T00:00:00,Embryonic Development,G08.686.785.760.170.104
17510275,2007-06-01T00:00:00,Aged,M01.060.116.100
17510275,2007-06-01T00:00:00,"Diagnosis, Differential",E01.171
17510275,2007-06-01T00:00:00,"Endocarditis, Bacterial",C01.252.300
17510275,2007-06-01T00:00:00,"Endocarditis, Bacterial",C01.539.190.249
17510275,2007-06-01T00:00:00,"Endocarditis, Bacterial",C14.260.249
17510275,2007-06-01T00:00:00,"Endocarditis, Bacterial",C14.280.282.407
17510275,2007-06-01T00:00:00,Gentamicins,D09.408.051.374
17510275,2007-06-01T00:00:00,Heart Valve Prosthesis,E07.695.310
17510275,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17510275,2007-06-01T00:00:00,Molecular Sequence Data,L01.453.245.667
17510275,2007-06-01T00:00:00,Prosthesis-Related Infections,C01.539.685
17510275,2007-06-01T00:00:00,Prosthesis-Related Infections,C23.550.767.868
17510275,2007-06-01T00:00:00,"Sequence Analysis, DNA",E05.393.760.700
17513714,2007-06-01T00:00:00,Animals,B01.050
17513714,2007-06-01T00:00:00,Interferon Type I,D12.644.276.374.440.890
17513714,2007-06-01T00:00:00,Interferon Type I,D12.644.276.718.500
17513714,2007-06-01T00:00:00,Interferon Type I,D12.776.467.374.440.890
17513714,2007-06-01T00:00:00,Interferon Type I,D12.776.467.718.500
17513714,2007-06-01T00:00:00,Interferon Type I,D23.529.374.440.890
17513714,2007-06-01T00:00:00,Interferon Type I,D23.529.718.500
17513714,2007-06-01T00:00:00,Interleukin-10,D12.644.276.374.465.510
17513714,2007-06-01T00:00:00,Interleukin-10,D12.776.467.374.465.510
17513714,2007-06-01T00:00:00,Interleukin-10,D23.529.374.465.510
17513714,2007-06-01T00:00:00,Lipopolysaccharides,D09.400.500
17513714,2007-06-01T00:00:00,Lipopolysaccharides,D09.698.718.450
17513714,2007-06-01T00:00:00,Lipopolysaccharides,D10.494
17513714,2007-06-01T00:00:00,Lipopolysaccharides,D23.050.161.616.525
17513714,2007-06-01T00:00:00,Lipopolysaccharides,D23.946.123.329.500
17513714,2007-06-01T00:00:00,Macrophages,A11.329.372
17513714,2007-06-01T00:00:00,Macrophages,A11.627.482
17513714,2007-06-01T00:00:00,Macrophages,A11.733.397
17513714,2007-06-01T00:00:00,Macrophages,A15.382.680.397
17513714,2007-06-01T00:00:00,Macrophages,A15.382.812.522
17513714,2007-06-01T00:00:00,Phosphorylation,G02.111.087.677
17513714,2007-06-01T00:00:00,Phosphorylation,G02.149.115.677
17513714,2007-06-01T00:00:00,Phosphorylation,G02.149.465.700
17513714,2007-06-01T00:00:00,Phosphorylation,G02.607.750.700
17513714,2007-06-01T00:00:00,Phosphorylation,G03.495.790
17513714,2007-06-01T00:00:00,Signal Transduction,G02.111.087.800
17513714,2007-06-01T00:00:00,Signal Transduction,G02.149.115.800
17513714,2007-06-01T00:00:00,Signal Transduction,G04.299.880
17513732,2007-06-01T00:00:00,Animals,B01.050
17513732,2007-06-01T00:00:00,Cell Proliferation,G04.299.233.750
17513732,2007-06-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
17513732,2007-06-01T00:00:00,"Disease Models, Animal",C22.232
17513732,2007-06-01T00:00:00,"Disease Models, Animal",E05.598.500
17513732,2007-06-01T00:00:00,"Disease Models, Animal",E05.599.395.080
17513732,2007-06-01T00:00:00,Disease Progression,C23.550.291.656
17513732,2007-06-01T00:00:00,"T-Lymphocytes, Regulatory",A11.118.637.555.567.569.200.700
17513732,2007-06-01T00:00:00,"T-Lymphocytes, Regulatory",A15.145.229.637.555.567.569.200.700
17513732,2007-06-01T00:00:00,"T-Lymphocytes, Regulatory",A15.382.490.555.567.569.200.700
17515375,2007-06-01T00:00:00,Adult,M01.060.116
17515375,2007-06-01T00:00:00,"Cartilage, Articular",A02.165.407.150
17515375,2007-06-01T00:00:00,"Cartilage, Articular",A02.835.583.192
17515375,2007-06-01T00:00:00,Forecasting,I01.320
17515375,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17515375,2007-06-01T00:00:00,Middle Aged,M01.060.116.630
17515375,2007-06-01T00:00:00,Physician's Practice Patterns,N04.590.748
17515375,2007-06-01T00:00:00,Physician's Practice Patterns,N05.300.625
17515375,2007-06-01T00:00:00,Sex Factors,N05.715.350.675
17515375,2007-06-01T00:00:00,Sex Factors,N06.850.490.875
17515375,2007-06-01T00:00:00,Temporomandibular Joint,A02.835.583.861
17515375,2007-06-01T00:00:00,Temporomandibular Joint,A14.907
17515682,2007-06-01T00:00:00,Activities of Daily Living,E02.831.067
17515682,2007-06-01T00:00:00,Activities of Daily Living,I03.050
17515682,2007-06-01T00:00:00,Activities of Daily Living,N02.421.784.110
17515682,2007-06-01T00:00:00,Adult,M01.060.116
17515682,2007-06-01T00:00:00,Aged,M01.060.116.100
17515682,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17515682,2007-06-01T00:00:00,Length of Stay,E02.760.400.480
17515682,2007-06-01T00:00:00,Length of Stay,N02.421.585.400.480
17515682,2007-06-01T00:00:00,Middle Aged,M01.060.116.630
17515682,2007-06-01T00:00:00,Vitamin D,D04.808.812.768
17515682,2007-06-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
17518929,2007-06-01T00:00:00,Adolescent,M01.060.057
17518929,2007-06-01T00:00:00,Adult,M01.060.116
17518929,2007-06-01T00:00:00,Cognition Disorders,F03.087.250
17518929,2007-06-01T00:00:00,Functional Laterality,F02.830.297.425
17518929,2007-06-01T00:00:00,Functional Laterality,G11.561.225.425
17518929,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17518929,2007-06-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.500.620.670.325.350
17518929,2007-06-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.750.600.670.325.350
17518929,2007-06-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.285.350
17518929,2007-06-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.661.475.350
17518929,2007-06-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17518929,2007-06-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17518929,2007-06-01T00:00:00,Middle Aged,M01.060.116.630
17518929,2007-06-01T00:00:00,Neural Pathways,A08.612
17518929,2007-06-01T00:00:00,Parietal Lobe,A08.186.211.730.885.287.500.670
17518929,2007-06-01T00:00:00,Visual Cortex,A08.186.211.730.885.287.500.571.735
17518929,2007-06-01T00:00:00,Wechsler Scales,F04.711.141.493.822
17523212,2007-06-01T00:00:00,Animals,B01.050
17523212,2007-06-01T00:00:00,Antigen-Antibody Complex,D12.776.124.486.485.114.257
17523212,2007-06-01T00:00:00,Antigen-Antibody Complex,D12.776.124.790.651.114.257
17523212,2007-06-01T00:00:00,Antigen-Antibody Complex,D12.776.377.715.548.114.257
17523212,2007-06-01T00:00:00,Antigen-Antibody Complex,D23.050.101
17523212,2007-06-01T00:00:00,Apoptosis,G04.299.139.160
17523212,2007-06-01T00:00:00,"Behavior, Animal",F01.145.113
17523212,2007-06-01T00:00:00,Brain,A08.186.211
17523212,2007-06-01T00:00:00,Brain Chemistry,G02.111.100
17523212,2007-06-01T00:00:00,Brain Chemistry,G03.200
17523212,2007-06-01T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
17523212,2007-06-01T00:00:00,Complement C3,D12.776.124.050.140
17523212,2007-06-01T00:00:00,Complement C3,D12.776.124.486.274.250
17523212,2007-06-01T00:00:00,"Complement Pathway, Alternative",G12.425.255.695
17523212,2007-06-01T00:00:00,Extracellular Matrix Proteins,D12.776.860.300
17523212,2007-06-01T00:00:00,Gene Expression,G05.355.310
17523212,2007-06-01T00:00:00,Hippocampus,A08.186.211.464.405
17523212,2007-06-01T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
17523212,2007-06-01T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
17523212,2007-06-01T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
17523212,2007-06-01T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
17523212,2007-06-01T00:00:00,PTEN Phosphohydrolase,D08.811.277.352.650.850
17523212,2007-06-01T00:00:00,PTEN Phosphohydrolase,D12.776.476.590
17523212,2007-06-01T00:00:00,PTEN Phosphohydrolase,D12.776.624.776.695
17523212,2007-06-01T00:00:00,Phosphorylation,G02.111.087.677
17523212,2007-06-01T00:00:00,Phosphorylation,G02.149.115.677
17523212,2007-06-01T00:00:00,Phosphorylation,G02.149.465.700
17523212,2007-06-01T00:00:00,Phosphorylation,G02.607.750.700
17523212,2007-06-01T00:00:00,Phosphorylation,G03.495.790
17523212,2007-06-01T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
17523212,2007-06-01T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
17523212,2007-06-01T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
17525560,2007-06-01T00:00:00,Adult,M01.060.116
17525560,2007-06-01T00:00:00,Anticonvulsants,D27.505.954.427.080
17525560,2007-06-01T00:00:00,Brain,A08.186.211
17525560,2007-06-01T00:00:00,Dehydration,C18.452.950.179
17525560,2007-06-01T00:00:00,Dehydration,C23.550.274
17525560,2007-06-01T00:00:00,Fever,C23.888.119.344
17525560,2007-06-01T00:00:00,Forensic Medicine,H02.403.330
17525560,2007-06-01T00:00:00,Forensic Medicine,I01.198.780.937
17525560,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17525564,2007-06-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
17525564,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17525564,2007-06-01T00:00:00,Hypercholesterolemia,C18.452.584.500.500.396
17525564,2007-06-01T00:00:00,Hypertension,C14.907.489
17525564,2007-06-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
17525564,2007-06-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
17525564,2007-06-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
17525564,2007-06-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
17525564,2007-06-01T00:00:00,Middle Aged,M01.060.116.630
17525564,2007-06-01T00:00:00,Verapamil,D02.092.471.683.953
17531637,2007-06-01T00:00:00,Animals,B01.050
17531637,2007-06-01T00:00:00,"Disease Models, Animal",C22.232
17531637,2007-06-01T00:00:00,"Disease Models, Animal",E05.598.500
17531637,2007-06-01T00:00:00,"Disease Models, Animal",E05.599.395.080
17531637,2007-06-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
17531637,2007-06-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
17531637,2007-06-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
17531637,2007-06-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
17531637,2007-06-01T00:00:00,Swine,B01.050.150.900.649.077.880
17531637,2007-06-01T00:00:00,Treatment Outcome,E01.789.800
17531637,2007-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17531637,2007-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17532415,2007-06-01T00:00:00,Aged,M01.060.116.100
17532415,2007-06-01T00:00:00,Blood Pressure,E01.370.600.875.249
17532415,2007-06-01T00:00:00,Blood Pressure,G09.330.380.076
17532415,2007-06-01T00:00:00,Cardiopulmonary Bypass,E04.292.413
17532415,2007-06-01T00:00:00,Cardiovascular Agents,D27.505.954.411
17532415,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17532415,2007-06-01T00:00:00,Isoxazoles,D03.383.129.385
17532415,2007-06-01T00:00:00,Middle Aged,M01.060.116.630
17532415,2007-06-01T00:00:00,Pulmonary Artery,A07.231.114.715
17532415,2007-06-01T00:00:00,"Receptor, Endothelin A",D12.776.543.750.100.220.100
17532415,2007-06-01T00:00:00,"Receptor, Endothelin A",D12.776.543.750.750.320.100
17532415,2007-06-01T00:00:00,Thiophenes,D02.886.778
17532415,2007-06-01T00:00:00,Thiophenes,D03.383.903
17532415,2007-06-01T00:00:00,Treatment Outcome,E01.789.800
17532415,2007-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17532415,2007-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17532892,2007-06-01T00:00:00,Aged,M01.060.116.100
17532892,2007-06-01T00:00:00,"Data Interpretation, Statistical",E05.245.380
17532892,2007-06-01T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
17532892,2007-06-01T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
17532892,2007-06-01T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
17532892,2007-06-01T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
17532892,2007-06-01T00:00:00,Disability Evaluation,E01.370.400
17532892,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17532892,2007-06-01T00:00:00,Movement,G07.700.560
17532892,2007-06-01T00:00:00,Movement,G11.427.590.530
17532892,2007-06-01T00:00:00,Recovery of Function,G16.757
17532892,2007-06-01T00:00:00,Stroke,C10.228.140.300.775
17532892,2007-06-01T00:00:00,Stroke,C14.907.253.855
17532892,2007-06-01T00:00:00,Upper Extremity,A01.378.800
17535934,2007-06-01T00:00:00,Evidence-Based Medicine,H02.249.750
17535934,2007-06-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
17535934,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17535934,2007-06-01T00:00:00,Mental Disorders,F03
17535934,2007-06-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
17535934,2007-06-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
17535934,2007-06-01T00:00:00,Treatment Outcome,E01.789.800
17535934,2007-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17535934,2007-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17535934,2007-06-01T00:00:00,United States,Z01.107.567.875
17538102,2007-06-01T00:00:00,Adult,M01.060.116
17538102,2007-06-01T00:00:00,Aged,M01.060.116.100
17538102,2007-06-01T00:00:00,Deglutition,G10.261.326.215
17538102,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17538102,2007-06-01T00:00:00,Middle Aged,M01.060.116.630
17539010,2007-06-01T00:00:00,Adolescent,M01.060.057
17539010,2007-06-01T00:00:00,Adult,M01.060.116
17539010,2007-06-01T00:00:00,Aged,M01.060.116.100
17539010,2007-06-01T00:00:00,Child,M01.060.406
17539010,2007-06-01T00:00:00,"Child, Preschool",M01.060.406.448
17539010,2007-06-01T00:00:00,"Herpesvirus 4, Human",B04.280.382.400.500.450
17539010,2007-06-01T00:00:00,"Herpesvirus 4, Human",B04.909.204.210.400.500.400
17539010,2007-06-01T00:00:00,"Herpesvirus 4, Human",B04.909.204.382.400.500.400
17539010,2007-06-01T00:00:00,"Herpesvirus 4, Human",B04.909.574.204.500.500.400
17539010,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17539010,2007-06-01T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
17539010,2007-06-01T00:00:00,Infant,M01.060.703
17539010,2007-06-01T00:00:00,Liver,A03.620
17539010,2007-06-01T00:00:00,Liver Transplantation,E04.210.650
17539010,2007-06-01T00:00:00,Liver Transplantation,E04.936.450.490
17539010,2007-06-01T00:00:00,Liver Transplantation,E04.936.580.490
17539010,2007-06-01T00:00:00,Middle Aged,M01.060.116.630
17539010,2007-06-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17539010,2007-06-01T00:00:00,Risk Factors,N05.715.350.200.700
17539010,2007-06-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17539010,2007-06-01T00:00:00,Risk Factors,N06.850.490.625.750
17539010,2007-06-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17539010,2007-06-01T00:00:00,Time Factors,G01.910.857
17540194,2007-06-01T00:00:00,"Arrhythmias, Cardiac",C14.280.067
17540194,2007-06-01T00:00:00,"Arrhythmias, Cardiac",C23.550.073
17540194,2007-06-01T00:00:00,Biological Markers,D23.101
17540194,2007-06-01T00:00:00,Cardiovascular Diseases,C14
17540194,2007-06-01T00:00:00,"Death, Sudden, Cardiac",C14.280.383.220
17540194,2007-06-01T00:00:00,"Death, Sudden, Cardiac",C23.550.260.322.250
17540194,2007-06-01T00:00:00,Genetic Testing,E01.370.427
17540194,2007-06-01T00:00:00,Genetic Testing,E05.393.435
17540194,2007-06-01T00:00:00,Genetic Testing,N02.421.143.827.233.221
17540194,2007-06-01T00:00:00,Genetic Testing,N02.421.308.430
17540194,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17540194,2007-06-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
17540194,2007-06-01T00:00:00,Risk Assessment,N04.452.871.715
17540194,2007-06-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17540194,2007-06-01T00:00:00,Risk Assessment,N06.850.505.715
17540194,2007-06-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17540194,2007-06-01T00:00:00,"Tachycardia, Ventricular",C14.280.067.845.940
17540194,2007-06-01T00:00:00,"Tachycardia, Ventricular",C23.550.073.845.940
17540195,2007-06-01T00:00:00,Age Factors,N05.715.350.075
17540195,2007-06-01T00:00:00,Age Factors,N06.850.490.250
17540195,2007-06-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
17540195,2007-06-01T00:00:00,"Death, Sudden, Cardiac",C14.280.383.220
17540195,2007-06-01T00:00:00,"Death, Sudden, Cardiac",C23.550.260.322.250
17540195,2007-06-01T00:00:00,Decision Support Techniques,E05.245
17540195,2007-06-01T00:00:00,Decision Support Techniques,L01.700.508.190
17540195,2007-06-01T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
17540195,2007-06-01T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
17540195,2007-06-01T00:00:00,"Defibrillators, Implantable",E07.695.175
17540195,2007-06-01T00:00:00,Forecasting,I01.320
17540195,2007-06-01T00:00:00,Heart Diseases,C14.280
17540195,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17540195,2007-06-01T00:00:00,Patient Satisfaction,N04.452.822.360.600
17540195,2007-06-01T00:00:00,Patient Satisfaction,N05.300.150.600.630
17540195,2007-06-01T00:00:00,Patient Satisfaction,N05.715.360.600
17540195,2007-06-01T00:00:00,Primary Prevention,N02.421.726.758
17540195,2007-06-01T00:00:00,Primary Prevention,N06.850.780.680
17540195,2007-06-01T00:00:00,Research,H01.770.644
17540195,2007-06-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
17540195,2007-06-01T00:00:00,Risk Assessment,N04.452.871.715
17540195,2007-06-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17540195,2007-06-01T00:00:00,Risk Assessment,N06.850.505.715
17540195,2007-06-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17540195,2007-06-01T00:00:00,Sex Factors,N05.715.350.675
17540195,2007-06-01T00:00:00,Sex Factors,N06.850.490.875
17541066,2007-06-01T00:00:00,Adult,M01.060.116
17541066,2007-06-01T00:00:00,"Analgesics, Opioid",D27.505.696.663.850.014.520
17541066,2007-06-01T00:00:00,"Analgesics, Opioid",D27.505.954.427.040.325
17541066,2007-06-01T00:00:00,"Analgesics, Opioid",D27.505.954.427.210.049
17541066,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17541066,2007-06-01T00:00:00,Narcotic Antagonists,D27.505.696.543
17541066,2007-06-01T00:00:00,Narcotic Antagonists,D27.505.696.663.850.512
17541066,2007-06-01T00:00:00,Narcotic Antagonists,D27.505.954.427.550
17541066,2007-06-01T00:00:00,Opioid-Related Disorders,C21.739.675
17541066,2007-06-01T00:00:00,Opioid-Related Disorders,F03.900.675
17541066,2007-06-01T00:00:00,"Pain, Postoperative",C23.550.767.700
17541066,2007-06-01T00:00:00,"Pain, Postoperative",C23.888.646.530
17541066,2007-06-01T00:00:00,Self Administration,E02.319.890
17541066,2007-06-01T00:00:00,Self Administration,E02.900.890
17541066,2007-06-01T00:00:00,"Surgical Procedures, Operative",E04
17541327,2007-06-01T00:00:00,Adult,M01.060.116
17541327,2007-06-01T00:00:00,Aged,M01.060.116.100
17541327,2007-06-01T00:00:00,Blood Pressure,E01.370.600.875.249
17541327,2007-06-01T00:00:00,Blood Pressure,G09.330.380.076
17541327,2007-06-01T00:00:00,Cardiovascular Diseases,C14
17541327,2007-06-01T00:00:00,Health Surveys,E05.318.308.250
17541327,2007-06-01T00:00:00,Health Surveys,N05.715.360.300.375
17541327,2007-06-01T00:00:00,Health Surveys,N06.850.520.308.250
17541327,2007-06-01T00:00:00,Homeostasis,G07.700.360
17541327,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17541327,2007-06-01T00:00:00,Hypertension,C14.907.489
17541327,2007-06-01T00:00:00,Insulin,D06.472.699.587.740.625
17541327,2007-06-01T00:00:00,Insulin,D12.644.548.586.740.625
17541327,2007-06-01T00:00:00,Insulin Resistance,C18.452.394.968.500
17541327,2007-06-01T00:00:00,Insulin Resistance,G07.690.320.617
17541327,2007-06-01T00:00:00,Middle Aged,M01.060.116.630
17541327,2007-06-01T00:00:00,Nutrition Surveys,E05.318.308.250.600
17541327,2007-06-01T00:00:00,Nutrition Surveys,E05.318.308.585.550
17541327,2007-06-01T00:00:00,Nutrition Surveys,N05.715.360.300.375.560
17541327,2007-06-01T00:00:00,Nutrition Surveys,N05.715.360.300.560.565
17541327,2007-06-01T00:00:00,Nutrition Surveys,N06.850.520.308.250.600
17541327,2007-06-01T00:00:00,Nutrition Surveys,N06.850.520.308.585.550
17541327,2007-06-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17541327,2007-06-01T00:00:00,Risk Factors,N05.715.350.200.700
17541327,2007-06-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17541327,2007-06-01T00:00:00,Risk Factors,N06.850.490.625.750
17541327,2007-06-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17541327,2007-06-01T00:00:00,United States,Z01.107.567.875
17545425,2007-06-01T00:00:00,Aged,M01.060.116.100
17545425,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17545425,2007-06-01T00:00:00,Knee Prosthesis,E07.695.400.410
17545425,2007-06-01T00:00:00,Middle Aged,M01.060.116.630
17545425,2007-06-01T00:00:00,Prosthesis-Related Infections,C01.539.685
17545425,2007-06-01T00:00:00,Prosthesis-Related Infections,C23.550.767.868
17545425,2007-06-01T00:00:00,Staphylococcal Infections,C01.252.410.868
17548665,2007-06-01T00:00:00,"History, 20th Century",K01.400.504.968
17548665,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17548665,2007-06-01T00:00:00,Neoplasms,C04
17548665,2007-06-01T00:00:00,Smoking,F01.145.466.753
17548665,2007-06-01T00:00:00,Tobacco,B01.650.388.100.905.900
17548665,2007-06-01T00:00:00,Tobacco Industry,J01.576.919
17558360,2007-06-01T00:00:00,Adolescent,M01.060.057
17558360,2007-06-01T00:00:00,Adult,M01.060.116
17558360,2007-06-01T00:00:00,Aged,M01.060.116.100
17558360,2007-06-01T00:00:00,Chronic Disease,C23.550.291.500
17558360,2007-06-01T00:00:00,Exercise Therapy,E02.779.483
17558360,2007-06-01T00:00:00,Exercise Therapy,E02.831.387
17558360,2007-06-01T00:00:00,Gait,E01.370.600.250
17558360,2007-06-01T00:00:00,Gait,G11.427.590.530.389
17558360,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17558360,2007-06-01T00:00:00,Motor Activity,F01.145.632
17558360,2007-06-01T00:00:00,Motor Activity,G11.427.590.530.698
17558360,2007-06-01T00:00:00,Pilot Projects,E05.318.760.750
17558360,2007-06-01T00:00:00,Pilot Projects,E05.337.737
17558360,2007-06-01T00:00:00,Pilot Projects,N05.715.360.775.625
17558360,2007-06-01T00:00:00,Pilot Projects,N06.850.520.450.720
17558360,2007-06-01T00:00:00,Postural Balance,G11.427.690
17558360,2007-06-01T00:00:00,Postural Balance,G11.561.600.810.541.595
17558360,2007-06-01T00:00:00,Recovery of Function,G16.757
17558360,2007-06-01T00:00:00,Stroke,C10.228.140.300.775
17558360,2007-06-01T00:00:00,Stroke,C14.907.253.855
17558360,2007-06-01T00:00:00,Treatment Outcome,E01.789.800
17558360,2007-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17558360,2007-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17567461,2007-06-01T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
17567461,2007-06-01T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
17567461,2007-06-01T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
17567461,2007-06-01T00:00:00,Animals,B01.050
17567461,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17567461,2007-06-01T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
17567461,2007-06-01T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
17567461,2007-06-01T00:00:00,Oxidative Stress,G03.495.710
17567461,2007-06-01T00:00:00,Oxidative Stress,G07.700.830.750
17567461,2007-06-01T00:00:00,Voltage-Dependent Anion Channels,D12.776.157.530.400.500.520
17567461,2007-06-01T00:00:00,Voltage-Dependent Anion Channels,D12.776.543.550.425.730.520
17567461,2007-06-01T00:00:00,Voltage-Dependent Anion Channels,D12.776.543.585.400.730.520
17567465,2007-06-01T00:00:00,Animals,B01.050
17567465,2007-06-01T00:00:00,Apoptosis,G04.299.139.160
17567465,2007-06-01T00:00:00,Cyclosporine,D04.345.566.235.300
17567465,2007-06-01T00:00:00,Cyclosporine,D12.644.641.235.300
17567465,2007-06-01T00:00:00,Drug-Induced Liver Injury,C06.552.195
17567465,2007-06-01T00:00:00,Drug-Induced Liver Injury,C21.613.260
17567465,2007-06-01T00:00:00,Glutathione,D12.644.456.448
17567465,2007-06-01T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
17567465,2007-06-01T00:00:00,"Microscopy, Confocal",E05.595.395
17567465,2007-06-01T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
17567465,2007-06-01T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
17567465,2007-06-01T00:00:00,Oxidative Stress,G03.495.710
17567465,2007-06-01T00:00:00,Oxidative Stress,G07.700.830.750
17567471,2007-06-01T00:00:00,Animals,B01.050
17567471,2007-06-01T00:00:00,DNA,D13.444.308
17567471,2007-06-01T00:00:00,Gene Expression,G05.355.310
17567471,2007-06-01T00:00:00,Gene Transfer Techniques,E05.393.350
17567471,2007-06-01T00:00:00,Hyaluronic Acid,D09.698.373.475
17567471,2007-06-01T00:00:00,Liver,A03.620
17567471,2007-06-01T00:00:00,Liver Diseases,C06.552
17567471,2007-06-01T00:00:00,Microcirculation,G09.330.190.163.645
17567471,2007-06-01T00:00:00,Polylysine,D12.125.068.555.750
17567471,2007-06-01T00:00:00,Polylysine,D12.125.095.647.750
17567471,2007-06-01T00:00:00,Polylysine,D12.644.760
17567471,2007-06-01T00:00:00,Polymers,D05.750
17567471,2007-06-01T00:00:00,Polymers,D25.720
17567471,2007-06-01T00:00:00,Polymers,J01.637.051.720
17567471,2007-06-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17572266,2007-06-01T00:00:00,"Diabetes, Gestational",C13.703.170
17572266,2007-06-01T00:00:00,"Diabetes, Gestational",C18.452.394.750.448
17572266,2007-06-01T00:00:00,"Diabetes, Gestational",C19.246.200
17572266,2007-06-01T00:00:00,Disease Outbreaks,N06.850.290
17572266,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17572266,2007-06-01T00:00:00,Mass Screening,E01.370.500
17572266,2007-06-01T00:00:00,Mass Screening,E05.318.308.250.580
17572266,2007-06-01T00:00:00,Mass Screening,N02.421.143.827.233.443
17572266,2007-06-01T00:00:00,Mass Screening,N02.421.726.233.443
17572266,2007-06-01T00:00:00,Mass Screening,N05.715.360.300.375.500
17572266,2007-06-01T00:00:00,Mass Screening,N06.850.520.308.250.580
17572266,2007-06-01T00:00:00,Mass Screening,N06.850.780.500
17572266,2007-06-01T00:00:00,Obesity,C18.654.726.500
17572266,2007-06-01T00:00:00,Obesity,C23.888.144.699.500
17572266,2007-06-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
17572266,2007-06-01T00:00:00,Obesity,G07.100.100.160.120.699.500
17572266,2007-06-01T00:00:00,Pregnancy,G08.686.785.760.769
17572339,2007-06-01T00:00:00,Cataract Extraction,E04.540.825.249
17572339,2007-06-01T00:00:00,Child,M01.060.406
17572339,2007-06-01T00:00:00,"Child, Preschool",M01.060.406.448
17572339,2007-06-01T00:00:00,Eye,A01.456.505.420
17572339,2007-06-01T00:00:00,Eye,A09.371
17572339,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17572339,2007-06-01T00:00:00,Infant,M01.060.703
17572339,2007-06-01T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
17572526,2007-06-01T00:00:00,Adolescent,M01.060.057
17572526,2007-06-01T00:00:00,Child,M01.060.406
17572526,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17572526,2007-06-01T00:00:00,Pregnancy,G08.686.785.760.769
17572526,2007-06-01T00:00:00,Time Factors,G01.910.857
17572526,2007-06-01T00:00:00,Treatment Outcome,E01.789.800
17572526,2007-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17572526,2007-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17576917,2007-06-01T00:00:00,Actins,D05.750.078.730.250
17576917,2007-06-01T00:00:00,Actins,D12.776.210.500.100
17576917,2007-06-01T00:00:00,Actins,D12.776.220.525.255
17576917,2007-06-01T00:00:00,"Diagnosis, Differential",E01.171
17576917,2007-06-01T00:00:00,Fibroblasts,A11.329.228
17576917,2007-06-01T00:00:00,Fibroblasts,A11.872.228
17576917,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17576917,2007-06-01T00:00:00,Infant,M01.060.703
17576917,2007-06-01T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
17579115,2007-06-01T00:00:00,Animals,B01.050
17579115,2007-06-01T00:00:00,Anoxia,C23.888.852.079
17579115,2007-06-01T00:00:00,Antineoplastic Agents,D27.505.954.248
17579115,2007-06-01T00:00:00,Cytokines,D12.644.276.374
17579115,2007-06-01T00:00:00,Cytokines,D12.776.467.374
17579115,2007-06-01T00:00:00,Cytokines,D23.529.374
17579115,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17579115,2007-06-01T00:00:00,Interferon-beta,D12.644.276.374.440.890.275
17579115,2007-06-01T00:00:00,Interferon-beta,D12.644.276.718.500.275
17579115,2007-06-01T00:00:00,Interferon-beta,D12.776.467.374.440.890.275
17579115,2007-06-01T00:00:00,Interferon-beta,D12.776.467.718.500.275
17579115,2007-06-01T00:00:00,Interferon-beta,D23.529.374.440.890.275
17579115,2007-06-01T00:00:00,Interferon-beta,D23.529.718.500.275
17579115,2007-06-01T00:00:00,Neoplasms,C04
17579115,2007-06-01T00:00:00,"Neovascularization, Pathologic",C23.550.589.500
17580143,2007-06-01T00:00:00,African Continental Ancestry Group,M01.686.508.100
17580143,2007-06-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
17580143,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17580143,2007-06-01T00:00:00,Interpersonal Relations,F01.829.401
17580143,2007-06-01T00:00:00,Kidney,A05.810.453
17580143,2007-06-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
17580143,2007-06-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
17580143,2007-06-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
17580143,2007-06-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
17580143,2007-06-01T00:00:00,Living Donors,M01.898.656
17580143,2007-06-01T00:00:00,Pain,C10.597.617
17580143,2007-06-01T00:00:00,Pain,C23.888.592.612
17580143,2007-06-01T00:00:00,Pain,C23.888.646
17580143,2007-06-01T00:00:00,Pain,F02.830.816.444
17580143,2007-06-01T00:00:00,Pain,G11.561.600.810.444
17593005,2007-06-01T00:00:00,Animals,B01.050
17593005,2007-06-01T00:00:00,Autoimmune Diseases,C20.111
17593005,2007-06-01T00:00:00,Cytokines,D12.644.276.374
17593005,2007-06-01T00:00:00,Cytokines,D12.776.467.374
17593005,2007-06-01T00:00:00,Cytokines,D23.529.374
17593005,2007-06-01T00:00:00,"Disease Models, Animal",C22.232
17593005,2007-06-01T00:00:00,"Disease Models, Animal",E05.598.500
17593005,2007-06-01T00:00:00,"Disease Models, Animal",E05.599.395.080
17593005,2007-06-01T00:00:00,Eye Proteins,D12.776.306
17593005,2007-06-01T00:00:00,Polymerase Chain Reaction,E05.393.620.500
17593005,2007-06-01T00:00:00,Retina,A09.371.729
17593005,2007-06-01T00:00:00,S-Nitrosoglutathione,D02.654.846.500.249
17593005,2007-06-01T00:00:00,S-Nitrosoglutathione,D02.886.489.650.750
17593005,2007-06-01T00:00:00,S-Nitrosoglutathione,D12.644.456.448.750
17593005,2007-06-01T00:00:00,Spleen,A10.549.700
17593005,2007-06-01T00:00:00,Spleen,A15.382.520.604.700
17593005,2007-06-01T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
17593005,2007-06-01T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
17593005,2007-06-01T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
17595943,2007-06-01T00:00:00,African Americans,M01.686.508.100.100
17595943,2007-06-01T00:00:00,African Americans,M01.686.754.100
17595943,2007-06-01T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
17595943,2007-06-01T00:00:00,Biological Markers,D23.101
17595943,2007-06-01T00:00:00,Biomedical Research,H01.770.644.145
17595943,2007-06-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17595943,2007-06-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
17595943,2007-06-01T00:00:00,Genetic Variation,G05.365
17595943,2007-06-01T00:00:00,Heart Failure,C14.280.434
17595943,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17595943,2007-06-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
17595943,2007-06-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
17595943,2007-06-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
17595943,2007-06-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
17595943,2007-06-01T00:00:00,United States,Z01.107.567.875
17661582,2007-06-01T00:00:00,Breast Feeding,G07.610.220.500.500
17661582,2007-06-01T00:00:00,Breast Feeding,G07.610.593.185
17661582,2007-06-01T00:00:00,Breast Feeding,G07.700.620.185
17661582,2007-06-01T00:00:00,"History, 19th Century",K01.400.504.937
17661582,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17688312,2007-06-01T00:00:00,Bacterial Proteins,D12.776.097
17688312,2007-06-01T00:00:00,Computational Biology,H01.158.273.180
17688312,2007-06-01T00:00:00,Computer Simulation,L01.224.160
17688312,2007-06-01T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
17688312,2007-06-01T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
17688312,2007-06-01T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
17688312,2007-06-01T00:00:00,"Models, Molecular",E05.599.595
17688312,2007-06-01T00:00:00,Protein Conformation,G02.111.570.790.709
17688312,2007-06-01T00:00:00,Static Electricity,G01.201.249.820
17712533,2007-06-01T00:00:00,Animals,B01.050
17712533,2007-06-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
17712533,2007-06-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
17712533,2007-06-01T00:00:00,Disease Progression,C23.550.291.656
17712533,2007-06-01T00:00:00,Head and Neck Neoplasms,C04.588.443
17712533,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17712533,2007-06-01T00:00:00,"Neovascularization, Pathologic",C23.550.589.500
17879577,2007-06-01T00:00:00,Adult,M01.060.116
17879577,2007-06-01T00:00:00,Case-Control Studies,E05.318.760.500.500
17879577,2007-06-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
17879577,2007-06-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
17879577,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17879577,2007-06-01T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
17879577,2007-06-01T00:00:00,Metabolic Syndrome X,C18.452.625
17879577,2007-06-01T00:00:00,Middle Aged,M01.060.116.630
17879577,2007-06-01T00:00:00,Obesity,C18.654.726.500
17879577,2007-06-01T00:00:00,Obesity,C23.888.144.699.500
17879577,2007-06-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
17879577,2007-06-01T00:00:00,Obesity,G07.100.100.160.120.699.500
17879577,2007-06-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17879577,2007-06-01T00:00:00,Risk Factors,N05.715.350.200.700
17879577,2007-06-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17879577,2007-06-01T00:00:00,Risk Factors,N06.850.490.625.750
17879577,2007-06-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17962911,2007-06-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
17962911,2007-06-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
17962911,2007-06-01T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
17962911,2007-06-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
17962911,2007-06-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
17962911,2007-06-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
17962911,2007-06-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
17962911,2007-06-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
17962911,2007-06-01T00:00:00,Head and Neck Neoplasms,C04.588.443
17962911,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18333577,2007-06-01T00:00:00,Hospitalists,M01.526.485.630.490.400
18333577,2007-06-01T00:00:00,Hospitalists,M01.526.485.740.422.400
18333577,2007-06-01T00:00:00,Hospitalists,M01.526.485.810.580
18333577,2007-06-01T00:00:00,Hospitalists,N02.360.630.490.400
18333577,2007-06-01T00:00:00,Hospitalists,N02.360.740.422.400
18333577,2007-06-01T00:00:00,Hospitalists,N02.360.810.580
18333577,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18333577,2007-06-01T00:00:00,Pediatrics,H02.403.670
18333577,2007-06-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18333577,2007-06-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18333577,2007-06-01T00:00:00,United States,Z01.107.567.875
18333578,2007-06-01T00:00:00,Child,M01.060.406
18333578,2007-06-01T00:00:00,"Child, Preschool",M01.060.406.448
18333578,2007-06-01T00:00:00,Drug Prescriptions,E02.319.307
18333578,2007-06-01T00:00:00,Drug Prescriptions,N02.421.668.778.500
18333578,2007-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18333578,2007-06-01T00:00:00,Pharmaceutical Preparations,D26
18333578,2007-06-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18333578,2007-06-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17542582,2007-06-02T00:00:00,Antibodies,D12.776.124.486.485.114
17542582,2007-06-02T00:00:00,Antibodies,D12.776.124.790.651.114
17542582,2007-06-02T00:00:00,Antibodies,D12.776.377.715.548.114
17542582,2007-06-02T00:00:00,Avidin,D12.776.034.614.300
17542582,2007-06-02T00:00:00,Avidin,D12.776.256.317.663.300
17542582,2007-06-02T00:00:00,Avidin,D12.776.290.663.100
17542582,2007-06-02T00:00:00,Avidin,D12.776.395.175
17542582,2007-06-02T00:00:00,Biological Transport,G03.495.166
17542582,2007-06-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17542582,2007-06-02T00:00:00,Luminescence,G01.201.875.770.578.665
17542582,2007-06-02T00:00:00,Luminescence,G01.590.540.665
17542582,2007-06-02T00:00:00,Nanoparticles,J01.637.512.600
17542582,2007-06-02T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
17542582,2007-06-02T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
17542582,2007-06-02T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
17542990,2007-06-03T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
17542990,2007-06-03T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
17542990,2007-06-03T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
17542990,2007-06-03T00:00:00,Amino Acid Sequence,G02.111.570.060
17542990,2007-06-03T00:00:00,Amino Acid Sequence,L01.453.245.667.060
17542990,2007-06-03T00:00:00,Amino Acids,D12.125
17542990,2007-06-03T00:00:00,Escherichia coli,B03.440.450.425.325.300
17542990,2007-06-03T00:00:00,Escherichia coli,B03.660.250.150.180.100
17542990,2007-06-03T00:00:00,Hydrogen Bonding,G02.149.767.620
17542990,2007-06-03T00:00:00,Hydrogen Bonding,G02.842.750.620
17542990,2007-06-03T00:00:00,"Models, Molecular",E05.599.595
17542990,2007-06-03T00:00:00,Molecular Sequence Data,L01.453.245.667
17542990,2007-06-03T00:00:00,Pyrimidines,D03.383.742
17542990,2007-06-03T00:00:00,"Sequence Homology, Amino Acid",G02.111.810.200
17542990,2007-06-03T00:00:00,"Sequence Homology, Amino Acid",G05.810.200
17542990,2007-06-03T00:00:00,Serine,D12.125.154.800
17542990,2007-06-03T00:00:00,Serine,D12.125.837
17548428,2007-06-04T00:00:00,Animals,B01.050
17548428,2007-06-04T00:00:00,Cell Line,A11.251.210
17548428,2007-06-04T00:00:00,Ceramides,D02.065.313
17548428,2007-06-04T00:00:00,Ceramides,D09.400.410.420.525.200
17548428,2007-06-04T00:00:00,Ceramides,D10.390.470.675.200
17548428,2007-06-04T00:00:00,Ceramides,D10.570.877.360.612.200
17548428,2007-06-04T00:00:00,Gene Expression Regulation,G05.355.315
17548428,2007-06-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17548428,2007-06-04T00:00:00,Molecular Sequence Data,L01.453.245.667
17548428,2007-06-04T00:00:00,Mutation,G05.365.590
17548428,2007-06-04T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
17548428,2007-06-04T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
17548428,2007-06-04T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
17548428,2007-06-04T00:00:00,Signal Transduction,G02.111.087.800
17548428,2007-06-04T00:00:00,Signal Transduction,G02.149.115.800
17548428,2007-06-04T00:00:00,Signal Transduction,G04.299.880
17548428,2007-06-04T00:00:00,Telomerase,D08.811.913.696.445.308.300.750.750
17548428,2007-06-04T00:00:00,Telomerase,D12.776.157.725.500.921
17548428,2007-06-04T00:00:00,Telomerase,D12.776.664.962.500.921
17549634,2007-06-05T00:00:00,Adolescent,M01.060.057
17549634,2007-06-05T00:00:00,Adult,M01.060.116
17549634,2007-06-05T00:00:00,Aged,M01.060.116.100
17549634,2007-06-05T00:00:00,Esophagus,A03.556.875.500
17549634,2007-06-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17549634,2007-06-05T00:00:00,Manometry,E05.559
17549634,2007-06-05T00:00:00,Middle Aged,M01.060.116.630
17549634,2007-06-05T00:00:00,Pressure,G01.374.715
17549634,2007-06-05T00:00:00,"Scleroderma, Systemic",C17.300.799
17549634,2007-06-05T00:00:00,"Scleroderma, Systemic",C17.800.784
17664589,2007-06-06T00:00:00,Computer Simulation,L01.224.160
17664589,2007-06-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17664589,2007-06-06T00:00:00,Melanoma,C04.557.465.625.650.510
17664589,2007-06-06T00:00:00,Melanoma,C04.557.580.625.650.510
17664589,2007-06-06T00:00:00,Melanoma,C04.557.665.510
17664589,2007-06-06T00:00:00,Monte Carlo Method,E05.318.740.525
17664589,2007-06-06T00:00:00,Monte Carlo Method,L01.906.575.422
17664589,2007-06-06T00:00:00,Monte Carlo Method,N05.715.360.750.540
17664589,2007-06-06T00:00:00,Monte Carlo Method,N06.850.520.830.525
17664589,2007-06-06T00:00:00,Particle Accelerators,E07.710.680
17664589,2007-06-06T00:00:00,"Phantoms, Imaging",E07.671
17664589,2007-06-06T00:00:00,Protons,D01.248.497.300.459.700
17664589,2007-06-06T00:00:00,Protons,D01.435.550
17664589,2007-06-06T00:00:00,Protons,G01.249.765
17664589,2007-06-06T00:00:00,Radiometry,E05.799
17664589,2007-06-06T00:00:00,Radiotherapy Dosage,E02.815.639
17664589,2007-06-06T00:00:00,"Radiotherapy, High-Energy",E02.815.722
17664589,2007-06-06T00:00:00,Uveal Neoplasms,C04.588.364.978
17664589,2007-06-06T00:00:00,Uveal Neoplasms,C11.319.494
17664589,2007-06-06T00:00:00,Uveal Neoplasms,C11.941.855
17554363,2007-06-07T00:00:00,Adolescent,M01.060.057
17554363,2007-06-07T00:00:00,Adult,M01.060.116
17554363,2007-06-07T00:00:00,Aged,M01.060.116.100
17554363,2007-06-07T00:00:00,Carcinoma,C04.557.470.200
17554363,2007-06-07T00:00:00,Child,M01.060.406
17554363,2007-06-07T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17554363,2007-06-07T00:00:00,Genetic Predisposition to Disease,G05.380.355
17554363,2007-06-07T00:00:00,Genetic Testing,E01.370.427
17554363,2007-06-07T00:00:00,Genetic Testing,E05.393.435
17554363,2007-06-07T00:00:00,Genetic Testing,N02.421.143.827.233.221
17554363,2007-06-07T00:00:00,Genetic Testing,N02.421.308.430
17554363,2007-06-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17554363,2007-06-07T00:00:00,Middle Aged,M01.060.116.630
17554363,2007-06-07T00:00:00,Mutation,G05.365.590
17554363,2007-06-07T00:00:00,"Remission, Spontaneous",C23.550.291.656.700
17554363,2007-06-07T00:00:00,"Remission, Spontaneous",G16.100.870
17554363,2007-06-07T00:00:00,Skin Neoplasms,C04.588.805
17554363,2007-06-07T00:00:00,Skin Neoplasms,C17.800.882
17562168,2007-06-12T00:00:00,Antineoplastic Agents,D27.505.954.248
17562168,2007-06-12T00:00:00,Apoptosis,G04.299.139.160
17562168,2007-06-12T00:00:00,Brain Neoplasms,C04.588.614.250.195
17562168,2007-06-12T00:00:00,Brain Neoplasms,C10.228.140.211
17562168,2007-06-12T00:00:00,Brain Neoplasms,C10.551.240.250
17562168,2007-06-12T00:00:00,Cell Survival,G04.299.316
17562168,2007-06-12T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
17562168,2007-06-12T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
17562168,2007-06-12T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
17562168,2007-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17562168,2007-06-12T00:00:00,Mitochondria,A11.284.430.214.190.875.564
17562168,2007-06-12T00:00:00,Mitochondria,A11.284.835.626
17562168,2007-06-12T00:00:00,NF-kappa B,D12.776.260.600
17562168,2007-06-12T00:00:00,NF-kappa B,D12.776.660.600
17562168,2007-06-12T00:00:00,NF-kappa B,D12.776.930.600
17562168,2007-06-12T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
17562168,2007-06-12T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
17562168,2007-06-12T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
17562168,2007-06-12T00:00:00,Signal Transduction,G02.111.087.800
17562168,2007-06-12T00:00:00,Signal Transduction,G02.149.115.800
17562168,2007-06-12T00:00:00,Signal Transduction,G04.299.880
17562168,2007-06-12T00:00:00,bcl-2-Associated X Protein,D12.644.360.075.718.400
17562168,2007-06-12T00:00:00,bcl-2-Associated X Protein,D12.776.476.075.718.400
17562834,2007-06-12T00:00:00,Age Factors,N05.715.350.075
17562834,2007-06-12T00:00:00,Age Factors,N06.850.490.250
17562834,2007-06-12T00:00:00,Aged,M01.060.116.100
17562834,2007-06-12T00:00:00,Blood Pressure,E01.370.600.875.249
17562834,2007-06-12T00:00:00,Blood Pressure,G09.330.380.076
17562834,2007-06-12T00:00:00,Brain Ischemia,C10.228.140.300.150
17562834,2007-06-12T00:00:00,Brain Ischemia,C14.907.253.092
17562834,2007-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17562834,2007-06-12T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
17562834,2007-06-12T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
17562834,2007-06-12T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
17562834,2007-06-12T00:00:00,Hypertension,C14.907.489
17562834,2007-06-12T00:00:00,Microcirculation,G09.330.190.163.645
17562834,2007-06-12T00:00:00,Middle Aged,M01.060.116.630
17562834,2007-06-12T00:00:00,Recovery of Function,G16.757
17562834,2007-06-12T00:00:00,Stroke,C10.228.140.300.775
17562834,2007-06-12T00:00:00,Stroke,C14.907.253.855
17562834,2007-06-12T00:00:00,Treatment Outcome,E01.789.800
17562834,2007-06-12T00:00:00,Treatment Outcome,N04.761.559.590.800
17562834,2007-06-12T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17568027,2007-06-14T00:00:00,Continuity of Patient Care,N04.590.233.727.210
17568027,2007-06-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17568027,2007-06-14T00:00:00,"Medical Records Systems, Computerized",E05.318.308.940.968.625
17568027,2007-06-14T00:00:00,"Medical Records Systems, Computerized",L01.280.900.968.775
17568027,2007-06-14T00:00:00,"Medical Records Systems, Computerized",L01.700.508.300.695
17568027,2007-06-14T00:00:00,"Medical Records Systems, Computerized",N04.452.859.564.650
17568027,2007-06-14T00:00:00,"Medical Records Systems, Computerized",N05.715.360.300.715.500.530
17568027,2007-06-14T00:00:00,"Medical Records Systems, Computerized",N06.850.520.308.940.968.625
17568027,2007-06-14T00:00:00,United States,Z01.107.567.875
17568027,2007-06-14T00:00:00,United States Department of Veterans Affairs,I01.409.137.500.700
17568027,2007-06-14T00:00:00,United States Department of Veterans Affairs,N03.540.348.500.500.700
17569698,2007-06-14T00:00:00,Adult,M01.060.116
17569698,2007-06-14T00:00:00,"Air Pollution, Indoor",N06.850.460.100.080
17569698,2007-06-14T00:00:00,Alcohol Drinking,F01.145.317.269
17569698,2007-06-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17569698,2007-06-14T00:00:00,Interviews as Topic,E05.318.308.420
17569698,2007-06-14T00:00:00,Interviews as Topic,L01.280.520
17569698,2007-06-14T00:00:00,Interviews as Topic,N05.715.360.300.400
17569698,2007-06-14T00:00:00,Interviews as Topic,N06.850.520.308.420
17569698,2007-06-14T00:00:00,Smoking,F01.145.466.753
17569698,2007-06-14T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
17569698,2007-06-14T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
17569698,2007-06-14T00:00:00,Workplace,N01.824.245.925
17569698,2007-06-14T00:00:00,Workplace,N04.452.677.975
17569776,2007-06-14T00:00:00,Animals,B01.050
17569776,2007-06-14T00:00:00,Apoptosis,G04.299.139.160
17569776,2007-06-14T00:00:00,Gene Deletion,G05.355.600.800.320
17569776,2007-06-14T00:00:00,Gene Deletion,G05.365.590.762.320
17569776,2007-06-14T00:00:00,"Mice, Inbred CBA",B01.050.050.157.520.440
17569776,2007-06-14T00:00:00,"Mice, Inbred CBA",B01.050.050.199.520.520.440
17569776,2007-06-14T00:00:00,"Mice, Inbred CBA",B01.050.150.900.649.865.635.505.500.400.440
17569776,2007-06-14T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
17569776,2007-06-14T00:00:00,"Microscopy, Confocal",E05.595.395
17569776,2007-06-14T00:00:00,Phenotype,G05.695
17569776,2007-06-14T00:00:00,Purkinje Cells,A08.186.211.132.810.428.200.212.600
17569776,2007-06-14T00:00:00,Purkinje Cells,A08.186.211.865.428.200.212.600
17569776,2007-06-14T00:00:00,Purkinje Cells,A08.663.784
17569776,2007-06-14T00:00:00,Purkinje Cells,A11.671.784
17569776,2007-06-14T00:00:00,Time Factors,G01.910.857
17569776,2007-06-14T00:00:00,bcl-2-Associated X Protein,D12.644.360.075.718.400
17569776,2007-06-14T00:00:00,bcl-2-Associated X Protein,D12.776.476.075.718.400
17569784,2007-06-14T00:00:00,Animals,B01.050
17569784,2007-06-14T00:00:00,Brain,A08.186.211
17569784,2007-06-14T00:00:00,Brain Mapping,E01.370.350.086
17569784,2007-06-14T00:00:00,Brain Mapping,E01.370.376.149
17569784,2007-06-14T00:00:00,Brain Mapping,E05.132
17569784,2007-06-14T00:00:00,"Models, Neurological",E05.599.395.642
17569784,2007-06-14T00:00:00,Motor Cortex,A08.186.211.730.885.287.500.270.548
17569784,2007-06-14T00:00:00,Motor Neurons,A08.663.655.500
17569784,2007-06-14T00:00:00,Motor Neurons,A11.671.655.500
17569784,2007-06-14T00:00:00,Movement,G07.700.560
17569784,2007-06-14T00:00:00,Movement,G11.427.590.530
17573044,2007-06-14T00:00:00,Adolescent,M01.060.057
17573044,2007-06-14T00:00:00,Adult,M01.060.116
17573044,2007-06-14T00:00:00,Aged,M01.060.116.100
17573044,2007-06-14T00:00:00,"Depressive Disorder, Major",F03.600.300.375
17573044,2007-06-14T00:00:00,Double-Blind Method,E05.318.780.300
17573044,2007-06-14T00:00:00,Double-Blind Method,E05.581.500.300
17573044,2007-06-14T00:00:00,Double-Blind Method,N05.715.360.780.320
17573044,2007-06-14T00:00:00,Double-Blind Method,N06.850.520.445.300
17573044,2007-06-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17573044,2007-06-14T00:00:00,Middle Aged,M01.060.116.630
17573044,2007-06-14T00:00:00,Psychiatric Status Rating Scales,F04.586
17573044,2007-06-14T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
17573044,2007-06-14T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
17573044,2007-06-14T00:00:00,Treatment Outcome,E01.789.800
17573044,2007-06-14T00:00:00,Treatment Outcome,N04.761.559.590.800
17573044,2007-06-14T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17637507,2007-06-14T00:00:00,Binding Sites,G02.111.570.120
17637507,2007-06-14T00:00:00,Computer Simulation,L01.224.160
17637507,2007-06-14T00:00:00,"Databases, Factual",L01.470.750.750
17637507,2007-06-14T00:00:00,"Databases, Factual",L01.700.508.300.188.400
17637507,2007-06-14T00:00:00,Enzyme Inhibitors,D27.505.519.389
17637507,2007-06-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17637507,2007-06-14T00:00:00,"Models, Molecular",E05.599.595
17637507,2007-06-14T00:00:00,Proto-Oncogene Proteins c-pim-1,D08.811.913.696.620.682.700.776
17637507,2007-06-14T00:00:00,Proto-Oncogene Proteins c-pim-1,D12.776.624.664.700.191
17637507,2007-06-14T00:00:00,Static Electricity,G01.201.249.820
17230463,2007-06-15T00:00:00,Adult,M01.060.116
17230463,2007-06-15T00:00:00,Aged,M01.060.116.100
17230463,2007-06-15T00:00:00,Brain,A08.186.211
17230463,2007-06-15T00:00:00,"Diagnosis, Differential",E01.171
17230463,2007-06-15T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
17230463,2007-06-15T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
17230463,2007-06-15T00:00:00,Dystonic Disorders,C10.228.662.300
17230463,2007-06-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17230463,2007-06-15T00:00:00,Middle Aged,M01.060.116.630
17440943,2007-06-15T00:00:00,Case-Control Studies,E05.318.760.500.500
17440943,2007-06-15T00:00:00,Case-Control Studies,N05.715.360.775.175.200
17440943,2007-06-15T00:00:00,Case-Control Studies,N06.850.520.450.500.500
17440943,2007-06-15T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17440943,2007-06-15T00:00:00,Genetic Predisposition to Disease,G05.380.355
17440943,2007-06-15T00:00:00,Homeodomain Proteins,D12.776.260.400
17440943,2007-06-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17440943,2007-06-15T00:00:00,"Polymorphism, Genetic",G05.365.795
17440943,2007-06-15T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
17440943,2007-06-15T00:00:00,Prostatic Neoplasms,C12.294.260.750
17440943,2007-06-15T00:00:00,Prostatic Neoplasms,C12.294.565.625
17440943,2007-06-15T00:00:00,Prostatic Neoplasms,C12.758.409.750
17440943,2007-06-15T00:00:00,Risk Assessment,E05.318.740.600.800.715
17440943,2007-06-15T00:00:00,Risk Assessment,N04.452.871.715
17440943,2007-06-15T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17440943,2007-06-15T00:00:00,Risk Assessment,N06.850.505.715
17440943,2007-06-15T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17440943,2007-06-15T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
17570061,2007-06-15T00:00:00,Animals,B01.050
17570061,2007-06-15T00:00:00,Apoptosis,G04.299.139.160
17570061,2007-06-15T00:00:00,Calpain,D08.811.277.656.262.500.120
17570061,2007-06-15T00:00:00,Calpain,D08.811.277.656.300.200.120
17570061,2007-06-15T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
17570061,2007-06-15T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
17570061,2007-06-15T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
17570061,2007-06-15T00:00:00,Indomethacin,D03.438.473.420
17570061,2007-06-15T00:00:00,Oxidative Stress,G03.495.710
17570061,2007-06-15T00:00:00,Oxidative Stress,G07.700.830.750
17570061,2007-06-15T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
17570061,2007-06-15T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
17570061,2007-06-15T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
17570061,2007-06-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17570061,2007-06-15T00:00:00,bcl-2-Associated X Protein,D12.644.360.075.718.400
17570061,2007-06-15T00:00:00,bcl-2-Associated X Protein,D12.776.476.075.718.400
17574983,2007-06-15T00:00:00,Adult,M01.060.116
17574983,2007-06-15T00:00:00,Aged,M01.060.116.100
17574983,2007-06-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17574983,2007-06-15T00:00:00,"Hyperparathyroidism, Primary",C19.642.355.239
17574983,2007-06-15T00:00:00,Middle Aged,M01.060.116.630
17574983,2007-06-15T00:00:00,Parathyroid Glands,A06.407.560
17574983,2007-06-15T00:00:00,Radiopharmaceuticals,D27.720.470.410.650
17574983,2007-06-15T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.350.800.800
17574983,2007-06-15T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.600.350.800.800
17574983,2007-06-15T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.710.800.800
17574983,2007-06-15T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.825.800.800
17574983,2007-06-15T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.384.730.800.800
17574983,2007-06-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17574983,2007-06-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17574983,2007-06-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17574983,2007-06-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17574983,2007-06-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17613211,2007-06-15T00:00:00,Animals,B01.050
17613211,2007-06-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17613211,2007-06-15T00:00:00,Neurilemmoma,C04.557.465.625.650.595
17613211,2007-06-15T00:00:00,Neurilemmoma,C04.557.580.600.290
17613211,2007-06-15T00:00:00,Neurilemmoma,C04.557.580.600.610.595
17613211,2007-06-15T00:00:00,Neurilemmoma,C04.557.580.625.650.595
17613211,2007-06-15T00:00:00,Neurilemmoma,C10.551.775.500.500
17613211,2007-06-15T00:00:00,Neurilemmoma,C10.668.829.725.500.500
17576863,2007-06-18T00:00:00,Child,M01.060.406
17576863,2007-06-18T00:00:00,Coronary Disease,C14.280.647.250
17576863,2007-06-18T00:00:00,Coronary Disease,C14.907.585.250
17576863,2007-06-18T00:00:00,Coronary Vessels,A07.231.114.269
17576863,2007-06-18T00:00:00,Coronary Vessels,A07.231.908.194
17576863,2007-06-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17576863,2007-06-18T00:00:00,Risk Factors,E05.318.740.600.800.725
17576863,2007-06-18T00:00:00,Risk Factors,N05.715.350.200.700
17576863,2007-06-18T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17576863,2007-06-18T00:00:00,Risk Factors,N06.850.490.625.750
17576863,2007-06-18T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17579226,2007-06-20T00:00:00,Confidentiality,F04.096.544.335.240
17579226,2007-06-20T00:00:00,Confidentiality,I01.880.604.473.650.500
17579226,2007-06-20T00:00:00,Confidentiality,I01.880.604.583.080
17579226,2007-06-20T00:00:00,Confidentiality,N03.706.437.650.124
17579226,2007-06-20T00:00:00,Confidentiality,N03.706.535.230
17579226,2007-06-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17579226,2007-06-20T00:00:00,Medical Records,E05.318.308.940.968
17579226,2007-06-20T00:00:00,Medical Records,L01.280.900.968
17579226,2007-06-20T00:00:00,Medical Records,N04.452.859.564
17579226,2007-06-20T00:00:00,Medical Records,N05.715.360.300.715.500
17579226,2007-06-20T00:00:00,Medical Records,N06.850.520.308.940.968
17579226,2007-06-20T00:00:00,United States,Z01.107.567.875
17581943,2007-06-20T00:00:00,Activities of Daily Living,E02.831.067
17581943,2007-06-20T00:00:00,Activities of Daily Living,I03.050
17581943,2007-06-20T00:00:00,Activities of Daily Living,N02.421.784.110
17581943,2007-06-20T00:00:00,Aged,M01.060.116.100
17581943,2007-06-20T00:00:00,Antidepressive Agents,D27.505.954.427.700.122
17581943,2007-06-20T00:00:00,Antiparkinson Agents,D27.505.954.427.090.050
17581943,2007-06-20T00:00:00,"Clinical Trials, Phase II as Topic",E05.318.760.535.210
17581943,2007-06-20T00:00:00,"Clinical Trials, Phase II as Topic",E05.337.250.210
17581943,2007-06-20T00:00:00,"Clinical Trials, Phase II as Topic",N05.715.360.775.235.210
17581943,2007-06-20T00:00:00,"Clinical Trials, Phase II as Topic",N06.850.520.450.535.210
17581943,2007-06-20T00:00:00,Depressive Disorder,F03.600.300
17581943,2007-06-20T00:00:00,Disability Evaluation,E01.370.400
17581943,2007-06-20T00:00:00,Double-Blind Method,E05.318.780.300
17581943,2007-06-20T00:00:00,Double-Blind Method,E05.581.500.300
17581943,2007-06-20T00:00:00,Double-Blind Method,N05.715.360.780.320
17581943,2007-06-20T00:00:00,Double-Blind Method,N06.850.520.445.300
17581943,2007-06-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17581943,2007-06-20T00:00:00,Mass Screening,E01.370.500
17581943,2007-06-20T00:00:00,Mass Screening,E05.318.308.250.580
17581943,2007-06-20T00:00:00,Mass Screening,N02.421.143.827.233.443
17581943,2007-06-20T00:00:00,Mass Screening,N02.421.726.233.443
17581943,2007-06-20T00:00:00,Mass Screening,N05.715.360.300.375.500
17581943,2007-06-20T00:00:00,Mass Screening,N06.850.520.308.250.580
17581943,2007-06-20T00:00:00,Mass Screening,N06.850.780.500
17581943,2007-06-20T00:00:00,Middle Aged,M01.060.116.630
17581943,2007-06-20T00:00:00,Motor Activity,F01.145.632
17581943,2007-06-20T00:00:00,Motor Activity,G11.427.590.530.698
17581943,2007-06-20T00:00:00,Neuropsychological Tests,F04.711.513
17581943,2007-06-20T00:00:00,Parkinson Disease,C10.228.140.079.862.500
17581943,2007-06-20T00:00:00,Parkinson Disease,C10.228.662.600.400
17581943,2007-06-20T00:00:00,Parkinson Disease,C10.574.812
17581943,2007-06-20T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
17581943,2007-06-20T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
17581943,2007-06-20T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
17581943,2007-06-20T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
17581944,2007-06-20T00:00:00,Adult,M01.060.116
17581944,2007-06-20T00:00:00,Age Factors,N05.715.350.075
17581944,2007-06-20T00:00:00,Age Factors,N06.850.490.250
17581944,2007-06-20T00:00:00,Coronary Artery Disease,C14.280.647.250.260
17581944,2007-06-20T00:00:00,Coronary Artery Disease,C14.907.137.126.339
17581944,2007-06-20T00:00:00,Coronary Artery Disease,C14.907.585.250.260
17581944,2007-06-20T00:00:00,Health Surveys,E05.318.308.250
17581944,2007-06-20T00:00:00,Health Surveys,N05.715.360.300.375
17581944,2007-06-20T00:00:00,Health Surveys,N06.850.520.308.250
17581944,2007-06-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17581944,2007-06-20T00:00:00,Middle Aged,M01.060.116.630
17581944,2007-06-20T00:00:00,Risk Factors,E05.318.740.600.800.725
17581944,2007-06-20T00:00:00,Risk Factors,N05.715.350.200.700
17581944,2007-06-20T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17581944,2007-06-20T00:00:00,Risk Factors,N06.850.490.625.750
17581944,2007-06-20T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17581944,2007-06-20T00:00:00,Sex Characteristics,G08.686.815
17581944,2007-06-20T00:00:00,Stroke,C10.228.140.300.775
17581944,2007-06-20T00:00:00,Stroke,C14.907.253.855
17581944,2007-06-20T00:00:00,United States,Z01.107.567.875
17660066,2007-06-21T00:00:00,Adolescent,M01.060.057
17660066,2007-06-21T00:00:00,Adult,M01.060.116
17660066,2007-06-21T00:00:00,Child,M01.060.406
17660066,2007-06-21T00:00:00,"Child, Preschool",M01.060.406.448
17660066,2007-06-21T00:00:00,Funnel Chest,C05.116.099.386
17660066,2007-06-21T00:00:00,Funnel Chest,C05.660.386
17660066,2007-06-21T00:00:00,Funnel Chest,C16.131.621.386
17660066,2007-06-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17660066,2007-06-21T00:00:00,Internet,L01.224.230.110.500
17660066,2007-06-21T00:00:00,Orthopedic Procedures,E02.718
17660066,2007-06-21T00:00:00,Orthopedic Procedures,E04.555
17660066,2007-06-21T00:00:00,"Pain, Postoperative",C23.550.767.700
17660066,2007-06-21T00:00:00,"Pain, Postoperative",C23.888.646.530
17660066,2007-06-21T00:00:00,Postoperative Complications,C23.550.767
17586303,2007-06-23T00:00:00,Aged,M01.060.116.100
17586303,2007-06-23T00:00:00,Antihypertensive Agents,D27.505.954.411.162
17586303,2007-06-23T00:00:00,Blood Pressure,E01.370.600.875.249
17586303,2007-06-23T00:00:00,Blood Pressure,G09.330.380.076
17586303,2007-06-23T00:00:00,Double-Blind Method,E05.318.780.300
17586303,2007-06-23T00:00:00,Double-Blind Method,E05.581.500.300
17586303,2007-06-23T00:00:00,Double-Blind Method,N05.715.360.780.320
17586303,2007-06-23T00:00:00,Double-Blind Method,N06.850.520.445.300
17586303,2007-06-23T00:00:00,Echocardiography,E01.370.350.850.220
17586303,2007-06-23T00:00:00,Echocardiography,E01.370.370.380.220
17586303,2007-06-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17586303,2007-06-23T00:00:00,Hypertension,C14.907.489
17586303,2007-06-23T00:00:00,"Hypertrophy, Left Ventricular",C14.280.195.400
17586303,2007-06-23T00:00:00,"Hypertrophy, Left Ventricular",C23.300.775.250.400
17586303,2007-06-23T00:00:00,Middle Aged,M01.060.116.630
17586303,2007-06-23T00:00:00,Renin-Angiotensin System,G03.495.805
17586303,2007-06-23T00:00:00,Renin-Angiotensin System,G09.330.190.400.750
17586303,2007-06-23T00:00:00,Stroke Volume,E01.370.370.380.150.700
17586303,2007-06-23T00:00:00,Stroke Volume,G09.330.380.124.882
17881906,2007-06-23T00:00:00,Animals,B01.050
17881906,2007-06-23T00:00:00,Cell Movement,G04.299.283
17881906,2007-06-23T00:00:00,Cell Movement,G07.700.560.500.180
17881906,2007-06-23T00:00:00,Cell Proliferation,G04.299.233.750
17881906,2007-06-23T00:00:00,Cell Proliferation,G07.700.320.249.410.750
17881906,2007-06-23T00:00:00,Cell Survival,G04.299.316
17881906,2007-06-23T00:00:00,Ceramides,D02.065.313
17881906,2007-06-23T00:00:00,Ceramides,D09.400.410.420.525.200
17881906,2007-06-23T00:00:00,Ceramides,D10.390.470.675.200
17881906,2007-06-23T00:00:00,Ceramides,D10.570.877.360.612.200
17881906,2007-06-23T00:00:00,Disease Progression,C23.550.291.656
17881906,2007-06-23T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
17881906,2007-06-23T00:00:00,Galactosylgalactosylglucosylceramidase,D08.811.277.450.410.150
17881906,2007-06-23T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
17881906,2007-06-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17881906,2007-06-23T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
17881906,2007-06-23T00:00:00,Prostatic Neoplasms,C12.294.260.750
17881906,2007-06-23T00:00:00,Prostatic Neoplasms,C12.294.565.625
17881906,2007-06-23T00:00:00,Prostatic Neoplasms,C12.758.409.750
17588224,2007-06-24T00:00:00,Affective Symptoms,F01.145.126.100
17588224,2007-06-24T00:00:00,Cues,F02.463.425.234
17588224,2007-06-24T00:00:00,Electromyography,E01.370.405.255
17588224,2007-06-24T00:00:00,Electromyography,E01.370.530.255
17588224,2007-06-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17588224,2007-06-24T00:00:00,Motivation,F01.658
17588224,2007-06-24T00:00:00,Motivation,F01.752.543.500.750
17588224,2007-06-24T00:00:00,Patient Compliance,F01.145.488.500
17588224,2007-06-24T00:00:00,Patient Compliance,N05.300.150.600.600
17588224,2007-06-24T00:00:00,Photic Stimulation,E05.723.729
17588224,2007-06-24T00:00:00,Self Disclosure,F01.752.747.792.662
17588224,2007-06-24T00:00:00,Smoking,F01.145.466.753
17588224,2007-06-24T00:00:00,Smoking Cessation,F01.145.940.700
17588224,2007-06-24T00:00:00,Startle Reaction,E01.370.376.550.650.800
17588224,2007-06-24T00:00:00,Startle Reaction,E01.370.600.550.650.800
17588224,2007-06-24T00:00:00,Startle Reaction,F02.830.702.807
17588224,2007-06-24T00:00:00,Startle Reaction,G11.561.600.765.869
17588224,2007-06-24T00:00:00,Tobacco Use Disorder,C21.739.912
17588224,2007-06-24T00:00:00,Tobacco Use Disorder,F03.900.912
17594516,2007-06-27T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
17594516,2007-06-27T00:00:00,Cell Death,G04.299.139
17594516,2007-06-27T00:00:00,Cell Line,A11.251.210
17594516,2007-06-27T00:00:00,Enzyme Inhibitors,D27.505.519.389
17594516,2007-06-27T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
17594516,2007-06-27T00:00:00,Flow Cytometry,E05.200.500.386.350
17594516,2007-06-27T00:00:00,Glucose,D09.546.359.448
17594516,2007-06-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17594516,2007-06-27T00:00:00,Motor Neurons,A08.663.655.500
17594516,2007-06-27T00:00:00,Motor Neurons,A11.671.655.500
17594516,2007-06-27T00:00:00,Neuroprotective Agents,D27.505.696.706.548
17594516,2007-06-27T00:00:00,Neuroprotective Agents,D27.505.954.427.575
17594516,2007-06-27T00:00:00,Pyridines,D03.383.725
17594516,2007-06-27T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
17594516,2007-06-27T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
17594516,2007-06-27T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
17594516,2007-06-27T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
17596361,2007-06-27T00:00:00,Adult,M01.060.116
17596361,2007-06-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17596361,2007-06-27T00:00:00,Molecular Diagnostic Techniques,E05.200.880
17596361,2007-06-27T00:00:00,Molecular Diagnostic Techniques,E05.393.520
17596361,2007-06-27T00:00:00,Polymerase Chain Reaction,E05.393.620.500
17596361,2007-06-27T00:00:00,Virology,H01.158.273.540.859
17596402,2007-06-27T00:00:00,Animals,B01.050
17596402,2007-06-27T00:00:00,Bone Marrow,A15.382.216
17596402,2007-06-27T00:00:00,Cytokines,D12.644.276.374
17596402,2007-06-27T00:00:00,Cytokines,D12.776.467.374
17596402,2007-06-27T00:00:00,Cytokines,D23.529.374
17596402,2007-06-27T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
17596402,2007-06-27T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
17596402,2007-06-27T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
17596402,2007-06-27T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
17596402,2007-06-27T00:00:00,Flow Cytometry,E05.200.500.386.350
17596402,2007-06-27T00:00:00,Hyperglycemia,C18.452.394.952
17596402,2007-06-27T00:00:00,Lymphocyte Activation,E01.450.495.482
17596402,2007-06-27T00:00:00,Lymphocyte Activation,E05.478.594.530
17596402,2007-06-27T00:00:00,Lymphocyte Activation,G12.425.747
17596402,2007-06-27T00:00:00,Lymphocyte Activation,G12.450.050.400.545
17596402,2007-06-27T00:00:00,Spleen,A10.549.700
17596402,2007-06-27T00:00:00,Spleen,A15.382.520.604.700
17596402,2007-06-27T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
17596402,2007-06-27T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
17596402,2007-06-27T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
17596525,2007-06-27T00:00:00,Animals,B01.050
17596525,2007-06-27T00:00:00,Blood Glucose,D09.546.359.448.500
17596525,2007-06-27T00:00:00,Connective Tissue Growth Factor,D12.644.276.200.100
17596525,2007-06-27T00:00:00,Connective Tissue Growth Factor,D12.776.467.200.100
17596525,2007-06-27T00:00:00,Connective Tissue Growth Factor,D12.776.860.300.200.100
17596525,2007-06-27T00:00:00,Connective Tissue Growth Factor,D23.529.237.100
17596525,2007-06-27T00:00:00,"Diabetes Mellitus, Experimental",C18.452.394.750.074
17596525,2007-06-27T00:00:00,"Diabetes Mellitus, Experimental",C19.246.240
17596525,2007-06-27T00:00:00,"Diabetes Mellitus, Experimental",E05.598.500.374
17596525,2007-06-27T00:00:00,Diabetic Nephropathies,C12.777.419.192
17596525,2007-06-27T00:00:00,Diabetic Nephropathies,C13.351.968.419.192
17596525,2007-06-27T00:00:00,Diabetic Nephropathies,C19.246.099.875
17596525,2007-06-27T00:00:00,"Disease Models, Animal",C22.232
17596525,2007-06-27T00:00:00,"Disease Models, Animal",E05.598.500
17596525,2007-06-27T00:00:00,"Disease Models, Animal",E05.599.395.080
17596525,2007-06-27T00:00:00,Gene Deletion,G05.355.600.800.320
17596525,2007-06-27T00:00:00,Gene Deletion,G05.365.590.762.320
17596525,2007-06-27T00:00:00,Immediate-Early Proteins,D12.776.460
17596525,2007-06-27T00:00:00,Immediate-Early Proteins,D12.776.964.925.968
17596525,2007-06-27T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
17596525,2007-06-27T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
17596525,2007-06-27T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
17596525,2007-06-27T00:00:00,Kidney,A05.810.453
17596525,2007-06-27T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.100.080.500
17596525,2007-06-27T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.720.600.220.500
17596525,2007-06-27T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.750.555.220.500
17596525,2007-06-27T00:00:00,Renin-Angiotensin System,G03.495.805
17596525,2007-06-27T00:00:00,Renin-Angiotensin System,G09.330.190.400.750
17596525,2007-06-27T00:00:00,Serum Albumin,D12.776.034.841
17596525,2007-06-27T00:00:00,Serum Albumin,D12.776.124.050.700
17596525,2007-06-27T00:00:00,Serum Albumin,D12.776.124.727
17596915,2007-06-27T00:00:00,Adult,M01.060.116
17596915,2007-06-27T00:00:00,Contrast Media,D27.720.259
17596915,2007-06-27T00:00:00,Double-Blind Method,E05.318.780.300
17596915,2007-06-27T00:00:00,Double-Blind Method,E05.581.500.300
17596915,2007-06-27T00:00:00,Double-Blind Method,N05.715.360.780.320
17596915,2007-06-27T00:00:00,Double-Blind Method,N06.850.520.445.300
17596915,2007-06-27T00:00:00,Functional Laterality,F02.830.297.425
17596915,2007-06-27T00:00:00,Functional Laterality,G11.561.225.425
17596915,2007-06-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17596915,2007-06-27T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17596915,2007-06-27T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17596915,2007-06-27T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
17596915,2007-06-27T00:00:00,Schizophrenia,F03.700.750
17596915,2007-06-27T00:00:00,Time Factors,G01.910.857
17601707,2007-06-29T00:00:00,Animals,B01.050
17601707,2007-06-29T00:00:00,Collagen,D05.750.078.280
17601707,2007-06-29T00:00:00,Collagen,D12.776.860.300.250
17601707,2007-06-29T00:00:00,Extracellular Matrix Proteins,D12.776.860.300
17601707,2007-06-29T00:00:00,Gonadal Steroid Hormones,D06.472.334.851
17601707,2007-06-29T00:00:00,"RNA, Messenger",D13.444.735.544
17601707,2007-06-29T00:00:00,Sex Factors,N05.715.350.675
17601707,2007-06-29T00:00:00,Sex Factors,N06.850.490.875
17601707,2007-06-29T00:00:00,Skin,A17.815
17601982,2007-06-29T00:00:00,Animals,B01.050
17601982,2007-06-29T00:00:00,"Behavior, Addictive",F01.145.527.100.120
17601982,2007-06-29T00:00:00,Cocaine,D02.145.074.722.388
17601982,2007-06-29T00:00:00,Cocaine,D03.132.889.354
17601982,2007-06-29T00:00:00,Cocaine,D03.605.869.388
17601982,2007-06-29T00:00:00,Cocaine,D04.075.080.875.099.722.388
17601982,2007-06-29T00:00:00,Cocaine-Related Disorders,C21.739.300
17601982,2007-06-29T00:00:00,Cocaine-Related Disorders,F03.900.300
17601982,2007-06-29T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17601982,2007-06-29T00:00:00,Self Administration,E02.319.890
17601982,2007-06-29T00:00:00,Self Administration,E02.900.890
17604092,2007-06-29T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
17604092,2007-06-29T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
17604092,2007-06-29T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
17604092,2007-06-29T00:00:00,Basophils,A11.118.637.415.120
17604092,2007-06-29T00:00:00,Basophils,A11.627.340.120
17604092,2007-06-29T00:00:00,Basophils,A15.145.229.637.415.120
17604092,2007-06-29T00:00:00,Basophils,A15.382.490.315.120
17604092,2007-06-29T00:00:00,Chronic Disease,C23.550.291.500
17604092,2007-06-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17604092,2007-06-29T00:00:00,Signal Transduction,G02.111.087.800
17604092,2007-06-29T00:00:00,Signal Transduction,G02.149.115.800
17604092,2007-06-29T00:00:00,Signal Transduction,G04.299.880
17604329,2007-06-29T00:00:00,Aging,G07.700.320.124
17604329,2007-06-29T00:00:00,Animals,B01.050
17604329,2007-06-29T00:00:00,"Animals, Newborn",B01.050.050.282
17604329,2007-06-29T00:00:00,"Endothelium, Vascular",A07.231.330
17604329,2007-06-29T00:00:00,"Endothelium, Vascular",A10.272.491.355
17604329,2007-06-29T00:00:00,Fetus,A16.378
17604329,2007-06-29T00:00:00,Fibroblasts,A11.329.228
17604329,2007-06-29T00:00:00,Fibroblasts,A11.872.228
17604329,2007-06-29T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
17604329,2007-06-29T00:00:00,Flow Cytometry,E05.200.500.386.350
17604329,2007-06-29T00:00:00,Heart,A07.541
17604329,2007-06-29T00:00:00,"Muscle, Smooth, Vascular",A02.633.570.491
17604329,2007-06-29T00:00:00,"Muscle, Smooth, Vascular",A07.231.491
17604329,2007-06-29T00:00:00,"Muscle, Smooth, Vascular",A10.690.467.491
17604329,2007-06-29T00:00:00,Myocardium,A02.633.580
17604329,2007-06-29T00:00:00,Myocardium,A07.541.704
17604329,2007-06-29T00:00:00,Myocardium,A10.690.552.750
17604329,2007-06-29T00:00:00,"Myocytes, Cardiac",A07.541.704.570
17604329,2007-06-29T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
17604329,2007-06-29T00:00:00,"Myocytes, Cardiac",A11.620.500
17604329,2007-06-29T00:00:00,Pregnancy,G08.686.785.760.769
17604329,2007-06-29T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17605095,2007-06-29T00:00:00,Aged,M01.060.116.100
17605095,2007-06-29T00:00:00,Algorithms,G17.035
17605095,2007-06-29T00:00:00,Algorithms,L01.224.050
17605095,2007-06-29T00:00:00,Atrial Fibrillation,C14.280.067.198
17605095,2007-06-29T00:00:00,Atrial Fibrillation,C23.550.073.198
17605095,2007-06-29T00:00:00,"Cardiac Output, Low",C14.280.148
17605095,2007-06-29T00:00:00,"Cardiac Output, Low",C23.888.192
17605095,2007-06-29T00:00:00,"Cardiac Pacing, Artificial",E02.145
17605095,2007-06-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17605095,2007-06-29T00:00:00,Incidence,E05.318.308.985.525.375
17605095,2007-06-29T00:00:00,Incidence,L01.280.975.525.375
17605095,2007-06-29T00:00:00,Incidence,N01.224.935.597.500
17605095,2007-06-29T00:00:00,Incidence,N06.850.505.400.975.525.375
17605095,2007-06-29T00:00:00,Incidence,N06.850.520.308.985.525.375
17605095,2007-06-29T00:00:00,"Pacemaker, Artificial",E07.858.082.748
17605095,2007-06-29T00:00:00,Treatment Outcome,E01.789.800
17605095,2007-06-29T00:00:00,Treatment Outcome,N04.761.559.590.800
17605095,2007-06-29T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17669586,2007-06-29T00:00:00,Amino Acid Sequence,G02.111.570.060
17669586,2007-06-29T00:00:00,Amino Acid Sequence,L01.453.245.667.060
17669586,2007-06-29T00:00:00,Animals,B01.050
17669586,2007-06-29T00:00:00,Estrogens,D27.505.696.399.472.277
17669586,2007-06-29T00:00:00,Molecular Sequence Data,L01.453.245.667
17669586,2007-06-29T00:00:00,Phylogeny,G05.697
17669586,2007-06-29T00:00:00,Phylogeny,G16.100.275.605
17669586,2007-06-29T00:00:00,Phylogeny,L01.100.697
17669586,2007-06-29T00:00:00,"Receptors, Androgen",D12.776.260.698.750.150
17669586,2007-06-29T00:00:00,"Receptors, Androgen",D12.776.826.750.150
17669586,2007-06-29T00:00:00,"Receptors, Androgen",D12.776.930.669.750.150
17669586,2007-06-29T00:00:00,"Receptors, Estrogen",D12.776.260.698.750.350
17669586,2007-06-29T00:00:00,"Receptors, Estrogen",D12.776.826.750.350
17669586,2007-06-29T00:00:00,"Receptors, Estrogen",D12.776.930.669.750.350
17669586,2007-06-29T00:00:00,"Sequence Homology, Amino Acid",G02.111.810.200
17669586,2007-06-29T00:00:00,"Sequence Homology, Amino Acid",G05.810.200
17602665,2007-06-30T00:00:00,Animals,B01.050
17602665,2007-06-30T00:00:00,Eye Proteins,D12.776.306
17706608,2007-06-30T00:00:00,Alcoholism,C21.739.100.250
17706608,2007-06-30T00:00:00,Alcoholism,F03.900.100.350
17706608,2007-06-30T00:00:00,Animals,B01.050
17706608,2007-06-30T00:00:00,Cannabinoids,D02.455.849.090
17706608,2007-06-30T00:00:00,Cocaine,D02.145.074.722.388
17706608,2007-06-30T00:00:00,Cocaine,D03.132.889.354
17706608,2007-06-30T00:00:00,Cocaine,D03.605.869.388
17706608,2007-06-30T00:00:00,Cocaine,D04.075.080.875.099.722.388
17706608,2007-06-30T00:00:00,"Disease Models, Animal",C22.232
17706608,2007-06-30T00:00:00,"Disease Models, Animal",E05.598.500
17706608,2007-06-30T00:00:00,"Disease Models, Animal",E05.599.395.080
17706608,2007-06-30T00:00:00,Glutamic Acid,D12.125.067.750
17706608,2007-06-30T00:00:00,Glutamic Acid,D12.125.119.450
17706608,2007-06-30T00:00:00,Glutamic Acid,D12.125.427.300
17706608,2007-06-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17706608,2007-06-30T00:00:00,Neuronal Plasticity,G11.561.600.635
17706608,2007-06-30T00:00:00,Nicotine,D03.132.760.570
17706608,2007-06-30T00:00:00,Nicotine,D03.383.725.518
17706608,2007-06-30T00:00:00,Substance-Related Disorders,C21.739
17706608,2007-06-30T00:00:00,Substance-Related Disorders,F03.900
17706608,2007-06-30T00:00:00,Synapses,A08.850
17706608,2007-06-30T00:00:00,Synapses,A11.284.149.165.420.780
17706608,2007-06-30T00:00:00,Synaptic Transmission,G02.111.087.800.850
17706608,2007-06-30T00:00:00,Synaptic Transmission,G02.149.115.800.850
17706608,2007-06-30T00:00:00,Synaptic Transmission,G04.299.880.850
17706608,2007-06-30T00:00:00,Synaptic Transmission,G07.265.337.900
17706608,2007-06-30T00:00:00,Synaptic Transmission,G07.700.240.900
17706608,2007-06-30T00:00:00,Synaptic Transmission,G11.561.600.835
17274048,2007-07-01T00:00:00,"Accidents, Traffic",N06.850.135.392
17274048,2007-07-01T00:00:00,Activities of Daily Living,E02.831.067
17274048,2007-07-01T00:00:00,Activities of Daily Living,I03.050
17274048,2007-07-01T00:00:00,Activities of Daily Living,N02.421.784.110
17274048,2007-07-01T00:00:00,Adult,M01.060.116
17274048,2007-07-01T00:00:00,Aged,M01.060.116.100
17274048,2007-07-01T00:00:00,Automobile Driving,I03.125
17274048,2007-07-01T00:00:00,Cognition Disorders,F03.087.250
17274048,2007-07-01T00:00:00,Head and Neck Neoplasms,C04.588.443
17274048,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17274048,2007-07-01T00:00:00,Middle Aged,M01.060.116.630
17274048,2007-07-01T00:00:00,Movement,G07.700.560
17274048,2007-07-01T00:00:00,Movement,G11.427.590.530
17274048,2007-07-01T00:00:00,Questionnaires,E05.318.308.750
17274048,2007-07-01T00:00:00,Questionnaires,L01.280.800
17274048,2007-07-01T00:00:00,Questionnaires,N05.715.360.300.695
17274048,2007-07-01T00:00:00,Questionnaires,N06.850.520.308.750
17301976,2007-07-01T00:00:00,Adolescent,M01.060.057
17301976,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17301976,2007-07-01T00:00:00,Leukemia,C04.557.337
17507829,2007-07-01T00:00:00,Antibodies,D12.776.124.486.485.114
17507829,2007-07-01T00:00:00,Antibodies,D12.776.124.790.651.114
17507829,2007-07-01T00:00:00,Antibodies,D12.776.377.715.548.114
17507829,2007-07-01T00:00:00,Chronic Disease,C23.550.291.500
17507829,2007-07-01T00:00:00,Cystic Fibrosis,C06.689.202
17507829,2007-07-01T00:00:00,Cystic Fibrosis,C08.381.187
17507829,2007-07-01T00:00:00,Cystic Fibrosis,C16.320.190
17507829,2007-07-01T00:00:00,Cystic Fibrosis,C16.614.213
17507829,2007-07-01T00:00:00,Gene Expression,G05.355.310
17507829,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17507829,2007-07-01T00:00:00,"RNA, Messenger",D13.444.735.544
17507829,2007-07-01T00:00:00,Respiratory Mucosa,A04.760
17507829,2007-07-01T00:00:00,Respiratory Mucosa,A10.615.550.760
17511575,2007-07-01T00:00:00,Adolescent,M01.060.057
17511575,2007-07-01T00:00:00,Adult,M01.060.116
17511575,2007-07-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
17511575,2007-07-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
17511575,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17511575,2007-07-01T00:00:00,Internet,L01.224.230.110.500
17511575,2007-07-01T00:00:00,Questionnaires,E05.318.308.750
17511575,2007-07-01T00:00:00,Questionnaires,L01.280.800
17511575,2007-07-01T00:00:00,Questionnaires,N05.715.360.300.695
17511575,2007-07-01T00:00:00,Questionnaires,N06.850.520.308.750
17511575,2007-07-01T00:00:00,Smoking,F01.145.466.753
17511575,2007-07-01T00:00:00,Students,I02.233.748
17511575,2007-07-01T00:00:00,Students,I02.851
17511575,2007-07-01T00:00:00,Students,M01.848
17511575,2007-07-01T00:00:00,Tobacco Industry,J01.576.919
17559499,2007-07-01T00:00:00,Animals,B01.050
17559499,2007-07-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
17559499,2007-07-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
17559499,2007-07-01T00:00:00,Cattle,B01.050.150.900.649.077.380.271
17559499,2007-07-01T00:00:00,Collagen,D05.750.078.280
17559499,2007-07-01T00:00:00,Collagen,D12.776.860.300.250
17559499,2007-07-01T00:00:00,"Disease Models, Animal",C22.232
17559499,2007-07-01T00:00:00,"Disease Models, Animal",E05.598.500
17559499,2007-07-01T00:00:00,"Disease Models, Animal",E05.599.395.080
17559499,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17559499,2007-07-01T00:00:00,Luminescent Measurements,E05.196.712.516
17559499,2007-07-01T00:00:00,Maxilla,A02.835.232.781.324.502.645
17559499,2007-07-01T00:00:00,Maxilla,A14.521.645
17559499,2007-07-01T00:00:00,Mouth Neoplasms,C04.588.443.591
17559499,2007-07-01T00:00:00,Mouth Neoplasms,C07.465.565
17559499,2007-07-01T00:00:00,Neoplasm Invasiveness,C04.697.645
17559499,2007-07-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
17559499,2007-07-01T00:00:00,RANK Ligand,D12.644.276.374.750.562
17559499,2007-07-01T00:00:00,RANK Ligand,D12.644.276.972.562
17559499,2007-07-01T00:00:00,RANK Ligand,D12.776.467.374.750.562
17559499,2007-07-01T00:00:00,RANK Ligand,D12.776.467.972.562
17559499,2007-07-01T00:00:00,RANK Ligand,D23.529.374.750.562
17559499,2007-07-01T00:00:00,RANK Ligand,D23.529.972.562
17559499,2007-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17559499,2007-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17559499,2007-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17559499,2007-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17559499,2007-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17563561,2007-07-01T00:00:00,African Americans,M01.686.508.100.100
17563561,2007-07-01T00:00:00,African Americans,M01.686.754.100
17563561,2007-07-01T00:00:00,Blood Pressure,E01.370.600.875.249
17563561,2007-07-01T00:00:00,Blood Pressure,G09.330.380.076
17563561,2007-07-01T00:00:00,Echocardiography,E01.370.350.850.220
17563561,2007-07-01T00:00:00,Echocardiography,E01.370.370.380.220
17563561,2007-07-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
17563561,2007-07-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17563561,2007-07-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
17563561,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17563561,2007-07-01T00:00:00,Hypertension,C14.907.489
17563561,2007-07-01T00:00:00,"Hypertrophy, Left Ventricular",C14.280.195.400
17563561,2007-07-01T00:00:00,"Hypertrophy, Left Ventricular",C23.300.775.250.400
17563561,2007-07-01T00:00:00,Middle Aged,M01.060.116.630
17563561,2007-07-01T00:00:00,Stroke Volume,E01.370.370.380.150.700
17563561,2007-07-01T00:00:00,Stroke Volume,G09.330.380.124.882
17563561,2007-07-01T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
17577111,2007-07-01T00:00:00,Aged,M01.060.116.100
17577111,2007-07-01T00:00:00,Ambulatory Care,E02.760.106
17577111,2007-07-01T00:00:00,Ambulatory Care,N02.421.585.106
17577111,2007-07-01T00:00:00,Decision Making,F02.463.785.373
17577111,2007-07-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
17577111,2007-07-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
17577111,2007-07-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
17577111,2007-07-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
17577111,2007-07-01T00:00:00,Gastrointestinal Hemorrhage,C06.405.227
17577111,2007-07-01T00:00:00,Gastrointestinal Hemorrhage,C23.550.414.788
17577111,2007-07-01T00:00:00,Hospitalization,E02.760.400
17577111,2007-07-01T00:00:00,Hospitalization,N02.421.585.400
17577111,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17577111,2007-07-01T00:00:00,Length of Stay,E02.760.400.480
17577111,2007-07-01T00:00:00,Length of Stay,N02.421.585.400.480
17577111,2007-07-01T00:00:00,Middle Aged,M01.060.116.630
17577111,2007-07-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
17577111,2007-07-01T00:00:00,Risk Assessment,N04.452.871.715
17577111,2007-07-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17577111,2007-07-01T00:00:00,Risk Assessment,N06.850.505.715
17577111,2007-07-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17577111,2007-07-01T00:00:00,Triage,N02.421.297.900
17578948,2007-07-01T00:00:00,Anesthesiology,H02.403.066
17578948,2007-07-01T00:00:00,Echocardiography,E01.370.350.850.220
17578948,2007-07-01T00:00:00,Echocardiography,E01.370.370.380.220
17578948,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17578948,2007-07-01T00:00:00,Pericardium,A07.541.795
17578948,2007-07-01T00:00:00,Pericardium,A10.615.789.470
17578952,2007-07-01T00:00:00,Aged,M01.060.116.100
17578952,2007-07-01T00:00:00,Heart Ventricles,A07.541.560
17578952,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17579112,2007-07-01T00:00:00,Adolescent,M01.060.057
17579112,2007-07-01T00:00:00,"Diagnosis, Differential",E01.171
17579112,2007-07-01T00:00:00,Emergencies,C23.550.291.781
17579112,2007-07-01T00:00:00,Emergencies,N06.230.100.083
17579112,2007-07-01T00:00:00,Emergencies,N06.850.376
17579112,2007-07-01T00:00:00,HIV Infections,C02.782.815.616.400
17579112,2007-07-01T00:00:00,HIV Infections,C02.800.801.400
17579112,2007-07-01T00:00:00,HIV Infections,C20.673.480
17579112,2007-07-01T00:00:00,HIV-1,B04.820.650.589.650.350.400
17579112,2007-07-01T00:00:00,HIV-1,B04.909.777.731.589.650.350.400
17579112,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17579112,2007-07-01T00:00:00,"Influenza, Human",C02.782.620.365
17579112,2007-07-01T00:00:00,"Influenza, Human",C08.730.310
17580367,2007-07-01T00:00:00,Aged,M01.060.116.100
17580367,2007-07-01T00:00:00,Cardiovascular Agents,D27.505.954.411
17580367,2007-07-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
17580367,2007-07-01T00:00:00,Coronary Angiography,E01.370.370.050.200
17580367,2007-07-01T00:00:00,Coronary Angiography,E01.370.370.380.200
17580367,2007-07-01T00:00:00,Coronary Restenosis,C14.280.647.250.285.200
17580367,2007-07-01T00:00:00,Coronary Restenosis,C14.907.585.250.285.200
17580367,2007-07-01T00:00:00,Heart Diseases,C14.280
17580367,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17580367,2007-07-01T00:00:00,Metals,D01.552
17580367,2007-07-01T00:00:00,Middle Aged,M01.060.116.630
17580367,2007-07-01T00:00:00,Prosthesis Design,E05.320.550
17580367,2007-07-01T00:00:00,Prosthesis Design,E07.695.680
17580367,2007-07-01T00:00:00,Reoperation,E04.690
17580367,2007-07-01T00:00:00,Stents,E07.695.750
17580367,2007-07-01T00:00:00,Time Factors,G01.910.857
17580367,2007-07-01T00:00:00,Treatment Outcome,E01.789.800
17580367,2007-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17580367,2007-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17581898,2007-07-01T00:00:00,Adult,M01.060.116
17581898,2007-07-01T00:00:00,Aged,M01.060.116.100
17581898,2007-07-01T00:00:00,Contrast Media,D27.720.259
17581898,2007-07-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
17581898,2007-07-01T00:00:00,Coronary Angiography,E01.370.370.050.200
17581898,2007-07-01T00:00:00,Coronary Angiography,E01.370.370.380.200
17581898,2007-07-01T00:00:00,Coronary Stenosis,C14.280.647.250.285
17581898,2007-07-01T00:00:00,Coronary Stenosis,C14.907.585.250.285
17581898,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17581898,2007-07-01T00:00:00,Middle Aged,M01.060.116.630
17581898,2007-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17581898,2007-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17581898,2007-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17581898,2007-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17581898,2007-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17582091,2007-07-01T00:00:00,Animals,B01.050
17582091,2007-07-01T00:00:00,Gas Chromatography-Mass Spectrometry,E05.196.181.349.500
17582091,2007-07-01T00:00:00,Gas Chromatography-Mass Spectrometry,E05.196.566.500
17582091,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17582091,2007-07-01T00:00:00,Time Factors,G01.910.857
17582091,2007-07-01T00:00:00,Water,D01.455.900
17582091,2007-07-01T00:00:00,Water,D01.650.550.925
17583985,2007-07-01T00:00:00,Brain Injuries,C10.228.140.199
17583985,2007-07-01T00:00:00,Brain Injuries,C10.900.300.087
17583985,2007-07-01T00:00:00,Brain Injuries,C21.866.260.118
17583985,2007-07-01T00:00:00,Brain Injuries,C21.866.915.300.200
17583985,2007-07-01T00:00:00,Brain Mapping,E01.370.350.086
17583985,2007-07-01T00:00:00,Brain Mapping,E01.370.376.149
17583985,2007-07-01T00:00:00,Brain Mapping,E05.132
17583985,2007-07-01T00:00:00,Computer Simulation,L01.224.160
17583985,2007-07-01T00:00:00,"Databases, Factual",L01.470.750.750
17583985,2007-07-01T00:00:00,"Databases, Factual",L01.700.508.300.188.400
17583985,2007-07-01T00:00:00,Diagnostic Imaging,E01.370.350
17583985,2007-07-01T00:00:00,Functional Laterality,F02.830.297.425
17583985,2007-07-01T00:00:00,Functional Laterality,G11.561.225.425
17583985,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17583985,2007-07-01T00:00:00,Monte Carlo Method,E05.318.740.525
17583985,2007-07-01T00:00:00,Monte Carlo Method,L01.906.575.422
17583985,2007-07-01T00:00:00,Monte Carlo Method,N05.715.360.750.540
17583985,2007-07-01T00:00:00,Monte Carlo Method,N06.850.520.830.525
17583985,2007-07-01T00:00:00,Neuropsychological Tests,F04.711.513
17584267,2007-07-01T00:00:00,"Adaptation, Psychological",F01.058
17584267,2007-07-01T00:00:00,Anxiety,F01.470.132
17584267,2007-07-01T00:00:00,Cognitive Therapy,F04.754.137.428
17584267,2007-07-01T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
17584267,2007-07-01T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
17584267,2007-07-01T00:00:00,"Defibrillators, Implantable",E07.695.175
17584267,2007-07-01T00:00:00,Depression,F01.145.126.350
17584267,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17584267,2007-07-01T00:00:00,Hydrocortisone,D04.808.745.745.654.600
17584267,2007-07-01T00:00:00,Hydrocortisone,D06.472.040.585.353.476
17584267,2007-07-01T00:00:00,Hydrocortisone,D06.472.040.585.478.392
17584267,2007-07-01T00:00:00,Middle Aged,M01.060.116.630
17584267,2007-07-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
17584267,2007-07-01T00:00:00,Patient Education as Topic,I02.233.332.500
17584267,2007-07-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
17584267,2007-07-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
17584267,2007-07-01T00:00:00,Psychiatric Status Rating Scales,F04.586
17584267,2007-07-01T00:00:00,Quality of Life,I01.800
17584267,2007-07-01T00:00:00,Quality of Life,K01.752.400.750
17584267,2007-07-01T00:00:00,Saliva,A12.200.666
17584267,2007-07-01T00:00:00,Social Support,I01.880.656.600
17584267,2007-07-01T00:00:00,"Stress, Psychological",F01.145.126.990
17584267,2007-07-01T00:00:00,"Stress, Psychological",F02.830.900
17584267,2007-07-01T00:00:00,Treatment Outcome,E01.789.800
17584267,2007-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17584267,2007-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17586395,2007-07-01T00:00:00,Cataract,C11.510.245
17586395,2007-07-01T00:00:00,Cataract Extraction,E04.540.825.249
17586395,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17586395,2007-07-01T00:00:00,Infant,M01.060.703
17586395,2007-07-01T00:00:00,Intraoperative Complications,C23.550.505
17586395,2007-07-01T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
17586395,2007-07-01T00:00:00,Syndrome,C23.550.288.500
17586760,2007-07-01T00:00:00,"Biopsy, Fine-Needle",E01.370.388.100.100.500
17586760,2007-07-01T00:00:00,"Biopsy, Fine-Needle",E01.450.230.100.100.500
17586760,2007-07-01T00:00:00,"Biopsy, Fine-Needle",E01.450.865.100.100.500
17586760,2007-07-01T00:00:00,"Biopsy, Fine-Needle",E04.074.119.500
17586760,2007-07-01T00:00:00,Bronchoscopy,E01.370.386.105
17586760,2007-07-01T00:00:00,Bronchoscopy,E01.370.388.250.100
17586760,2007-07-01T00:00:00,Bronchoscopy,E04.800.250.100
17586760,2007-07-01T00:00:00,Bronchoscopy,E04.928.600.080
17586760,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17586760,2007-07-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
17586760,2007-07-01T00:00:00,Lung Neoplasms,C08.381.540
17586760,2007-07-01T00:00:00,Lung Neoplasms,C08.785.520
17586760,2007-07-01T00:00:00,"Ultrasonography, Interventional",E01.370.350.850.855
17587361,2007-07-01T00:00:00,Adolescent,M01.060.057
17587361,2007-07-01T00:00:00,Adult,M01.060.116
17587361,2007-07-01T00:00:00,"Air Pollutants, Radioactive",D20.693.101
17587361,2007-07-01T00:00:00,"Air Pollutants, Radioactive",D27.888.284.101.393
17587361,2007-07-01T00:00:00,Child,M01.060.406
17587361,2007-07-01T00:00:00,"Child, Preschool",M01.060.406.448
17587361,2007-07-01T00:00:00,Environmental Exposure,N06.850.460.350
17587361,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17587361,2007-07-01T00:00:00,Incidence,E05.318.308.985.525.375
17587361,2007-07-01T00:00:00,Incidence,L01.280.975.525.375
17587361,2007-07-01T00:00:00,Incidence,N01.224.935.597.500
17587361,2007-07-01T00:00:00,Incidence,N06.850.505.400.975.525.375
17587361,2007-07-01T00:00:00,Incidence,N06.850.520.308.985.525.375
17587361,2007-07-01T00:00:00,Infant,M01.060.703
17587361,2007-07-01T00:00:00,"Infant, Newborn",M01.060.703.520
17587361,2007-07-01T00:00:00,Power Plants,E07.305.437
17587361,2007-07-01T00:00:00,Power Plants,J01.780
17587361,2007-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17587361,2007-07-01T00:00:00,Risk Factors,N05.715.350.200.700
17587361,2007-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17587361,2007-07-01T00:00:00,Risk Factors,N06.850.490.625.750
17587361,2007-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17591505,2007-07-01T00:00:00,Adult,M01.060.116
17591505,2007-07-01T00:00:00,Aged,M01.060.116.100
17591505,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17591505,2007-07-01T00:00:00,Middle Aged,M01.060.116.630
17591505,2007-07-01T00:00:00,Primary Health Care,N04.590.233.727
17591505,2007-07-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17591505,2007-07-01T00:00:00,United States,Z01.107.567.875
17591505,2007-07-01T00:00:00,United States Department of Veterans Affairs,I01.409.137.500.700
17591505,2007-07-01T00:00:00,United States Department of Veterans Affairs,N03.540.348.500.500.700
17591959,2007-07-01T00:00:00,Animals,B01.050
17591959,2007-07-01T00:00:00,Calcium,D01.268.552.100
17591959,2007-07-01T00:00:00,Calcium,D01.552.539.288
17591959,2007-07-01T00:00:00,Calcium,D23.119.100
17591959,2007-07-01T00:00:00,Cell Differentiation,G04.299.151
17591959,2007-07-01T00:00:00,Collagen Type I,D05.750.078.280.300.100
17591959,2007-07-01T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
17591959,2007-07-01T00:00:00,Elastin,D05.750.078.421
17591959,2007-07-01T00:00:00,Elastin,D12.776.860.300.350
17591959,2007-07-01T00:00:00,Fibroblasts,A11.329.228
17591959,2007-07-01T00:00:00,Fibroblasts,A11.872.228
17591959,2007-07-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.205.352
17591959,2007-07-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.252.420
17591959,2007-07-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.525.700.150
17591959,2007-07-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.205.352
17591959,2007-07-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.252.420
17591959,2007-07-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.525.700.150
17591959,2007-07-01T00:00:00,"Muscle, Smooth",A02.633.570
17591959,2007-07-01T00:00:00,"Muscle, Smooth",A10.690.467
17591959,2007-07-01T00:00:00,Osteogenesis,G07.700.320.500.325.377.625.100.729
17591959,2007-07-01T00:00:00,Osteogenesis,G11.427.590.560.100.729
17591959,2007-07-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17591959,2007-07-01T00:00:00,Skin,A17.815
17591959,2007-07-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.374.687.100
17591959,2007-07-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.954.800.720.100
17591959,2007-07-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.963.720.100
17591959,2007-07-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.374.687.100
17591959,2007-07-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.942.800.720.100
17591959,2007-07-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.960.720.100
17591959,2007-07-01T00:00:00,Transforming Growth Factor beta1,D23.529.374.687.100
17591959,2007-07-01T00:00:00,Transforming Growth Factor beta1,D23.529.942.800.720.100
17591959,2007-07-01T00:00:00,Transforming Growth Factor beta1,D23.529.960.720.100
17592284,2007-07-01T00:00:00,Adenocarcinoma,C04.557.470.200.025
17592284,2007-07-01T00:00:00,Disease Progression,C23.550.291.656
17592284,2007-07-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
17592284,2007-07-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
17592284,2007-07-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
17592284,2007-07-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
17592284,2007-07-01T00:00:00,Esophageal Neoplasms,C04.588.274.476.205
17592284,2007-07-01T00:00:00,Esophageal Neoplasms,C04.588.443.353
17592284,2007-07-01T00:00:00,Esophageal Neoplasms,C06.301.371.205
17592284,2007-07-01T00:00:00,Esophageal Neoplasms,C06.405.117.430
17592284,2007-07-01T00:00:00,Esophageal Neoplasms,C06.405.249.205
17592284,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17592284,2007-07-01T00:00:00,Incidence,E05.318.308.985.525.375
17592284,2007-07-01T00:00:00,Incidence,L01.280.975.525.375
17592284,2007-07-01T00:00:00,Incidence,N01.224.935.597.500
17592284,2007-07-01T00:00:00,Incidence,N06.850.505.400.975.525.375
17592284,2007-07-01T00:00:00,Incidence,N06.850.520.308.985.525.375
17592284,2007-07-01T00:00:00,Treatment Outcome,E01.789.800
17592284,2007-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17592284,2007-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17592284,2007-07-01T00:00:00,United States,Z01.107.567.875
17599490,2007-07-01T00:00:00,"Child, Preschool",M01.060.406.448
17599490,2007-07-01T00:00:00,Echocardiography,E01.370.350.850.220
17599490,2007-07-01T00:00:00,Echocardiography,E01.370.370.380.220
17599490,2007-07-01T00:00:00,Heart Valve Diseases,C14.280.484
17599490,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17599490,2007-07-01T00:00:00,Hypoplastic Left Heart Syndrome,C14.240.400.625
17599490,2007-07-01T00:00:00,Hypoplastic Left Heart Syndrome,C14.280.400.625
17599490,2007-07-01T00:00:00,Hypoplastic Left Heart Syndrome,C16.131.240.400.625
17599490,2007-07-01T00:00:00,Infant,M01.060.703
17599490,2007-07-01T00:00:00,"Models, Cardiovascular",E05.599.395.161
17599490,2007-07-01T00:00:00,"Models, Statistical",E05.318.740.500
17599490,2007-07-01T00:00:00,"Models, Statistical",E05.599.835
17599490,2007-07-01T00:00:00,"Models, Statistical",N05.715.360.750.530
17599490,2007-07-01T00:00:00,"Models, Statistical",N06.850.520.830.500
17599490,2007-07-01T00:00:00,"Monitoring, Intraoperative",E01.370.520.510
17599490,2007-07-01T00:00:00,"Monitoring, Intraoperative",E04.510
17599490,2007-07-01T00:00:00,Palliative Care,E02.760.666
17599490,2007-07-01T00:00:00,Palliative Care,N02.421.585.666
17599490,2007-07-01T00:00:00,Preoperative Care,E02.760.795
17599490,2007-07-01T00:00:00,Preoperative Care,E04.641
17599490,2007-07-01T00:00:00,Preoperative Care,N02.421.585.795
17599490,2007-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17599490,2007-07-01T00:00:00,Risk Factors,N05.715.350.200.700
17599490,2007-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17599490,2007-07-01T00:00:00,Risk Factors,N06.850.490.625.750
17599490,2007-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17599490,2007-07-01T00:00:00,Treatment Outcome,E01.789.800
17599490,2007-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17599490,2007-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17599561,2007-07-01T00:00:00,Chronic Disease,C23.550.291.500
17599561,2007-07-01T00:00:00,Cystic Fibrosis,C06.689.202
17599561,2007-07-01T00:00:00,Cystic Fibrosis,C08.381.187
17599561,2007-07-01T00:00:00,Cystic Fibrosis,C16.320.190
17599561,2007-07-01T00:00:00,Cystic Fibrosis,C16.614.213
17599561,2007-07-01T00:00:00,Gene Expression,G05.355.310
17599561,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17599561,2007-07-01T00:00:00,Nasal Polyps,C08.460.572
17599561,2007-07-01T00:00:00,Nasal Polyps,C09.603.557
17599561,2007-07-01T00:00:00,Nasal Polyps,C23.300.825.557
17599561,2007-07-01T00:00:00,Paranasal Sinuses,A04.531.621
17599561,2007-07-01T00:00:00,Polymerase Chain Reaction,E05.393.620.500
17599561,2007-07-01T00:00:00,Pulmonary Surfactants,D27.505.954.796.600
17599561,2007-07-01T00:00:00,Rhinitis,C08.460.799
17599561,2007-07-01T00:00:00,Rhinitis,C08.730.674
17599561,2007-07-01T00:00:00,Rhinitis,C09.603.799
17599561,2007-07-01T00:00:00,Sinusitis,C08.460.692.752
17599561,2007-07-01T00:00:00,Sinusitis,C08.730.749
17599561,2007-07-01T00:00:00,Sinusitis,C09.603.692.752
17599773,2007-07-01T00:00:00,African Continental Ancestry Group,M01.686.508.100
17599773,2007-07-01T00:00:00,Connective Tissue Growth Factor,D12.644.276.200.100
17599773,2007-07-01T00:00:00,Connective Tissue Growth Factor,D12.776.467.200.100
17599773,2007-07-01T00:00:00,Connective Tissue Growth Factor,D12.776.860.300.200.100
17599773,2007-07-01T00:00:00,Connective Tissue Growth Factor,D23.529.237.100
17599773,2007-07-01T00:00:00,Cytokines,D12.644.276.374
17599773,2007-07-01T00:00:00,Cytokines,D12.776.467.374
17599773,2007-07-01T00:00:00,Cytokines,D23.529.374
17599773,2007-07-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
17599773,2007-07-01T00:00:00,Fibroblasts,A11.329.228
17599773,2007-07-01T00:00:00,Fibroblasts,A11.872.228
17599773,2007-07-01T00:00:00,Fibrosis,C23.550.355
17599773,2007-07-01T00:00:00,Hepatocyte Growth Factor,D12.644.276.374.420
17599773,2007-07-01T00:00:00,Hepatocyte Growth Factor,D12.776.467.374.420
17599773,2007-07-01T00:00:00,Hepatocyte Growth Factor,D23.529.374.420
17599773,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17599773,2007-07-01T00:00:00,Immediate-Early Proteins,D12.776.460
17599773,2007-07-01T00:00:00,Immediate-Early Proteins,D12.776.964.925.968
17599773,2007-07-01T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
17599773,2007-07-01T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
17599773,2007-07-01T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
17599773,2007-07-01T00:00:00,Lung,A04.411
17599773,2007-07-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
17599773,2007-07-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
17599773,2007-07-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
17599773,2007-07-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
17599773,2007-07-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
17599773,2007-07-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
17599773,2007-07-01T00:00:00,"Scleroderma, Systemic",C17.300.799
17599773,2007-07-01T00:00:00,"Scleroderma, Systemic",C17.800.784
17599773,2007-07-01T00:00:00,United States,Z01.107.567.875
17601858,2007-07-01T00:00:00,Aged,M01.060.116.100
17601858,2007-07-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
17601858,2007-07-01T00:00:00,Body Mass Index,E05.041.124.125
17601858,2007-07-01T00:00:00,Body Mass Index,G07.100.100.125
17601858,2007-07-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
17601858,2007-07-01T00:00:00,Case-Control Studies,E05.318.760.500.500
17601858,2007-07-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
17601858,2007-07-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
17601858,2007-07-01T00:00:00,Chronic Disease,C23.550.291.500
17601858,2007-07-01T00:00:00,Clinical Nursing Research,H02.478.395.234
17601858,2007-07-01T00:00:00,Clinical Nursing Research,N04.590.233.508.613.234
17601858,2007-07-01T00:00:00,Diabetes Complications,C19.246.099
17601858,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17601858,2007-07-01T00:00:00,Hypertension,C14.907.489
17601858,2007-07-01T00:00:00,Inflammation,C23.550.470
17601858,2007-07-01T00:00:00,Microcirculation,G09.330.190.163.645
17601858,2007-07-01T00:00:00,Middle Aged,M01.060.116.630
17601858,2007-07-01T00:00:00,Nursing Assessment,N04.590.233.508.480
17601858,2007-07-01T00:00:00,Obesity,C18.654.726.500
17601858,2007-07-01T00:00:00,Obesity,C23.888.144.699.500
17601858,2007-07-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
17601858,2007-07-01T00:00:00,Obesity,G07.100.100.160.120.699.500
17601858,2007-07-01T00:00:00,Oxygen,D01.268.185.550
17601858,2007-07-01T00:00:00,Oxygen,D01.362.670
17601858,2007-07-01T00:00:00,Skin Temperature,G07.110.753
17601858,2007-07-01T00:00:00,Skin Temperature,G13.750.844
17601858,2007-07-01T00:00:00,Venous Insufficiency,C14.907.952
17602322,2007-07-01T00:00:00,Biomedical Research,H01.770.644.145
17602322,2007-07-01T00:00:00,Family Practice,H02.403.280
17602322,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17602322,2007-07-01T00:00:00,Internship and Residency,I02.358.399.644
17602322,2007-07-01T00:00:00,Program Evaluation,E05.337.820
17602322,2007-07-01T00:00:00,Program Evaluation,N04.761.685
17602322,2007-07-01T00:00:00,Program Evaluation,N05.715.360.650
17602322,2007-07-01T00:00:00,United States,Z01.107.567.875
17603315,2007-07-01T00:00:00,Adult,M01.060.116
17603315,2007-07-01T00:00:00,Aged,M01.060.116.100
17603315,2007-07-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
17603315,2007-07-01T00:00:00,Fluorodeoxyglucose F18,D09.254.229.500
17603315,2007-07-01T00:00:00,Head and Neck Neoplasms,C04.588.443
17603315,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17603315,2007-07-01T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
17603315,2007-07-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17603315,2007-07-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17603315,2007-07-01T00:00:00,Middle Aged,M01.060.116.630
17603315,2007-07-01T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
17603315,2007-07-01T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
17603315,2007-07-01T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
17603315,2007-07-01T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
17603315,2007-07-01T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
17603315,2007-07-01T00:00:00,Radiopharmaceuticals,D27.720.470.410.650
17603315,2007-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17603315,2007-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17603315,2007-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17603315,2007-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17603315,2007-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17605688,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17605688,2007-07-01T00:00:00,Liver Neoplasms,C04.588.274.623
17605688,2007-07-01T00:00:00,Liver Neoplasms,C06.301.623
17605688,2007-07-01T00:00:00,Liver Neoplasms,C06.552.697
17605688,2007-07-01T00:00:00,"Surgical Procedures, Operative",E04
17605751,2007-07-01T00:00:00,BK Virus,B04.280.640.615.100
17605751,2007-07-01T00:00:00,BK Virus,B04.909.204.210.620.615.100
17605751,2007-07-01T00:00:00,BK Virus,B04.909.574.204.670.615.100
17605751,2007-07-01T00:00:00,BK Virus,B04.909.675.615.100
17605751,2007-07-01T00:00:00,Graft Rejection,G12.425.901.545.328
17605751,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17605751,2007-07-01T00:00:00,Immunosuppression,E02.095.465.425.450
17605751,2007-07-01T00:00:00,Immunosuppression,E05.478.610
17605751,2007-07-01T00:00:00,Kidney Diseases,C12.777.419
17605751,2007-07-01T00:00:00,Kidney Diseases,C13.351.968.419
17605751,2007-07-01T00:00:00,Kidney Transplantation,E02.870.500
17605751,2007-07-01T00:00:00,Kidney Transplantation,E04.936.450.485
17605751,2007-07-01T00:00:00,Kidney Transplantation,E04.950.774.400
17605751,2007-07-01T00:00:00,Middle Aged,M01.060.116.630
17606132,2007-07-01T00:00:00,"Anastomosis, Surgical",E04.035
17606132,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17606132,2007-07-01T00:00:00,Middle Aged,M01.060.116.630
17606132,2007-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17606132,2007-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17606132,2007-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17606132,2007-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17606132,2007-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17606132,2007-07-01T00:00:00,Treatment Outcome,E01.789.800
17606132,2007-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17606132,2007-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17606132,2007-07-01T00:00:00,Vascular Neoplasms,C04.588.839.750
17606132,2007-07-01T00:00:00,Vascular Neoplasms,C14.907.936
17606132,2007-07-01T00:00:00,Vascular Patency,G09.330.920
17606132,2007-07-01T00:00:00,Vascular Surgical Procedures,E04.100.814
17606132,2007-07-01T00:00:00,"Vena Cava, Inferior",A07.231.908.949.648
17606664,2007-07-01T00:00:00,Acetylcysteine,D02.886.030.230.259
17606664,2007-07-01T00:00:00,Acetylcysteine,D12.125.166.230.259
17606664,2007-07-01T00:00:00,Adult,M01.060.116
17606664,2007-07-01T00:00:00,"Behavior, Addictive",F01.145.527.100.120
17606664,2007-07-01T00:00:00,Cocaine-Related Disorders,C21.739.300
17606664,2007-07-01T00:00:00,Cocaine-Related Disorders,F03.900.300
17606664,2007-07-01T00:00:00,Cues,F02.463.425.234
17606664,2007-07-01T00:00:00,Double-Blind Method,E05.318.780.300
17606664,2007-07-01T00:00:00,Double-Blind Method,E05.581.500.300
17606664,2007-07-01T00:00:00,Double-Blind Method,N05.715.360.780.320
17606664,2007-07-01T00:00:00,Double-Blind Method,N06.850.520.445.300
17606664,2007-07-01T00:00:00,Hospitalization,E02.760.400
17606664,2007-07-01T00:00:00,Hospitalization,N02.421.585.400
17606664,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17606664,2007-07-01T00:00:00,Middle Aged,M01.060.116.630
17606664,2007-07-01T00:00:00,Visual Perception,F02.463.593.932
17606819,2007-07-01T00:00:00,Age Factors,N05.715.350.075
17606819,2007-07-01T00:00:00,Age Factors,N06.850.490.250
17606819,2007-07-01T00:00:00,Autistic Disorder,F03.550.325.125
17606819,2007-07-01T00:00:00,Child Development,F01.525.200
17606819,2007-07-01T00:00:00,Child Development,G07.700.320.374.750
17606819,2007-07-01T00:00:00,"Child, Preschool",M01.060.406.448
17606819,2007-07-01T00:00:00,Developmental Disabilities,F03.550.362
17606819,2007-07-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17606819,2007-07-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
17606819,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17606819,2007-07-01T00:00:00,Infant,M01.060.703
17606819,2007-07-01T00:00:00,Nonverbal Communication,F01.145.209.530
17606819,2007-07-01T00:00:00,Nonverbal Communication,L01.143.649
17606819,2007-07-01T00:00:00,Personality Inventory,F04.711.647.513
17606819,2007-07-01T00:00:00,Phenotype,G05.695
17606819,2007-07-01T00:00:00,Psychiatric Status Rating Scales,F04.586
17606819,2007-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17606819,2007-07-01T00:00:00,Risk Factors,N05.715.350.200.700
17606819,2007-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17606819,2007-07-01T00:00:00,Risk Factors,N06.850.490.625.750
17606819,2007-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17606819,2007-07-01T00:00:00,Socialization,I01.880.813
17611401,2007-07-01T00:00:00,Adult,M01.060.116
17611401,2007-07-01T00:00:00,Age Factors,N05.715.350.075
17611401,2007-07-01T00:00:00,Age Factors,N06.850.490.250
17611401,2007-07-01T00:00:00,Aged,M01.060.116.100
17611401,2007-07-01T00:00:00,Breast Neoplasms,C04.588.180
17611401,2007-07-01T00:00:00,Breast Neoplasms,C17.800.090.500
17611401,2007-07-01T00:00:00,DNA Methylation,G02.111.087.029.538.161
17611401,2007-07-01T00:00:00,DNA Methylation,G02.111.087.218
17611401,2007-07-01T00:00:00,DNA Methylation,G02.149.115.029.538.161
17611401,2007-07-01T00:00:00,DNA Methylation,G02.149.115.218
17611401,2007-07-01T00:00:00,DNA Methylation,G03.495.130.538.161
17611401,2007-07-01T00:00:00,DNA Methylation,G05.355.190
17611401,2007-07-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
17611401,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17611401,2007-07-01T00:00:00,Middle Aged,M01.060.116.630
17611401,2007-07-01T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
17611401,2007-07-01T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
17611401,2007-07-01T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
17611401,2007-07-01T00:00:00,"Receptors, Estrogen",D12.776.260.698.750.350
17611401,2007-07-01T00:00:00,"Receptors, Estrogen",D12.776.826.750.350
17611401,2007-07-01T00:00:00,"Receptors, Estrogen",D12.776.930.669.750.350
17611401,2007-07-01T00:00:00,"Receptors, Progesterone",D12.776.260.698.750.765
17611401,2007-07-01T00:00:00,"Receptors, Progesterone",D12.776.826.750.765
17611401,2007-07-01T00:00:00,"Receptors, Progesterone",D12.776.930.669.750.765
17611401,2007-07-01T00:00:00,Tumor Suppressor Proteins,D12.776.624.776
17613906,2007-07-01T00:00:00,Emergency Medical Services,N02.421.297
17613906,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17613906,2007-07-01T00:00:00,Societies,N03.540.828
17613906,2007-07-01T00:00:00,Stroke,C10.228.140.300.775
17613906,2007-07-01T00:00:00,Stroke,C14.907.253.855
17613906,2007-07-01T00:00:00,Triage,N02.421.297.900
17613906,2007-07-01T00:00:00,United States,Z01.107.567.875
17614504,2007-07-01T00:00:00,Acoustic Stimulation,E02.037
17614504,2007-07-01T00:00:00,Acoustic Stimulation,E02.190.888.030
17614504,2007-07-01T00:00:00,Acoustic Stimulation,E05.723.136
17614504,2007-07-01T00:00:00,Adult,M01.060.116
17614504,2007-07-01T00:00:00,Age Factors,N05.715.350.075
17614504,2007-07-01T00:00:00,Age Factors,N06.850.490.250
17614504,2007-07-01T00:00:00,Aged,M01.060.116.100
17614504,2007-07-01T00:00:00,Aging,G07.700.320.124
17614504,2007-07-01T00:00:00,Auditory Perception,F02.463.593.071
17614504,2007-07-01T00:00:00,Auditory Threshold,F02.463.593.071.173
17614504,2007-07-01T00:00:00,Auditory Threshold,F02.463.593.710.190
17614504,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17614504,2007-07-01T00:00:00,Psychometrics,F04.711.780
17614504,2007-07-01T00:00:00,Time Factors,G01.910.857
17618337,2007-07-01T00:00:00,Aged,M01.060.116.100
17618337,2007-07-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
17618337,2007-07-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
17618337,2007-07-01T00:00:00,Cysts,C04.182
17618337,2007-07-01T00:00:00,Cysts,C23.300.306
17618337,2007-07-01T00:00:00,"Diagnosis, Differential",E01.171
17618337,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17618337,2007-07-01T00:00:00,Tongue Diseases,C07.465.910
17620431,2007-07-01T00:00:00,Animals,B01.050
17620431,2007-07-01T00:00:00,Antineoplastic Agents,D27.505.954.248
17620431,2007-07-01T00:00:00,Cornea,A09.371.060.217
17620431,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17620431,2007-07-01T00:00:00,Indazoles,D03.383.129.539.487
17620431,2007-07-01T00:00:00,Indazoles,D03.438.449
17620431,2007-07-01T00:00:00,"Neovascularization, Pathologic",C23.550.589.500
17620431,2007-07-01T00:00:00,Phosphorylation,G02.111.087.677
17620431,2007-07-01T00:00:00,Phosphorylation,G02.149.115.677
17620431,2007-07-01T00:00:00,Phosphorylation,G02.149.465.700
17620431,2007-07-01T00:00:00,Phosphorylation,G02.607.750.700
17620431,2007-07-01T00:00:00,Phosphorylation,G03.495.790
17620431,2007-07-01T00:00:00,Phosphotyrosine,D12.125.072.050.875.750
17620431,2007-07-01T00:00:00,Phosphotyrosine,D12.125.740.740
17620431,2007-07-01T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
17620431,2007-07-01T00:00:00,Pyrimidines,D03.383.742
17620431,2007-07-01T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
17620431,2007-07-01T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
17620431,2007-07-01T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
17622864,2007-07-01T00:00:00,"Accidents, Traffic",N06.850.135.392
17622864,2007-07-01T00:00:00,Adult,M01.060.116
17622864,2007-07-01T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
17622864,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17622864,2007-07-01T00:00:00,Multiple Trauma,C21.866.640
17622864,2007-07-01T00:00:00,Thoracic Injuries,C21.866.891
17622864,2007-07-01T00:00:00,Triage,N02.421.297.900
17622864,2007-07-01T00:00:00,"Wounds, Nonpenetrating",C21.866.974
17639654,2007-07-01T00:00:00,Adult,M01.060.116
17639654,2007-07-01T00:00:00,African Americans,M01.686.508.100.100
17639654,2007-07-01T00:00:00,African Americans,M01.686.754.100
17639654,2007-07-01T00:00:00,Age Factors,N05.715.350.075
17639654,2007-07-01T00:00:00,Age Factors,N06.850.490.250
17639654,2007-07-01T00:00:00,Aged,M01.060.116.100
17639654,2007-07-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
17639654,2007-07-01T00:00:00,Body Mass Index,E05.041.124.125
17639654,2007-07-01T00:00:00,Body Mass Index,G07.100.100.125
17639654,2007-07-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
17639654,2007-07-01T00:00:00,Cardiovascular Diseases,C14
17639654,2007-07-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
17639654,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17639654,2007-07-01T00:00:00,Middle Aged,M01.060.116.630
17639654,2007-07-01T00:00:00,Overweight,C23.888.144.699
17639654,2007-07-01T00:00:00,Overweight,E01.370.600.115.100.160.120.699
17639654,2007-07-01T00:00:00,Overweight,G07.100.100.160.120.699
17666173,2007-07-01T00:00:00,Bone Nails,E07.695.120
17666173,2007-07-01T00:00:00,Bone Nails,E07.858.442.660.100
17666173,2007-07-01T00:00:00,Bone Nails,E07.858.690.650.100
17666173,2007-07-01T00:00:00,Bone Screws,E07.695.130
17666173,2007-07-01T00:00:00,Bone Screws,E07.858.442.660.115
17666173,2007-07-01T00:00:00,Bone Screws,E07.858.690.650.115
17666173,2007-07-01T00:00:00,Cadaver,C23.550.260.224
17666173,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17666931,2007-07-01T00:00:00,Anemia,C15.378.071
17666931,2007-07-01T00:00:00,Child,M01.060.406
17666931,2007-07-01T00:00:00,Child Abuse,I01.198.240.856.350.250
17666931,2007-07-01T00:00:00,Child Abuse,I01.880.735.900.350.250
17666931,2007-07-01T00:00:00,Child Abuse,I01.880.787.293.292
17666931,2007-07-01T00:00:00,Debridement,E04.176
17666931,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17666931,2007-07-01T00:00:00,Rhabdomyolysis,C05.651.807
17666931,2007-07-01T00:00:00,Wounds and Injuries,C21.866
17667103,2007-07-01T00:00:00,Adolescent,M01.060.057
17667103,2007-07-01T00:00:00,Adult,M01.060.116
17667103,2007-07-01T00:00:00,Aged,M01.060.116.100
17667103,2007-07-01T00:00:00,Anti-Infective Agents,D27.505.954.122
17667103,2007-07-01T00:00:00,Bacteria,B03
17667103,2007-07-01T00:00:00,Cephalosporins,D02.065.589.099.249
17667103,2007-07-01T00:00:00,Cephalosporins,D02.886.665.074
17667103,2007-07-01T00:00:00,Cephalosporins,D04.075.080.875.099.221.249
17667103,2007-07-01T00:00:00,Child,M01.060.406
17667103,2007-07-01T00:00:00,"Child, Preschool",M01.060.406.448
17667103,2007-07-01T00:00:00,Chronic Disease,C23.550.291.500
17667103,2007-07-01T00:00:00,Dacryocystitis,C11.496.221
17667103,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17667103,2007-07-01T00:00:00,Infant,M01.060.703
17667103,2007-07-01T00:00:00,Middle Aged,M01.060.116.630
17672162,2007-07-01T00:00:00,Aged,M01.060.116.100
17672162,2007-07-01T00:00:00,Drug Interactions,G07.690.812.240
17672162,2007-07-01T00:00:00,Drug Interactions,G07.700.680.240
17672162,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17672162,2007-07-01T00:00:00,Physician's Practice Patterns,N04.590.748
17672162,2007-07-01T00:00:00,Physician's Practice Patterns,N05.300.625
17672162,2007-07-01T00:00:00,Polypharmacy,E02.319.698
17674946,2007-07-01T00:00:00,"Accidents, Traffic",N06.850.135.392
17674946,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17674946,2007-07-01T00:00:00,Incidence,E05.318.308.985.525.375
17674946,2007-07-01T00:00:00,Incidence,L01.280.975.525.375
17674946,2007-07-01T00:00:00,Incidence,N01.224.935.597.500
17674946,2007-07-01T00:00:00,Incidence,N06.850.505.400.975.525.375
17674946,2007-07-01T00:00:00,Incidence,N06.850.520.308.985.525.375
17674946,2007-07-01T00:00:00,Multiple Trauma,C21.866.640
17691681,2007-07-01T00:00:00,Adult,M01.060.116
17691681,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17691681,2007-07-01T00:00:00,Mental Disorders,F03
17691681,2007-07-01T00:00:00,Military Personnel,M01.526.625
17691681,2007-07-01T00:00:00,Neuropsychological Tests,F04.711.513
17691681,2007-07-01T00:00:00,Psychometrics,F04.711.780
17691681,2007-07-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17691681,2007-07-01T00:00:00,United States,Z01.107.567.875
17691681,2007-07-01T00:00:00,Veterans,M01.930
17696672,2007-07-01T00:00:00,Adolescent,M01.060.057
17696672,2007-07-01T00:00:00,Child,M01.060.406
17696672,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17696672,2007-07-01T00:00:00,Questionnaires,E05.318.308.750
17696672,2007-07-01T00:00:00,Questionnaires,L01.280.800
17696672,2007-07-01T00:00:00,Questionnaires,N05.715.360.300.695
17696672,2007-07-01T00:00:00,Questionnaires,N06.850.520.308.750
17696672,2007-07-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17696672,2007-07-01T00:00:00,Urban Population,N01.600.900
17696672,2007-07-01T00:00:00,Violence,I01.198.240.856
17696672,2007-07-01T00:00:00,Violence,I01.880.735.900
17697720,2007-07-01T00:00:00,Animals,B01.050
17697720,2007-07-01T00:00:00,Industrial Waste,D20.944.420
17697720,2007-07-01T00:00:00,Industrial Waste,D27.888.284.404
17697720,2007-07-01T00:00:00,Industrial Waste,N06.850.460.710.420
17697720,2007-07-01T00:00:00,Liver,A03.620
17697720,2007-07-01T00:00:00,Reproduction,G08.686.785.760
17697720,2007-07-01T00:00:00,Rivers,G01.311.750
17697720,2007-07-01T00:00:00,Rivers,G16.500.275.280.500
17697720,2007-07-01T00:00:00,Rivers,N06.230.232.500
17697720,2007-07-01T00:00:00,Testis,A05.360.444.849
17697720,2007-07-01T00:00:00,Testis,A05.360.576.782
17697720,2007-07-01T00:00:00,Testis,A06.407.312.782
17697720,2007-07-01T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
17703518,2007-07-01T00:00:00,Adolescent,M01.060.057
17703518,2007-07-01T00:00:00,Adult,M01.060.116
17703518,2007-07-01T00:00:00,HIV Infections,C02.782.815.616.400
17703518,2007-07-01T00:00:00,HIV Infections,C02.800.801.400
17703518,2007-07-01T00:00:00,HIV Infections,C20.673.480
17703518,2007-07-01T00:00:00,HIV-1,B04.820.650.589.650.350.400
17703518,2007-07-01T00:00:00,HIV-1,B04.909.777.731.589.650.350.400
17703518,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17703518,2007-07-01T00:00:00,Polymerase Chain Reaction,E05.393.620.500
17703518,2007-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17703518,2007-07-01T00:00:00,Risk Factors,N05.715.350.200.700
17703518,2007-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17703518,2007-07-01T00:00:00,Risk Factors,N06.850.490.625.750
17703518,2007-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17717851,2007-07-01T00:00:00,"Diagnosis, Differential",E01.171
17717851,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17717851,2007-07-01T00:00:00,"Lung Diseases, Interstitial",C08.381.483
17717851,2007-07-01T00:00:00,"Scleroderma, Systemic",C17.300.799
17717851,2007-07-01T00:00:00,"Scleroderma, Systemic",C17.800.784
17724408,2007-07-01T00:00:00,"Adaptation, Psychological",F01.058
17724408,2007-07-01T00:00:00,Attitude of Health Personnel,F01.100.050
17724408,2007-07-01T00:00:00,Attitude of Health Personnel,N05.300.100
17724408,2007-07-01T00:00:00,Disease Progression,C23.550.291.656
17724408,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17724408,2007-07-01T00:00:00,Nurse Administrators,M01.526.070.670
17724408,2007-07-01T00:00:00,Nurse Administrators,M01.526.485.650.580
17724408,2007-07-01T00:00:00,Nurse Administrators,N02.360.650.580
17724408,2007-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17724408,2007-07-01T00:00:00,Risk Factors,N05.715.350.200.700
17724408,2007-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17724408,2007-07-01T00:00:00,Risk Factors,N06.850.490.625.750
17724408,2007-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17724408,2007-07-01T00:00:00,Self Care,E02.900
17724408,2007-07-01T00:00:00,Self Care,N02.421.784.680
17724408,2007-07-01T00:00:00,Workplace,N01.824.245.925
17724408,2007-07-01T00:00:00,Workplace,N04.452.677.975
17762407,2007-07-01T00:00:00,Aged,M01.060.116.100
17762407,2007-07-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
17762407,2007-07-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
17762407,2007-07-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
17762407,2007-07-01T00:00:00,Deoxycytidine,D03.383.742.680.245.500
17762407,2007-07-01T00:00:00,Deoxycytidine,D13.570.230.329
17762407,2007-07-01T00:00:00,Deoxycytidine,D13.570.685.245.500
17762407,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17762407,2007-07-01T00:00:00,Neoplasm Invasiveness,C04.697.645
17762407,2007-07-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
17762407,2007-07-01T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
17762407,2007-07-01T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
17762407,2007-07-01T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
17762407,2007-07-01T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
17762407,2007-07-01T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
17849680,2007-07-01T00:00:00,Evaluation Studies as Topic,E05.337
17849680,2007-07-01T00:00:00,Evaluation Studies as Topic,N05.715.360.335
17849680,2007-07-01T00:00:00,"Hospitals, Psychiatric",N02.278.421.556.508
17849680,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17849680,2007-07-01T00:00:00,"Models, Theoretical",E05.599
17849680,2007-07-01T00:00:00,Patient Isolation,E02.770
17849680,2007-07-01T00:00:00,Patient Isolation,N06.850.780.200.450.650
17849680,2007-07-01T00:00:00,"Restraint, Physical",E02.085.700
17849680,2007-07-01T00:00:00,"Restraint, Physical",E05.472.760
17849680,2007-07-01T00:00:00,United States,Z01.107.567.875
17931522,2007-07-01T00:00:00,Adult,M01.060.116
17931522,2007-07-01T00:00:00,"Cerclage, Cervical",E04.520.100
17931522,2007-07-01T00:00:00,Device Removal,E04.199
17931522,2007-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17931522,2007-07-01T00:00:00,Laparoscopy,E01.370.388.250.520
17931522,2007-07-01T00:00:00,Laparoscopy,E04.800.250.520
17931522,2007-07-01T00:00:00,Pregnancy,G08.686.785.760.769
17931522,2007-07-01T00:00:00,Prostheses and Implants,E07.695
18428664,2007-07-01T00:00:00,Animals,B01.050
18428664,2007-07-01T00:00:00,"Behavior, Animal",F01.145.113
18428664,2007-07-01T00:00:00,Motor Activity,F01.145.632
18428664,2007-07-01T00:00:00,Motor Activity,G11.427.590.530.698
17603559,2007-07-02T00:00:00,Antineoplastic Agents,D27.505.954.248
17603559,2007-07-02T00:00:00,Apoptosis Regulatory Proteins,D12.644.360.075
17603559,2007-07-02T00:00:00,Apoptosis Regulatory Proteins,D12.776.476.075
17603559,2007-07-02T00:00:00,Cell Proliferation,G04.299.233.750
17603559,2007-07-02T00:00:00,Cell Proliferation,G07.700.320.249.410.750
17603559,2007-07-02T00:00:00,Cisplatin,D01.210.375
17603559,2007-07-02T00:00:00,Cisplatin,D01.625.125
17603559,2007-07-02T00:00:00,Cisplatin,D01.710.100
17603559,2007-07-02T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
17603559,2007-07-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17603559,2007-07-02T00:00:00,Neoplasm Invasiveness,C04.697.645
17603559,2007-07-02T00:00:00,Neoplasm Invasiveness,C23.550.727.645
17603559,2007-07-02T00:00:00,Thromboxane-A Synthase,D08.811.399.475.900
17603559,2007-07-02T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
17603559,2007-07-02T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
17603559,2007-07-02T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
17603559,2007-07-02T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
17603559,2007-07-02T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
17604198,2007-07-02T00:00:00,Child,M01.060.406
17604198,2007-07-02T00:00:00,Endophthalmitis,C01.252.354.900.350
17604198,2007-07-02T00:00:00,Endophthalmitis,C01.539.375.354.900.350
17604198,2007-07-02T00:00:00,Endophthalmitis,C01.539.375.450.900.350
17604198,2007-07-02T00:00:00,Endophthalmitis,C01.703.343.900.350
17604198,2007-07-02T00:00:00,Endophthalmitis,C11.294.354.900.350
17604198,2007-07-02T00:00:00,Endophthalmitis,C11.294.450.900.350
17604198,2007-07-02T00:00:00,Endophthalmitis,C11.941.879.960.380
17604198,2007-07-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17604198,2007-07-02T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
17604198,2007-07-02T00:00:00,"Lenses, Intraocular",E07.632.500.460
17604198,2007-07-02T00:00:00,"Lenses, Intraocular",E07.695.460
17604198,2007-07-02T00:00:00,Postoperative Complications,C23.550.767
17604198,2007-07-02T00:00:00,Risk Factors,E05.318.740.600.800.725
17604198,2007-07-02T00:00:00,Risk Factors,N05.715.350.200.700
17604198,2007-07-02T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17604198,2007-07-02T00:00:00,Risk Factors,N06.850.490.625.750
17604198,2007-07-02T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17606295,2007-07-02T00:00:00,Animals,B01.050
17606295,2007-07-02T00:00:00,B-Lymphocytes,A11.063.438
17606295,2007-07-02T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
17606295,2007-07-02T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
17606295,2007-07-02T00:00:00,B-Lymphocytes,A15.382.032.438
17606295,2007-07-02T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
17606295,2007-07-02T00:00:00,Binding Sites,G02.111.570.120
17606295,2007-07-02T00:00:00,Cell Line,A11.251.210
17606295,2007-07-02T00:00:00,DNA-Binding Proteins,D12.776.260
17606295,2007-07-02T00:00:00,"Disease Models, Animal",C22.232
17606295,2007-07-02T00:00:00,"Disease Models, Animal",E05.598.500
17606295,2007-07-02T00:00:00,"Disease Models, Animal",E05.599.395.080
17606295,2007-07-02T00:00:00,Down-Regulation,G02.111.087.225
17606295,2007-07-02T00:00:00,Down-Regulation,G02.149.115.225
17606295,2007-07-02T00:00:00,Down-Regulation,G05.355.315.200
17606295,2007-07-02T00:00:00,Down-Regulation,G07.690.812.230
17606295,2007-07-02T00:00:00,Down-Regulation,G07.700.680.230
17606295,2007-07-02T00:00:00,Lymphocytes,A11.118.637.555.567
17606295,2007-07-02T00:00:00,Lymphocytes,A15.145.229.637.555.567
17606295,2007-07-02T00:00:00,Lymphocytes,A15.382.490.555.567
17606295,2007-07-02T00:00:00,Molecular Sequence Data,L01.453.245.667
17606295,2007-07-02T00:00:00,Nuclear Proteins,D12.776.660
17606295,2007-07-02T00:00:00,"Polymorphism, Genetic",G05.365.795
17606295,2007-07-02T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
17606295,2007-07-02T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
17606295,2007-07-02T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
17606295,2007-07-02T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.260.665.400
17606295,2007-07-02T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.624.664.700.175.400
17606295,2007-07-02T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.930.635.400
17606295,2007-07-02T00:00:00,Proto-Oncogene Proteins c-ets,D12.776.260.665
17606295,2007-07-02T00:00:00,Proto-Oncogene Proteins c-ets,D12.776.624.664.700.175
17606295,2007-07-02T00:00:00,Proto-Oncogene Proteins c-ets,D12.776.930.635
17606295,2007-07-02T00:00:00,Repressor Proteins,D12.776.260.703
17606295,2007-07-02T00:00:00,Repressor Proteins,D12.776.930.700
17606295,2007-07-02T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
17606295,2007-07-02T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
17606295,2007-07-02T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
17606295,2007-07-02T00:00:00,Transcription Factors,D12.776.930
17606682,2007-07-02T00:00:00,Animals,B01.050
17606682,2007-07-02T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
17606682,2007-07-02T00:00:00,Dog Diseases,C22.268
17606682,2007-07-02T00:00:00,Dogs,B01.050.150.900.649.147.153.200
17606682,2007-07-02T00:00:00,Ehrlichia canis,B03.440.040.287.090
17606682,2007-07-02T00:00:00,Ehrlichia canis,B03.660.050.020.287.090
17606682,2007-07-02T00:00:00,Ehrlichiosis,C01.252.400.054.160
17606682,2007-07-02T00:00:00,Ehrlichiosis,C01.252.400.825.200
17606807,2007-07-02T00:00:00,Aged,M01.060.116.100
17606807,2007-07-02T00:00:00,Apoptosis,G04.299.139.160
17606807,2007-07-02T00:00:00,Biological Markers,D23.101
17606807,2007-07-02T00:00:00,Brain Ischemia,C10.228.140.300.150
17606807,2007-07-02T00:00:00,Brain Ischemia,C14.907.253.092
17606807,2007-07-02T00:00:00,Case-Control Studies,E05.318.760.500.500
17606807,2007-07-02T00:00:00,Case-Control Studies,N05.715.360.775.175.200
17606807,2007-07-02T00:00:00,Case-Control Studies,N06.850.520.450.500.500
17606807,2007-07-02T00:00:00,"Diagnosis, Differential",E01.171
17606807,2007-07-02T00:00:00,Endothelial Cells,A11.436.275
17606807,2007-07-02T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
17606807,2007-07-02T00:00:00,Flow Cytometry,E05.200.500.386.350
17606807,2007-07-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17606807,2007-07-02T00:00:00,Middle Aged,M01.060.116.630
17606807,2007-07-02T00:00:00,Probability,E05.318.740.600
17606807,2007-07-02T00:00:00,Probability,G17.680
17606807,2007-07-02T00:00:00,Probability,N05.715.360.750.625
17606807,2007-07-02T00:00:00,Probability,N06.850.520.830.600
17606807,2007-07-02T00:00:00,Stroke,C10.228.140.300.775
17606807,2007-07-02T00:00:00,Stroke,C14.907.253.855
17826379,2007-07-02T00:00:00,Aged,M01.060.116.100
17826379,2007-07-02T00:00:00,Coronary Restenosis,C14.280.647.250.285.200
17826379,2007-07-02T00:00:00,Coronary Restenosis,C14.907.585.250.285.200
17826379,2007-07-02T00:00:00,Coronary Vessels,A07.231.114.269
17826379,2007-07-02T00:00:00,Coronary Vessels,A07.231.908.194
17826379,2007-07-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17826379,2007-07-02T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
17826379,2007-07-02T00:00:00,Middle Aged,M01.060.116.630
17826379,2007-07-02T00:00:00,Stents,E07.695.750
17826379,2007-07-02T00:00:00,"Ultrasonography, Interventional",E01.370.350.850.855
17607304,2007-07-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17607304,2007-07-03T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
17607304,2007-07-03T00:00:00,Prostatic Neoplasms,C12.294.260.750
17607304,2007-07-03T00:00:00,Prostatic Neoplasms,C12.294.565.625
17607304,2007-07-03T00:00:00,Prostatic Neoplasms,C12.758.409.750
17609208,2007-07-03T00:00:00,Animals,B01.050
17609208,2007-07-03T00:00:00,Brain Ischemia,C10.228.140.300.150
17609208,2007-07-03T00:00:00,Brain Ischemia,C14.907.253.092
17609208,2007-07-03T00:00:00,Ceramides,D02.065.313
17609208,2007-07-03T00:00:00,Ceramides,D09.400.410.420.525.200
17609208,2007-07-03T00:00:00,Ceramides,D10.390.470.675.200
17609208,2007-07-03T00:00:00,Ceramides,D10.570.877.360.612.200
17609208,2007-07-03T00:00:00,Mitochondria,A11.284.430.214.190.875.564
17609208,2007-07-03T00:00:00,Mitochondria,A11.284.835.626
17609208,2007-07-03T00:00:00,Oxidoreductases,D08.811.682
17609208,2007-07-03T00:00:00,Reperfusion Injury,C14.907.725
17609208,2007-07-03T00:00:00,Reperfusion Injury,C23.550.767.877
17609251,2007-07-03T00:00:00,Alternative Splicing,G02.111.087.750.700.100
17609251,2007-07-03T00:00:00,Alternative Splicing,G02.149.115.750.700.100
17609251,2007-07-03T00:00:00,Alternative Splicing,G03.495.839.700.100
17609251,2007-07-03T00:00:00,Alternative Splicing,G05.355.315.700.700.100
17609251,2007-07-03T00:00:00,Amino Acid Sequence,G02.111.570.060
17609251,2007-07-03T00:00:00,Amino Acid Sequence,L01.453.245.667.060
17609251,2007-07-03T00:00:00,Cell Line,A11.251.210
17609251,2007-07-03T00:00:00,Endothelial Cells,A11.436.275
17609251,2007-07-03T00:00:00,GTP-Binding Proteins,D08.811.277.040.330.300
17609251,2007-07-03T00:00:00,GTP-Binding Proteins,D12.776.157.325
17609251,2007-07-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17609251,2007-07-03T00:00:00,Molecular Sequence Data,L01.453.245.667
17609251,2007-07-03T00:00:00,"Muscle, Smooth, Vascular",A02.633.570.491
17609251,2007-07-03T00:00:00,"Muscle, Smooth, Vascular",A07.231.491
17609251,2007-07-03T00:00:00,"Muscle, Smooth, Vascular",A10.690.467.491
17609251,2007-07-03T00:00:00,Transglutaminases,D08.811.913.050.200.800
17609251,2007-07-03T00:00:00,Umbilical Veins,A07.231.908.670.874
17609251,2007-07-03T00:00:00,Umbilical Veins,A16.378.693.807
17711594,2007-07-03T00:00:00,Bronchoscopy,E01.370.386.105
17711594,2007-07-03T00:00:00,Bronchoscopy,E01.370.388.250.100
17711594,2007-07-03T00:00:00,Bronchoscopy,E04.800.250.100
17711594,2007-07-03T00:00:00,Bronchoscopy,E04.928.600.080
17711594,2007-07-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17711594,2007-07-03T00:00:00,Palliative Care,E02.760.666
17711594,2007-07-03T00:00:00,Palliative Care,N02.421.585.666
17711594,2007-07-03T00:00:00,Pneumonectomy,E04.928.600.600
17711594,2007-07-03T00:00:00,Prostheses and Implants,E07.695
17711594,2007-07-03T00:00:00,Prosthesis Design,E05.320.550
17711594,2007-07-03T00:00:00,Prosthesis Design,E07.695.680
17893044,2007-07-03T00:00:00,Apoptosis,G04.299.139.160
17893044,2007-07-03T00:00:00,Cell Cycle,G04.299.134
17893044,2007-07-03T00:00:00,Doxorubicin,D02.455.426.559.847.562.050.200.175
17893044,2007-07-03T00:00:00,Doxorubicin,D04.615.562.050.200.175
17893044,2007-07-03T00:00:00,Doxorubicin,D09.408.051.059.200.175
17893044,2007-07-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17893044,2007-07-03T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
17893044,2007-07-03T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
17893044,2007-07-03T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
17893044,2007-07-03T00:00:00,Phenotype,G05.695
17893044,2007-07-03T00:00:00,Phosphorylation,G02.111.087.677
17893044,2007-07-03T00:00:00,Phosphorylation,G02.149.115.677
17893044,2007-07-03T00:00:00,Phosphorylation,G02.149.465.700
17893044,2007-07-03T00:00:00,Phosphorylation,G02.607.750.700
17893044,2007-07-03T00:00:00,Phosphorylation,G03.495.790
17893044,2007-07-03T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
17893044,2007-07-03T00:00:00,Prostatic Neoplasms,C12.294.260.750
17893044,2007-07-03T00:00:00,Prostatic Neoplasms,C12.294.565.625
17893044,2007-07-03T00:00:00,Prostatic Neoplasms,C12.758.409.750
17893044,2007-07-03T00:00:00,Protein Biosynthesis,G02.111.087.675.871
17893044,2007-07-03T00:00:00,Protein Biosynthesis,G02.149.115.675.871
17893044,2007-07-03T00:00:00,Protein Biosynthesis,G03.495.770.871
17893044,2007-07-03T00:00:00,Protein Biosynthesis,G05.355.310.670
17893044,2007-07-03T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.374.750.625
17893044,2007-07-03T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.972.625
17893044,2007-07-03T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.374.750.625
17893044,2007-07-03T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.972.625
17893044,2007-07-03T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.374.750.625
17893044,2007-07-03T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.972.625
17612563,2007-07-05T00:00:00,Breast Neoplasms,C04.588.180
17612563,2007-07-05T00:00:00,Breast Neoplasms,C17.800.090.500
17612563,2007-07-05T00:00:00,Cell Survival,G04.299.316
17612563,2007-07-05T00:00:00,Epithelial Cells,A11.436
17612563,2007-07-05T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
17612563,2007-07-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17612563,2007-07-05T00:00:00,Neoplasm Invasiveness,C04.697.645
17612563,2007-07-05T00:00:00,Neoplasm Invasiveness,C23.550.727.645
17612563,2007-07-05T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
17612563,2007-07-05T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
17612563,2007-07-05T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
17612563,2007-07-05T00:00:00,"Receptor, erbB-2",D08.811.913.696.620.682.725.400.150
17612563,2007-07-05T00:00:00,"Receptor, erbB-2",D12.776.543.750.060.374
17612563,2007-07-05T00:00:00,"Receptor, erbB-2",D12.776.543.750.750.400.350
17612563,2007-07-05T00:00:00,"Receptor, erbB-2",D12.776.624.664.700.642
17612563,2007-07-05T00:00:00,"Receptor, erbB-2",D23.101.840.642
17612563,2007-07-05T00:00:00,Signal Transduction,G02.111.087.800
17612563,2007-07-05T00:00:00,Signal Transduction,G02.149.115.800
17612563,2007-07-05T00:00:00,Signal Transduction,G04.299.880
17612563,2007-07-05T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
17612563,2007-07-05T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
17612563,2007-07-05T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
17612563,2007-07-05T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
17614978,2007-07-05T00:00:00,Antigen-Antibody Complex,D12.776.124.486.485.114.257
17614978,2007-07-05T00:00:00,Antigen-Antibody Complex,D12.776.124.790.651.114.257
17614978,2007-07-05T00:00:00,Antigen-Antibody Complex,D12.776.377.715.548.114.257
17614978,2007-07-05T00:00:00,Antigen-Antibody Complex,D23.050.101
17614978,2007-07-05T00:00:00,Coronary Artery Disease,C14.280.647.250.260
17614978,2007-07-05T00:00:00,Coronary Artery Disease,C14.907.137.126.339
17614978,2007-07-05T00:00:00,Coronary Artery Disease,C14.907.585.250.260
17614978,2007-07-05T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
17614978,2007-07-05T00:00:00,Flow Cytometry,E05.200.500.386.350
17614978,2007-07-05T00:00:00,Graft Rejection,G12.425.901.545.328
17614978,2007-07-05T00:00:00,Heart Transplantation,E04.100.376.475
17614978,2007-07-05T00:00:00,Heart Transplantation,E04.928.220.390
17614978,2007-07-05T00:00:00,Heart Transplantation,E04.936.450.475
17614978,2007-07-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17614978,2007-07-05T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
17614978,2007-07-05T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
17614978,2007-07-05T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
17614978,2007-07-05T00:00:00,Incidence,E05.318.308.985.525.375
17614978,2007-07-05T00:00:00,Incidence,L01.280.975.525.375
17614978,2007-07-05T00:00:00,Incidence,N01.224.935.597.500
17614978,2007-07-05T00:00:00,Incidence,N06.850.505.400.975.525.375
17614978,2007-07-05T00:00:00,Incidence,N06.850.520.308.985.525.375
17614978,2007-07-05T00:00:00,Risk Factors,E05.318.740.600.800.725
17614978,2007-07-05T00:00:00,Risk Factors,N05.715.350.200.700
17614978,2007-07-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17614978,2007-07-05T00:00:00,Risk Factors,N06.850.490.625.750
17614978,2007-07-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17615121,2007-07-05T00:00:00,Adult,M01.060.116
17615121,2007-07-05T00:00:00,Feedback,L01.143.283.425
17615121,2007-07-05T00:00:00,H-Reflex,G11.561.600.765.643.474
17615121,2007-07-05T00:00:00,Hand,A01.378.800.667
17615121,2007-07-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17615121,2007-07-05T00:00:00,Leg,A01.378.610.500
17615121,2007-07-05T00:00:00,"Models, Neurological",E05.599.395.642
17615121,2007-07-05T00:00:00,Motor Activity,F01.145.632
17615121,2007-07-05T00:00:00,Motor Activity,G11.427.590.530.698
17615121,2007-07-05T00:00:00,Skin,A17.815
17618058,2007-07-06T00:00:00,Aging,G07.700.320.124
17618058,2007-07-06T00:00:00,Animals,B01.050
17618058,2007-07-06T00:00:00,"Disease Models, Animal",C22.232
17618058,2007-07-06T00:00:00,"Disease Models, Animal",E05.598.500
17618058,2007-07-06T00:00:00,"Disease Models, Animal",E05.599.395.080
17618058,2007-07-06T00:00:00,Hypothalamus,A08.186.211.464.482
17618058,2007-07-06T00:00:00,Hypothalamus,A08.186.211.730.317.357
17618058,2007-07-06T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
17618058,2007-07-06T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
17618058,2007-07-06T00:00:00,Narcolepsy,C10.886.425.800.200.750
17618058,2007-07-06T00:00:00,Narcolepsy,F03.870.400.800.200.750
17618058,2007-07-06T00:00:00,Nerve Tissue Proteins,D12.776.641
17618058,2007-07-06T00:00:00,Neurons,A08.663
17618058,2007-07-06T00:00:00,Neurons,A11.671
17618058,2007-07-06T00:00:00,Neuropeptides,D12.644.400
17618058,2007-07-06T00:00:00,Neuropeptides,D12.776.641.650
17618058,2007-07-06T00:00:00,Nuclear Proteins,D12.776.660
17618058,2007-07-06T00:00:00,Peptides,D12.644
17618058,2007-07-06T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
17618058,2007-07-06T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
17618058,2007-07-06T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
17618058,2007-07-06T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17618058,2007-07-06T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17618058,2007-07-06T00:00:00,Repressor Proteins,D12.776.260.703
17618058,2007-07-06T00:00:00,Repressor Proteins,D12.776.930.700
17618058,2007-07-06T00:00:00,"Sleep, REM",F02.830.855.796.671
17618058,2007-07-06T00:00:00,"Sleep, REM",G11.561.600.815.754.671
17618058,2007-07-06T00:00:00,Wakefulness,F02.830.104.821
17618058,2007-07-06T00:00:00,Wakefulness,G11.561.600.042.738
17616812,2007-07-07T00:00:00,Apoptosis,G04.299.139.160
17616812,2007-07-07T00:00:00,Brain Neoplasms,C04.588.614.250.195
17616812,2007-07-07T00:00:00,Brain Neoplasms,C10.228.140.211
17616812,2007-07-07T00:00:00,Brain Neoplasms,C10.551.240.250
17616812,2007-07-07T00:00:00,Cell Survival,G04.299.316
17616812,2007-07-07T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
17616812,2007-07-07T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
17616812,2007-07-07T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
17616812,2007-07-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17616812,2007-07-07T00:00:00,Interferon-gamma,D12.644.276.374.440.893
17616812,2007-07-07T00:00:00,Interferon-gamma,D12.644.276.374.480.350
17616812,2007-07-07T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
17616812,2007-07-07T00:00:00,Interferon-gamma,D12.644.276.718.550
17616812,2007-07-07T00:00:00,Interferon-gamma,D12.776.467.374.440.893
17616812,2007-07-07T00:00:00,Interferon-gamma,D12.776.467.374.480.350
17616812,2007-07-07T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
17616812,2007-07-07T00:00:00,Interferon-gamma,D12.776.467.718.550
17616812,2007-07-07T00:00:00,Interferon-gamma,D23.529.374.440.893
17616812,2007-07-07T00:00:00,Interferon-gamma,D23.529.374.480.350
17616812,2007-07-07T00:00:00,Interferon-gamma,D23.529.374.480.615.350
17616812,2007-07-07T00:00:00,Interferon-gamma,D23.529.718.550
17616812,2007-07-07T00:00:00,NF-kappa B,D12.776.260.600
17616812,2007-07-07T00:00:00,NF-kappa B,D12.776.660.600
17616812,2007-07-07T00:00:00,NF-kappa B,D12.776.930.600
17616812,2007-07-07T00:00:00,Nerve Tissue Proteins,D12.776.641
17616812,2007-07-07T00:00:00,PTEN Phosphohydrolase,D08.811.277.352.650.850
17616812,2007-07-07T00:00:00,PTEN Phosphohydrolase,D12.776.476.590
17616812,2007-07-07T00:00:00,PTEN Phosphohydrolase,D12.776.624.776.695
17616812,2007-07-07T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
17616812,2007-07-07T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
17616812,2007-07-07T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
17616812,2007-07-07T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
17616812,2007-07-07T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
17616812,2007-07-07T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
17616812,2007-07-07T00:00:00,Recombinant Proteins,D12.776.828
17616812,2007-07-07T00:00:00,Signal Transduction,G02.111.087.800
17616812,2007-07-07T00:00:00,Signal Transduction,G02.149.115.800
17616812,2007-07-07T00:00:00,Signal Transduction,G04.299.880
17616812,2007-07-07T00:00:00,bcl-2-Associated X Protein,D12.644.360.075.718.400
17616812,2007-07-07T00:00:00,bcl-2-Associated X Protein,D12.776.476.075.718.400
17616815,2007-07-07T00:00:00,Antineoplastic Agents,D27.505.954.248
17616815,2007-07-07T00:00:00,Apoptosis,G04.299.139.160
17616815,2007-07-07T00:00:00,Brain Neoplasms,C04.588.614.250.195
17616815,2007-07-07T00:00:00,Brain Neoplasms,C10.228.140.211
17616815,2007-07-07T00:00:00,Brain Neoplasms,C10.551.240.250
17616815,2007-07-07T00:00:00,Calpain,D08.811.277.656.262.500.120
17616815,2007-07-07T00:00:00,Calpain,D08.811.277.656.300.200.120
17616815,2007-07-07T00:00:00,Caspases,D08.811.277.656.262.500.126
17616815,2007-07-07T00:00:00,Caspases,D08.811.277.656.300.200.126
17616815,2007-07-07T00:00:00,Caspases,D12.644.360.075.405
17616815,2007-07-07T00:00:00,Caspases,D12.776.476.075.405
17616815,2007-07-07T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
17616815,2007-07-07T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
17616815,2007-07-07T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
17616815,2007-07-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17616815,2007-07-07T00:00:00,Nerve Tissue Proteins,D12.776.641
17616815,2007-07-07T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
17616815,2007-07-07T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
17616815,2007-07-07T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
17616815,2007-07-07T00:00:00,bcl-2-Associated X Protein,D12.644.360.075.718.400
17616815,2007-07-07T00:00:00,bcl-2-Associated X Protein,D12.776.476.075.718.400
17619081,2007-07-09T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
17619081,2007-07-09T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
17619081,2007-07-09T00:00:00,Case-Control Studies,E05.318.760.500.500
17619081,2007-07-09T00:00:00,Case-Control Studies,N05.715.360.775.175.200
17619081,2007-07-09T00:00:00,Case-Control Studies,N06.850.520.450.500.500
17619081,2007-07-09T00:00:00,Ceramides,D02.065.313
17619081,2007-07-09T00:00:00,Ceramides,D09.400.410.420.525.200
17619081,2007-07-09T00:00:00,Ceramides,D10.390.470.675.200
17619081,2007-07-09T00:00:00,Ceramides,D10.570.877.360.612.200
17619081,2007-07-09T00:00:00,Head and Neck Neoplasms,C04.588.443
17619081,2007-07-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17619081,2007-07-09T00:00:00,Larynx,A04.329
17619081,2007-07-09T00:00:00,Lysophospholipids,D10.570.755.375.760.550
17619081,2007-07-09T00:00:00,Mass Spectrometry,E05.196.566
17619081,2007-07-09T00:00:00,Neoplasm Invasiveness,C04.697.645
17619081,2007-07-09T00:00:00,Neoplasm Invasiveness,C23.550.727.645
17619081,2007-07-09T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
17619081,2007-07-09T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
17619081,2007-07-09T00:00:00,Sphingosine,D02.033.100.700
17619081,2007-07-09T00:00:00,Sphingosine,D02.033.455.843
17619081,2007-07-09T00:00:00,Sphingosine,D02.092.063.700
17619081,2007-07-09T00:00:00,"Tumor Markers, Biological",D23.101.840
17620336,2007-07-09T00:00:00,Cell Line,A11.251.210
17620336,2007-07-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17620336,2007-07-09T00:00:00,Insulin,D06.472.699.587.740.625
17620336,2007-07-09T00:00:00,Insulin,D12.644.548.586.740.625
17620336,2007-07-09T00:00:00,Insulin-Like Growth Factor I,D12.644.276.937.400
17620336,2007-07-09T00:00:00,Insulin-Like Growth Factor I,D12.776.124.862.400
17620336,2007-07-09T00:00:00,Insulin-Like Growth Factor I,D12.776.467.937.400
17620336,2007-07-09T00:00:00,Insulin-Like Growth Factor I,D23.529.937.400
17620336,2007-07-09T00:00:00,Insulin-Like Growth Factor II,D12.644.276.937.420
17620336,2007-07-09T00:00:00,Insulin-Like Growth Factor II,D12.776.124.862.425
17620336,2007-07-09T00:00:00,Insulin-Like Growth Factor II,D12.776.467.937.420
17620336,2007-07-09T00:00:00,Insulin-Like Growth Factor II,D23.529.937.420
17620336,2007-07-09T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
17620336,2007-07-09T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
17620336,2007-07-09T00:00:00,MAP Kinase Signaling System,G03.495.553.560
17620336,2007-07-09T00:00:00,MAP Kinase Signaling System,G04.299.880.560
17620336,2007-07-09T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.567.342.500
17620336,2007-07-09T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.646.750.249.500
17620336,2007-07-09T00:00:00,Mitogen-Activated Protein Kinase 1,D12.644.360.450.169.500
17620336,2007-07-09T00:00:00,Mitogen-Activated Protein Kinase 1,D12.776.476.450.169.500
17620336,2007-07-09T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.567.342.750
17620336,2007-07-09T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.646.750.249.750
17620336,2007-07-09T00:00:00,Mitogen-Activated Protein Kinase 3,D12.644.360.450.169.750
17620336,2007-07-09T00:00:00,Mitogen-Activated Protein Kinase 3,D12.776.476.450.169.750
17620336,2007-07-09T00:00:00,Phosphorylation,G02.111.087.677
17620336,2007-07-09T00:00:00,Phosphorylation,G02.149.115.677
17620336,2007-07-09T00:00:00,Phosphorylation,G02.149.465.700
17620336,2007-07-09T00:00:00,Phosphorylation,G02.607.750.700
17620336,2007-07-09T00:00:00,Phosphorylation,G03.495.790
17620336,2007-07-09T00:00:00,Phosphotransferases (Alcohol Group Acceptor),D08.811.913.696.620
17620336,2007-07-09T00:00:00,Proteins,D12.776
17620336,2007-07-09T00:00:00,RNA Interference,G05.355.315.203.374.790
17620336,2007-07-09T00:00:00,"Receptor, IGF Type 1",D08.811.913.696.620.682.725.400.185
17620336,2007-07-09T00:00:00,"Receptor, IGF Type 1",D12.776.543.750.060.468
17620336,2007-07-09T00:00:00,"Receptor, IGF Type 1",D12.776.543.750.750.400.780.400
17620336,2007-07-09T00:00:00,"Receptor, IGF Type 2",D12.776.543.750.750.400.780.410
17620336,2007-07-09T00:00:00,"Receptors, Lysosphingolipid",D12.776.543.750.100.420.500
17621313,2007-07-10T00:00:00,Adolescent,M01.060.057
17621313,2007-07-10T00:00:00,Adult,M01.060.116
17621313,2007-07-10T00:00:00,African Americans,M01.686.508.100.100
17621313,2007-07-10T00:00:00,African Americans,M01.686.754.100
17621313,2007-07-10T00:00:00,Alleles,G05.360.340.024.340.030
17621313,2007-07-10T00:00:00,Child,M01.060.406
17621313,2007-07-10T00:00:00,"Child, Preschool",M01.060.406.448
17621313,2007-07-10T00:00:00,European Continental Ancestry Group,M01.686.508.400
17621313,2007-07-10T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17621313,2007-07-10T00:00:00,Genetic Predisposition to Disease,G05.380.355
17621313,2007-07-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17621313,2007-07-10T00:00:00,Obesity,C18.654.726.500
17621313,2007-07-10T00:00:00,Obesity,C23.888.144.699.500
17621313,2007-07-10T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
17621313,2007-07-10T00:00:00,Obesity,G07.100.100.160.120.699.500
17621313,2007-07-10T00:00:00,"Polymorphism, Genetic",G05.365.795
17623090,2007-07-10T00:00:00,Antineoplastic Agents,D27.505.954.248
17623090,2007-07-10T00:00:00,Apoptosis,G04.299.139.160
17623090,2007-07-10T00:00:00,Cell Division,G04.299.134.220
17623090,2007-07-10T00:00:00,Cell Division,G04.299.233.750.500
17623090,2007-07-10T00:00:00,Cell Division,G05.355.105
17623090,2007-07-10T00:00:00,Cell Division,G07.700.320.249.410.750.500
17623090,2007-07-10T00:00:00,DNA Replication,G02.111.087.222
17623090,2007-07-10T00:00:00,DNA Replication,G02.149.115.222
17623090,2007-07-10T00:00:00,DNA Replication,G05.355.200
17623090,2007-07-10T00:00:00,Drug Delivery Systems,E02.319.300
17623090,2007-07-10T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
17623090,2007-07-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17623090,2007-07-10T00:00:00,Neoplasm Proteins,D12.776.624
17623090,2007-07-10T00:00:00,Phosphorylation,G02.111.087.677
17623090,2007-07-10T00:00:00,Phosphorylation,G02.149.115.677
17623090,2007-07-10T00:00:00,Phosphorylation,G02.149.465.700
17623090,2007-07-10T00:00:00,Phosphorylation,G02.607.750.700
17623090,2007-07-10T00:00:00,Phosphorylation,G03.495.790
17623090,2007-07-10T00:00:00,"Protein Processing, Post-Translational",G02.111.087.675.871.790.600
17623090,2007-07-10T00:00:00,"Protein Processing, Post-Translational",G02.111.087.693.600
17623090,2007-07-10T00:00:00,"Protein Processing, Post-Translational",G02.149.115.675.871.790.600
17623090,2007-07-10T00:00:00,"Protein Processing, Post-Translational",G02.149.115.693.600
17623090,2007-07-10T00:00:00,"Protein Processing, Post-Translational",G03.495.770.871.790.600
17623090,2007-07-10T00:00:00,"Protein Processing, Post-Translational",G05.355.315.670.600
17623090,2007-07-10T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
17623090,2007-07-10T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
17623090,2007-07-10T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
17623090,2007-07-10T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
17623090,2007-07-10T00:00:00,Pyridines,D03.383.725
17623090,2007-07-10T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
17623090,2007-07-10T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
17623090,2007-07-10T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
17623090,2007-07-10T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
17623801,2007-07-10T00:00:00,Aged,M01.060.116.100
17623801,2007-07-10T00:00:00,Case-Control Studies,E05.318.760.500.500
17623801,2007-07-10T00:00:00,Case-Control Studies,N05.715.360.775.175.200
17623801,2007-07-10T00:00:00,Case-Control Studies,N06.850.520.450.500.500
17623801,2007-07-10T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
17623801,2007-07-10T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
17623801,2007-07-10T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
17623801,2007-07-10T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
17623801,2007-07-10T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
17623801,2007-07-10T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
17623801,2007-07-10T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
17623801,2007-07-10T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
17623801,2007-07-10T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
17623801,2007-07-10T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
17623801,2007-07-10T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
17623801,2007-07-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17623801,2007-07-10T00:00:00,Incidence,E05.318.308.985.525.375
17623801,2007-07-10T00:00:00,Incidence,L01.280.975.525.375
17623801,2007-07-10T00:00:00,Incidence,N01.224.935.597.500
17623801,2007-07-10T00:00:00,Incidence,N06.850.505.400.975.525.375
17623801,2007-07-10T00:00:00,Incidence,N06.850.520.308.985.525.375
17623801,2007-07-10T00:00:00,Middle Aged,M01.060.116.630
17623801,2007-07-10T00:00:00,Vitamin D,D04.808.812.768
17623823,2007-07-10T00:00:00,Adolescent,M01.060.057
17623823,2007-07-10T00:00:00,Adult,M01.060.116
17623823,2007-07-10T00:00:00,Age of Onset,N05.715.350.075.100
17623823,2007-07-10T00:00:00,Age of Onset,N06.850.490.250.100
17623823,2007-07-10T00:00:00,Brachial Artery,A07.231.114.139
17623823,2007-07-10T00:00:00,Calcinosis,C18.452.174.130
17623823,2007-07-10T00:00:00,Diabetes Mellitus,C18.452.394.750
17623823,2007-07-10T00:00:00,Diabetes Mellitus,C19.246
17623823,2007-07-10T00:00:00,Diabetic Angiopathies,C14.907.320
17623823,2007-07-10T00:00:00,Diabetic Angiopathies,C19.246.099.500
17623823,2007-07-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17623823,2007-07-10T00:00:00,Peripheral Vascular Diseases,C14.907.617
17634651,2007-07-10T00:00:00,Algorithms,G17.035
17634651,2007-07-10T00:00:00,Algorithms,L01.224.050
17634651,2007-07-10T00:00:00,Computer Simulation,L01.224.160
17634651,2007-07-10T00:00:00,"Models, Biological",E05.599.395
17634651,2007-07-10T00:00:00,Monte Carlo Method,E05.318.740.525
17634651,2007-07-10T00:00:00,Monte Carlo Method,L01.906.575.422
17634651,2007-07-10T00:00:00,Monte Carlo Method,N05.715.360.750.540
17634651,2007-07-10T00:00:00,Monte Carlo Method,N06.850.520.830.525
17634651,2007-07-10T00:00:00,Neoplasms,C04
17634651,2007-07-10T00:00:00,Protons,D01.248.497.300.459.700
17634651,2007-07-10T00:00:00,Protons,D01.435.550
17634651,2007-07-10T00:00:00,Protons,G01.249.765
17634651,2007-07-10T00:00:00,Radiometry,E05.799
17634651,2007-07-10T00:00:00,Radiotherapy Dosage,E02.815.639
17634651,2007-07-10T00:00:00,"Radiotherapy Planning, Computer-Assisted",E02.950.825
17634651,2007-07-10T00:00:00,"Radiotherapy Planning, Computer-Assisted",L01.700.508.100.710.600.608
17634651,2007-07-10T00:00:00,"Radiotherapy, Conformal",E02.815.635.700
17634651,2007-07-10T00:00:00,"Radiotherapy, Conformal",L01.700.508.100.710.600.550
17624435,2007-07-12T00:00:00,Adult,M01.060.116
17624435,2007-07-12T00:00:00,Aged,M01.060.116.100
17624435,2007-07-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17624435,2007-07-12T00:00:00,Middle Aged,M01.060.116.630
17624435,2007-07-12T00:00:00,Oculomotor Muscles,A02.633.567.700
17624435,2007-07-12T00:00:00,Oculomotor Muscles,A09.371.613
17624435,2007-07-12T00:00:00,Syndrome,C23.550.288.500
17625571,2007-07-12T00:00:00,African Americans,M01.686.508.100.100
17625571,2007-07-12T00:00:00,African Americans,M01.686.754.100
17625571,2007-07-12T00:00:00,European Continental Ancestry Group,M01.686.508.400
17625571,2007-07-12T00:00:00,Fetal Blood,A12.207.152.200
17625571,2007-07-12T00:00:00,Fetal Blood,A15.145.300
17625571,2007-07-12T00:00:00,Fetal Blood,A16.378.200
17625571,2007-07-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17625571,2007-07-12T00:00:00,"Infant, Newborn",M01.060.703.520
17625571,2007-07-12T00:00:00,United States,Z01.107.567.875
17625571,2007-07-12T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
17628569,2007-07-12T00:00:00,Aged,M01.060.116.100
17628569,2007-07-12T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
17628569,2007-07-12T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
17628569,2007-07-12T00:00:00,Computer Simulation,L01.224.160
17628569,2007-07-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17628569,2007-07-12T00:00:00,Middle Aged,M01.060.116.630
17628569,2007-07-12T00:00:00,"Stress, Mechanical",G01.374.676.830
17628569,2007-07-12T00:00:00,"Stress, Mechanical",G01.595.540.830
17631503,2007-07-13T00:00:00,Animals,B01.050
17631503,2007-07-13T00:00:00,Apoptosis,G04.299.139.160
17631503,2007-07-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17631503,2007-07-13T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
17631503,2007-07-13T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
17631503,2007-07-13T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
17631503,2007-07-13T00:00:00,"Models, Molecular",E05.599.595
17631503,2007-07-13T00:00:00,Phosphorylation,G02.111.087.677
17631503,2007-07-13T00:00:00,Phosphorylation,G02.149.115.677
17631503,2007-07-13T00:00:00,Phosphorylation,G02.149.465.700
17631503,2007-07-13T00:00:00,Phosphorylation,G02.607.750.700
17631503,2007-07-13T00:00:00,Phosphorylation,G03.495.790
17631503,2007-07-13T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
17631503,2007-07-13T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
17631503,2007-07-13T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
17632764,2007-07-14T00:00:00,Adult,M01.060.116
17632764,2007-07-14T00:00:00,Aged,M01.060.116.100
17632764,2007-07-14T00:00:00,Air Pollutants,D27.888.284.101
17632764,2007-07-14T00:00:00,Breast Neoplasms,C04.588.180
17632764,2007-07-14T00:00:00,Breast Neoplasms,C17.800.090.500
17632764,2007-07-14T00:00:00,Case-Control Studies,E05.318.760.500.500
17632764,2007-07-14T00:00:00,Case-Control Studies,N05.715.360.775.175.200
17632764,2007-07-14T00:00:00,Case-Control Studies,N06.850.520.450.500.500
17632764,2007-07-14T00:00:00,Environmental Exposure,N06.850.460.350
17632764,2007-07-14T00:00:00,Ethnic Groups,M01.686.754
17632764,2007-07-14T00:00:00,Ethnic Groups,N01.224.317
17632764,2007-07-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17632764,2007-07-14T00:00:00,Incidence,E05.318.308.985.525.375
17632764,2007-07-14T00:00:00,Incidence,L01.280.975.525.375
17632764,2007-07-14T00:00:00,Incidence,N01.224.935.597.500
17632764,2007-07-14T00:00:00,Incidence,N06.850.505.400.975.525.375
17632764,2007-07-14T00:00:00,Incidence,N06.850.520.308.985.525.375
17632764,2007-07-14T00:00:00,Interviews as Topic,E05.318.308.420
17632764,2007-07-14T00:00:00,Interviews as Topic,L01.280.520
17632764,2007-07-14T00:00:00,Interviews as Topic,N05.715.360.300.400
17632764,2007-07-14T00:00:00,Interviews as Topic,N06.850.520.308.420
17632764,2007-07-14T00:00:00,Middle Aged,M01.060.116.630
17632764,2007-07-14T00:00:00,New York,Z01.107.567.875.075.437
17632764,2007-07-14T00:00:00,New York,Z01.107.567.875.350.530
17632764,2007-07-14T00:00:00,New York,Z01.107.567.875.500.530
17632764,2007-07-14T00:00:00,"Polycyclic Hydrocarbons, Aromatic",D02.455.426.559.847
17632764,2007-07-14T00:00:00,"Polycyclic Hydrocarbons, Aromatic",D04.615
17632764,2007-07-14T00:00:00,Pregnancy,G08.686.785.760.769
17632764,2007-07-14T00:00:00,Risk Factors,E05.318.740.600.800.725
17632764,2007-07-14T00:00:00,Risk Factors,N05.715.350.200.700
17632764,2007-07-14T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17632764,2007-07-14T00:00:00,Risk Factors,N06.850.490.625.750
17632764,2007-07-14T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17638909,2007-07-15T00:00:00,Animals,B01.050
17638909,2007-07-15T00:00:00,Doxorubicin,D02.455.426.559.847.562.050.200.175
17638909,2007-07-15T00:00:00,Doxorubicin,D04.615.562.050.200.175
17638909,2007-07-15T00:00:00,Doxorubicin,D09.408.051.059.200.175
17638909,2007-07-15T00:00:00,"Fatty Acids, Unsaturated",D10.251.355
17638909,2007-07-15T00:00:00,Lipid Metabolism,G03.495.520
17638909,2007-07-15T00:00:00,Lipids,D10
17638909,2007-07-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17638909,2007-07-15T00:00:00,Sertoli Cells,A05.360.444.849.789
17638909,2007-07-15T00:00:00,Sertoli Cells,A11.382.952
17638909,2007-07-15T00:00:00,Sertoli Cells,A11.436.837
17638909,2007-07-15T00:00:00,Testis,A05.360.444.849
17638909,2007-07-15T00:00:00,Testis,A05.360.576.782
17638909,2007-07-15T00:00:00,Testis,A06.407.312.782
17638909,2007-07-15T00:00:00,Time Factors,G01.910.857
17635856,2007-07-16T00:00:00,Blood Pressure,E01.370.600.875.249
17635856,2007-07-16T00:00:00,Blood Pressure,G09.330.380.076
17635856,2007-07-16T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17635856,2007-07-16T00:00:00,Genetic Predisposition to Disease,G05.380.355
17635856,2007-07-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17635856,2007-07-16T00:00:00,Monte Carlo Method,E05.318.740.525
17635856,2007-07-16T00:00:00,Monte Carlo Method,L01.906.575.422
17635856,2007-07-16T00:00:00,Monte Carlo Method,N05.715.360.750.540
17635856,2007-07-16T00:00:00,Monte Carlo Method,N06.850.520.830.525
17637484,2007-07-16T00:00:00,Adult,M01.060.116
17637484,2007-07-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17637484,2007-07-16T00:00:00,Middle Aged,M01.060.116.630
17637484,2007-07-16T00:00:00,Skin,A17.815
17637484,2007-07-16T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
17635666,2007-07-17T00:00:00,Amphetamine,D02.092.471.683.152.110
17635666,2007-07-17T00:00:00,Animals,B01.050
17635666,2007-07-17T00:00:00,"Behavior, Animal",F01.145.113
17635666,2007-07-17T00:00:00,Central Nervous System Stimulants,D27.505.696.282
17635666,2007-07-17T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
17635666,2007-07-17T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.567.342
17635666,2007-07-17T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.646.750.249
17635666,2007-07-17T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.644.360.450.169
17635666,2007-07-17T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.776.476.450.169
17635666,2007-07-17T00:00:00,Motor Activity,F01.145.632
17635666,2007-07-17T00:00:00,Motor Activity,G11.427.590.530.698
17635666,2007-07-17T00:00:00,Phosphorylation,G02.111.087.677
17635666,2007-07-17T00:00:00,Phosphorylation,G02.149.115.677
17635666,2007-07-17T00:00:00,Phosphorylation,G02.149.465.700
17635666,2007-07-17T00:00:00,Phosphorylation,G02.607.750.700
17635666,2007-07-17T00:00:00,Phosphorylation,G03.495.790
17635666,2007-07-17T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
17635666,2007-07-17T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
17635666,2007-07-17T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
17635666,2007-07-17T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17635666,2007-07-17T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17646693,2007-07-17T00:00:00,Adult,M01.060.116
17646693,2007-07-17T00:00:00,Aged,M01.060.116.100
17646693,2007-07-17T00:00:00,Anticoagulants,D27.505.954.502.119
17646693,2007-07-17T00:00:00,"Constriction, Pathologic",C23.300.287
17646693,2007-07-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17646693,2007-07-17T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
17646693,2007-07-17T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
17646693,2007-07-17T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
17646693,2007-07-17T00:00:00,Middle Aged,M01.060.116.630
17646693,2007-07-17T00:00:00,Myocardial Infarction,C14.280.647.500
17646693,2007-07-17T00:00:00,Myocardial Infarction,C14.907.585.500
17646693,2007-07-17T00:00:00,Risk Assessment,E05.318.740.600.800.715
17646693,2007-07-17T00:00:00,Risk Assessment,N04.452.871.715
17646693,2007-07-17T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17646693,2007-07-17T00:00:00,Risk Assessment,N06.850.505.715
17646693,2007-07-17T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17646693,2007-07-17T00:00:00,Risk Factors,E05.318.740.600.800.725
17646693,2007-07-17T00:00:00,Risk Factors,N05.715.350.200.700
17646693,2007-07-17T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17646693,2007-07-17T00:00:00,Risk Factors,N06.850.490.625.750
17646693,2007-07-17T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17646693,2007-07-17T00:00:00,Stroke,C10.228.140.300.775
17646693,2007-07-17T00:00:00,Stroke,C14.907.253.855
17646693,2007-07-17T00:00:00,Time Factors,G01.910.857
17646693,2007-07-17T00:00:00,Warfarin,D03.438.150.446.520.914
17646693,2007-07-17T00:00:00,Warfarin,D03.830.219.446.520.914
17634185,2007-07-18T00:00:00,"Adaptation, Psychological",F01.058
17634185,2007-07-18T00:00:00,Adolescent,M01.060.057
17634185,2007-07-18T00:00:00,Adult,M01.060.116
17634185,2007-07-18T00:00:00,Child,M01.060.406
17634185,2007-07-18T00:00:00,Connective Tissue Diseases,C17.300
17634185,2007-07-18T00:00:00,Cost of Illness,I01.137
17634185,2007-07-18T00:00:00,Cost of Illness,N03.219.151.165
17634185,2007-07-18T00:00:00,European Continental Ancestry Group,M01.686.508.400
17634185,2007-07-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17634185,2007-07-18T00:00:00,Parents,F01.829.263.500.320
17634185,2007-07-18T00:00:00,Parents,I01.880.225.500.340
17634185,2007-07-18T00:00:00,Parents,M01.620
17634185,2007-07-18T00:00:00,Regression Analysis,E05.318.740.750
17634185,2007-07-18T00:00:00,Regression Analysis,N05.715.360.750.695
17634185,2007-07-18T00:00:00,Regression Analysis,N06.850.520.830.750
17634185,2007-07-18T00:00:00,Rheumatic Diseases,C05.799
17634185,2007-07-18T00:00:00,Rheumatic Diseases,C17.300.775
17634371,2007-07-18T00:00:00,Animals,B01.050
17634371,2007-07-18T00:00:00,Apoptosis,G04.299.139.160
17634371,2007-07-18T00:00:00,Enzyme Inhibitors,D27.505.519.389
17634371,2007-07-18T00:00:00,Gene Expression Regulation,G05.355.315
17634371,2007-07-18T00:00:00,Mitochondria,A11.284.430.214.190.875.564
17634371,2007-07-18T00:00:00,Mitochondria,A11.284.835.626
17634371,2007-07-18T00:00:00,Motor Neurons,A08.663.655.500
17634371,2007-07-18T00:00:00,Motor Neurons,A11.671.655.500
17634371,2007-07-18T00:00:00,NF-E2-Related Factor 2,D12.776.260.108.737
17634371,2007-07-18T00:00:00,NF-E2-Related Factor 2,D12.776.930.127.737
17634371,2007-07-18T00:00:00,Nerve Growth Factor,D12.644.276.860.437
17634371,2007-07-18T00:00:00,Nerve Growth Factor,D12.776.467.860.437
17634371,2007-07-18T00:00:00,Nerve Growth Factor,D12.776.641.600.437
17634371,2007-07-18T00:00:00,Nerve Growth Factor,D23.529.850.437
17634371,2007-07-18T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17634371,2007-07-18T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17634371,2007-07-18T00:00:00,Reactive Oxygen Species,D01.339.431
17634371,2007-07-18T00:00:00,Reactive Oxygen Species,D01.650.775
17634371,2007-07-18T00:00:00,Sphingomyelin Phosphodiesterase,D08.811.277.352.640.750
17634371,2007-07-18T00:00:00,Spinal Cord,A08.186.854
17634371,2007-07-18T00:00:00,Superoxide Dismutase,D08.811.682.881
17884372,2007-07-18T00:00:00,Coronary Restenosis,C14.280.647.250.285.200
17884372,2007-07-18T00:00:00,Coronary Restenosis,C14.907.585.250.285.200
17884372,2007-07-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17884372,2007-07-18T00:00:00,Myocardial Infarction,C14.280.647.500
17884372,2007-07-18T00:00:00,Myocardial Infarction,C14.907.585.500
17884372,2007-07-18T00:00:00,Stents,E07.695.750
17884372,2007-07-18T00:00:00,Time Factors,G01.910.857
17641106,2007-07-19T00:00:00,"Cartilage, Articular",A02.165.407.150
17641106,2007-07-19T00:00:00,"Cartilage, Articular",A02.835.583.192
17641106,2007-07-19T00:00:00,Chondrocytes,A11.329.171
17641106,2007-07-19T00:00:00,Clinical Trials as Topic,E05.318.760.535
17641106,2007-07-19T00:00:00,Clinical Trials as Topic,E05.337.250
17641106,2007-07-19T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
17641106,2007-07-19T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
17641106,2007-07-19T00:00:00,Conflict of Interest,K01.316.130
17641106,2007-07-19T00:00:00,Conflict of Interest,N05.350.225
17641106,2007-07-19T00:00:00,Evidence-Based Medicine,H02.249.750
17641106,2007-07-19T00:00:00,Evidence-Based Medicine,H02.403.200.400
17641106,2007-07-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17641106,2007-07-19T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
17641106,2007-07-19T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
17641106,2007-07-19T00:00:00,Publishing,L01.737
17641122,2007-07-19T00:00:00,Autistic Disorder,F03.550.325.125
17641122,2007-07-19T00:00:00,Child Behavior,F01.145.179
17641122,2007-07-19T00:00:00,"Child, Preschool",M01.060.406.448
17641122,2007-07-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17641122,2007-07-19T00:00:00,Infant,M01.060.703
17641122,2007-07-19T00:00:00,Infant Behavior,F01.145.179.500
17641122,2007-07-19T00:00:00,Parents,F01.829.263.500.320
17641122,2007-07-19T00:00:00,Parents,I01.880.225.500.340
17641122,2007-07-19T00:00:00,Parents,M01.620
17641122,2007-07-19T00:00:00,Questionnaires,E05.318.308.750
17641122,2007-07-19T00:00:00,Questionnaires,L01.280.800
17641122,2007-07-19T00:00:00,Questionnaires,N05.715.360.300.695
17641122,2007-07-19T00:00:00,Questionnaires,N06.850.520.308.750
17706887,2007-07-19T00:00:00,Adolescent,M01.060.057
17706887,2007-07-19T00:00:00,Adult,M01.060.116
17706887,2007-07-19T00:00:00,Cocaine-Related Disorders,C21.739.300
17706887,2007-07-19T00:00:00,Cocaine-Related Disorders,F03.900.300
17706887,2007-07-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17706887,2007-07-19T00:00:00,Middle Aged,M01.060.116.630
17706887,2007-07-19T00:00:00,Sex Factors,N05.715.350.675
17706887,2007-07-19T00:00:00,Sex Factors,N06.850.490.875
17706887,2007-07-19T00:00:00,"Stress, Psychological",F01.145.126.990
17706887,2007-07-19T00:00:00,"Stress, Psychological",F02.830.900
17645419,2007-07-20T00:00:00,Clinical Trials as Topic,E05.318.760.535
17645419,2007-07-20T00:00:00,Clinical Trials as Topic,E05.337.250
17645419,2007-07-20T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
17645419,2007-07-20T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
17645419,2007-07-20T00:00:00,Graft Rejection,G12.425.901.545.328
17645419,2007-07-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17645419,2007-07-20T00:00:00,Immunosuppression,E02.095.465.425.450
17645419,2007-07-20T00:00:00,Immunosuppression,E05.478.610
17645419,2007-07-20T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
17645419,2007-07-20T00:00:00,Kidney Transplantation,E02.870.500
17645419,2007-07-20T00:00:00,Kidney Transplantation,E04.936.450.485
17645419,2007-07-20T00:00:00,Kidney Transplantation,E04.950.774.400
17645419,2007-07-20T00:00:00,Treatment Outcome,E01.789.800
17645419,2007-07-20T00:00:00,Treatment Outcome,N04.761.559.590.800
17645419,2007-07-20T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17700069,2007-07-20T00:00:00,Cell Cycle,G04.299.134
17700069,2007-07-20T00:00:00,Cell Cycle Proteins,D12.776.167
17700069,2007-07-20T00:00:00,DNA Repair,G02.111.087.219
17700069,2007-07-20T00:00:00,DNA Repair,G02.149.115.219
17700069,2007-07-20T00:00:00,DNA Repair,G05.355.195
17700069,2007-07-20T00:00:00,DNA-Binding Proteins,D12.776.260
17700069,2007-07-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17700069,2007-07-20T00:00:00,Phosphorylation,G02.111.087.677
17700069,2007-07-20T00:00:00,Phosphorylation,G02.149.115.677
17700069,2007-07-20T00:00:00,Phosphorylation,G02.149.465.700
17700069,2007-07-20T00:00:00,Phosphorylation,G02.607.750.700
17700069,2007-07-20T00:00:00,Phosphorylation,G03.495.790
17700069,2007-07-20T00:00:00,Proteasome Endopeptidase Complex,D05.500.562.500
17700069,2007-07-20T00:00:00,Proteasome Endopeptidase Complex,D08.811.277.656.918
17700069,2007-07-20T00:00:00,Proteasome Endopeptidase Complex,D08.811.600.730
17700070,2007-07-20T00:00:00,Cell Cycle Proteins,D12.776.167
17700070,2007-07-20T00:00:00,DNA Repair,G02.111.087.219
17700070,2007-07-20T00:00:00,DNA Repair,G02.149.115.219
17700070,2007-07-20T00:00:00,DNA Repair,G05.355.195
17700070,2007-07-20T00:00:00,DNA Repair Enzymes,D08.811.074
17700070,2007-07-20T00:00:00,DNA-Binding Proteins,D12.776.260
17700070,2007-07-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17700070,2007-07-20T00:00:00,Nuclear Proteins,D12.776.660
17976776,2007-07-20T00:00:00,Child,M01.060.406
17976776,2007-07-20T00:00:00,Esophagus,A03.556.875.500
17976776,2007-07-20T00:00:00,Foreign Bodies,C21.866.392
17976776,2007-07-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17976776,2007-07-20T00:00:00,Trachea,A04.889
17646976,2007-07-24T00:00:00,Carotid Stenosis,C10.228.140.300.200.360
17646976,2007-07-24T00:00:00,Carotid Stenosis,C14.907.137.230
17646976,2007-07-24T00:00:00,Carotid Stenosis,C14.907.253.123.360
17646976,2007-07-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17646976,2007-07-24T00:00:00,Time Factors,G01.910.857
17646976,2007-07-24T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17646976,2007-07-24T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17646976,2007-07-24T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17646976,2007-07-24T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17646976,2007-07-24T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17646976,2007-07-24T00:00:00,Treatment Outcome,E01.789.800
17646976,2007-07-24T00:00:00,Treatment Outcome,N04.761.559.590.800
17646976,2007-07-24T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17652308,2007-07-24T00:00:00,Animals,B01.050
17652308,2007-07-24T00:00:00,"Models, Biological",E05.599.395
17652308,2007-07-24T00:00:00,"Models, Molecular",E05.599.595
17652308,2007-07-24T00:00:00,"Mutagenesis, Site-Directed",E05.393.420.601.575
17652308,2007-07-24T00:00:00,Mutation,G05.365.590
17652308,2007-07-24T00:00:00,Peroxiredoxin VI,D08.811.277.352.100.680.750.937.300.500
17652308,2007-07-24T00:00:00,Peroxiredoxin VI,D08.811.277.352.100.680.750.937.625.624
17652308,2007-07-24T00:00:00,Peroxiredoxin VI,D08.811.682.732.850.500
17652308,2007-07-24T00:00:00,Phospholipids,D10.570.755
17652308,2007-07-24T00:00:00,Phospholipids,D10.695
17652308,2007-07-24T00:00:00,"Protein Structure, Secondary",G02.111.570.790.709.600
17652308,2007-07-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17652308,2007-07-24T00:00:00,Recombinant Proteins,D12.776.828
17719937,2007-07-24T00:00:00,Adolescent,M01.060.057
17719937,2007-07-24T00:00:00,Adult,M01.060.116
17719937,2007-07-24T00:00:00,Body Mass Index,E01.370.600.115.100.125
17719937,2007-07-24T00:00:00,Body Mass Index,E05.041.124.125
17719937,2007-07-24T00:00:00,Body Mass Index,G07.100.100.125
17719937,2007-07-24T00:00:00,Body Mass Index,N06.850.505.200.100.175
17719937,2007-07-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17719937,2007-07-24T00:00:00,Insulin Resistance,C18.452.394.968.500
17719937,2007-07-24T00:00:00,Insulin Resistance,G07.690.320.617
17719937,2007-07-24T00:00:00,Nutrition Surveys,E05.318.308.250.600
17719937,2007-07-24T00:00:00,Nutrition Surveys,E05.318.308.585.550
17719937,2007-07-24T00:00:00,Nutrition Surveys,N05.715.360.300.375.560
17719937,2007-07-24T00:00:00,Nutrition Surveys,N05.715.360.300.560.565
17719937,2007-07-24T00:00:00,Nutrition Surveys,N06.850.520.308.250.600
17719937,2007-07-24T00:00:00,Nutrition Surveys,N06.850.520.308.585.550
17719937,2007-07-24T00:00:00,Oxygen Consumption,G03.730
17651427,2007-07-25T00:00:00,Animals,B01.050
17651427,2007-07-25T00:00:00,"Behavior, Animal",F01.145.113
17651427,2007-07-25T00:00:00,Cocaine,D02.145.074.722.388
17651427,2007-07-25T00:00:00,Cocaine,D03.132.889.354
17651427,2007-07-25T00:00:00,Cocaine,D03.605.869.388
17651427,2007-07-25T00:00:00,Cocaine,D04.075.080.875.099.722.388
17651427,2007-07-25T00:00:00,Cocaine-Related Disorders,C21.739.300
17651427,2007-07-25T00:00:00,Cocaine-Related Disorders,F03.900.300
17651427,2007-07-25T00:00:00,Conditioning (Psychology),F02.463.425.179
17651427,2007-07-25T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
17651427,2007-07-25T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
17651427,2007-07-25T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
17651427,2007-07-25T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
17651427,2007-07-25T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.567.342
17651427,2007-07-25T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.646.750.249
17651427,2007-07-25T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.644.360.450.169
17651427,2007-07-25T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.776.476.450.169
17651427,2007-07-25T00:00:00,Neural Pathways,A08.612
17651427,2007-07-25T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
17651427,2007-07-25T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
17651427,2007-07-25T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17651427,2007-07-25T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17651427,2007-07-25T00:00:00,Self Administration,E02.319.890
17651427,2007-07-25T00:00:00,Self Administration,E02.900.890
17651427,2007-07-25T00:00:00,Substance Withdrawal Syndrome,C21.739.835
17651427,2007-07-25T00:00:00,Substance Withdrawal Syndrome,F03.900.825
17651427,2007-07-25T00:00:00,Time Factors,G01.910.857
17660456,2007-07-27T00:00:00,Acoustic Stimulation,E02.037
17660456,2007-07-27T00:00:00,Acoustic Stimulation,E02.190.888.030
17660456,2007-07-27T00:00:00,Acoustic Stimulation,E05.723.136
17660456,2007-07-27T00:00:00,Adult,M01.060.116
17660456,2007-07-27T00:00:00,Aged,M01.060.116.100
17660456,2007-07-27T00:00:00,Cues,F02.463.425.234
17660456,2007-07-27T00:00:00,Disability Evaluation,E01.370.400
17660456,2007-07-27T00:00:00,Functional Laterality,F02.830.297.425
17660456,2007-07-27T00:00:00,Functional Laterality,G11.561.225.425
17660456,2007-07-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17660456,2007-07-27T00:00:00,Middle Aged,M01.060.116.630
17660456,2007-07-27T00:00:00,"Muscle, Skeletal",A02.633.567
17660456,2007-07-27T00:00:00,"Muscle, Skeletal",A10.690.552.500
17660456,2007-07-27T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
17660456,2007-07-27T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
17660456,2007-07-27T00:00:00,Paresis,C10.597.636
17660456,2007-07-27T00:00:00,Paresis,C23.888.592.643
17660456,2007-07-27T00:00:00,Periodicity,G01.910.645
17660456,2007-07-27T00:00:00,Periodicity,G07.180.562
17660456,2007-07-27T00:00:00,Physical Therapy Modalities,E02.779
17660456,2007-07-27T00:00:00,Recovery of Function,G16.757
17660456,2007-07-27T00:00:00,Stroke,C10.228.140.300.775
17660456,2007-07-27T00:00:00,Stroke,C14.907.253.855
17662617,2007-07-27T00:00:00,Adult,M01.060.116
17662617,2007-07-27T00:00:00,Blood Glucose,D09.546.359.448.500
17662617,2007-07-27T00:00:00,Coronary Disease,C14.280.647.250
17662617,2007-07-27T00:00:00,Coronary Disease,C14.907.585.250
17662617,2007-07-27T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
17662617,2007-07-27T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
17662617,2007-07-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17662617,2007-07-27T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
17662617,2007-07-27T00:00:00,Metabolic Syndrome X,C18.452.625
17662617,2007-07-27T00:00:00,Middle Aged,M01.060.116.630
17662617,2007-07-27T00:00:00,Risk Factors,E05.318.740.600.800.725
17662617,2007-07-27T00:00:00,Risk Factors,N05.715.350.200.700
17662617,2007-07-27T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17662617,2007-07-27T00:00:00,Risk Factors,N06.850.490.625.750
17662617,2007-07-27T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17768031,2007-07-27T00:00:00,Animals,B01.050
17768031,2007-07-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17768031,2007-07-27T00:00:00,"Models, Animal",E05.598
17768031,2007-07-27T00:00:00,National Institutes of Health (U.S.),I01.409.137.500.600.480
17768031,2007-07-27T00:00:00,National Institutes of Health (U.S.),N03.540.348.500.500.600.480
17768031,2007-07-27T00:00:00,Pregnancy,G08.686.785.760.769
17768031,2007-07-27T00:00:00,Prenatal Exposure Delayed Effects,C13.703.824.500
17768031,2007-07-27T00:00:00,Risk Assessment,E05.318.740.600.800.715
17768031,2007-07-27T00:00:00,Risk Assessment,N04.452.871.715
17768031,2007-07-27T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17768031,2007-07-27T00:00:00,Risk Assessment,N06.850.505.715
17768031,2007-07-27T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17768031,2007-07-27T00:00:00,United States,Z01.107.567.875
17653644,2007-07-30T00:00:00,Adolescent,M01.060.057
17653644,2007-07-30T00:00:00,Cholestasis,C06.130.120.135
17653644,2007-07-30T00:00:00,"Granuloma, Plasma Cell",C23.550.382.875
17653644,2007-07-30T00:00:00,Hepatectomy,E04.210.556
17653644,2007-07-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17653644,2007-07-30T00:00:00,Liver Diseases,C06.552
17653644,2007-07-30T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17653644,2007-07-30T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17664294,2007-07-30T00:00:00,Animals,B01.050
17664294,2007-07-30T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
17664294,2007-07-30T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
17664294,2007-07-30T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
17664294,2007-07-30T00:00:00,Cell Membrane,A11.284.149
17664294,2007-07-30T00:00:00,Cell Proliferation,G04.299.233.750
17664294,2007-07-30T00:00:00,Cell Proliferation,G07.700.320.249.410.750
17664294,2007-07-30T00:00:00,Cell Separation,E05.200.500.363
17664294,2007-07-30T00:00:00,Interleukin-15,D12.644.276.374.465.515
17664294,2007-07-30T00:00:00,Interleukin-15,D12.776.467.374.465.515
17664294,2007-07-30T00:00:00,Interleukin-15,D23.529.374.465.515
17664294,2007-07-30T00:00:00,Interleukin-2,D12.644.276.374.465.502
17664294,2007-07-30T00:00:00,Interleukin-2,D12.644.276.374.480.372
17664294,2007-07-30T00:00:00,Interleukin-2,D12.776.467.374.465.502
17664294,2007-07-30T00:00:00,Interleukin-2,D12.776.467.374.480.372
17664294,2007-07-30T00:00:00,Interleukin-2,D23.529.374.465.502
17664294,2007-07-30T00:00:00,Interleukin-2,D23.529.374.480.372
17664294,2007-07-30T00:00:00,Major Histocompatibility Complex,G05.360.340.024.340.610
17664294,2007-07-30T00:00:00,Major Histocompatibility Complex,G05.360.340.024.380.500
17664294,2007-07-30T00:00:00,Major Histocompatibility Complex,G12.500.500
17664294,2007-07-30T00:00:00,"Models, Biological",E05.599.395
17664294,2007-07-30T00:00:00,Phenotype,G05.695
17665192,2007-07-31T00:00:00,"Biodegradation, Environmental",N06.850.460.375.500
17665192,2007-07-31T00:00:00,"Biodegradation, Environmental",N06.850.860.510.900.299
17665192,2007-07-31T00:00:00,Biosensing Techniques,E05.601.123
17665192,2007-07-31T00:00:00,Cholinesterase Inhibitors,D27.505.519.389.275
17665192,2007-07-31T00:00:00,Cholinesterase Inhibitors,D27.505.519.625.120.300
17665192,2007-07-31T00:00:00,Cholinesterase Inhibitors,D27.505.696.577.120.300
17665192,2007-07-31T00:00:00,Gene Expression Profiling,E05.393.332
17665192,2007-07-31T00:00:00,"Gene Expression Regulation, Fungal",G05.355.315.330
17665192,2007-07-31T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
17665192,2007-07-31T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
17665192,2007-07-31T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
17665192,2007-07-31T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
17665192,2007-07-31T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
17665192,2007-07-31T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
17666107,2007-07-31T00:00:00,Alcoholism,C21.739.100.250
17666107,2007-07-31T00:00:00,Alcoholism,F03.900.100.350
17666107,2007-07-31T00:00:00,Animals,B01.050
17666107,2007-07-31T00:00:00,"Behavior, Addictive",F01.145.527.100.120
17666107,2007-07-31T00:00:00,"Behavior, Animal",F01.145.113
17666107,2007-07-31T00:00:00,Central Nervous System Depressants,D27.505.696.277
17666107,2007-07-31T00:00:00,Central Nervous System Depressants,D27.505.954.427.210
17666107,2007-07-31T00:00:00,"Disease Models, Animal",C22.232
17666107,2007-07-31T00:00:00,"Disease Models, Animal",E05.598.500
17666107,2007-07-31T00:00:00,"Disease Models, Animal",E05.599.395.080
17666107,2007-07-31T00:00:00,Ethanol,D02.033.375
17666107,2007-07-31T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
17666107,2007-07-31T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17666107,2007-07-31T00:00:00,Self Administration,E02.319.890
17666107,2007-07-31T00:00:00,Self Administration,E02.900.890
17666399,2007-07-31T00:00:00,Animals,B01.050
17666399,2007-07-31T00:00:00,Arrestins,D12.776.306.090
17666399,2007-07-31T00:00:00,Arrestins,D12.776.543.090
17666399,2007-07-31T00:00:00,Clathrin,D12.776.543.990.200
17666399,2007-07-31T00:00:00,Endocytosis,G04.299.482
17666399,2007-07-31T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.567.342
17666399,2007-07-31T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.646.750.249
17666399,2007-07-31T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.644.360.450.169
17666399,2007-07-31T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.776.476.450.169
17666399,2007-07-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17666399,2007-07-31T00:00:00,"Models, Biological",E05.599.395
17666399,2007-07-31T00:00:00,Protein Conformation,G02.111.570.790.709
17666399,2007-07-31T00:00:00,Signal Transduction,G02.111.087.800
17666399,2007-07-31T00:00:00,Signal Transduction,G02.149.115.800
17666399,2007-07-31T00:00:00,Signal Transduction,G04.299.880
17666454,2007-07-31T00:00:00,Amino Acid Sequence,G02.111.570.060
17666454,2007-07-31T00:00:00,Amino Acid Sequence,L01.453.245.667.060
17666454,2007-07-31T00:00:00,Amyloid Precursor Protein Secretases,D08.811.277.656.300.032
17666454,2007-07-31T00:00:00,Amyloid beta-Protein Precursor,D12.776.049.025.150
17666454,2007-07-31T00:00:00,Amyloid beta-Protein Precursor,D12.776.811.050
17666454,2007-07-31T00:00:00,Animals,B01.050
17666454,2007-07-31T00:00:00,CHO Cells,A11.251.210.200
17666454,2007-07-31T00:00:00,CHO Cells,A11.436.155
17666454,2007-07-31T00:00:00,Cell Line,A11.251.210
17666454,2007-07-31T00:00:00,Cricetinae,B01.050.150.900.649.865.635.150
17666454,2007-07-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17666454,2007-07-31T00:00:00,Lovastatin,D02.455.426.559.847.638.400
17666454,2007-07-31T00:00:00,Lovastatin,D04.615.638.400
17666454,2007-07-31T00:00:00,Molecular Sequence Data,L01.453.245.667
17666454,2007-07-31T00:00:00,Peptide Fragments,D12.644.541
17825509,2007-07-31T00:00:00,Adenosine Triphosphatases,D08.811.277.040.025
17825509,2007-07-31T00:00:00,Animals,B01.050
17825509,2007-07-31T00:00:00,Gerbillinae,B01.050.150.900.649.865.635.300
17825509,2007-07-31T00:00:00,"Hair Cells, Auditory",A08.663.650.250
17825509,2007-07-31T00:00:00,"Hair Cells, Auditory",A08.663.650.915.750.600.350
17825509,2007-07-31T00:00:00,"Hair Cells, Auditory",A08.800.950.750.600.350
17825509,2007-07-31T00:00:00,"Hair Cells, Auditory",A09.246.631.246.577.325
17825509,2007-07-31T00:00:00,"Hair Cells, Auditory",A11.671.650.250
17825509,2007-07-31T00:00:00,"Hair Cells, Auditory",A11.671.650.915.750.600.350
17825509,2007-07-31T00:00:00,Mitochondria,A11.284.430.214.190.875.564
17825509,2007-07-31T00:00:00,Mitochondria,A11.284.835.626
17825509,2007-07-31T00:00:00,Organ of Corti,A09.246.631.246.577
17377995,2007-08-01T00:00:00,Cardiovascular Agents,D27.505.954.411
17377995,2007-08-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
17377995,2007-08-01T00:00:00,Coronary Angiography,E01.370.370.050.200
17377995,2007-08-01T00:00:00,Coronary Angiography,E01.370.370.380.200
17377995,2007-08-01T00:00:00,Device Removal,E04.199
17377995,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17377995,2007-08-01T00:00:00,Prosthesis Design,E05.320.550
17377995,2007-08-01T00:00:00,Prosthesis Design,E07.695.680
17377995,2007-08-01T00:00:00,Prosthesis Failure,C23.550.767.865
17377995,2007-08-01T00:00:00,Prosthesis Failure,E05.325.771
17377995,2007-08-01T00:00:00,"Radiography, Interventional",E01.370.350.700.725
17377995,2007-08-01T00:00:00,"Radiography, Interventional",E02.148.694
17377995,2007-08-01T00:00:00,"Radiography, Interventional",E04.800.780
17377995,2007-08-01T00:00:00,Stents,E07.695.750
17405115,2007-08-01T00:00:00,"Models, Molecular",E05.599.595
17405115,2007-08-01T00:00:00,Peptides,D12.644
17405115,2007-08-01T00:00:00,Solvents,D27.720.844
17405115,2007-08-01T00:00:00,Surface Properties,G02.842.850
17503503,2007-08-01T00:00:00,Aged,M01.060.116.100
17503503,2007-08-01T00:00:00,Cardiovascular Agents,D27.505.954.411
17503503,2007-08-01T00:00:00,Cardiovascular Diseases,C14
17503503,2007-08-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
17503503,2007-08-01T00:00:00,Coronary Angiography,E01.370.370.050.200
17503503,2007-08-01T00:00:00,Coronary Angiography,E01.370.370.380.200
17503503,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17503503,2007-08-01T00:00:00,Middle Aged,M01.060.116.630
17503503,2007-08-01T00:00:00,Myocardial Ischemia,C14.280.647
17503503,2007-08-01T00:00:00,Myocardial Ischemia,C14.907.585
17503503,2007-08-01T00:00:00,Prosthesis Design,E05.320.550
17503503,2007-08-01T00:00:00,Prosthesis Design,E07.695.680
17503503,2007-08-01T00:00:00,Research Design,E05.581.500
17503503,2007-08-01T00:00:00,Research Design,H01.770.644.728
17503503,2007-08-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
17503503,2007-08-01T00:00:00,Risk Assessment,N04.452.871.715
17503503,2007-08-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17503503,2007-08-01T00:00:00,Risk Assessment,N06.850.505.715
17503503,2007-08-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17503503,2007-08-01T00:00:00,Stents,E07.695.750
17503503,2007-08-01T00:00:00,Thrombosis,C14.907.355.830
17503503,2007-08-01T00:00:00,Time Factors,G01.910.857
17503503,2007-08-01T00:00:00,Treatment Outcome,E01.789.800
17503503,2007-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17503503,2007-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17508252,2007-08-01T00:00:00,Adolescent,M01.060.057
17508252,2007-08-01T00:00:00,Adult,M01.060.116
17508252,2007-08-01T00:00:00,Aged,M01.060.116.100
17508252,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17508252,2007-08-01T00:00:00,Middle Aged,M01.060.116.630
17508252,2007-08-01T00:00:00,Pancreatectomy,E04.210.752
17508252,2007-08-01T00:00:00,"Pancreatitis, Chronic",C06.689.750.830
17508252,2007-08-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17508252,2007-08-01T00:00:00,Risk Factors,N05.715.350.200.700
17508252,2007-08-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17508252,2007-08-01T00:00:00,Risk Factors,N06.850.490.625.750
17508252,2007-08-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17518716,2007-08-01T00:00:00,Animals,B01.050
17518716,2007-08-01T00:00:00,Cell Line,A11.251.210
17518716,2007-08-01T00:00:00,Diabetes Mellitus,C18.452.394.750
17518716,2007-08-01T00:00:00,Diabetes Mellitus,C19.246
17518716,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17518716,2007-08-01T00:00:00,Insulin,D06.472.699.587.740.625
17518716,2007-08-01T00:00:00,Insulin,D12.644.548.586.740.625
17518716,2007-08-01T00:00:00,Keratinocytes,A11.436.397
17518716,2007-08-01T00:00:00,"Skin, Artificial",E07.858.082.800
17518716,2007-08-01T00:00:00,"Transduction, Genetic",E05.393.350.800
17518716,2007-08-01T00:00:00,"Transduction, Genetic",G05.355.760.850
17534195,2007-08-01T00:00:00,Adult,M01.060.116
17534195,2007-08-01T00:00:00,Aged,M01.060.116.100
17534195,2007-08-01T00:00:00,Hip Prosthesis,E07.695.400.400
17534195,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17534195,2007-08-01T00:00:00,Knee Prosthesis,E07.695.400.410
17534195,2007-08-01T00:00:00,Methicillin Resistance,G06.099.225.500.600.525
17534195,2007-08-01T00:00:00,Methicillin Resistance,G06.225.347.500.600.525
17534195,2007-08-01T00:00:00,Methicillin Resistance,G07.690.320.269.347.500.600.525
17534195,2007-08-01T00:00:00,Middle Aged,M01.060.116.630
17534195,2007-08-01T00:00:00,Prosthesis-Related Infections,C01.539.685
17534195,2007-08-01T00:00:00,Prosthesis-Related Infections,C23.550.767.868
17534195,2007-08-01T00:00:00,Staphylococcus aureus,B03.300.390.400.800.750.100
17534195,2007-08-01T00:00:00,Staphylococcus aureus,B03.510.100.750.750.100
17534195,2007-08-01T00:00:00,Staphylococcus aureus,B03.510.400.790.750.100
17613920,2007-08-01T00:00:00,Deglutition,G10.261.326.215
17613920,2007-08-01T00:00:00,Esophageal Motility Disorders,C06.405.117.119.500
17613920,2007-08-01T00:00:00,Esophagus,A03.556.875.500
17613920,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17613920,2007-08-01T00:00:00,Manometry,E05.559
17613920,2007-08-01T00:00:00,Middle Aged,M01.060.116.630
17618817,2007-08-01T00:00:00,Adult,M01.060.116
17618817,2007-08-01T00:00:00,Aged,M01.060.116.100
17618817,2007-08-01T00:00:00,Attitude of Health Personnel,F01.100.050
17618817,2007-08-01T00:00:00,Attitude of Health Personnel,N05.300.100
17618817,2007-08-01T00:00:00,Documentation,L01.453.245
17618817,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17618817,2007-08-01T00:00:00,Insurance Claim Reporting,N03.219.521.576.210
17618817,2007-08-01T00:00:00,Internship and Residency,I02.358.399.644
17618817,2007-08-01T00:00:00,"Medical Staff, Hospital",M01.526.485.630.490
17618817,2007-08-01T00:00:00,"Medical Staff, Hospital",M01.526.485.740.422
17618817,2007-08-01T00:00:00,"Medical Staff, Hospital",N02.360.630.490
17618817,2007-08-01T00:00:00,"Medical Staff, Hospital",N02.360.740.422
17618817,2007-08-01T00:00:00,Middle Aged,M01.060.116.630
17618817,2007-08-01T00:00:00,Needs Assessment,I02.594
17618817,2007-08-01T00:00:00,Needs Assessment,N03.349.380.565
17618817,2007-08-01T00:00:00,Needs Assessment,N05.300.537
17618817,2007-08-01T00:00:00,Professional Competence,I02.399.630
17618817,2007-08-01T00:00:00,"Specialties, Surgical",H02.403.810
17626828,2007-08-01T00:00:00,Animals,B01.050
17626828,2007-08-01T00:00:00,Chickens,B01.050.150.900.248.350.150
17626828,2007-08-01T00:00:00,Chickens,B01.050.150.900.248.617.192
17626828,2007-08-01T00:00:00,Diet,E05.272
17626828,2007-08-01T00:00:00,Diet,G07.610.240
17626828,2007-08-01T00:00:00,Dietary Supplements,J02.500.456
17626828,2007-08-01T00:00:00,Mycoplasma Infections,C01.252.400.610.610
17626828,2007-08-01T00:00:00,Mycoplasma gallisepticum,B03.440.560.580.553.553.345
17626828,2007-08-01T00:00:00,Ovary,A05.360.319.114.630
17626828,2007-08-01T00:00:00,Ovary,A05.360.576.497
17626828,2007-08-01T00:00:00,Ovary,A06.407.312.497
17626828,2007-08-01T00:00:00,Poultry Diseases,C22.131.728
17637075,2007-08-01T00:00:00,Animals,B01.050
17637075,2007-08-01T00:00:00,Apoptosis,G04.299.139.160
17637075,2007-08-01T00:00:00,Collagen,D05.750.078.280
17637075,2007-08-01T00:00:00,Collagen,D12.776.860.300.250
17637075,2007-08-01T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
17637075,2007-08-01T00:00:00,"Microscopy, Confocal",E05.595.395
17637075,2007-08-01T00:00:00,"Myocytes, Cardiac",A07.541.704.570
17637075,2007-08-01T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
17637075,2007-08-01T00:00:00,"Myocytes, Cardiac",A11.620.500
17637075,2007-08-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17637075,2007-08-01T00:00:00,Tissue Engineering,E05.200.249.750
17637075,2007-08-01T00:00:00,Toxicity Tests,E05.940
17638283,2007-08-01T00:00:00,Biometry,E05.318.740.225
17638283,2007-08-01T00:00:00,Biometry,N06.850.505.200
17638283,2007-08-01T00:00:00,Computer Simulation,L01.224.160
17638283,2007-08-01T00:00:00,"Data Interpretation, Statistical",E05.245.380
17638283,2007-08-01T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
17638283,2007-08-01T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
17638283,2007-08-01T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
17638283,2007-08-01T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
17638283,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17638283,2007-08-01T00:00:00,Markov Chains,E05.318.740.600.500
17638283,2007-08-01T00:00:00,Markov Chains,E05.318.740.996.500
17638283,2007-08-01T00:00:00,Markov Chains,G17.830.500
17638283,2007-08-01T00:00:00,Markov Chains,N05.715.360.750.625.500
17638283,2007-08-01T00:00:00,Markov Chains,N05.715.360.750.770.500
17638283,2007-08-01T00:00:00,Markov Chains,N06.850.520.830.600.500
17638283,2007-08-01T00:00:00,Markov Chains,N06.850.520.830.996.500
17638283,2007-08-01T00:00:00,"Models, Biological",E05.599.395
17638283,2007-08-01T00:00:00,Monte Carlo Method,E05.318.740.525
17638283,2007-08-01T00:00:00,Monte Carlo Method,L01.906.575.422
17638283,2007-08-01T00:00:00,Monte Carlo Method,N05.715.360.750.540
17638283,2007-08-01T00:00:00,Monte Carlo Method,N06.850.520.830.525
17638283,2007-08-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
17638283,2007-08-01T00:00:00,Risk Assessment,N04.452.871.715
17638283,2007-08-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17638283,2007-08-01T00:00:00,Risk Assessment,N06.850.505.715
17638283,2007-08-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17638283,2007-08-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17638283,2007-08-01T00:00:00,Risk Factors,N05.715.350.200.700
17638283,2007-08-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17638283,2007-08-01T00:00:00,Risk Factors,N06.850.490.625.750
17638283,2007-08-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17640234,2007-08-01T00:00:00,Aged,M01.060.116.100
17640234,2007-08-01T00:00:00,Hamartoma,C04.445
17640234,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17640234,2007-08-01T00:00:00,"Muscle, Skeletal",A02.633.567
17640234,2007-08-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
17640234,2007-08-01T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
17640234,2007-08-01T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
17640234,2007-08-01T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
17640234,2007-08-01T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
17640234,2007-08-01T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
17640234,2007-08-01T00:00:00,Skin Diseases,C17.800
17641362,2007-08-01T00:00:00,Adult,M01.060.116
17641362,2007-08-01T00:00:00,Aged,M01.060.116.100
17641362,2007-08-01T00:00:00,Breast Neoplasms,C04.588.180
17641362,2007-08-01T00:00:00,Breast Neoplasms,C17.800.090.500
17641362,2007-08-01T00:00:00,"Genes, BRCA1",G05.360.340.024.340.375.249.100
17641362,2007-08-01T00:00:00,"Genes, BRCA1",G05.360.340.024.340.415.400.100
17641362,2007-08-01T00:00:00,"Genes, BRCA2",G05.360.340.024.340.375.249.105
17641362,2007-08-01T00:00:00,"Genes, BRCA2",G05.360.340.024.340.415.400.105
17641362,2007-08-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17641362,2007-08-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
17641362,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17641362,2007-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17641362,2007-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17641362,2007-08-01T00:00:00,Mammography,E01.370.350.700.500
17641362,2007-08-01T00:00:00,Middle Aged,M01.060.116.630
17641362,2007-08-01T00:00:00,Pilot Projects,E05.318.760.750
17641362,2007-08-01T00:00:00,Pilot Projects,E05.337.737
17641362,2007-08-01T00:00:00,Pilot Projects,N05.715.360.775.625
17641362,2007-08-01T00:00:00,Pilot Projects,N06.850.520.450.720
17641362,2007-08-01T00:00:00,Population Surveillance,E05.318.308.250.700
17641362,2007-08-01T00:00:00,Population Surveillance,N05.715.360.300.375.625
17641362,2007-08-01T00:00:00,Population Surveillance,N06.850.520.308.250.700
17641362,2007-08-01T00:00:00,Population Surveillance,N06.850.780.675
17641362,2007-08-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17641362,2007-08-01T00:00:00,Risk Factors,N05.715.350.200.700
17641362,2007-08-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17641362,2007-08-01T00:00:00,Risk Factors,N06.850.490.625.750
17641362,2007-08-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17641362,2007-08-01T00:00:00,"Ultrasonography, Mammary",E01.370.350.850.860
17641362,2007-08-01T00:00:00,"Ultrasonography, Mammary",E01.370.378.850
17641362,2007-08-01T00:00:00,United States,Z01.107.567.875
17654299,2007-08-01T00:00:00,Carcinogens,D27.888.569.100
17654299,2007-08-01T00:00:00,Filtration,E05.196.454
17654299,2007-08-01T00:00:00,Filtration,G01.595.280
17654299,2007-08-01T00:00:00,Filtration,G02.149.767.600
17654299,2007-08-01T00:00:00,Filtration,G02.842.750.600
17654299,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17654299,2007-08-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
17654299,2007-08-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
17654299,2007-08-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
17654299,2007-08-01T00:00:00,Smoking,F01.145.466.753
17657310,2007-08-01T00:00:00,Animals,B01.050
17657310,2007-08-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
17657310,2007-08-01T00:00:00,Autoimmune Diseases,C20.111
17657310,2007-08-01T00:00:00,Autoimmunity,G12.450.192
17657310,2007-08-01T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
17657310,2007-08-01T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
17657310,2007-08-01T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
17657310,2007-08-01T00:00:00,Cytokines,D12.644.276.374
17657310,2007-08-01T00:00:00,Cytokines,D12.776.467.374
17657310,2007-08-01T00:00:00,Cytokines,D23.529.374
17657310,2007-08-01T00:00:00,Lipopolysaccharides,D09.400.500
17657310,2007-08-01T00:00:00,Lipopolysaccharides,D09.698.718.450
17657310,2007-08-01T00:00:00,Lipopolysaccharides,D10.494
17657310,2007-08-01T00:00:00,Lipopolysaccharides,D23.050.161.616.525
17657310,2007-08-01T00:00:00,Lipopolysaccharides,D23.946.123.329.500
17657310,2007-08-01T00:00:00,Lymphocyte Activation,E01.450.495.482
17657310,2007-08-01T00:00:00,Lymphocyte Activation,E05.478.594.530
17657310,2007-08-01T00:00:00,Lymphocyte Activation,G12.425.747
17657310,2007-08-01T00:00:00,Lymphocyte Activation,G12.450.050.400.545
17657310,2007-08-01T00:00:00,Signal Transduction,G02.111.087.800
17657310,2007-08-01T00:00:00,Signal Transduction,G02.149.115.800
17657310,2007-08-01T00:00:00,Signal Transduction,G04.299.880
17657310,2007-08-01T00:00:00,Toll-Like Receptor 4,D12.776.543.750.705.910.500.400
17664344,2007-08-01T00:00:00,Action Potentials,G04.580.100
17664344,2007-08-01T00:00:00,Action Potentials,G07.265.750.100
17664344,2007-08-01T00:00:00,Action Potentials,G11.561.570.100
17664344,2007-08-01T00:00:00,Animals,B01.050
17664344,2007-08-01T00:00:00,Calcium,D01.268.552.100
17664344,2007-08-01T00:00:00,Calcium,D01.552.539.288
17664344,2007-08-01T00:00:00,Calcium,D23.119.100
17664344,2007-08-01T00:00:00,Heart,A07.541
17664344,2007-08-01T00:00:00,Muscle Contraction,G11.427.590.540
17664344,2007-08-01T00:00:00,"Myocytes, Cardiac",A07.541.704.570
17664344,2007-08-01T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
17664344,2007-08-01T00:00:00,"Myocytes, Cardiac",A11.620.500
17664344,2007-08-01T00:00:00,Sodium-Calcium Exchanger,D12.776.157.530.450.162.442
17664344,2007-08-01T00:00:00,Sodium-Calcium Exchanger,D12.776.543.585.450.162.442
17664477,2007-08-01T00:00:00,Adult,M01.060.116
17664477,2007-08-01T00:00:00,Aged,M01.060.116.100
17664477,2007-08-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
17664477,2007-08-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
17664477,2007-08-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
17664477,2007-08-01T00:00:00,"Carcinoma, Renal Cell",C04.557.470.200.025.390
17664477,2007-08-01T00:00:00,"Carcinoma, Renal Cell",C04.588.945.947.535.160
17664477,2007-08-01T00:00:00,"Carcinoma, Renal Cell",C12.758.820.750.160
17664477,2007-08-01T00:00:00,"Carcinoma, Renal Cell",C12.777.419.473.160
17664477,2007-08-01T00:00:00,"Carcinoma, Renal Cell",C13.351.937.820.535.160
17664477,2007-08-01T00:00:00,"Carcinoma, Renal Cell",C13.351.968.419.473.160
17664477,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17664477,2007-08-01T00:00:00,Interferon-alpha,D12.644.276.374.440.890.250
17664477,2007-08-01T00:00:00,Interferon-alpha,D12.644.276.718.500.250
17664477,2007-08-01T00:00:00,Interferon-alpha,D12.776.467.374.440.890.250
17664477,2007-08-01T00:00:00,Interferon-alpha,D12.776.467.718.500.250
17664477,2007-08-01T00:00:00,Interferon-alpha,D23.529.374.440.890.250
17664477,2007-08-01T00:00:00,Interferon-alpha,D23.529.718.500.250
17664477,2007-08-01T00:00:00,Kidney Neoplasms,C04.588.945.947.535
17664477,2007-08-01T00:00:00,Kidney Neoplasms,C12.758.820.750
17664477,2007-08-01T00:00:00,Kidney Neoplasms,C12.777.419.473
17664477,2007-08-01T00:00:00,Kidney Neoplasms,C13.351.937.820.535
17664477,2007-08-01T00:00:00,Kidney Neoplasms,C13.351.968.419.473
17664477,2007-08-01T00:00:00,Middle Aged,M01.060.116.630
17664477,2007-08-01T00:00:00,Pyridines,D03.383.725
17664477,2007-08-01T00:00:00,Recombinant Proteins,D12.776.828
17664477,2007-08-01T00:00:00,Treatment Outcome,E01.789.800
17664477,2007-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17664477,2007-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17664477,2007-08-01T00:00:00,"Tumor Markers, Biological",D23.101.840
17666604,2007-08-01T00:00:00,Adult,M01.060.116
17666604,2007-08-01T00:00:00,Double-Blind Method,E05.318.780.300
17666604,2007-08-01T00:00:00,Double-Blind Method,E05.581.500.300
17666604,2007-08-01T00:00:00,Double-Blind Method,N05.715.360.780.320
17666604,2007-08-01T00:00:00,Double-Blind Method,N06.850.520.445.300
17666604,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17666604,2007-08-01T00:00:00,Patient Compliance,F01.145.488.500
17666604,2007-08-01T00:00:00,Patient Compliance,N05.300.150.600.600
17666604,2007-08-01T00:00:00,Patient Satisfaction,N04.452.822.360.600
17666604,2007-08-01T00:00:00,Patient Satisfaction,N05.300.150.600.630
17666604,2007-08-01T00:00:00,Patient Satisfaction,N05.715.360.600
17666604,2007-08-01T00:00:00,Treatment Outcome,E01.789.800
17666604,2007-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17666604,2007-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17668448,2007-08-01T00:00:00,"Electrophoresis, Capillary",E05.196.401.190
17668448,2007-08-01T00:00:00,"Electrophoresis, Capillary",E05.301.300.190
17668448,2007-08-01T00:00:00,"Models, Theoretical",E05.599
17668448,2007-08-01T00:00:00,Temperature,G01.906.595
17668448,2007-08-01T00:00:00,Temperature,G16.500.275.063.725.710
17668448,2007-08-01T00:00:00,Temperature,G16.500.750.775.710
17668448,2007-08-01T00:00:00,Temperature,N06.230.150.450
17668448,2007-08-01T00:00:00,Temperature,N06.230.300.100.725.710
17670878,2007-08-01T00:00:00,"Diagnosis, Differential",E01.171
17670878,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17670887,2007-08-01T00:00:00,Adult,M01.060.116
17670887,2007-08-01T00:00:00,"Cardiomyopathy, Dilated",C14.280.195.160
17670887,2007-08-01T00:00:00,"Cardiomyopathy, Dilated",C14.280.238.070
17670887,2007-08-01T00:00:00,Cell Membrane,A11.284.149
17670887,2007-08-01T00:00:00,Fibroblasts,A11.329.228
17670887,2007-08-01T00:00:00,Fibroblasts,A11.872.228
17670887,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17670887,2007-08-01T00:00:00,Matrix Metalloproteinase 14,D08.811.277.656.300.480.525.300.500
17670887,2007-08-01T00:00:00,Matrix Metalloproteinase 14,D08.811.277.656.675.374.525.300.500
17670887,2007-08-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.205.352
17670887,2007-08-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.252.420
17670887,2007-08-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.525.700.150
17670887,2007-08-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.205.352
17670887,2007-08-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.252.420
17670887,2007-08-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.525.700.150
17670887,2007-08-01T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
17670887,2007-08-01T00:00:00,"Microscopy, Confocal",E05.595.395
17670887,2007-08-01T00:00:00,Middle Aged,M01.060.116.630
17670887,2007-08-01T00:00:00,Myocardium,A02.633.580
17670887,2007-08-01T00:00:00,Myocardium,A07.541.704
17670887,2007-08-01T00:00:00,Myocardium,A10.690.552.750
17670887,2007-08-01T00:00:00,Protein Biosynthesis,G02.111.087.675.871
17670887,2007-08-01T00:00:00,Protein Biosynthesis,G02.149.115.675.871
17670887,2007-08-01T00:00:00,Protein Biosynthesis,G03.495.770.871
17670887,2007-08-01T00:00:00,Protein Biosynthesis,G05.355.310.670
17670887,2007-08-01T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.260.108.820
17670887,2007-08-01T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.624.664.700.182
17670887,2007-08-01T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.660.763
17670887,2007-08-01T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.930.127.820
17670887,2007-08-01T00:00:00,"RNA, Messenger",D13.444.735.544
17670887,2007-08-01T00:00:00,"Transcription, Genetic",G02.111.087.847
17670887,2007-08-01T00:00:00,"Transcription, Genetic",G02.149.115.847
17670887,2007-08-01T00:00:00,"Transcription, Genetic",G05.355.310.700
17670887,2007-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
17670887,2007-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
17670887,2007-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
17670887,2007-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
17670887,2007-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
17670887,2007-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
17670887,2007-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
17670887,2007-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
17670887,2007-08-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
17670887,2007-08-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
17670887,2007-08-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
17670887,2007-08-01T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
17670913,2007-08-01T00:00:00,Breast Neoplasms,C04.588.180
17670913,2007-08-01T00:00:00,Breast Neoplasms,C17.800.090.500
17670913,2007-08-01T00:00:00,Cell Line,A11.251.210
17670913,2007-08-01T00:00:00,Cell Proliferation,G04.299.233.750
17670913,2007-08-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
17670913,2007-08-01T00:00:00,Epithelial Cells,A11.436
17670913,2007-08-01T00:00:00,"Feedback, Physiological",G07.700.360.732
17670913,2007-08-01T00:00:00,"Feedback, Physiological",L01.143.283.425.311
17670913,2007-08-01T00:00:00,Glycoproteins,D09.400.430
17670913,2007-08-01T00:00:00,Glycoproteins,D12.776.395
17670913,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17670913,2007-08-01T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
17670913,2007-08-01T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
17670913,2007-08-01T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
17670913,2007-08-01T00:00:00,Interleukin-1,D12.644.276.374.465.501
17670913,2007-08-01T00:00:00,Interleukin-1,D12.644.276.374.500.400
17670913,2007-08-01T00:00:00,Interleukin-1,D12.776.467.374.465.501
17670913,2007-08-01T00:00:00,Interleukin-1,D12.776.467.374.500.400
17670913,2007-08-01T00:00:00,Interleukin-1,D23.529.374.465.501
17670913,2007-08-01T00:00:00,Interleukin-1,D23.529.374.500.400
17670913,2007-08-01T00:00:00,NF-kappa B,D12.776.260.600
17670913,2007-08-01T00:00:00,NF-kappa B,D12.776.660.600
17670913,2007-08-01T00:00:00,NF-kappa B,D12.776.930.600
17670913,2007-08-01T00:00:00,Neoplasm Invasiveness,C04.697.645
17670913,2007-08-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
17670913,2007-08-01T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
17670913,2007-08-01T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
17670913,2007-08-01T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
17670913,2007-08-01T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
17670913,2007-08-01T00:00:00,Signal Transduction,G02.111.087.800
17670913,2007-08-01T00:00:00,Signal Transduction,G02.149.115.800
17670913,2007-08-01T00:00:00,Signal Transduction,G04.299.880
17670913,2007-08-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.374.687.100
17670913,2007-08-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.954.800.720.100
17670913,2007-08-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.963.720.100
17670913,2007-08-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.374.687.100
17670913,2007-08-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.942.800.720.100
17670913,2007-08-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.960.720.100
17670913,2007-08-01T00:00:00,Transforming Growth Factor beta1,D23.529.374.687.100
17670913,2007-08-01T00:00:00,Transforming Growth Factor beta1,D23.529.942.800.720.100
17670913,2007-08-01T00:00:00,Transforming Growth Factor beta1,D23.529.960.720.100
17670996,2007-08-01T00:00:00,Adolescent,M01.060.057
17670996,2007-08-01T00:00:00,Adult,M01.060.116
17670996,2007-08-01T00:00:00,Age Factors,N05.715.350.075
17670996,2007-08-01T00:00:00,Age Factors,N06.850.490.250
17670996,2007-08-01T00:00:00,Aged,M01.060.116.100
17670996,2007-08-01T00:00:00,Combat Disorders,F03.080.931.249
17670996,2007-08-01T00:00:00,Health Surveys,E05.318.308.250
17670996,2007-08-01T00:00:00,Health Surveys,N05.715.360.300.375
17670996,2007-08-01T00:00:00,Health Surveys,N06.850.520.308.250
17670996,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17670996,2007-08-01T00:00:00,Mental Disorders,F03
17670996,2007-08-01T00:00:00,Middle Aged,M01.060.116.630
17670996,2007-08-01T00:00:00,Primary Health Care,N04.590.233.727
17670996,2007-08-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17670996,2007-08-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17670996,2007-08-01T00:00:00,Veterans,M01.930
17671284,2007-08-01T00:00:00,Adult,M01.060.116
17671284,2007-08-01T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
17671284,2007-08-01T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
17671284,2007-08-01T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
17671284,2007-08-01T00:00:00,Dibenzothiazepines,D02.886.680.702.500
17671284,2007-08-01T00:00:00,Dibenzothiazepines,D03.494.276
17671284,2007-08-01T00:00:00,Fetal Blood,A12.207.152.200
17671284,2007-08-01T00:00:00,Fetal Blood,A15.145.300
17671284,2007-08-01T00:00:00,Fetal Blood,A16.378.200
17671284,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17671284,2007-08-01T00:00:00,"Infant, Low Birth Weight",M01.060.703.520.460
17671284,2007-08-01T00:00:00,"Infant, Newborn",M01.060.703.520
17671284,2007-08-01T00:00:00,"Intensive Care Units, Neonatal",N02.278.388.493.390.380
17671284,2007-08-01T00:00:00,Maternal-Fetal Exchange,G08.686.785.760.769.455
17671284,2007-08-01T00:00:00,Pregnancy,G08.686.785.760.769
17671284,2007-08-01T00:00:00,Pregnancy Complications,C13.703
17671284,2007-08-01T00:00:00,Pregnancy Outcome,E01.789.700
17671284,2007-08-01T00:00:00,Pregnancy Outcome,G08.686.785.760.769.530
17671284,2007-08-01T00:00:00,Psychotic Disorders,F03.700.675
17671284,2007-08-01T00:00:00,Risperidone,D03.383.742.698.685
17678825,2007-08-01T00:00:00,Antirheumatic Agents,D27.505.954.329
17678825,2007-08-01T00:00:00,"Arthritis, Rheumatoid",C05.550.114.154
17678825,2007-08-01T00:00:00,"Arthritis, Rheumatoid",C05.799.114
17678825,2007-08-01T00:00:00,"Arthritis, Rheumatoid",C17.300.775.099
17678825,2007-08-01T00:00:00,"Arthritis, Rheumatoid",C20.111.199
17678825,2007-08-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
17678825,2007-08-01T00:00:00,Clinical Trials as Topic,E05.337.250
17678825,2007-08-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
17678825,2007-08-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
17678825,2007-08-01T00:00:00,Decision Making,F02.463.785.373
17678825,2007-08-01T00:00:00,Health Status,I01.240.425
17678825,2007-08-01T00:00:00,Health Status,N01.224.425
17678825,2007-08-01T00:00:00,Health Status,N06.850.505.400.425
17678825,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17678825,2007-08-01T00:00:00,Internet,L01.224.230.110.500
17678825,2007-08-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
17678825,2007-08-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
17678825,2007-08-01T00:00:00,Pain Measurement,E01.370.376.550.600
17678825,2007-08-01T00:00:00,Quality of Life,I01.800
17678825,2007-08-01T00:00:00,Quality of Life,K01.752.400.750
17678825,2007-08-01T00:00:00,Questionnaires,E05.318.308.750
17678825,2007-08-01T00:00:00,Questionnaires,L01.280.800
17678825,2007-08-01T00:00:00,Questionnaires,N05.715.360.300.695
17678825,2007-08-01T00:00:00,Questionnaires,N06.850.520.308.750
17678825,2007-08-01T00:00:00,Rheumatology,H02.403.429.730
17678825,2007-08-01T00:00:00,User-Computer Interface,L01.224.900.910
17678841,2007-08-01T00:00:00,Aged,M01.060.116.100
17678841,2007-08-01T00:00:00,"Biopsy, Fine-Needle",E01.370.388.100.100.500
17678841,2007-08-01T00:00:00,"Biopsy, Fine-Needle",E01.450.230.100.100.500
17678841,2007-08-01T00:00:00,"Biopsy, Fine-Needle",E01.450.865.100.100.500
17678841,2007-08-01T00:00:00,"Biopsy, Fine-Needle",E04.074.119.500
17678841,2007-08-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
17678841,2007-08-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
17678841,2007-08-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
17678841,2007-08-01T00:00:00,"Diagnosis, Differential",E01.171
17678841,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17678841,2007-08-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
17678841,2007-08-01T00:00:00,Lung Neoplasms,C08.381.540
17678841,2007-08-01T00:00:00,Lung Neoplasms,C08.785.520
17678841,2007-08-01T00:00:00,Lymph Nodes,A10.549.400
17678841,2007-08-01T00:00:00,Lymph Nodes,A15.382.520.604.412
17678841,2007-08-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.350.800.800
17678841,2007-08-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.600.350.800.800
17678841,2007-08-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.710.800.800
17678841,2007-08-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.825.800.800
17678841,2007-08-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.384.730.800.800
17678841,2007-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17678841,2007-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17678841,2007-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17678841,2007-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17678841,2007-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17681185,2007-08-01T00:00:00,Anesthesiology,H02.403.066
17681185,2007-08-01T00:00:00,Certification,N03.706.110.120
17681185,2007-08-01T00:00:00,Certification,N05.700.200.190
17681185,2007-08-01T00:00:00,Clinical Competence,I02.399.630.210
17681185,2007-08-01T00:00:00,Clinical Competence,N04.761.210
17681185,2007-08-01T00:00:00,Conscious Sedation,E03.250
17681185,2007-08-01T00:00:00,"Education, Medical, Graduate",I02.358.337.350
17681185,2007-08-01T00:00:00,"Education, Medical, Graduate",I02.358.399.350
17681185,2007-08-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
17681185,2007-08-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
17681185,2007-08-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
17681185,2007-08-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
17681185,2007-08-01T00:00:00,Gastroenterology,H02.403.429.405
17681185,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17681185,2007-08-01T00:00:00,"Liability, Legal",I01.880.604.583.490
17681185,2007-08-01T00:00:00,"Liability, Legal",N03.706.535.547
17681185,2007-08-01T00:00:00,"Monitoring, Intraoperative",E01.370.520.510
17681185,2007-08-01T00:00:00,"Monitoring, Intraoperative",E04.510
17681185,2007-08-01T00:00:00,United States,Z01.107.567.875
17683090,2007-08-01T00:00:00,Aged,M01.060.116.100
17683090,2007-08-01T00:00:00,Blood-Brain Barrier,A07.035
17683090,2007-08-01T00:00:00,Blood-Brain Barrier,A08.186.211.035
17683090,2007-08-01T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
17683090,2007-08-01T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
17683090,2007-08-01T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
17683090,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17683090,2007-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17683090,2007-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17683090,2007-08-01T00:00:00,Middle Aged,M01.060.116.630
17683090,2007-08-01T00:00:00,Stroke,C10.228.140.300.775
17683090,2007-08-01T00:00:00,Stroke,C14.907.253.855
17683090,2007-08-01T00:00:00,Thrombolytic Therapy,E02.319.913
17683090,2007-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17683090,2007-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17683090,2007-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17683090,2007-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17683090,2007-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17684111,2007-08-01T00:00:00,Adult,M01.060.116
17684111,2007-08-01T00:00:00,Alcoholism,C21.739.100.250
17684111,2007-08-01T00:00:00,Alcoholism,F03.900.100.350
17684111,2007-08-01T00:00:00,Cost of Illness,I01.137
17684111,2007-08-01T00:00:00,Cost of Illness,N03.219.151.165
17684111,2007-08-01T00:00:00,Health Expenditures,N03.219.151.450
17684111,2007-08-01T00:00:00,Health Expenditures,N05.300.385
17684111,2007-08-01T00:00:00,Health Services Accessibility,N04.590.374.350
17684111,2007-08-01T00:00:00,Health Services Accessibility,N05.300.430
17684111,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17684111,2007-08-01T00:00:00,Mental Disorders,F03
17684111,2007-08-01T00:00:00,Mental Health Services,F04.408
17684111,2007-08-01T00:00:00,Mental Health Services,N02.421.461
17684111,2007-08-01T00:00:00,Middle Aged,M01.060.116.630
17684111,2007-08-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
17684111,2007-08-01T00:00:00,Risk-Taking,F01.145.722
17686383,2007-08-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
17686383,2007-08-01T00:00:00,Blood Pressure,E01.370.600.875.249
17686383,2007-08-01T00:00:00,Blood Pressure,G09.330.380.076
17686383,2007-08-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
17686383,2007-08-01T00:00:00,Clinical Trials as Topic,E05.337.250
17686383,2007-08-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
17686383,2007-08-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
17686383,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17686383,2007-08-01T00:00:00,Hypertension,C14.907.489
17686383,2007-08-01T00:00:00,Life Style,F01.829.458
17689640,2007-08-01T00:00:00,Adult,M01.060.116
17689640,2007-08-01T00:00:00,"Antigens, CD",D23.050.301.264.035
17689640,2007-08-01T00:00:00,"Antigens, CD",D23.101.100.110
17689640,2007-08-01T00:00:00,Biological Markers,D23.101
17689640,2007-08-01T00:00:00,Case-Control Studies,E05.318.760.500.500
17689640,2007-08-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
17689640,2007-08-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
17689640,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17689640,2007-08-01T00:00:00,Pre-Eclampsia,C13.703.395.249
17689640,2007-08-01T00:00:00,Pregnancy,G08.686.785.760.769
17689640,2007-08-01T00:00:00,Signal Transduction,G02.111.087.800
17689640,2007-08-01T00:00:00,Signal Transduction,G02.149.115.800
17689640,2007-08-01T00:00:00,Signal Transduction,G04.299.880
17689640,2007-08-01T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
17689640,2007-08-01T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
17689640,2007-08-01T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
17689640,2007-08-01T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
17689640,2007-08-01T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
17689640,2007-08-01T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
17689640,2007-08-01T00:00:00,Transforming Growth Factor beta,D23.529.374.687
17689640,2007-08-01T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
17689640,2007-08-01T00:00:00,Transforming Growth Factor beta,D23.529.960.720
17689647,2007-08-01T00:00:00,Adenocarcinoma,C04.557.470.200.025
17689647,2007-08-01T00:00:00,Adolescent,M01.060.057
17689647,2007-08-01T00:00:00,Adult,M01.060.116
17689647,2007-08-01T00:00:00,Aged,M01.060.116.100
17689647,2007-08-01T00:00:00,Cervix Uteri,A05.360.319.679.256
17689647,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17689647,2007-08-01T00:00:00,Middle Aged,M01.060.116.630
17689647,2007-08-01T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
17689647,2007-08-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
17689647,2007-08-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
17689647,2007-08-01T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
17689655,2007-08-01T00:00:00,Adult,M01.060.116
17689655,2007-08-01T00:00:00,Biological Markers,D23.101
17689655,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17689655,2007-08-01T00:00:00,Hypertension,C14.907.489
17689655,2007-08-01T00:00:00,Pre-Eclampsia,C13.703.395.249
17689655,2007-08-01T00:00:00,Pregnancy,G08.686.785.760.769
17689655,2007-08-01T00:00:00,Vascular Endothelial Growth Factor Receptor-1,D08.811.913.696.620.682.725.400.950.100
17689655,2007-08-01T00:00:00,Vascular Endothelial Growth Factor Receptor-1,D12.776.543.750.060.750.100
17689655,2007-08-01T00:00:00,Vascular Endothelial Growth Factor Receptor-1,D12.776.543.750.750.400.910.100
17696644,2007-08-01T00:00:00,Animals,B01.050
17696644,2007-08-01T00:00:00,Brain,A08.186.211
17696644,2007-08-01T00:00:00,Gene Expression Profiling,E05.393.332
17696644,2007-08-01T00:00:00,Glioma,C04.557.465.625.600.380
17696644,2007-08-01T00:00:00,Glioma,C04.557.470.670.380
17696644,2007-08-01T00:00:00,Glioma,C04.557.580.625.600.380
17696644,2007-08-01T00:00:00,Green Fluorescent Proteins,D12.776.532.265
17696644,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17696644,2007-08-01T00:00:00,Neoplasm Invasiveness,C04.697.645
17696644,2007-08-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
17696644,2007-08-01T00:00:00,Nerve Growth Factors,D12.644.276.860
17696644,2007-08-01T00:00:00,Nerve Growth Factors,D12.776.467.860
17696644,2007-08-01T00:00:00,Nerve Growth Factors,D12.776.641.600
17696644,2007-08-01T00:00:00,Nerve Growth Factors,D23.529.850
17696644,2007-08-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
17696644,2007-08-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
17696644,2007-08-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
17696644,2007-08-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
17696644,2007-08-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
17696644,2007-08-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
17700298,2007-08-01T00:00:00,Adult,M01.060.116
17700298,2007-08-01T00:00:00,"Behavior, Addictive",F01.145.527.100.120
17700298,2007-08-01T00:00:00,Cognitive Therapy,F04.754.137.428
17700298,2007-08-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
17700298,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17700298,2007-08-01T00:00:00,Mathematics,H01.548
17700298,2007-08-01T00:00:00,Pilot Projects,E05.318.760.750
17700298,2007-08-01T00:00:00,Pilot Projects,E05.337.737
17700298,2007-08-01T00:00:00,Pilot Projects,N05.715.360.775.625
17700298,2007-08-01T00:00:00,Pilot Projects,N06.850.520.450.720
17700298,2007-08-01T00:00:00,Psychiatric Status Rating Scales,F04.586
17700298,2007-08-01T00:00:00,"Stress, Psychological",F01.145.126.990
17700298,2007-08-01T00:00:00,"Stress, Psychological",F02.830.900
17700298,2007-08-01T00:00:00,Substance-Related Disorders,C21.739
17700298,2007-08-01T00:00:00,Substance-Related Disorders,F03.900
17700298,2007-08-01T00:00:00,Task Performance and Analysis,F02.784.412.846
17700298,2007-08-01T00:00:00,Task Performance and Analysis,F02.784.692.746
17700298,2007-08-01T00:00:00,Task Performance and Analysis,F02.808.600
17700298,2007-08-01T00:00:00,Treatment Outcome,E01.789.800
17700298,2007-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17700298,2007-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17713304,2007-08-01T00:00:00,Adult,M01.060.116
17713304,2007-08-01T00:00:00,African Americans,M01.686.508.100.100
17713304,2007-08-01T00:00:00,African Americans,M01.686.754.100
17713304,2007-08-01T00:00:00,Aged,M01.060.116.100
17713304,2007-08-01T00:00:00,Amputation,E04.555.080
17713304,2007-08-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
17713304,2007-08-01T00:00:00,Health Surveys,E05.318.308.250
17713304,2007-08-01T00:00:00,Health Surveys,N05.715.360.300.375
17713304,2007-08-01T00:00:00,Health Surveys,N06.850.520.308.250
17713304,2007-08-01T00:00:00,Hospitalization,E02.760.400
17713304,2007-08-01T00:00:00,Hospitalization,N02.421.585.400
17713304,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17713304,2007-08-01T00:00:00,International Classification of Diseases,L01.453.245.945.400
17713304,2007-08-01T00:00:00,Middle Aged,M01.060.116.630
17713304,2007-08-01T00:00:00,Patient Education as Topic,I02.233.332.500
17713304,2007-08-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
17713304,2007-08-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
17713304,2007-08-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17713304,2007-08-01T00:00:00,Risk Factors,N05.715.350.200.700
17713304,2007-08-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17713304,2007-08-01T00:00:00,Risk Factors,N06.850.490.625.750
17713304,2007-08-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17713304,2007-08-01T00:00:00,Rural Population,N01.600.725
17713304,2007-08-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17713304,2007-08-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17713304,2007-08-01T00:00:00,United States,Z01.107.567.875
17713304,2007-08-01T00:00:00,Urban Population,N01.600.900
17721965,2007-08-01T00:00:00,"Adaptation, Psychological",F01.058
17721965,2007-08-01T00:00:00,Bias (Epidemiology),N05.715.350.150
17721965,2007-08-01T00:00:00,Bias (Epidemiology),N06.850.490.500
17721965,2007-08-01T00:00:00,Combat Disorders,F03.080.931.249
17721965,2007-08-01T00:00:00,Health Surveys,E05.318.308.250
17721965,2007-08-01T00:00:00,Health Surveys,N05.715.360.300.375
17721965,2007-08-01T00:00:00,Health Surveys,N06.850.520.308.250
17721965,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17721965,2007-08-01T00:00:00,Self Disclosure,F01.752.747.792.662
17721965,2007-08-01T00:00:00,United States,Z01.107.567.875
17721965,2007-08-01T00:00:00,Veterans,M01.930
17725868,2007-08-01T00:00:00,"Chromatography, Ion Exchange",E05.196.181.400.383
17725868,2007-08-01T00:00:00,Polymers,D05.750
17725868,2007-08-01T00:00:00,Polymers,D25.720
17725868,2007-08-01T00:00:00,Polymers,J01.637.051.720
17725868,2007-08-01T00:00:00,Proteins,D12.776
17761651,2007-08-01T00:00:00,Animals,B01.050
17761651,2007-08-01T00:00:00,Bone Development,G07.700.320.500.325.377.625.100
17761651,2007-08-01T00:00:00,Bone Development,G11.427.590.560.100
17761651,2007-08-01T00:00:00,Bone and Bones,A02.835.232
17761651,2007-08-01T00:00:00,Bone and Bones,A10.165.265
17761651,2007-08-01T00:00:00,Child,M01.060.406
17761651,2007-08-01T00:00:00,"Disease Models, Animal",C22.232
17761651,2007-08-01T00:00:00,"Disease Models, Animal",E05.598.500
17761651,2007-08-01T00:00:00,"Disease Models, Animal",E05.599.395.080
17761651,2007-08-01T00:00:00,"Fractures, Bone",C21.866.404
17761651,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17761651,2007-08-01T00:00:00,Nerve Tissue Proteins,D12.776.641
17761651,2007-08-01T00:00:00,Osteoclasts,A11.329.372.700
17761651,2007-08-01T00:00:00,Osteoclasts,A11.627.482.700
17761651,2007-08-01T00:00:00,Peptides,D12.644
17761651,2007-08-01T00:00:00,RNA-Binding Proteins,D12.776.157.725
17761651,2007-08-01T00:00:00,RNA-Binding Proteins,D12.776.664.962
17762332,2007-08-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
17762332,2007-08-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
17762332,2007-08-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
17762332,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17762332,2007-08-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
17762332,2007-08-01T00:00:00,Lung Neoplasms,C08.381.540
17762332,2007-08-01T00:00:00,Lung Neoplasms,C08.785.520
17762332,2007-08-01T00:00:00,Neoplasm Staging,E01.370.550
17763004,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17763004,2007-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17763004,2007-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17763004,2007-08-01T00:00:00,Middle Aged,M01.060.116.630
17763004,2007-08-01T00:00:00,Neurosurgical Procedures,E04.525
17763004,2007-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17763004,2007-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17763004,2007-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17763004,2007-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17763004,2007-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17765582,2007-08-01T00:00:00,"Decompression, Surgical",E04.188
17765582,2007-08-01T00:00:00,"Fractures, Bone",C21.866.404
17765582,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17826637,2007-08-01T00:00:00,Angioplasty,E02.148.050
17826637,2007-08-01T00:00:00,Angioplasty,E04.100.814.050
17826637,2007-08-01T00:00:00,Anticoagulants,D27.505.954.502.119
17826637,2007-08-01T00:00:00,Brain,A08.186.211
17826637,2007-08-01T00:00:00,Carotid Arteries,A07.231.114.186
17826637,2007-08-01T00:00:00,Carotid Stenosis,C10.228.140.300.200.360
17826637,2007-08-01T00:00:00,Carotid Stenosis,C14.907.137.230
17826637,2007-08-01T00:00:00,Carotid Stenosis,C14.907.253.123.360
17826637,2007-08-01T00:00:00,"Constriction, Pathologic",C23.300.287
17826637,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17826637,2007-08-01T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
17826637,2007-08-01T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
17826637,2007-08-01T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
17826637,2007-08-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
17826637,2007-08-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
17826637,2007-08-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
17826637,2007-08-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
17826637,2007-08-01T00:00:00,Stents,E07.695.750
17849875,2007-08-01T00:00:00,Animals,B01.050
17849875,2007-08-01T00:00:00,Feeding Behavior,F01.145.113.547
17849875,2007-08-01T00:00:00,Feeding Behavior,F01.145.407
17849875,2007-08-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17849875,2007-08-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17867378,2007-08-01T00:00:00,Biological Markers,D23.101
17867378,2007-08-01T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
17867378,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17867378,2007-08-01T00:00:00,Luminescent Measurements,E05.196.712.516
18333581,2007-08-01T00:00:00,Adolescent,M01.060.057
18333581,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18333581,2007-08-01T00:00:00,Pediatrics,H02.403.670
18333581,2007-08-01T00:00:00,Scoliosis,C05.116.900.800.875
18333581,2007-08-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18333581,2007-08-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18333581,2007-08-01T00:00:00,Treatment Outcome,E01.789.800
18333581,2007-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18333581,2007-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18333582,2007-08-01T00:00:00,Evidence-Based Medicine,H02.249.750
18333582,2007-08-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
18333582,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18333582,2007-08-01T00:00:00,Internet,L01.224.230.110.500
18333582,2007-08-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18333582,2007-08-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18705947,2007-08-01T00:00:00,Albumins,D12.776.034
18705947,2007-08-01T00:00:00,Double-Blind Method,E05.318.780.300
18705947,2007-08-01T00:00:00,Double-Blind Method,E05.581.500.300
18705947,2007-08-01T00:00:00,Double-Blind Method,N05.715.360.780.320
18705947,2007-08-01T00:00:00,Double-Blind Method,N06.850.520.445.300
18705947,2007-08-01T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
18705947,2007-08-01T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
18705947,2007-08-01T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
18705947,2007-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18705947,2007-08-01T00:00:00,Research Design,E05.581.500
18705947,2007-08-01T00:00:00,Research Design,H01.770.644.728
18705947,2007-08-01T00:00:00,Stroke,C10.228.140.300.775
18705947,2007-08-01T00:00:00,Stroke,C14.907.253.855
18705947,2007-08-01T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
18705947,2007-08-01T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
18705947,2007-08-01T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
18705947,2007-08-01T00:00:00,Tissue Plasminogen Activator,D23.119.970
17671263,2007-08-02T00:00:00,"Ethics, Medical",K01.316.333.132.750
17671263,2007-08-02T00:00:00,"Ethics, Medical",N05.350.340.162.500
17671263,2007-08-02T00:00:00,Interprofessional Relations,F01.829.401.205
17671263,2007-08-02T00:00:00,Organizational Policy,I01.880.604.825.550
17671263,2007-08-02T00:00:00,Organizational Policy,N03.706.825.550
17671263,2007-08-02T00:00:00,Physicians,M01.526.485.810
17671263,2007-08-02T00:00:00,Physicians,N02.360.810
17671263,2007-08-02T00:00:00,United States,Z01.107.567.875
17767965,2007-08-02T00:00:00,Animals,B01.050
17767965,2007-08-02T00:00:00,Environmental Exposure,N06.850.460.350
17767965,2007-08-02T00:00:00,Muscles,A02.633
17767965,2007-08-02T00:00:00,Muscles,A10.690
17767965,2007-08-02T00:00:00,Reproduction,G08.686.785.760
17767965,2007-08-02T00:00:00,Temperature,G01.906.595
17767965,2007-08-02T00:00:00,Temperature,G16.500.275.063.725.710
17767965,2007-08-02T00:00:00,Temperature,G16.500.750.775.710
17767965,2007-08-02T00:00:00,Temperature,N06.230.150.450
17767965,2007-08-02T00:00:00,Temperature,N06.230.300.100.725.710
17767965,2007-08-02T00:00:00,Testis,A05.360.444.849
17767965,2007-08-02T00:00:00,Testis,A05.360.576.782
17767965,2007-08-02T00:00:00,Testis,A06.407.312.782
17767965,2007-08-02T00:00:00,Testosterone,D04.808.054.079.429.824
17767965,2007-08-02T00:00:00,Testosterone,D06.472.334.851.968.984
17767965,2007-08-02T00:00:00,Water,D01.455.900
17767965,2007-08-02T00:00:00,Water,D01.650.550.925
17767965,2007-08-02T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
17673682,2007-08-03T00:00:00,Animals,B01.050
17673682,2007-08-03T00:00:00,Cell Adhesion,G04.299.117
17673682,2007-08-03T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
17673682,2007-08-03T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
17673682,2007-08-03T00:00:00,Cell Adhesion Molecules,D23.050.301.350
17673682,2007-08-03T00:00:00,Cicatrix,A10.165.450.300
17673682,2007-08-03T00:00:00,Cicatrix,C23.550.355.274
17673682,2007-08-03T00:00:00,Cicatrix,G16.100.856.891.249
17673682,2007-08-03T00:00:00,Collagen,D05.750.078.280
17673682,2007-08-03T00:00:00,Collagen,D12.776.860.300.250
17673682,2007-08-03T00:00:00,Fibroblasts,A11.329.228
17673682,2007-08-03T00:00:00,Fibroblasts,A11.872.228
17673682,2007-08-03T00:00:00,Fibrosis,C23.550.355
17673682,2007-08-03T00:00:00,Gene Expression Regulation,G05.355.315
17673682,2007-08-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17673682,2007-08-03T00:00:00,Myocardial Infarction,C14.280.647.500
17673682,2007-08-03T00:00:00,Myocardial Infarction,C14.907.585.500
17673682,2007-08-03T00:00:00,"Myocytes, Cardiac",A07.541.704.570
17673682,2007-08-03T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
17673682,2007-08-03T00:00:00,"Myocytes, Cardiac",A11.620.500
17673682,2007-08-03T00:00:00,Ventricular Remodeling,C23.300.985
17673682,2007-08-03T00:00:00,Ventricular Remodeling,G09.330.190.962.975
17674077,2007-08-03T00:00:00,Alligators and Crocodiles,B01.050.150.900.833.100
17674077,2007-08-03T00:00:00,Animals,B01.050
17674077,2007-08-03T00:00:00,"Evolution, Molecular",G05.355.265.250
17674077,2007-08-03T00:00:00,"Evolution, Molecular",G16.100.275.250
17674077,2007-08-03T00:00:00,Gene Expression Profiling,E05.393.332
17674077,2007-08-03T00:00:00,"Models, Biological",E05.599.395
17674077,2007-08-03T00:00:00,"Models, Genetic",E05.599.395.397
17674077,2007-08-03T00:00:00,Phylogeny,G05.697
17674077,2007-08-03T00:00:00,Phylogeny,G16.100.275.605
17674077,2007-08-03T00:00:00,Phylogeny,L01.100.697
17675337,2007-08-03T00:00:00,Animals,B01.050
17675337,2007-08-03T00:00:00,Skin Neoplasms,C04.588.805
17675337,2007-08-03T00:00:00,Skin Neoplasms,C17.800.882
17676766,2007-08-03T00:00:00,Cell Membrane,A11.284.149
17676766,2007-08-03T00:00:00,Cyclic AMP,D03.438.759.646.138.395
17676766,2007-08-03T00:00:00,Cyclic AMP,D13.695.462.200
17676766,2007-08-03T00:00:00,Cyclic AMP,D13.695.667.138.395
17676766,2007-08-03T00:00:00,Cyclic AMP,D13.695.827.068.395
17676766,2007-08-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17676766,2007-08-03T00:00:00,Insulin,D06.472.699.587.740.625
17676766,2007-08-03T00:00:00,Insulin,D12.644.548.586.740.625
17676766,2007-08-03T00:00:00,Peptide Fragments,D12.644.541
17676766,2007-08-03T00:00:00,Proteins,D12.776
17676766,2007-08-03T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
17676766,2007-08-03T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
17889355,2007-08-03T00:00:00,Adult,M01.060.116
17889355,2007-08-03T00:00:00,Cyclosporine,D04.345.566.235.300
17889355,2007-08-03T00:00:00,Cyclosporine,D12.644.641.235.300
17889355,2007-08-03T00:00:00,Hematopoietic Stem Cell Transplantation,E04.936.225.687.500
17889355,2007-08-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17889355,2007-08-03T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
17889355,2007-08-03T00:00:00,Interferon-gamma,D12.644.276.374.440.893
17889355,2007-08-03T00:00:00,Interferon-gamma,D12.644.276.374.480.350
17889355,2007-08-03T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
17889355,2007-08-03T00:00:00,Interferon-gamma,D12.644.276.718.550
17889355,2007-08-03T00:00:00,Interferon-gamma,D12.776.467.374.440.893
17889355,2007-08-03T00:00:00,Interferon-gamma,D12.776.467.374.480.350
17889355,2007-08-03T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
17889355,2007-08-03T00:00:00,Interferon-gamma,D12.776.467.718.550
17889355,2007-08-03T00:00:00,Interferon-gamma,D23.529.374.440.893
17889355,2007-08-03T00:00:00,Interferon-gamma,D23.529.374.480.350
17889355,2007-08-03T00:00:00,Interferon-gamma,D23.529.374.480.615.350
17889355,2007-08-03T00:00:00,Interferon-gamma,D23.529.718.550
17889355,2007-08-03T00:00:00,Interleukin-2,D12.644.276.374.465.502
17889355,2007-08-03T00:00:00,Interleukin-2,D12.644.276.374.480.372
17889355,2007-08-03T00:00:00,Interleukin-2,D12.776.467.374.465.502
17889355,2007-08-03T00:00:00,Interleukin-2,D12.776.467.374.480.372
17889355,2007-08-03T00:00:00,Interleukin-2,D23.529.374.465.502
17889355,2007-08-03T00:00:00,Interleukin-2,D23.529.374.480.372
17889355,2007-08-03T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
17889355,2007-08-03T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
17889355,2007-08-03T00:00:00,Recombinant Proteins,D12.776.828
17889355,2007-08-03T00:00:00,Salvage Therapy,E02.186.800
17889355,2007-08-03T00:00:00,Salvage Therapy,E02.895
17889355,2007-08-03T00:00:00,Syndrome,C23.550.288.500
17889355,2007-08-03T00:00:00,Transplantation Conditioning,E02.095.465.425.450.800
17889355,2007-08-03T00:00:00,Transplantation Conditioning,E05.478.610.800
17676387,2007-08-04T00:00:00,Animals,B01.050
17676387,2007-08-04T00:00:00,Apoptosis,G04.299.139.160
17676387,2007-08-04T00:00:00,Calpain,D08.811.277.656.262.500.120
17676387,2007-08-04T00:00:00,Calpain,D08.811.277.656.300.200.120
17676387,2007-08-04T00:00:00,Cell Death,G04.299.139
17676387,2007-08-04T00:00:00,Neurons,A08.663
17676387,2007-08-04T00:00:00,Neurons,A11.671
17676387,2007-08-04T00:00:00,Neuroprotective Agents,D27.505.696.706.548
17676387,2007-08-04T00:00:00,Neuroprotective Agents,D27.505.954.427.575
17676387,2007-08-04T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17676387,2007-08-04T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17676387,2007-08-04T00:00:00,Spinal Cord Injuries,C10.228.854.770
17676387,2007-08-04T00:00:00,Spinal Cord Injuries,C10.900.850
17676387,2007-08-04T00:00:00,Spinal Cord Injuries,C21.866.819
17676389,2007-08-04T00:00:00,Animals,B01.050
17676389,2007-08-04T00:00:00,Antineoplastic Agents,D27.505.954.248
17676389,2007-08-04T00:00:00,Apoptosis,G04.299.139.160
17676389,2007-08-04T00:00:00,Brain Neoplasms,C04.588.614.250.195
17676389,2007-08-04T00:00:00,Brain Neoplasms,C10.228.140.211
17676389,2007-08-04T00:00:00,Brain Neoplasms,C10.551.240.250
17676389,2007-08-04T00:00:00,Cancer Vaccines,D20.215.894.200
17676389,2007-08-04T00:00:00,Combined Modality Therapy,E02.186
17676389,2007-08-04T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
17676389,2007-08-04T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
17676389,2007-08-04T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
17676389,2007-08-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17676389,2007-08-04T00:00:00,Interferon-gamma,D12.644.276.374.440.893
17676389,2007-08-04T00:00:00,Interferon-gamma,D12.644.276.374.480.350
17676389,2007-08-04T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
17676389,2007-08-04T00:00:00,Interferon-gamma,D12.644.276.718.550
17676389,2007-08-04T00:00:00,Interferon-gamma,D12.776.467.374.440.893
17676389,2007-08-04T00:00:00,Interferon-gamma,D12.776.467.374.480.350
17676389,2007-08-04T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
17676389,2007-08-04T00:00:00,Interferon-gamma,D12.776.467.718.550
17676389,2007-08-04T00:00:00,Interferon-gamma,D23.529.374.440.893
17676389,2007-08-04T00:00:00,Interferon-gamma,D23.529.374.480.350
17676389,2007-08-04T00:00:00,Interferon-gamma,D23.529.374.480.615.350
17676389,2007-08-04T00:00:00,Interferon-gamma,D23.529.718.550
17676389,2007-08-04T00:00:00,Recombinant Proteins,D12.776.828
17632270,2007-08-06T00:00:00,Acoustic Stimulation,E02.037
17632270,2007-08-06T00:00:00,Acoustic Stimulation,E02.190.888.030
17632270,2007-08-06T00:00:00,Acoustic Stimulation,E05.723.136
17632270,2007-08-06T00:00:00,Adult,M01.060.116
17632270,2007-08-06T00:00:00,Attention,F02.830.104.214
17632270,2007-08-06T00:00:00,Brain Mapping,E01.370.350.086
17632270,2007-08-06T00:00:00,Brain Mapping,E01.370.376.149
17632270,2007-08-06T00:00:00,Brain Mapping,E05.132
17632270,2007-08-06T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
17632270,2007-08-06T00:00:00,Functional Laterality,F02.830.297.425
17632270,2007-08-06T00:00:00,Functional Laterality,G11.561.225.425
17632270,2007-08-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17632270,2007-08-06T00:00:00,Language,F01.145.209.399
17632270,2007-08-06T00:00:00,Language,L01.143.506
17632270,2007-08-06T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17632270,2007-08-06T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17632270,2007-08-06T00:00:00,Neural Pathways,A08.612
17632270,2007-08-06T00:00:00,Parietal Lobe,A08.186.211.730.885.287.500.670
17632270,2007-08-06T00:00:00,Space Perception,F02.463.593.778
17632270,2007-08-06T00:00:00,Space Perception,F02.463.593.932.869
17632270,2007-08-06T00:00:00,Speech Perception,F02.463.593.071.875
17632270,2007-08-06T00:00:00,Temporal Lobe,A08.186.211.730.885.287.500.863
17632279,2007-08-06T00:00:00,Animals,B01.050
17632279,2007-08-06T00:00:00,"Behavior, Addictive",F01.145.527.100.120
17632279,2007-08-06T00:00:00,Cocaine,D02.145.074.722.388
17632279,2007-08-06T00:00:00,Cocaine,D03.132.889.354
17632279,2007-08-06T00:00:00,Cocaine,D03.605.869.388
17632279,2007-08-06T00:00:00,Cocaine,D04.075.080.875.099.722.388
17632279,2007-08-06T00:00:00,Cocaine-Related Disorders,C21.739.300
17632279,2007-08-06T00:00:00,Cocaine-Related Disorders,F03.900.300
17632279,2007-08-06T00:00:00,"Disease Models, Animal",C22.232
17632279,2007-08-06T00:00:00,"Disease Models, Animal",E05.598.500
17632279,2007-08-06T00:00:00,"Disease Models, Animal",E05.599.395.080
17632279,2007-08-06T00:00:00,Dopamine,D02.092.211.215.311.342
17632279,2007-08-06T00:00:00,Dopamine,D02.092.311.342
17632279,2007-08-06T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
17632279,2007-08-06T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
17632279,2007-08-06T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
17632279,2007-08-06T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
17632279,2007-08-06T00:00:00,Down-Regulation,G02.111.087.225
17632279,2007-08-06T00:00:00,Down-Regulation,G02.149.115.225
17632279,2007-08-06T00:00:00,Down-Regulation,G05.355.315.200
17632279,2007-08-06T00:00:00,Down-Regulation,G07.690.812.230
17632279,2007-08-06T00:00:00,Down-Regulation,G07.700.680.230
17632279,2007-08-06T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
17632279,2007-08-06T00:00:00,RGS Proteins,D12.644.360.325.150.750
17632279,2007-08-06T00:00:00,RGS Proteins,D12.776.402.150.750
17632279,2007-08-06T00:00:00,RGS Proteins,D12.776.476.325.150.750
17632279,2007-08-06T00:00:00,"RNA, Messenger",D13.444.735.544
17632279,2007-08-06T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17632279,2007-08-06T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17632279,2007-08-06T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
17632279,2007-08-06T00:00:00,Self Administration,E02.319.890
17632279,2007-08-06T00:00:00,Self Administration,E02.900.890
17632279,2007-08-06T00:00:00,Substance Withdrawal Syndrome,C21.739.835
17632279,2007-08-06T00:00:00,Substance Withdrawal Syndrome,F03.900.825
17679629,2007-08-07T00:00:00,Coronary Circulation,G09.330.190.163.324
17679629,2007-08-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17679629,2007-08-07T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
17679629,2007-08-07T00:00:00,Practice Guidelines as Topic,N05.700.350.650
17679629,2007-08-07T00:00:00,Prostheses and Implants,E07.695
17679629,2007-08-07T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
17679629,2007-08-07T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
17679629,2007-08-07T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
17679629,2007-08-07T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
17679629,2007-08-07T00:00:00,United States,Z01.107.567.875
17686178,2007-08-08T00:00:00,Animals,B01.050
17686178,2007-08-08T00:00:00,Cancer Vaccines,D20.215.894.200
17686178,2007-08-08T00:00:00,Dendritic Cells,A11.066.270
17686178,2007-08-08T00:00:00,Dendritic Cells,A11.436.270
17686178,2007-08-08T00:00:00,Dendritic Cells,A15.382.066.270
17686178,2007-08-08T00:00:00,Dendritic Cells,A15.382.812.260
17686178,2007-08-08T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
17686178,2007-08-08T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
17686178,2007-08-08T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
17686178,2007-08-08T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
17686178,2007-08-08T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
17686178,2007-08-08T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
17686178,2007-08-08T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
17686178,2007-08-08T00:00:00,Spleen,A10.549.700
17686178,2007-08-08T00:00:00,Spleen,A15.382.520.604.700
17687330,2007-08-08T00:00:00,"Adaptor Proteins, Signal Transducing",D12.644.360.024
17687330,2007-08-08T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.157.057
17687330,2007-08-08T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.476.024
17687330,2007-08-08T00:00:00,Animals,B01.050
17687330,2007-08-08T00:00:00,Biological Transport,G03.495.166
17687330,2007-08-08T00:00:00,Cell Line,A11.251.210
17687330,2007-08-08T00:00:00,Cell Membrane,A11.284.149
17687330,2007-08-08T00:00:00,Ceramides,D02.065.313
17687330,2007-08-08T00:00:00,Ceramides,D09.400.410.420.525.200
17687330,2007-08-08T00:00:00,Ceramides,D10.390.470.675.200
17687330,2007-08-08T00:00:00,Ceramides,D10.570.877.360.612.200
17687330,2007-08-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17687330,2007-08-08T00:00:00,"Models, Biological",E05.599.395
17687330,2007-08-08T00:00:00,Sphingosine,D02.033.100.700
17687330,2007-08-08T00:00:00,Sphingosine,D02.033.455.843
17687330,2007-08-08T00:00:00,Sphingosine,D02.092.063.700
17822691,2007-08-09T00:00:00,Animals,B01.050
17822691,2007-08-09T00:00:00,Extracellular Matrix,A11.284.295.310
17822691,2007-08-09T00:00:00,Extracellular Matrix Proteins,D12.776.860.300
17822691,2007-08-09T00:00:00,Heart,A07.541
17822691,2007-08-09T00:00:00,Hyaluronic Acid,D09.698.373.475
17822691,2007-08-09T00:00:00,Mesoderm,A16.504.660
17822691,2007-08-09T00:00:00,Myocardium,A02.633.580
17822691,2007-08-09T00:00:00,Myocardium,A07.541.704
17822691,2007-08-09T00:00:00,Myocardium,A10.690.552.750
17822691,2007-08-09T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
17822691,2007-08-09T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
17822691,2007-08-09T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
17822691,2007-08-09T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
17822691,2007-08-09T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
17822691,2007-08-09T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
17822691,2007-08-09T00:00:00,Versicans,D09.698.735.830.750
17822691,2007-08-09T00:00:00,Versicans,D12.776.395.650.750.750
17822691,2007-08-09T00:00:00,Versicans,D12.776.503.280.625
17850859,2007-08-09T00:00:00,Amino Acid Sequence,G02.111.570.060
17850859,2007-08-09T00:00:00,Amino Acid Sequence,L01.453.245.667.060
17850859,2007-08-09T00:00:00,Binding Sites,G02.111.570.120
17850859,2007-08-09T00:00:00,"Models, Molecular",E05.599.595
17850859,2007-08-09T00:00:00,Protein Conformation,G02.111.570.790.709
17850859,2007-08-09T00:00:00,Proteins,D12.776
17690929,2007-08-10T00:00:00,Animals,B01.050
17690929,2007-08-10T00:00:00,Extracellular Matrix,A11.284.295.310
17690929,2007-08-10T00:00:00,"Models, Biological",E05.599.395
17690929,2007-08-10T00:00:00,"Muscle, Smooth",A02.633.570
17690929,2007-08-10T00:00:00,"Muscle, Smooth",A10.690.467
17690929,2007-08-10T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17690929,2007-08-10T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17690929,2007-08-10T00:00:00,"Stress, Mechanical",G01.374.676.830
17690929,2007-08-10T00:00:00,"Stress, Mechanical",G01.595.540.830
17690929,2007-08-10T00:00:00,Urinary Bladder,A05.810.890
17690929,2007-08-10T00:00:00,"Urinary Bladder, Neurogenic",C10.597.900
17690929,2007-08-10T00:00:00,"Urinary Bladder, Neurogenic",C12.777.829.839
17690929,2007-08-10T00:00:00,"Urinary Bladder, Neurogenic",C13.351.968.829.760
17690929,2007-08-10T00:00:00,"Urinary Bladder, Neurogenic",C23.888.592.900
17693468,2007-08-10T00:00:00,Binding Sites,G02.111.570.120
17693468,2007-08-10T00:00:00,Carrier Proteins,D12.776.157
17693468,2007-08-10T00:00:00,Computer Simulation,L01.224.160
17693468,2007-08-10T00:00:00,"Models, Molecular",E05.599.595
17693468,2007-08-10T00:00:00,"Models, Statistical",E05.318.740.500
17693468,2007-08-10T00:00:00,"Models, Statistical",E05.599.835
17693468,2007-08-10T00:00:00,"Models, Statistical",N05.715.360.750.530
17693468,2007-08-10T00:00:00,"Models, Statistical",N06.850.520.830.500
17693468,2007-08-10T00:00:00,Protein Conformation,G02.111.570.790.709
17693468,2007-08-10T00:00:00,Protein Interaction Mapping,E05.601.690
17693468,2007-08-10T00:00:00,Proteins,D12.776
17693468,2007-08-10T00:00:00,Software,L01.224.900
17693468,2007-08-10T00:00:00,Static Electricity,G01.201.249.820
17693584,2007-08-10T00:00:00,Amphetamine,D02.092.471.683.152.110
17693584,2007-08-10T00:00:00,Animals,B01.050
17693584,2007-08-10T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
17693584,2007-08-10T00:00:00,RGS Proteins,D12.644.360.325.150.750
17693584,2007-08-10T00:00:00,RGS Proteins,D12.776.402.150.750
17693584,2007-08-10T00:00:00,RGS Proteins,D12.776.476.325.150.750
17693584,2007-08-10T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17693584,2007-08-10T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17693584,2007-08-10T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.100.450
17693584,2007-08-10T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.720.200.450.500
17693597,2007-08-10T00:00:00,Animals,B01.050
17693597,2007-08-10T00:00:00,Cryptococcosis,C01.703.248
17693597,2007-08-10T00:00:00,Cryptococcus neoformans,B01.300.381.258.366
17693597,2007-08-10T00:00:00,Cryptococcus neoformans,B01.300.930.316.366
17693597,2007-08-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17880915,2007-08-10T00:00:00,Mitochondria,A11.284.430.214.190.875.564
17880915,2007-08-10T00:00:00,Mitochondria,A11.284.835.626
17880915,2007-08-10T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
17880915,2007-08-10T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
17880915,2007-08-10T00:00:00,Saccharomyces cerevisiae Proteins,D12.776.354.750
17880915,2007-08-10T00:00:00,Sphingolipids,D10.570.877
17880915,2007-08-10T00:00:00,Sphingolipids,D10.808
17691832,2007-08-11T00:00:00,Algorithms,G17.035
17691832,2007-08-11T00:00:00,Algorithms,L01.224.050
17691832,2007-08-11T00:00:00,Bacterial Proteins,D12.776.097
17691832,2007-08-11T00:00:00,Bayes Theorem,E05.318.740.600.200
17691832,2007-08-11T00:00:00,Bayes Theorem,N05.715.360.750.625.150
17691832,2007-08-11T00:00:00,Bayes Theorem,N06.850.520.830.600.200
17691832,2007-08-11T00:00:00,Biological Assay,E05.091
17691832,2007-08-11T00:00:00,Mass Spectrometry,E05.196.566
17691832,2007-08-11T00:00:00,"Models, Statistical",E05.318.740.500
17691832,2007-08-11T00:00:00,"Models, Statistical",E05.599.835
17691832,2007-08-11T00:00:00,"Models, Statistical",N05.715.360.750.530
17691832,2007-08-11T00:00:00,"Models, Statistical",N06.850.520.830.500
17691832,2007-08-11T00:00:00,Monte Carlo Method,E05.318.740.525
17691832,2007-08-11T00:00:00,Monte Carlo Method,L01.906.575.422
17691832,2007-08-11T00:00:00,Monte Carlo Method,N05.715.360.750.540
17691832,2007-08-11T00:00:00,Monte Carlo Method,N06.850.520.830.525
17691832,2007-08-11T00:00:00,Protein Interaction Mapping,E05.601.690
17691832,2007-08-11T00:00:00,Proteins,D12.776
17691832,2007-08-11T00:00:00,Proteomics,H01.158.201.843
17691832,2007-08-11T00:00:00,Proteomics,H01.158.273.180.350.700
17691832,2007-08-11T00:00:00,Proteomics,H01.158.273.343.350.700
17691832,2007-08-11T00:00:00,Proteomics,H01.181.122.738
17693660,2007-08-11T00:00:00,Adult,M01.060.116
17693660,2007-08-11T00:00:00,Breast Neoplasms,C04.588.180
17693660,2007-08-11T00:00:00,Breast Neoplasms,C17.800.090.500
17693660,2007-08-11T00:00:00,DNA,D13.444.308
17693660,2007-08-11T00:00:00,Glutathione Transferase,D08.811.913.225.500
17693660,2007-08-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17693660,2007-08-11T00:00:00,Middle Aged,M01.060.116.630
17693660,2007-08-11T00:00:00,"Polymorphism, Genetic",G05.365.795
17693660,2007-08-11T00:00:00,Questionnaires,E05.318.308.750
17693660,2007-08-11T00:00:00,Questionnaires,L01.280.800
17693660,2007-08-11T00:00:00,Questionnaires,N05.715.360.300.695
17693660,2007-08-11T00:00:00,Questionnaires,N06.850.520.308.750
17693660,2007-08-11T00:00:00,Regression Analysis,E05.318.740.750
17693660,2007-08-11T00:00:00,Regression Analysis,N05.715.360.750.695
17693660,2007-08-11T00:00:00,Regression Analysis,N06.850.520.830.750
17694433,2007-08-13T00:00:00,Animals,B01.050
17694433,2007-08-13T00:00:00,Antineoplastic Agents,D27.505.954.248
17694433,2007-08-13T00:00:00,Apoptosis,G04.299.139.160
17694433,2007-08-13T00:00:00,Brain Neoplasms,C04.588.614.250.195
17694433,2007-08-13T00:00:00,Brain Neoplasms,C10.228.140.211
17694433,2007-08-13T00:00:00,Brain Neoplasms,C10.551.240.250
17694433,2007-08-13T00:00:00,Calcium,D01.268.552.100
17694433,2007-08-13T00:00:00,Calcium,D01.552.539.288
17694433,2007-08-13T00:00:00,Calcium,D23.119.100
17694433,2007-08-13T00:00:00,Cell Differentiation,G04.299.151
17694433,2007-08-13T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
17694433,2007-08-13T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
17694433,2007-08-13T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
17694433,2007-08-13T00:00:00,Interferon-gamma,D12.644.276.374.440.893
17694433,2007-08-13T00:00:00,Interferon-gamma,D12.644.276.374.480.350
17694433,2007-08-13T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
17694433,2007-08-13T00:00:00,Interferon-gamma,D12.644.276.718.550
17694433,2007-08-13T00:00:00,Interferon-gamma,D12.776.467.374.440.893
17694433,2007-08-13T00:00:00,Interferon-gamma,D12.776.467.374.480.350
17694433,2007-08-13T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
17694433,2007-08-13T00:00:00,Interferon-gamma,D12.776.467.718.550
17694433,2007-08-13T00:00:00,Interferon-gamma,D23.529.374.440.893
17694433,2007-08-13T00:00:00,Interferon-gamma,D23.529.374.480.350
17694433,2007-08-13T00:00:00,Interferon-gamma,D23.529.374.480.615.350
17694433,2007-08-13T00:00:00,Interferon-gamma,D23.529.718.550
17694433,2007-08-13T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
17694433,2007-08-13T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
17694433,2007-08-13T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
17694433,2007-08-13T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17694433,2007-08-13T00:00:00,Recombinant Proteins,D12.776.828
17694433,2007-08-13T00:00:00,Retinoids,D02.455.326.271.665.202.495
17694433,2007-08-13T00:00:00,Retinoids,D02.455.426.392.368.367.379.249.700
17694433,2007-08-13T00:00:00,Retinoids,D02.455.849.131.495
17694433,2007-08-13T00:00:00,Retinoids,D23.767.261.700
17694433,2007-08-13T00:00:00,Telomerase,D08.811.913.696.445.308.300.750.750
17694433,2007-08-13T00:00:00,Telomerase,D12.776.157.725.500.921
17694433,2007-08-13T00:00:00,Telomerase,D12.776.664.962.500.921
17697737,2007-08-13T00:00:00,Aged,M01.060.116.100
17697737,2007-08-13T00:00:00,Cardiopulmonary Resuscitation,E02.365.647.110
17697737,2007-08-13T00:00:00,Diabetes Mellitus,C18.452.394.750
17697737,2007-08-13T00:00:00,Diabetes Mellitus,C19.246
17697737,2007-08-13T00:00:00,Heart Arrest,C14.280.383
17697737,2007-08-13T00:00:00,Hospitalization,E02.760.400
17697737,2007-08-13T00:00:00,Hospitalization,N02.421.585.400
17697737,2007-08-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17698855,2007-08-13T00:00:00,ATP-Binding Cassette Transporters,D12.776.157.530.100
17698855,2007-08-13T00:00:00,ATP-Binding Cassette Transporters,D12.776.395.550.020
17698855,2007-08-13T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.550.192
17698855,2007-08-13T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.585.100
17698855,2007-08-13T00:00:00,Animals,B01.050
17698855,2007-08-13T00:00:00,Cardiovascular System,A07
17698855,2007-08-13T00:00:00,Cell Movement,G04.299.283
17698855,2007-08-13T00:00:00,Cell Movement,G07.700.560.500.180
17698855,2007-08-13T00:00:00,Cystic Fibrosis Transmembrane Conductance Regulator,D12.776.157.530.400.175.125
17698855,2007-08-13T00:00:00,Cystic Fibrosis Transmembrane Conductance Regulator,D12.776.543.550.425.175.125
17698855,2007-08-13T00:00:00,Cystic Fibrosis Transmembrane Conductance Regulator,D12.776.543.585.400.175.125
17698855,2007-08-13T00:00:00,Endothelial Cells,A11.436.275
17698855,2007-08-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17698855,2007-08-13T00:00:00,Immunologic Factors,D27.505.696.477
17698855,2007-08-13T00:00:00,"Lipoproteins, HDL",D10.532.432
17698855,2007-08-13T00:00:00,"Lipoproteins, HDL",D12.776.521.479
17698855,2007-08-13T00:00:00,Lysophospholipids,D10.570.755.375.760.550
17698855,2007-08-13T00:00:00,"Muscle, Smooth, Vascular",A02.633.570.491
17698855,2007-08-13T00:00:00,"Muscle, Smooth, Vascular",A07.231.491
17698855,2007-08-13T00:00:00,"Muscle, Smooth, Vascular",A10.690.467.491
17698855,2007-08-13T00:00:00,Phosphotransferases (Alcohol Group Acceptor),D08.811.913.696.620
17698855,2007-08-13T00:00:00,Reperfusion Injury,C14.907.725
17698855,2007-08-13T00:00:00,Reperfusion Injury,C23.550.767.877
17698855,2007-08-13T00:00:00,Signal Transduction,G02.111.087.800
17698855,2007-08-13T00:00:00,Signal Transduction,G02.149.115.800
17698855,2007-08-13T00:00:00,Signal Transduction,G04.299.880
17698855,2007-08-13T00:00:00,Sphingosine,D02.033.100.700
17698855,2007-08-13T00:00:00,Sphingosine,D02.033.455.843
17698855,2007-08-13T00:00:00,Sphingosine,D02.092.063.700
17697349,2007-08-14T00:00:00,Algorithms,G17.035
17697349,2007-08-14T00:00:00,Algorithms,L01.224.050
17697349,2007-08-14T00:00:00,Computer Simulation,L01.224.160
17697349,2007-08-14T00:00:00,Gene Expression Profiling,E05.393.332
17697349,2007-08-14T00:00:00,"Models, Biological",E05.599.395
17697349,2007-08-14T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
17697349,2007-08-14T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
17697349,2007-08-14T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
17697349,2007-08-14T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
17697349,2007-08-14T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
17697349,2007-08-14T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
17697349,2007-08-14T00:00:00,Signal Transduction,G02.111.087.800
17697349,2007-08-14T00:00:00,Signal Transduction,G02.149.115.800
17697349,2007-08-14T00:00:00,Signal Transduction,G04.299.880
17665464,2007-08-15T00:00:00,Adolescent,M01.060.057
17665464,2007-08-15T00:00:00,Adult,M01.060.116
17665464,2007-08-15T00:00:00,African Americans,M01.686.508.100.100
17665464,2007-08-15T00:00:00,African Americans,M01.686.754.100
17665464,2007-08-15T00:00:00,Age Factors,N05.715.350.075
17665464,2007-08-15T00:00:00,Age Factors,N06.850.490.250
17665464,2007-08-15T00:00:00,Disease Progression,C23.550.291.656
17665464,2007-08-15T00:00:00,Health Status,I01.240.425
17665464,2007-08-15T00:00:00,Health Status,N01.224.425
17665464,2007-08-15T00:00:00,Health Status,N06.850.505.400.425
17665464,2007-08-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17665464,2007-08-15T00:00:00,Income,N01.824.417
17665464,2007-08-15T00:00:00,Kidney,A05.810.453
17665464,2007-08-15T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
17665464,2007-08-15T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
17665464,2007-08-15T00:00:00,Middle Aged,M01.060.116.630
17665464,2007-08-15T00:00:00,Risk Factors,E05.318.740.600.800.725
17665464,2007-08-15T00:00:00,Risk Factors,N05.715.350.200.700
17665464,2007-08-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17665464,2007-08-15T00:00:00,Risk Factors,N06.850.490.625.750
17665464,2007-08-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17665464,2007-08-15T00:00:00,Skin,A17.815
17665465,2007-08-15T00:00:00,Adult,M01.060.116
17665465,2007-08-15T00:00:00,Antirheumatic Agents,D27.505.954.329
17665465,2007-08-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17665465,2007-08-15T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
17665465,2007-08-15T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
17665465,2007-08-15T00:00:00,Middle Aged,M01.060.116.630
17665465,2007-08-15T00:00:00,Patient Compliance,F01.145.488.500
17665465,2007-08-15T00:00:00,Patient Compliance,N05.300.150.600.600
17665465,2007-08-15T00:00:00,Pilot Projects,E05.318.760.750
17665465,2007-08-15T00:00:00,Pilot Projects,E05.337.737
17665465,2007-08-15T00:00:00,Pilot Projects,N05.715.360.775.625
17665465,2007-08-15T00:00:00,Pilot Projects,N06.850.520.450.720
17665465,2007-08-15T00:00:00,Prednisone,D04.808.745.432.719.702
17665465,2007-08-15T00:00:00,Questionnaires,E05.318.308.750
17665465,2007-08-15T00:00:00,Questionnaires,L01.280.800
17665465,2007-08-15T00:00:00,Questionnaires,N05.715.360.300.695
17665465,2007-08-15T00:00:00,Questionnaires,N06.850.520.308.750
17699663,2007-08-15T00:00:00,Age Factors,N05.715.350.075
17699663,2007-08-15T00:00:00,Age Factors,N06.850.490.250
17699663,2007-08-15T00:00:00,Animals,B01.050
17699663,2007-08-15T00:00:00,"Animals, Newborn",B01.050.050.282
17699663,2007-08-15T00:00:00,"Behavior, Animal",F01.145.113
17699663,2007-08-15T00:00:00,Central Nervous System Stimulants,D27.505.696.282
17699663,2007-08-15T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
17699663,2007-08-15T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
17699663,2007-08-15T00:00:00,Dopamine,D02.092.211.215.311.342
17699663,2007-08-15T00:00:00,Dopamine,D02.092.311.342
17699663,2007-08-15T00:00:00,Gene Expression Regulation,G05.355.315
17699663,2007-08-15T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.644.276.860.381.500
17699663,2007-08-15T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.776.467.860.381.500
17699663,2007-08-15T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.776.641.600.381.500
17699663,2007-08-15T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D23.529.850.381.500
17699663,2007-08-15T00:00:00,Methamphetamine,D02.092.471.683.152.619
17699663,2007-08-15T00:00:00,Microglia,A08.637.400
17699663,2007-08-15T00:00:00,Microglia,A11.650.400
17699663,2007-08-15T00:00:00,Motor Activity,F01.145.632
17699663,2007-08-15T00:00:00,Motor Activity,G11.427.590.530.698
17699663,2007-08-15T00:00:00,Tyrosine 3-Monooxygenase,D08.811.682.690.708.923
17699663,2007-08-15T00:00:00,Tyrosine 3-Monooxygenase,D12.776.556.579.374.925
17699672,2007-08-15T00:00:00,Animals,B01.050
17699672,2007-08-15T00:00:00,"Animals, Newborn",B01.050.050.282
17699672,2007-08-15T00:00:00,Cell Cycle Proteins,D12.776.167
17699672,2007-08-15T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
17699672,2007-08-15T00:00:00,Green Fluorescent Proteins,D12.776.532.265
17699672,2007-08-15T00:00:00,Nerve Tissue Proteins,D12.776.641
17699672,2007-08-15T00:00:00,Neurons,A08.663
17699672,2007-08-15T00:00:00,Neurons,A11.671
17699672,2007-08-15T00:00:00,Proteasome Endopeptidase Complex,D05.500.562.500
17699672,2007-08-15T00:00:00,Proteasome Endopeptidase Complex,D08.811.277.656.918
17699672,2007-08-15T00:00:00,Proteasome Endopeptidase Complex,D08.811.600.730
17699672,2007-08-15T00:00:00,Protein Transport,G03.495.166.700
17699672,2007-08-15T00:00:00,RNA-Binding Proteins,D12.776.157.725
17699672,2007-08-15T00:00:00,RNA-Binding Proteins,D12.776.664.962
17699672,2007-08-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17699672,2007-08-15T00:00:00,Repressor Proteins,D12.776.260.703
17699672,2007-08-15T00:00:00,Repressor Proteins,D12.776.930.700
17701328,2007-08-15T00:00:00,Adult,M01.060.116
17701328,2007-08-15T00:00:00,African Continental Ancestry Group,M01.686.508.100
17701328,2007-08-15T00:00:00,Anxiety,F01.470.132
17701328,2007-08-15T00:00:00,Breast Neoplasms,C04.588.180
17701328,2007-08-15T00:00:00,Breast Neoplasms,C17.800.090.500
17701328,2007-08-15T00:00:00,Fear,F01.470.361
17701328,2007-08-15T00:00:00,Genetic Counseling,H01.158.273.343.315.384
17701328,2007-08-15T00:00:00,Genetic Counseling,N02.421.308.400
17701328,2007-08-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17701328,2007-08-15T00:00:00,Mammography,E01.370.350.700.500
17701328,2007-08-15T00:00:00,Middle Aged,M01.060.116.630
17701328,2007-08-15T00:00:00,Patient Education as Topic,I02.233.332.500
17701328,2007-08-15T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
17701328,2007-08-15T00:00:00,Patient Education as Topic,N02.421.726.407.680
17701328,2007-08-15T00:00:00,Perception,F02.463.593
17701328,2007-08-15T00:00:00,Questionnaires,E05.318.308.750
17701328,2007-08-15T00:00:00,Questionnaires,L01.280.800
17701328,2007-08-15T00:00:00,Questionnaires,N05.715.360.300.695
17701328,2007-08-15T00:00:00,Questionnaires,N06.850.520.308.750
17701328,2007-08-15T00:00:00,United States,Z01.107.567.875
17701328,2007-08-15T00:00:00,Urban Population,N01.600.900
17701349,2007-08-15T00:00:00,Animals,B01.050
17701349,2007-08-15T00:00:00,Brain Neoplasms,C04.588.614.250.195
17701349,2007-08-15T00:00:00,Brain Neoplasms,C10.228.140.211
17701349,2007-08-15T00:00:00,Brain Neoplasms,C10.551.240.250
17701349,2007-08-15T00:00:00,Catheterization,E02.148
17701349,2007-08-15T00:00:00,Catheterization,E05.157
17701349,2007-08-15T00:00:00,Coloring Agents,D27.720.233
17701349,2007-08-15T00:00:00,Coloring Agents,D27.720.470.330
17701349,2007-08-15T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
17701349,2007-08-15T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
17701349,2007-08-15T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
17701349,2007-08-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17701349,2007-08-15T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17701349,2007-08-15T00:00:00,"Tumor Markers, Biological",D23.101.840
17701350,2007-08-15T00:00:00,Amino Acid Sequence,G02.111.570.060
17701350,2007-08-15T00:00:00,Amino Acid Sequence,L01.453.245.667.060
17701350,2007-08-15T00:00:00,Amyloid beta-Protein Precursor,D12.776.049.025.150
17701350,2007-08-15T00:00:00,Amyloid beta-Protein Precursor,D12.776.811.050
17701350,2007-08-15T00:00:00,Animals,B01.050
17701350,2007-08-15T00:00:00,CHO Cells,A11.251.210.200
17701350,2007-08-15T00:00:00,CHO Cells,A11.436.155
17701350,2007-08-15T00:00:00,Cricetinae,B01.050.150.900.649.865.635.150
17701350,2007-08-15T00:00:00,Fluorescent Dyes,D27.720.233.348
17701350,2007-08-15T00:00:00,Fluorescent Dyes,D27.720.470.330.348
17701350,2007-08-15T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
17701350,2007-08-15T00:00:00,Molecular Sequence Data,L01.453.245.667
17786259,2007-08-15T00:00:00,"Education, Pharmacy",I02.358.525
17786259,2007-08-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17786259,2007-08-15T00:00:00,Teaching,I02.903
17701358,2007-08-16T00:00:00,Animals,B01.050
17701358,2007-08-16T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
17701358,2007-08-16T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
17701358,2007-08-16T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
17701358,2007-08-16T00:00:00,Apoptosis,G04.299.139.160
17701358,2007-08-16T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
17701358,2007-08-16T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
17701358,2007-08-16T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
17701358,2007-08-16T00:00:00,Graft Survival,G12.425.901.545.340
17701358,2007-08-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17701406,2007-08-16T00:00:00,Animals,B01.050
17701406,2007-08-16T00:00:00,"Coated Materials, Biocompatible",D25.130.420
17701406,2007-08-16T00:00:00,"Coated Materials, Biocompatible",J01.637.051.130.420
17701406,2007-08-16T00:00:00,"Disease Models, Animal",C22.232
17701406,2007-08-16T00:00:00,"Disease Models, Animal",E05.598.500
17701406,2007-08-16T00:00:00,"Disease Models, Animal",E05.599.395.080
17701406,2007-08-16T00:00:00,Dogs,B01.050.150.900.649.147.153.200
17701406,2007-08-16T00:00:00,"Embolization, Therapeutic",E02.520.360
17701406,2007-08-16T00:00:00,Thrombosis,C14.907.355.830
17702809,2007-08-16T00:00:00,Adenylate Cyclase,D08.811.520.650.200
17702809,2007-08-16T00:00:00,Adenylate Cyclase,D12.644.360.050
17702809,2007-08-16T00:00:00,Adenylate Cyclase,D12.776.476.050
17702809,2007-08-16T00:00:00,Animals,B01.050
17702809,2007-08-16T00:00:00,Neuronal Plasticity,G11.561.600.635
17702809,2007-08-16T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
17702809,2007-08-16T00:00:00,Protein Kinase C,D08.811.913.696.620.682.700.725
17702809,2007-08-16T00:00:00,Pyrimidines,D03.383.742
17702809,2007-08-16T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17702809,2007-08-16T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17702809,2007-08-16T00:00:00,Synapses,A08.850
17702809,2007-08-16T00:00:00,Synapses,A11.284.149.165.420.780
17702809,2007-08-16T00:00:00,Synaptic Transmission,G02.111.087.800.850
17702809,2007-08-16T00:00:00,Synaptic Transmission,G02.149.115.800.850
17702809,2007-08-16T00:00:00,Synaptic Transmission,G04.299.880.850
17702809,2007-08-16T00:00:00,Synaptic Transmission,G07.265.337.900
17702809,2007-08-16T00:00:00,Synaptic Transmission,G07.700.240.900
17702809,2007-08-16T00:00:00,Synaptic Transmission,G11.561.600.835
17702809,2007-08-16T00:00:00,Time Factors,G01.910.857
17705822,2007-08-16T00:00:00,Adolescent,M01.060.057
17705822,2007-08-16T00:00:00,Adult,M01.060.116
17705822,2007-08-16T00:00:00,Aged,M01.060.116.100
17705822,2007-08-16T00:00:00,Animals,B01.050
17705822,2007-08-16T00:00:00,Carbohydrates,D09
17705822,2007-08-16T00:00:00,Cattle,B01.050.150.900.649.077.380.271
17705822,2007-08-16T00:00:00,Cell Survival,G04.299.316
17705822,2007-08-16T00:00:00,Child,M01.060.406
17705822,2007-08-16T00:00:00,"Child, Preschool",M01.060.406.448
17705822,2007-08-16T00:00:00,Dehydration,C18.452.950.179
17705822,2007-08-16T00:00:00,Dehydration,C23.550.274
17705822,2007-08-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17705822,2007-08-16T00:00:00,Middle Aged,M01.060.116.630
17705822,2007-08-16T00:00:00,"Models, Biological",E05.599.395
17705822,2007-08-16T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.712.726.676.700
17705822,2007-08-16T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.867.826.676.700
17705822,2007-08-16T00:00:00,"Stress, Physiological",G07.700.830
17707014,2007-08-17T00:00:00,Child,M01.060.406
17707014,2007-08-17T00:00:00,"Child, Preschool",M01.060.406.448
17707014,2007-08-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17707014,2007-08-17T00:00:00,Incidence,E05.318.308.985.525.375
17707014,2007-08-17T00:00:00,Incidence,L01.280.975.525.375
17707014,2007-08-17T00:00:00,Incidence,N01.224.935.597.500
17707014,2007-08-17T00:00:00,Incidence,N06.850.505.400.975.525.375
17707014,2007-08-17T00:00:00,Incidence,N06.850.520.308.985.525.375
17707014,2007-08-17T00:00:00,Infant,M01.060.703
17707014,2007-08-17T00:00:00,Testis,A05.360.444.849
17707014,2007-08-17T00:00:00,Testis,A05.360.576.782
17707014,2007-08-17T00:00:00,Testis,A06.407.312.782
17707020,2007-08-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17707020,2007-08-17T00:00:00,Postoperative Complications,C23.550.767
17707020,2007-08-17T00:00:00,Treatment Outcome,E01.789.800
17707020,2007-08-17T00:00:00,Treatment Outcome,N04.761.559.590.800
17707020,2007-08-17T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17707020,2007-08-17T00:00:00,Urethra,A05.360.444.492.726
17707020,2007-08-17T00:00:00,Urethra,A05.810.876
17804308,2007-08-19T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
17804308,2007-08-19T00:00:00,Gas Chromatography-Mass Spectrometry,E05.196.181.349.500
17804308,2007-08-19T00:00:00,Gas Chromatography-Mass Spectrometry,E05.196.566.500
17804308,2007-08-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17804308,2007-08-19T00:00:00,Methylphenidate,D02.241.223.601.600
17804308,2007-08-19T00:00:00,Methylphenidate,D03.383.621.460
17804308,2007-08-19T00:00:00,Molecular Structure,G02.111.570
17804308,2007-08-19T00:00:00,Molecular Structure,G02.575
17804308,2007-08-19T00:00:00,Molecular Structure,G02.842.575
17804308,2007-08-19T00:00:00,"Spectrometry, Fluorescence",E05.196.712.516.600.676
17804308,2007-08-19T00:00:00,"Spectrometry, Fluorescence",E05.196.867.726
17704006,2007-08-20T00:00:00,Anxiety Disorders,F03.080
17704006,2007-08-20T00:00:00,Chronic Disease,C23.550.291.500
17704006,2007-08-20T00:00:00,Health Status,I01.240.425
17704006,2007-08-20T00:00:00,Health Status,N01.224.425
17704006,2007-08-20T00:00:00,Health Status,N06.850.505.400.425
17704006,2007-08-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17704006,2007-08-20T00:00:00,Military Personnel,M01.526.625
17704006,2007-08-20T00:00:00,Pain,C10.597.617
17704006,2007-08-20T00:00:00,Pain,C23.888.592.612
17704006,2007-08-20T00:00:00,Pain,C23.888.646
17704006,2007-08-20T00:00:00,Pain,F02.830.816.444
17704006,2007-08-20T00:00:00,Pain,G11.561.600.810.444
17704006,2007-08-20T00:00:00,Pain Measurement,E01.370.376.550.600
17704006,2007-08-20T00:00:00,Quality of Life,I01.800
17704006,2007-08-20T00:00:00,Quality of Life,K01.752.400.750
17704006,2007-08-20T00:00:00,Risk Factors,E05.318.740.600.800.725
17704006,2007-08-20T00:00:00,Risk Factors,N05.715.350.200.700
17704006,2007-08-20T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17704006,2007-08-20T00:00:00,Risk Factors,N06.850.490.625.750
17704006,2007-08-20T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17704006,2007-08-20T00:00:00,Veterans,M01.930
17711354,2007-08-22T00:00:00,Animals,B01.050
17711354,2007-08-22T00:00:00,Cell Line,A11.251.210
17711354,2007-08-22T00:00:00,Cholesterol,D04.808.247.222.284
17711354,2007-08-22T00:00:00,Cholesterol,D04.808.247.808.197
17711354,2007-08-22T00:00:00,Cholesterol,D10.570.938.208
17711354,2007-08-22T00:00:00,Cholesterol,D10.851.208
17711354,2007-08-22T00:00:00,Diffusion,G01.595.200
17711354,2007-08-22T00:00:00,Diffusion,G02.149.767.560
17711354,2007-08-22T00:00:00,Diffusion,G02.842.750.560
17711354,2007-08-22T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.450.625.124
17711354,2007-08-22T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.562.374.500.500
17711354,2007-08-22T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.450.625.124
17711354,2007-08-22T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.562.374.500.500
17711354,2007-08-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17711354,2007-08-22T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17711354,2007-08-22T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17711354,2007-08-22T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
17711354,2007-08-22T00:00:00,"Spectrometry, Fluorescence",E05.196.712.516.600.676
17711354,2007-08-22T00:00:00,"Spectrometry, Fluorescence",E05.196.867.726
17713573,2007-08-23T00:00:00,Acid Ceramidase,D08.811.277.087.250.100
17713573,2007-08-23T00:00:00,Alkaline Ceramidase,D08.811.277.087.250.300
17713573,2007-08-23T00:00:00,Amidohydrolases,D08.811.277.087
17713573,2007-08-23T00:00:00,Calcium,D01.268.552.100
17713573,2007-08-23T00:00:00,Calcium,D01.552.539.288
17713573,2007-08-23T00:00:00,Calcium,D23.119.100
17713573,2007-08-23T00:00:00,Cell Differentiation,G04.299.151
17713573,2007-08-23T00:00:00,Cell Division,G04.299.134.220
17713573,2007-08-23T00:00:00,Cell Division,G04.299.233.750.500
17713573,2007-08-23T00:00:00,Cell Division,G05.355.105
17713573,2007-08-23T00:00:00,Cell Division,G07.700.320.249.410.750.500
17713573,2007-08-23T00:00:00,Ceramides,D02.065.313
17713573,2007-08-23T00:00:00,Ceramides,D09.400.410.420.525.200
17713573,2007-08-23T00:00:00,Ceramides,D10.390.470.675.200
17713573,2007-08-23T00:00:00,Ceramides,D10.570.877.360.612.200
17713573,2007-08-23T00:00:00,Endoplasmic Reticulum,A11.284.430.214.190.875.248
17713573,2007-08-23T00:00:00,Epidermis,A10.272.497
17713573,2007-08-23T00:00:00,Epidermis,A17.815.250
17713573,2007-08-23T00:00:00,"Fatty Acids, Unsaturated",D10.251.355
17713573,2007-08-23T00:00:00,Galactosylgalactosylglucosylceramidase,D08.811.277.450.410.150
17713573,2007-08-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17713573,2007-08-23T00:00:00,Keratinocytes,A11.436.397
17715409,2007-08-23T00:00:00,Body Mass Index,E01.370.600.115.100.125
17715409,2007-08-23T00:00:00,Body Mass Index,E05.041.124.125
17715409,2007-08-23T00:00:00,Body Mass Index,G07.100.100.125
17715409,2007-08-23T00:00:00,Body Mass Index,N06.850.505.200.100.175
17715409,2007-08-23T00:00:00,Cardiovascular Diseases,C14
17715409,2007-08-23T00:00:00,Cause of Death,E05.318.308.985.550.250
17715409,2007-08-23T00:00:00,Cause of Death,L01.280.975.550.250
17715409,2007-08-23T00:00:00,Cause of Death,N01.224.935.698.100
17715409,2007-08-23T00:00:00,Cause of Death,N06.850.505.400.975.550.250
17715409,2007-08-23T00:00:00,Cause of Death,N06.850.520.308.985.550.250
17715409,2007-08-23T00:00:00,Diabetes Mellitus,C18.452.394.750
17715409,2007-08-23T00:00:00,Diabetes Mellitus,C19.246
17715409,2007-08-23T00:00:00,Gastric Bypass,E02.065.062.249
17715409,2007-08-23T00:00:00,Gastric Bypass,E04.035.398.385
17715409,2007-08-23T00:00:00,Gastric Bypass,E04.062.249
17715409,2007-08-23T00:00:00,Gastric Bypass,E04.210.457.430
17715409,2007-08-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17715409,2007-08-23T00:00:00,Middle Aged,M01.060.116.630
17715409,2007-08-23T00:00:00,Neoplasms,C04
17715409,2007-08-23T00:00:00,Obesity,C18.654.726.500
17715409,2007-08-23T00:00:00,Obesity,C23.888.144.699.500
17715409,2007-08-23T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
17715409,2007-08-23T00:00:00,Obesity,G07.100.100.160.120.699.500
17715409,2007-08-23T00:00:00,Risk Factors,E05.318.740.600.800.725
17715409,2007-08-23T00:00:00,Risk Factors,N05.715.350.200.700
17715409,2007-08-23T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17715409,2007-08-23T00:00:00,Risk Factors,N06.850.490.625.750
17715409,2007-08-23T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17715409,2007-08-23T00:00:00,Suicide,F01.145.126.980.875
17715409,2007-08-23T00:00:00,Suicide,I01.880.735.856
17715409,2007-08-23T00:00:00,Weight Loss,C23.888.144.243.963
17715409,2007-08-23T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
17717203,2007-08-23T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
17717203,2007-08-23T00:00:00,Cyclophosphamide,D02.705.670.243
17717203,2007-08-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17717203,2007-08-23T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
17717203,2007-08-23T00:00:00,Middle Aged,M01.060.116.630
17717203,2007-08-23T00:00:00,Pulmonary Fibrosis,C08.381.765
17717203,2007-08-23T00:00:00,"Scleroderma, Systemic",C17.300.799
17717203,2007-08-23T00:00:00,"Scleroderma, Systemic",C17.800.784
17717203,2007-08-23T00:00:00,Time Factors,G01.910.857
17717203,2007-08-23T00:00:00,Treatment Outcome,E01.789.800
17717203,2007-08-23T00:00:00,Treatment Outcome,N04.761.559.590.800
17717203,2007-08-23T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18028958,2007-08-23T00:00:00,Adenocarcinoma,C04.557.470.200.025
18028958,2007-08-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18028958,2007-08-23T00:00:00,Mesenteric Veins,A07.231.908.670.385
18028958,2007-08-23T00:00:00,Middle Aged,M01.060.116.630
18028958,2007-08-23T00:00:00,Pancreatic Neoplasms,C04.588.274.761
18028958,2007-08-23T00:00:00,Pancreatic Neoplasms,C04.588.322.421
18028958,2007-08-23T00:00:00,Pancreatic Neoplasms,C06.301.761
18028958,2007-08-23T00:00:00,Pancreatic Neoplasms,C06.689.667
18028958,2007-08-23T00:00:00,Pancreatic Neoplasms,C19.344.421
18028958,2007-08-23T00:00:00,Pancreaticoduodenectomy,E04.210.760
18028958,2007-08-23T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18028958,2007-08-23T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18028958,2007-08-23T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18028958,2007-08-23T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18028958,2007-08-23T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18028958,2007-08-23T00:00:00,Vascular Surgical Procedures,E04.100.814
17719565,2007-08-24T00:00:00,Acetylcysteine,D02.886.030.230.259
17719565,2007-08-24T00:00:00,Acetylcysteine,D12.125.166.230.259
17719565,2007-08-24T00:00:00,Animals,B01.050
17719565,2007-08-24T00:00:00,"Behavior, Animal",F01.145.113
17719565,2007-08-24T00:00:00,Cues,F02.463.425.234
17719565,2007-08-24T00:00:00,"Disease Models, Animal",C22.232
17719565,2007-08-24T00:00:00,"Disease Models, Animal",E05.598.500
17719565,2007-08-24T00:00:00,"Disease Models, Animal",E05.599.395.080
17719565,2007-08-24T00:00:00,Drug Interactions,G07.690.812.240
17719565,2007-08-24T00:00:00,Drug Interactions,G07.700.680.240
17719565,2007-08-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17719565,2007-08-24T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17719565,2007-08-24T00:00:00,Time Factors,G01.910.857
17725630,2007-08-24T00:00:00,Adult,M01.060.116
17725630,2007-08-24T00:00:00,Body Mass Index,E01.370.600.115.100.125
17725630,2007-08-24T00:00:00,Body Mass Index,E05.041.124.125
17725630,2007-08-24T00:00:00,Body Mass Index,G07.100.100.125
17725630,2007-08-24T00:00:00,Body Mass Index,N06.850.505.200.100.175
17725630,2007-08-24T00:00:00,Diabetes Mellitus,C18.452.394.750
17725630,2007-08-24T00:00:00,Diabetes Mellitus,C19.246
17725630,2007-08-24T00:00:00,England,Z01.542.363.300
17725630,2007-08-24T00:00:00,Ethnic Groups,M01.686.754
17725630,2007-08-24T00:00:00,Ethnic Groups,N01.224.317
17725630,2007-08-24T00:00:00,Health Surveys,E05.318.308.250
17725630,2007-08-24T00:00:00,Health Surveys,N05.715.360.300.375
17725630,2007-08-24T00:00:00,Health Surveys,N06.850.520.308.250
17725630,2007-08-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17725630,2007-08-24T00:00:00,Middle Aged,M01.060.116.630
17725630,2007-08-24T00:00:00,Obesity,C18.654.726.500
17725630,2007-08-24T00:00:00,Obesity,C23.888.144.699.500
17725630,2007-08-24T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
17725630,2007-08-24T00:00:00,Obesity,G07.100.100.160.120.699.500
17869115,2007-08-24T00:00:00,Amides,D02.065
17869115,2007-08-24T00:00:00,Amidohydrolases,D08.811.277.087
17869115,2007-08-24T00:00:00,Antineoplastic Agents,D27.505.954.248
17869115,2007-08-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17869115,2007-08-24T00:00:00,Molecular Structure,G02.111.570
17869115,2007-08-24T00:00:00,Molecular Structure,G02.575
17869115,2007-08-24T00:00:00,Molecular Structure,G02.842.575
17869115,2007-08-24T00:00:00,Propanolamines,D02.033.100.624
17869115,2007-08-24T00:00:00,Propanolamines,D02.033.755.624
17869115,2007-08-24T00:00:00,Propanolamines,D02.092.063.624
17881234,2007-08-24T00:00:00,Amides,D02.065
17881234,2007-08-24T00:00:00,Amidohydrolases,D08.811.277.087
17881234,2007-08-24T00:00:00,Antineoplastic Agents,D27.505.954.248
17881234,2007-08-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17881234,2007-08-24T00:00:00,Molecular Structure,G02.111.570
17881234,2007-08-24T00:00:00,Molecular Structure,G02.575
17881234,2007-08-24T00:00:00,Molecular Structure,G02.842.575
17881234,2007-08-24T00:00:00,Propanolamines,D02.033.100.624
17881234,2007-08-24T00:00:00,Propanolamines,D02.033.755.624
17881234,2007-08-24T00:00:00,Propanolamines,D02.092.063.624
17881234,2007-08-24T00:00:00,Sphingolipids,D10.570.877
17881234,2007-08-24T00:00:00,Sphingolipids,D10.808
17904594,2007-08-24T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
17904594,2007-08-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17904594,2007-08-24T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17904594,2007-08-24T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17904594,2007-08-24T00:00:00,Movement,G07.700.560
17904594,2007-08-24T00:00:00,Movement,G11.427.590.530
17904594,2007-08-24T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
17904594,2007-08-24T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
17904594,2007-08-24T00:00:00,Recovery of Function,G16.757
17904594,2007-08-24T00:00:00,Stroke,C10.228.140.300.775
17904594,2007-08-24T00:00:00,Stroke,C14.907.253.855
17904594,2007-08-24T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
17904594,2007-08-24T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
17915218,2007-08-24T00:00:00,Animals,B01.050
17915218,2007-08-24T00:00:00,Cell Line,A11.251.210
17915218,2007-08-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17915218,2007-08-24T00:00:00,Pigment Epithelium of Eye,A09.371.670
17915218,2007-08-24T00:00:00,Pigment Epithelium of Eye,A10.272.640
17915218,2007-08-24T00:00:00,Pyrroles,D03.383.129.578
17915218,2007-08-24T00:00:00,Quinazolines,D03.438.786
17915218,2007-08-24T00:00:00,Retina,A09.371.729
17915218,2007-08-24T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
17915218,2007-08-24T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
17915218,2007-08-24T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
17720239,2007-08-27T00:00:00,Biocompatible Materials,D25.130
17720239,2007-08-27T00:00:00,Biocompatible Materials,D27.720.102.130
17720239,2007-08-27T00:00:00,Biocompatible Materials,J01.637.051.130
17720239,2007-08-27T00:00:00,Cell Proliferation,G04.299.233.750
17720239,2007-08-27T00:00:00,Cell Proliferation,G07.700.320.249.410.750
17720239,2007-08-27T00:00:00,Cell Survival,G04.299.316
17720239,2007-08-27T00:00:00,Fibroblasts,A11.329.228
17720239,2007-08-27T00:00:00,Fibroblasts,A11.872.228
17720239,2007-08-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17720239,2007-08-27T00:00:00,Hyaluronic Acid,D09.698.373.475
17720239,2007-08-27T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
17720239,2007-08-27T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
17720239,2007-08-27T00:00:00,"Microscopy, Confocal",E05.595.395
17720239,2007-08-27T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
17720239,2007-08-27T00:00:00,Polyethylene Glycols,D02.033.455.250.700
17720239,2007-08-27T00:00:00,Polyethylene Glycols,D05.750.741
17720239,2007-08-27T00:00:00,Polyethylene Glycols,D25.720.741
17720239,2007-08-27T00:00:00,Polyethylene Glycols,J01.637.051.720.741
17720239,2007-08-27T00:00:00,Tissue Engineering,E05.200.249.750
17724269,2007-08-28T00:00:00,Catecholamines,D02.092.211.215.311
17724269,2007-08-28T00:00:00,Catecholamines,D02.092.311
17724269,2007-08-28T00:00:00,Homeostasis,G07.700.360
17724269,2007-08-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17724269,2007-08-28T00:00:00,Hypertension,C14.907.489
17724269,2007-08-28T00:00:00,Tyrosine 3-Monooxygenase,D08.811.682.690.708.923
17724269,2007-08-28T00:00:00,Tyrosine 3-Monooxygenase,D12.776.556.579.374.925
17726021,2007-08-28T00:00:00,3T3 Cells,A11.251.210.700
17726021,2007-08-28T00:00:00,3T3 Cells,A11.329.228.900
17726021,2007-08-28T00:00:00,Adipocytes,A11.329.114
17726021,2007-08-28T00:00:00,Animals,B01.050
17726021,2007-08-28T00:00:00,Biological Markers,D23.101
17726021,2007-08-28T00:00:00,Cell Differentiation,G04.299.151
17726021,2007-08-28T00:00:00,Diabetes Complications,C19.246.099
17726021,2007-08-28T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
17726021,2007-08-28T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
17726021,2007-08-28T00:00:00,Fibroblasts,A11.329.228
17726021,2007-08-28T00:00:00,Fibroblasts,A11.872.228
17726021,2007-08-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17726021,2007-08-28T00:00:00,Insulin Resistance,C18.452.394.968.500
17726021,2007-08-28T00:00:00,Insulin Resistance,G07.690.320.617
17726021,2007-08-28T00:00:00,Lysine,D12.125.068.555
17726021,2007-08-28T00:00:00,Lysine,D12.125.095.647
17726021,2007-08-28T00:00:00,Lysine,D12.125.142.497
17726021,2007-08-28T00:00:00,Mitochondria,A11.284.430.214.190.875.564
17726021,2007-08-28T00:00:00,Mitochondria,A11.284.835.626
17726021,2007-08-28T00:00:00,Obesity,C18.654.726.500
17726021,2007-08-28T00:00:00,Obesity,C23.888.144.699.500
17726021,2007-08-28T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
17726021,2007-08-28T00:00:00,Obesity,G07.100.100.160.120.699.500
17726021,2007-08-28T00:00:00,"Protein Processing, Post-Translational",G02.111.087.675.871.790.600
17726021,2007-08-28T00:00:00,"Protein Processing, Post-Translational",G02.111.087.693.600
17726021,2007-08-28T00:00:00,"Protein Processing, Post-Translational",G02.149.115.675.871.790.600
17726021,2007-08-28T00:00:00,"Protein Processing, Post-Translational",G02.149.115.693.600
17726021,2007-08-28T00:00:00,"Protein Processing, Post-Translational",G03.495.770.871.790.600
17726021,2007-08-28T00:00:00,"Protein Processing, Post-Translational",G05.355.315.670.600
17726021,2007-08-28T00:00:00,Risk Factors,E05.318.740.600.800.725
17726021,2007-08-28T00:00:00,Risk Factors,N05.715.350.200.700
17726021,2007-08-28T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17726021,2007-08-28T00:00:00,Risk Factors,N06.850.490.625.750
17726021,2007-08-28T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17726021,2007-08-28T00:00:00,"Stress, Physiological",G07.700.830
17726606,2007-08-28T00:00:00,Animals,B01.050
17726606,2007-08-28T00:00:00,Apoptosis,G04.299.139.160
17726606,2007-08-28T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
17726606,2007-08-28T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
17726606,2007-08-28T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
17726606,2007-08-28T00:00:00,Cell Differentiation,G04.299.151
17726606,2007-08-28T00:00:00,Cell Survival,G04.299.316
17726606,2007-08-28T00:00:00,"Disease Models, Animal",C22.232
17726606,2007-08-28T00:00:00,"Disease Models, Animal",E05.598.500
17726606,2007-08-28T00:00:00,"Disease Models, Animal",E05.599.395.080
17726606,2007-08-28T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
17726606,2007-08-28T00:00:00,Flow Cytometry,E05.200.500.386.350
17726606,2007-08-28T00:00:00,"Immunotherapy, Adoptive",E02.095.465.425.400.330.050.400
17726606,2007-08-28T00:00:00,"Immunotherapy, Adoptive",E05.478.550.520.050.400
17726606,2007-08-28T00:00:00,Interleukin-12,D12.644.276.374.465.512
17726606,2007-08-28T00:00:00,Interleukin-12,D12.776.467.374.465.512
17726606,2007-08-28T00:00:00,Interleukin-12,D23.529.374.465.512
17726606,2007-08-28T00:00:00,Lymphocyte Activation,E01.450.495.482
17726606,2007-08-28T00:00:00,Lymphocyte Activation,E05.478.594.530
17726606,2007-08-28T00:00:00,Lymphocyte Activation,G12.425.747
17726606,2007-08-28T00:00:00,Lymphocyte Activation,G12.450.050.400.545
17726606,2007-08-28T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.550.500
17726606,2007-08-28T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.569.500
17726606,2007-08-28T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.550.500
17726606,2007-08-28T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.569.500
17726606,2007-08-28T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.550.500
17726606,2007-08-28T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.569.500
17569640,2007-08-29T00:00:00,Animals,B01.050
17569640,2007-08-29T00:00:00,Heart Valves,A07.541.510
17569640,2007-08-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17569640,2007-08-29T00:00:00,Signal Transduction,G02.111.087.800
17569640,2007-08-29T00:00:00,Signal Transduction,G02.149.115.800
17569640,2007-08-29T00:00:00,Signal Transduction,G04.299.880
17761616,2007-08-29T00:00:00,Anti-Asthmatic Agents,D27.505.954.796.050
17761616,2007-08-29T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
17761616,2007-08-29T00:00:00,Child,M01.060.406
17761616,2007-08-29T00:00:00,Cystic Fibrosis,C06.689.202
17761616,2007-08-29T00:00:00,Cystic Fibrosis,C08.381.187
17761616,2007-08-29T00:00:00,Cystic Fibrosis,C16.320.190
17761616,2007-08-29T00:00:00,Cystic Fibrosis,C16.614.213
17761616,2007-08-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17761809,2007-08-30T00:00:00,Brain,A08.186.211
17761809,2007-08-30T00:00:00,Cognition,F02.463.188
17761809,2007-08-30T00:00:00,Cognition Disorders,F03.087.250
17761809,2007-08-30T00:00:00,Computer Simulation,L01.224.160
17761809,2007-08-30T00:00:00,Disability Evaluation,E01.370.400
17761809,2007-08-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17761809,2007-08-30T00:00:00,Neuropsychological Tests,F04.711.513
17761809,2007-08-30T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
17761809,2007-08-30T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
17761809,2007-08-30T00:00:00,Psychometrics,F04.711.780
17761809,2007-08-30T00:00:00,Stroke,C10.228.140.300.775
17761809,2007-08-30T00:00:00,Stroke,C14.907.253.855
17905471,2007-08-30T00:00:00,Computer Simulation,L01.224.160
17905471,2007-08-30T00:00:00,"Models, Theoretical",E05.599
17905471,2007-08-30T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
17765449,2007-08-31T00:00:00,Aged,M01.060.116.100
17765449,2007-08-31T00:00:00,Amputation,E04.555.080
17765449,2007-08-31T00:00:00,Angioplasty,E02.148.050
17765449,2007-08-31T00:00:00,Angioplasty,E04.100.814.050
17765449,2007-08-31T00:00:00,Decision Support Techniques,E05.245
17765449,2007-08-31T00:00:00,Decision Support Techniques,L01.700.508.190
17765449,2007-08-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17765449,2007-08-31T00:00:00,Lower Extremity,A01.378.610
17765449,2007-08-31T00:00:00,Markov Chains,E05.318.740.600.500
17765449,2007-08-31T00:00:00,Markov Chains,E05.318.740.996.500
17765449,2007-08-31T00:00:00,Markov Chains,G17.830.500
17765449,2007-08-31T00:00:00,Markov Chains,N05.715.360.750.625.500
17765449,2007-08-31T00:00:00,Markov Chains,N05.715.360.750.770.500
17765449,2007-08-31T00:00:00,Markov Chains,N06.850.520.830.600.500
17765449,2007-08-31T00:00:00,Markov Chains,N06.850.520.830.996.500
17765449,2007-08-31T00:00:00,Middle Aged,M01.060.116.630
17765449,2007-08-31T00:00:00,Peripheral Vascular Diseases,C14.907.617
17765449,2007-08-31T00:00:00,Quality of Life,I01.800
17765449,2007-08-31T00:00:00,Quality of Life,K01.752.400.750
17765449,2007-08-31T00:00:00,Vascular Surgical Procedures,E04.100.814
17804879,2007-08-31T00:00:00,Albumins,D12.776.034
17804879,2007-08-31T00:00:00,Animals,B01.050
17804879,2007-08-31T00:00:00,Blood-Brain Barrier,A07.035
17804879,2007-08-31T00:00:00,Blood-Brain Barrier,A08.186.211.035
17804879,2007-08-31T00:00:00,Computer Simulation,L01.224.160
17804879,2007-08-31T00:00:00,Drug Delivery Systems,E02.319.300
17804879,2007-08-31T00:00:00,Fluorocarbons,D02.455.526.510.435
17804879,2007-08-31T00:00:00,Hippocampus,A08.186.211.464.405
17804879,2007-08-31T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
17804879,2007-08-31T00:00:00,"Models, Biological",E05.599.395
17989818,2007-08-31T00:00:00,Fluorescent Dyes,D27.720.233.348
17989818,2007-08-31T00:00:00,Fluorescent Dyes,D27.720.470.330.348
17989818,2007-08-31T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
17989818,2007-08-31T00:00:00,Molecular Structure,G02.111.570
17989818,2007-08-31T00:00:00,Molecular Structure,G02.575
17989818,2007-08-31T00:00:00,Molecular Structure,G02.842.575
17989818,2007-08-31T00:00:00,Organometallic Compounds,D01.632
17989818,2007-08-31T00:00:00,Organometallic Compounds,D02.691
17989818,2007-08-31T00:00:00,Zinc,D01.268.556.940
17989818,2007-08-31T00:00:00,Zinc,D01.268.956.906
17989818,2007-08-31T00:00:00,Zinc,D01.552.544.940
17243135,2007-09-01T00:00:00,Adolescent,M01.060.057
17243135,2007-09-01T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
17243135,2007-09-01T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
17243135,2007-09-01T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
17243135,2007-09-01T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
17243135,2007-09-01T00:00:00,Child,M01.060.406
17243135,2007-09-01T00:00:00,"Child, Preschool",M01.060.406.448
17243135,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17243135,2007-09-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
17243135,2007-09-01T00:00:00,Risk Assessment,N04.452.871.715
17243135,2007-09-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17243135,2007-09-01T00:00:00,Risk Assessment,N06.850.505.715
17243135,2007-09-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17243135,2007-09-01T00:00:00,Stroke,C10.228.140.300.775
17243135,2007-09-01T00:00:00,Stroke,C14.907.253.855
17243135,2007-09-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.700.560.260.850
17243135,2007-09-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.260.850
17243135,2007-09-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.850.870
17243135,2007-09-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.376.560.260.850
17539022,2007-09-01T00:00:00,Adult,M01.060.116
17539022,2007-09-01T00:00:00,Alleles,G05.360.340.024.340.030
17539022,2007-09-01T00:00:00,"Carcinoma, Renal Cell",C04.557.470.200.025.390
17539022,2007-09-01T00:00:00,"Carcinoma, Renal Cell",C04.588.945.947.535.160
17539022,2007-09-01T00:00:00,"Carcinoma, Renal Cell",C12.758.820.750.160
17539022,2007-09-01T00:00:00,"Carcinoma, Renal Cell",C12.777.419.473.160
17539022,2007-09-01T00:00:00,"Carcinoma, Renal Cell",C13.351.937.820.535.160
17539022,2007-09-01T00:00:00,"Carcinoma, Renal Cell",C13.351.968.419.473.160
17539022,2007-09-01T00:00:00,"Chromosomes, Human, Pair 3",A11.284.187.520.300.235.250
17539022,2007-09-01T00:00:00,"Chromosomes, Human, Pair 3",G05.360.162.520.300.235.250
17539022,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17539022,2007-09-01T00:00:00,Kidney Neoplasms,C04.588.945.947.535
17539022,2007-09-01T00:00:00,Kidney Neoplasms,C12.758.820.750
17539022,2007-09-01T00:00:00,Kidney Neoplasms,C12.777.419.473
17539022,2007-09-01T00:00:00,Kidney Neoplasms,C13.351.937.820.535
17539022,2007-09-01T00:00:00,Kidney Neoplasms,C13.351.968.419.473
17539022,2007-09-01T00:00:00,Middle Aged,M01.060.116.630
17539022,2007-09-01T00:00:00,Mutation,G05.365.590
17539022,2007-09-01T00:00:00,Neoplasm Proteins,D12.776.624
17539022,2007-09-01T00:00:00,"Translocation, Genetic",C23.550.210.870
17539022,2007-09-01T00:00:00,"Translocation, Genetic",G05.355.600.860
17539022,2007-09-01T00:00:00,"Translocation, Genetic",G05.365.590.175.870
17600796,2007-09-01T00:00:00,Adenocarcinoma,C04.557.470.200.025
17600796,2007-09-01T00:00:00,Antineoplastic Agents,D27.505.954.248
17600796,2007-09-01T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
17600796,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17600796,2007-09-01T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
17600796,2007-09-01T00:00:00,"Microscopy, Fluorescence",E05.595.458
17600796,2007-09-01T00:00:00,Nanoparticles,J01.637.512.600
17600796,2007-09-01T00:00:00,Pharmaceutical Preparations,D26
17600796,2007-09-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
17600796,2007-09-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
17600796,2007-09-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
17600796,2007-09-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
17628485,2007-09-01T00:00:00,Antineoplastic Agents,D27.505.954.248
17628485,2007-09-01T00:00:00,"Clinical Trials, Phase I as Topic",E05.318.760.535.200
17628485,2007-09-01T00:00:00,"Clinical Trials, Phase I as Topic",E05.337.250.200
17628485,2007-09-01T00:00:00,"Clinical Trials, Phase I as Topic",N05.715.360.775.235.200
17628485,2007-09-01T00:00:00,"Clinical Trials, Phase I as Topic",N06.850.520.450.535.200
17628485,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17628485,2007-09-01T00:00:00,Neoplasms,C04
17628485,2007-09-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
17628485,2007-09-01T00:00:00,Risk Assessment,N04.452.871.715
17628485,2007-09-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17628485,2007-09-01T00:00:00,Risk Assessment,N06.850.505.715
17628485,2007-09-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17628485,2007-09-01T00:00:00,Treatment Outcome,E01.789.800
17628485,2007-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17628485,2007-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17647244,2007-09-01T00:00:00,Apoptosis,G04.299.139.160
17647244,2007-09-01T00:00:00,Apoptosis Regulatory Proteins,D12.644.360.075
17647244,2007-09-01T00:00:00,Apoptosis Regulatory Proteins,D12.776.476.075
17647244,2007-09-01T00:00:00,Calcium,D01.268.552.100
17647244,2007-09-01T00:00:00,Calcium,D01.552.539.288
17647244,2007-09-01T00:00:00,Calcium,D23.119.100
17647244,2007-09-01T00:00:00,Cell Survival,G04.299.316
17647244,2007-09-01T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
17647244,2007-09-01T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
17647244,2007-09-01T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
17647244,2007-09-01T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
17647244,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17647244,2007-09-01T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567
17647244,2007-09-01T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750
17647244,2007-09-01T00:00:00,Mitogen-Activated Protein Kinases,D12.644.360.450
17647244,2007-09-01T00:00:00,Mitogen-Activated Protein Kinases,D12.776.476.450
17647244,2007-09-01T00:00:00,"Models, Biological",E05.599.395
17647244,2007-09-01T00:00:00,Phosphorylation,G02.111.087.677
17647244,2007-09-01T00:00:00,Phosphorylation,G02.149.115.677
17647244,2007-09-01T00:00:00,Phosphorylation,G02.149.465.700
17647244,2007-09-01T00:00:00,Phosphorylation,G02.607.750.700
17647244,2007-09-01T00:00:00,Phosphorylation,G03.495.790
17647244,2007-09-01T00:00:00,"RNA, Messenger",D13.444.735.544
17647244,2007-09-01T00:00:00,Reactive Oxygen Species,D01.339.431
17647244,2007-09-01T00:00:00,Reactive Oxygen Species,D01.650.775
17647244,2007-09-01T00:00:00,Signal Transduction,G02.111.087.800
17647244,2007-09-01T00:00:00,Signal Transduction,G02.149.115.800
17647244,2007-09-01T00:00:00,Signal Transduction,G04.299.880
17667139,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17667139,2007-09-01T00:00:00,"Surgical Procedures, Minimally Invasive",E04.800
17667139,2007-09-01T00:00:00,Tracheotomy,E04.580.907
17667139,2007-09-01T00:00:00,Tracheotomy,E04.928.790
17678924,2007-09-01T00:00:00,Colonic Diseases,C06.405.469.158
17678924,2007-09-01T00:00:00,Fraud,I01.198.240.300
17678924,2007-09-01T00:00:00,Gastroenterology,H02.403.429.405
17678924,2007-09-01T00:00:00,Health Policy,I01.880.604.825.608.400
17678924,2007-09-01T00:00:00,Health Policy,N03.706.825.608.428
17678924,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17678924,2007-09-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
17678924,2007-09-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
17678924,2007-09-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
17678924,2007-09-01T00:00:00,United States,Z01.107.567.875
17696783,2007-09-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
17696783,2007-09-01T00:00:00,Alzheimer Disease,C10.574.945.249
17696783,2007-09-01T00:00:00,Alzheimer Disease,F03.087.400.100
17696783,2007-09-01T00:00:00,Amyloid Precursor Protein Secretases,D08.811.277.656.300.032
17696783,2007-09-01T00:00:00,Animals,B01.050
17696783,2007-09-01T00:00:00,Brain,A08.186.211
17696783,2007-09-01T00:00:00,Cathepsin B,D08.811.277.656.224.125
17696783,2007-09-01T00:00:00,Cathepsin B,D08.811.277.656.262.500.133
17696783,2007-09-01T00:00:00,Cathepsin B,D08.811.277.656.300.200.133
17696783,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17696783,2007-09-01T00:00:00,Oligopeptides,D12.644.456
17697869,2007-09-01T00:00:00,Amino Acid Sequence,G02.111.570.060
17697869,2007-09-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
17697869,2007-09-01T00:00:00,Animals,B01.050
17697869,2007-09-01T00:00:00,Cholesterol,D04.808.247.222.284
17697869,2007-09-01T00:00:00,Cholesterol,D04.808.247.808.197
17697869,2007-09-01T00:00:00,Cholesterol,D10.570.938.208
17697869,2007-09-01T00:00:00,Cholesterol,D10.851.208
17697869,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17697869,2007-09-01T00:00:00,Molecular Sequence Data,L01.453.245.667
17697869,2007-09-01T00:00:00,"Mutagenesis, Site-Directed",E05.393.420.601.575
17697869,2007-09-01T00:00:00,Vitamin D,D04.808.812.768
17703382,2007-09-01T00:00:00,Animals,B01.050
17703382,2007-09-01T00:00:00,Digestive System Surgical Procedures,E04.210
17703382,2007-09-01T00:00:00,Esophagus,A03.556.875.500
17703382,2007-09-01T00:00:00,Manometry,E05.559
17703382,2007-09-01T00:00:00,"Models, Animal",E05.598
17703382,2007-09-01T00:00:00,Muscles,A02.633
17703382,2007-09-01T00:00:00,Muscles,A10.690
17703382,2007-09-01T00:00:00,Swine,B01.050.150.900.649.077.880
17709452,2007-09-01T00:00:00,Adult,M01.060.116
17709452,2007-09-01T00:00:00,Aged,M01.060.116.100
17709452,2007-09-01T00:00:00,Beverages,J02.200
17709452,2007-09-01T00:00:00,Biological Markers,D23.101
17709452,2007-09-01T00:00:00,Carbohydrates,D09
17709452,2007-09-01T00:00:00,Fruit,A18.024.500
17709452,2007-09-01T00:00:00,Fruit,J02.500.562
17709452,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17709452,2007-09-01T00:00:00,Insulin,D06.472.699.587.740.625
17709452,2007-09-01T00:00:00,Insulin,D12.644.548.586.740.625
17709452,2007-09-01T00:00:00,Insulin Resistance,C18.452.394.968.500
17709452,2007-09-01T00:00:00,Insulin Resistance,G07.690.320.617
17709452,2007-09-01T00:00:00,Middle Aged,M01.060.116.630
17715433,2007-09-01T00:00:00,Bone Density Conservation Agents,D27.505.696.242
17715433,2007-09-01T00:00:00,Child,M01.060.406
17715433,2007-09-01T00:00:00,Dietary Supplements,J02.500.456
17715433,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17715433,2007-09-01T00:00:00,"Infant, Newborn",M01.060.703.520
17715433,2007-09-01T00:00:00,Internationality,I01.615
17715433,2007-09-01T00:00:00,Pregnancy,G08.686.785.760.769
17715433,2007-09-01T00:00:00,Pregnancy Complications,C13.703
17715433,2007-09-01T00:00:00,Vitamin D,D04.808.812.768
17715433,2007-09-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
17717597,2007-09-01T00:00:00,Animals,B01.050
17717597,2007-09-01T00:00:00,Cell Survival,G04.299.316
17717597,2007-09-01T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
17717597,2007-09-01T00:00:00,"Fusion Proteins, bcr-abl",D08.811.913.696.620.682.725.500.500
17717597,2007-09-01T00:00:00,"Fusion Proteins, bcr-abl",D12.776.602.500.500.100
17717597,2007-09-01T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.100
17717597,2007-09-01T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.664.500.100
17717597,2007-09-01T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
17717597,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17717597,2007-09-01T00:00:00,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C04.557.337.539.250
17717597,2007-09-01T00:00:00,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C15.378.190.636.370
17717597,2007-09-01T00:00:00,Molecular Structure,G02.111.570
17717597,2007-09-01T00:00:00,Molecular Structure,G02.575
17717597,2007-09-01T00:00:00,Molecular Structure,G02.842.575
17717597,2007-09-01T00:00:00,Phosphoprotein Phosphatases,D08.811.277.352.650.625
17717597,2007-09-01T00:00:00,Phosphorylation,G02.111.087.677
17717597,2007-09-01T00:00:00,Phosphorylation,G02.149.115.677
17717597,2007-09-01T00:00:00,Phosphorylation,G02.149.465.700
17717597,2007-09-01T00:00:00,Phosphorylation,G02.607.750.700
17717597,2007-09-01T00:00:00,Phosphorylation,G03.495.790
17717597,2007-09-01T00:00:00,Piperazines,D03.383.606
17717597,2007-09-01T00:00:00,Propylene Glycols,D02.033.455.706
17717597,2007-09-01T00:00:00,Protein Phosphatase 2,D08.811.277.352.650.625.706
17717597,2007-09-01T00:00:00,Protein Phosphatase 2,D12.644.360.583
17717597,2007-09-01T00:00:00,Protein Phosphatase 2,D12.776.476.561
17717597,2007-09-01T00:00:00,Pyrimidines,D03.383.742
17717597,2007-09-01T00:00:00,Signal Transduction,G02.111.087.800
17717597,2007-09-01T00:00:00,Signal Transduction,G02.149.115.800
17717597,2007-09-01T00:00:00,Signal Transduction,G04.299.880
17717597,2007-09-01T00:00:00,Sphingosine,D02.033.100.700
17717597,2007-09-01T00:00:00,Sphingosine,D02.033.455.843
17717597,2007-09-01T00:00:00,Sphingosine,D02.092.063.700
17717597,2007-09-01T00:00:00,Thiazoles,D02.886.675
17717597,2007-09-01T00:00:00,Thiazoles,D03.383.129.708
17717597,2007-09-01T00:00:00,Time Factors,G01.910.857
17720093,2007-09-01T00:00:00,Child,M01.060.406
17720093,2007-09-01T00:00:00,"Child, Preschool",M01.060.406.448
17720093,2007-09-01T00:00:00,Health Surveys,E05.318.308.250
17720093,2007-09-01T00:00:00,Health Surveys,N05.715.360.300.375
17720093,2007-09-01T00:00:00,Health Surveys,N06.850.520.308.250
17720093,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17720093,2007-09-01T00:00:00,Infant,M01.060.703
17720093,2007-09-01T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
17720093,2007-09-01T00:00:00,"Lenses, Intraocular",E07.632.500.460
17720093,2007-09-01T00:00:00,"Lenses, Intraocular",E07.695.460
17720093,2007-09-01T00:00:00,Ophthalmology,H02.403.810.468
17720093,2007-09-01T00:00:00,Physician's Practice Patterns,N04.590.748
17720093,2007-09-01T00:00:00,Physician's Practice Patterns,N05.300.625
17720367,2007-09-01T00:00:00,"Ethics, Medical",K01.316.333.132.750
17720367,2007-09-01T00:00:00,"Ethics, Medical",N05.350.340.162.500
17720367,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17720367,2007-09-01T00:00:00,Physician-Patient Relations,F01.829.401.650.675
17720367,2007-09-01T00:00:00,Physician-Patient Relations,N05.300.660.625
17720367,2007-09-01T00:00:00,"Surgical Procedures, Operative",E04
17720848,2007-09-01T00:00:00,Animals,B01.050
17720848,2007-09-01T00:00:00,Cytokines,D12.644.276.374
17720848,2007-09-01T00:00:00,Cytokines,D12.776.467.374
17720848,2007-09-01T00:00:00,Cytokines,D23.529.374
17720848,2007-09-01T00:00:00,DNA-Binding Proteins,D12.776.260
17720848,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17720848,2007-09-01T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
17720848,2007-09-01T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
17720848,2007-09-01T00:00:00,MAP Kinase Signaling System,G03.495.553.560
17720848,2007-09-01T00:00:00,MAP Kinase Signaling System,G04.299.880.560
17720848,2007-09-01T00:00:00,Mucositis,C06.405.205.798
17720848,2007-09-01T00:00:00,Mucositis,C07.465.584
17720848,2007-09-01T00:00:00,Periodontitis,C07.465.714.533
17720848,2007-09-01T00:00:00,RNA Stability,G02.111.780
17720848,2007-09-01T00:00:00,"Skin Diseases, Vesiculobullous",C17.800.865
17720848,2007-09-01T00:00:00,Temporomandibular Joint Disorders,C05.500.607.221.897
17720848,2007-09-01T00:00:00,Temporomandibular Joint Disorders,C05.550.905
17720848,2007-09-01T00:00:00,Temporomandibular Joint Disorders,C05.651.243.897
17720848,2007-09-01T00:00:00,Temporomandibular Joint Disorders,C07.320.610.291.897
17720848,2007-09-01T00:00:00,Temporomandibular Joint Disorders,C07.678
17720848,2007-09-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
17720848,2007-09-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
17720848,2007-09-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
17720848,2007-09-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
17720849,2007-09-01T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
17720849,2007-09-01T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
17720849,2007-09-01T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
17720849,2007-09-01T00:00:00,Autoimmune Diseases,C20.111
17720849,2007-09-01T00:00:00,Autoimmunity,G12.450.192
17720849,2007-09-01T00:00:00,Chronic Disease,C23.550.291.500
17720849,2007-09-01T00:00:00,DNA-Binding Proteins,D12.776.260
17720849,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17720849,2007-09-01T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
17720849,2007-09-01T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
17720849,2007-09-01T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
17720849,2007-09-01T00:00:00,Protein Isoforms,D12.776.800
17720849,2007-09-01T00:00:00,Trans-Activators,D12.776.260.755
17720849,2007-09-01T00:00:00,Trans-Activators,D12.776.930.900
17720849,2007-09-01T00:00:00,Trans-Activators,D12.776.964.925.984
17720849,2007-09-01T00:00:00,Transcription Factors,D12.776.930
17720849,2007-09-01T00:00:00,Tumor Suppressor Protein p53,D12.776.260.820
17720849,2007-09-01T00:00:00,Tumor Suppressor Protein p53,D12.776.624.776.775
17720849,2007-09-01T00:00:00,Tumor Suppressor Protein p53,D12.776.660.825
17720849,2007-09-01T00:00:00,Tumor Suppressor Protein p53,D12.776.744.845
17720849,2007-09-01T00:00:00,Tumor Suppressor Proteins,D12.776.624.776
17723909,2007-09-01T00:00:00,Activities of Daily Living,E02.831.067
17723909,2007-09-01T00:00:00,Activities of Daily Living,I03.050
17723909,2007-09-01T00:00:00,Activities of Daily Living,N02.421.784.110
17723909,2007-09-01T00:00:00,Chronic Disease,C23.550.291.500
17723909,2007-09-01T00:00:00,Clinical Nursing Research,H02.478.395.234
17723909,2007-09-01T00:00:00,Clinical Nursing Research,N04.590.233.508.613.234
17723909,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17723909,2007-09-01T00:00:00,Middle Aged,M01.060.116.630
17723909,2007-09-01T00:00:00,"Monitoring, Physiologic",E01.370.520
17723909,2007-09-01T00:00:00,Nursing Assessment,N04.590.233.508.480
17723909,2007-09-01T00:00:00,"Obesity, Morbid",C18.654.726.500.700
17723909,2007-09-01T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
17723909,2007-09-01T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
17723909,2007-09-01T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
17723909,2007-09-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
17723909,2007-09-01T00:00:00,Risk Assessment,N04.452.871.715
17723909,2007-09-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17723909,2007-09-01T00:00:00,Risk Assessment,N06.850.505.715
17723909,2007-09-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17723909,2007-09-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17723909,2007-09-01T00:00:00,Risk Factors,N05.715.350.200.700
17723909,2007-09-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17723909,2007-09-01T00:00:00,Risk Factors,N06.850.490.625.750
17723909,2007-09-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17723909,2007-09-01T00:00:00,Self Care,E02.900
17723909,2007-09-01T00:00:00,Self Care,N02.421.784.680
17723909,2007-09-01T00:00:00,Skin Temperature,G07.110.753
17723909,2007-09-01T00:00:00,Skin Temperature,G13.750.844
17723909,2007-09-01T00:00:00,Varicose Ulcer,C14.907.927.730
17723909,2007-09-01T00:00:00,Varicose Ulcer,C17.800.893.592.730
17724354,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17724354,2007-09-01T00:00:00,Intensive Care Units,N02.278.388.493
17724354,2007-09-01T00:00:00,Medication Errors,E02.319.529
17724354,2007-09-01T00:00:00,Medication Errors,N02.421.450.500
17724354,2007-09-01T00:00:00,Patient Care,E02.760
17724354,2007-09-01T00:00:00,Patient Care,N02.421.585
17724354,2007-09-01T00:00:00,"Stress, Physiological",G07.700.830
17724354,2007-09-01T00:00:00,"Students, Pharmacy",I02.851.686.768
17724354,2007-09-01T00:00:00,"Students, Pharmacy",M01.848.769.768
17724354,2007-09-01T00:00:00,Ulcer,C23.550.891
17760557,2007-09-01T00:00:00,Adult,M01.060.116
17760557,2007-09-01T00:00:00,Gingival Neoplasms,C04.588.443.591.402
17760557,2007-09-01T00:00:00,Gingival Neoplasms,C07.465.565.402
17760557,2007-09-01T00:00:00,Gingival Neoplasms,C07.465.714.258.409
17760557,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17760557,2007-09-01T00:00:00,Maxilla,A02.835.232.781.324.502.645
17760557,2007-09-01T00:00:00,Maxilla,A14.521.645
17760557,2007-09-01T00:00:00,Rhabdomyosarcoma,C04.557.450.590.550.660
17760557,2007-09-01T00:00:00,Rhabdomyosarcoma,C04.557.450.795.550.660
17761474,2007-09-01T00:00:00,Animals,B01.050
17761474,2007-09-01T00:00:00,Candida albicans,B01.300.381.147.326
17761474,2007-09-01T00:00:00,Candida albicans,B01.300.930.176.326
17761474,2007-09-01T00:00:00,Candidiasis,C01.703.160
17761474,2007-09-01T00:00:00,Cytokines,D12.644.276.374
17761474,2007-09-01T00:00:00,Cytokines,D12.776.467.374
17761474,2007-09-01T00:00:00,Cytokines,D23.529.374
17761474,2007-09-01T00:00:00,DNA-Binding Proteins,D12.776.260
17761474,2007-09-01T00:00:00,Gastrointestinal Tract,A03.556
17761474,2007-09-01T00:00:00,Gene Expression,G05.355.310
17761474,2007-09-01T00:00:00,Inflammation,C23.550.470
17761474,2007-09-01T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
17761474,2007-09-01T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
17761474,2007-09-01T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
17761474,2007-09-01T00:00:00,Transcription Factors,D12.776.930
17761627,2007-09-01T00:00:00,Clinical Competence,I02.399.630.210
17761627,2007-09-01T00:00:00,Clinical Competence,N04.761.210
17761627,2007-09-01T00:00:00,Communication,F01.145.209
17761627,2007-09-01T00:00:00,Communication,L01.143
17761627,2007-09-01T00:00:00,Counseling,F02.784.176
17761627,2007-09-01T00:00:00,Counseling,F04.408.413
17761627,2007-09-01T00:00:00,Counseling,N02.421.143.303
17761627,2007-09-01T00:00:00,Counseling,N02.421.461.363
17761627,2007-09-01T00:00:00,"Education, Dental",I02.358.274
17761627,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17761627,2007-09-01T00:00:00,Professional-Patient Relations,F01.829.401.650
17761627,2007-09-01T00:00:00,Professional-Patient Relations,N05.300.660
17761627,2007-09-01T00:00:00,Smoking,F01.145.466.753
17761627,2007-09-01T00:00:00,Smoking Cessation,F01.145.940.700
17761627,2007-09-01T00:00:00,Teaching,I02.903
17761981,2007-09-01T00:00:00,Adenocarcinoma,C04.557.470.200.025
17761981,2007-09-01T00:00:00,Aged,M01.060.116.100
17761981,2007-09-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
17761981,2007-09-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
17761981,2007-09-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
17761981,2007-09-01T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
17761981,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17761981,2007-09-01T00:00:00,Pain,C10.597.617
17761981,2007-09-01T00:00:00,Pain,C23.888.592.612
17761981,2007-09-01T00:00:00,Pain,C23.888.646
17761981,2007-09-01T00:00:00,Pain,F02.830.816.444
17761981,2007-09-01T00:00:00,Pain,G11.561.600.810.444
17761981,2007-09-01T00:00:00,Pain Measurement,E01.370.376.550.600
17761981,2007-09-01T00:00:00,Prednisone,D04.808.745.432.719.702
17761981,2007-09-01T00:00:00,Prostate-Specific Antigen,D08.811.277.656.300.760.442.750
17761981,2007-09-01T00:00:00,Prostate-Specific Antigen,D08.811.277.656.959.350.442.750
17761981,2007-09-01T00:00:00,Prostate-Specific Antigen,D12.776.866.249.500
17761981,2007-09-01T00:00:00,Prostate-Specific Antigen,D23.050.285.625
17761981,2007-09-01T00:00:00,Prostate-Specific Antigen,D23.101.840.625
17761981,2007-09-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
17761981,2007-09-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
17761981,2007-09-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
17761981,2007-09-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
17765132,2007-09-01T00:00:00,Blood Pressure,E01.370.600.875.249
17765132,2007-09-01T00:00:00,Blood Pressure,G09.330.380.076
17765132,2007-09-01T00:00:00,C-Reactive Protein,D12.776.034.145
17765132,2007-09-01T00:00:00,C-Reactive Protein,D12.776.124.050.120
17765132,2007-09-01T00:00:00,C-Reactive Protein,D12.776.124.486.157
17765132,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17765132,2007-09-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
17765132,2007-09-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
17765132,2007-09-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
17765132,2007-09-01T00:00:00,Middle Aged,M01.060.116.630
17767363,2007-09-01T00:00:00,Adult,M01.060.116
17767363,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17767363,2007-09-01T00:00:00,Piperazines,D03.383.606
17767363,2007-09-01T00:00:00,Sexuality,F01.145.802.975
17767363,2007-09-01T00:00:00,Sexuality,G08.686.867
17768665,2007-09-01T00:00:00,Adenocarcinoma,C04.557.470.200.025
17768665,2007-09-01T00:00:00,Contrast Media,D27.720.259
17768665,2007-09-01T00:00:00,"Diagnosis, Differential",E01.171
17768665,2007-09-01T00:00:00,Esophageal Neoplasms,C04.588.274.476.205
17768665,2007-09-01T00:00:00,Esophageal Neoplasms,C04.588.443.353
17768665,2007-09-01T00:00:00,Esophageal Neoplasms,C06.301.371.205
17768665,2007-09-01T00:00:00,Esophageal Neoplasms,C06.405.117.430
17768665,2007-09-01T00:00:00,Esophageal Neoplasms,C06.405.249.205
17768665,2007-09-01T00:00:00,Heterocyclic Compounds,D03
17768665,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17768665,2007-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17768665,2007-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17768665,2007-09-01T00:00:00,Organometallic Compounds,D01.632
17768665,2007-09-01T00:00:00,Organometallic Compounds,D02.691
17768665,2007-09-01T00:00:00,Pilot Projects,E05.318.760.750
17768665,2007-09-01T00:00:00,Pilot Projects,E05.337.737
17768665,2007-09-01T00:00:00,Pilot Projects,N05.715.360.775.625
17768665,2007-09-01T00:00:00,Pilot Projects,N06.850.520.450.720
17785575,2007-09-01T00:00:00,Animals,B01.050
17785575,2007-09-01T00:00:00,Antineoplastic Agents,D27.505.954.248
17785575,2007-09-01T00:00:00,Apoptosis,G04.299.139.160
17785575,2007-09-01T00:00:00,Caspases,D08.811.277.656.262.500.126
17785575,2007-09-01T00:00:00,Caspases,D08.811.277.656.300.200.126
17785575,2007-09-01T00:00:00,Caspases,D12.644.360.075.405
17785575,2007-09-01T00:00:00,Caspases,D12.776.476.075.405
17785575,2007-09-01T00:00:00,Cell Proliferation,G04.299.233.750
17785575,2007-09-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
17785575,2007-09-01T00:00:00,Endoplasmic Reticulum,A11.284.430.214.190.875.248
17785575,2007-09-01T00:00:00,HIV Protease Inhibitors,D27.505.519.389.745.420
17785575,2007-09-01T00:00:00,HIV Protease Inhibitors,D27.505.954.122.388.077.088.420
17785575,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17785575,2007-09-01T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
17785575,2007-09-01T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
17785575,2007-09-01T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
17804982,2007-09-01T00:00:00,Acoustic Stimulation,E02.037
17804982,2007-09-01T00:00:00,Acoustic Stimulation,E02.190.888.030
17804982,2007-09-01T00:00:00,Acoustic Stimulation,E05.723.136
17804982,2007-09-01T00:00:00,Adult,M01.060.116
17804982,2007-09-01T00:00:00,Aged,M01.060.116.100
17804982,2007-09-01T00:00:00,Auditory Threshold,F02.463.593.071.173
17804982,2007-09-01T00:00:00,Auditory Threshold,F02.463.593.710.190
17804982,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17804982,2007-09-01T00:00:00,Middle Aged,M01.060.116.630
17804982,2007-09-01T00:00:00,Nonlinear Dynamics,E05.599.850
17804982,2007-09-01T00:00:00,Nonlinear Dynamics,H01.548.675
17804982,2007-09-01T00:00:00,"Otoacoustic Emissions, Spontaneous",G11.561.600.810.263.570
17804982,2007-09-01T00:00:00,Perceptual Masking,F02.463.593.071.594
17804982,2007-09-01T00:00:00,Perceptual Masking,F02.463.593.932.733
17804982,2007-09-01T00:00:00,Speech Perception,F02.463.593.071.875
17804986,2007-09-01T00:00:00,Adult,M01.060.116
17804986,2007-09-01T00:00:00,Aged,M01.060.116.100
17804986,2007-09-01T00:00:00,Depressive Disorder,F03.600.300
17804986,2007-09-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
17804986,2007-09-01T00:00:00,Electroconvulsive Therapy,F04.570.200.583
17804986,2007-09-01T00:00:00,Electroconvulsive Therapy,F04.669.224.300
17804986,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17804986,2007-09-01T00:00:00,Middle Aged,M01.060.116.630
17804986,2007-09-01T00:00:00,Psychotic Disorders,F03.700.675
17804986,2007-09-01T00:00:00,Remission Induction,E02.860
17804986,2007-09-01T00:00:00,Treatment Outcome,E01.789.800
17804986,2007-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17804986,2007-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17805005,2007-09-01T00:00:00,Electroconvulsive Therapy,F04.570.200.583
17805005,2007-09-01T00:00:00,Electroconvulsive Therapy,F04.669.224.300
17805005,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17805005,2007-09-01T00:00:00,Ketamine,D02.455.426.392.368.367.652
17805005,2007-09-01T00:00:00,Treatment Outcome,E01.789.800
17805005,2007-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17805005,2007-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17823454,2007-09-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
17823454,2007-09-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
17823454,2007-09-01T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
17823454,2007-09-01T00:00:00,Equipment Failure Analysis,E05.325.192
17823454,2007-09-01T00:00:00,Radiopharmaceuticals,D27.720.470.410.650
17823454,2007-09-01T00:00:00,Radiotherapy Dosage,E02.815.639
17823454,2007-09-01T00:00:00,Whole-Body Counting,E05.799.950
17826412,2007-09-01T00:00:00,Adult,M01.060.116
17826412,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17826412,2007-09-01T00:00:00,Hydroxyprogesterones,D04.808.745.745.654.829.395
17826412,2007-09-01T00:00:00,Hydroxyprogesterones,D06.472.334.851.687.750.478
17826412,2007-09-01T00:00:00,Pregnancy,G08.686.785.760.769
17826412,2007-09-01T00:00:00,Pregnancy Outcome,E01.789.700
17826412,2007-09-01T00:00:00,Pregnancy Outcome,G08.686.785.760.769.530
17826412,2007-09-01T00:00:00,Premature Birth,C13.703.420.491.500
17826412,2007-09-01T00:00:00,Tocolytic Agents,D27.505.696.875.825
17826412,2007-09-01T00:00:00,Tocolytic Agents,D27.505.954.705.825
17826457,2007-09-01T00:00:00,Chronic Disease,C23.550.291.500
17826457,2007-09-01T00:00:00,Electromyography,E01.370.405.255
17826457,2007-09-01T00:00:00,Electromyography,E01.370.530.255
17826457,2007-09-01T00:00:00,Gait,E01.370.600.250
17826457,2007-09-01T00:00:00,Gait,G11.427.590.530.389
17826457,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17826457,2007-09-01T00:00:00,Leg,A01.378.610.500
17826457,2007-09-01T00:00:00,Middle Aged,M01.060.116.630
17826457,2007-09-01T00:00:00,"Muscle, Skeletal",A02.633.567
17826457,2007-09-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
17826457,2007-09-01T00:00:00,Paresis,C10.597.636
17826457,2007-09-01T00:00:00,Paresis,C23.888.592.643
17826457,2007-09-01T00:00:00,Stroke,C10.228.140.300.775
17826457,2007-09-01T00:00:00,Stroke,C14.907.253.855
17826457,2007-09-01T00:00:00,Walking,G11.427.590.530.568.900
17826457,2007-09-01T00:00:00,Walking,G11.427.590.530.698.940
17826457,2007-09-01T00:00:00,Walking,I03.450.642.845.940
17826643,2007-09-01T00:00:00,Adult,M01.060.116
17826643,2007-09-01T00:00:00,Aged,M01.060.116.100
17826643,2007-09-01T00:00:00,Aging,G07.700.320.124
17826643,2007-09-01T00:00:00,Blood Pressure,E01.370.600.875.249
17826643,2007-09-01T00:00:00,Blood Pressure,G09.330.380.076
17826643,2007-09-01T00:00:00,Echocardiography,E01.370.350.850.220
17826643,2007-09-01T00:00:00,Echocardiography,E01.370.370.380.220
17826643,2007-09-01T00:00:00,Extracellular Matrix,A11.284.295.310
17826643,2007-09-01T00:00:00,Heart Ventricles,A07.541.560
17826643,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17826643,2007-09-01T00:00:00,Matrix Metalloproteinase 7,D08.811.277.656.300.480.525.700.250
17826643,2007-09-01T00:00:00,Matrix Metalloproteinase 7,D08.811.277.656.675.374.525.700.250
17826643,2007-09-01T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
17826643,2007-09-01T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
17826643,2007-09-01T00:00:00,Middle Aged,M01.060.116.630
17826643,2007-09-01T00:00:00,Mitral Valve,A07.541.510.507
17826643,2007-09-01T00:00:00,Myocardium,A02.633.580
17826643,2007-09-01T00:00:00,Myocardium,A07.541.704
17826643,2007-09-01T00:00:00,Myocardium,A10.690.552.750
17826643,2007-09-01T00:00:00,Tissue Inhibitor of Metalloproteinase-1,D12.776.926.450
17826643,2007-09-01T00:00:00,Tissue Inhibitor of Metalloproteinases,D12.776.926
17826643,2007-09-01T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
17826650,2007-09-01T00:00:00,Animals,B01.050
17826650,2007-09-01T00:00:00,"Cardiac Output, Low",C14.280.148
17826650,2007-09-01T00:00:00,"Cardiac Output, Low",C23.888.192
17826650,2007-09-01T00:00:00,Cardiomegaly,C14.280.195
17826650,2007-09-01T00:00:00,Cardiomegaly,C23.300.775.250
17826650,2007-09-01T00:00:00,Collagen,D05.750.078.280
17826650,2007-09-01T00:00:00,Collagen,D12.776.860.300.250
17826650,2007-09-01T00:00:00,Coronary Vessels,A07.231.114.269
17826650,2007-09-01T00:00:00,Coronary Vessels,A07.231.908.194
17826650,2007-09-01T00:00:00,Fibroblasts,A11.329.228
17826650,2007-09-01T00:00:00,Fibroblasts,A11.872.228
17826650,2007-09-01T00:00:00,Heart,A07.541
17826650,2007-09-01T00:00:00,Kinins,D12.644.276.812
17826650,2007-09-01T00:00:00,Kinins,D12.776.467.812
17826650,2007-09-01T00:00:00,Kinins,D23.469.050.375
17826650,2007-09-01T00:00:00,Kinins,D23.529.812
17826650,2007-09-01T00:00:00,Myocardial Contraction,G09.330.190.541
17826650,2007-09-01T00:00:00,Myocardial Contraction,G11.427.590.540.570
17826650,2007-09-01T00:00:00,Myocardial Infarction,C14.280.647.500
17826650,2007-09-01T00:00:00,Myocardial Infarction,C14.907.585.500
17826650,2007-09-01T00:00:00,Myocardium,A02.633.580
17826650,2007-09-01T00:00:00,Myocardium,A07.541.704
17826650,2007-09-01T00:00:00,Myocardium,A10.690.552.750
17826650,2007-09-01T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
17826650,2007-09-01T00:00:00,Oxidative Stress,G03.495.710
17826650,2007-09-01T00:00:00,Oxidative Stress,G07.700.830.750
17826650,2007-09-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17826650,2007-09-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17826650,2007-09-01T00:00:00,Salvage Therapy,E02.186.800
17826650,2007-09-01T00:00:00,Salvage Therapy,E02.895
17826650,2007-09-01T00:00:00,Tissue Kallikreins,D08.811.277.656.300.760.442.875
17826650,2007-09-01T00:00:00,Tissue Kallikreins,D08.811.277.656.959.350.442.875
17826650,2007-09-01T00:00:00,Tissue Kallikreins,D23.101.840.870
17826650,2007-09-01T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
17826650,2007-09-01T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
17826650,2007-09-01T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
17826650,2007-09-01T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
17826650,2007-09-01T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
17826650,2007-09-01T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
17826650,2007-09-01T00:00:00,Transforming Growth Factor beta,D23.529.374.687
17826650,2007-09-01T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
17826650,2007-09-01T00:00:00,Transforming Growth Factor beta,D23.529.960.720
17826650,2007-09-01T00:00:00,Ventricular Remodeling,C23.300.985
17826650,2007-09-01T00:00:00,Ventricular Remodeling,G09.330.190.962.975
17845919,2007-09-01T00:00:00,Aged,M01.060.116.100
17845919,2007-09-01T00:00:00,Anticoagulants,D27.505.954.502.119
17845919,2007-09-01T00:00:00,"Constriction, Pathologic",C23.300.287
17845919,2007-09-01T00:00:00,Double-Blind Method,E05.318.780.300
17845919,2007-09-01T00:00:00,Double-Blind Method,E05.581.500.300
17845919,2007-09-01T00:00:00,Double-Blind Method,N05.715.360.780.320
17845919,2007-09-01T00:00:00,Double-Blind Method,N06.850.520.445.300
17845919,2007-09-01T00:00:00,"Echocardiography, Transesophageal",E01.370.350.850.220.235
17845919,2007-09-01T00:00:00,"Echocardiography, Transesophageal",E01.370.370.380.220.235
17845919,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17845919,2007-09-01T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
17845919,2007-09-01T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
17845919,2007-09-01T00:00:00,Middle Aged,M01.060.116.630
17845919,2007-09-01T00:00:00,Myocardial Infarction,C14.280.647.500
17845919,2007-09-01T00:00:00,Myocardial Infarction,C14.907.585.500
17845919,2007-09-01T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
17845919,2007-09-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
17845919,2007-09-01T00:00:00,Risk Assessment,N04.452.871.715
17845919,2007-09-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17845919,2007-09-01T00:00:00,Risk Assessment,N06.850.505.715
17845919,2007-09-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17845919,2007-09-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17845919,2007-09-01T00:00:00,Risk Factors,N05.715.350.200.700
17845919,2007-09-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17845919,2007-09-01T00:00:00,Risk Factors,N06.850.490.625.750
17845919,2007-09-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17845919,2007-09-01T00:00:00,Stroke,C10.228.140.300.775
17845919,2007-09-01T00:00:00,Stroke,C14.907.253.855
17845919,2007-09-01T00:00:00,Warfarin,D03.438.150.446.520.914
17845919,2007-09-01T00:00:00,Warfarin,D03.830.219.446.520.914
17846267,2007-09-01T00:00:00,Adult,M01.060.116
17846267,2007-09-01T00:00:00,Aged,M01.060.116.100
17846267,2007-09-01T00:00:00,Brain,A08.186.211
17846267,2007-09-01T00:00:00,Brain Ischemia,C10.228.140.300.150
17846267,2007-09-01T00:00:00,Brain Ischemia,C14.907.253.092
17846267,2007-09-01T00:00:00,Calcium,D01.268.552.100
17846267,2007-09-01T00:00:00,Calcium,D01.552.539.288
17846267,2007-09-01T00:00:00,Calcium,D23.119.100
17846267,2007-09-01T00:00:00,Extracellular Space,A10.082.500
17846267,2007-09-01T00:00:00,Extracellular Space,A11.284.295
17846267,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17846267,2007-09-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
17846267,2007-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17846267,2007-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17846267,2007-09-01T00:00:00,Middle Aged,M01.060.116.630
17846267,2007-09-01T00:00:00,Stroke,C10.228.140.300.775
17846267,2007-09-01T00:00:00,Stroke,C14.907.253.855
17849343,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17849343,2007-09-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17849343,2007-09-01T00:00:00,United States,Z01.107.567.875
17849346,2007-09-01T00:00:00,Brain Mapping,E01.370.350.086
17849346,2007-09-01T00:00:00,Brain Mapping,E01.370.376.149
17849346,2007-09-01T00:00:00,Brain Mapping,E05.132
17849346,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17849346,2007-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17849346,2007-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17867918,2007-09-01T00:00:00,Balloon Occlusion,E02.148.106
17867918,2007-09-01T00:00:00,Balloon Occlusion,E02.520.179
17867918,2007-09-01T00:00:00,"Foramen Ovale, Patent",C14.240.400.560.375.258
17867918,2007-09-01T00:00:00,"Foramen Ovale, Patent",C14.280.400.560.375.258
17867918,2007-09-01T00:00:00,"Foramen Ovale, Patent",C16.131.240.400.560.375.258
17867918,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17873159,2007-09-01T00:00:00,Air Pollutants,D27.888.284.101
17873159,2007-09-01T00:00:00,Evidence-Based Medicine,H02.249.750
17873159,2007-09-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
17873159,2007-09-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17873159,2007-09-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
17873159,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17873159,2007-09-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
17873159,2007-09-01T00:00:00,Lung Neoplasms,C08.381.540
17873159,2007-09-01T00:00:00,Lung Neoplasms,C08.785.520
17873159,2007-09-01T00:00:00,Occupational Exposure,N06.850.460.350.600
17873159,2007-09-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
17873159,2007-09-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
17873159,2007-09-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17873159,2007-09-01T00:00:00,Risk Factors,N05.715.350.200.700
17873159,2007-09-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17873159,2007-09-01T00:00:00,Risk Factors,N06.850.490.625.750
17873159,2007-09-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17873159,2007-09-01T00:00:00,Sex Factors,N05.715.350.675
17873159,2007-09-01T00:00:00,Sex Factors,N06.850.490.875
17873159,2007-09-01T00:00:00,Smoking,F01.145.466.753
17873159,2007-09-01T00:00:00,United States,Z01.107.567.875
17873161,2007-09-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
17873161,2007-09-01T00:00:00,Evidence-Based Medicine,H02.249.750
17873161,2007-09-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
17873161,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17873161,2007-09-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
17873161,2007-09-01T00:00:00,Lung Neoplasms,C08.381.540
17873161,2007-09-01T00:00:00,Lung Neoplasms,C08.785.520
17873161,2007-09-01T00:00:00,Mass Screening,E01.370.500
17873161,2007-09-01T00:00:00,Mass Screening,E05.318.308.250.580
17873161,2007-09-01T00:00:00,Mass Screening,N02.421.143.827.233.443
17873161,2007-09-01T00:00:00,Mass Screening,N02.421.726.233.443
17873161,2007-09-01T00:00:00,Mass Screening,N05.715.360.300.375.500
17873161,2007-09-01T00:00:00,Mass Screening,N06.850.520.308.250.580
17873161,2007-09-01T00:00:00,Mass Screening,N06.850.780.500
17873161,2007-09-01T00:00:00,Neoplasm Staging,E01.370.550
17873161,2007-09-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
17873161,2007-09-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
17873161,2007-09-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
17873161,2007-09-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
17873161,2007-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17873161,2007-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17873161,2007-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17873161,2007-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17873161,2007-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17873168,2007-09-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
17873168,2007-09-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
17873168,2007-09-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
17873168,2007-09-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
17873168,2007-09-01T00:00:00,Clinical Trials as Topic,E05.337.250
17873168,2007-09-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
17873168,2007-09-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
17873168,2007-09-01T00:00:00,"Diagnosis, Differential",E01.171
17873168,2007-09-01T00:00:00,Evidence-Based Medicine,H02.249.750
17873168,2007-09-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
17873168,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17873168,2007-09-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
17873168,2007-09-01T00:00:00,Lung Neoplasms,C08.381.540
17873168,2007-09-01T00:00:00,Lung Neoplasms,C08.785.520
17873168,2007-09-01T00:00:00,Neoplasm Staging,E01.370.550
17873168,2007-09-01T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
17873168,2007-09-01T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
17873168,2007-09-01T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
17873168,2007-09-01T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
17873168,2007-09-01T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
17873168,2007-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17873168,2007-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17873168,2007-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17873168,2007-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17873168,2007-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17873169,2007-09-01T00:00:00,"Biopsy, Needle",E01.370.388.100.100
17873169,2007-09-01T00:00:00,"Biopsy, Needle",E01.450.230.100.100
17873169,2007-09-01T00:00:00,"Biopsy, Needle",E01.450.865.100.100
17873169,2007-09-01T00:00:00,"Biopsy, Needle",E01.450.865.632.100
17873169,2007-09-01T00:00:00,"Biopsy, Needle",E04.074.119
17873169,2007-09-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
17873169,2007-09-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
17873169,2007-09-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
17873169,2007-09-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
17873169,2007-09-01T00:00:00,Clinical Trials as Topic,E05.337.250
17873169,2007-09-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
17873169,2007-09-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
17873169,2007-09-01T00:00:00,Evidence-Based Medicine,H02.249.750
17873169,2007-09-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
17873169,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17873169,2007-09-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
17873169,2007-09-01T00:00:00,Lung Neoplasms,C08.381.540
17873169,2007-09-01T00:00:00,Lung Neoplasms,C08.785.520
17873169,2007-09-01T00:00:00,Neoplasm Staging,E01.370.550
17874921,2007-09-01T00:00:00,Adolescent,M01.060.057
17874921,2007-09-01T00:00:00,Behavior Therapy,F04.754.137
17874921,2007-09-01T00:00:00,Child,M01.060.406
17874921,2007-09-01T00:00:00,Combined Modality Therapy,E02.186
17874921,2007-09-01T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
17874921,2007-09-01T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
17874921,2007-09-01T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
17874921,2007-09-01T00:00:00,Health Status,I01.240.425
17874921,2007-09-01T00:00:00,Health Status,N01.224.425
17874921,2007-09-01T00:00:00,Health Status,N06.850.505.400.425
17874921,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17874921,2007-09-01T00:00:00,Hypoglycemic Agents,D27.505.696.422
17874921,2007-09-01T00:00:00,Patient Compliance,F01.145.488.500
17874921,2007-09-01T00:00:00,Patient Compliance,N05.300.150.600.600
17874921,2007-09-01T00:00:00,Questionnaires,E05.318.308.750
17874921,2007-09-01T00:00:00,Questionnaires,L01.280.800
17874921,2007-09-01T00:00:00,Questionnaires,N05.715.360.300.695
17874921,2007-09-01T00:00:00,Questionnaires,N06.850.520.308.750
17875857,2007-09-01T00:00:00,Adult,M01.060.116
17875857,2007-09-01T00:00:00,Aged,M01.060.116.100
17875857,2007-09-01T00:00:00,Attention,F02.830.104.214
17875857,2007-09-01T00:00:00,Automobile Driving,I03.125
17875857,2007-09-01T00:00:00,Computer Simulation,L01.224.160
17875857,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17875857,2007-09-01T00:00:00,Middle Aged,M01.060.116.630
17875857,2007-09-01T00:00:00,Pilot Projects,E05.318.760.750
17875857,2007-09-01T00:00:00,Pilot Projects,E05.337.737
17875857,2007-09-01T00:00:00,Pilot Projects,N05.715.360.775.625
17875857,2007-09-01T00:00:00,Pilot Projects,N06.850.520.450.720
17875857,2007-09-01T00:00:00,Psychomotor Performance,F02.808
17875857,2007-09-01T00:00:00,Psychomotor Performance,G11.427.700
17875857,2007-09-01T00:00:00,Psychomotor Performance,G11.561.623
17875857,2007-09-01T00:00:00,Reaction Time,F02.830.650
17875857,2007-09-01T00:00:00,Reaction Time,F04.669.817
17875857,2007-09-01T00:00:00,Reaction Time,G11.561.677
17875857,2007-09-01T00:00:00,User-Computer Interface,L01.224.900.910
17876045,2007-09-01T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
17876045,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17876045,2007-09-01T00:00:00,NF-kappa B,D12.776.260.600
17876045,2007-09-01T00:00:00,NF-kappa B,D12.776.660.600
17876045,2007-09-01T00:00:00,NF-kappa B,D12.776.930.600
17876045,2007-09-01T00:00:00,PTEN Phosphohydrolase,D08.811.277.352.650.850
17876045,2007-09-01T00:00:00,PTEN Phosphohydrolase,D12.776.476.590
17876045,2007-09-01T00:00:00,PTEN Phosphohydrolase,D12.776.624.776.695
17876045,2007-09-01T00:00:00,Phosphorylation,G02.111.087.677
17876045,2007-09-01T00:00:00,Phosphorylation,G02.149.115.677
17876045,2007-09-01T00:00:00,Phosphorylation,G02.149.465.700
17876045,2007-09-01T00:00:00,Phosphorylation,G02.607.750.700
17876045,2007-09-01T00:00:00,Phosphorylation,G03.495.790
17876045,2007-09-01T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
17876045,2007-09-01T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
17876045,2007-09-01T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
17876045,2007-09-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
17876045,2007-09-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
17876045,2007-09-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
17876045,2007-09-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
17876045,2007-09-01T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
17876045,2007-09-01T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
17876045,2007-09-01T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
17876045,2007-09-01T00:00:00,Sesquiterpenes,D02.455.849.765
17876045,2007-09-01T00:00:00,Signal Transduction,G02.111.087.800
17876045,2007-09-01T00:00:00,Signal Transduction,G02.149.115.800
17876045,2007-09-01T00:00:00,Signal Transduction,G04.299.880
17876045,2007-09-01T00:00:00,Superoxide Dismutase,D08.811.682.881
17876247,2007-09-01T00:00:00,Adolescent,M01.060.057
17876247,2007-09-01T00:00:00,Adult,M01.060.116
17876247,2007-09-01T00:00:00,Aged,M01.060.116.100
17876247,2007-09-01T00:00:00,Catheterization,E02.148
17876247,2007-09-01T00:00:00,Catheterization,E05.157
17876247,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17876247,2007-09-01T00:00:00,Laparoscopy,E01.370.388.250.520
17876247,2007-09-01T00:00:00,Laparoscopy,E04.800.250.520
17876247,2007-09-01T00:00:00,Middle Aged,M01.060.116.630
17876247,2007-09-01T00:00:00,Prosthesis Implantation,E04.650
17876247,2007-09-01T00:00:00,Treatment Outcome,E01.789.800
17876247,2007-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17876247,2007-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17880841,2007-09-01T00:00:00,Aged,M01.060.116.100
17880841,2007-09-01T00:00:00,Gynecologic Surgical Procedures,E04.950.300
17880841,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17880841,2007-09-01T00:00:00,Intraoperative Complications,C23.550.505
17880841,2007-09-01T00:00:00,Middle Aged,M01.060.116.630
17880841,2007-09-01T00:00:00,Postoperative Complications,C23.550.767
17880841,2007-09-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
17880841,2007-09-01T00:00:00,Risk Assessment,N04.452.871.715
17880841,2007-09-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17880841,2007-09-01T00:00:00,Risk Assessment,N06.850.505.715
17880841,2007-09-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17880841,2007-09-01T00:00:00,Suburethral Slings,E07.695.752
17880841,2007-09-01T00:00:00,Surgical Mesh,E07.858.708
17880841,2007-09-01T00:00:00,"Urinary Incontinence, Stress",C12.777.934.852.249
17880841,2007-09-01T00:00:00,"Urinary Incontinence, Stress",C13.351.968.934.814.500
17880841,2007-09-01T00:00:00,"Urinary Incontinence, Stress",C23.888.942.800.500
17880841,2007-09-01T00:00:00,Uterine Prolapse,C13.351.500.852.833
17880841,2007-09-01T00:00:00,Uterine Prolapse,C23.300.842.500.750
17881980,2007-09-01T00:00:00,Coronary Restenosis,C14.280.647.250.285.200
17881980,2007-09-01T00:00:00,Coronary Restenosis,C14.907.585.250.285.200
17881980,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17881980,2007-09-01T00:00:00,Incidence,E05.318.308.985.525.375
17881980,2007-09-01T00:00:00,Incidence,L01.280.975.525.375
17881980,2007-09-01T00:00:00,Incidence,N01.224.935.597.500
17881980,2007-09-01T00:00:00,Incidence,N06.850.505.400.975.525.375
17881980,2007-09-01T00:00:00,Incidence,N06.850.520.308.985.525.375
17881980,2007-09-01T00:00:00,Middle Aged,M01.060.116.630
17881980,2007-09-01T00:00:00,Stents,E07.695.750
17881980,2007-09-01T00:00:00,Thrombosis,C14.907.355.830
17888771,2007-09-01T00:00:00,Data Display,F02.784.412.221
17888771,2007-09-01T00:00:00,Data Display,L01.296
17888771,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17888771,2007-09-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
17888771,2007-09-01T00:00:00,Mammography,E01.370.350.700.500
17888771,2007-09-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
17888771,2007-09-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
17888771,2007-09-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
17888771,2007-09-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
17888771,2007-09-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
17888771,2007-09-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
17888771,2007-09-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
17888807,2007-09-01T00:00:00,Adolescent,M01.060.057
17888807,2007-09-01T00:00:00,Adult,M01.060.116
17888807,2007-09-01T00:00:00,Aged,M01.060.116.100
17888807,2007-09-01T00:00:00,Chronic Disease,C23.550.291.500
17888807,2007-09-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
17888807,2007-09-01T00:00:00,Disability Evaluation,E01.370.400
17888807,2007-09-01T00:00:00,Employment,N01.824.245
17888807,2007-09-01T00:00:00,Health Services,N02.421
17888807,2007-09-01T00:00:00,Health Surveys,E05.318.308.250
17888807,2007-09-01T00:00:00,Health Surveys,N05.715.360.300.375
17888807,2007-09-01T00:00:00,Health Surveys,N06.850.520.308.250
17888807,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17888807,2007-09-01T00:00:00,Middle Aged,M01.060.116.630
17888807,2007-09-01T00:00:00,United States,Z01.107.567.875
17890413,2007-09-01T00:00:00,Brain,A08.186.211
17890413,2007-09-01T00:00:00,Child,M01.060.406
17890413,2007-09-01T00:00:00,Epilepsy,C10.228.140.490
17890413,2007-09-01T00:00:00,Face,A01.456.505
17890413,2007-09-01T00:00:00,Gene Deletion,G05.355.600.800.320
17890413,2007-09-01T00:00:00,Gene Deletion,G05.365.590.762.320
17890413,2007-09-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17890413,2007-09-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
17890413,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17890413,2007-09-01T00:00:00,Kyphosis,C05.116.900.800.500
17890413,2007-09-01T00:00:00,Mutation,G05.365.590
17890413,2007-09-01T00:00:00,Phenotype,G05.695
17890413,2007-09-01T00:00:00,Skull,A02.835.232.781
17890413,2007-09-01T00:00:00,Syndrome,C23.550.288.500
17893381,2007-09-01T00:00:00,Aged,M01.060.116.100
17893381,2007-09-01T00:00:00,Coronary Disease,C14.280.647.250
17893381,2007-09-01T00:00:00,Coronary Disease,C14.907.585.250
17893381,2007-09-01T00:00:00,Disease Progression,C23.550.291.656
17893381,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17893381,2007-09-01T00:00:00,Hypertension,C14.907.489
17893381,2007-09-01T00:00:00,Middle Aged,M01.060.116.630
17893381,2007-09-01T00:00:00,Regression Analysis,E05.318.740.750
17893381,2007-09-01T00:00:00,Regression Analysis,N05.715.360.750.695
17893381,2007-09-01T00:00:00,Regression Analysis,N06.850.520.830.750
17893381,2007-09-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17893381,2007-09-01T00:00:00,Risk Factors,N05.715.350.200.700
17893381,2007-09-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17893381,2007-09-01T00:00:00,Risk Factors,N06.850.490.625.750
17893381,2007-09-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17893381,2007-09-01T00:00:00,"Stress, Psychological",F01.145.126.990
17893381,2007-09-01T00:00:00,"Stress, Psychological",F02.830.900
17893381,2007-09-01T00:00:00,United States,Z01.107.567.875
17893384,2007-09-01T00:00:00,Adolescent,M01.060.057
17893384,2007-09-01T00:00:00,Adult,M01.060.116
17893384,2007-09-01T00:00:00,Age Factors,N05.715.350.075
17893384,2007-09-01T00:00:00,Age Factors,N06.850.490.250
17893384,2007-09-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
17893384,2007-09-01T00:00:00,Body Mass Index,E05.041.124.125
17893384,2007-09-01T00:00:00,Body Mass Index,G07.100.100.125
17893384,2007-09-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
17893384,2007-09-01T00:00:00,Diabetes Mellitus,C18.452.394.750
17893384,2007-09-01T00:00:00,Diabetes Mellitus,C19.246
17893384,2007-09-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17893384,2007-09-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
17893384,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17893384,2007-09-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
17893384,2007-09-01T00:00:00,Risk Assessment,N04.452.871.715
17893384,2007-09-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17893384,2007-09-01T00:00:00,Risk Assessment,N06.850.505.715
17893384,2007-09-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17893384,2007-09-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17893384,2007-09-01T00:00:00,Risk Factors,N05.715.350.200.700
17893384,2007-09-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17893384,2007-09-01T00:00:00,Risk Factors,N06.850.490.625.750
17893384,2007-09-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17897057,2007-09-01T00:00:00,Animals,B01.050
17897057,2007-09-01T00:00:00,Bacterial Proteins,D12.776.097
17897057,2007-09-01T00:00:00,Drug Delivery Systems,E02.319.300
17897057,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17897057,2007-09-01T00:00:00,Iron,D01.268.556.412
17897057,2007-09-01T00:00:00,Iron,D01.268.956.287
17897057,2007-09-01T00:00:00,Iron,D01.552.544.412
17897057,2007-09-01T00:00:00,Mycobacterium tuberculosis,B03.510.024.049.525.500.702
17897057,2007-09-01T00:00:00,Mycobacterium tuberculosis,B03.510.460.400.410.552.552.702
17897057,2007-09-01T00:00:00,Repressor Proteins,D12.776.260.703
17897057,2007-09-01T00:00:00,Repressor Proteins,D12.776.930.700
17903782,2007-09-01T00:00:00,"Adaptation, Psychological",F01.058
17903782,2007-09-01T00:00:00,Attitude of Health Personnel,F01.100.050
17903782,2007-09-01T00:00:00,Attitude of Health Personnel,N05.300.100
17903782,2007-09-01T00:00:00,Communication,F01.145.209
17903782,2007-09-01T00:00:00,Communication,L01.143
17903782,2007-09-01T00:00:00,Cooperative Behavior,F01.145.813.115
17903782,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17903782,2007-09-01T00:00:00,Interprofessional Relations,F01.829.401.205
17903782,2007-09-01T00:00:00,Nurse Administrators,M01.526.070.670
17903782,2007-09-01T00:00:00,Nurse Administrators,M01.526.485.650.580
17903782,2007-09-01T00:00:00,Nurse Administrators,N02.360.650.580
17903782,2007-09-01T00:00:00,Nurse's Role,F01.829.316.616.625.450
17903782,2007-09-01T00:00:00,Nurse's Role,N05.300.100.337
17903782,2007-09-01T00:00:00,"Schools, Nursing",I02.783.660.623
17908040,2007-09-01T00:00:00,Animals,B01.050
17908040,2007-09-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
17908040,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17908040,2007-09-01T00:00:00,Neurodegenerative Diseases,C10.574
17908040,2007-09-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
17908040,2007-09-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
17908040,2007-09-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
17908040,2007-09-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
17908040,2007-09-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
17908040,2007-09-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
17908040,2007-09-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
17908040,2007-09-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
17908040,2007-09-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
17908040,2007-09-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
17908040,2007-09-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
17917493,2007-09-01T00:00:00,Aged,M01.060.116.100
17917493,2007-09-01T00:00:00,Decision Making,F02.463.785.373
17917493,2007-09-01T00:00:00,Disease Progression,C23.550.291.656
17917493,2007-09-01T00:00:00,Health Services Accessibility,N04.590.374.350
17917493,2007-09-01T00:00:00,Health Services Accessibility,N05.300.430
17917493,2007-09-01T00:00:00,Heart Failure,C14.280.434
17917493,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17917493,2007-09-01T00:00:00,Internship and Residency,I02.358.399.644
17917493,2007-09-01T00:00:00,Middle Aged,M01.060.116.630
17917493,2007-09-01T00:00:00,Patient-Centered Care,N04.590.233.675
17917493,2007-09-01T00:00:00,Patient-Centered Care,N04.590.233.727.407
17917493,2007-09-01T00:00:00,Patient-Centered Care,N04.590.720
17917493,2007-09-01T00:00:00,Physicians,M01.526.485.810
17917493,2007-09-01T00:00:00,Physicians,N02.360.810
17917493,2007-09-01T00:00:00,Questionnaires,E05.318.308.750
17917493,2007-09-01T00:00:00,Questionnaires,L01.280.800
17917493,2007-09-01T00:00:00,Questionnaires,N05.715.360.300.695
17917493,2007-09-01T00:00:00,Questionnaires,N06.850.520.308.750
17917493,2007-09-01T00:00:00,Treatment Outcome,E01.789.800
17917493,2007-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17917493,2007-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17944164,2007-09-01T00:00:00,"Adaptation, Psychological",F01.058
17944164,2007-09-01T00:00:00,Adult,M01.060.116
17944164,2007-09-01T00:00:00,African Americans,M01.686.508.100.100
17944164,2007-09-01T00:00:00,African Americans,M01.686.754.100
17944164,2007-09-01T00:00:00,Attitude to Health,F01.100.150
17944164,2007-09-01T00:00:00,Attitude to Health,N05.300.150
17944164,2007-09-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
17944164,2007-09-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
17944164,2007-09-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
17944164,2007-09-01T00:00:00,Health Services Accessibility,N04.590.374.350
17944164,2007-09-01T00:00:00,Health Services Accessibility,N05.300.430
17944164,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17944164,2007-09-01T00:00:00,Kidney Transplantation,E02.870.500
17944164,2007-09-01T00:00:00,Kidney Transplantation,E04.936.450.485
17944164,2007-09-01T00:00:00,Kidney Transplantation,E04.950.774.400
17944164,2007-09-01T00:00:00,Living Donors,M01.898.656
17944164,2007-09-01T00:00:00,Middle Aged,M01.060.116.630
17944164,2007-09-01T00:00:00,Motivation,F01.658
17944164,2007-09-01T00:00:00,Motivation,F01.752.543.500.750
17944164,2007-09-01T00:00:00,Needs Assessment,I02.594
17944164,2007-09-01T00:00:00,Needs Assessment,N03.349.380.565
17944164,2007-09-01T00:00:00,Needs Assessment,N05.300.537
17944164,2007-09-01T00:00:00,Nephrectomy,E04.950.774.435
17944164,2007-09-01T00:00:00,Patient Education as Topic,I02.233.332.500
17944164,2007-09-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
17944164,2007-09-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
17944164,2007-09-01T00:00:00,Qualitative Research,H01.770.644.241.850
17944164,2007-09-01T00:00:00,Questionnaires,E05.318.308.750
17944164,2007-09-01T00:00:00,Questionnaires,L01.280.800
17944164,2007-09-01T00:00:00,Questionnaires,N05.715.360.300.695
17944164,2007-09-01T00:00:00,Questionnaires,N06.850.520.308.750
17999785,2007-09-01T00:00:00,Cystic Fibrosis,C06.689.202
17999785,2007-09-01T00:00:00,Cystic Fibrosis,C08.381.187
17999785,2007-09-01T00:00:00,Cystic Fibrosis,C16.320.190
17999785,2007-09-01T00:00:00,Cystic Fibrosis,C16.614.213
17999785,2007-09-01T00:00:00,Gene Expression Regulation,G05.355.315
17999785,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17999785,2007-09-01T00:00:00,Immune System,A15.382
17999785,2007-09-01T00:00:00,"Immunity, Innate",G12.450.575
17999785,2007-09-01T00:00:00,Inflammation,C23.550.470
17999785,2007-09-01T00:00:00,"Models, Biological",E05.599.395
17999785,2007-09-01T00:00:00,Respiratory Mucosa,A04.760
17999785,2007-09-01T00:00:00,Respiratory Mucosa,A10.615.550.760
17999785,2007-09-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
17999785,2007-09-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
17999785,2007-09-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
17999785,2007-09-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
17999785,2007-09-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
17999785,2007-09-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
17999785,2007-09-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
17999785,2007-09-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
17999785,2007-09-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
17999785,2007-09-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
17999785,2007-09-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
17999790,2007-09-01T00:00:00,Adolescent,M01.060.057
17999790,2007-09-01T00:00:00,Adult,M01.060.116
17999790,2007-09-01T00:00:00,Aged,M01.060.116.100
17999790,2007-09-01T00:00:00,Bone and Bones,A02.835.232
17999790,2007-09-01T00:00:00,Bone and Bones,A10.165.265
17999790,2007-09-01T00:00:00,Child,M01.060.406
17999790,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17999790,2007-09-01T00:00:00,Middle Aged,M01.060.116.630
17999790,2007-09-01T00:00:00,Paranasal Sinuses,A04.531.621
17999790,2007-09-01T00:00:00,Rhinitis,C08.460.799
17999790,2007-09-01T00:00:00,Rhinitis,C08.730.674
17999790,2007-09-01T00:00:00,Rhinitis,C09.603.799
17999790,2007-09-01T00:00:00,Sex Factors,N05.715.350.675
17999790,2007-09-01T00:00:00,Sex Factors,N06.850.490.875
17999790,2007-09-01T00:00:00,Sinusitis,C08.460.692.752
17999790,2007-09-01T00:00:00,Sinusitis,C08.730.749
17999790,2007-09-01T00:00:00,Sinusitis,C09.603.692.752
18039397,2007-09-01T00:00:00,"Abnormalities, Multiple",C16.131.077
18039397,2007-09-01T00:00:00,Angiography,E01.370.350.700.060
18039397,2007-09-01T00:00:00,Angiography,E01.370.370.050
18039397,2007-09-01T00:00:00,Animals,B01.050
18039397,2007-09-01T00:00:00,"Diagnosis, Differential",E01.171
18039397,2007-09-01T00:00:00,"Heart Defects, Congenital",C14.240.400
18039397,2007-09-01T00:00:00,"Heart Defects, Congenital",C14.280.400
18039397,2007-09-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
18039397,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18039397,2007-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18039397,2007-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18039397,2007-09-01T00:00:00,Phenotype,G05.695
18039397,2007-09-01T00:00:00,Situs Inversus,C16.131.810
18039397,2007-09-01T00:00:00,Syndrome,C23.550.288.500
18039398,2007-09-01T00:00:00,"Abnormalities, Multiple",C16.131.077
18039398,2007-09-01T00:00:00,Adolescent,M01.060.057
18039398,2007-09-01T00:00:00,Child,M01.060.406
18039398,2007-09-01T00:00:00,"Child, Preschool",M01.060.406.448
18039398,2007-09-01T00:00:00,Echocardiography,E01.370.350.850.220
18039398,2007-09-01T00:00:00,Echocardiography,E01.370.370.380.220
18039398,2007-09-01T00:00:00,Fontan Procedure,E04.035.410.295
18039398,2007-09-01T00:00:00,Fontan Procedure,E04.100.376.410.295
18039398,2007-09-01T00:00:00,Fontan Procedure,E04.928.220.370.295
18039398,2007-09-01T00:00:00,Health Status,I01.240.425
18039398,2007-09-01T00:00:00,Health Status,N01.224.425
18039398,2007-09-01T00:00:00,Health Status,N06.850.505.400.425
18039398,2007-09-01T00:00:00,Heart Atria,A07.541.358
18039398,2007-09-01T00:00:00,"Heart Defects, Congenital",C14.240.400
18039398,2007-09-01T00:00:00,"Heart Defects, Congenital",C14.280.400
18039398,2007-09-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
18039398,2007-09-01T00:00:00,Heart Ventricles,A07.541.560
18039398,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18039398,2007-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18039398,2007-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18039398,2007-09-01T00:00:00,Questionnaires,E05.318.308.750
18039398,2007-09-01T00:00:00,Questionnaires,L01.280.800
18039398,2007-09-01T00:00:00,Questionnaires,N05.715.360.300.695
18039398,2007-09-01T00:00:00,Questionnaires,N06.850.520.308.750
18039398,2007-09-01T00:00:00,Situs Inversus,C16.131.810
18039398,2007-09-01T00:00:00,Syndrome,C23.550.288.500
18039398,2007-09-01T00:00:00,Treatment Outcome,E01.789.800
18039398,2007-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18039398,2007-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18049209,2007-09-01T00:00:00,Age Factors,N05.715.350.075
18049209,2007-09-01T00:00:00,Age Factors,N06.850.490.250
18049209,2007-09-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
18049209,2007-09-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
18049209,2007-09-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
18049209,2007-09-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
18049209,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18049209,2007-09-01T00:00:00,Leadership,F01.752.609
18049209,2007-09-01T00:00:00,Middle Aged,M01.060.116.630
18049209,2007-09-01T00:00:00,Nurse Administrators,M01.526.070.670
18049209,2007-09-01T00:00:00,Nurse Administrators,M01.526.485.650.580
18049209,2007-09-01T00:00:00,Nurse Administrators,N02.360.650.580
18049209,2007-09-01T00:00:00,Nurse's Role,F01.829.316.616.625.450
18049209,2007-09-01T00:00:00,Nurse's Role,N05.300.100.337
18049209,2007-09-01T00:00:00,Personnel Staffing and Scheduling,N04.452.677.650
18049209,2007-09-01T00:00:00,Staff Development,I02.574.700
18049209,2007-09-01T00:00:00,Staff Development,N04.452.677.822
18073600,2007-09-01T00:00:00,Adolescent,M01.060.057
18073600,2007-09-01T00:00:00,Adult,M01.060.116
18073600,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18073600,2007-09-01T00:00:00,Patient Care Team,N04.590.715
18073600,2007-09-01T00:00:00,Pregnancy,G08.686.785.760.769
18073600,2007-09-01T00:00:00,Pregnancy Complications,C13.703
18073600,2007-09-01T00:00:00,Pregnancy Outcome,E01.789.700
18073600,2007-09-01T00:00:00,Pregnancy Outcome,G08.686.785.760.769.530
18073600,2007-09-01T00:00:00,Trauma Centers,N02.278.354.422.336.500
18073600,2007-09-01T00:00:00,Trauma Centers,N02.421.297.195.480
18073600,2007-09-01T00:00:00,Trauma Centers,N04.452.442.422.336.400
18073600,2007-09-01T00:00:00,Wounds and Injuries,C21.866
18073623,2007-09-01T00:00:00,"Diagnosis, Differential",E01.171
18073623,2007-09-01T00:00:00,Diagnostic Imaging,E01.370.350
18073623,2007-09-01T00:00:00,Evidence-Based Medicine,H02.249.750
18073623,2007-09-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
18073623,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18073623,2007-09-01T00:00:00,Lumbar Vertebrae,A02.835.232.834.519
18073623,2007-09-01T00:00:00,Spinal Fractures,C21.866.117.500.500
18073623,2007-09-01T00:00:00,Spinal Fractures,C21.866.404.812
18073623,2007-09-01T00:00:00,Spinal Fractures,C21.866.831.600
18073623,2007-09-01T00:00:00,Thoracic Vertebrae,A02.835.232.834.892
18074504,2007-09-01T00:00:00,Adult,M01.060.116
18074504,2007-09-01T00:00:00,Algorithms,G17.035
18074504,2007-09-01T00:00:00,Algorithms,L01.224.050
18074504,2007-09-01T00:00:00,"Embolization, Therapeutic",E02.520.360
18074504,2007-09-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
18074504,2007-09-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
18074504,2007-09-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
18074504,2007-09-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
18074504,2007-09-01T00:00:00,Gastric Bypass,E02.065.062.249
18074504,2007-09-01T00:00:00,Gastric Bypass,E04.035.398.385
18074504,2007-09-01T00:00:00,Gastric Bypass,E04.062.249
18074504,2007-09-01T00:00:00,Gastric Bypass,E04.210.457.430
18074504,2007-09-01T00:00:00,Gastrointestinal Hemorrhage,C06.405.227
18074504,2007-09-01T00:00:00,Gastrointestinal Hemorrhage,C23.550.414.788
18074504,2007-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18074504,2007-09-01T00:00:00,Middle Aged,M01.060.116.630
18074504,2007-09-01T00:00:00,Time Factors,G01.910.857
18254313,2007-09-01T00:00:00,"Air Pollution, Indoor",N06.850.460.100.080
18254313,2007-09-01T00:00:00,Workplace,N01.824.245.925
18254313,2007-09-01T00:00:00,Workplace,N04.452.677.975
17764007,2007-09-02T00:00:00,Alcohol Deterrents,D27.505.954.427.020
17764007,2007-09-02T00:00:00,Animals,B01.050
17764007,2007-09-02T00:00:00,"Behavior, Addictive",F01.145.527.100.120
17764007,2007-09-02T00:00:00,Cocaine,D02.145.074.722.388
17764007,2007-09-02T00:00:00,Cocaine,D03.132.889.354
17764007,2007-09-02T00:00:00,Cocaine,D03.605.869.388
17764007,2007-09-02T00:00:00,Cocaine,D04.075.080.875.099.722.388
17764007,2007-09-02T00:00:00,Cocaine-Related Disorders,C21.739.300
17764007,2007-09-02T00:00:00,Cocaine-Related Disorders,F03.900.300
17764007,2007-09-02T00:00:00,"Conditioning, Operant",F02.463.425.179.509
17764007,2007-09-02T00:00:00,Cues,F02.463.425.234
17764007,2007-09-02T00:00:00,Motor Activity,F01.145.632
17764007,2007-09-02T00:00:00,Motor Activity,G11.427.590.530.698
17764007,2007-09-02T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17764007,2007-09-02T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17764007,2007-09-02T00:00:00,Self Administration,E02.319.890
17764007,2007-09-02T00:00:00,Self Administration,E02.900.890
17764007,2007-09-02T00:00:00,Taurine,D02.455.326.146.100.850
17764007,2007-09-02T00:00:00,Taurine,D02.886.645.600.055.850
17945361,2007-09-02T00:00:00,Amphetamine,D02.092.471.683.152.110
17945361,2007-09-02T00:00:00,Animals,B01.050
17945361,2007-09-02T00:00:00,"Behavior, Animal",F01.145.113
17945361,2007-09-02T00:00:00,Brain Chemistry,G02.111.100
17945361,2007-09-02T00:00:00,Brain Chemistry,G03.200
17945361,2007-09-02T00:00:00,Central Nervous System Stimulants,D27.505.696.282
17945361,2007-09-02T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
17945361,2007-09-02T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
17945361,2007-09-02T00:00:00,Cocaine,D02.145.074.722.388
17945361,2007-09-02T00:00:00,Cocaine,D03.132.889.354
17945361,2007-09-02T00:00:00,Cocaine,D03.605.869.388
17945361,2007-09-02T00:00:00,Cocaine,D04.075.080.875.099.722.388
17945361,2007-09-02T00:00:00,"Conditioning, Operant",F02.463.425.179.509
17945361,2007-09-02T00:00:00,Dopamine,D02.092.211.215.311.342
17945361,2007-09-02T00:00:00,Dopamine,D02.092.311.342
17945361,2007-09-02T00:00:00,Motor Activity,F01.145.632
17945361,2007-09-02T00:00:00,Motor Activity,G11.427.590.530.698
17945361,2007-09-02T00:00:00,Nerve Tissue Proteins,D12.776.641
17945361,2007-09-02T00:00:00,RNA,D13.444.735
17945361,2007-09-02T00:00:00,Repressor Proteins,D12.776.260.703
17945361,2007-09-02T00:00:00,Repressor Proteins,D12.776.930.700
17768171,2007-09-03T00:00:00,Coronary Angiography,E01.370.350.700.060.200
17768171,2007-09-03T00:00:00,Coronary Angiography,E01.370.370.050.200
17768171,2007-09-03T00:00:00,Coronary Angiography,E01.370.370.380.200
17768171,2007-09-03T00:00:00,Coronary Disease,C14.280.647.250
17768171,2007-09-03T00:00:00,Coronary Disease,C14.907.585.250
17768171,2007-09-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17768171,2007-09-03T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17768171,2007-09-03T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17768171,2007-09-03T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17768171,2007-09-03T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17768171,2007-09-03T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17765980,2007-09-04T00:00:00,Biological Markers,D23.101
17765980,2007-09-04T00:00:00,Calcium,D01.268.552.100
17765980,2007-09-04T00:00:00,Calcium,D01.552.539.288
17765980,2007-09-04T00:00:00,Calcium,D23.119.100
17765980,2007-09-04T00:00:00,Calcium Signaling,G02.111.087.800.800.100
17765980,2007-09-04T00:00:00,Calcium Signaling,G02.149.115.800.800.100
17765980,2007-09-04T00:00:00,Calcium Signaling,G03.495.166.500.100
17765980,2007-09-04T00:00:00,Calcium Signaling,G04.299.880.800.100
17765980,2007-09-04T00:00:00,Calpain,D08.811.277.656.262.500.120
17765980,2007-09-04T00:00:00,Calpain,D08.811.277.656.300.200.120
17765980,2007-09-04T00:00:00,Cytokines,D12.644.276.374
17765980,2007-09-04T00:00:00,Cytokines,D12.776.467.374
17765980,2007-09-04T00:00:00,Cytokines,D23.529.374
17765980,2007-09-04T00:00:00,Enzyme Inhibitors,D27.505.519.389
17765980,2007-09-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17765980,2007-09-04T00:00:00,Multiple Sclerosis,C10.114.375.500
17765980,2007-09-04T00:00:00,Multiple Sclerosis,C10.314.350.500
17765980,2007-09-04T00:00:00,Multiple Sclerosis,C20.111.258.250.500
17765980,2007-09-04T00:00:00,Neutrophils,A11.118.637.415.583
17765980,2007-09-04T00:00:00,Neutrophils,A11.627.340.583
17765980,2007-09-04T00:00:00,Neutrophils,A11.733.689
17765980,2007-09-04T00:00:00,Neutrophils,A15.145.229.637.415.583
17765980,2007-09-04T00:00:00,Neutrophils,A15.382.490.315.583
17765980,2007-09-04T00:00:00,Neutrophils,A15.382.680.689
17868806,2007-09-04T00:00:00,Aged,M01.060.116.100
17868806,2007-09-04T00:00:00,Anti-Arrhythmia Agents,D27.505.954.411.097
17868806,2007-09-04T00:00:00,Cause of Death,E05.318.308.985.550.250
17868806,2007-09-04T00:00:00,Cause of Death,L01.280.975.550.250
17868806,2007-09-04T00:00:00,Cause of Death,N01.224.935.698.100
17868806,2007-09-04T00:00:00,Cause of Death,N06.850.505.400.975.550.250
17868806,2007-09-04T00:00:00,Cause of Death,N06.850.520.308.985.550.250
17868806,2007-09-04T00:00:00,Coronary Artery Disease,C14.280.647.250.260
17868806,2007-09-04T00:00:00,Coronary Artery Disease,C14.907.137.126.339
17868806,2007-09-04T00:00:00,Coronary Artery Disease,C14.907.585.250.260
17868806,2007-09-04T00:00:00,"Death, Sudden, Cardiac",C14.280.383.220
17868806,2007-09-04T00:00:00,"Death, Sudden, Cardiac",C23.550.260.322.250
17868806,2007-09-04T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
17868806,2007-09-04T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
17868806,2007-09-04T00:00:00,"Defibrillators, Implantable",E07.695.175
17868806,2007-09-04T00:00:00,Heart Arrest,C14.280.383
17868806,2007-09-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17868806,2007-09-04T00:00:00,Middle Aged,M01.060.116.630
17868806,2007-09-04T00:00:00,Probability,E05.318.740.600
17868806,2007-09-04T00:00:00,Probability,G17.680
17868806,2007-09-04T00:00:00,Probability,N05.715.360.750.625
17868806,2007-09-04T00:00:00,Probability,N06.850.520.830.600
17868806,2007-09-04T00:00:00,Risk Assessment,E05.318.740.600.800.715
17868806,2007-09-04T00:00:00,Risk Assessment,N04.452.871.715
17868806,2007-09-04T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17868806,2007-09-04T00:00:00,Risk Assessment,N06.850.505.715
17868806,2007-09-04T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17868806,2007-09-04T00:00:00,Stroke Volume,E01.370.370.380.150.700
17868806,2007-09-04T00:00:00,Stroke Volume,G09.330.380.124.882
17868806,2007-09-04T00:00:00,"Tachycardia, Ventricular",C14.280.067.845.940
17868806,2007-09-04T00:00:00,"Tachycardia, Ventricular",C23.550.073.845.940
17804603,2007-09-05T00:00:00,Adult,M01.060.116
17804603,2007-09-05T00:00:00,Energy Metabolism,G03.495.335
17804603,2007-09-05T00:00:00,Gene Expression Profiling,E05.393.332
17804603,2007-09-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17804603,2007-09-05T00:00:00,"Muscle, Skeletal",A02.633.567
17804603,2007-09-05T00:00:00,"Muscle, Skeletal",A10.690.552.500
17804603,2007-09-05T00:00:00,"Transcription, Genetic",G02.111.087.847
17804603,2007-09-05T00:00:00,"Transcription, Genetic",G02.149.115.847
17804603,2007-09-05T00:00:00,"Transcription, Genetic",G05.355.310.700
17805308,2007-09-05T00:00:00,Animals,B01.050
17805308,2007-09-05T00:00:00,Dopamine,D02.092.211.215.311.342
17805308,2007-09-05T00:00:00,Dopamine,D02.092.311.342
17805308,2007-09-05T00:00:00,Glutamic Acid,D12.125.067.750
17805308,2007-09-05T00:00:00,Glutamic Acid,D12.125.119.450
17805308,2007-09-05T00:00:00,Glutamic Acid,D12.125.427.300
17805308,2007-09-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17805308,2007-09-05T00:00:00,Neuronal Plasticity,G11.561.600.635
17805308,2007-09-05T00:00:00,Neurons,A08.663
17805308,2007-09-05T00:00:00,Neurons,A11.671
17805308,2007-09-05T00:00:00,Substance-Related Disorders,C21.739
17805308,2007-09-05T00:00:00,Substance-Related Disorders,F03.900
17823261,2007-09-06T00:00:00,Animals,B01.050
17823261,2007-09-06T00:00:00,Blood Pressure,E01.370.600.875.249
17823261,2007-09-06T00:00:00,Blood Pressure,G09.330.380.076
17823261,2007-09-06T00:00:00,Cardiomegaly,C14.280.195
17823261,2007-09-06T00:00:00,Cardiomegaly,C23.300.775.250
17823261,2007-09-06T00:00:00,Echocardiography,E01.370.350.850.220
17823261,2007-09-06T00:00:00,Echocardiography,E01.370.370.380.220
17823261,2007-09-06T00:00:00,Heart,A07.541
17823261,2007-09-06T00:00:00,Insulin,D06.472.699.587.740.625
17823261,2007-09-06T00:00:00,Insulin,D12.644.548.586.740.625
17823261,2007-09-06T00:00:00,Lipids,D10
17823261,2007-09-06T00:00:00,Myocardium,A02.633.580
17823261,2007-09-06T00:00:00,Myocardium,A07.541.704
17823261,2007-09-06T00:00:00,Myocardium,A10.690.552.750
17823261,2007-09-06T00:00:00,Signal Transduction,G02.111.087.800
17823261,2007-09-06T00:00:00,Signal Transduction,G02.149.115.800
17823261,2007-09-06T00:00:00,Signal Transduction,G04.299.880
17826018,2007-09-07T00:00:00,"Accidents, Traffic",N06.850.135.392
17826018,2007-09-07T00:00:00,Adolescent,M01.060.057
17826018,2007-09-07T00:00:00,Adult,M01.060.116
17826018,2007-09-07T00:00:00,Aged,M01.060.116.100
17826018,2007-09-07T00:00:00,"Databases, Factual",L01.470.750.750
17826018,2007-09-07T00:00:00,"Databases, Factual",L01.700.508.300.188.400
17826018,2007-09-07T00:00:00,Forensic Medicine,H02.403.330
17826018,2007-09-07T00:00:00,Forensic Medicine,I01.198.780.937
17826018,2007-09-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17826018,2007-09-07T00:00:00,Middle Aged,M01.060.116.630
17826018,2007-09-07T00:00:00,Tibial Fractures,C21.866.404.875
17826018,2007-09-07T00:00:00,Tibial Fractures,C21.866.558.857
17825878,2007-09-10T00:00:00,Animals,B01.050
17825878,2007-09-10T00:00:00,Environmental Monitoring,N06.850.460.350.080
17825878,2007-09-10T00:00:00,Environmental Monitoring,N06.850.780.375
17825878,2007-09-10T00:00:00,Gene Expression Regulation,G05.355.315
17825878,2007-09-10T00:00:00,Geologic Sediments,G01.311.500
17825878,2007-09-10T00:00:00,Geologic Sediments,G16.500.320
17825878,2007-09-10T00:00:00,Liver,A03.620
17825878,2007-09-10T00:00:00,Phosphoproteins,D12.776.744
17825878,2007-09-10T00:00:00,"RNA, Messenger",D13.444.735.544
17825878,2007-09-10T00:00:00,Rivers,G01.311.750
17825878,2007-09-10T00:00:00,Rivers,G16.500.275.280.500
17825878,2007-09-10T00:00:00,Rivers,N06.230.232.500
17825878,2007-09-10T00:00:00,Steroids,D04.808
17825878,2007-09-10T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
17845730,2007-09-10T00:00:00,Adult,M01.060.116
17845730,2007-09-10T00:00:00,African Americans,M01.686.508.100.100
17845730,2007-09-10T00:00:00,African Americans,M01.686.754.100
17845730,2007-09-10T00:00:00,Aged,M01.060.116.100
17845730,2007-09-10T00:00:00,European Continental Ancestry Group,M01.686.508.400
17845730,2007-09-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17845730,2007-09-10T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
17845730,2007-09-10T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
17845730,2007-09-10T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
17845730,2007-09-10T00:00:00,Hypertension,C14.907.489
17845730,2007-09-10T00:00:00,Middle Aged,M01.060.116.630
17845730,2007-09-10T00:00:00,Phenotype,G05.695
17846295,2007-09-11T00:00:00,Aortic Valve,A07.541.510.110
17846295,2007-09-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17846295,2007-09-11T00:00:00,Middle Aged,M01.060.116.630
17846295,2007-09-11T00:00:00,Mitral Valve,A07.541.510.507
17846295,2007-09-11T00:00:00,Protein Kinase C,D08.811.913.696.620.682.700.725
17846304,2007-09-11T00:00:00,Aged,M01.060.116.100
17846304,2007-09-11T00:00:00,Coronary Artery Disease,C14.280.647.250.260
17846304,2007-09-11T00:00:00,Coronary Artery Disease,C14.907.137.126.339
17846304,2007-09-11T00:00:00,Coronary Artery Disease,C14.907.585.250.260
17846304,2007-09-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17846304,2007-09-11T00:00:00,Middle Aged,M01.060.116.630
17846304,2007-09-11T00:00:00,Stents,E07.695.750
17846304,2007-09-11T00:00:00,Treatment Outcome,E01.789.800
17846304,2007-09-11T00:00:00,Treatment Outcome,N04.761.559.590.800
17846304,2007-09-11T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17846319,2007-09-11T00:00:00,Animals,B01.050
17846319,2007-09-11T00:00:00,Extracellular Matrix Proteins,D12.776.860.300
17846319,2007-09-11T00:00:00,Myocardial Ischemia,C14.280.647
17846319,2007-09-11T00:00:00,Myocardial Ischemia,C14.907.585
17846319,2007-09-11T00:00:00,Ventricular Remodeling,C23.300.985
17846319,2007-09-11T00:00:00,Ventricular Remodeling,G09.330.190.962.975
17936489,2007-09-11T00:00:00,Animals,B01.050
17936489,2007-09-11T00:00:00,Apoptosis,G04.299.139.160
17936489,2007-09-11T00:00:00,Cell Line,A11.251.210
17936489,2007-09-11T00:00:00,Cell Survival,G04.299.316
17936489,2007-09-11T00:00:00,Hepatocytes,A11.436.348
17936489,2007-09-11T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
17936489,2007-09-11T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
17936489,2007-09-11T00:00:00,Plasmids,G05.360.600
17936489,2007-09-11T00:00:00,Reactive Oxygen Species,D01.339.431
17936489,2007-09-11T00:00:00,Reactive Oxygen Species,D01.650.775
17936489,2007-09-11T00:00:00,Time Factors,G01.910.857
17936489,2007-09-11T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
17936489,2007-09-11T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
17936489,2007-09-11T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
17936489,2007-09-11T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
17936489,2007-09-11T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
17936489,2007-09-11T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
17936489,2007-09-11T00:00:00,Transforming Growth Factor beta,D23.529.374.687
17936489,2007-09-11T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
17936489,2007-09-11T00:00:00,Transforming Growth Factor beta,D23.529.960.720
17854835,2007-09-12T00:00:00,Aged,M01.060.116.100
17854835,2007-09-12T00:00:00,Brain,A08.186.211
17854835,2007-09-12T00:00:00,Brain Infarction,C10.228.140.300.150.477
17854835,2007-09-12T00:00:00,Brain Infarction,C10.228.140.300.775.200
17854835,2007-09-12T00:00:00,Brain Infarction,C14.907.253.092.477
17854835,2007-09-12T00:00:00,Brain Infarction,C14.907.253.855.200
17854835,2007-09-12T00:00:00,Brain Ischemia,C10.228.140.300.150
17854835,2007-09-12T00:00:00,Brain Ischemia,C14.907.253.092
17854835,2007-09-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17854835,2007-09-12T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
17854835,2007-09-12T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
17854835,2007-09-12T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
17854835,2007-09-12T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
17854835,2007-09-12T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
17854835,2007-09-12T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
17854835,2007-09-12T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
17854835,2007-09-12T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
17854835,2007-09-12T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17854835,2007-09-12T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17854835,2007-09-12T00:00:00,Microcirculation,G09.330.190.163.645
17854835,2007-09-12T00:00:00,Middle Aged,M01.060.116.630
17854835,2007-09-12T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
17854835,2007-09-12T00:00:00,Risk Factors,E05.318.740.600.800.725
17854835,2007-09-12T00:00:00,Risk Factors,N05.715.350.200.700
17854835,2007-09-12T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17854835,2007-09-12T00:00:00,Risk Factors,N06.850.490.625.750
17854835,2007-09-12T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17855639,2007-09-12T00:00:00,Animals,B01.050
17855639,2007-09-12T00:00:00,Blood Pressure,E01.370.600.875.249
17855639,2007-09-12T00:00:00,Blood Pressure,G09.330.380.076
17855639,2007-09-12T00:00:00,Body Weight,C23.888.144
17855639,2007-09-12T00:00:00,Body Weight,E01.370.600.115.100.160.120
17855639,2007-09-12T00:00:00,Body Weight,E05.041.124.160.750
17855639,2007-09-12T00:00:00,Body Weight,G07.100.100.160.120
17855639,2007-09-12T00:00:00,Body Weight,G07.700.320.249.314.120
17855639,2007-09-12T00:00:00,Fructose,D09.546.359.250
17855639,2007-09-12T00:00:00,Fructose,D09.546.465.354
17855639,2007-09-12T00:00:00,Hyperglycemia,C18.452.394.952
17855639,2007-09-12T00:00:00,Hypertension,C14.907.489
17855639,2007-09-12T00:00:00,Insulin,D06.472.699.587.740.625
17855639,2007-09-12T00:00:00,Insulin,D12.644.548.586.740.625
17855639,2007-09-12T00:00:00,Insulin Resistance,C18.452.394.968.500
17855639,2007-09-12T00:00:00,Insulin Resistance,G07.690.320.617
17855639,2007-09-12T00:00:00,Kidney,A05.810.453
17855639,2007-09-12T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
17855639,2007-09-12T00:00:00,Metabolic Syndrome X,C18.452.625
17855639,2007-09-12T00:00:00,Nitric Oxide,D01.339.387
17855639,2007-09-12T00:00:00,Nitric Oxide,D01.625.550.500
17855639,2007-09-12T00:00:00,Nitric Oxide,D01.625.700.500
17855639,2007-09-12T00:00:00,Nitric Oxide,D01.650.550.587.600
17855639,2007-09-12T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17855639,2007-09-12T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17855639,2007-09-12T00:00:00,Sodium,D01.268.549.750
17855639,2007-09-12T00:00:00,Sodium,D01.552.528.850
17928041,2007-09-12T00:00:00,Animals,B01.050
17928041,2007-09-12T00:00:00,Dopamine,D02.092.211.215.311.342
17928041,2007-09-12T00:00:00,Dopamine,D02.092.311.342
17928041,2007-09-12T00:00:00,Glutamic Acid,D12.125.067.750
17928041,2007-09-12T00:00:00,Glutamic Acid,D12.125.119.450
17928041,2007-09-12T00:00:00,Glutamic Acid,D12.125.427.300
17928041,2007-09-12T00:00:00,Neuronal Plasticity,G11.561.600.635
17928041,2007-09-12T00:00:00,Substance-Related Disorders,C21.739
17928041,2007-09-12T00:00:00,Substance-Related Disorders,F03.900
17928041,2007-09-12T00:00:00,Synaptic Transmission,G02.111.087.800.850
17928041,2007-09-12T00:00:00,Synaptic Transmission,G02.149.115.800.850
17928041,2007-09-12T00:00:00,Synaptic Transmission,G04.299.880.850
17928041,2007-09-12T00:00:00,Synaptic Transmission,G07.265.337.900
17928041,2007-09-12T00:00:00,Synaptic Transmission,G07.700.240.900
17928041,2007-09-12T00:00:00,Synaptic Transmission,G11.561.600.835
17928041,2007-09-12T00:00:00,gamma-Aminobutyric Acid,D02.241.081.160.050.350
17928041,2007-09-12T00:00:00,gamma-Aminobutyric Acid,D12.125.190.350
17855763,2007-09-13T00:00:00,Adult,M01.060.116
17855763,2007-09-13T00:00:00,Deglutition,G10.261.326.215
17855763,2007-09-13T00:00:00,Esophagus,A03.556.875.500
17855763,2007-09-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17855763,2007-09-13T00:00:00,Middle Aged,M01.060.116.630
17855763,2007-09-13T00:00:00,Pressure,G01.374.715
17868871,2007-09-14T00:00:00,Apoptosis,G04.299.139.160
17868871,2007-09-14T00:00:00,Cell Death,G04.299.139
17868871,2007-09-14T00:00:00,Chromosome Aberrations,C23.550.210
17868871,2007-09-14T00:00:00,Chromosome Aberrations,G05.365.590.175
17868871,2007-09-14T00:00:00,Gene Expression,G05.355.310
17868871,2007-09-14T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
17868871,2007-09-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17868871,2007-09-14T00:00:00,"Immunity, Innate",G12.450.575
17868871,2007-09-14T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
17868871,2007-09-14T00:00:00,Prostatic Neoplasms,C12.294.260.750
17868871,2007-09-14T00:00:00,Prostatic Neoplasms,C12.294.565.625
17868871,2007-09-14T00:00:00,Prostatic Neoplasms,C12.758.409.750
17868871,2007-09-14T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.260.676
17868871,2007-09-14T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.624.664.700.189
17868871,2007-09-14T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.660.765
17868871,2007-09-14T00:00:00,Tumor Suppressor Proteins,D12.776.624.776
17868871,2007-09-14T00:00:00,beta-Defensins,D12.644.050.200.075
17868871,2007-09-14T00:00:00,beta-Defensins,D12.776.543.695.054.200.075
17872969,2007-09-14T00:00:00,Animals,B01.050
17872969,2007-09-14T00:00:00,Apoptosis,G04.299.139.160
17872969,2007-09-14T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
17872969,2007-09-14T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
17872969,2007-09-14T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
17872969,2007-09-14T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
17872969,2007-09-14T00:00:00,"Receptors, Aryl Hydrocarbon",D12.776.260.698.209.715
17872969,2007-09-14T00:00:00,"Receptors, Aryl Hydrocarbon",D12.776.826.209.715
17872969,2007-09-14T00:00:00,"Receptors, Aryl Hydrocarbon",D12.776.930.662
17872969,2007-09-14T00:00:00,"Receptors, Aryl Hydrocarbon",D12.776.930.669.209.715
17872969,2007-09-14T00:00:00,"Receptors, Estrogen",D12.776.260.698.750.350
17872969,2007-09-14T00:00:00,"Receptors, Estrogen",D12.776.826.750.350
17872969,2007-09-14T00:00:00,"Receptors, Estrogen",D12.776.930.669.750.350
17872969,2007-09-14T00:00:00,Stilbenes,D02.455.426.559.389.150.700
17872969,2007-09-14T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.550.500
17872969,2007-09-14T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.569.500
17872969,2007-09-14T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.550.500
17872969,2007-09-14T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.569.500
17872969,2007-09-14T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.550.500
17872969,2007-09-14T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.569.500
17873151,2007-09-14T00:00:00,Bias (Epidemiology),N05.715.350.150
17873151,2007-09-14T00:00:00,Bias (Epidemiology),N06.850.490.500
17873151,2007-09-14T00:00:00,Breast Neoplasms,C04.588.180
17873151,2007-09-14T00:00:00,Breast Neoplasms,C17.800.090.500
17873151,2007-09-14T00:00:00,"Databases, Genetic",L01.470.750.750.325
17873151,2007-09-14T00:00:00,"Databases, Genetic",L01.700.508.300.188.400.325
17873151,2007-09-14T00:00:00,Gene Expression Profiling,E05.393.332
17873151,2007-09-14T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
17873151,2007-09-14T00:00:00,Genomics,H01.158.273.180.350
17873151,2007-09-14T00:00:00,Genomics,H01.158.273.343.350
17873151,2007-09-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17873151,2007-09-14T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
17873151,2007-09-14T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
17873151,2007-09-14T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
17873151,2007-09-14T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
17873151,2007-09-14T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
17873151,2007-09-14T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
17520678,2007-09-15T00:00:00,Animals,B01.050
17520678,2007-09-15T00:00:00,Breast Neoplasms,C04.588.180
17520678,2007-09-15T00:00:00,Breast Neoplasms,C17.800.090.500
17520678,2007-09-15T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
17520678,2007-09-15T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
17520678,2007-09-15T00:00:00,Gene Expression,G05.355.310
17520678,2007-09-15T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
17520678,2007-09-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17520678,2007-09-15T00:00:00,Neoplasm Proteins,D12.776.624
17520678,2007-09-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
17520678,2007-09-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
17520678,2007-09-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
17520678,2007-09-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
17520678,2007-09-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
17520678,2007-09-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
17520678,2007-09-15T00:00:00,Pyrimidines,D03.383.742
17520678,2007-09-15T00:00:00,"RNA, Messenger",D13.444.735.544
17520678,2007-09-15T00:00:00,Signal Transduction,G02.111.087.800
17520678,2007-09-15T00:00:00,Signal Transduction,G02.149.115.800
17520678,2007-09-15T00:00:00,Signal Transduction,G04.299.880
17520678,2007-09-15T00:00:00,beta Catenin,D12.776.091.249
17520678,2007-09-15T00:00:00,beta Catenin,D12.776.220.145.500
17520678,2007-09-15T00:00:00,beta Catenin,D12.776.930.130
17875256,2007-09-15T00:00:00,African Americans,M01.686.508.100.100
17875256,2007-09-15T00:00:00,African Americans,M01.686.754.100
17875256,2007-09-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17875256,2007-09-15T00:00:00,"Models, Theoretical",E05.599
17875256,2007-09-15T00:00:00,Obesity,C18.654.726.500
17875256,2007-09-15T00:00:00,Obesity,C23.888.144.699.500
17875256,2007-09-15T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
17875256,2007-09-15T00:00:00,Obesity,G07.100.100.160.120.699.500
17875256,2007-09-15T00:00:00,Research,H01.770.644
17875256,2007-09-15T00:00:00,Research Design,E05.581.500
17875256,2007-09-15T00:00:00,Research Design,H01.770.644.728
17875256,2007-09-15T00:00:00,United States,Z01.107.567.875
17875262,2007-09-15T00:00:00,Adult,M01.060.116
17875262,2007-09-15T00:00:00,Aged,M01.060.116.100
17875262,2007-09-15T00:00:00,Consumer Participation,N02.421.143.262
17875262,2007-09-15T00:00:00,Consumer Participation,N03.540.245.360
17875262,2007-09-15T00:00:00,Exercise,G11.427.590.237
17875262,2007-09-15T00:00:00,Exercise,I03.350
17875262,2007-09-15T00:00:00,Health Promotion,N02.370
17875262,2007-09-15T00:00:00,Health Promotion,N02.421.726.507
17875262,2007-09-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17875262,2007-09-15T00:00:00,Middle Aged,M01.060.116.630
17875262,2007-09-15T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
17875262,2007-09-15T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
17875262,2007-09-15T00:00:00,South Carolina,Z01.107.567.875.075.662
17875262,2007-09-15T00:00:00,South Carolina,Z01.107.567.875.750.700
17875711,2007-09-15T00:00:00,Animals,B01.050
17875711,2007-09-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17875711,2007-09-15T00:00:00,Lung Neoplasms,C04.588.894.797.520
17875711,2007-09-15T00:00:00,Lung Neoplasms,C08.381.540
17875711,2007-09-15T00:00:00,Lung Neoplasms,C08.785.520
17875711,2007-09-15T00:00:00,Membrane Proteins,D12.776.543
17875711,2007-09-15T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.567.342.500
17875711,2007-09-15T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.646.750.249.500
17875711,2007-09-15T00:00:00,Mitogen-Activated Protein Kinase 1,D12.644.360.450.169.500
17875711,2007-09-15T00:00:00,Mitogen-Activated Protein Kinase 1,D12.776.476.450.169.500
17875711,2007-09-15T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.567.342.750
17875711,2007-09-15T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.646.750.249.750
17875711,2007-09-15T00:00:00,Mitogen-Activated Protein Kinase 3,D12.644.360.450.169.750
17875711,2007-09-15T00:00:00,Mitogen-Activated Protein Kinase 3,D12.776.476.450.169.750
17875711,2007-09-15T00:00:00,"Neovascularization, Pathologic",C23.550.589.500
17875711,2007-09-15T00:00:00,Nerve Tissue Proteins,D12.776.641
17875711,2007-09-15T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
17875711,2007-09-15T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
17875711,2007-09-15T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
17875711,2007-09-15T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
17875711,2007-09-15T00:00:00,Signal Transduction,G02.111.087.800
17875711,2007-09-15T00:00:00,Signal Transduction,G02.149.115.800
17875711,2007-09-15T00:00:00,Signal Transduction,G04.299.880
17875756,2007-09-15T00:00:00,Animals,B01.050
17875756,2007-09-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17875756,2007-09-15T00:00:00,"Immunotherapy, Adoptive",E02.095.465.425.400.330.050.400
17875756,2007-09-15T00:00:00,"Immunotherapy, Adoptive",E05.478.550.520.050.400
17875756,2007-09-15T00:00:00,Neoplasms,C04
17875756,2007-09-15T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
17875756,2007-09-15T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
17875756,2007-09-15T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
17875756,2007-09-15T00:00:00,Toll-Like Receptors,D12.776.543.750.705.910.500
17896805,2007-09-15T00:00:00,Adult,M01.060.116
17896805,2007-09-15T00:00:00,African Americans,M01.686.508.100.100
17896805,2007-09-15T00:00:00,African Americans,M01.686.754.100
17896805,2007-09-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17896805,2007-09-15T00:00:00,Kidney Diseases,C12.777.419
17896805,2007-09-15T00:00:00,Kidney Diseases,C13.351.968.419
17896805,2007-09-15T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
17896805,2007-09-15T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
17896805,2007-09-15T00:00:00,Middle Aged,M01.060.116.630
17896805,2007-09-15T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
17896805,2007-09-15T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
17896805,2007-09-15T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
17896805,2007-09-15T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
17904368,2007-09-15T00:00:00,Molecular Structure,G02.111.570
17904368,2007-09-15T00:00:00,Molecular Structure,G02.575
17904368,2007-09-15T00:00:00,Molecular Structure,G02.842.575
17870169,2007-09-17T00:00:00,Amino Acid Sequence,G02.111.570.060
17870169,2007-09-17T00:00:00,Amino Acid Sequence,L01.453.245.667.060
17870169,2007-09-17T00:00:00,Animals,B01.050
17870169,2007-09-17T00:00:00,B-Lymphocytes,A11.063.438
17870169,2007-09-17T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
17870169,2007-09-17T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
17870169,2007-09-17T00:00:00,B-Lymphocytes,A15.382.032.438
17870169,2007-09-17T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
17870169,2007-09-17T00:00:00,Catfishes,B01.050.150.900.493.080
17870169,2007-09-17T00:00:00,Cell Line,A11.251.210
17870169,2007-09-17T00:00:00,Gene Expression Regulation,G05.355.315
17870169,2007-09-17T00:00:00,Molecular Sequence Data,L01.453.245.667
17870169,2007-09-17T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
17870169,2007-09-17T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
17870169,2007-09-17T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
17870169,2007-09-17T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
17870169,2007-09-17T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
17870169,2007-09-17T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
17875368,2007-09-17T00:00:00,Alcoholism,C21.739.100.250
17875368,2007-09-17T00:00:00,Alcoholism,F03.900.100.350
17875368,2007-09-17T00:00:00,Confidentiality,F04.096.544.335.240
17875368,2007-09-17T00:00:00,Confidentiality,I01.880.604.473.650.500
17875368,2007-09-17T00:00:00,Confidentiality,I01.880.604.583.080
17875368,2007-09-17T00:00:00,Confidentiality,N03.706.437.650.124
17875368,2007-09-17T00:00:00,Confidentiality,N03.706.535.230
17875368,2007-09-17T00:00:00,"Data Interpretation, Statistical",E05.245.380
17875368,2007-09-17T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
17875368,2007-09-17T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
17875368,2007-09-17T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
17875368,2007-09-17T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
17875368,2007-09-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17875368,2007-09-17T00:00:00,Methadone,D02.522.675
17875368,2007-09-17T00:00:00,"Models, Organizational",E05.599.670
17875368,2007-09-17T00:00:00,"Models, Organizational",N04.452.534
17875368,2007-09-17T00:00:00,"Quality Assurance, Health Care",N04.761.700
17875368,2007-09-17T00:00:00,"Quality Assurance, Health Care",N05.700
17875368,2007-09-17T00:00:00,Substance Abuse Treatment Centers,N02.278.035.128.800
17875368,2007-09-17T00:00:00,Substance Abuse Treatment Centers,N02.278.808.930
17875368,2007-09-17T00:00:00,Substance-Related Disorders,C21.739
17875368,2007-09-17T00:00:00,Substance-Related Disorders,F03.900
17875368,2007-09-17T00:00:00,United States,Z01.107.567.875
17876014,2007-09-17T00:00:00,Adult,M01.060.116
17876014,2007-09-17T00:00:00,Aged,M01.060.116.100
17876014,2007-09-17T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
17876014,2007-09-17T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
17876014,2007-09-17T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
17876014,2007-09-17T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
17876014,2007-09-17T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
17876014,2007-09-17T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
17876014,2007-09-17T00:00:00,"Carcinoma, Renal Cell",C04.557.470.200.025.390
17876014,2007-09-17T00:00:00,"Carcinoma, Renal Cell",C04.588.945.947.535.160
17876014,2007-09-17T00:00:00,"Carcinoma, Renal Cell",C12.758.820.750.160
17876014,2007-09-17T00:00:00,"Carcinoma, Renal Cell",C12.777.419.473.160
17876014,2007-09-17T00:00:00,"Carcinoma, Renal Cell",C13.351.937.820.535.160
17876014,2007-09-17T00:00:00,"Carcinoma, Renal Cell",C13.351.968.419.473.160
17876014,2007-09-17T00:00:00,Double-Blind Method,E05.318.780.300
17876014,2007-09-17T00:00:00,Double-Blind Method,E05.581.500.300
17876014,2007-09-17T00:00:00,Double-Blind Method,N05.715.360.780.320
17876014,2007-09-17T00:00:00,Double-Blind Method,N06.850.520.445.300
17876014,2007-09-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17876014,2007-09-17T00:00:00,Kidney Neoplasms,C04.588.945.947.535
17876014,2007-09-17T00:00:00,Kidney Neoplasms,C12.758.820.750
17876014,2007-09-17T00:00:00,Kidney Neoplasms,C12.777.419.473
17876014,2007-09-17T00:00:00,Kidney Neoplasms,C13.351.937.820.535
17876014,2007-09-17T00:00:00,Kidney Neoplasms,C13.351.968.419.473
17876014,2007-09-17T00:00:00,Middle Aged,M01.060.116.630
17876014,2007-09-17T00:00:00,Quinazolines,D03.438.786
17876014,2007-09-17T00:00:00,Treatment Outcome,E01.789.800
17876014,2007-09-17T00:00:00,Treatment Outcome,N04.761.559.590.800
17876014,2007-09-17T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17930496,2007-09-17T00:00:00,Computer Simulation,L01.224.160
17930496,2007-09-17T00:00:00,"Models, Theoretical",E05.599
17930496,2007-09-17T00:00:00,Particle Accelerators,E07.710.680
17930496,2007-09-17T00:00:00,Photons,G01.201.875.770.578.782
17930496,2007-09-17T00:00:00,Photons,G01.249.705
17930496,2007-09-17T00:00:00,Photons,G01.590.540.782
17876711,2007-09-18T00:00:00,Albumins,D12.776.034
17876711,2007-09-18T00:00:00,Biological Markers,D23.101
17876711,2007-09-18T00:00:00,Cardiovascular Diseases,C14
17876711,2007-09-18T00:00:00,"Databases, Factual",L01.470.750.750
17876711,2007-09-18T00:00:00,"Databases, Factual",L01.700.508.300.188.400
17876711,2007-09-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17876711,2007-09-18T00:00:00,Inflammation,C23.550.470
17876711,2007-09-18T00:00:00,Lipids,D10
17876711,2007-09-18T00:00:00,"Lipoproteins, HDL",D10.532.432
17876711,2007-09-18T00:00:00,"Lipoproteins, HDL",D12.776.521.479
17876711,2007-09-18T00:00:00,Risk Factors,E05.318.740.600.800.725
17876711,2007-09-18T00:00:00,Risk Factors,N05.715.350.200.700
17876711,2007-09-18T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17876711,2007-09-18T00:00:00,Risk Factors,N06.850.490.625.750
17876711,2007-09-18T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17878731,2007-09-19T00:00:00,Aged,M01.060.116.100
17878731,2007-09-19T00:00:00,Attention,F02.830.104.214
17878731,2007-09-19T00:00:00,Automobile Driving,I03.125
17878731,2007-09-19T00:00:00,Brain Mapping,E01.370.350.086
17878731,2007-09-19T00:00:00,Brain Mapping,E01.370.376.149
17878731,2007-09-19T00:00:00,Brain Mapping,E05.132
17878731,2007-09-19T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
17878731,2007-09-19T00:00:00,Cognition,F02.463.188
17878731,2007-09-19T00:00:00,Field Dependence-Independence,F02.463.593.343
17878731,2007-09-19T00:00:00,Field Dependence-Independence,F02.463.593.932.345
17878731,2007-09-19T00:00:00,Geriatric Assessment,E05.318.308.225
17878731,2007-09-19T00:00:00,Geriatric Assessment,I01.240.425.350
17878731,2007-09-19T00:00:00,Geriatric Assessment,L01.280.360
17878731,2007-09-19T00:00:00,Geriatric Assessment,N01.224.425.350
17878731,2007-09-19T00:00:00,Geriatric Assessment,N05.715.360.300.360
17878731,2007-09-19T00:00:00,Geriatric Assessment,N06.850.505.400.425.350
17878731,2007-09-19T00:00:00,Geriatric Assessment,N06.850.520.308.225
17878731,2007-09-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17878731,2007-09-19T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17878731,2007-09-19T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17878731,2007-09-19T00:00:00,Neuropsychological Tests,F04.711.513
17878731,2007-09-19T00:00:00,Reaction Time,F02.830.650
17878731,2007-09-19T00:00:00,Reaction Time,F04.669.817
17878731,2007-09-19T00:00:00,Reaction Time,G11.561.677
17884920,2007-09-20T00:00:00,Animals,B01.050
17884920,2007-09-20T00:00:00,Light,G01.201.875.770.578
17884920,2007-09-20T00:00:00,Light,G01.590.540
17884920,2007-09-20T00:00:00,Photic Stimulation,E05.723.729
17884920,2007-09-20T00:00:00,Retinal Rod Photoreceptor Cells,A08.663.650.850.625.670.650
17884920,2007-09-20T00:00:00,Retinal Rod Photoreceptor Cells,A08.663.650.915.937.670.650
17884920,2007-09-20T00:00:00,Retinal Rod Photoreceptor Cells,A08.800.950.937.670.650
17884920,2007-09-20T00:00:00,Retinal Rod Photoreceptor Cells,A09.371.729.831.625.670.650
17884920,2007-09-20T00:00:00,Retinal Rod Photoreceptor Cells,A11.671.650.850.625.670.650
17884920,2007-09-20T00:00:00,Retinal Rod Photoreceptor Cells,A11.671.650.915.937.670.650
17884920,2007-09-20T00:00:00,Retinaldehyde,D02.047.850
17884920,2007-09-20T00:00:00,Retinaldehyde,D02.455.326.271.665.202.495.690
17884920,2007-09-20T00:00:00,Retinaldehyde,D02.455.426.392.368.367.379.249.700.690
17884920,2007-09-20T00:00:00,Retinaldehyde,D02.455.849.131.495.690
17884920,2007-09-20T00:00:00,Retinaldehyde,D23.767.261.700.690
17884920,2007-09-20T00:00:00,Time Factors,G01.910.857
17884920,2007-09-20T00:00:00,"Vision, Ocular",F02.830.816.964
17884920,2007-09-20T00:00:00,"Vision, Ocular",G02.111.087.800.480.900
17884920,2007-09-20T00:00:00,"Vision, Ocular",G02.149.115.800.480.900
17884920,2007-09-20T00:00:00,"Vision, Ocular",G04.299.880.480.900
17884920,2007-09-20T00:00:00,"Vision, Ocular",G11.561.600.810.964
17884920,2007-09-20T00:00:00,"Vision, Ocular",G14.640.816
17886200,2007-09-21T00:00:00,Adult,M01.060.116
17886200,2007-09-21T00:00:00,Aged,M01.060.116.100
17886200,2007-09-21T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
17886200,2007-09-21T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
17886200,2007-09-21T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
17886200,2007-09-21T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
17886200,2007-09-21T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
17886200,2007-09-21T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
17886200,2007-09-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17886200,2007-09-21T00:00:00,Middle Aged,M01.060.116.630
17886200,2007-09-21T00:00:00,Pancreatitis,C06.689.750
17886200,2007-09-21T00:00:00,Prosthesis Implantation,E04.650
17886200,2007-09-21T00:00:00,Risk Assessment,E05.318.740.600.800.715
17886200,2007-09-21T00:00:00,Risk Assessment,N04.452.871.715
17886200,2007-09-21T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17886200,2007-09-21T00:00:00,Risk Assessment,N06.850.505.715
17886200,2007-09-21T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17886200,2007-09-21T00:00:00,Stents,E07.695.750
17886200,2007-09-21T00:00:00,Treatment Outcome,E01.789.800
17886200,2007-09-21T00:00:00,Treatment Outcome,N04.761.559.590.800
17886200,2007-09-21T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17890246,2007-09-21T00:00:00,Adult,M01.060.116
17890246,2007-09-21T00:00:00,Contrast Media,D27.720.259
17890246,2007-09-21T00:00:00,Fibrosis,C23.550.355
17890246,2007-09-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17890246,2007-09-21T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
17890246,2007-09-21T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
17890246,2007-09-21T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
17890246,2007-09-21T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
17890246,2007-09-21T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17890246,2007-09-21T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17890246,2007-09-21T00:00:00,Renal Insufficiency,C12.777.419.780
17890246,2007-09-21T00:00:00,Renal Insufficiency,C13.351.968.419.780
17890246,2007-09-21T00:00:00,Skin Diseases,C17.800
17890467,2007-09-21T00:00:00,Adult,M01.060.116
17890467,2007-09-21T00:00:00,Aged,M01.060.116.100
17890467,2007-09-21T00:00:00,"Biopsy, Needle",E01.370.388.100.100
17890467,2007-09-21T00:00:00,"Biopsy, Needle",E01.450.230.100.100
17890467,2007-09-21T00:00:00,"Biopsy, Needle",E01.450.865.100.100
17890467,2007-09-21T00:00:00,"Biopsy, Needle",E01.450.865.632.100
17890467,2007-09-21T00:00:00,"Biopsy, Needle",E04.074.119
17890467,2007-09-21T00:00:00,Endosonography,E01.370.350.850.280
17890467,2007-09-21T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
17890467,2007-09-21T00:00:00,Flow Cytometry,E05.200.500.386.350
17890467,2007-09-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17890467,2007-09-21T00:00:00,Middle Aged,M01.060.116.630
17890467,2007-09-21T00:00:00,"Sarcoidosis, Pulmonary",C08.381.483.725
17890467,2007-09-21T00:00:00,"Sarcoidosis, Pulmonary",C15.604.515.827.725
17893225,2007-09-24T00:00:00,Adult,M01.060.116
17893225,2007-09-24T00:00:00,Algorithms,G17.035
17893225,2007-09-24T00:00:00,Algorithms,L01.224.050
17893225,2007-09-24T00:00:00,Brain,A08.186.211
17893225,2007-09-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17893225,2007-09-24T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
17893225,2007-09-24T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
17893225,2007-09-24T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
17893225,2007-09-24T00:00:00,Iron,D01.268.556.412
17893225,2007-09-24T00:00:00,Iron,D01.268.956.287
17893225,2007-09-24T00:00:00,Iron,D01.552.544.412
17893225,2007-09-24T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17893225,2007-09-24T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17893225,2007-09-24T00:00:00,Middle Aged,M01.060.116.630
17893225,2007-09-24T00:00:00,Multiple Sclerosis,C10.114.375.500
17893225,2007-09-24T00:00:00,Multiple Sclerosis,C10.314.350.500
17893225,2007-09-24T00:00:00,Multiple Sclerosis,C20.111.258.250.500
17893225,2007-09-24T00:00:00,Neurons,A08.663
17893225,2007-09-24T00:00:00,Neurons,A11.671
17918072,2007-09-26T00:00:00,Adult,M01.060.116
17918072,2007-09-26T00:00:00,Aged,M01.060.116.100
17918072,2007-09-26T00:00:00,Anti-Infective Agents,D27.505.954.122
17918072,2007-09-26T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
17918072,2007-09-26T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
17918072,2007-09-26T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
17918072,2007-09-26T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
17918072,2007-09-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17918072,2007-09-26T00:00:00,Joint Prosthesis,E07.695.400
17918072,2007-09-26T00:00:00,Middle Aged,M01.060.116.630
17918072,2007-09-26T00:00:00,Prosthesis-Related Infections,C01.539.685
17918072,2007-09-26T00:00:00,Prosthesis-Related Infections,C23.550.767.868
17918072,2007-09-26T00:00:00,Risk Factors,E05.318.740.600.800.725
17918072,2007-09-26T00:00:00,Risk Factors,N05.715.350.200.700
17918072,2007-09-26T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17918072,2007-09-26T00:00:00,Risk Factors,N06.850.490.625.750
17918072,2007-09-26T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17899048,2007-09-27T00:00:00,Animals,B01.050
17899048,2007-09-27T00:00:00,Carotid Arteries,A07.231.114.186
17899048,2007-09-27T00:00:00,"Disease Models, Animal",C22.232
17899048,2007-09-27T00:00:00,"Disease Models, Animal",E05.598.500
17899048,2007-09-27T00:00:00,"Disease Models, Animal",E05.599.395.080
17899048,2007-09-27T00:00:00,Dogs,B01.050.150.900.649.147.153.200
17899048,2007-09-27T00:00:00,"Embolization, Therapeutic",E02.520.360
17899048,2007-09-27T00:00:00,Intracranial Aneurysm,C10.228.140.300.510.600
17899048,2007-09-27T00:00:00,Intracranial Aneurysm,C14.907.055.635
17899048,2007-09-27T00:00:00,Intracranial Aneurysm,C14.907.253.560.300
17900927,2007-09-27T00:00:00,Adult,M01.060.116
17900927,2007-09-27T00:00:00,Aged,M01.060.116.100
17900927,2007-09-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17900927,2007-09-27T00:00:00,Middle Aged,M01.060.116.630
17900927,2007-09-27T00:00:00,Sex Factors,N05.715.350.675
17900927,2007-09-27T00:00:00,Sex Factors,N06.850.490.875
17900927,2007-09-27T00:00:00,Smoking,F01.145.466.753
17900927,2007-09-27T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
17900927,2007-09-27T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
17901393,2007-09-27T00:00:00,Education,I02
17901393,2007-09-27T00:00:00,Emergency Medical Service Communication Systems,N02.421.297.058
17901393,2007-09-27T00:00:00,Emergency Medical Services,N02.421.297
17901393,2007-09-27T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
17901393,2007-09-27T00:00:00,"Emergency Service, Hospital",N02.421.297.195
17901393,2007-09-27T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
17901393,2007-09-27T00:00:00,Health Education,I02.233.332
17901393,2007-09-27T00:00:00,Health Education,N02.421.143.827.407
17901393,2007-09-27T00:00:00,Health Education,N02.421.726.407
17901393,2007-09-27T00:00:00,Health Services Accessibility,N04.590.374.350
17901393,2007-09-27T00:00:00,Health Services Accessibility,N05.300.430
17901393,2007-09-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17901393,2007-09-27T00:00:00,Patient Care Team,N04.590.715
17901393,2007-09-27T00:00:00,Stroke,C10.228.140.300.775
17901393,2007-09-27T00:00:00,Stroke,C14.907.253.855
17901414,2007-09-27T00:00:00,Adult,M01.060.116
17901414,2007-09-27T00:00:00,Aged,M01.060.116.100
17901414,2007-09-27T00:00:00,Bronchoalveolar Lavage Fluid,E05.510.100.500
17901414,2007-09-27T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
17901414,2007-09-27T00:00:00,Cyclophosphamide,D02.705.670.243
17901414,2007-09-27T00:00:00,Double-Blind Method,E05.318.780.300
17901414,2007-09-27T00:00:00,Double-Blind Method,E05.581.500.300
17901414,2007-09-27T00:00:00,Double-Blind Method,N05.715.360.780.320
17901414,2007-09-27T00:00:00,Double-Blind Method,N06.850.520.445.300
17901414,2007-09-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17901414,2007-09-27T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
17901414,2007-09-27T00:00:00,"Lung Diseases, Interstitial",C08.381.483
17901414,2007-09-27T00:00:00,Middle Aged,M01.060.116.630
17901414,2007-09-27T00:00:00,Neutrophils,A11.118.637.415.583
17901414,2007-09-27T00:00:00,Neutrophils,A11.627.340.583
17901414,2007-09-27T00:00:00,Neutrophils,A11.733.689
17901414,2007-09-27T00:00:00,Neutrophils,A15.145.229.637.415.583
17901414,2007-09-27T00:00:00,Neutrophils,A15.382.490.315.583
17901414,2007-09-27T00:00:00,Neutrophils,A15.382.680.689
17901414,2007-09-27T00:00:00,"Scleroderma, Systemic",C17.300.799
17901414,2007-09-27T00:00:00,"Scleroderma, Systemic",C17.800.784
17901414,2007-09-27T00:00:00,"Tomography, Spiral Computed",E01.370.350.350.810.800
17901414,2007-09-27T00:00:00,"Tomography, Spiral Computed",E01.370.350.600.350.700.810.800
17901414,2007-09-27T00:00:00,"Tomography, Spiral Computed",E01.370.350.700.700.810.800
17901414,2007-09-27T00:00:00,"Tomography, Spiral Computed",E01.370.350.700.810.810.800
17901414,2007-09-27T00:00:00,"Tomography, Spiral Computed",E01.370.350.825.810.810.800
17901466,2007-09-27T00:00:00,Animals,B01.050
17901466,2007-09-27T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17901466,2007-09-27T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17901466,2007-09-27T00:00:00,Schwann Cells,A08.637.800
17901466,2007-09-27T00:00:00,Schwann Cells,A08.800.800.690
17901466,2007-09-27T00:00:00,Schwann Cells,A11.650.800
17901466,2007-09-27T00:00:00,Sciatic Nerve,A08.800.800.720.450.760
17901988,2007-09-28T00:00:00,Biological Markers,D23.101
17901988,2007-09-28T00:00:00,Child,M01.060.406
17901988,2007-09-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17901988,2007-09-28T00:00:00,Lupus Nephritis,C12.777.419.570.363.680
17901988,2007-09-28T00:00:00,Lupus Nephritis,C13.351.968.419.570.363.680
17901988,2007-09-28T00:00:00,Lupus Nephritis,C17.300.480.680
17901988,2007-09-28T00:00:00,Lupus Nephritis,C20.111.590.560
17901988,2007-09-28T00:00:00,Proteinuria,C12.777.934.734
17901988,2007-09-28T00:00:00,Proteinuria,C13.351.968.934.734
17901988,2007-09-28T00:00:00,Proteinuria,C23.888.942.750
17901988,2007-09-28T00:00:00,Proteomics,H01.158.201.843
17901988,2007-09-28T00:00:00,Proteomics,H01.158.273.180.350.700
17901988,2007-09-28T00:00:00,Proteomics,H01.158.273.343.350.700
17901988,2007-09-28T00:00:00,Proteomics,H01.181.122.738
17901988,2007-09-28T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
17906064,2007-09-28T00:00:00,"Analgesics, Non-Narcotic",D27.505.696.663.850.014.040
17906064,2007-09-28T00:00:00,"Analgesics, Non-Narcotic",D27.505.954.427.040.100
17906064,2007-09-28T00:00:00,Animals,B01.050
17906064,2007-09-28T00:00:00,"Disease Models, Animal",C22.232
17906064,2007-09-28T00:00:00,"Disease Models, Animal",E05.598.500
17906064,2007-09-28T00:00:00,"Disease Models, Animal",E05.599.395.080
17906064,2007-09-28T00:00:00,Drug-Induced Liver Injury,C06.552.195
17906064,2007-09-28T00:00:00,Drug-Induced Liver Injury,C21.613.260
17906064,2007-09-28T00:00:00,Liver Diseases,C06.552
17906064,2007-09-28T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
17906064,2007-09-28T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
17906064,2007-09-28T00:00:00,Peroxynitrous Acid,D01.625.600.800
17906064,2007-09-28T00:00:00,Peroxynitrous Acid,D01.625.700.750
17906064,2007-09-28T00:00:00,bcl-2-Associated X Protein,D12.644.360.075.718.400
17906064,2007-09-28T00:00:00,bcl-2-Associated X Protein,D12.776.476.075.718.400
17904813,2007-09-29T00:00:00,Child,M01.060.406
17904813,2007-09-29T00:00:00,"Child, Preschool",M01.060.406.448
17904813,2007-09-29T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.400.200
17904813,2007-09-29T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.850.220.230
17904813,2007-09-29T00:00:00,"Echocardiography, Three-Dimensional",E01.370.370.380.220.230
17904813,2007-09-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17904813,2007-09-29T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
17904813,2007-09-29T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
17904813,2007-09-29T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
17904813,2007-09-29T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
17904813,2007-09-29T00:00:00,Ventricular Fibrillation,C14.280.067.922
17904813,2007-09-29T00:00:00,Ventricular Fibrillation,C23.550.073.922
17964738,2007-09-29T00:00:00,Adult,M01.060.116
17964738,2007-09-29T00:00:00,Age Factors,N05.715.350.075
17964738,2007-09-29T00:00:00,Age Factors,N06.850.490.250
17964738,2007-09-29T00:00:00,Alcoholism,C21.739.100.250
17964738,2007-09-29T00:00:00,Alcoholism,F03.900.100.350
17964738,2007-09-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17964738,2007-09-29T00:00:00,Middle Aged,M01.060.116.630
17964738,2007-09-29T00:00:00,Psychiatric Status Rating Scales,F04.586
17964738,2007-09-29T00:00:00,Risk Factors,E05.318.740.600.800.725
17964738,2007-09-29T00:00:00,Risk Factors,N05.715.350.200.700
17964738,2007-09-29T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17964738,2007-09-29T00:00:00,Risk Factors,N06.850.490.625.750
17964738,2007-09-29T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17964738,2007-09-29T00:00:00,Sleep Initiation and Maintenance Disorders,C10.886.425.800.800
17964738,2007-09-29T00:00:00,Sleep Initiation and Maintenance Disorders,F03.870.400.800.800
17964738,2007-09-29T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17988760,2007-09-29T00:00:00,Computer Simulation,L01.224.160
17988760,2007-09-29T00:00:00,Disasters,N06.230.100
17988760,2007-09-29T00:00:00,"Models, Chemical",E05.599.495
17988760,2007-09-29T00:00:00,Solvents,D27.720.844
17988760,2007-09-29T00:00:00,Tetrachloroethylene,D02.455.526.439.880
17988760,2007-09-29T00:00:00,Water,D01.455.900
17988760,2007-09-29T00:00:00,Water,D01.650.550.925
17385231,2007-10-01T00:00:00,Animals,B01.050
17385231,2007-10-01T00:00:00,Cattle,B01.050.150.900.649.077.380.271
17385231,2007-10-01T00:00:00,Collagen Type I,D05.750.078.280.300.100
17385231,2007-10-01T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
17385231,2007-10-01T00:00:00,Nanostructures,J01.637.512
17385231,2007-10-01T00:00:00,Surface Properties,G02.842.850
17638300,2007-10-01T00:00:00,Animals,B01.050
17638300,2007-10-01T00:00:00,Brain,A08.186.211
17638300,2007-10-01T00:00:00,Gerbillinae,B01.050.150.900.649.865.635.300
17638300,2007-10-01T00:00:00,"Microscopy, Electron, Transmission",E01.370.350.515.402.580
17638300,2007-10-01T00:00:00,"Microscopy, Electron, Transmission",E05.595.402.580
17638300,2007-10-01T00:00:00,Neuroglia,A08.637
17638300,2007-10-01T00:00:00,Neuroglia,A11.650
17638300,2007-10-01T00:00:00,Neurons,A08.663
17638300,2007-10-01T00:00:00,Neurons,A11.671
17638300,2007-10-01T00:00:00,Oligodendroglia,A08.637.600
17638300,2007-10-01T00:00:00,Oligodendroglia,A11.650.600
17638300,2007-10-01T00:00:00,Rabbits,B01.050.150.900.649.521.700
17638300,2007-10-01T00:00:00,Sphingosine,D02.033.100.700
17638300,2007-10-01T00:00:00,Sphingosine,D02.033.455.843
17638300,2007-10-01T00:00:00,Sphingosine,D02.092.063.700
17729385,2007-10-01T00:00:00,Adult,M01.060.116
17729385,2007-10-01T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
17729385,2007-10-01T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
17729385,2007-10-01T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
17729385,2007-10-01T00:00:00,Bipolar Disorder,F03.600.150.150
17729385,2007-10-01T00:00:00,Dibenzothiazepines,D02.886.680.702.500
17729385,2007-10-01T00:00:00,Dibenzothiazepines,D03.494.276
17729385,2007-10-01T00:00:00,Drug Interactions,G07.690.812.240
17729385,2007-10-01T00:00:00,Drug Interactions,G07.700.680.240
17729385,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17729385,2007-10-01T00:00:00,Middle Aged,M01.060.116.630
17729385,2007-10-01T00:00:00,Schizophrenia,F03.700.750
17729385,2007-10-01T00:00:00,United States,Z01.107.567.875
17729385,2007-10-01T00:00:00,Valproic Acid,D02.241.081.944.509.900
17729385,2007-10-01T00:00:00,Valproic Acid,D10.251.400.895.593.900
17846179,2007-10-01T00:00:00,Combat Disorders,F03.080.931.249
17846179,2007-10-01T00:00:00,Health Status,I01.240.425
17846179,2007-10-01T00:00:00,Health Status,N01.224.425
17846179,2007-10-01T00:00:00,Health Status,N06.850.505.400.425
17846179,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17846179,2007-10-01T00:00:00,Life Change Events,F01.829.458.410
17846179,2007-10-01T00:00:00,Military Personnel,M01.526.625
17846179,2007-10-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17846179,2007-10-01T00:00:00,United States,Z01.107.567.875
17846179,2007-10-01T00:00:00,Veterans,M01.930
17846179,2007-10-01T00:00:00,Violence,I01.198.240.856
17846179,2007-10-01T00:00:00,Violence,I01.880.735.900
17854475,2007-10-01T00:00:00,Animals,B01.050
17854475,2007-10-01T00:00:00,Candida albicans,B01.300.381.147.326
17854475,2007-10-01T00:00:00,Candida albicans,B01.300.930.176.326
17854475,2007-10-01T00:00:00,Candidiasis,C01.703.160
17854475,2007-10-01T00:00:00,Esophagus,A03.556.875.500
17854475,2007-10-01T00:00:00,Gastric Mucosa,A03.556.875.875.440
17854475,2007-10-01T00:00:00,Gastric Mucosa,A10.615.550.291
17854475,2007-10-01T00:00:00,"Mice, Inbred CBA",B01.050.050.157.520.440
17854475,2007-10-01T00:00:00,"Mice, Inbred CBA",B01.050.050.199.520.520.440
17854475,2007-10-01T00:00:00,"Mice, Inbred CBA",B01.050.150.900.649.865.635.505.500.400.440
17854475,2007-10-01T00:00:00,Mouth Mucosa,A10.615.550.599
17854475,2007-10-01T00:00:00,Mouth Mucosa,A14.549.512
17854475,2007-10-01T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
17854475,2007-10-01T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
17854475,2007-10-01T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
17873732,2007-10-01T00:00:00,Attitude of Health Personnel,F01.100.050
17873732,2007-10-01T00:00:00,Attitude of Health Personnel,N05.300.100
17873732,2007-10-01T00:00:00,Cooperative Behavior,F01.145.813.115
17873732,2007-10-01T00:00:00,Diffusion of Innovation,L01.143.320
17873732,2007-10-01T00:00:00,Evidence-Based Medicine,H02.249.750
17873732,2007-10-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
17873732,2007-10-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
17873732,2007-10-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
17873732,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17873732,2007-10-01T00:00:00,Information Dissemination,F01.145.209.364
17873732,2007-10-01T00:00:00,Information Dissemination,L01.143.443
17873732,2007-10-01T00:00:00,Interprofessional Relations,F01.829.401.205
17873732,2007-10-01T00:00:00,"Medical Records Systems, Computerized",E05.318.308.940.968.625
17873732,2007-10-01T00:00:00,"Medical Records Systems, Computerized",L01.280.900.968.775
17873732,2007-10-01T00:00:00,"Medical Records Systems, Computerized",L01.700.508.300.695
17873732,2007-10-01T00:00:00,"Medical Records Systems, Computerized",N04.452.859.564.650
17873732,2007-10-01T00:00:00,"Medical Records Systems, Computerized",N05.715.360.300.715.500.530
17873732,2007-10-01T00:00:00,"Medical Records Systems, Computerized",N06.850.520.308.940.968.625
17873732,2007-10-01T00:00:00,"Models, Organizational",E05.599.670
17873732,2007-10-01T00:00:00,"Models, Organizational",N04.452.534
17873732,2007-10-01T00:00:00,Nurse's Role,F01.829.316.616.625.450
17873732,2007-10-01T00:00:00,Nurse's Role,N05.300.100.337
17873732,2007-10-01T00:00:00,Outcome and Process Assessment (Health Care),N04.761.559
17873732,2007-10-01T00:00:00,Outcome and Process Assessment (Health Care),N05.715.360.575
17873732,2007-10-01T00:00:00,Patient Care Team,N04.590.715
17873732,2007-10-01T00:00:00,Patient Education as Topic,I02.233.332.500
17873732,2007-10-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
17873732,2007-10-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
17873732,2007-10-01T00:00:00,Primary Health Care,N04.590.233.727
17873732,2007-10-01T00:00:00,Qualitative Research,H01.770.644.241.850
17873732,2007-10-01T00:00:00,"Quality Indicators, Health Care",N04.761.789
17873732,2007-10-01T00:00:00,Questionnaires,E05.318.308.750
17873732,2007-10-01T00:00:00,Questionnaires,L01.280.800
17873732,2007-10-01T00:00:00,Questionnaires,N05.715.360.300.695
17873732,2007-10-01T00:00:00,Questionnaires,N06.850.520.308.750
17873732,2007-10-01T00:00:00,Total Quality Management,N04.452.955
17873732,2007-10-01T00:00:00,Total Quality Management,N04.761.700.675
17873732,2007-10-01T00:00:00,Total Quality Management,N05.700.792
17875186,2007-10-01T00:00:00,Aged,M01.060.116.100
17875186,2007-10-01T00:00:00,Cardiopulmonary Resuscitation,E02.365.647.110
17875186,2007-10-01T00:00:00,Heart Arrest,C14.280.383
17875186,2007-10-01T00:00:00,Hospitalization,E02.760.400
17875186,2007-10-01T00:00:00,Hospitalization,N02.421.585.400
17875186,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17875186,2007-10-01T00:00:00,Middle Aged,M01.060.116.630
17875186,2007-10-01T00:00:00,Patient Discharge,E02.760.400.610
17875186,2007-10-01T00:00:00,Patient Discharge,N02.421.585.400.610
17875186,2007-10-01T00:00:00,Time Factors,G01.910.857
17875186,2007-10-01T00:00:00,Treatment Outcome,E01.789.800
17875186,2007-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17875186,2007-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17875186,2007-10-01T00:00:00,Ventricular Fibrillation,C14.280.067.922
17875186,2007-10-01T00:00:00,Ventricular Fibrillation,C23.550.073.922
17880326,2007-10-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
17880326,2007-10-01T00:00:00,Coronary Angiography,E01.370.370.050.200
17880326,2007-10-01T00:00:00,Coronary Angiography,E01.370.370.380.200
17880326,2007-10-01T00:00:00,Coronary Restenosis,C14.280.647.250.285.200
17880326,2007-10-01T00:00:00,Coronary Restenosis,C14.907.585.250.285.200
17880326,2007-10-01T00:00:00,Drug-Eluting Stents,E07.695.750.500
17880326,2007-10-01T00:00:00,Heparin,D09.698.373.400
17880326,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17880326,2007-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17880326,2007-10-01T00:00:00,Risk Factors,N05.715.350.200.700
17880326,2007-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17880326,2007-10-01T00:00:00,Risk Factors,N06.850.490.625.750
17880326,2007-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17880326,2007-10-01T00:00:00,Ticlopidine,D02.886.778.834
17880326,2007-10-01T00:00:00,Ticlopidine,D03.383.903.834
17880326,2007-10-01T00:00:00,Treatment Outcome,E01.789.800
17880326,2007-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17880326,2007-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17885176,2007-10-01T00:00:00,Age Factors,N05.715.350.075
17885176,2007-10-01T00:00:00,Age Factors,N06.850.490.250
17885176,2007-10-01T00:00:00,Breast Neoplasms,C04.588.180
17885176,2007-10-01T00:00:00,Breast Neoplasms,C17.800.090.500
17885176,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17885176,2007-10-01T00:00:00,Mammography,E01.370.350.700.500
17885176,2007-10-01T00:00:00,Middle Aged,M01.060.116.630
17885176,2007-10-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
17885176,2007-10-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
17885176,2007-10-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
17885683,2007-10-01T00:00:00,Animals,B01.050
17885683,2007-10-01T00:00:00,Phosphotransferases (Alcohol Group Acceptor),D08.811.913.696.620
17885683,2007-10-01T00:00:00,Pregnancy,G08.686.785.760.769
17885683,2007-10-01T00:00:00,Progesterone,D04.808.745.745.654.829
17885683,2007-10-01T00:00:00,Progesterone,D06.472.334.734.623
17885683,2007-10-01T00:00:00,Progesterone,D06.472.334.851.687.750
17885683,2007-10-01T00:00:00,Sphingolipids,D10.570.877
17885683,2007-10-01T00:00:00,Sphingolipids,D10.808
17885683,2007-10-01T00:00:00,Sphingosine,D02.033.100.700
17885683,2007-10-01T00:00:00,Sphingosine,D02.033.455.843
17885683,2007-10-01T00:00:00,Sphingosine,D02.092.063.700
17885683,2007-10-01T00:00:00,Uterus,A05.360.319.679
17888951,2007-10-01T00:00:00,Attitude of Health Personnel,F01.100.050
17888951,2007-10-01T00:00:00,Attitude of Health Personnel,N05.300.100
17888951,2007-10-01T00:00:00,Conflict of Interest,K01.316.130
17888951,2007-10-01T00:00:00,Conflict of Interest,N05.350.225
17888951,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17888951,2007-10-01T00:00:00,Physician's Practice Patterns,N04.590.748
17888951,2007-10-01T00:00:00,Physician's Practice Patterns,N05.300.625
17888951,2007-10-01T00:00:00,Physician-Patient Relations,F01.829.401.650.675
17888951,2007-10-01T00:00:00,Physician-Patient Relations,N05.300.660.625
17888951,2007-10-01T00:00:00,United States,Z01.107.567.875
17890275,2007-10-01T00:00:00,Child,M01.060.406
17890275,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17890909,2007-10-01T00:00:00,"Antigens, CD",D23.050.301.264.035
17890909,2007-10-01T00:00:00,"Antigens, CD",D23.101.100.110
17890909,2007-10-01T00:00:00,Case-Control Studies,E05.318.760.500.500
17890909,2007-10-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
17890909,2007-10-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
17890909,2007-10-01T00:00:00,Contrast Media,D27.720.259
17890909,2007-10-01T00:00:00,Fibroblasts,A11.329.228
17890909,2007-10-01T00:00:00,Fibroblasts,A11.872.228
17890909,2007-10-01T00:00:00,Fibrosis,C23.550.355
17890909,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17890909,2007-10-01T00:00:00,Middle Aged,M01.060.116.630
17890909,2007-10-01T00:00:00,Renal Insufficiency,C12.777.419.780
17890909,2007-10-01T00:00:00,Renal Insufficiency,C13.351.968.419.780
17890909,2007-10-01T00:00:00,Skin,A17.815
17890909,2007-10-01T00:00:00,Skin Diseases,C17.800
17890909,2007-10-01T00:00:00,Syndrome,C23.550.288.500
17890909,2007-10-01T00:00:00,Transglutaminases,D08.811.913.050.200.800
17893014,2007-10-01T00:00:00,Cataract,C11.510.245
17893014,2007-10-01T00:00:00,Cataract Extraction,E04.540.825.249
17893014,2007-10-01T00:00:00,"Child, Preschool",M01.060.406.448
17893014,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17893014,2007-10-01T00:00:00,Infant,M01.060.703
17893014,2007-10-01T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
17893014,2007-10-01T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
17893014,2007-10-01T00:00:00,Multicenter Studies as Topic,E05.337.250.500
17893014,2007-10-01T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
17893014,2007-10-01T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
17893014,2007-10-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
17893014,2007-10-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
17893014,2007-10-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
17893014,2007-10-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
17893014,2007-10-01T00:00:00,Treatment Outcome,E01.789.800
17893014,2007-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17893014,2007-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17898291,2007-10-01T00:00:00,Adolescent,M01.060.057
17898291,2007-10-01T00:00:00,African Americans,M01.686.508.100.100
17898291,2007-10-01T00:00:00,African Americans,M01.686.754.100
17898291,2007-10-01T00:00:00,Biometry,E05.318.740.225
17898291,2007-10-01T00:00:00,Biometry,N06.850.505.200
17898291,2007-10-01T00:00:00,Cataract,C11.510.245
17898291,2007-10-01T00:00:00,Child,M01.060.406
17898291,2007-10-01T00:00:00,"Child, Preschool",M01.060.406.448
17898291,2007-10-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
17898291,2007-10-01T00:00:00,Eye,A01.456.505.420
17898291,2007-10-01T00:00:00,Eye,A09.371
17898291,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17898291,2007-10-01T00:00:00,Infant,M01.060.703
17898291,2007-10-01T00:00:00,"Infant, Newborn",M01.060.703.520
17898291,2007-10-01T00:00:00,"Lens, Crystalline",A09.371.060.500
17898372,2007-10-01T00:00:00,Aprotinin,D12.776.083
17898372,2007-10-01T00:00:00,Brain,A08.186.211
17898372,2007-10-01T00:00:00,Cardiac Surgical Procedures,E04.100.376
17898372,2007-10-01T00:00:00,Cardiac Surgical Procedures,E04.928.220
17898372,2007-10-01T00:00:00,Cardiopulmonary Bypass,E04.292.413
17898372,2007-10-01T00:00:00,Heart,A07.541
17898372,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17898372,2007-10-01T00:00:00,Kidney,A05.810.453
17898372,2007-10-01T00:00:00,Lung,A04.411
17902856,2007-10-01T00:00:00,Acoustic Stimulation,E02.037
17902856,2007-10-01T00:00:00,Acoustic Stimulation,E02.190.888.030
17902856,2007-10-01T00:00:00,Acoustic Stimulation,E05.723.136
17902856,2007-10-01T00:00:00,Adolescent,M01.060.057
17902856,2007-10-01T00:00:00,Adult,M01.060.116
17902856,2007-10-01T00:00:00,Auditory Threshold,F02.463.593.071.173
17902856,2007-10-01T00:00:00,Auditory Threshold,F02.463.593.710.190
17902856,2007-10-01T00:00:00,Ear Canal,A09.246.272.396
17902856,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17902856,2007-10-01T00:00:00,Middle Aged,M01.060.116.630
17902856,2007-10-01T00:00:00,"Otoacoustic Emissions, Spontaneous",G11.561.600.810.263.570
17902856,2007-10-01T00:00:00,"Signal Processing, Computer-Assisted",L01.224.800
17903687,2007-10-01T00:00:00,Adolescent,M01.060.057
17903687,2007-10-01T00:00:00,Adult,M01.060.116
17903687,2007-10-01T00:00:00,African Americans,M01.686.508.100.100
17903687,2007-10-01T00:00:00,African Americans,M01.686.754.100
17903687,2007-10-01T00:00:00,Blood Pressure,E01.370.600.875.249
17903687,2007-10-01T00:00:00,Blood Pressure,G09.330.380.076
17903687,2007-10-01T00:00:00,Cardiovascular Diseases,C14
17903687,2007-10-01T00:00:00,Carotid Arteries,A07.231.114.186
17903687,2007-10-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
17903687,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17903687,2007-10-01T00:00:00,Hypertension,C14.907.489
17903687,2007-10-01T00:00:00,Phenotype,G05.695
17903687,2007-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17903687,2007-10-01T00:00:00,Risk Factors,N05.715.350.200.700
17903687,2007-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17903687,2007-10-01T00:00:00,Risk Factors,N06.850.490.625.750
17903687,2007-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17903687,2007-10-01T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
17903689,2007-10-01T00:00:00,Adolescent,M01.060.057
17903689,2007-10-01T00:00:00,Adult,M01.060.116
17903689,2007-10-01T00:00:00,African Americans,M01.686.508.100.100
17903689,2007-10-01T00:00:00,African Americans,M01.686.754.100
17903689,2007-10-01T00:00:00,Blood Pressure,E01.370.600.875.249
17903689,2007-10-01T00:00:00,Blood Pressure,G09.330.380.076
17903689,2007-10-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
17903689,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17903689,2007-10-01T00:00:00,Hypertension,C14.907.489
17903689,2007-10-01T00:00:00,"Models, Genetic",E05.599.395.397
17903689,2007-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17903689,2007-10-01T00:00:00,Risk Factors,N05.715.350.200.700
17903689,2007-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17903689,2007-10-01T00:00:00,Risk Factors,N06.850.490.625.750
17903689,2007-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17903689,2007-10-01T00:00:00,Sex Characteristics,G08.686.815
17905666,2007-10-01T00:00:00,Epilepsy,C10.228.140.490
17905666,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17905666,2007-10-01T00:00:00,Pediatrics,H02.403.670
17905666,2007-10-01T00:00:00,Psychology,F04.096.628
17906007,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17906007,2007-10-01T00:00:00,Inservice Training,I02.574
17906007,2007-10-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
17906007,2007-10-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
17906007,2007-10-01T00:00:00,Pregnancy,G08.686.785.760.769
17906007,2007-10-01T00:00:00,Questionnaires,E05.318.308.750
17906007,2007-10-01T00:00:00,Questionnaires,L01.280.800
17906007,2007-10-01T00:00:00,Questionnaires,N05.715.360.300.695
17906007,2007-10-01T00:00:00,Questionnaires,N06.850.520.308.750
17906007,2007-10-01T00:00:00,Smoking Cessation,F01.145.940.700
17906567,2007-10-01T00:00:00,Adolescent,M01.060.057
17906567,2007-10-01T00:00:00,Adult,M01.060.116
17906567,2007-10-01T00:00:00,Aged,M01.060.116.100
17906567,2007-10-01T00:00:00,Double-Blind Method,E05.318.780.300
17906567,2007-10-01T00:00:00,Double-Blind Method,E05.581.500.300
17906567,2007-10-01T00:00:00,Double-Blind Method,N05.715.360.780.320
17906567,2007-10-01T00:00:00,Double-Blind Method,N06.850.520.445.300
17906567,2007-10-01T00:00:00,Factor VIIa,D08.811.277.656.300.760.300
17906567,2007-10-01T00:00:00,Factor VIIa,D08.811.277.656.959.350.300
17906567,2007-10-01T00:00:00,Factor VIIa,D12.776.124.125.325.300
17906567,2007-10-01T00:00:00,Factor VIIa,D23.119.325.300
17906567,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17906567,2007-10-01T00:00:00,Middle Aged,M01.060.116.630
17906567,2007-10-01T00:00:00,Recombinant Proteins,D12.776.828
17906567,2007-10-01T00:00:00,Spinal Diseases,C05.116.900
17906567,2007-10-01T00:00:00,Spinal Fusion,E04.555.100.700
17907155,2007-10-01T00:00:00,Collagen Type I,D05.750.078.280.300.100
17907155,2007-10-01T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
17907155,2007-10-01T00:00:00,Connective Tissue Growth Factor,D12.644.276.200.100
17907155,2007-10-01T00:00:00,Connective Tissue Growth Factor,D12.776.467.200.100
17907155,2007-10-01T00:00:00,Connective Tissue Growth Factor,D12.776.860.300.200.100
17907155,2007-10-01T00:00:00,Connective Tissue Growth Factor,D23.529.237.100
17907155,2007-10-01T00:00:00,Down-Regulation,G02.111.087.225
17907155,2007-10-01T00:00:00,Down-Regulation,G02.149.115.225
17907155,2007-10-01T00:00:00,Down-Regulation,G05.355.315.200
17907155,2007-10-01T00:00:00,Down-Regulation,G07.690.812.230
17907155,2007-10-01T00:00:00,Down-Regulation,G07.700.680.230
17907155,2007-10-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
17907155,2007-10-01T00:00:00,Fibroblasts,A11.329.228
17907155,2007-10-01T00:00:00,Fibroblasts,A11.872.228
17907155,2007-10-01T00:00:00,Hepatocyte Growth Factor,D12.644.276.374.420
17907155,2007-10-01T00:00:00,Hepatocyte Growth Factor,D12.776.467.374.420
17907155,2007-10-01T00:00:00,Hepatocyte Growth Factor,D23.529.374.420
17907155,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17907155,2007-10-01T00:00:00,Immediate-Early Proteins,D12.776.460
17907155,2007-10-01T00:00:00,Immediate-Early Proteins,D12.776.964.925.968
17907155,2007-10-01T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
17907155,2007-10-01T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
17907155,2007-10-01T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
17907155,2007-10-01T00:00:00,Lung,A04.411
17907155,2007-10-01T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
17907155,2007-10-01T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
17907155,2007-10-01T00:00:00,MAP Kinase Signaling System,G03.495.553.560
17907155,2007-10-01T00:00:00,MAP Kinase Signaling System,G04.299.880.560
17907155,2007-10-01T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.205.351
17907155,2007-10-01T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.525.700.100
17907155,2007-10-01T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.205.351
17907155,2007-10-01T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.525.700.100
17907155,2007-10-01T00:00:00,Mitogen-Activated Protein Kinase Kinases,D08.811.913.696.620.682.700.565
17907155,2007-10-01T00:00:00,Mitogen-Activated Protein Kinase Kinases,D08.811.913.696.620.682.725.200
17907155,2007-10-01T00:00:00,Mitogen-Activated Protein Kinase Kinases,D12.644.360.440
17907155,2007-10-01T00:00:00,Mitogen-Activated Protein Kinase Kinases,D12.776.476.440
17907155,2007-10-01T00:00:00,NF-kappa B,D12.776.260.600
17907155,2007-10-01T00:00:00,NF-kappa B,D12.776.660.600
17907155,2007-10-01T00:00:00,NF-kappa B,D12.776.930.600
17907155,2007-10-01T00:00:00,"Scleroderma, Systemic",C17.300.799
17907155,2007-10-01T00:00:00,"Scleroderma, Systemic",C17.800.784
17907862,2007-10-01T00:00:00,Adult,M01.060.116
17907862,2007-10-01T00:00:00,Ambulatory Care,E02.760.106
17907862,2007-10-01T00:00:00,Ambulatory Care,N02.421.585.106
17907862,2007-10-01T00:00:00,Amphetamine-Related Disorders,C21.739.225
17907862,2007-10-01T00:00:00,Amphetamine-Related Disorders,F03.900.225
17907862,2007-10-01T00:00:00,Central Nervous System Stimulants,D27.505.696.282
17907862,2007-10-01T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
17907862,2007-10-01T00:00:00,Cocaine-Related Disorders,C21.739.300
17907862,2007-10-01T00:00:00,Cocaine-Related Disorders,F03.900.300
17907862,2007-10-01T00:00:00,Counseling,F02.784.176
17907862,2007-10-01T00:00:00,Counseling,F04.408.413
17907862,2007-10-01T00:00:00,Counseling,N02.421.143.303
17907862,2007-10-01T00:00:00,Counseling,N02.421.461.363
17907862,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17907862,2007-10-01T00:00:00,Methamphetamine,D02.092.471.683.152.619
17907862,2007-10-01T00:00:00,Middle Aged,M01.060.116.630
17907862,2007-10-01T00:00:00,Motivation,F01.658
17907862,2007-10-01T00:00:00,Motivation,F01.752.543.500.750
17907862,2007-10-01T00:00:00,Patient Dropouts,M01.643.673
17907862,2007-10-01T00:00:00,Substance Abuse Detection,E05.885
17907862,2007-10-01T00:00:00,Substance Abuse Detection,N06.850.780.500.765
17907862,2007-10-01T00:00:00,Treatment Outcome,E01.789.800
17907862,2007-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17907862,2007-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17907864,2007-10-01T00:00:00,Adult,M01.060.116
17907864,2007-10-01T00:00:00,Alcoholism,C21.739.100.250
17907864,2007-10-01T00:00:00,Alcoholism,F03.900.100.350
17907864,2007-10-01T00:00:00,Hospitalization,E02.760.400
17907864,2007-10-01T00:00:00,Hospitalization,N02.421.585.400
17907864,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17907864,2007-10-01T00:00:00,"Interview, Psychological",F04.669.599
17907864,2007-10-01T00:00:00,Mental Disorders,F03
17907864,2007-10-01T00:00:00,Middle Aged,M01.060.116.630
17907864,2007-10-01T00:00:00,Motivation,F01.658
17907864,2007-10-01T00:00:00,Motivation,F01.752.543.500.750
17907864,2007-10-01T00:00:00,Patient Dropouts,M01.643.673
17907864,2007-10-01T00:00:00,Substance-Related Disorders,C21.739
17907864,2007-10-01T00:00:00,Substance-Related Disorders,F03.900
17907864,2007-10-01T00:00:00,Treatment Outcome,E01.789.800
17907864,2007-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17907864,2007-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17908558,2007-10-01T00:00:00,"Adaptation, Physiological",G07.700.062
17908558,2007-10-01T00:00:00,"Adaptation, Physiological",G16.100.057.500
17908558,2007-10-01T00:00:00,Animals,B01.050
17908558,2007-10-01T00:00:00,Cardiomegaly,C14.280.195
17908558,2007-10-01T00:00:00,Cardiomegaly,C23.300.775.250
17908558,2007-10-01T00:00:00,Fatty Acids,D10.251
17908558,2007-10-01T00:00:00,Gene Expression Regulation,G05.355.315
17908558,2007-10-01T00:00:00,Mitochondria,A11.284.430.214.190.875.564
17908558,2007-10-01T00:00:00,Mitochondria,A11.284.835.626
17908558,2007-10-01T00:00:00,"Myocytes, Cardiac",A07.541.704.570
17908558,2007-10-01T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
17908558,2007-10-01T00:00:00,"Myocytes, Cardiac",A11.620.500
17908558,2007-10-01T00:00:00,Protein Isoforms,D12.776.800
17908558,2007-10-01T00:00:00,Protein Kinase C,D08.811.913.696.620.682.700.725
17908558,2007-10-01T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
17908558,2007-10-01T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
17908558,2007-10-01T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
17908558,2007-10-01T00:00:00,Signal Transduction,G02.111.087.800
17908558,2007-10-01T00:00:00,Signal Transduction,G02.149.115.800
17908558,2007-10-01T00:00:00,Signal Transduction,G04.299.880
17908852,2007-10-01T00:00:00,Curriculum,I02.158
17908852,2007-10-01T00:00:00,Dental Clinics,N02.278.192.250
17908852,2007-10-01T00:00:00,Dental Health Services,N02.421.240
17908852,2007-10-01T00:00:00,"Education, Dental",I02.358.274
17908852,2007-10-01T00:00:00,Healthcare Disparities,N04.590.374.380
17908852,2007-10-01T00:00:00,Healthcare Disparities,N05.300.493
17908852,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17908852,2007-10-01T00:00:00,Interviews as Topic,E05.318.308.420
17908852,2007-10-01T00:00:00,Interviews as Topic,L01.280.520
17908852,2007-10-01T00:00:00,Interviews as Topic,N05.715.360.300.400
17908852,2007-10-01T00:00:00,Interviews as Topic,N06.850.520.308.420
17908852,2007-10-01T00:00:00,"Schools, Dental",I02.783.660.481
17908852,2007-10-01T00:00:00,United States,Z01.107.567.875
17908879,2007-10-01T00:00:00,Aged,M01.060.116.100
17908879,2007-10-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
17908879,2007-10-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
17908879,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17908879,2007-10-01T00:00:00,Middle Aged,M01.060.116.630
17909064,2007-10-01T00:00:00,Animals,B01.050
17909064,2007-10-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
17909064,2007-10-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
17909064,2007-10-01T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
17909064,2007-10-01T00:00:00,Complement Activation,G12.425.255
17909064,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17909064,2007-10-01T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
17909064,2007-10-01T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
17909064,2007-10-01T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
17909064,2007-10-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
17909064,2007-10-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
17909064,2007-10-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
17909064,2007-10-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
17909064,2007-10-01T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
17914336,2007-10-01T00:00:00,Breast Neoplasms,C04.588.180
17914336,2007-10-01T00:00:00,Breast Neoplasms,C17.800.090.500
17914336,2007-10-01T00:00:00,Computational Biology,H01.158.273.180
17914336,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17914336,2007-10-01T00:00:00,Proteomics,H01.158.201.843
17914336,2007-10-01T00:00:00,Proteomics,H01.158.273.180.350.700
17914336,2007-10-01T00:00:00,Proteomics,H01.158.273.343.350.700
17914336,2007-10-01T00:00:00,Proteomics,H01.181.122.738
17914336,2007-10-01T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
17914336,2007-10-01T00:00:00,"Tumor Markers, Biological",D23.101.840
17915076,2007-10-01T00:00:00,Alcoholism,C21.739.100.250
17915076,2007-10-01T00:00:00,Alcoholism,F03.900.100.350
17915076,2007-10-01T00:00:00,Combined Modality Therapy,E02.186
17915076,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17915076,2007-10-01T00:00:00,Mental Disorders,F03
17915076,2007-10-01T00:00:00,Substance-Related Disorders,C21.739
17915076,2007-10-01T00:00:00,Substance-Related Disorders,F03.900
17915076,2007-10-01T00:00:00,Treatment Outcome,E01.789.800
17915076,2007-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17915076,2007-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17916476,2007-10-01T00:00:00,Anterior Cruciate Ligament,A02.513.514.100
17916476,2007-10-01T00:00:00,Anterior Cruciate Ligament,A02.835.583.512.100
17916476,2007-10-01T00:00:00,Antibiotic Prophylaxis,E02.319.162.150
17916476,2007-10-01T00:00:00,Antibiotic Prophylaxis,E02.319.703.150
17916476,2007-10-01T00:00:00,Bacteria,B03
17916476,2007-10-01T00:00:00,Bacterial Infections,C01.252
17916476,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17918691,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17918691,2007-10-01T00:00:00,"Medical Records Systems, Computerized",E05.318.308.940.968.625
17918691,2007-10-01T00:00:00,"Medical Records Systems, Computerized",L01.280.900.968.775
17918691,2007-10-01T00:00:00,"Medical Records Systems, Computerized",L01.700.508.300.695
17918691,2007-10-01T00:00:00,"Medical Records Systems, Computerized",N04.452.859.564.650
17918691,2007-10-01T00:00:00,"Medical Records Systems, Computerized",N05.715.360.300.715.500.530
17918691,2007-10-01T00:00:00,"Medical Records Systems, Computerized",N06.850.520.308.940.968.625
17918691,2007-10-01T00:00:00,"Models, Organizational",E05.599.670
17918691,2007-10-01T00:00:00,"Models, Organizational",N04.452.534
17918691,2007-10-01T00:00:00,United States,Z01.107.567.875
17920715,2007-10-01T00:00:00,Adult,M01.060.116
17920715,2007-10-01T00:00:00,Aged,M01.060.116.100
17920715,2007-10-01T00:00:00,Head and Neck Neoplasms,C04.588.443
17920715,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17920715,2007-10-01T00:00:00,Middle Aged,M01.060.116.630
17920715,2007-10-01T00:00:00,Time Factors,G01.910.857
17922777,2007-10-01T00:00:00,Adult,M01.060.116
17922777,2007-10-01T00:00:00,Anticonvulsants,D27.505.954.427.080
17922777,2007-10-01T00:00:00,Electroencephalography,E01.370.376.300
17922777,2007-10-01T00:00:00,Electroencephalography,E01.370.405.245
17922777,2007-10-01T00:00:00,Epilepsy,C10.228.140.490
17922777,2007-10-01T00:00:00,Fructose,D09.546.359.250
17922777,2007-10-01T00:00:00,Fructose,D09.546.465.354
17922777,2007-10-01T00:00:00,Functional Laterality,F02.830.297.425
17922777,2007-10-01T00:00:00,Functional Laterality,G11.561.225.425
17922777,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17922777,2007-10-01T00:00:00,Middle Aged,M01.060.116.630
17923630,2007-10-01T00:00:00,Algorithms,G17.035
17923630,2007-10-01T00:00:00,Algorithms,L01.224.050
17923630,2007-10-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
17923630,2007-10-01T00:00:00,Alzheimer Disease,C10.574.945.249
17923630,2007-10-01T00:00:00,Alzheimer Disease,F03.087.400.100
17923630,2007-10-01T00:00:00,Amyloid beta-Protein Precursor,D12.776.049.025.150
17923630,2007-10-01T00:00:00,Amyloid beta-Protein Precursor,D12.776.811.050
17923630,2007-10-01T00:00:00,Animals,B01.050
17923630,2007-10-01T00:00:00,Brain Mapping,E01.370.350.086
17923630,2007-10-01T00:00:00,Brain Mapping,E01.370.376.149
17923630,2007-10-01T00:00:00,Brain Mapping,E05.132
17923630,2007-10-01T00:00:00,Dentate Gyrus,A08.186.211.464.405.200
17923630,2007-10-01T00:00:00,Dentate Gyrus,A08.186.211.730.885.287.500.345.200
17923630,2007-10-01T00:00:00,"Disease Models, Animal",C22.232
17923630,2007-10-01T00:00:00,"Disease Models, Animal",E05.598.500
17923630,2007-10-01T00:00:00,"Disease Models, Animal",E05.599.395.080
17923630,2007-10-01T00:00:00,Disease Progression,C23.550.291.656
17923630,2007-10-01T00:00:00,Hippocampus,A08.186.211.464.405
17923630,2007-10-01T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
17923630,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17923630,2007-10-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17923630,2007-10-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17923630,2007-10-01T00:00:00,Neuropsychological Tests,F04.711.513
17924784,2007-10-01T00:00:00,Animals,B01.050
17924784,2007-10-01T00:00:00,Attention Deficit Disorder with Hyperactivity,F03.550.150.150
17924784,2007-10-01T00:00:00,"Behavior, Animal",F01.145.113
17924784,2007-10-01T00:00:00,Cocaine,D02.145.074.722.388
17924784,2007-10-01T00:00:00,Cocaine,D03.132.889.354
17924784,2007-10-01T00:00:00,Cocaine,D03.605.869.388
17924784,2007-10-01T00:00:00,Cocaine,D04.075.080.875.099.722.388
17924784,2007-10-01T00:00:00,Conditioning (Psychology),F02.463.425.179
17924784,2007-10-01T00:00:00,"Conditioning, Operant",F02.463.425.179.509
17924784,2007-10-01T00:00:00,Discrimination Learning,F02.463.425.280
17924784,2007-10-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
17924784,2007-10-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
17924784,2007-10-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
17924784,2007-10-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
17924784,2007-10-01T00:00:00,Methylphenidate,D02.241.223.601.600
17924784,2007-10-01T00:00:00,Methylphenidate,D03.383.621.460
17924784,2007-10-01T00:00:00,Nicotine,D03.132.760.570
17924784,2007-10-01T00:00:00,Nicotine,D03.383.725.518
17924784,2007-10-01T00:00:00,Piperazines,D03.383.606
17924784,2007-10-01T00:00:00,Propylamines,D02.092.831
17924784,2007-10-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17924784,2007-10-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17925477,2007-10-01T00:00:00,Adolescent,M01.060.057
17925477,2007-10-01T00:00:00,Adult,M01.060.116
17925477,2007-10-01T00:00:00,Aged,M01.060.116.100
17925477,2007-10-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
17925477,2007-10-01T00:00:00,Body Mass Index,E05.041.124.125
17925477,2007-10-01T00:00:00,Body Mass Index,G07.100.100.125
17925477,2007-10-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
17925477,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17925477,2007-10-01T00:00:00,Laparoscopy,E01.370.388.250.520
17925477,2007-10-01T00:00:00,Laparoscopy,E04.800.250.520
17925477,2007-10-01T00:00:00,Middle Aged,M01.060.116.630
17925477,2007-10-01T00:00:00,Obesity,C18.654.726.500
17925477,2007-10-01T00:00:00,Obesity,C23.888.144.699.500
17925477,2007-10-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
17925477,2007-10-01T00:00:00,Obesity,G07.100.100.160.120.699.500
17925477,2007-10-01T00:00:00,Polysomnography,E01.370.520.625
17925477,2007-10-01T00:00:00,Questionnaires,E05.318.308.750
17925477,2007-10-01T00:00:00,Questionnaires,L01.280.800
17925477,2007-10-01T00:00:00,Questionnaires,N05.715.360.300.695
17925477,2007-10-01T00:00:00,Questionnaires,N06.850.520.308.750
17925477,2007-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17925477,2007-10-01T00:00:00,Risk Factors,N05.715.350.200.700
17925477,2007-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17925477,2007-10-01T00:00:00,Risk Factors,N06.850.490.625.750
17925477,2007-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17925477,2007-10-01T00:00:00,"Sleep Apnea, Obstructive",C08.618.085.852.850
17925477,2007-10-01T00:00:00,"Sleep Apnea, Obstructive",C10.886.425.800.750.850
17925632,2007-10-01T00:00:00,"Arrhythmias, Cardiac",C14.280.067
17925632,2007-10-01T00:00:00,"Arrhythmias, Cardiac",C23.550.073
17925632,2007-10-01T00:00:00,"Death, Sudden, Cardiac",C14.280.383.220
17925632,2007-10-01T00:00:00,"Death, Sudden, Cardiac",C23.550.260.322.250
17925632,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17925632,2007-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17925632,2007-10-01T00:00:00,Risk Factors,N05.715.350.200.700
17925632,2007-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17925632,2007-10-01T00:00:00,Risk Factors,N06.850.490.625.750
17925632,2007-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17925632,2007-10-01T00:00:00,Sports,I03.450.642.845
17928585,2007-10-01T00:00:00,Animals,B01.050
17928585,2007-10-01T00:00:00,Extracellular Matrix,A11.284.295.310
17928585,2007-10-01T00:00:00,Gene Expression,G05.355.310
17928585,2007-10-01T00:00:00,Heart,A07.541
17928585,2007-10-01T00:00:00,Heart Diseases,C14.280
17928585,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17928585,2007-10-01T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
17928585,2007-10-01T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
17928585,2007-10-01T00:00:00,Myocardium,A02.633.580
17928585,2007-10-01T00:00:00,Myocardium,A07.541.704
17928585,2007-10-01T00:00:00,Myocardium,A10.690.552.750
17928585,2007-10-01T00:00:00,Ventricular Remodeling,C23.300.985
17928585,2007-10-01T00:00:00,Ventricular Remodeling,G09.330.190.962.975
17938330,2007-10-01T00:00:00,Adult,M01.060.116
17938330,2007-10-01T00:00:00,Aged,M01.060.116.100
17938330,2007-10-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
17938330,2007-10-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
17938330,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17938330,2007-10-01T00:00:00,Middle Aged,M01.060.116.630
17938330,2007-10-01T00:00:00,Neoplasm Staging,E01.370.550
17938330,2007-10-01T00:00:00,Postoperative Care,E02.760.722.700
17938330,2007-10-01T00:00:00,Postoperative Care,E04.624
17938330,2007-10-01T00:00:00,Postoperative Care,N02.421.585.722.700
17938330,2007-10-01T00:00:00,Treatment Outcome,E01.789.800
17938330,2007-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17938330,2007-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17943619,2007-10-01T00:00:00,Adult,M01.060.116
17943619,2007-10-01T00:00:00,"Behavior, Addictive",F01.145.527.100.120
17943619,2007-10-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
17943619,2007-10-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
17943619,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17943619,2007-10-01T00:00:00,Middle Aged,M01.060.116.630
17943619,2007-10-01T00:00:00,Questionnaires,E05.318.308.750
17943619,2007-10-01T00:00:00,Questionnaires,L01.280.800
17943619,2007-10-01T00:00:00,Questionnaires,N05.715.360.300.695
17943619,2007-10-01T00:00:00,Questionnaires,N06.850.520.308.750
17943619,2007-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17943619,2007-10-01T00:00:00,Risk Factors,N05.715.350.200.700
17943619,2007-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17943619,2007-10-01T00:00:00,Risk Factors,N06.850.490.625.750
17943619,2007-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17943619,2007-10-01T00:00:00,Risk Reduction Behavior,F01.145.699
17943619,2007-10-01T00:00:00,Risk-Taking,F01.145.722
17943619,2007-10-01T00:00:00,Self Concept,F01.752.747.792
17943619,2007-10-01T00:00:00,Smoking,F01.145.466.753
17943619,2007-10-01T00:00:00,Smoking Cessation,F01.145.940.700
17943619,2007-10-01T00:00:00,Tobacco Use Disorder,C21.739.912
17943619,2007-10-01T00:00:00,Tobacco Use Disorder,F03.900.912
17943619,2007-10-01T00:00:00,United States,Z01.107.567.875
17955525,2007-10-01T00:00:00,Adolescent,M01.060.057
17955525,2007-10-01T00:00:00,Alcoholism,C21.739.100.250
17955525,2007-10-01T00:00:00,Alcoholism,F03.900.100.350
17955525,2007-10-01T00:00:00,Child,M01.060.406
17955525,2007-10-01T00:00:00,Crime Victims,M01.135
17955525,2007-10-01T00:00:00,Depression,F01.145.126.350
17955525,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17955525,2007-10-01T00:00:00,Interviews as Topic,E05.318.308.420
17955525,2007-10-01T00:00:00,Interviews as Topic,L01.280.520
17955525,2007-10-01T00:00:00,Interviews as Topic,N05.715.360.300.400
17955525,2007-10-01T00:00:00,Interviews as Topic,N06.850.520.308.420
17955525,2007-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17955525,2007-10-01T00:00:00,Risk Factors,N05.715.350.200.700
17955525,2007-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17955525,2007-10-01T00:00:00,Risk Factors,N06.850.490.625.750
17955525,2007-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17955525,2007-10-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17955525,2007-10-01T00:00:00,Substance-Related Disorders,C21.739
17955525,2007-10-01T00:00:00,Substance-Related Disorders,F03.900
17955525,2007-10-01T00:00:00,United States,Z01.107.567.875
17955525,2007-10-01T00:00:00,Violence,I01.198.240.856
17955525,2007-10-01T00:00:00,Violence,I01.880.735.900
17962611,2007-10-01T00:00:00,Adult,M01.060.116
17962611,2007-10-01T00:00:00,Antineoplastic Agents,D27.505.954.248
17962611,2007-10-01T00:00:00,"Carcinoma, Renal Cell",C04.557.470.200.025.390
17962611,2007-10-01T00:00:00,"Carcinoma, Renal Cell",C04.588.945.947.535.160
17962611,2007-10-01T00:00:00,"Carcinoma, Renal Cell",C12.758.820.750.160
17962611,2007-10-01T00:00:00,"Carcinoma, Renal Cell",C12.777.419.473.160
17962611,2007-10-01T00:00:00,"Carcinoma, Renal Cell",C13.351.937.820.535.160
17962611,2007-10-01T00:00:00,"Carcinoma, Renal Cell",C13.351.968.419.473.160
17962611,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17962611,2007-10-01T00:00:00,Kidney Neoplasms,C04.588.945.947.535
17962611,2007-10-01T00:00:00,Kidney Neoplasms,C12.758.820.750
17962611,2007-10-01T00:00:00,Kidney Neoplasms,C12.777.419.473
17962611,2007-10-01T00:00:00,Kidney Neoplasms,C13.351.937.820.535
17962611,2007-10-01T00:00:00,Kidney Neoplasms,C13.351.968.419.473
17962611,2007-10-01T00:00:00,Pyridines,D03.383.725
17962611,2007-10-01T00:00:00,Skin Diseases,C17.800
17967373,2007-10-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
17967373,2007-10-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
17967373,2007-10-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
17967373,2007-10-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
17967373,2007-10-01T00:00:00,Enteral Nutrition,E02.421.360
17967373,2007-10-01T00:00:00,Enteral Nutrition,E02.642.500.360
17967373,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17967373,2007-10-01T00:00:00,Jejunostomy,E04.210.338.523
17967373,2007-10-01T00:00:00,Jejunostomy,E04.579.338.523
17968798,2007-10-01T00:00:00,Animals,B01.050
17968798,2007-10-01T00:00:00,"Disease Models, Animal",C22.232
17968798,2007-10-01T00:00:00,"Disease Models, Animal",E05.598.500
17968798,2007-10-01T00:00:00,"Disease Models, Animal",E05.599.395.080
17968798,2007-10-01T00:00:00,Laparoscopy,E01.370.388.250.520
17968798,2007-10-01T00:00:00,Laparoscopy,E04.800.250.520
17968798,2007-10-01T00:00:00,Pilot Projects,E05.318.760.750
17968798,2007-10-01T00:00:00,Pilot Projects,E05.337.737
17968798,2007-10-01T00:00:00,Pilot Projects,N05.715.360.775.625
17968798,2007-10-01T00:00:00,Pilot Projects,N06.850.520.450.720
17968798,2007-10-01T00:00:00,Swine,B01.050.150.900.649.077.880
17968803,2007-10-01T00:00:00,Animals,B01.050
17968803,2007-10-01T00:00:00,"Disease Models, Animal",C22.232
17968803,2007-10-01T00:00:00,"Disease Models, Animal",E05.598.500
17968803,2007-10-01T00:00:00,"Disease Models, Animal",E05.599.395.080
17968803,2007-10-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
17968803,2007-10-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
17968803,2007-10-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
17968803,2007-10-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
17968803,2007-10-01T00:00:00,Peritoneal Diseases,C06.844
17968803,2007-10-01T00:00:00,Pilot Projects,E05.318.760.750
17968803,2007-10-01T00:00:00,Pilot Projects,E05.337.737
17968803,2007-10-01T00:00:00,Pilot Projects,N05.715.360.775.625
17968803,2007-10-01T00:00:00,Pilot Projects,N06.850.520.450.720
17968803,2007-10-01T00:00:00,Suture Techniques,E04.901
17968803,2007-10-01T00:00:00,Treatment Outcome,E01.789.800
17968803,2007-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17968803,2007-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17989623,2007-10-01T00:00:00,Angiography,E01.370.350.700.060
17989623,2007-10-01T00:00:00,Angiography,E01.370.370.050
17989623,2007-10-01T00:00:00,Arteries,A07.231.114
17989623,2007-10-01T00:00:00,Blood Vessel Prosthesis,E07.695.110
17989623,2007-10-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.100.814.200
17989623,2007-10-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.650.200
17989623,2007-10-01T00:00:00,Brachiocephalic Trunk,A07.231.114.145
17989623,2007-10-01T00:00:00,Carotid Artery Injuries,C10.228.140.300.200.345
17989623,2007-10-01T00:00:00,Carotid Artery Injuries,C10.228.140.300.350.500
17989623,2007-10-01T00:00:00,Carotid Artery Injuries,C10.900.250.300
17989623,2007-10-01T00:00:00,Carotid Artery Injuries,C14.907.253.123.345
17989623,2007-10-01T00:00:00,Carotid Artery Injuries,C14.907.253.535.500
17989623,2007-10-01T00:00:00,Carotid Artery Injuries,C21.866.915.200.200
17989623,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17989623,2007-10-01T00:00:00,Prosthesis Design,E05.320.550
17989623,2007-10-01T00:00:00,Prosthesis Design,E07.695.680
17989623,2007-10-01T00:00:00,Stents,E07.695.750
17989623,2007-10-01T00:00:00,"Surgical Procedures, Minimally Invasive",E04.800
17989623,2007-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17989623,2007-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17989623,2007-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17989623,2007-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17989623,2007-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17989623,2007-10-01T00:00:00,Treatment Outcome,E01.789.800
17989623,2007-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17989623,2007-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17989623,2007-10-01T00:00:00,Vertebral Artery,A07.231.114.955
17989623,2007-10-01T00:00:00,Wounds and Injuries,C21.866
17991565,2007-10-01T00:00:00,"Child, Preschool",M01.060.406.448
17991565,2007-10-01T00:00:00,"Circumcision, Male",E02.218.085.170
17991565,2007-10-01T00:00:00,"Circumcision, Male",E04.085.170
17991565,2007-10-01T00:00:00,"Circumcision, Male",E04.950.774.860.226
17991565,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18025867,2007-10-01T00:00:00,Environmental Remediation,N06.850.460.375
18025867,2007-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18025867,2007-10-01T00:00:00,"Models, Theoretical",E05.599
18025867,2007-10-01T00:00:00,Relief Work,I01.880.787.839
18025867,2007-10-01T00:00:00,Relief Work,N06.230.100.300
18062121,2007-10-01T00:00:00,Alveolar Bone Loss,C05.116.264.150
18062121,2007-10-01T00:00:00,Alveolar Bone Loss,C07.465.714.354.500
18062121,2007-10-01T00:00:00,Animals,B01.050
18062121,2007-10-01T00:00:00,Interleukin-1,D12.644.276.374.465.501
18062121,2007-10-01T00:00:00,Interleukin-1,D12.644.276.374.500.400
18062121,2007-10-01T00:00:00,Interleukin-1,D12.776.467.374.465.501
18062121,2007-10-01T00:00:00,Interleukin-1,D12.776.467.374.500.400
18062121,2007-10-01T00:00:00,Interleukin-1,D23.529.374.465.501
18062121,2007-10-01T00:00:00,Interleukin-1,D23.529.374.500.400
18062121,2007-10-01T00:00:00,Lipopolysaccharides,D09.400.500
18062121,2007-10-01T00:00:00,Lipopolysaccharides,D09.698.718.450
18062121,2007-10-01T00:00:00,Lipopolysaccharides,D10.494
18062121,2007-10-01T00:00:00,Lipopolysaccharides,D23.050.161.616.525
18062121,2007-10-01T00:00:00,Lipopolysaccharides,D23.946.123.329.500
18062121,2007-10-01T00:00:00,Osteoclasts,A11.329.372.700
18062121,2007-10-01T00:00:00,Osteoclasts,A11.627.482.700
18062121,2007-10-01T00:00:00,Periodontitis,C07.465.714.533
18062121,2007-10-01T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
18062121,2007-10-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18062121,2007-10-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18062121,2007-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
18062121,2007-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
18062121,2007-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
18062121,2007-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
18062121,2007-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
18062121,2007-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
18062121,2007-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
18062121,2007-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
18062121,2007-10-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
18062121,2007-10-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
18062121,2007-10-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
18062121,2007-10-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
18062121,2007-10-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
18062121,2007-10-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
18062121,2007-10-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
17911356,2007-10-02T00:00:00,Adult,M01.060.116
17911356,2007-10-02T00:00:00,Algorithms,G17.035
17911356,2007-10-02T00:00:00,Algorithms,L01.224.050
17911356,2007-10-02T00:00:00,Blood Pressure,E01.370.600.875.249
17911356,2007-10-02T00:00:00,Blood Pressure,G09.330.380.076
17911356,2007-10-02T00:00:00,Cardiac Output,E01.370.370.380.150
17911356,2007-10-02T00:00:00,Cardiac Output,G09.330.380.124
17911356,2007-10-02T00:00:00,Gene Expression,G05.355.310
17911356,2007-10-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17911356,2007-10-02T00:00:00,Hypoxia-Inducible Factor 1,D12.776.260.103.625
17911356,2007-10-02T00:00:00,Hypoxia-Inducible Factor 1,D12.776.930.125.625
17911356,2007-10-02T00:00:00,Pulmonary Circulation,G09.330.190.163.770
17911356,2007-10-02T00:00:00,Pulmonary Circulation,G09.772.770.690
17911356,2007-10-02T00:00:00,Respiratory Mechanics,G09.772.770.755.700
17911356,2007-10-02T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
17911356,2007-10-02T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
17911356,2007-10-02T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
17911356,2007-10-02T00:00:00,Vasodilator Agents,D27.505.954.411.918
17912478,2007-10-03T00:00:00,Adult,M01.060.116
17912478,2007-10-03T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.400.200
17912478,2007-10-03T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.850.220.230
17912478,2007-10-03T00:00:00,"Echocardiography, Three-Dimensional",E01.370.370.380.220.230
17912478,2007-10-03T00:00:00,"Echocardiography, Transesophageal",E01.370.350.850.220.235
17912478,2007-10-03T00:00:00,"Echocardiography, Transesophageal",E01.370.370.380.220.235
17912478,2007-10-03T00:00:00,"Heart Defects, Congenital",C14.240.400
17912478,2007-10-03T00:00:00,"Heart Defects, Congenital",C14.280.400
17912478,2007-10-03T00:00:00,"Heart Defects, Congenital",C16.131.240.400
17912478,2007-10-03T00:00:00,Heart Valve Prosthesis,E07.695.310
17912478,2007-10-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17912478,2007-10-03T00:00:00,Mitral Valve,A07.541.510.507
17915862,2007-10-04T00:00:00,Enzymes,D08.811
17915862,2007-10-04T00:00:00,Zinc,D01.268.556.940
17915862,2007-10-04T00:00:00,Zinc,D01.268.956.906
17915862,2007-10-04T00:00:00,Zinc,D01.552.544.940
17916628,2007-10-04T00:00:00,Amino Acid Sequence,G02.111.570.060
17916628,2007-10-04T00:00:00,Amino Acid Sequence,L01.453.245.667.060
17916628,2007-10-04T00:00:00,Animals,B01.050
17916628,2007-10-04T00:00:00,CHO Cells,A11.251.210.200
17916628,2007-10-04T00:00:00,CHO Cells,A11.436.155
17916628,2007-10-04T00:00:00,Cricetinae,B01.050.150.900.649.865.635.150
17916628,2007-10-04T00:00:00,Molecular Sequence Data,L01.453.245.667
17916628,2007-10-04T00:00:00,Phylogeny,G05.697
17916628,2007-10-04T00:00:00,Phylogeny,G16.100.275.605
17916628,2007-10-04T00:00:00,Phylogeny,L01.100.697
17916628,2007-10-04T00:00:00,"Receptors, Androgen",D12.776.260.698.750.150
17916628,2007-10-04T00:00:00,"Receptors, Androgen",D12.776.826.750.150
17916628,2007-10-04T00:00:00,"Receptors, Androgen",D12.776.930.669.750.150
17916628,2007-10-04T00:00:00,"Receptors, Estrogen",D12.776.260.698.750.350
17916628,2007-10-04T00:00:00,"Receptors, Estrogen",D12.776.826.750.350
17916628,2007-10-04T00:00:00,"Receptors, Estrogen",D12.776.930.669.750.350
17916628,2007-10-04T00:00:00,"Receptors, Progesterone",D12.776.260.698.750.765
17916628,2007-10-04T00:00:00,"Receptors, Progesterone",D12.776.826.750.765
17916628,2007-10-04T00:00:00,"Receptors, Progesterone",D12.776.930.669.750.765
17916628,2007-10-04T00:00:00,Turtles,B01.050.150.900.833.848
17976640,2007-10-04T00:00:00,Animals,B01.050
17976640,2007-10-04T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.567.342
17976640,2007-10-04T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.646.750.249
17976640,2007-10-04T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.644.360.450.169
17976640,2007-10-04T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.776.476.450.169
17976640,2007-10-04T00:00:00,"Models, Biological",E05.599.395
17976640,2007-10-04T00:00:00,"Myocytes, Cardiac",A07.541.704.570
17976640,2007-10-04T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
17976640,2007-10-04T00:00:00,"Myocytes, Cardiac",A11.620.500
17976640,2007-10-04T00:00:00,Phosphorylation,G02.111.087.677
17976640,2007-10-04T00:00:00,Phosphorylation,G02.149.115.677
17976640,2007-10-04T00:00:00,Phosphorylation,G02.149.465.700
17976640,2007-10-04T00:00:00,Phosphorylation,G02.607.750.700
17976640,2007-10-04T00:00:00,Phosphorylation,G03.495.790
17976640,2007-10-04T00:00:00,Protein Kinase C,D08.811.913.696.620.682.700.725
17976640,2007-10-04T00:00:00,Protein Kinases,D08.811.913.696.620.682
17963743,2007-10-05T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
17963743,2007-10-05T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
17963743,2007-10-05T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
17963743,2007-10-05T00:00:00,Amphetamine,D02.092.471.683.152.110
17963743,2007-10-05T00:00:00,Animals,B01.050
17963743,2007-10-05T00:00:00,Attention Deficit Disorder with Hyperactivity,F03.550.150.150
17963743,2007-10-05T00:00:00,Biological Transport,G03.495.166
17963743,2007-10-05T00:00:00,Central Nervous System Stimulants,D27.505.696.282
17963743,2007-10-05T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
17963743,2007-10-05T00:00:00,Doxorubicin,D02.455.426.559.847.562.050.200.175
17963743,2007-10-05T00:00:00,Doxorubicin,D04.615.562.050.200.175
17963743,2007-10-05T00:00:00,Doxorubicin,D09.408.051.059.200.175
17963743,2007-10-05T00:00:00,Methylphenidate,D02.241.223.601.600
17963743,2007-10-05T00:00:00,Methylphenidate,D03.383.621.460
17963743,2007-10-05T00:00:00,P-Glycoprotein,D12.776.157.530.100.652.500
17963743,2007-10-05T00:00:00,P-Glycoprotein,D12.776.157.530.450.074.500.500.750
17963743,2007-10-05T00:00:00,P-Glycoprotein,D12.776.395.550.020.610.610
17963743,2007-10-05T00:00:00,P-Glycoprotein,D12.776.543.550.192.610.610
17963743,2007-10-05T00:00:00,P-Glycoprotein,D12.776.543.585.100.610.500
17963743,2007-10-05T00:00:00,P-Glycoprotein,D12.776.543.585.450.074.500.500.750
17963743,2007-10-05T00:00:00,Propylamines,D02.092.831
17963743,2007-10-05T00:00:00,Swine,B01.050.150.900.649.077.880
17918941,2007-10-06T00:00:00,Fluorescent Dyes,D27.720.233.348
17918941,2007-10-06T00:00:00,Fluorescent Dyes,D27.720.470.330.348
17918941,2007-10-06T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
17918941,2007-10-06T00:00:00,Molecular Structure,G02.111.570
17918941,2007-10-06T00:00:00,Molecular Structure,G02.575
17918941,2007-10-06T00:00:00,Molecular Structure,G02.842.575
17918941,2007-10-06T00:00:00,Photons,G01.201.875.770.578.782
17918941,2007-10-06T00:00:00,Photons,G01.249.705
17918941,2007-10-06T00:00:00,Photons,G01.590.540.782
17918941,2007-10-06T00:00:00,Polymers,D05.750
17918941,2007-10-06T00:00:00,Polymers,D25.720
17918941,2007-10-06T00:00:00,Polymers,J01.637.051.720
17918963,2007-10-06T00:00:00,Animals,B01.050
17918963,2007-10-06T00:00:00,Cattle,B01.050.150.900.649.077.380.271
17918963,2007-10-06T00:00:00,"Models, Molecular",E05.599.595
17918963,2007-10-06T00:00:00,Mutation,G05.365.590
17918963,2007-10-06T00:00:00,Protein Engineering,E05.393.420.601
17918963,2007-10-06T00:00:00,Rhodopsin,D12.776.543.750.100.955
17918963,2007-10-06T00:00:00,Rhodopsin,D23.767.930.750.500.500
18242541,2007-10-06T00:00:00,Heart Conduction System,A07.541.409
18242541,2007-10-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18242541,2007-10-06T00:00:00,Middle Aged,M01.060.116.630
18242541,2007-10-06T00:00:00,Myocardial Infarction,C14.280.647.500
18242541,2007-10-06T00:00:00,Myocardial Infarction,C14.907.585.500
18242541,2007-10-06T00:00:00,Risk Assessment,E05.318.740.600.800.715
18242541,2007-10-06T00:00:00,Risk Assessment,N04.452.871.715
18242541,2007-10-06T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18242541,2007-10-06T00:00:00,Risk Assessment,N06.850.505.715
18242541,2007-10-06T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18242541,2007-10-06T00:00:00,Stroke Volume,E01.370.370.380.150.700
18242541,2007-10-06T00:00:00,Stroke Volume,G09.330.380.124.882
18242541,2007-10-06T00:00:00,Time Factors,G01.910.857
18242541,2007-10-06T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
17885601,2007-10-08T00:00:00,Adult,M01.060.116
17885601,2007-10-08T00:00:00,Basal Ganglia,A08.186.211.730.885.287.249
17885601,2007-10-08T00:00:00,"Data Interpretation, Statistical",E05.245.380
17885601,2007-10-08T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
17885601,2007-10-08T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
17885601,2007-10-08T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
17885601,2007-10-08T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
17885601,2007-10-08T00:00:00,Hand,A01.378.800.667
17885601,2007-10-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17885601,2007-10-08T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
17885601,2007-10-08T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17885601,2007-10-08T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17885601,2007-10-08T00:00:00,Middle Aged,M01.060.116.630
17885601,2007-10-08T00:00:00,Motor Cortex,A08.186.211.730.885.287.500.270.548
17885601,2007-10-08T00:00:00,Movement,G07.700.560
17885601,2007-10-08T00:00:00,Movement,G11.427.590.530
17922036,2007-10-08T00:00:00,"Adaptor Proteins, Vesicular Transport",D12.776.543.990.150
17922036,2007-10-08T00:00:00,Animals,B01.050
17922036,2007-10-08T00:00:00,Cell Differentiation,G04.299.151
17922036,2007-10-08T00:00:00,Cell Proliferation,G04.299.233.750
17922036,2007-10-08T00:00:00,Cell Proliferation,G07.700.320.249.410.750
17922036,2007-10-08T00:00:00,Epithelial Cells,A11.436
17922036,2007-10-08T00:00:00,Mesoderm,A16.504.660
17922036,2007-10-08T00:00:00,Repressor Proteins,D12.776.260.703
17922036,2007-10-08T00:00:00,Repressor Proteins,D12.776.930.700
17922036,2007-10-08T00:00:00,Signal Transduction,G02.111.087.800
17922036,2007-10-08T00:00:00,Signal Transduction,G02.149.115.800
17922036,2007-10-08T00:00:00,Signal Transduction,G04.299.880
17922036,2007-10-08T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
17922036,2007-10-08T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
17922036,2007-10-08T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
17922036,2007-10-08T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
17922036,2007-10-08T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
17922036,2007-10-08T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
17922036,2007-10-08T00:00:00,Transforming Growth Factor beta,D23.529.374.687
17922036,2007-10-08T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
17922036,2007-10-08T00:00:00,Transforming Growth Factor beta,D23.529.960.720
17922036,2007-10-08T00:00:00,Wnt Proteins,D12.644.276.984
17922036,2007-10-08T00:00:00,Wnt Proteins,D12.776.467.984
17922036,2007-10-08T00:00:00,Wnt Proteins,D23.529.984
17922036,2007-10-08T00:00:00,beta Catenin,D12.776.091.249
17922036,2007-10-08T00:00:00,beta Catenin,D12.776.220.145.500
17922036,2007-10-08T00:00:00,beta Catenin,D12.776.930.130
17923483,2007-10-08T00:00:00,Cell Line,A11.251.210
17923483,2007-10-08T00:00:00,Dopamine,D02.092.211.215.311.342
17923483,2007-10-08T00:00:00,Dopamine,D02.092.311.342
17923483,2007-10-08T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.450.625.124
17923483,2007-10-08T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.562.374.500.500
17923483,2007-10-08T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.450.625.124
17923483,2007-10-08T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.562.374.500.500
17923483,2007-10-08T00:00:00,Gene Expression Regulation,G05.355.315
17923483,2007-10-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17923483,2007-10-08T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
17923483,2007-10-08T00:00:00,"Microscopy, Fluorescence",E05.595.458
17923483,2007-10-08T00:00:00,Mitogen-Activated Protein Kinase Kinases,D08.811.913.696.620.682.700.565
17923483,2007-10-08T00:00:00,Mitogen-Activated Protein Kinase Kinases,D08.811.913.696.620.682.725.200
17923483,2007-10-08T00:00:00,Mitogen-Activated Protein Kinase Kinases,D12.644.360.440
17923483,2007-10-08T00:00:00,Mitogen-Activated Protein Kinase Kinases,D12.776.476.440
17923483,2007-10-08T00:00:00,Neurons,A08.663
17923483,2007-10-08T00:00:00,Neurons,A11.671
17924968,2007-10-09T00:00:00,"Epistasis, Genetic",G05.355.315.207
17924968,2007-10-09T00:00:00,"Genes, Immunoglobulin",G05.360.340.024.340.335
17924968,2007-10-09T00:00:00,"Genes, Immunoglobulin",G12.500.299
17924968,2007-10-09T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17924968,2007-10-09T00:00:00,Genetic Predisposition to Disease,G05.380.355
17924968,2007-10-09T00:00:00,"Hepatitis C, Chronic",C02.440.440.120
17924968,2007-10-09T00:00:00,"Hepatitis C, Chronic",C02.782.350.350.120
17924968,2007-10-09T00:00:00,"Hepatitis C, Chronic",C06.552.380.350.120
17924968,2007-10-09T00:00:00,"Hepatitis C, Chronic",C06.552.380.705.440.120
17924968,2007-10-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17924968,2007-10-09T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.606.586
17924968,2007-10-09T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.619.393.522.400
17924968,2007-10-09T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.705.500.380.500
17924968,2007-10-09T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.606.586
17924968,2007-10-09T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.619.393.522.400
17924968,2007-10-09T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.705.500.380.500
17924968,2007-10-09T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.606.586
17924968,2007-10-09T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.619.393.522.400
17924968,2007-10-09T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.705.500.380.500
17924968,2007-10-09T00:00:00,Immunoglobulin Gm Allotypes,G12.500.400.586
17925397,2007-10-09T00:00:00,Animals,B01.050
17925397,2007-10-09T00:00:00,B-Lymphocytes,A11.063.438
17925397,2007-10-09T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
17925397,2007-10-09T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
17925397,2007-10-09T00:00:00,B-Lymphocytes,A15.382.032.438
17925397,2007-10-09T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
17925397,2007-10-09T00:00:00,Dendritic Cells,A11.066.270
17925397,2007-10-09T00:00:00,Dendritic Cells,A11.436.270
17925397,2007-10-09T00:00:00,Dendritic Cells,A15.382.066.270
17925397,2007-10-09T00:00:00,Dendritic Cells,A15.382.812.260
17925397,2007-10-09T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
17925397,2007-10-09T00:00:00,Flow Cytometry,E05.200.500.386.350
17925397,2007-10-09T00:00:00,Interferon Type I,D12.644.276.374.440.890
17925397,2007-10-09T00:00:00,Interferon Type I,D12.644.276.718.500
17925397,2007-10-09T00:00:00,Interferon Type I,D12.776.467.374.440.890
17925397,2007-10-09T00:00:00,Interferon Type I,D12.776.467.718.500
17925397,2007-10-09T00:00:00,Interferon Type I,D23.529.374.440.890
17925397,2007-10-09T00:00:00,Interferon Type I,D23.529.718.500
17925397,2007-10-09T00:00:00,Phosphorylation,G02.111.087.677
17925397,2007-10-09T00:00:00,Phosphorylation,G02.149.115.677
17925397,2007-10-09T00:00:00,Phosphorylation,G02.149.465.700
17925397,2007-10-09T00:00:00,Phosphorylation,G02.607.750.700
17925397,2007-10-09T00:00:00,Phosphorylation,G03.495.790
17925397,2007-10-09T00:00:00,STAT1 Transcription Factor,D12.644.360.024.303.500.500
17925397,2007-10-09T00:00:00,STAT1 Transcription Factor,D12.644.360.024.342.100
17925397,2007-10-09T00:00:00,STAT1 Transcription Factor,D12.776.157.057.061.500.500
17925397,2007-10-09T00:00:00,STAT1 Transcription Factor,D12.776.157.057.186.100
17925397,2007-10-09T00:00:00,STAT1 Transcription Factor,D12.776.260.513.249.500
17925397,2007-10-09T00:00:00,STAT1 Transcription Factor,D12.776.476.024.387.500.500
17925397,2007-10-09T00:00:00,STAT1 Transcription Factor,D12.776.476.024.421.100
17925397,2007-10-09T00:00:00,STAT1 Transcription Factor,D12.776.930.354.249.500
17925397,2007-10-09T00:00:00,STAT1 Transcription Factor,D12.776.930.840.100
17925491,2007-10-09T00:00:00,3' Untranslated Regions,D13.444.735.544.875.880
17925491,2007-10-09T00:00:00,3' Untranslated Regions,D13.444.735.790.878.880
17925491,2007-10-09T00:00:00,3' Untranslated Regions,G05.360.340.024.220.880.880
17925491,2007-10-09T00:00:00,3' Untranslated Regions,G05.360.340.024.340.137.910.880
17925491,2007-10-09T00:00:00,Animals,B01.050
17925491,2007-10-09T00:00:00,Apoptosis,G04.299.139.160
17925491,2007-10-09T00:00:00,Cell Survival,G04.299.316
17925491,2007-10-09T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
17925491,2007-10-09T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
17925491,2007-10-09T00:00:00,"Fusion Proteins, bcr-abl",D08.811.913.696.620.682.725.500.500
17925491,2007-10-09T00:00:00,"Fusion Proteins, bcr-abl",D12.776.602.500.500.100
17925491,2007-10-09T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.100
17925491,2007-10-09T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.664.500.100
17925491,2007-10-09T00:00:00,Hematopoietic Stem Cells,A11.148.378
17925491,2007-10-09T00:00:00,Hematopoietic Stem Cells,A11.872.378
17925491,2007-10-09T00:00:00,Hematopoietic Stem Cells,A15.378.316.378
17925491,2007-10-09T00:00:00,Heterogeneous-Nuclear Ribonucleoproteins,D12.776.157.725.500.500
17925491,2007-10-09T00:00:00,Heterogeneous-Nuclear Ribonucleoproteins,D12.776.664.962.500.500
17925491,2007-10-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17925491,2007-10-09T00:00:00,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C04.557.337.539.250
17925491,2007-10-09T00:00:00,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C15.378.190.636.370
17925491,2007-10-09T00:00:00,Protein-Tyrosine Kinases,D08.811.913.696.620.682.725
17925491,2007-10-09T00:00:00,RNA-Binding Proteins,D12.776.157.725
17925491,2007-10-09T00:00:00,RNA-Binding Proteins,D12.776.664.962
17925516,2007-10-10T00:00:00,Adult,M01.060.116
17925516,2007-10-10T00:00:00,Alcoholism,C21.739.100.250
17925516,2007-10-10T00:00:00,Alcoholism,F03.900.100.350
17925516,2007-10-10T00:00:00,Behavior Therapy,F04.754.137
17925516,2007-10-10T00:00:00,Double-Blind Method,E05.318.780.300
17925516,2007-10-10T00:00:00,Double-Blind Method,E05.581.500.300
17925516,2007-10-10T00:00:00,Double-Blind Method,N05.715.360.780.320
17925516,2007-10-10T00:00:00,Double-Blind Method,N06.850.520.445.300
17925516,2007-10-10T00:00:00,Excitatory Amino Acid Antagonists,D27.505.519.625.190.300
17925516,2007-10-10T00:00:00,Excitatory Amino Acid Antagonists,D27.505.696.577.190.300
17925516,2007-10-10T00:00:00,Fructose,D09.546.359.250
17925516,2007-10-10T00:00:00,Fructose,D09.546.465.354
17925516,2007-10-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17925516,2007-10-10T00:00:00,Middle Aged,M01.060.116.630
17925516,2007-10-10T00:00:00,Patient Compliance,F01.145.488.500
17925516,2007-10-10T00:00:00,Patient Compliance,N05.300.150.600.600
17928425,2007-10-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17928425,2007-10-10T00:00:00,Polymerase Chain Reaction,E05.393.620.500
17928827,2007-10-10T00:00:00,Animals,B01.050
17928827,2007-10-10T00:00:00,Blood Pressure,E01.370.600.875.249
17928827,2007-10-10T00:00:00,Blood Pressure,G09.330.380.076
17928827,2007-10-10T00:00:00,Body Weight,C23.888.144
17928827,2007-10-10T00:00:00,Body Weight,E01.370.600.115.100.160.120
17928827,2007-10-10T00:00:00,Body Weight,E05.041.124.160.750
17928827,2007-10-10T00:00:00,Body Weight,G07.100.100.160.120
17928827,2007-10-10T00:00:00,Body Weight,G07.700.320.249.314.120
17928827,2007-10-10T00:00:00,Insulin,D06.472.699.587.740.625
17928827,2007-10-10T00:00:00,Insulin,D12.644.548.586.740.625
17928827,2007-10-10T00:00:00,Insulin Resistance,C18.452.394.968.500
17928827,2007-10-10T00:00:00,Insulin Resistance,G07.690.320.617
17928827,2007-10-10T00:00:00,Kidney,A05.810.453
17928827,2007-10-10T00:00:00,"Muscle, Skeletal",A02.633.567
17928827,2007-10-10T00:00:00,"Muscle, Skeletal",A10.690.552.500
17928827,2007-10-10T00:00:00,Nitric Oxide,D01.339.387
17928827,2007-10-10T00:00:00,Nitric Oxide,D01.625.550.500
17928827,2007-10-10T00:00:00,Nitric Oxide,D01.625.700.500
17928827,2007-10-10T00:00:00,Nitric Oxide,D01.650.550.587.600
17928827,2007-10-10T00:00:00,Oxidative Stress,G03.495.710
17928827,2007-10-10T00:00:00,Oxidative Stress,G07.700.830.750
17928827,2007-10-10T00:00:00,Proteinuria,C12.777.934.734
17928827,2007-10-10T00:00:00,Proteinuria,C13.351.968.934.734
17928827,2007-10-10T00:00:00,Proteinuria,C23.888.942.750
17928827,2007-10-10T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17928827,2007-10-10T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17928827,2007-10-10T00:00:00,Sodium,D01.268.549.750
17928827,2007-10-10T00:00:00,Sodium,D01.552.528.850
18693821,2007-10-11T00:00:00,Disasters,N06.230.100
18693821,2007-10-11T00:00:00,Emergency Medical Service Communication Systems,N02.421.297.058
18693821,2007-10-11T00:00:00,Emergency Medical Services,N02.421.297
18693821,2007-10-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18693821,2007-10-11T00:00:00,Information Systems,L01.700.508.300
18693821,2007-10-11T00:00:00,Internet,L01.224.230.110.500
18693821,2007-10-11T00:00:00,Rescue Work,N06.230.100.350
18693821,2007-10-11T00:00:00,User-Computer Interface,L01.224.900.910
18693987,2007-10-11T00:00:00,Disasters,N06.230.100
18693987,2007-10-11T00:00:00,Emergency Medical Service Communication Systems,N02.421.297.058
18693987,2007-10-11T00:00:00,Emergency Medical Services,N02.421.297
18693987,2007-10-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18693987,2007-10-11T00:00:00,Medical Records,E05.318.308.940.968
18693987,2007-10-11T00:00:00,Medical Records,L01.280.900.968
18693987,2007-10-11T00:00:00,Medical Records,N04.452.859.564
18693987,2007-10-11T00:00:00,Medical Records,N05.715.360.300.715.500
18693987,2007-10-11T00:00:00,Medical Records,N06.850.520.308.940.968
18693987,2007-10-11T00:00:00,Rescue Work,N06.230.100.350
18693998,2007-10-11T00:00:00,Disaster Planning,N06.230.100.035
18693998,2007-10-11T00:00:00,Disasters,N06.230.100
18693998,2007-10-11T00:00:00,Emergency Medical Service Communication Systems,N02.421.297.058
18693998,2007-10-11T00:00:00,Geographic Information Systems,L01.470.750.750.462
18693998,2007-10-11T00:00:00,Geographic Information Systems,L01.700.508.300.314
18693998,2007-10-11T00:00:00,Rescue Work,N06.230.100.350
18694020,2007-10-11T00:00:00,Delphi Technique,L01.280.800.310
18694020,2007-10-11T00:00:00,Disaster Planning,N06.230.100.035
18694020,2007-10-11T00:00:00,Emergency Medical Services,N02.421.297
18694020,2007-10-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18694020,2007-10-11T00:00:00,Mass Casualty Incidents,I01.198.240.856.800.537
18694020,2007-10-11T00:00:00,Mass Casualty Incidents,I01.880.735.900.800.575
18694020,2007-10-11T00:00:00,Mass Casualty Incidents,N06.230.100.160
18694020,2007-10-11T00:00:00,"Models, Organizational",E05.599.670
18694020,2007-10-11T00:00:00,"Models, Organizational",N04.452.534
17932767,2007-10-12T00:00:00,Adolescent,M01.060.057
17932767,2007-10-12T00:00:00,Adult,M01.060.116
17932767,2007-10-12T00:00:00,Aged,M01.060.116.100
17932767,2007-10-12T00:00:00,Chest Pain,C23.888.646.215
17932767,2007-10-12T00:00:00,Deglutition,G10.261.326.215
17932767,2007-10-12T00:00:00,Deglutition Disorders,C06.405.117.119
17932767,2007-10-12T00:00:00,Deglutition Disorders,C09.775.174
17932767,2007-10-12T00:00:00,Esophageal Motility Disorders,C06.405.117.119.500
17932767,2007-10-12T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
17932767,2007-10-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17932767,2007-10-12T00:00:00,Manometry,E05.559
17932767,2007-10-12T00:00:00,Middle Aged,M01.060.116.630
17932767,2007-10-12T00:00:00,Posture,G11.427.695
17932767,2007-10-12T00:00:00,Questionnaires,E05.318.308.750
17932767,2007-10-12T00:00:00,Questionnaires,L01.280.800
17932767,2007-10-12T00:00:00,Questionnaires,N05.715.360.300.695
17932767,2007-10-12T00:00:00,Questionnaires,N06.850.520.308.750
17932767,2007-10-12T00:00:00,Water,D01.455.900
17932767,2007-10-12T00:00:00,Water,D01.650.550.925
17661355,2007-10-15T00:00:00,Animals,B01.050
17661355,2007-10-15T00:00:00,Breast Neoplasms,C04.588.180
17661355,2007-10-15T00:00:00,Breast Neoplasms,C17.800.090.500
17661355,2007-10-15T00:00:00,Disease Progression,C23.550.291.656
17661355,2007-10-15T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
17661355,2007-10-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17661355,2007-10-15T00:00:00,Inflammation,C23.550.470
17661355,2007-10-15T00:00:00,"Models, Genetic",E05.599.395.397
17661355,2007-10-15T00:00:00,Neoplasms,C04
17661355,2007-10-15T00:00:00,Phenotype,G05.695
17661355,2007-10-15T00:00:00,Proteomics,H01.158.201.843
17661355,2007-10-15T00:00:00,Proteomics,H01.158.273.180.350.700
17661355,2007-10-15T00:00:00,Proteomics,H01.158.273.343.350.700
17661355,2007-10-15T00:00:00,Proteomics,H01.181.122.738
17661355,2007-10-15T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.260.665.100
17661355,2007-10-15T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.624.664.700.175.100
17661355,2007-10-15T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.930.635.100
17661355,2007-10-15T00:00:00,Signal Transduction,G02.111.087.800
17661355,2007-10-15T00:00:00,Signal Transduction,G02.149.115.800
17661355,2007-10-15T00:00:00,Signal Transduction,G04.299.880
17661355,2007-10-15T00:00:00,"Transcription, Genetic",G02.111.087.847
17661355,2007-10-15T00:00:00,"Transcription, Genetic",G02.149.115.847
17661355,2007-10-15T00:00:00,"Transcription, Genetic",G05.355.310.700
17907235,2007-10-15T00:00:00,Adolescent,M01.060.057
17907235,2007-10-15T00:00:00,Adult,M01.060.116
17907235,2007-10-15T00:00:00,Child,M01.060.406
17907235,2007-10-15T00:00:00,Cognition Disorders,F03.087.250
17907235,2007-10-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17907235,2007-10-15T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
17907235,2007-10-15T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
17907235,2007-10-15T00:00:00,Neuropsychological Tests,F04.711.513
17911604,2007-10-15T00:00:00,Animals,B01.050
17911604,2007-10-15T00:00:00,"Antigens, CD",D23.050.301.264.035
17911604,2007-10-15T00:00:00,"Antigens, CD",D23.101.100.110
17911604,2007-10-15T00:00:00,Dendritic Cells,A11.066.270
17911604,2007-10-15T00:00:00,Dendritic Cells,A11.436.270
17911604,2007-10-15T00:00:00,Dendritic Cells,A15.382.066.270
17911604,2007-10-15T00:00:00,Dendritic Cells,A15.382.812.260
17911604,2007-10-15T00:00:00,"Epitopes, T-Lymphocyte",D23.050.550.402
17911604,2007-10-15T00:00:00,Immune Tolerance,G12.425.746.425
17911604,2007-10-15T00:00:00,"Mice, Inbred CBA",B01.050.050.157.520.440
17911604,2007-10-15T00:00:00,"Mice, Inbred CBA",B01.050.050.199.520.520.440
17911604,2007-10-15T00:00:00,"Mice, Inbred CBA",B01.050.150.900.649.865.635.505.500.400.440
17911604,2007-10-15T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.550.500
17911604,2007-10-15T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.569.500
17911604,2007-10-15T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.550.500
17911604,2007-10-15T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.569.500
17911604,2007-10-15T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.550.500
17911604,2007-10-15T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.569.500
17911604,2007-10-15T00:00:00,"T-Lymphocytes, Regulatory",A11.118.637.555.567.569.200.700
17911604,2007-10-15T00:00:00,"T-Lymphocytes, Regulatory",A15.145.229.637.555.567.569.200.700
17911604,2007-10-15T00:00:00,"T-Lymphocytes, Regulatory",A15.382.490.555.567.569.200.700
17911604,2007-10-15T00:00:00,Transforming Growth Factor beta1,D12.644.276.374.687.100
17911604,2007-10-15T00:00:00,Transforming Growth Factor beta1,D12.644.276.954.800.720.100
17911604,2007-10-15T00:00:00,Transforming Growth Factor beta1,D12.644.276.963.720.100
17911604,2007-10-15T00:00:00,Transforming Growth Factor beta1,D12.776.467.374.687.100
17911604,2007-10-15T00:00:00,Transforming Growth Factor beta1,D12.776.467.942.800.720.100
17911604,2007-10-15T00:00:00,Transforming Growth Factor beta1,D12.776.467.960.720.100
17911604,2007-10-15T00:00:00,Transforming Growth Factor beta1,D23.529.374.687.100
17911604,2007-10-15T00:00:00,Transforming Growth Factor beta1,D23.529.942.800.720.100
17911604,2007-10-15T00:00:00,Transforming Growth Factor beta1,D23.529.960.720.100
17934879,2007-10-15T00:00:00,Antihypertensive Agents,D27.505.954.411.162
17934879,2007-10-15T00:00:00,Combined Modality Therapy,E02.186
17934879,2007-10-15T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
17934879,2007-10-15T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
17934879,2007-10-15T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
17934879,2007-10-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17934879,2007-10-15T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
17934879,2007-10-15T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
17934879,2007-10-15T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
17934879,2007-10-15T00:00:00,Ischemia,C23.550.513
17934879,2007-10-15T00:00:00,Risk Factors,E05.318.740.600.800.725
17934879,2007-10-15T00:00:00,Risk Factors,N05.715.350.200.700
17934879,2007-10-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17934879,2007-10-15T00:00:00,Risk Factors,N06.850.490.625.750
17934879,2007-10-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17934879,2007-10-15T00:00:00,Stroke,C10.228.140.300.775
17934879,2007-10-15T00:00:00,Stroke,C14.907.253.855
17934879,2007-10-15T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
17934879,2007-10-15T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
17934879,2007-10-15T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
17934879,2007-10-15T00:00:00,Tissue Plasminogen Activator,D23.119.970
17936714,2007-10-15T00:00:00,Adult,M01.060.116
17936714,2007-10-15T00:00:00,Aged,M01.060.116.100
17936714,2007-10-15T00:00:00,Case-Control Studies,E05.318.760.500.500
17936714,2007-10-15T00:00:00,Case-Control Studies,N05.715.360.775.175.200
17936714,2007-10-15T00:00:00,Case-Control Studies,N06.850.520.450.500.500
17936714,2007-10-15T00:00:00,Cataract,C11.510.245
17936714,2007-10-15T00:00:00,Eye,A01.456.505.420
17936714,2007-10-15T00:00:00,Eye,A09.371
17936714,2007-10-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17936714,2007-10-15T00:00:00,Middle Aged,M01.060.116.630
17936714,2007-10-15T00:00:00,Urban Population,N01.600.900
17937475,2007-10-15T00:00:00,Adult,M01.060.116
17937475,2007-10-15T00:00:00,Aged,M01.060.116.100
17937475,2007-10-15T00:00:00,Animals,B01.050
17937475,2007-10-15T00:00:00,"Arthritis, Experimental",C05.550.114.015
17937475,2007-10-15T00:00:00,"Arthritis, Experimental",E05.598.500.249
17937475,2007-10-15T00:00:00,"Arthritis, Rheumatoid",C05.550.114.154
17937475,2007-10-15T00:00:00,"Arthritis, Rheumatoid",C05.799.114
17937475,2007-10-15T00:00:00,"Arthritis, Rheumatoid",C17.300.775.099
17937475,2007-10-15T00:00:00,"Arthritis, Rheumatoid",C20.111.199
17937475,2007-10-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17937475,2007-10-15T00:00:00,Kallikreins,D08.811.277.656.300.760.442
17937475,2007-10-15T00:00:00,Kallikreins,D08.811.277.656.959.350.442
17937475,2007-10-15T00:00:00,Kallikreins,D12.776.124.125.597
17937475,2007-10-15T00:00:00,Kallikreins,D23.119.597
17937475,2007-10-15T00:00:00,Middle Aged,M01.060.116.630
17937475,2007-10-15T00:00:00,"Neovascularization, Pathologic",C23.550.589.500
17937475,2007-10-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17937475,2007-10-15T00:00:00,Serpins,D12.644.822.750
17937475,2007-10-15T00:00:00,Serpins,D12.644.861
17937475,2007-10-15T00:00:00,Serpins,D12.776.645.750
17937475,2007-10-15T00:00:00,Serpins,D12.776.872
17942931,2007-10-15T00:00:00,Angiogenesis Inhibitors,D27.505.696.377.077.099
17942931,2007-10-15T00:00:00,Angiogenesis Inhibitors,D27.505.696.377.450.100
17942931,2007-10-15T00:00:00,Angiogenesis Inhibitors,D27.505.954.248.025
17942931,2007-10-15T00:00:00,Animals,B01.050
17942931,2007-10-15T00:00:00,"Antigens, Bacterial",D23.050.161
17942931,2007-10-15T00:00:00,Bacterial Toxins,D23.946.123
17942931,2007-10-15T00:00:00,"Carcinoma, Lewis Lung",C04.557.470.200.280
17942931,2007-10-15T00:00:00,"Carcinoma, Lewis Lung",C04.619.230
17942931,2007-10-15T00:00:00,Cornea,A09.371.060.217
17942931,2007-10-15T00:00:00,Endothelial Cells,A11.436.275
17942931,2007-10-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17942931,2007-10-15T00:00:00,Membrane Proteins,D12.776.543
17942931,2007-10-15T00:00:00,Mutation,G05.365.590
17942931,2007-10-15T00:00:00,Neoplasm Proteins,D12.776.624
17942931,2007-10-15T00:00:00,"Neovascularization, Pathologic",C23.550.589.500
17942931,2007-10-15T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
17942931,2007-10-15T00:00:00,"Receptors, Peptide",D12.776.543.750.750
17942931,2007-10-15T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
17942931,2007-10-15T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
17942931,2007-10-15T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
17939007,2007-10-16T00:00:00,Adult,M01.060.116
17939007,2007-10-16T00:00:00,Aged,M01.060.116.100
17939007,2007-10-16T00:00:00,Attitude of Health Personnel,F01.100.050
17939007,2007-10-16T00:00:00,Attitude of Health Personnel,N05.300.100
17939007,2007-10-16T00:00:00,Colonoscopy,E01.370.372.250.250.200
17939007,2007-10-16T00:00:00,Colonoscopy,E01.370.388.250.250.250.160
17939007,2007-10-16T00:00:00,Colonoscopy,E04.210.240.250.160
17939007,2007-10-16T00:00:00,Colonoscopy,E04.800.250.250.250.160
17939007,2007-10-16T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
17939007,2007-10-16T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
17939007,2007-10-16T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
17939007,2007-10-16T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
17939007,2007-10-16T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
17939007,2007-10-16T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
17939007,2007-10-16T00:00:00,Health Services Accessibility,N04.590.374.350
17939007,2007-10-16T00:00:00,Health Services Accessibility,N05.300.430
17939007,2007-10-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17939007,2007-10-16T00:00:00,Mass Screening,E01.370.500
17939007,2007-10-16T00:00:00,Mass Screening,E05.318.308.250.580
17939007,2007-10-16T00:00:00,Mass Screening,N02.421.143.827.233.443
17939007,2007-10-16T00:00:00,Mass Screening,N02.421.726.233.443
17939007,2007-10-16T00:00:00,Mass Screening,N05.715.360.300.375.500
17939007,2007-10-16T00:00:00,Mass Screening,N06.850.520.308.250.580
17939007,2007-10-16T00:00:00,Mass Screening,N06.850.780.500
17939007,2007-10-16T00:00:00,Middle Aged,M01.060.116.630
17939007,2007-10-16T00:00:00,Physician's Practice Patterns,N04.590.748
17939007,2007-10-16T00:00:00,Physician's Practice Patterns,N05.300.625
17939007,2007-10-16T00:00:00,Physician-Patient Relations,F01.829.401.650.675
17939007,2007-10-16T00:00:00,Physician-Patient Relations,N05.300.660.625
17939007,2007-10-16T00:00:00,Sigmoidoscopy,E01.370.372.250.250.200.700
17939007,2007-10-16T00:00:00,Sigmoidoscopy,E01.370.388.250.250.250.160.800
17939007,2007-10-16T00:00:00,Sigmoidoscopy,E04.210.240.250.160.800
17939007,2007-10-16T00:00:00,Sigmoidoscopy,E04.800.250.250.250.160.800
17923382,2007-10-17T00:00:00,Actins,D05.750.078.730.250
17923382,2007-10-17T00:00:00,Actins,D12.776.210.500.100
17923382,2007-10-17T00:00:00,Actins,D12.776.220.525.255
17923382,2007-10-17T00:00:00,Animals,B01.050
17923382,2007-10-17T00:00:00,Cell Line,A11.251.210
17923382,2007-10-17T00:00:00,Cell Proliferation,G04.299.233.750
17923382,2007-10-17T00:00:00,Cell Proliferation,G07.700.320.249.410.750
17923382,2007-10-17T00:00:00,"Models, Animal",E05.598
17923382,2007-10-17T00:00:00,"Muscle, Smooth, Vascular",A02.633.570.491
17923382,2007-10-17T00:00:00,"Muscle, Smooth, Vascular",A07.231.491
17923382,2007-10-17T00:00:00,"Muscle, Smooth, Vascular",A10.690.467.491
17923382,2007-10-17T00:00:00,Phenotype,G05.695
17923382,2007-10-17T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17923382,2007-10-17T00:00:00,"Stress, Mechanical",G01.374.676.830
17923382,2007-10-17T00:00:00,"Stress, Mechanical",G01.595.540.830
17923382,2007-10-17T00:00:00,Time Factors,G01.910.857
17943175,2007-10-18T00:00:00,Animals,B01.050
17943175,2007-10-18T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
17943175,2007-10-18T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
17943175,2007-10-18T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
17943175,2007-10-18T00:00:00,Apoptosis,G04.299.139.160
17943175,2007-10-18T00:00:00,Cell Cycle Proteins,D12.776.167
17943175,2007-10-18T00:00:00,Down-Regulation,G02.111.087.225
17943175,2007-10-18T00:00:00,Down-Regulation,G02.149.115.225
17943175,2007-10-18T00:00:00,Down-Regulation,G05.355.315.200
17943175,2007-10-18T00:00:00,Down-Regulation,G07.690.812.230
17943175,2007-10-18T00:00:00,Down-Regulation,G07.700.680.230
17943175,2007-10-18T00:00:00,Doxorubicin,D02.455.426.559.847.562.050.200.175
17943175,2007-10-18T00:00:00,Doxorubicin,D04.615.562.050.200.175
17943175,2007-10-18T00:00:00,Doxorubicin,D09.408.051.059.200.175
17943175,2007-10-18T00:00:00,Gene Expression Profiling,E05.393.332
17943175,2007-10-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17943175,2007-10-18T00:00:00,Indazoles,D03.383.129.539.487
17943175,2007-10-18T00:00:00,Indazoles,D03.438.449
17943175,2007-10-18T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567
17943175,2007-10-18T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750
17943175,2007-10-18T00:00:00,Mitogen-Activated Protein Kinases,D12.644.360.450
17943175,2007-10-18T00:00:00,Mitogen-Activated Protein Kinases,D12.776.476.450
17943175,2007-10-18T00:00:00,Signal Transduction,G02.111.087.800
17943175,2007-10-18T00:00:00,Signal Transduction,G02.149.115.800
17943175,2007-10-18T00:00:00,Signal Transduction,G04.299.880
17947796,2007-10-18T00:00:00,Animals,B01.050
17947796,2007-10-18T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
17947796,2007-10-18T00:00:00,Heart,A07.541
17947796,2007-10-18T00:00:00,"Heart Defects, Congenital",C14.240.400
17947796,2007-10-18T00:00:00,"Heart Defects, Congenital",C14.280.400
17947796,2007-10-18T00:00:00,"Heart Defects, Congenital",C16.131.240.400
17947796,2007-10-18T00:00:00,Homeodomain Proteins,D12.776.260.400
17947796,2007-10-18T00:00:00,Mesoderm,A16.504.660
17947796,2007-10-18T00:00:00,Pregnancy,G08.686.785.760.769
17947796,2007-10-18T00:00:00,Transcription Factors,D12.776.930
17949467,2007-10-19T00:00:00,Animals,B01.050
17949467,2007-10-19T00:00:00,Cues,F02.463.425.234
17949467,2007-10-19T00:00:00,Ethanol,D02.033.375
17949467,2007-10-19T00:00:00,Motivation,F01.658
17949467,2007-10-19T00:00:00,Motivation,F01.752.543.500.750
17949467,2007-10-19T00:00:00,Pregnancy,G08.686.785.760.769
17949467,2007-10-19T00:00:00,Prenatal Exposure Delayed Effects,C13.703.824.500
17949467,2007-10-19T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17955327,2007-10-19T00:00:00,Actins,D05.750.078.730.250
17955327,2007-10-19T00:00:00,Actins,D12.776.210.500.100
17955327,2007-10-19T00:00:00,Actins,D12.776.220.525.255
17955327,2007-10-19T00:00:00,Animals,B01.050
17955327,2007-10-19T00:00:00,"Disease Models, Animal",C22.232
17955327,2007-10-19T00:00:00,"Disease Models, Animal",E05.598.500
17955327,2007-10-19T00:00:00,"Disease Models, Animal",E05.599.395.080
17955327,2007-10-19T00:00:00,Insulin,D06.472.699.587.740.625
17955327,2007-10-19T00:00:00,Insulin,D12.644.548.586.740.625
17955327,2007-10-19T00:00:00,"Myocytes, Cardiac",A07.541.704.570
17955327,2007-10-19T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
17955327,2007-10-19T00:00:00,"Myocytes, Cardiac",A11.620.500
17955327,2007-10-19T00:00:00,Oligopeptides,D12.644.456
17955327,2007-10-19T00:00:00,Phosphorylation,G02.111.087.677
17955327,2007-10-19T00:00:00,Phosphorylation,G02.149.115.677
17955327,2007-10-19T00:00:00,Phosphorylation,G02.149.465.700
17955327,2007-10-19T00:00:00,Phosphorylation,G02.607.750.700
17955327,2007-10-19T00:00:00,Phosphorylation,G03.495.790
17955327,2007-10-19T00:00:00,Protein Biosynthesis,G02.111.087.675.871
17955327,2007-10-19T00:00:00,Protein Biosynthesis,G02.149.115.675.871
17955327,2007-10-19T00:00:00,Protein Biosynthesis,G03.495.770.871
17955327,2007-10-19T00:00:00,Protein Biosynthesis,G05.355.310.670
17955327,2007-10-19T00:00:00,Protein Kinases,D08.811.913.696.620.682
17955327,2007-10-19T00:00:00,"RNA, Messenger",D13.444.735.544
17955327,2007-10-19T00:00:00,Signal Transduction,G02.111.087.800
17955327,2007-10-19T00:00:00,Signal Transduction,G02.149.115.800
17955327,2007-10-19T00:00:00,Signal Transduction,G04.299.880
17945230,2007-10-22T00:00:00,Endosonography,E01.370.350.850.280
17945230,2007-10-22T00:00:00,Esophageal Neoplasms,C04.588.274.476.205
17945230,2007-10-22T00:00:00,Esophageal Neoplasms,C04.588.443.353
17945230,2007-10-22T00:00:00,Esophageal Neoplasms,C06.301.371.205
17945230,2007-10-22T00:00:00,Esophageal Neoplasms,C06.405.117.430
17945230,2007-10-22T00:00:00,Esophageal Neoplasms,C06.405.249.205
17945230,2007-10-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17945230,2007-10-22T00:00:00,Middle Aged,M01.060.116.630
17945230,2007-10-22T00:00:00,Polyps,C23.300.825
17954039,2007-10-22T00:00:00,Animals,B01.050
17954039,2007-10-22T00:00:00,Lung,A04.411
17954039,2007-10-22T00:00:00,Swine,B01.050.150.900.649.077.880
18631913,2007-10-22T00:00:00,Bladder Exstrophy,C12.706.132
18631913,2007-10-22T00:00:00,Bladder Exstrophy,C12.777.829.132
18631913,2007-10-22T00:00:00,Bladder Exstrophy,C13.351.875.132
18631913,2007-10-22T00:00:00,Bladder Exstrophy,C13.351.968.829.132
18631913,2007-10-22T00:00:00,Bladder Exstrophy,C16.131.939.132
18631913,2007-10-22T00:00:00,"Child, Preschool",M01.060.406.448
18631913,2007-10-22T00:00:00,"Databases, Factual",L01.470.750.750
18631913,2007-10-22T00:00:00,"Databases, Factual",L01.700.508.300.188.400
18631913,2007-10-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18631913,2007-10-22T00:00:00,Infant,M01.060.703
18631913,2007-10-22T00:00:00,Postoperative Complications,C23.550.767
18631913,2007-10-22T00:00:00,Treatment Outcome,E01.789.800
18631913,2007-10-22T00:00:00,Treatment Outcome,N04.761.559.590.800
18631913,2007-10-22T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18631913,2007-10-22T00:00:00,Urinary Bladder,A05.810.890
18631913,2007-10-22T00:00:00,Urologic Surgical Procedures,E04.950.774
17951021,2007-10-24T00:00:00,Adult,M01.060.116
17951021,2007-10-24T00:00:00,Counseling,F02.784.176
17951021,2007-10-24T00:00:00,Counseling,F04.408.413
17951021,2007-10-24T00:00:00,Counseling,N02.421.143.303
17951021,2007-10-24T00:00:00,Counseling,N02.421.461.363
17951021,2007-10-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17951021,2007-10-24T00:00:00,Middle Aged,M01.060.116.630
17951021,2007-10-24T00:00:00,Nicotine,D03.132.760.570
17951021,2007-10-24T00:00:00,Nicotine,D03.383.725.518
17951021,2007-10-24T00:00:00,Patient Compliance,F01.145.488.500
17951021,2007-10-24T00:00:00,Patient Compliance,N05.300.150.600.600
17951021,2007-10-24T00:00:00,Smoking Cessation,F01.145.940.700
17951021,2007-10-24T00:00:00,Substance-Related Disorders,C21.739
17951021,2007-10-24T00:00:00,Substance-Related Disorders,F03.900
17951021,2007-10-24T00:00:00,Treatment Outcome,E01.789.800
17951021,2007-10-24T00:00:00,Treatment Outcome,N04.761.559.590.800
17951021,2007-10-24T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17959749,2007-10-24T00:00:00,Animals,B01.050
17959749,2007-10-24T00:00:00,Brain,A08.186.211
17959749,2007-10-24T00:00:00,"Kidney Tubules, Proximal",A05.810.453.736.560.570
17959749,2007-10-24T00:00:00,Rabbits,B01.050.150.900.649.521.700
17959749,2007-10-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17959749,2007-10-24T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17960142,2007-10-24T00:00:00,Aged,M01.060.116.100
17960142,2007-10-24T00:00:00,Alzheimer Disease,C10.228.140.380.100
17960142,2007-10-24T00:00:00,Alzheimer Disease,C10.574.945.249
17960142,2007-10-24T00:00:00,Alzheimer Disease,F03.087.400.100
17960142,2007-10-24T00:00:00,Brain,A08.186.211
17960142,2007-10-24T00:00:00,Brain Mapping,E01.370.350.086
17960142,2007-10-24T00:00:00,Brain Mapping,E01.370.376.149
17960142,2007-10-24T00:00:00,Brain Mapping,E05.132
17960142,2007-10-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17960142,2007-10-24T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
17960142,2007-10-24T00:00:00,Magnetic Resonance Angiography,E01.370.350.500.500
17960142,2007-10-24T00:00:00,Magnetic Resonance Angiography,E01.370.350.825.500.500
17960142,2007-10-24T00:00:00,Magnetic Resonance Angiography,E01.370.370.050.500
18036834,2007-10-24T00:00:00,Aged,M01.060.116.100
18036834,2007-10-24T00:00:00,Algorithms,G17.035
18036834,2007-10-24T00:00:00,Algorithms,L01.224.050
18036834,2007-10-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18036834,2007-10-24T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
17960384,2007-10-25T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
17960384,2007-10-25T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
17960384,2007-10-25T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
17960384,2007-10-25T00:00:00,Apoptosis,G04.299.139.160
17960384,2007-10-25T00:00:00,Astrocytes,A08.637.200
17960384,2007-10-25T00:00:00,Astrocytes,A11.650.200
17960384,2007-10-25T00:00:00,Cell Cycle,G04.299.134
17960384,2007-10-25T00:00:00,Cell Survival,G04.299.316
17960384,2007-10-25T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.644.360.225.600
17960384,2007-10-25T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.776.167.187.600
17960384,2007-10-25T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.776.476.225.600
17960384,2007-10-25T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.776.624.776.355.600
17960384,2007-10-25T00:00:00,Down-Regulation,G02.111.087.225
17960384,2007-10-25T00:00:00,Down-Regulation,G02.149.115.225
17960384,2007-10-25T00:00:00,Down-Regulation,G05.355.315.200
17960384,2007-10-25T00:00:00,Down-Regulation,G07.690.812.230
17960384,2007-10-25T00:00:00,Down-Regulation,G07.700.680.230
17960384,2007-10-25T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
17960384,2007-10-25T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
17960384,2007-10-25T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
17960384,2007-10-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17960384,2007-10-25T00:00:00,Interferon-gamma,D12.644.276.374.440.893
17960384,2007-10-25T00:00:00,Interferon-gamma,D12.644.276.374.480.350
17960384,2007-10-25T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
17960384,2007-10-25T00:00:00,Interferon-gamma,D12.644.276.718.550
17960384,2007-10-25T00:00:00,Interferon-gamma,D12.776.467.374.440.893
17960384,2007-10-25T00:00:00,Interferon-gamma,D12.776.467.374.480.350
17960384,2007-10-25T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
17960384,2007-10-25T00:00:00,Interferon-gamma,D12.776.467.718.550
17960384,2007-10-25T00:00:00,Interferon-gamma,D23.529.374.440.893
17960384,2007-10-25T00:00:00,Interferon-gamma,D23.529.374.480.350
17960384,2007-10-25T00:00:00,Interferon-gamma,D23.529.374.480.615.350
17960384,2007-10-25T00:00:00,Interferon-gamma,D23.529.718.550
17960384,2007-10-25T00:00:00,Mitochondria,A11.284.430.214.190.875.564
17960384,2007-10-25T00:00:00,Mitochondria,A11.284.835.626
17960384,2007-10-25T00:00:00,PTEN Phosphohydrolase,D08.811.277.352.650.850
17960384,2007-10-25T00:00:00,PTEN Phosphohydrolase,D12.776.476.590
17960384,2007-10-25T00:00:00,PTEN Phosphohydrolase,D12.776.624.776.695
17960384,2007-10-25T00:00:00,Recombinant Proteins,D12.776.828
18036610,2007-10-25T00:00:00,Animals,B01.050
18036610,2007-10-25T00:00:00,Gene Expression Regulation,G05.355.315
18036610,2007-10-25T00:00:00,Heart Ventricles,A07.541.560
18036610,2007-10-25T00:00:00,Myocardium,A02.633.580
18036610,2007-10-25T00:00:00,Myocardium,A07.541.704
18036610,2007-10-25T00:00:00,Myocardium,A10.690.552.750
18036610,2007-10-25T00:00:00,Protein Biosynthesis,G02.111.087.675.871
18036610,2007-10-25T00:00:00,Protein Biosynthesis,G02.149.115.675.871
18036610,2007-10-25T00:00:00,Protein Biosynthesis,G03.495.770.871
18036610,2007-10-25T00:00:00,Protein Biosynthesis,G05.355.310.670
18036610,2007-10-25T00:00:00,"RNA, Messenger",D13.444.735.544
18036610,2007-10-25T00:00:00,Time Factors,G01.910.857
18036610,2007-10-25T00:00:00,Ventricular Pressure,G09.330.190.962.950
18036610,2007-10-25T00:00:00,Ventricular Pressure,G09.330.380.937
17965070,2007-10-26T00:00:00,Adult,M01.060.116
17965070,2007-10-26T00:00:00,Aged,M01.060.116.100
17965070,2007-10-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17965070,2007-10-26T00:00:00,Lung Neoplasms,C04.588.894.797.520
17965070,2007-10-26T00:00:00,Lung Neoplasms,C08.381.540
17965070,2007-10-26T00:00:00,Lung Neoplasms,C08.785.520
17965070,2007-10-26T00:00:00,Middle Aged,M01.060.116.630
17965070,2007-10-26T00:00:00,"Models, Biological",E05.599.395
17965070,2007-10-26T00:00:00,Probability,E05.318.740.600
17965070,2007-10-26T00:00:00,Probability,G17.680
17965070,2007-10-26T00:00:00,Probability,N05.715.360.750.625
17965070,2007-10-26T00:00:00,Probability,N06.850.520.830.600
18023650,2007-10-26T00:00:00,Adolescent,M01.060.057
18023650,2007-10-26T00:00:00,Cardiac Surgical Procedures,E04.100.376
18023650,2007-10-26T00:00:00,Cardiac Surgical Procedures,E04.928.220
18023650,2007-10-26T00:00:00,Child,M01.060.406
18023650,2007-10-26T00:00:00,"Child, Preschool",M01.060.406.448
18023650,2007-10-26T00:00:00,Fontan Procedure,E04.035.410.295
18023650,2007-10-26T00:00:00,Fontan Procedure,E04.100.376.410.295
18023650,2007-10-26T00:00:00,Fontan Procedure,E04.928.220.370.295
18023650,2007-10-26T00:00:00,"Heart Defects, Congenital",C14.240.400
18023650,2007-10-26T00:00:00,"Heart Defects, Congenital",C14.280.400
18023650,2007-10-26T00:00:00,"Heart Defects, Congenital",C16.131.240.400
18023650,2007-10-26T00:00:00,Hemodynamics,G09.330.190.400
18023650,2007-10-26T00:00:00,Hemodynamics,G09.330.380
18023650,2007-10-26T00:00:00,Hepatic Veins,A07.231.908.380
18023650,2007-10-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18023650,2007-10-26T00:00:00,Infant,M01.060.703
18023650,2007-10-26T00:00:00,Portal Vein,A07.231.908.670.567
18023650,2007-10-26T00:00:00,"Vena Cava, Inferior",A07.231.908.949.648
17979328,2007-10-28T00:00:00,Computer Simulation,L01.224.160
17979328,2007-10-28T00:00:00,Peptides,D12.644
17979328,2007-10-28T00:00:00,Protein Conformation,G02.111.570.790.709
17979328,2007-10-28T00:00:00,Temperature,G01.906.595
17979328,2007-10-28T00:00:00,Temperature,G16.500.275.063.725.710
17979328,2007-10-28T00:00:00,Temperature,G16.500.750.775.710
17979328,2007-10-28T00:00:00,Temperature,N06.230.150.450
17979328,2007-10-28T00:00:00,Temperature,N06.230.300.100.725.710
17979328,2007-10-28T00:00:00,Water,D01.455.900
17979328,2007-10-28T00:00:00,Water,D01.650.550.925
17967565,2007-10-29T00:00:00,Adolescent,M01.060.057
17967565,2007-10-29T00:00:00,Adult,M01.060.116
17967565,2007-10-29T00:00:00,Aged,M01.060.116.100
17967565,2007-10-29T00:00:00,Apoptosis,G04.299.139.160
17967565,2007-10-29T00:00:00,Biological Markers,D23.101
17967565,2007-10-29T00:00:00,Hepatocyte Growth Factor,D12.644.276.374.420
17967565,2007-10-29T00:00:00,Hepatocyte Growth Factor,D12.776.467.374.420
17967565,2007-10-29T00:00:00,Hepatocyte Growth Factor,D23.529.374.420
17967565,2007-10-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17967565,2007-10-29T00:00:00,Interleukin-6,D12.644.276.374.465.506
17967565,2007-10-29T00:00:00,Interleukin-6,D12.776.467.374.465.506
17967565,2007-10-29T00:00:00,Interleukin-6,D23.529.374.465.506
17967565,2007-10-29T00:00:00,Liver,A03.620
17967565,2007-10-29T00:00:00,Middle Aged,M01.060.116.630
17967565,2007-10-29T00:00:00,Pilot Projects,E05.318.760.750
17967565,2007-10-29T00:00:00,Pilot Projects,E05.337.737
17967565,2007-10-29T00:00:00,Pilot Projects,N05.715.360.775.625
17967565,2007-10-29T00:00:00,Pilot Projects,N06.850.520.450.720
17967565,2007-10-29T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
17967565,2007-10-29T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
17967565,2007-10-29T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
17967565,2007-10-29T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
17967565,2007-10-29T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
17967565,2007-10-29T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
17967565,2007-10-29T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
17967565,2007-10-29T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
17967565,2007-10-29T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
17967565,2007-10-29T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
17967565,2007-10-29T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
18029213,2007-10-29T00:00:00,Adolescent,M01.060.057
18029213,2007-10-29T00:00:00,Cataract,C11.510.245
18029213,2007-10-29T00:00:00,Cataract Extraction,E04.540.825.249
18029213,2007-10-29T00:00:00,Child,M01.060.406
18029213,2007-10-29T00:00:00,"Child, Preschool",M01.060.406.448
18029213,2007-10-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18029213,2007-10-29T00:00:00,Infant,M01.060.703
18029213,2007-10-29T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
18029213,2007-10-29T00:00:00,"Lens, Crystalline",A09.371.060.500
18029213,2007-10-29T00:00:00,Preoperative Care,E02.760.795
18029213,2007-10-29T00:00:00,Preoperative Care,E04.641
18029213,2007-10-29T00:00:00,Preoperative Care,N02.421.585.795
18029213,2007-10-29T00:00:00,Treatment Outcome,E01.789.800
18029213,2007-10-29T00:00:00,Treatment Outcome,N04.761.559.590.800
18029213,2007-10-29T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18029213,2007-10-29T00:00:00,Visual Acuity,E01.370.380.850.950
18029213,2007-10-29T00:00:00,Visual Acuity,F02.463.593.932.901
18029213,2007-10-29T00:00:00,Visual Acuity,G14.940
17971542,2007-10-30T00:00:00,Combat Disorders,F03.080.931.249
17971542,2007-10-30T00:00:00,Fraud,I01.198.240.300
17971542,2007-10-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17971542,2007-10-30T00:00:00,Insurance Claim Reporting,N03.219.521.576.210
17971542,2007-10-30T00:00:00,Organizational Policy,I01.880.604.825.550
17971542,2007-10-30T00:00:00,Organizational Policy,N03.706.825.550
17971542,2007-10-30T00:00:00,United States,Z01.107.567.875
17971542,2007-10-30T00:00:00,United States Department of Veterans Affairs,I01.409.137.500.700
17971542,2007-10-30T00:00:00,United States Department of Veterans Affairs,N03.540.348.500.500.700
17971542,2007-10-30T00:00:00,Veterans,M01.930
17971549,2007-10-30T00:00:00,Ambulatory Care,E02.760.106
17971549,2007-10-30T00:00:00,Ambulatory Care,N02.421.585.106
17971549,2007-10-30T00:00:00,Emergency Medical Services,N02.421.297
17971549,2007-10-30T00:00:00,Health Services,N02.421
17971549,2007-10-30T00:00:00,Health Status,I01.240.425
17971549,2007-10-30T00:00:00,Health Status,N01.224.425
17971549,2007-10-30T00:00:00,Health Status,N06.850.505.400.425
17971549,2007-10-30T00:00:00,Health Surveys,E05.318.308.250
17971549,2007-10-30T00:00:00,Health Surveys,N05.715.360.300.375
17971549,2007-10-30T00:00:00,Health Surveys,N06.850.520.308.250
17971549,2007-10-30T00:00:00,Hospitalization,E02.760.400
17971549,2007-10-30T00:00:00,Hospitalization,N02.421.585.400
17971549,2007-10-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17971549,2007-10-30T00:00:00,United States,Z01.107.567.875
17971549,2007-10-30T00:00:00,Veterans,M01.930
17976702,2007-10-31T00:00:00,Aged,M01.060.116.100
17976702,2007-10-31T00:00:00,Antineoplastic Agents,D27.505.954.248
17976702,2007-10-31T00:00:00,Cranial Nerve Diseases,C10.292
17976702,2007-10-31T00:00:00,Glioma,C04.557.465.625.600.380
17976702,2007-10-31T00:00:00,Glioma,C04.557.470.670.380
17976702,2007-10-31T00:00:00,Glioma,C04.557.580.625.600.380
17976702,2007-10-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17976702,2007-10-31T00:00:00,Light,G01.201.875.770.578
17976702,2007-10-31T00:00:00,Light,G01.590.540
17976702,2007-10-31T00:00:00,Middle Aged,M01.060.116.630
17976702,2007-10-31T00:00:00,Peripheral Nervous System Diseases,C10.668.829
17976702,2007-10-31T00:00:00,Photic Stimulation,E05.723.729
17976702,2007-10-31T00:00:00,Photochemotherapy,E02.186.500
17976702,2007-10-31T00:00:00,Photochemotherapy,E02.319.685
17976702,2007-10-31T00:00:00,Photochemotherapy,E02.774.722
17976702,2007-10-31T00:00:00,Preoperative Care,E02.760.795
17976702,2007-10-31T00:00:00,Preoperative Care,E04.641
17976702,2007-10-31T00:00:00,Preoperative Care,N02.421.585.795
17976702,2007-10-31T00:00:00,Temporal Lobe,A08.186.211.730.885.287.500.863
17471491,2007-11-01T00:00:00,Adult,M01.060.116
17471491,2007-11-01T00:00:00,Aged,M01.060.116.100
17471491,2007-11-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
17471491,2007-11-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
17471491,2007-11-01T00:00:00,Equipment Failure Analysis,E05.325.192
17471491,2007-11-01T00:00:00,Hip Joint,A02.835.583.411
17471491,2007-11-01T00:00:00,Hip Prosthesis,E07.695.400.400
17471491,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17471491,2007-11-01T00:00:00,Middle Aged,M01.060.116.630
17471491,2007-11-01T00:00:00,Polyethylene,D02.455.326.271.665.550.500
17471491,2007-11-01T00:00:00,Polyethylene,D05.750.716.507.500
17471491,2007-11-01T00:00:00,Polyethylene,D25.720.716.507.500
17471491,2007-11-01T00:00:00,Polyethylene,J01.637.051.720.716.507.500
17471491,2007-11-01T00:00:00,Prosthesis Design,E05.320.550
17471491,2007-11-01T00:00:00,Prosthesis Design,E07.695.680
17471491,2007-11-01T00:00:00,Prosthesis Failure,C23.550.767.865
17471491,2007-11-01T00:00:00,Prosthesis Failure,E05.325.771
17724673,2007-11-01T00:00:00,Animals,B01.050
17724673,2007-11-01T00:00:00,Energy Metabolism,G03.495.335
17724673,2007-11-01T00:00:00,Ovary,A05.360.319.114.630
17724673,2007-11-01T00:00:00,Ovary,A05.360.576.497
17724673,2007-11-01T00:00:00,Ovary,A06.407.312.497
17724673,2007-11-01T00:00:00,Testis,A05.360.444.849
17724673,2007-11-01T00:00:00,Testis,A05.360.576.782
17724673,2007-11-01T00:00:00,Testis,A06.407.312.782
17724673,2007-11-01T00:00:00,Xenopus laevis,B01.050.150.900.090.180.610.500.562
17880268,2007-11-01T00:00:00,Animals,B01.050
17880268,2007-11-01T00:00:00,"Animals, Newborn",B01.050.050.282
17880268,2007-11-01T00:00:00,Cell Separation,E05.200.500.363
17880268,2007-11-01T00:00:00,Cell Survival,G04.299.316
17880268,2007-11-01T00:00:00,Collagen Type I,D05.750.078.280.300.100
17880268,2007-11-01T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
17880268,2007-11-01T00:00:00,Fluorescent Dyes,D27.720.233.348
17880268,2007-11-01T00:00:00,Fluorescent Dyes,D27.720.470.330.348
17880268,2007-11-01T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
17880268,2007-11-01T00:00:00,Isometric Contraction,G11.427.590.540.472
17880268,2007-11-01T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
17880268,2007-11-01T00:00:00,"Microscopy, Confocal",E05.595.395
17880268,2007-11-01T00:00:00,Muscle Contraction,G11.427.590.540
17880268,2007-11-01T00:00:00,"Muscle, Skeletal",A02.633.567
17880268,2007-11-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
17880268,2007-11-01T00:00:00,"RNA, Messenger",D13.444.735.544
17880268,2007-11-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17880268,2007-11-01T00:00:00,"Satellite Cells, Skeletal Muscle",A11.635.500.700
17880268,2007-11-01T00:00:00,"Satellite Cells, Skeletal Muscle",A11.872.645.500.700
17880268,2007-11-01T00:00:00,Temperature,G01.906.595
17880268,2007-11-01T00:00:00,Temperature,G16.500.275.063.725.710
17880268,2007-11-01T00:00:00,Temperature,G16.500.750.775.710
17880268,2007-11-01T00:00:00,Temperature,N06.230.150.450
17880268,2007-11-01T00:00:00,Temperature,N06.230.300.100.725.710
17880268,2007-11-01T00:00:00,Time Factors,G01.910.857
17880268,2007-11-01T00:00:00,Tissue Engineering,E05.200.249.750
17921754,2007-11-01T00:00:00,"Affective Disorders, Psychotic",F03.600.150
17921754,2007-11-01T00:00:00,Age of Onset,N05.715.350.075.100
17921754,2007-11-01T00:00:00,Age of Onset,N06.850.490.250.100
17921754,2007-11-01T00:00:00,Aged,M01.060.116.100
17921754,2007-11-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
17921754,2007-11-01T00:00:00,Alzheimer Disease,C10.574.945.249
17921754,2007-11-01T00:00:00,Alzheimer Disease,F03.087.400.100
17921754,2007-11-01T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
17921754,2007-11-01T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
17921754,2007-11-01T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
17921754,2007-11-01T00:00:00,Delirium,C10.597.606.337.500
17921754,2007-11-01T00:00:00,Delirium,C23.888.592.604.339.500
17921754,2007-11-01T00:00:00,Delirium,F01.700.250.500
17921754,2007-11-01T00:00:00,Delirium,F03.087.350
17921754,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17921754,2007-11-01T00:00:00,Psychotic Disorders,F03.700.675
17921754,2007-11-01T00:00:00,Schizophrenia,F03.700.750
17932240,2007-11-01T00:00:00,Cognitive Therapy,F04.754.137.428
17932240,2007-11-01T00:00:00,Educational Technology,J01.897.280
17932240,2007-11-01T00:00:00,Health Personnel,M01.526.485
17932240,2007-11-01T00:00:00,Health Personnel,N02.360
17932240,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17932240,2007-11-01T00:00:00,Middle Aged,M01.060.116.630
17932240,2007-11-01T00:00:00,Professional Competence,I02.399.630
17932240,2007-11-01T00:00:00,Rural Population,N01.600.725
17932240,2007-11-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17932240,2007-11-01T00:00:00,Telemedicine,H02.403.840
17932240,2007-11-01T00:00:00,Telemedicine,L01.178.847.652
17932240,2007-11-01T00:00:00,Telemedicine,N04.590.374.800
17932240,2007-11-01T00:00:00,Veterans,M01.930
17944723,2007-11-01T00:00:00,Adolescent,M01.060.057
17944723,2007-11-01T00:00:00,Dysplastic Nevus Syndrome,C04.557.665.560.260
17944723,2007-11-01T00:00:00,Dysplastic Nevus Syndrome,C04.700.305
17944723,2007-11-01T00:00:00,Dysplastic Nevus Syndrome,C16.320.700.305
17944723,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17944723,2007-11-01T00:00:00,Middle Aged,M01.060.116.630
17949392,2007-11-01T00:00:00,Adult,M01.060.116
17949392,2007-11-01T00:00:00,Alcoholism,C21.739.100.250
17949392,2007-11-01T00:00:00,Alcoholism,F03.900.100.350
17949392,2007-11-01T00:00:00,Cognitive Therapy,F04.754.137.428
17949392,2007-11-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
17949392,2007-11-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17949392,2007-11-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
17949392,2007-11-01T00:00:00,Genetic Variation,G05.365
17949392,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17949392,2007-11-01T00:00:00,Middle Aged,M01.060.116.630
17949392,2007-11-01T00:00:00,Motivation,F01.658
17949392,2007-11-01T00:00:00,Motivation,F01.752.543.500.750
17949392,2007-11-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17949392,2007-11-01T00:00:00,Risk Factors,N05.715.350.200.700
17949392,2007-11-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17949392,2007-11-01T00:00:00,Risk Factors,N06.850.490.625.750
17949392,2007-11-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17949392,2007-11-01T00:00:00,Social Support,I01.880.656.600
17949392,2007-11-01T00:00:00,Treatment Outcome,E01.789.800
17949392,2007-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17949392,2007-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17951477,2007-11-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
17951477,2007-11-01T00:00:00,Antioxidants,D27.505.519.217
17951477,2007-11-01T00:00:00,Antioxidants,D27.505.696.706.125
17951477,2007-11-01T00:00:00,Antioxidants,D27.720.799.047
17951477,2007-11-01T00:00:00,Blood Pressure,E01.370.600.875.249
17951477,2007-11-01T00:00:00,Blood Pressure,G09.330.380.076
17951477,2007-11-01T00:00:00,Coronary Disease,C14.280.647.250
17951477,2007-11-01T00:00:00,Coronary Disease,C14.907.585.250
17951477,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17951477,2007-11-01T00:00:00,Hypertension,C14.907.489
17951477,2007-11-01T00:00:00,Patient Selection,E05.581.500.653
17951477,2007-11-01T00:00:00,Patient Selection,N04.590.731
17951477,2007-11-01T00:00:00,Stroke,C10.228.140.300.775
17951477,2007-11-01T00:00:00,Stroke,C14.907.253.855
17954042,2007-11-01T00:00:00,Delivery of Health Care,N04.590.374
17954042,2007-11-01T00:00:00,Delivery of Health Care,N05.300
17954042,2007-11-01T00:00:00,Health Policy,I01.880.604.825.608.400
17954042,2007-11-01T00:00:00,Health Policy,N03.706.825.608.428
17954042,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17954042,2007-11-01T00:00:00,United States,Z01.107.567.875
17954044,2007-11-01T00:00:00,Delivery of Health Care,N04.590.374
17954044,2007-11-01T00:00:00,Delivery of Health Care,N05.300
17954044,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17954044,2007-11-01T00:00:00,"Insurance, Health, Reimbursement",N03.219.521.576.343.480
17954044,2007-11-01T00:00:00,"Insurance, Health, Reimbursement",N03.219.521.710
17954044,2007-11-01T00:00:00,United States,Z01.107.567.875
17954868,2007-11-01T00:00:00,Adult,M01.060.116
17954868,2007-11-01T00:00:00,Demography,I01.240
17954868,2007-11-01T00:00:00,Demography,N01.224
17954868,2007-11-01T00:00:00,Demography,N06.850.505.400
17954868,2007-11-01T00:00:00,Diabetes Mellitus,C18.452.394.750
17954868,2007-11-01T00:00:00,Diabetes Mellitus,C19.246
17954868,2007-11-01T00:00:00,Ethnic Groups,M01.686.754
17954868,2007-11-01T00:00:00,Ethnic Groups,N01.224.317
17954868,2007-11-01T00:00:00,Health Services Accessibility,N04.590.374.350
17954868,2007-11-01T00:00:00,Health Services Accessibility,N05.300.430
17954868,2007-11-01T00:00:00,Hispanic Americans,M01.686.754.441
17954868,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17954868,2007-11-01T00:00:00,Interviews as Topic,E05.318.308.420
17954868,2007-11-01T00:00:00,Interviews as Topic,L01.280.520
17954868,2007-11-01T00:00:00,Interviews as Topic,N05.715.360.300.400
17954868,2007-11-01T00:00:00,Interviews as Topic,N06.850.520.308.420
17954868,2007-11-01T00:00:00,Middle Aged,M01.060.116.630
17954868,2007-11-01T00:00:00,Quality of Health Care,N04.761
17954868,2007-11-01T00:00:00,Quality of Health Care,N05.715
17954868,2007-11-01T00:00:00,Treatment Outcome,E01.789.800
17954868,2007-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17954868,2007-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17954868,2007-11-01T00:00:00,United States,Z01.107.567.875
17954941,2007-11-01T00:00:00,Adolescent,M01.060.057
17954941,2007-11-01T00:00:00,Adult,M01.060.116
17954941,2007-11-01T00:00:00,Aged,M01.060.116.100
17954941,2007-11-01T00:00:00,Child,M01.060.406
17954941,2007-11-01T00:00:00,"Child Abuse, Sexual",I01.198.240.748.300
17954941,2007-11-01T00:00:00,"Child Abuse, Sexual",I01.198.240.856.350.250.255
17954941,2007-11-01T00:00:00,"Child Abuse, Sexual",I01.880.735.900.350.250.255
17954941,2007-11-01T00:00:00,"Child Abuse, Sexual",I01.880.787.293.292.325
17954941,2007-11-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
17954941,2007-11-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
17954941,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17954941,2007-11-01T00:00:00,Middle Aged,M01.060.116.630
17954941,2007-11-01T00:00:00,Parents,F01.829.263.500.320
17954941,2007-11-01T00:00:00,Parents,I01.880.225.500.340
17954941,2007-11-01T00:00:00,Parents,M01.620
17954941,2007-11-01T00:00:00,Primary Prevention,N02.421.726.758
17954941,2007-11-01T00:00:00,Primary Prevention,N06.850.780.680
17954941,2007-11-01T00:00:00,United States,Z01.107.567.875
17961680,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17961680,2007-11-01T00:00:00,Internship and Residency,I02.358.399.644
17961680,2007-11-01T00:00:00,Life Style,F01.829.458
17961680,2007-11-01T00:00:00,Pediatrics,H02.403.670
17961680,2007-11-01T00:00:00,Questionnaires,E05.318.308.750
17961680,2007-11-01T00:00:00,Questionnaires,L01.280.800
17961680,2007-11-01T00:00:00,Questionnaires,N05.715.360.300.695
17961680,2007-11-01T00:00:00,Questionnaires,N06.850.520.308.750
17961680,2007-11-01T00:00:00,Social Perception,F02.463.593.752
17961680,2007-11-01T00:00:00,United States,Z01.107.567.875
17962484,2007-11-01T00:00:00,Animals,B01.050
17962484,2007-11-01T00:00:00,Complement Activation,G12.425.255
17962484,2007-11-01T00:00:00,"Complement Pathway, Alternative",G12.425.255.695
17962484,2007-11-01T00:00:00,Gene Expression Profiling,E05.393.332
17962484,2007-11-01T00:00:00,Gene Expression Regulation,G05.355.315
17962484,2007-11-01T00:00:00,Light,G01.201.875.770.578
17962484,2007-11-01T00:00:00,Light,G01.590.540
17962484,2007-11-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
17962484,2007-11-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
17962484,2007-11-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
17962484,2007-11-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
17962484,2007-11-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
17962484,2007-11-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
17962484,2007-11-01T00:00:00,"RNA, Messenger",D13.444.735.544
17962484,2007-11-01T00:00:00,Retinal Degeneration,C11.768.585
17962484,2007-11-01T00:00:00,Transcription Factors,D12.776.930
17964311,2007-11-01T00:00:00,Diet,E05.272
17964311,2007-11-01T00:00:00,Diet,G07.610.240
17964311,2007-11-01T00:00:00,Fruit,A18.024.500
17964311,2007-11-01T00:00:00,Fruit,J02.500.562
17964311,2007-11-01T00:00:00,Health Behavior,F01.145.488
17964311,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17964311,2007-11-01T00:00:00,Rural Population,N01.600.725
17964311,2007-11-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17964311,2007-11-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17964406,2007-11-01T00:00:00,Adolescent,M01.060.057
17964406,2007-11-01T00:00:00,Cataract,C11.510.245
17964406,2007-11-01T00:00:00,Child,M01.060.406
17964406,2007-11-01T00:00:00,"Child, Preschool",M01.060.406.448
17964406,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17964406,2007-11-01T00:00:00,Infant,M01.060.703
17964406,2007-11-01T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
17964406,2007-11-01T00:00:00,"Lenses, Intraocular",E07.632.500.460
17964406,2007-11-01T00:00:00,"Lenses, Intraocular",E07.695.460
17964406,2007-11-01T00:00:00,Physician's Practice Patterns,N04.590.748
17964406,2007-11-01T00:00:00,Physician's Practice Patterns,N05.300.625
17964406,2007-11-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
17964406,2007-11-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
17964879,2007-11-01T00:00:00,Adolescent,M01.060.057
17964879,2007-11-01T00:00:00,Adult,M01.060.116
17964879,2007-11-01T00:00:00,Age Factors,N05.715.350.075
17964879,2007-11-01T00:00:00,Age Factors,N06.850.490.250
17964879,2007-11-01T00:00:00,Brain Injuries,C10.228.140.199
17964879,2007-11-01T00:00:00,Brain Injuries,C10.900.300.087
17964879,2007-11-01T00:00:00,Brain Injuries,C21.866.260.118
17964879,2007-11-01T00:00:00,Brain Injuries,C21.866.915.300.200
17964879,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17964879,2007-11-01T00:00:00,Middle Aged,M01.060.116.630
17964879,2007-11-01T00:00:00,Regression Analysis,E05.318.740.750
17964879,2007-11-01T00:00:00,Regression Analysis,N05.715.360.750.695
17964879,2007-11-01T00:00:00,Regression Analysis,N06.850.520.830.750
17964879,2007-11-01T00:00:00,"Rehabilitation, Vocational",E02.831.782
17964879,2007-11-01T00:00:00,"Rehabilitation, Vocational",N02.421.784.644
17964879,2007-11-01T00:00:00,Sex Factors,N05.715.350.675
17964879,2007-11-01T00:00:00,Sex Factors,N06.850.490.875
17964879,2007-11-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17964879,2007-11-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17964893,2007-11-01T00:00:00,Health Policy,I01.880.604.825.608.400
17964893,2007-11-01T00:00:00,Health Policy,N03.706.825.608.428
17964893,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17964893,2007-11-01T00:00:00,Outcome and Process Assessment (Health Care),N04.761.559
17964893,2007-11-01T00:00:00,Outcome and Process Assessment (Health Care),N05.715.360.575
17964893,2007-11-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
17964893,2007-11-01T00:00:00,"Quality Assurance, Health Care",N05.700
17964893,2007-11-01T00:00:00,"Quality Indicators, Health Care",N04.761.789
17968874,2007-11-01T00:00:00,Adult,M01.060.116
17968874,2007-11-01T00:00:00,Antiviral Agents,D27.505.954.122.388
17968874,2007-11-01T00:00:00,Apoptosis,G04.299.139.160
17968874,2007-11-01T00:00:00,Complement System Proteins,D12.776.124.486.274
17968874,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17968874,2007-11-01T00:00:00,Interferon-gamma,D12.644.276.374.440.893
17968874,2007-11-01T00:00:00,Interferon-gamma,D12.644.276.374.480.350
17968874,2007-11-01T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
17968874,2007-11-01T00:00:00,Interferon-gamma,D12.644.276.718.550
17968874,2007-11-01T00:00:00,Interferon-gamma,D12.776.467.374.440.893
17968874,2007-11-01T00:00:00,Interferon-gamma,D12.776.467.374.480.350
17968874,2007-11-01T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
17968874,2007-11-01T00:00:00,Interferon-gamma,D12.776.467.718.550
17968874,2007-11-01T00:00:00,Interferon-gamma,D23.529.374.440.893
17968874,2007-11-01T00:00:00,Interferon-gamma,D23.529.374.480.350
17968874,2007-11-01T00:00:00,Interferon-gamma,D23.529.374.480.615.350
17968874,2007-11-01T00:00:00,Interferon-gamma,D23.529.718.550
17968874,2007-11-01T00:00:00,"Leukocytes, Mononuclear",A11.118.637.555
17968874,2007-11-01T00:00:00,"Leukocytes, Mononuclear",A15.145.229.637.555
17968874,2007-11-01T00:00:00,"Leukocytes, Mononuclear",A15.382.490.555
17968874,2007-11-01T00:00:00,Lipopolysaccharides,D09.400.500
17968874,2007-11-01T00:00:00,Lipopolysaccharides,D09.698.718.450
17968874,2007-11-01T00:00:00,Lipopolysaccharides,D10.494
17968874,2007-11-01T00:00:00,Lipopolysaccharides,D23.050.161.616.525
17968874,2007-11-01T00:00:00,Lipopolysaccharides,D23.946.123.329.500
17968874,2007-11-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
17968874,2007-11-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
17968874,2007-11-01T00:00:00,Reactive Nitrogen Species,D01.625.700
17968874,2007-11-01T00:00:00,Reactive Nitrogen Species,D02.654.846
17968874,2007-11-01T00:00:00,Reactive Oxygen Species,D01.339.431
17968874,2007-11-01T00:00:00,Reactive Oxygen Species,D01.650.775
17971600,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17971600,2007-11-01T00:00:00,Prostatectomy,E04.950.774.860.625
17971600,2007-11-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
17971600,2007-11-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
17971600,2007-11-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
17971600,2007-11-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
17971600,2007-11-01T00:00:00,"Radiotherapy, Adjuvant",E02.186.775
17971600,2007-11-01T00:00:00,"Radiotherapy, Adjuvant",E02.815.600
17974612,2007-11-01T00:00:00,Brain Neoplasms,C04.588.614.250.195
17974612,2007-11-01T00:00:00,Brain Neoplasms,C10.228.140.211
17974612,2007-11-01T00:00:00,Brain Neoplasms,C10.551.240.250
17974612,2007-11-01T00:00:00,Glioma,C04.557.465.625.600.380
17974612,2007-11-01T00:00:00,Glioma,C04.557.470.670.380
17974612,2007-11-01T00:00:00,Glioma,C04.557.580.625.600.380
17974612,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17974612,2007-11-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
17974612,2007-11-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
17974612,2007-11-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
17974612,2007-11-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17974612,2007-11-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17974612,2007-11-01T00:00:00,Middle Aged,M01.060.116.630
17974612,2007-11-01T00:00:00,"Neovascularization, Pathologic",C23.550.589.500
17974864,2007-11-01T00:00:00,Aged,M01.060.116.100
17974864,2007-11-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
17974864,2007-11-01T00:00:00,Alzheimer Disease,C10.574.945.249
17974864,2007-11-01T00:00:00,Alzheimer Disease,F03.087.400.100
17974864,2007-11-01T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
17974864,2007-11-01T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
17974864,2007-11-01T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
17974864,2007-11-01T00:00:00,Double-Blind Method,E05.318.780.300
17974864,2007-11-01T00:00:00,Double-Blind Method,E05.581.500.300
17974864,2007-11-01T00:00:00,Double-Blind Method,N05.715.360.780.320
17974864,2007-11-01T00:00:00,Double-Blind Method,N06.850.520.445.300
17974864,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17974864,2007-11-01T00:00:00,Middle Aged,M01.060.116.630
17974864,2007-11-01T00:00:00,Piperazines,D03.383.606
17974864,2007-11-01T00:00:00,Psychiatric Status Rating Scales,F04.586
17974864,2007-11-01T00:00:00,Psychomotor Agitation,C10.597.350.600
17974864,2007-11-01T00:00:00,Psychomotor Agitation,C10.597.606.881.700
17974864,2007-11-01T00:00:00,Psychomotor Agitation,C23.888.592.350.600
17974864,2007-11-01T00:00:00,Psychomotor Agitation,C23.888.592.604.882.700
17974864,2007-11-01T00:00:00,Psychomotor Agitation,F01.700.875.700
17974864,2007-11-01T00:00:00,Psychotic Disorders,F03.700.675
17974864,2007-11-01T00:00:00,Quinolones,D03.438.810.835
17974864,2007-11-01T00:00:00,Treatment Outcome,E01.789.800
17974864,2007-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17974864,2007-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17974934,2007-11-01T00:00:00,Adolescent,M01.060.057
17974934,2007-11-01T00:00:00,Adult,M01.060.116
17974934,2007-11-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
17974934,2007-11-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
17974934,2007-11-01T00:00:00,Disasters,N06.230.100
17974934,2007-11-01T00:00:00,Genetic Variation,G05.365
17974934,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17974934,2007-11-01T00:00:00,Life Change Events,F01.829.458.410
17974934,2007-11-01T00:00:00,Middle Aged,M01.060.116.630
17974934,2007-11-01T00:00:00,"Polymorphism, Genetic",G05.365.795
17974934,2007-11-01T00:00:00,Psychiatric Status Rating Scales,F04.586
17974934,2007-11-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17974934,2007-11-01T00:00:00,Risk Factors,N05.715.350.200.700
17974934,2007-11-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17974934,2007-11-01T00:00:00,Risk Factors,N06.850.490.625.750
17974934,2007-11-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17974934,2007-11-01T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.157.530.450.625.311
17974934,2007-11-01T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.157.530.562.374.875
17974934,2007-11-01T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.543.585.450.625.374
17974934,2007-11-01T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.543.585.562.374.875
17974934,2007-11-01T00:00:00,Social Support,I01.880.656.600
17974934,2007-11-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17975152,2007-11-01T00:00:00,Algorithms,G17.035
17975152,2007-11-01T00:00:00,Algorithms,L01.224.050
17975152,2007-11-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
17975152,2007-11-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
17975152,2007-11-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
17975152,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17975152,2007-11-01T00:00:00,Prednisone,D04.808.745.432.719.702
17975152,2007-11-01T00:00:00,Prostate-Specific Antigen,D08.811.277.656.300.760.442.750
17975152,2007-11-01T00:00:00,Prostate-Specific Antigen,D08.811.277.656.959.350.442.750
17975152,2007-11-01T00:00:00,Prostate-Specific Antigen,D12.776.866.249.500
17975152,2007-11-01T00:00:00,Prostate-Specific Antigen,D23.050.285.625
17975152,2007-11-01T00:00:00,Prostate-Specific Antigen,D23.101.840.625
17975152,2007-11-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
17975152,2007-11-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
17975152,2007-11-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
17975152,2007-11-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
17975152,2007-11-01T00:00:00,Regression Analysis,E05.318.740.750
17975152,2007-11-01T00:00:00,Regression Analysis,N05.715.360.750.695
17975152,2007-11-01T00:00:00,Regression Analysis,N06.850.520.830.750
17975152,2007-11-01T00:00:00,Treatment Outcome,E01.789.800
17975152,2007-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17975152,2007-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17976095,2007-11-01T00:00:00,"Anastomosis, Surgical",E04.035
17976095,2007-11-01T00:00:00,Heart Ventricles,A07.541.560
17976095,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17976095,2007-11-01T00:00:00,Pulmonary Artery,A07.231.114.715
17976095,2007-11-01T00:00:00,Treatment Outcome,E01.789.800
17976095,2007-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17976095,2007-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17976095,2007-11-01T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
17978105,2007-11-01T00:00:00,Bacterial Toxins,D23.946.123
17978105,2007-11-01T00:00:00,Clostridium sordellii,B03.300.390.400.200.700
17978105,2007-11-01T00:00:00,Clostridium sordellii,B03.510.415.400.200.700
17978105,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17978105,2007-11-01T00:00:00,Pregnancy,G08.686.785.760.769
17978105,2007-11-01T00:00:00,"Shock, Septic",C01.539.757.800
17978105,2007-11-01T00:00:00,"Shock, Septic",C23.550.470.790.500.800
17978105,2007-11-01T00:00:00,"Shock, Septic",C23.550.835.900.712
17978987,2007-11-01T00:00:00,Adult,M01.060.116
17978987,2007-11-01T00:00:00,Counseling,F02.784.176
17978987,2007-11-01T00:00:00,Counseling,F04.408.413
17978987,2007-11-01T00:00:00,Counseling,N02.421.143.303
17978987,2007-11-01T00:00:00,Counseling,N02.421.461.363
17978987,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17978987,2007-11-01T00:00:00,Middle Aged,M01.060.116.630
17978987,2007-11-01T00:00:00,Nicotine,D03.132.760.570
17978987,2007-11-01T00:00:00,Nicotine,D03.383.725.518
17978987,2007-11-01T00:00:00,Nicotinic Agonists,D27.505.519.625.120.140.700
17978987,2007-11-01T00:00:00,Nicotinic Agonists,D27.505.696.577.120.140.700
17978987,2007-11-01T00:00:00,Smoking,F01.145.466.753
17978987,2007-11-01T00:00:00,Smoking Cessation,F01.145.940.700
17978987,2007-11-01T00:00:00,Substance Withdrawal Syndrome,C21.739.835
17978987,2007-11-01T00:00:00,Substance Withdrawal Syndrome,F03.900.825
17978987,2007-11-01T00:00:00,Tobacco Use Disorder,C21.739.912
17978987,2007-11-01T00:00:00,Tobacco Use Disorder,F03.900.912
17978987,2007-11-01T00:00:00,Treatment Outcome,E01.789.800
17978987,2007-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17978987,2007-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17979865,2007-11-01T00:00:00,Adult,M01.060.116
17979865,2007-11-01T00:00:00,Age Factors,N05.715.350.075
17979865,2007-11-01T00:00:00,Age Factors,N06.850.490.250
17979865,2007-11-01T00:00:00,Child,M01.060.406
17979865,2007-11-01T00:00:00,Disease Progression,C23.550.291.656
17979865,2007-11-01T00:00:00,Hispanic Americans,M01.686.754.441
17979865,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17979865,2007-11-01T00:00:00,Phenotype,G05.695
17982215,2007-11-01T00:00:00,Adolescent,M01.060.057
17982215,2007-11-01T00:00:00,Case Management,N04.590.233.624.250
17982215,2007-11-01T00:00:00,Child,M01.060.406
17982215,2007-11-01T00:00:00,"Child, Preschool",M01.060.406.448
17982215,2007-11-01T00:00:00,Continuity of Patient Care,N04.590.233.727.210
17982215,2007-11-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
17982215,2007-11-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
17982215,2007-11-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
17982215,2007-11-01T00:00:00,Health Services Accessibility,N04.590.374.350
17982215,2007-11-01T00:00:00,Health Services Accessibility,N05.300.430
17982215,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17982215,2007-11-01T00:00:00,Needs Assessment,I02.594
17982215,2007-11-01T00:00:00,Needs Assessment,N03.349.380.565
17982215,2007-11-01T00:00:00,Needs Assessment,N05.300.537
17982215,2007-11-01T00:00:00,Pilot Projects,E05.318.760.750
17982215,2007-11-01T00:00:00,Pilot Projects,E05.337.737
17982215,2007-11-01T00:00:00,Pilot Projects,N05.715.360.775.625
17982215,2007-11-01T00:00:00,Pilot Projects,N06.850.520.450.720
17982215,2007-11-01T00:00:00,Program Development,N04.452.760
17982215,2007-11-01T00:00:00,Program Evaluation,E05.337.820
17982215,2007-11-01T00:00:00,Program Evaluation,N04.761.685
17982215,2007-11-01T00:00:00,Program Evaluation,N05.715.360.650
17982215,2007-11-01T00:00:00,Quality of Life,I01.800
17982215,2007-11-01T00:00:00,Quality of Life,K01.752.400.750
17982215,2007-11-01T00:00:00,Time Factors,G01.910.857
17983292,2007-11-01T00:00:00,Adult,M01.060.116
17983292,2007-11-01T00:00:00,Attention,F02.830.104.214
17983292,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17983292,2007-11-01T00:00:00,"Memory, Short-Term",F02.463.425.540.407
17983292,2007-11-01T00:00:00,Neuropsychological Tests,F04.711.513
17983292,2007-11-01T00:00:00,Verbal Learning,F02.463.425.952
17983940,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17983940,2007-11-01T00:00:00,Physician's Practice Patterns,N04.590.748
17983940,2007-11-01T00:00:00,Physician's Practice Patterns,N05.300.625
17983940,2007-11-01T00:00:00,Thoracic Surgery,H02.403.810.803
17983940,2007-11-01T00:00:00,"Ultrasonography, Interventional",E01.370.350.850.855
17983940,2007-11-01T00:00:00,United States,Z01.107.567.875
17984704,2007-11-01T00:00:00,Health Personnel,M01.526.485
17984704,2007-11-01T00:00:00,Health Personnel,N02.360
17984704,2007-11-01T00:00:00,Health Promotion,N02.370
17984704,2007-11-01T00:00:00,Health Promotion,N02.421.726.507
17984704,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17984704,2007-11-01T00:00:00,Interprofessional Relations,F01.829.401.205
17984717,2007-11-01T00:00:00,Adolescent,M01.060.057
17984717,2007-11-01T00:00:00,Health Policy,I01.880.604.825.608.400
17984717,2007-11-01T00:00:00,Health Policy,N03.706.825.608.428
17984717,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17984717,2007-11-01T00:00:00,Smoking,F01.145.466.753
17984717,2007-11-01T00:00:00,Tobacco,B01.650.388.100.905.900
17986153,2007-11-01T00:00:00,Animals,B01.050
17986153,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17986153,2007-11-01T00:00:00,Inflammation,C23.550.470
17986153,2007-11-01T00:00:00,"Models, Biological",E05.599.395
17987415,2007-11-01T00:00:00,Adult,M01.060.116
17987415,2007-11-01T00:00:00,Aged,M01.060.116.100
17987415,2007-11-01T00:00:00,Clinical Competence,I02.399.630.210
17987415,2007-11-01T00:00:00,Clinical Competence,N04.761.210
17987415,2007-11-01T00:00:00,Family Practice,H02.403.280
17987415,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17987415,2007-11-01T00:00:00,Internship and Residency,I02.358.399.644
17987415,2007-11-01T00:00:00,Middle Aged,M01.060.116.630
17987415,2007-11-01T00:00:00,Physician's Practice Patterns,N04.590.748
17987415,2007-11-01T00:00:00,Physician's Practice Patterns,N05.300.625
17987415,2007-11-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17987415,2007-11-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17987415,2007-11-01T00:00:00,"Surgical Procedures, Operative",E04
17987480,2007-11-01T00:00:00,Adult,M01.060.116
17987480,2007-11-01T00:00:00,Aged,M01.060.116.100
17987480,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17987480,2007-11-01T00:00:00,Interpersonal Relations,F01.829.401
17987480,2007-11-01T00:00:00,Middle Aged,M01.060.116.630
17987480,2007-11-01T00:00:00,"Models, Psychological",E05.599.695
17987480,2007-11-01T00:00:00,"Nursing Staff, Hospital",M01.526.485.680.490
17987480,2007-11-01T00:00:00,"Nursing Staff, Hospital",M01.526.485.740.523
17987480,2007-11-01T00:00:00,"Nursing Staff, Hospital",N02.360.680.490
17987480,2007-11-01T00:00:00,"Nursing Staff, Hospital",N02.360.740.523
17987480,2007-11-01T00:00:00,Pilot Projects,E05.318.760.750
17987480,2007-11-01T00:00:00,Pilot Projects,E05.337.737
17987480,2007-11-01T00:00:00,Pilot Projects,N05.715.360.775.625
17987480,2007-11-01T00:00:00,Pilot Projects,N06.850.520.450.720
17987480,2007-11-01T00:00:00,Violence,I01.198.240.856
17987480,2007-11-01T00:00:00,Violence,I01.880.735.900
17991053,2007-11-01T00:00:00,Adolescent,M01.060.057
17991053,2007-11-01T00:00:00,Child,M01.060.406
17991053,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17991053,2007-11-01T00:00:00,"Models, Organizational",E05.599.670
17991053,2007-11-01T00:00:00,"Models, Organizational",N04.452.534
17991053,2007-11-01T00:00:00,Nurse Practitioners,M01.526.485.650.640
17991053,2007-11-01T00:00:00,Nurse Practitioners,N02.360.650.640
17991053,2007-11-01T00:00:00,Pilot Projects,E05.318.760.750
17991053,2007-11-01T00:00:00,Pilot Projects,E05.337.737
17991053,2007-11-01T00:00:00,Pilot Projects,N05.715.360.775.625
17991053,2007-11-01T00:00:00,Pilot Projects,N06.850.520.450.720
17991053,2007-11-01T00:00:00,Psychiatric Nursing,H02.478.676.710
17991053,2007-11-01T00:00:00,Psychiatric Nursing,N02.421.533.778
17991053,2007-11-01T00:00:00,Rural Health Services,N02.421.816
17991053,2007-11-01T00:00:00,School Health Services,N02.421.143.827.809
17991053,2007-11-01T00:00:00,School Health Services,N02.421.726.809
17991053,2007-11-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17991053,2007-11-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17998439,2007-11-01T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
17998439,2007-11-01T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
17998439,2007-11-01T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
17998439,2007-11-01T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
17998439,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17998439,2007-11-01T00:00:00,"Models, Biological",E05.599.395
17998439,2007-11-01T00:00:00,Pediatrics,H02.403.670
17998439,2007-11-01T00:00:00,Stroke,C10.228.140.300.775
17998439,2007-11-01T00:00:00,Stroke,C14.907.253.855
17998439,2007-11-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.700.560.260.850
17998439,2007-11-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.260.850
17998439,2007-11-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.850.870
17998439,2007-11-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.376.560.260.850
18006917,2007-11-01T00:00:00,Adult,M01.060.116
18006917,2007-11-01T00:00:00,Aged,M01.060.116.100
18006917,2007-11-01T00:00:00,Breast Neoplasms,C04.588.180
18006917,2007-11-01T00:00:00,Breast Neoplasms,C17.800.090.500
18006917,2007-11-01T00:00:00,Case-Control Studies,E05.318.760.500.500
18006917,2007-11-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18006917,2007-11-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18006917,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18006917,2007-11-01T00:00:00,Middle Aged,M01.060.116.630
18006917,2007-11-01T00:00:00,New York,Z01.107.567.875.075.437
18006917,2007-11-01T00:00:00,New York,Z01.107.567.875.350.530
18006917,2007-11-01T00:00:00,New York,Z01.107.567.875.500.530
18032980,2007-11-01T00:00:00,"Hospitals, Psychiatric",N02.278.421.556.508
18032980,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18032980,2007-11-01T00:00:00,Mental Disorders,F03
18032980,2007-11-01T00:00:00,"Models, Psychological",E05.599.695
18032980,2007-11-01T00:00:00,Patient Isolation,E02.770
18032980,2007-11-01T00:00:00,Patient Isolation,N06.850.780.200.450.650
18032980,2007-11-01T00:00:00,"Restraint, Physical",E02.085.700
18032980,2007-11-01T00:00:00,"Restraint, Physical",E05.472.760
18032980,2007-11-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18032980,2007-11-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18034752,2007-11-01T00:00:00,Adolescent,M01.060.057
18034752,2007-11-01T00:00:00,Adult,M01.060.116
18034752,2007-11-01T00:00:00,Age Factors,N05.715.350.075
18034752,2007-11-01T00:00:00,Age Factors,N06.850.490.250
18034752,2007-11-01T00:00:00,Animals,B01.050
18034752,2007-11-01T00:00:00,Child,M01.060.406
18034752,2007-11-01T00:00:00,Color,G01.201.875.770.578.199
18034752,2007-11-01T00:00:00,Color,G01.590.540.199
18034752,2007-11-01T00:00:00,Consumer Satisfaction,N04.452.822.360
18034752,2007-11-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
18034752,2007-11-01T00:00:00,Hispanic Americans,M01.686.754.441
18034752,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18034752,2007-11-01T00:00:00,Middle Aged,M01.060.116.630
18034752,2007-11-01T00:00:00,Perception,F02.463.593
18038286,2007-11-01T00:00:00,Algorithms,G17.035
18038286,2007-11-01T00:00:00,Algorithms,L01.224.050
18038286,2007-11-01T00:00:00,Computer Simulation,L01.224.160
18038286,2007-11-01T00:00:00,Finite Element Analysis,E05.355
18038286,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18038286,2007-11-01T00:00:00,"Hyperthermia, Induced",E02.565
18038286,2007-11-01T00:00:00,"Hyperthermia, Induced",E02.779.496
18038286,2007-11-01T00:00:00,Neoplasms,C04
18038286,2007-11-01T00:00:00,"Phantoms, Imaging",E07.671
18038286,2007-11-01T00:00:00,Skin Temperature,G07.110.753
18038286,2007-11-01T00:00:00,Skin Temperature,G13.750.844
18043385,2007-11-01T00:00:00,Algorithms,G17.035
18043385,2007-11-01T00:00:00,Algorithms,L01.224.050
18043385,2007-11-01T00:00:00,"Diagnosis, Computer-Assisted",E01.158
18043385,2007-11-01T00:00:00,"Diagnosis, Computer-Assisted",L01.700.508.100.158
18043385,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18043385,2007-11-01T00:00:00,Middle Aged,M01.060.116.630
18043385,2007-11-01T00:00:00,Pulmonary Embolism,C08.381.746
18043385,2007-11-01T00:00:00,Pulmonary Embolism,C14.907.355.350.700
18043385,2007-11-01T00:00:00,"Tomography, Spiral Computed",E01.370.350.350.810.800
18043385,2007-11-01T00:00:00,"Tomography, Spiral Computed",E01.370.350.600.350.700.810.800
18043385,2007-11-01T00:00:00,"Tomography, Spiral Computed",E01.370.350.700.700.810.800
18043385,2007-11-01T00:00:00,"Tomography, Spiral Computed",E01.370.350.700.810.810.800
18043385,2007-11-01T00:00:00,"Tomography, Spiral Computed",E01.370.350.825.810.810.800
18044427,2007-11-01T00:00:00,Animals,B01.050
18044427,2007-11-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
18044427,2007-11-01T00:00:00,"Colony Count, Microbial",E05.200.875.220
18044427,2007-11-01T00:00:00,Food Preservation,J01.576.423.850.700
18044427,2007-11-01T00:00:00,Hot Temperature,G01.906.595.543
18044427,2007-11-01T00:00:00,Hot Temperature,G16.500.275.063.725.710.380
18044427,2007-11-01T00:00:00,Hot Temperature,G16.500.750.775.710.380
18044427,2007-11-01T00:00:00,Hot Temperature,N06.230.300.100.725.232
18044427,2007-11-01T00:00:00,Hot Temperature,N06.230.300.100.725.710.380
18044427,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18044427,2007-11-01T00:00:00,Meat Products,J02.500.600.500
18044427,2007-11-01T00:00:00,Muramidase,D08.811.277.450.642
18044427,2007-11-01T00:00:00,Time Factors,G01.910.857
18044520,2007-11-01T00:00:00,Geologic Sediments,G01.311.500
18044520,2007-11-01T00:00:00,Geologic Sediments,G16.500.320
18044520,2007-11-01T00:00:00,Plutonium,D01.268.033.700
18044520,2007-11-01T00:00:00,Plutonium,D01.268.271.100.700
18044520,2007-11-01T00:00:00,Plutonium,D01.268.556.700
18044520,2007-11-01T00:00:00,Plutonium,D01.552.020.734
18044520,2007-11-01T00:00:00,Plutonium,D01.552.544.700
18044520,2007-11-01T00:00:00,"Water Pollutants, Radioactive",D20.693.903
18044520,2007-11-01T00:00:00,"Water Pollutants, Radioactive",D27.888.284.903.821
18044520,2007-11-01T00:00:00,Water Supply,N06.850.860.510.915
18044520,2007-11-01T00:00:00,X-Rays,G01.201.875.750.918
18052563,2007-11-01T00:00:00,Adult,M01.060.116
18052563,2007-11-01T00:00:00,Antidepressive Agents,D27.505.954.427.700.122
18052563,2007-11-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
18052563,2007-11-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
18052563,2007-11-01T00:00:00,Drug Resistance,G07.690.320
18052563,2007-11-01T00:00:00,Electroconvulsive Therapy,F04.570.200.583
18052563,2007-11-01T00:00:00,Electroconvulsive Therapy,F04.669.224.300
18052563,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18052563,2007-11-01T00:00:00,Psychomotor Agitation,C10.597.350.600
18052563,2007-11-01T00:00:00,Psychomotor Agitation,C10.597.606.881.700
18052563,2007-11-01T00:00:00,Psychomotor Agitation,C23.888.592.350.600
18052563,2007-11-01T00:00:00,Psychomotor Agitation,C23.888.592.604.882.700
18052563,2007-11-01T00:00:00,Psychomotor Agitation,F01.700.875.700
18052563,2007-11-01T00:00:00,Questionnaires,E05.318.308.750
18052563,2007-11-01T00:00:00,Questionnaires,L01.280.800
18052563,2007-11-01T00:00:00,Questionnaires,N05.715.360.300.695
18052563,2007-11-01T00:00:00,Questionnaires,N06.850.520.308.750
18052563,2007-11-01T00:00:00,Remission Induction,E02.860
18052563,2007-11-01T00:00:00,Sleep Initiation and Maintenance Disorders,C10.886.425.800.800
18052563,2007-11-01T00:00:00,Sleep Initiation and Maintenance Disorders,F03.870.400.800.800
18058407,2007-11-01T00:00:00,Adolescent,M01.060.057
18058407,2007-11-01T00:00:00,Adult,M01.060.116
18058407,2007-11-01T00:00:00,Age Factors,N05.715.350.075
18058407,2007-11-01T00:00:00,Age Factors,N06.850.490.250
18058407,2007-11-01T00:00:00,Age of Onset,N05.715.350.075.100
18058407,2007-11-01T00:00:00,Age of Onset,N06.850.490.250.100
18058407,2007-11-01T00:00:00,Alcohol Drinking,F01.145.317.269
18058407,2007-11-01T00:00:00,Alcoholism,C21.739.100.250
18058407,2007-11-01T00:00:00,Alcoholism,F03.900.100.350
18058407,2007-11-01T00:00:00,Child Psychology,F04.096.628.193
18058407,2007-11-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
18058407,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18058407,2007-11-01T00:00:00,Life Change Events,F01.829.458.410
18058407,2007-11-01T00:00:00,Middle Aged,M01.060.116.630
18058407,2007-11-01T00:00:00,Probability,E05.318.740.600
18058407,2007-11-01T00:00:00,Probability,G17.680
18058407,2007-11-01T00:00:00,Probability,N05.715.360.750.625
18058407,2007-11-01T00:00:00,Probability,N06.850.520.830.600
18058407,2007-11-01T00:00:00,Psychiatric Status Rating Scales,F04.586
18058407,2007-11-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
18058407,2007-11-01T00:00:00,Survivors,M01.643.836
18058407,2007-11-01T00:00:00,Survivors,M01.860
18058415,2007-11-01T00:00:00,Adolescent,M01.060.057
18058415,2007-11-01T00:00:00,Adult,M01.060.116
18058415,2007-11-01T00:00:00,Age of Onset,N05.715.350.075.100
18058415,2007-11-01T00:00:00,Age of Onset,N06.850.490.250.100
18058415,2007-11-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
18058415,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18058415,2007-11-01T00:00:00,Marijuana Abuse,C21.739.635
18058415,2007-11-01T00:00:00,Marijuana Abuse,F03.900.635
18058415,2007-11-01T00:00:00,Methamphetamine,D02.092.471.683.152.619
18058415,2007-11-01T00:00:00,Motivation,F01.658
18058415,2007-11-01T00:00:00,Motivation,F01.752.543.500.750
18058415,2007-11-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
18058415,2007-11-01T00:00:00,Personality Inventory,F04.711.647.513
18058415,2007-11-01T00:00:00,Psychiatric Status Rating Scales,F04.586
18058415,2007-11-01T00:00:00,Questionnaires,E05.318.308.750
18058415,2007-11-01T00:00:00,Questionnaires,L01.280.800
18058415,2007-11-01T00:00:00,Questionnaires,N05.715.360.300.695
18058415,2007-11-01T00:00:00,Questionnaires,N06.850.520.308.750
18058415,2007-11-01T00:00:00,Substance-Related Disorders,C21.739
18058415,2007-11-01T00:00:00,Substance-Related Disorders,F03.900
18063273,2007-11-01T00:00:00,Educational Measurement,I02.399
18063273,2007-11-01T00:00:00,"Faculty, Medical",I02.463.373
18063273,2007-11-01T00:00:00,"Faculty, Medical",M01.526.339.373
18063273,2007-11-01T00:00:00,"Faculty, Medical",M01.526.485.375
18063273,2007-11-01T00:00:00,"Faculty, Medical",N02.360.375
18063273,2007-11-01T00:00:00,General Surgery,H02.403.810.300
18063273,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18063273,2007-11-01T00:00:00,Internship and Residency,I02.358.399.644
18063273,2007-11-01T00:00:00,Interviews as Topic,E05.318.308.420
18063273,2007-11-01T00:00:00,Interviews as Topic,L01.280.520
18063273,2007-11-01T00:00:00,Interviews as Topic,N05.715.360.300.400
18063273,2007-11-01T00:00:00,Interviews as Topic,N06.850.520.308.420
18063273,2007-11-01T00:00:00,Professional Competence,I02.399.630
18063273,2007-11-01T00:00:00,School Admission Criteria,I02.399.750
18073339,2007-11-01T00:00:00,Diet,E05.272
18073339,2007-11-01T00:00:00,Diet,G07.610.240
18073339,2007-11-01T00:00:00,Exercise,G11.427.590.237
18073339,2007-11-01T00:00:00,Exercise,I03.350
18073339,2007-11-01T00:00:00,Health Education,I02.233.332
18073339,2007-11-01T00:00:00,Health Education,N02.421.143.827.407
18073339,2007-11-01T00:00:00,Health Education,N02.421.726.407
18073339,2007-11-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
18073339,2007-11-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
18073339,2007-11-01T00:00:00,Health Promotion,N02.370
18073339,2007-11-01T00:00:00,Health Promotion,N02.421.726.507
18073339,2007-11-01T00:00:00,Hospitals,N02.278.421
18073339,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18073339,2007-11-01T00:00:00,Obesity,C18.654.726.500
18073339,2007-11-01T00:00:00,Obesity,C23.888.144.699.500
18073339,2007-11-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
18073339,2007-11-01T00:00:00,Obesity,G07.100.100.160.120.699.500
18073339,2007-11-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
18073339,2007-11-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
18073339,2007-11-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
18073339,2007-11-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
18073339,2007-11-01T00:00:00,Workplace,N01.824.245.925
18073339,2007-11-01T00:00:00,Workplace,N04.452.677.975
18082500,2007-11-01T00:00:00,Aged,M01.060.116.100
18082500,2007-11-01T00:00:00,Combined Modality Therapy,E02.186
18082500,2007-11-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
18082500,2007-11-01T00:00:00,Coronary Angiography,E01.370.370.050.200
18082500,2007-11-01T00:00:00,Coronary Angiography,E01.370.370.380.200
18082500,2007-11-01T00:00:00,Double-Blind Method,E05.318.780.300
18082500,2007-11-01T00:00:00,Double-Blind Method,E05.581.500.300
18082500,2007-11-01T00:00:00,Double-Blind Method,N05.715.360.780.320
18082500,2007-11-01T00:00:00,Double-Blind Method,N06.850.520.445.300
18082500,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18082500,2007-11-01T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
18082500,2007-11-01T00:00:00,Middle Aged,M01.060.116.630
18082500,2007-11-01T00:00:00,Myocardial Infarction,C14.280.647.500
18082500,2007-11-01T00:00:00,Myocardial Infarction,C14.907.585.500
18082500,2007-11-01T00:00:00,Piperazines,D03.383.606
18082500,2007-11-01T00:00:00,Probability,E05.318.740.600
18082500,2007-11-01T00:00:00,Probability,G17.680
18082500,2007-11-01T00:00:00,Probability,N05.715.360.750.625
18082500,2007-11-01T00:00:00,Probability,N06.850.520.830.600
18082500,2007-11-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18082500,2007-11-01T00:00:00,Risk Assessment,N04.452.871.715
18082500,2007-11-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18082500,2007-11-01T00:00:00,Risk Assessment,N06.850.505.715
18082500,2007-11-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18082500,2007-11-01T00:00:00,Salvage Therapy,E02.186.800
18082500,2007-11-01T00:00:00,Salvage Therapy,E02.895
18082500,2007-11-01T00:00:00,Stroke Volume,E01.370.370.380.150.700
18082500,2007-11-01T00:00:00,Stroke Volume,G09.330.380.124.882
18082500,2007-11-01T00:00:00,Treatment Outcome,E01.789.800
18082500,2007-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18082500,2007-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18082500,2007-11-01T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
18160750,2007-11-01T00:00:00,Adolescent,M01.060.057
18160750,2007-11-01T00:00:00,Adult,M01.060.116
18160750,2007-11-01T00:00:00,Aged,M01.060.116.100
18160750,2007-11-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
18160750,2007-11-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
18160750,2007-11-01T00:00:00,HIV Infections,C02.782.815.616.400
18160750,2007-11-01T00:00:00,HIV Infections,C02.800.801.400
18160750,2007-11-01T00:00:00,HIV Infections,C20.673.480
18160750,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18160750,2007-11-01T00:00:00,Middle Aged,M01.060.116.630
18160750,2007-11-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18160750,2007-11-01T00:00:00,Risk Factors,N05.715.350.200.700
18160750,2007-11-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18160750,2007-11-01T00:00:00,Risk Factors,N06.850.490.625.750
18160750,2007-11-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18160750,2007-11-01T00:00:00,Treatment Outcome,E01.789.800
18160750,2007-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18160750,2007-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18189030,2007-11-01T00:00:00,"Diagnosis, Differential",E01.171
18189030,2007-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18189030,2007-11-01T00:00:00,Melanoma,C04.557.465.625.650.510
18189030,2007-11-01T00:00:00,Melanoma,C04.557.580.625.650.510
18189030,2007-11-01T00:00:00,Melanoma,C04.557.665.510
18189030,2007-11-01T00:00:00,Middle Aged,M01.060.116.630
18189030,2007-11-01T00:00:00,Skin Neoplasms,C04.588.805
18189030,2007-11-01T00:00:00,Skin Neoplasms,C17.800.882
18429316,2007-11-01T00:00:00,Algorithms,G17.035
18429316,2007-11-01T00:00:00,Algorithms,L01.224.050
18429316,2007-11-01T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
18429316,2007-11-01T00:00:00,Internet,L01.224.230.110.500
18429316,2007-11-01T00:00:00,Protein Conformation,G02.111.570.790.709
18429316,2007-11-01T00:00:00,Static Electricity,G01.201.249.820
17979999,2007-11-02T00:00:00,Adolescent,M01.060.057
17979999,2007-11-02T00:00:00,Adult,M01.060.116
17979999,2007-11-02T00:00:00,Aged,M01.060.116.100
17979999,2007-11-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17979999,2007-11-02T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
17979999,2007-11-02T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
17979999,2007-11-02T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
17979999,2007-11-02T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
17979999,2007-11-02T00:00:00,Kidney Transplantation,E02.870.500
17979999,2007-11-02T00:00:00,Kidney Transplantation,E04.936.450.485
17979999,2007-11-02T00:00:00,Kidney Transplantation,E04.950.774.400
17979999,2007-11-02T00:00:00,Middle Aged,M01.060.116.630
17979999,2007-11-02T00:00:00,Renal Dialysis,E02.870.300
17979999,2007-11-02T00:00:00,Renal Dialysis,E02.912.800
17979999,2007-11-02T00:00:00,Risk Assessment,E05.318.740.600.800.715
17979999,2007-11-02T00:00:00,Risk Assessment,N04.452.871.715
17979999,2007-11-02T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17979999,2007-11-02T00:00:00,Risk Assessment,N06.850.505.715
17979999,2007-11-02T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17979999,2007-11-02T00:00:00,Tissue and Organ Procurement,N02.421.911
17979999,2007-11-02T00:00:00,Waiting Lists,N04.452.095.738
17982122,2007-11-02T00:00:00,Aged,M01.060.116.100
17982122,2007-11-02T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
17982122,2007-11-02T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
17982122,2007-11-02T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
17982122,2007-11-02T00:00:00,"Antigens, CD",D23.050.301.264.035
17982122,2007-11-02T00:00:00,"Antigens, CD",D23.101.100.110
17982122,2007-11-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17982122,2007-11-02T00:00:00,Melanoma,C04.557.465.625.650.510
17982122,2007-11-02T00:00:00,Melanoma,C04.557.580.625.650.510
17982122,2007-11-02T00:00:00,Melanoma,C04.557.665.510
17982122,2007-11-02T00:00:00,Middle Aged,M01.060.116.630
17982122,2007-11-02T00:00:00,Skin Neoplasms,C04.588.805
17982122,2007-11-02T00:00:00,Skin Neoplasms,C17.800.882
17982122,2007-11-02T00:00:00,Treatment Outcome,E01.789.800
17982122,2007-11-02T00:00:00,Treatment Outcome,N04.761.559.590.800
17982122,2007-11-02T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17982573,2007-11-02T00:00:00,"Adaptation, Physiological",G07.700.062
17982573,2007-11-02T00:00:00,"Adaptation, Physiological",G16.100.057.500
17982573,2007-11-02T00:00:00,Animals,B01.050
17982573,2007-11-02T00:00:00,"Behavior, Addictive",F01.145.527.100.120
17982573,2007-11-02T00:00:00,Biological Transport,G03.495.166
17982573,2007-11-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17982573,2007-11-02T00:00:00,Neuronal Plasticity,G11.561.600.635
17982573,2007-11-02T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
17982573,2007-11-02T00:00:00,Signal Transduction,G02.111.087.800
17982573,2007-11-02T00:00:00,Signal Transduction,G02.149.115.800
17982573,2007-11-02T00:00:00,Signal Transduction,G04.299.880
17980431,2007-11-05T00:00:00,Binding Sites,G02.111.570.120
17980431,2007-11-05T00:00:00,HLA-D Antigens,D23.050.301.500.410.400
17980431,2007-11-05T00:00:00,HLA-D Antigens,D23.050.301.500.450.400
17980431,2007-11-05T00:00:00,HLA-D Antigens,D23.050.705.552.410.400
17980431,2007-11-05T00:00:00,HLA-D Antigens,D23.050.705.552.450.400
17980431,2007-11-05T00:00:00,Histocompatibility Antigens Class II,D23.050.301.500.410
17980431,2007-11-05T00:00:00,Histocompatibility Antigens Class II,D23.050.705.552.410
17980431,2007-11-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17980431,2007-11-05T00:00:00,Hydrogen Bonding,G02.149.767.620
17980431,2007-11-05T00:00:00,Hydrogen Bonding,G02.842.750.620
17980431,2007-11-05T00:00:00,Peptides,D12.644
17987264,2007-11-07T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
17987264,2007-11-07T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
17987264,2007-11-07T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
17987264,2007-11-07T00:00:00,Apoptosis,G04.299.139.160
17987264,2007-11-07T00:00:00,Astrocytes,A08.637.200
17987264,2007-11-07T00:00:00,Astrocytes,A11.650.200
17987264,2007-11-07T00:00:00,Brain Neoplasms,C04.588.614.250.195
17987264,2007-11-07T00:00:00,Brain Neoplasms,C10.228.140.211
17987264,2007-11-07T00:00:00,Brain Neoplasms,C10.551.240.250
17987264,2007-11-07T00:00:00,Cell Differentiation,G04.299.151
17987264,2007-11-07T00:00:00,Down-Regulation,G02.111.087.225
17987264,2007-11-07T00:00:00,Down-Regulation,G02.149.115.225
17987264,2007-11-07T00:00:00,Down-Regulation,G05.355.315.200
17987264,2007-11-07T00:00:00,Down-Regulation,G07.690.812.230
17987264,2007-11-07T00:00:00,Down-Regulation,G07.700.680.230
17987264,2007-11-07T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
17987264,2007-11-07T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
17987264,2007-11-07T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
17987264,2007-11-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17987264,2007-11-07T00:00:00,"RNA, Messenger",D13.444.735.544
17987264,2007-11-07T00:00:00,Reactive Oxygen Species,D01.339.431
17987264,2007-11-07T00:00:00,Reactive Oxygen Species,D01.650.775
17987264,2007-11-07T00:00:00,Retinoids,D02.455.326.271.665.202.495
17987264,2007-11-07T00:00:00,Retinoids,D02.455.426.392.368.367.379.249.700
17987264,2007-11-07T00:00:00,Retinoids,D02.455.849.131.495
17987264,2007-11-07T00:00:00,Retinoids,D23.767.261.700
17987264,2007-11-07T00:00:00,Signal Transduction,G02.111.087.800
17987264,2007-11-07T00:00:00,Signal Transduction,G02.149.115.800
17987264,2007-11-07T00:00:00,Signal Transduction,G04.299.880
17987264,2007-11-07T00:00:00,Telomerase,D08.811.913.696.445.308.300.750.750
17987264,2007-11-07T00:00:00,Telomerase,D12.776.157.725.500.921
17987264,2007-11-07T00:00:00,Telomerase,D12.776.664.962.500.921
18055129,2007-11-07T00:00:00,Animals,B01.050
18055129,2007-11-07T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
18055129,2007-11-07T00:00:00,Excitatory Amino Acid Antagonists,D27.505.519.625.190.300
18055129,2007-11-07T00:00:00,Excitatory Amino Acid Antagonists,D27.505.696.577.190.300
18055129,2007-11-07T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.567.342
18055129,2007-11-07T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.646.750.249
18055129,2007-11-07T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.644.360.450.169
18055129,2007-11-07T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.776.476.450.169
18055129,2007-11-07T00:00:00,Extracellular Space,A10.082.500
18055129,2007-11-07T00:00:00,Extracellular Space,A11.284.295
18055129,2007-11-07T00:00:00,Neurons,A08.663
18055129,2007-11-07T00:00:00,Neurons,A11.671
18055129,2007-11-07T00:00:00,Piperidines,D03.383.621
18055129,2007-11-07T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18055129,2007-11-07T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18055129,2007-11-07T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
18055129,2007-11-07T00:00:00,Signal Transduction,G02.111.087.800
18055129,2007-11-07T00:00:00,Signal Transduction,G02.149.115.800
18055129,2007-11-07T00:00:00,Signal Transduction,G04.299.880
17996206,2007-11-08T00:00:00,Cell Movement,G04.299.283
17996206,2007-11-08T00:00:00,Cell Movement,G07.700.560.500.180
17996206,2007-11-08T00:00:00,Ceramides,D02.065.313
17996206,2007-11-08T00:00:00,Ceramides,D09.400.410.420.525.200
17996206,2007-11-08T00:00:00,Ceramides,D10.390.470.675.200
17996206,2007-11-08T00:00:00,Ceramides,D10.570.877.360.612.200
17996206,2007-11-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17996206,2007-11-08T00:00:00,Protein Phosphatase 1,D08.811.277.352.650.625.687
17996206,2007-11-08T00:00:00,Serine,D12.125.154.800
17996206,2007-11-08T00:00:00,Serine,D12.125.837
17996206,2007-11-08T00:00:00,Sphingomyelin Phosphodiesterase,D08.811.277.352.640.750
17996206,2007-11-08T00:00:00,Threonine,D12.125.142.815
17996206,2007-11-08T00:00:00,Threonine,D12.125.154.900
17996206,2007-11-08T00:00:00,Threonine,D12.125.901
17996206,2007-11-08T00:00:00,beta Catenin,D12.776.091.249
17996206,2007-11-08T00:00:00,beta Catenin,D12.776.220.145.500
17996206,2007-11-08T00:00:00,beta Catenin,D12.776.930.130
17990877,2007-11-09T00:00:00,HIV Long Terminal Repeat,G02.111.570.080.708.850.400
17990877,2007-11-09T00:00:00,HIV Long Terminal Repeat,G05.360.080.708.850.400
17990877,2007-11-09T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
17990877,2007-11-09T00:00:00,"Models, Molecular",E05.599.595
17990877,2007-11-09T00:00:00,Nucleic Acid Conformation,G02.111.570.790.486
17990877,2007-11-09T00:00:00,Nucleic Acid Conformation,G05.360.580
17990877,2007-11-09T00:00:00,Pyrimidines,D03.383.742
17990877,2007-11-09T00:00:00,RNA,D13.444.735
17990877,2007-11-09T00:00:00,Temperature,G01.906.595
17990877,2007-11-09T00:00:00,Temperature,G16.500.275.063.725.710
17990877,2007-11-09T00:00:00,Temperature,G16.500.750.775.710
17990877,2007-11-09T00:00:00,Temperature,N06.230.150.450
17990877,2007-11-09T00:00:00,Temperature,N06.230.300.100.725.710
17993477,2007-11-09T00:00:00,Biomedical Research,H01.770.644.145
17993477,2007-11-09T00:00:00,Cardiopulmonary Resuscitation,E02.365.647.110
17993477,2007-11-09T00:00:00,Emergency Medical Services,N02.421.297
17993477,2007-11-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17993477,2007-11-09T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
17993477,2007-11-09T00:00:00,Practice Guidelines as Topic,N05.700.350.650
17993477,2007-11-09T00:00:00,Stroke,C10.228.140.300.775
17993477,2007-11-09T00:00:00,Stroke,C14.907.253.855
18035065,2007-11-09T00:00:00,Animals,B01.050
18035065,2007-11-09T00:00:00,Breast Neoplasms,C04.588.180
18035065,2007-11-09T00:00:00,Breast Neoplasms,C17.800.090.500
18035065,2007-11-09T00:00:00,Ceramides,D02.065.313
18035065,2007-11-09T00:00:00,Ceramides,D09.400.410.420.525.200
18035065,2007-11-09T00:00:00,Ceramides,D10.390.470.675.200
18035065,2007-11-09T00:00:00,Ceramides,D10.570.877.360.612.200
18035065,2007-11-09T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
18035065,2007-11-09T00:00:00,Gene Expression Regulation,G05.355.315
18035065,2007-11-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18035065,2007-11-09T00:00:00,P-Glycoprotein,D12.776.157.530.100.652.500
18035065,2007-11-09T00:00:00,P-Glycoprotein,D12.776.157.530.450.074.500.500.750
18035065,2007-11-09T00:00:00,P-Glycoprotein,D12.776.395.550.020.610.610
18035065,2007-11-09T00:00:00,P-Glycoprotein,D12.776.543.550.192.610.610
18035065,2007-11-09T00:00:00,P-Glycoprotein,D12.776.543.585.100.610.500
18035065,2007-11-09T00:00:00,P-Glycoprotein,D12.776.543.585.450.074.500.500.750
18068196,2007-11-09T00:00:00,Adenoviridae,B04.280.030
18068196,2007-11-09T00:00:00,Adenoviridae,B04.909.204.097
18068196,2007-11-09T00:00:00,Animals,B01.050
18068196,2007-11-09T00:00:00,Bradykinin,D12.644.276.812.169
18068196,2007-11-09T00:00:00,Bradykinin,D12.644.400.090
18068196,2007-11-09T00:00:00,Bradykinin,D12.644.456.193
18068196,2007-11-09T00:00:00,Bradykinin,D12.776.467.812.169
18068196,2007-11-09T00:00:00,Bradykinin,D12.776.641.650.090
18068196,2007-11-09T00:00:00,Bradykinin,D23.469.050.375.110
18068196,2007-11-09T00:00:00,Bradykinin,D23.529.812.169
18068196,2007-11-09T00:00:00,Enzyme Inhibitors,D27.505.519.389
18068196,2007-11-09T00:00:00,Gene Expression,G05.355.310
18068196,2007-11-09T00:00:00,Gene Transfer Techniques,E05.393.350
18068196,2007-11-09T00:00:00,Heart Ventricles,A07.541.560
18068196,2007-11-09T00:00:00,Hemodynamics,G09.330.190.400
18068196,2007-11-09T00:00:00,Hemodynamics,G09.330.380
18068196,2007-11-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18068196,2007-11-09T00:00:00,Kallikreins,D08.811.277.656.300.760.442
18068196,2007-11-09T00:00:00,Kallikreins,D08.811.277.656.959.350.442
18068196,2007-11-09T00:00:00,Kallikreins,D12.776.124.125.597
18068196,2007-11-09T00:00:00,Kallikreins,D23.119.597
18068196,2007-11-09T00:00:00,Myocardial Infarction,C14.280.647.500
18068196,2007-11-09T00:00:00,Myocardial Infarction,C14.907.585.500
18068196,2007-11-09T00:00:00,Myocardium,A02.633.580
18068196,2007-11-09T00:00:00,Myocardium,A07.541.704
18068196,2007-11-09T00:00:00,Myocardium,A10.690.552.750
18068196,2007-11-09T00:00:00,Nitric Oxide,D01.339.387
18068196,2007-11-09T00:00:00,Nitric Oxide,D01.625.550.500
18068196,2007-11-09T00:00:00,Nitric Oxide,D01.625.700.500
18068196,2007-11-09T00:00:00,Nitric Oxide,D01.650.550.587.600
18068196,2007-11-09T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
18068196,2007-11-09T00:00:00,Nitric Oxide Synthase Type III,D08.811.682.664.500.772.750
18068196,2007-11-09T00:00:00,Phosphorylation,G02.111.087.677
18068196,2007-11-09T00:00:00,Phosphorylation,G02.149.115.677
18068196,2007-11-09T00:00:00,Phosphorylation,G02.149.465.700
18068196,2007-11-09T00:00:00,Phosphorylation,G02.607.750.700
18068196,2007-11-09T00:00:00,Phosphorylation,G03.495.790
18068196,2007-11-09T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18068196,2007-11-09T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.100.080.500
18068196,2007-11-09T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.720.600.220.500
18068196,2007-11-09T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.750.555.220.500
18068196,2007-11-09T00:00:00,Ventricular Remodeling,C23.300.985
18068196,2007-11-09T00:00:00,Ventricular Remodeling,G09.330.190.962.975
17999176,2007-11-13T00:00:00,Child,M01.060.406
17999176,2007-11-13T00:00:00,Child Health Services,N02.421.143.130
17999176,2007-11-13T00:00:00,Community Mental Health Services,F04.408.307
17999176,2007-11-13T00:00:00,Community Mental Health Services,N02.421.143.183
17999176,2007-11-13T00:00:00,Community Mental Health Services,N02.421.461.232
17999176,2007-11-13T00:00:00,Health Education,I02.233.332
17999176,2007-11-13T00:00:00,Health Education,N02.421.143.827.407
17999176,2007-11-13T00:00:00,Health Education,N02.421.726.407
17999176,2007-11-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17999176,2007-11-13T00:00:00,Interviews as Topic,E05.318.308.420
17999176,2007-11-13T00:00:00,Interviews as Topic,L01.280.520
17999176,2007-11-13T00:00:00,Interviews as Topic,N05.715.360.300.400
17999176,2007-11-13T00:00:00,Interviews as Topic,N06.850.520.308.420
17999176,2007-11-13T00:00:00,Mental Disorders,F03
17999176,2007-11-13T00:00:00,Social Support,I01.880.656.600
17999176,2007-11-13T00:00:00,United States,Z01.107.567.875
18000750,2007-11-14T00:00:00,Child,M01.060.406
18000750,2007-11-14T00:00:00,Child Health Services,N02.421.143.130
18000750,2007-11-14T00:00:00,Community Mental Health Services,F04.408.307
18000750,2007-11-14T00:00:00,Community Mental Health Services,N02.421.143.183
18000750,2007-11-14T00:00:00,Community Mental Health Services,N02.421.461.232
18000750,2007-11-14T00:00:00,Diffusion of Innovation,L01.143.320
18000750,2007-11-14T00:00:00,Evidence-Based Medicine,H02.249.750
18000750,2007-11-14T00:00:00,Evidence-Based Medicine,H02.403.200.400
18000750,2007-11-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18000750,2007-11-14T00:00:00,Interviews as Topic,E05.318.308.420
18000750,2007-11-14T00:00:00,Interviews as Topic,L01.280.520
18000750,2007-11-14T00:00:00,Interviews as Topic,N05.715.360.300.400
18000750,2007-11-14T00:00:00,Interviews as Topic,N06.850.520.308.420
18000750,2007-11-14T00:00:00,Mental Disorders,F03
18006221,2007-11-14T00:00:00,Adult,M01.060.116
18006221,2007-11-14T00:00:00,Case-Control Studies,E05.318.760.500.500
18006221,2007-11-14T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18006221,2007-11-14T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18006221,2007-11-14T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
18006221,2007-11-14T00:00:00,Hand,A01.378.800.667
18006221,2007-11-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18006221,2007-11-14T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18006221,2007-11-14T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18006221,2007-11-14T00:00:00,Middle Aged,M01.060.116.630
18006221,2007-11-14T00:00:00,Motor Activity,F01.145.632
18006221,2007-11-14T00:00:00,Motor Activity,G11.427.590.530.698
18006221,2007-11-14T00:00:00,Task Performance and Analysis,F02.784.412.846
18006221,2007-11-14T00:00:00,Task Performance and Analysis,F02.784.692.746
18006221,2007-11-14T00:00:00,Task Performance and Analysis,F02.808.600
18006221,2007-11-14T00:00:00,Torticollis,C10.228.662.300.750
18006221,2007-11-14T00:00:00,Torticollis,C10.597.350.300.800
18006221,2007-11-14T00:00:00,Torticollis,C23.888.592.350.300.800
17621656,2007-11-15T00:00:00,Aged,M01.060.116.100
17621656,2007-11-15T00:00:00,Biological Markers,D23.101
17621656,2007-11-15T00:00:00,Blood Vessel Prosthesis Implantation,E04.100.814.200
17621656,2007-11-15T00:00:00,Blood Vessel Prosthesis Implantation,E04.650.200
17621656,2007-11-15T00:00:00,"Coated Materials, Biocompatible",D25.130.420
17621656,2007-11-15T00:00:00,"Coated Materials, Biocompatible",J01.637.051.130.420
17621656,2007-11-15T00:00:00,Coronary Angiography,E01.370.350.700.060.200
17621656,2007-11-15T00:00:00,Coronary Angiography,E01.370.370.050.200
17621656,2007-11-15T00:00:00,Coronary Angiography,E01.370.370.380.200
17621656,2007-11-15T00:00:00,Coronary Disease,C14.280.647.250
17621656,2007-11-15T00:00:00,Coronary Disease,C14.907.585.250
17621656,2007-11-15T00:00:00,"Creatine Kinase, MB Form",D08.811.913.696.640.150.625
17621656,2007-11-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17621656,2007-11-15T00:00:00,Middle Aged,M01.060.116.630
17621656,2007-11-15T00:00:00,Regression Analysis,E05.318.740.750
17621656,2007-11-15T00:00:00,Regression Analysis,N05.715.360.750.695
17621656,2007-11-15T00:00:00,Regression Analysis,N06.850.520.830.750
17621656,2007-11-15T00:00:00,Risk Factors,E05.318.740.600.800.725
17621656,2007-11-15T00:00:00,Risk Factors,N05.715.350.200.700
17621656,2007-11-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17621656,2007-11-15T00:00:00,Risk Factors,N06.850.490.625.750
17621656,2007-11-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17621656,2007-11-15T00:00:00,Stents,E07.695.750
17621656,2007-11-15T00:00:00,Time Factors,G01.910.857
17621656,2007-11-15T00:00:00,Treatment Outcome,E01.789.800
17621656,2007-11-15T00:00:00,Treatment Outcome,N04.761.559.590.800
17621656,2007-11-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17996525,2007-11-15T00:00:00,Anxiety,F01.470.132
17996525,2007-11-15T00:00:00,"Cardiomyopathy, Hypertrophic",C14.280.238.100
17996525,2007-11-15T00:00:00,"Cardiomyopathy, Hypertrophic",C14.280.484.150.070.160
17996525,2007-11-15T00:00:00,Catheter Ablation,E01.370.370.380.410.200
17996525,2007-11-15T00:00:00,Catheter Ablation,E02.148.110
17996525,2007-11-15T00:00:00,Catheter Ablation,E02.148.442.110
17996525,2007-11-15T00:00:00,Catheter Ablation,E02.154.402.110
17996525,2007-11-15T00:00:00,Catheter Ablation,E04.014.170.402.110
17996525,2007-11-15T00:00:00,Depression,F01.145.126.350
17996525,2007-11-15T00:00:00,Ethanol,D02.033.375
17996525,2007-11-15T00:00:00,Heart Septum,A07.541.459
17996525,2007-11-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17996525,2007-11-15T00:00:00,Middle Aged,M01.060.116.630
17996525,2007-11-15T00:00:00,Quality of Life,I01.800
17996525,2007-11-15T00:00:00,Quality of Life,K01.752.400.750
17996525,2007-11-15T00:00:00,Questionnaires,E05.318.308.750
17996525,2007-11-15T00:00:00,Questionnaires,L01.280.800
17996525,2007-11-15T00:00:00,Questionnaires,N05.715.360.300.695
17996525,2007-11-15T00:00:00,Questionnaires,N06.850.520.308.750
17996525,2007-11-15T00:00:00,Solvents,D27.720.844
17996525,2007-11-15T00:00:00,"Stress, Psychological",F01.145.126.990
17996525,2007-11-15T00:00:00,"Stress, Psychological",F02.830.900
18006496,2007-11-15T00:00:00,Angiotensin II,D06.472.699.094.078
18006496,2007-11-15T00:00:00,Angiotensin II,D12.644.400.070.078
18006496,2007-11-15T00:00:00,Angiotensin II,D12.644.456.073.041
18006496,2007-11-15T00:00:00,Angiotensin II,D12.644.548.058.078
18006496,2007-11-15T00:00:00,Angiotensin II,D12.776.641.650.070.078
18006496,2007-11-15T00:00:00,Angiotensin II,D23.469.050.050.050
18006496,2007-11-15T00:00:00,Animals,B01.050
18006496,2007-11-15T00:00:00,Arrestins,D12.776.306.090
18006496,2007-11-15T00:00:00,Arrestins,D12.776.543.090
18006496,2007-11-15T00:00:00,Cell Line,A11.251.210
18006496,2007-11-15T00:00:00,Gene Expression Profiling,E05.393.332
18006496,2007-11-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18006496,2007-11-15T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
18006496,2007-11-15T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
18006496,2007-11-15T00:00:00,MAP Kinase Signaling System,G03.495.553.560
18006496,2007-11-15T00:00:00,MAP Kinase Signaling System,G04.299.880.560
18006496,2007-11-15T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.567.342.500
18006496,2007-11-15T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.646.750.249.500
18006496,2007-11-15T00:00:00,Mitogen-Activated Protein Kinase 1,D12.644.360.450.169.500
18006496,2007-11-15T00:00:00,Mitogen-Activated Protein Kinase 1,D12.776.476.450.169.500
18006496,2007-11-15T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.567.342.750
18006496,2007-11-15T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.646.750.249.750
18006496,2007-11-15T00:00:00,Mitogen-Activated Protein Kinase 3,D12.644.360.450.169.750
18006496,2007-11-15T00:00:00,Mitogen-Activated Protein Kinase 3,D12.776.476.450.169.750
18006496,2007-11-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
18006496,2007-11-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
18006496,2007-11-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
18006496,2007-11-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
18006496,2007-11-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
18006496,2007-11-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
18006496,2007-11-15T00:00:00,Protein Isoforms,D12.776.800
18006496,2007-11-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18006496,2007-11-15T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.100.047.625
18006496,2007-11-15T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.720.600.150.625
18006496,2007-11-15T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.750.130.750
18006496,2007-11-15T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.750.555.150.750
18006496,2007-11-15T00:00:00,"Transcription, Genetic",G02.111.087.847
18006496,2007-11-15T00:00:00,"Transcription, Genetic",G02.149.115.847
18006496,2007-11-15T00:00:00,"Transcription, Genetic",G05.355.310.700
18006496,2007-11-15T00:00:00,Vasoconstrictor Agents,D27.505.954.411.793
18075104,2007-11-15T00:00:00,Adsorption,G02.149.047
18075104,2007-11-15T00:00:00,Adsorption,G02.149.767.029
18075104,2007-11-15T00:00:00,Adsorption,G02.842.750.029
18075104,2007-11-15T00:00:00,Carbon,D01.268.150
18075104,2007-11-15T00:00:00,Environmental Monitoring,N06.850.460.350.080
18075104,2007-11-15T00:00:00,Environmental Monitoring,N06.850.780.375
18075104,2007-11-15T00:00:00,Nitrogen,D01.268.604
18075104,2007-11-15T00:00:00,Nitrogen,D01.362.625
18075104,2007-11-15T00:00:00,Organic Chemicals,D02
18075104,2007-11-15T00:00:00,Solubility,G02.842.800
18075104,2007-11-15T00:00:00,Solvents,D27.720.844
18075104,2007-11-15T00:00:00,Temperature,G01.906.595
18075104,2007-11-15T00:00:00,Temperature,G16.500.275.063.725.710
18075104,2007-11-15T00:00:00,Temperature,G16.500.750.775.710
18075104,2007-11-15T00:00:00,Temperature,N06.230.150.450
18075104,2007-11-15T00:00:00,Temperature,N06.230.300.100.725.710
18075104,2007-11-15T00:00:00,Trichloroethylene,D02.455.526.439.939
18075104,2007-11-15T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
18256531,2007-11-16T00:00:00,Animals,B01.050
18256531,2007-11-16T00:00:00,Apoptosis,G04.299.139.160
18256531,2007-11-16T00:00:00,Cell Line,A11.251.210
18256531,2007-11-16T00:00:00,DNA-Binding Proteins,D12.776.260
18256531,2007-11-16T00:00:00,Fibroblasts,A11.329.228
18256531,2007-11-16T00:00:00,Fibroblasts,A11.872.228
18256531,2007-11-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18256531,2007-11-16T00:00:00,Nuclear Proteins,D12.776.660
18256531,2007-11-16T00:00:00,Protein Isoforms,D12.776.800
18256531,2007-11-16T00:00:00,Proto-Oncogene Proteins,D12.776.624.664.700
18256531,2007-11-16T00:00:00,Tumor Suppressor Protein p53,D12.776.260.820
18256531,2007-11-16T00:00:00,Tumor Suppressor Protein p53,D12.776.624.776.775
18256531,2007-11-16T00:00:00,Tumor Suppressor Protein p53,D12.776.660.825
18256531,2007-11-16T00:00:00,Tumor Suppressor Protein p53,D12.776.744.845
18256531,2007-11-16T00:00:00,Tumor Suppressor Proteins,D12.776.624.776
18256531,2007-11-16T00:00:00,Viral Proteins,D12.776.964
18024967,2007-11-17T00:00:00,Internet,L01.224.230.110.500
18024967,2007-11-17T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
18024967,2007-11-17T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
18024967,2007-11-17T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
18024967,2007-11-17T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
18024967,2007-11-17T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
18024967,2007-11-17T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
18024967,2007-11-17T00:00:00,User-Computer Interface,L01.224.900.910
18028370,2007-11-17T00:00:00,Anilides,D02.065.199
18028370,2007-11-17T00:00:00,Animals,B01.050
18028370,2007-11-17T00:00:00,Immune Tolerance,G12.425.746.425
18028370,2007-11-17T00:00:00,Lipopolysaccharides,D09.400.500
18028370,2007-11-17T00:00:00,Lipopolysaccharides,D09.698.718.450
18028370,2007-11-17T00:00:00,Lipopolysaccharides,D10.494
18028370,2007-11-17T00:00:00,Lipopolysaccharides,D23.050.161.616.525
18028370,2007-11-17T00:00:00,Lipopolysaccharides,D23.946.123.329.500
18028370,2007-11-17T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18028370,2007-11-17T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
18028370,2007-11-17T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
18028370,2007-11-17T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
18028370,2007-11-17T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
18028370,2007-11-17T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
18028370,2007-11-17T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
18028370,2007-11-17T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
18028370,2007-11-17T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
18028370,2007-11-17T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
18028370,2007-11-17T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
18028370,2007-11-17T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
18005993,2007-11-19T00:00:00,Adult,M01.060.116
18005993,2007-11-19T00:00:00,Aged,M01.060.116.100
18005993,2007-11-19T00:00:00,Ambulatory Care,E02.760.106
18005993,2007-11-19T00:00:00,Ambulatory Care,N02.421.585.106
18005993,2007-11-19T00:00:00,Disability Evaluation,E01.370.400
18005993,2007-11-19T00:00:00,Health Services Accessibility,N04.590.374.350
18005993,2007-11-19T00:00:00,Health Services Accessibility,N05.300.430
18005993,2007-11-19T00:00:00,Health Surveys,E05.318.308.250
18005993,2007-11-19T00:00:00,Health Surveys,N05.715.360.300.375
18005993,2007-11-19T00:00:00,Health Surveys,N06.850.520.308.250
18005993,2007-11-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18005993,2007-11-19T00:00:00,Mental Disorders,F03
18005993,2007-11-19T00:00:00,Mental Health Services,F04.408
18005993,2007-11-19T00:00:00,Mental Health Services,N02.421.461
18005993,2007-11-19T00:00:00,Middle Aged,M01.060.116.630
18005993,2007-11-19T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
18005993,2007-11-19T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
18005993,2007-11-19T00:00:00,Regression Analysis,E05.318.740.750
18005993,2007-11-19T00:00:00,Regression Analysis,N05.715.360.750.695
18005993,2007-11-19T00:00:00,Regression Analysis,N06.850.520.830.750
18005993,2007-11-19T00:00:00,Risk Factors,E05.318.740.600.800.725
18005993,2007-11-19T00:00:00,Risk Factors,N05.715.350.200.700
18005993,2007-11-19T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18005993,2007-11-19T00:00:00,Risk Factors,N06.850.490.625.750
18005993,2007-11-19T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18005993,2007-11-19T00:00:00,United States,Z01.107.567.875
18005993,2007-11-19T00:00:00,Veterans,M01.930
18025079,2007-11-19T00:00:00,Adolescent,M01.060.057
18025079,2007-11-19T00:00:00,Child,M01.060.406
18025079,2007-11-19T00:00:00,"Child, Preschool",M01.060.406.448
18025079,2007-11-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18025079,2007-11-19T00:00:00,Infant,M01.060.703
18025079,2007-11-19T00:00:00,"Infant, Newborn",M01.060.703.520
18025079,2007-11-19T00:00:00,Risk Factors,E05.318.740.600.800.725
18025079,2007-11-19T00:00:00,Risk Factors,N05.715.350.200.700
18025079,2007-11-19T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18025079,2007-11-19T00:00:00,Risk Factors,N06.850.490.625.750
18025079,2007-11-19T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18025079,2007-11-19T00:00:00,Time Factors,G01.910.857
18025294,2007-11-19T00:00:00,Activities of Daily Living,E02.831.067
18025294,2007-11-19T00:00:00,Activities of Daily Living,I03.050
18025294,2007-11-19T00:00:00,Activities of Daily Living,N02.421.784.110
18025294,2007-11-19T00:00:00,African Americans,M01.686.508.100.100
18025294,2007-11-19T00:00:00,African Americans,M01.686.754.100
18025294,2007-11-19T00:00:00,Aged,M01.060.116.100
18025294,2007-11-19T00:00:00,Antihypertensive Agents,D27.505.954.411.162
18025294,2007-11-19T00:00:00,Blood Pressure,E01.370.600.875.249
18025294,2007-11-19T00:00:00,Blood Pressure,G09.330.380.076
18025294,2007-11-19T00:00:00,Disability Evaluation,E01.370.400
18025294,2007-11-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18025294,2007-11-19T00:00:00,Hypertension,C14.907.489
18025294,2007-11-19T00:00:00,Risk Assessment,E05.318.740.600.800.715
18025294,2007-11-19T00:00:00,Risk Assessment,N04.452.871.715
18025294,2007-11-19T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18025294,2007-11-19T00:00:00,Risk Assessment,N06.850.505.715
18025294,2007-11-19T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18028346,2007-11-20T00:00:00,Adult,M01.060.116
18028346,2007-11-20T00:00:00,Aging,G07.700.320.124
18028346,2007-11-20T00:00:00,Curriculum,I02.158
18028346,2007-11-20T00:00:00,"Education, Medical, Undergraduate",I02.358.399.450
18028346,2007-11-20T00:00:00,Educational Measurement,I02.399
18028346,2007-11-20T00:00:00,General Surgery,H02.403.810.300
18028346,2007-11-20T00:00:00,Geriatrics,H02.403.355
18028346,2007-11-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18028346,2007-11-20T00:00:00,Internship and Residency,I02.358.399.644
18028346,2007-11-20T00:00:00,Questionnaires,E05.318.308.750
18028346,2007-11-20T00:00:00,Questionnaires,L01.280.800
18028346,2007-11-20T00:00:00,Questionnaires,N05.715.360.300.695
18028346,2007-11-20T00:00:00,Questionnaires,N06.850.520.308.750
18028346,2007-11-20T00:00:00,United States,Z01.107.567.875
18028529,2007-11-20T00:00:00,Adult,M01.060.116
18028529,2007-11-20T00:00:00,Alcohol Drinking,F01.145.317.269
18028529,2007-11-20T00:00:00,Anxiety Disorders,F03.080
18028529,2007-11-20T00:00:00,Double-Blind Method,E05.318.780.300
18028529,2007-11-20T00:00:00,Double-Blind Method,E05.581.500.300
18028529,2007-11-20T00:00:00,Double-Blind Method,N05.715.360.780.320
18028529,2007-11-20T00:00:00,Double-Blind Method,N06.850.520.445.300
18028529,2007-11-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18028529,2007-11-20T00:00:00,Paroxetine,D03.383.621.600
18028529,2007-11-20T00:00:00,Patient Compliance,F01.145.488.500
18028529,2007-11-20T00:00:00,Patient Compliance,N05.300.150.600.600
18028529,2007-11-20T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.600.850
18028529,2007-11-20T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.850.900
18028529,2007-11-20T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.600.850
18028529,2007-11-20T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.850.900
18036149,2007-11-23T00:00:00,Animals,B01.050
18036149,2007-11-23T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
18036149,2007-11-23T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.450.625.124
18036149,2007-11-23T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.562.374.500.500
18036149,2007-11-23T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.450.625.124
18036149,2007-11-23T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.562.374.500.500
18036149,2007-11-23T00:00:00,Lumbar Vertebrae,A02.835.232.834.519
18038244,2007-11-24T00:00:00,Animals,B01.050
18038244,2007-11-24T00:00:00,Biological Markers,D23.101
18038244,2007-11-24T00:00:00,"Disease Models, Animal",C22.232
18038244,2007-11-24T00:00:00,"Disease Models, Animal",E05.598.500
18038244,2007-11-24T00:00:00,"Disease Models, Animal",E05.599.395.080
18038244,2007-11-24T00:00:00,Osteoporosis,C05.116.198.579
18038244,2007-11-24T00:00:00,RANK Ligand,D12.644.276.374.750.562
18038244,2007-11-24T00:00:00,RANK Ligand,D12.644.276.972.562
18038244,2007-11-24T00:00:00,RANK Ligand,D12.776.467.374.750.562
18038244,2007-11-24T00:00:00,RANK Ligand,D12.776.467.972.562
18038244,2007-11-24T00:00:00,RANK Ligand,D23.529.374.750.562
18038244,2007-11-24T00:00:00,RANK Ligand,D23.529.972.562
18038244,2007-11-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18038244,2007-11-24T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18166496,2007-11-24T00:00:00,Animals,B01.050
18166496,2007-11-24T00:00:00,Apoptosis,G04.299.139.160
18166496,2007-11-24T00:00:00,Inflammation,C23.550.470
18166496,2007-11-24T00:00:00,Lipopolysaccharides,D09.400.500
18166496,2007-11-24T00:00:00,Lipopolysaccharides,D09.698.718.450
18166496,2007-11-24T00:00:00,Lipopolysaccharides,D10.494
18166496,2007-11-24T00:00:00,Lipopolysaccharides,D23.050.161.616.525
18166496,2007-11-24T00:00:00,Lipopolysaccharides,D23.946.123.329.500
18166496,2007-11-24T00:00:00,Lysophospholipids,D10.570.755.375.760.550
18166496,2007-11-24T00:00:00,Macrophages,A11.329.372
18166496,2007-11-24T00:00:00,Macrophages,A11.627.482
18166496,2007-11-24T00:00:00,Macrophages,A11.733.397
18166496,2007-11-24T00:00:00,Macrophages,A15.382.680.397
18166496,2007-11-24T00:00:00,Macrophages,A15.382.812.522
18166496,2007-11-24T00:00:00,Phosphotransferases (Alcohol Group Acceptor),D08.811.913.696.620
18166496,2007-11-24T00:00:00,Sphingosine,D02.033.100.700
18166496,2007-11-24T00:00:00,Sphingosine,D02.033.455.843
18166496,2007-11-24T00:00:00,Sphingosine,D02.092.063.700
18166496,2007-11-24T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
18166496,2007-11-24T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
18166496,2007-11-24T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
18166496,2007-11-24T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
18166496,2007-11-24T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
18166496,2007-11-24T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
18166496,2007-11-24T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
18166496,2007-11-24T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
18166496,2007-11-24T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
18166496,2007-11-24T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
18166496,2007-11-24T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
18039674,2007-11-25T00:00:00,Adult,M01.060.116
18039674,2007-11-25T00:00:00,Alcohol Drinking,F01.145.317.269
18039674,2007-11-25T00:00:00,Alcoholism,C21.739.100.250
18039674,2007-11-25T00:00:00,Alcoholism,F03.900.100.350
18039674,2007-11-25T00:00:00,Biological Markers,D23.101
18039674,2007-11-25T00:00:00,Blood Pressure,E01.370.600.875.249
18039674,2007-11-25T00:00:00,Blood Pressure,G09.330.380.076
18039674,2007-11-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18039674,2007-11-25T00:00:00,Hypertension,C14.907.489
18039674,2007-11-25T00:00:00,Middle Aged,M01.060.116.630
18039674,2007-11-25T00:00:00,Substance Abuse Treatment Centers,N02.278.035.128.800
18039674,2007-11-25T00:00:00,Substance Abuse Treatment Centers,N02.278.808.930
18039674,2007-11-25T00:00:00,Transferrin,D12.776.124.050.800
18039674,2007-11-25T00:00:00,Transferrin,D12.776.124.790.223.839
18039674,2007-11-25T00:00:00,Transferrin,D12.776.157.427.500
18039674,2007-11-25T00:00:00,Transferrin,D12.776.377.715.182.839
18039674,2007-11-25T00:00:00,Transferrin,D12.776.556.579.500
18031989,2007-11-26T00:00:00,Adolescent,M01.060.057
18031989,2007-11-26T00:00:00,Adult,M01.060.116
18031989,2007-11-26T00:00:00,Aged,M01.060.116.100
18031989,2007-11-26T00:00:00,Endoscopy,E01.370.388.250
18031989,2007-11-26T00:00:00,Endoscopy,E04.800.250
18031989,2007-11-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18031989,2007-11-26T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
18031989,2007-11-26T00:00:00,Middle Aged,M01.060.116.630
18031989,2007-11-26T00:00:00,Phonation,G09.772.770.680
18031989,2007-11-26T00:00:00,Stroboscopy,E01.370.350.755
18031989,2007-11-26T00:00:00,Video Recording,L01.240.960
18031989,2007-11-26T00:00:00,Voice,G09.772.925
18031989,2007-11-26T00:00:00,Young Adult,M01.060.116.815
18037310,2007-11-26T00:00:00,Adolescent,M01.060.057
18037310,2007-11-26T00:00:00,Adult,M01.060.116
18037310,2007-11-26T00:00:00,Algorithms,G17.035
18037310,2007-11-26T00:00:00,Algorithms,L01.224.050
18037310,2007-11-26T00:00:00,Brain Mapping,E01.370.350.086
18037310,2007-11-26T00:00:00,Brain Mapping,E01.370.376.149
18037310,2007-11-26T00:00:00,Brain Mapping,E05.132
18037310,2007-11-26T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
18037310,2007-11-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18037310,2007-11-26T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
18037310,2007-11-26T00:00:00,"Models, Statistical",E05.318.740.500
18037310,2007-11-26T00:00:00,"Models, Statistical",E05.599.835
18037310,2007-11-26T00:00:00,"Models, Statistical",N05.715.360.750.530
18037310,2007-11-26T00:00:00,"Models, Statistical",N06.850.520.830.500
18037310,2007-11-26T00:00:00,Nonlinear Dynamics,E05.599.850
18037310,2007-11-26T00:00:00,Nonlinear Dynamics,H01.548.675
18037585,2007-11-26T00:00:00,Brachytherapy,E02.815.150
18037585,2007-11-26T00:00:00,Breast Neoplasms,C04.588.180
18037585,2007-11-26T00:00:00,Breast Neoplasms,C17.800.090.500
18037585,2007-11-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18037585,2007-11-26T00:00:00,Radiodermatitis,C17.800.174.826
18037585,2007-11-26T00:00:00,Radiodermatitis,C21.866.733.804
18037585,2007-11-26T00:00:00,Treatment Outcome,E01.789.800
18037585,2007-11-26T00:00:00,Treatment Outcome,N04.761.559.590.800
18037585,2007-11-26T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18040012,2007-11-27T00:00:00,Aged,M01.060.116.100
18040012,2007-11-27T00:00:00,"Constriction, Pathologic",C23.300.287
18040012,2007-11-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18040012,2007-11-27T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
18040012,2007-11-27T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
18040012,2007-11-27T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
18040012,2007-11-27T00:00:00,Middle Aged,M01.060.116.630
18040012,2007-11-27T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
18040012,2007-11-27T00:00:00,Multicenter Studies as Topic,E05.337.250.500
18040012,2007-11-27T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
18040012,2007-11-27T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
18040012,2007-11-27T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
18040012,2007-11-27T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
18040012,2007-11-27T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
18040012,2007-11-27T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
18040012,2007-11-27T00:00:00,Risk Factors,E05.318.740.600.800.725
18040012,2007-11-27T00:00:00,Risk Factors,N05.715.350.200.700
18040012,2007-11-27T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18040012,2007-11-27T00:00:00,Risk Factors,N06.850.490.625.750
18040012,2007-11-27T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18040012,2007-11-27T00:00:00,Stroke,C10.228.140.300.775
18040012,2007-11-27T00:00:00,Stroke,C14.907.253.855
18040012,2007-11-27T00:00:00,Warfarin,D03.438.150.446.520.914
18040012,2007-11-27T00:00:00,Warfarin,D03.830.219.446.520.914
18042545,2007-11-27T00:00:00,3' Untranslated Regions,D13.444.735.544.875.880
18042545,2007-11-27T00:00:00,3' Untranslated Regions,D13.444.735.790.878.880
18042545,2007-11-27T00:00:00,3' Untranslated Regions,G05.360.340.024.220.880.880
18042545,2007-11-27T00:00:00,3' Untranslated Regions,G05.360.340.024.340.137.910.880
18042545,2007-11-27T00:00:00,Animals,B01.050
18042545,2007-11-27T00:00:00,Fibroblasts,A11.329.228
18042545,2007-11-27T00:00:00,Fibroblasts,A11.872.228
18042545,2007-11-27T00:00:00,Interleukin-1,D12.644.276.374.465.501
18042545,2007-11-27T00:00:00,Interleukin-1,D12.644.276.374.500.400
18042545,2007-11-27T00:00:00,Interleukin-1,D12.776.467.374.465.501
18042545,2007-11-27T00:00:00,Interleukin-1,D12.776.467.374.500.400
18042545,2007-11-27T00:00:00,Interleukin-1,D23.529.374.465.501
18042545,2007-11-27T00:00:00,Interleukin-1,D23.529.374.500.400
18042545,2007-11-27T00:00:00,Interleukin-6,D12.644.276.374.465.506
18042545,2007-11-27T00:00:00,Interleukin-6,D12.776.467.374.465.506
18042545,2007-11-27T00:00:00,Interleukin-6,D23.529.374.465.506
18042545,2007-11-27T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
18042545,2007-11-27T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
18042545,2007-11-27T00:00:00,MAP Kinase Signaling System,G03.495.553.560
18042545,2007-11-27T00:00:00,MAP Kinase Signaling System,G04.299.880.560
18042545,2007-11-27T00:00:00,Nucleic Acid Conformation,G02.111.570.790.486
18042545,2007-11-27T00:00:00,Nucleic Acid Conformation,G05.360.580
18042545,2007-11-27T00:00:00,"RNA Processing, Post-Transcriptional",G02.111.087.750
18042545,2007-11-27T00:00:00,"RNA Processing, Post-Transcriptional",G02.149.115.750
18042545,2007-11-27T00:00:00,"RNA Processing, Post-Transcriptional",G03.495.839
18042545,2007-11-27T00:00:00,"RNA Processing, Post-Transcriptional",G05.355.315.700
18042545,2007-11-27T00:00:00,RNA Stability,G02.111.780
20614286,2007-11-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20614286,2007-11-27T00:00:00,Terminology as Topic,L01.143.506.598.400
18048799,2007-11-29T00:00:00,African Continental Ancestry Group,M01.686.508.100
18048799,2007-11-29T00:00:00,Body Mass Index,E01.370.600.115.100.125
18048799,2007-11-29T00:00:00,Body Mass Index,E05.041.124.125
18048799,2007-11-29T00:00:00,Body Mass Index,G07.100.100.125
18048799,2007-11-29T00:00:00,Body Mass Index,N06.850.505.200.100.175
18048799,2007-11-29T00:00:00,Cardiovascular Diseases,C14
18048799,2007-11-29T00:00:00,European Continental Ancestry Group,M01.686.508.400
18048799,2007-11-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18048799,2007-11-29T00:00:00,Middle Aged,M01.060.116.630
18048799,2007-11-29T00:00:00,Nutrition Surveys,E05.318.308.250.600
18048799,2007-11-29T00:00:00,Nutrition Surveys,E05.318.308.585.550
18048799,2007-11-29T00:00:00,Nutrition Surveys,N05.715.360.300.375.560
18048799,2007-11-29T00:00:00,Nutrition Surveys,N05.715.360.300.560.565
18048799,2007-11-29T00:00:00,Nutrition Surveys,N06.850.520.308.250.600
18048799,2007-11-29T00:00:00,Nutrition Surveys,N06.850.520.308.585.550
18048799,2007-11-29T00:00:00,Obesity,C18.654.726.500
18048799,2007-11-29T00:00:00,Obesity,C23.888.144.699.500
18048799,2007-11-29T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
18048799,2007-11-29T00:00:00,Obesity,G07.100.100.160.120.699.500
18048799,2007-11-29T00:00:00,Risk Factors,E05.318.740.600.800.725
18048799,2007-11-29T00:00:00,Risk Factors,N05.715.350.200.700
18048799,2007-11-29T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18048799,2007-11-29T00:00:00,Risk Factors,N06.850.490.625.750
18048799,2007-11-29T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18048843,2007-11-29T00:00:00,Antioxidants,D27.505.519.217
18048843,2007-11-29T00:00:00,Antioxidants,D27.505.696.706.125
18048843,2007-11-29T00:00:00,Antioxidants,D27.720.799.047
18048843,2007-11-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18048843,2007-11-29T00:00:00,"Models, Statistical",E05.318.740.500
18048843,2007-11-29T00:00:00,"Models, Statistical",E05.599.835
18048843,2007-11-29T00:00:00,"Models, Statistical",N05.715.360.750.530
18048843,2007-11-29T00:00:00,"Models, Statistical",N06.850.520.830.500
18048843,2007-11-29T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
18048843,2007-11-29T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
18048843,2007-11-29T00:00:00,Stroke,C10.228.140.300.775
18048843,2007-11-29T00:00:00,Stroke,C14.907.253.855
18048843,2007-11-29T00:00:00,Treatment Outcome,E01.789.800
18048843,2007-11-29T00:00:00,Treatment Outcome,N04.761.559.590.800
18048843,2007-11-29T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18057909,2007-11-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18057909,2007-11-30T00:00:00,Laryngoscopy,E01.370.386.460
18057909,2007-11-30T00:00:00,Laryngoscopy,E01.370.388.250.525
18057909,2007-11-30T00:00:00,Laryngoscopy,E04.580.373
18057909,2007-11-30T00:00:00,Laryngoscopy,E04.800.250.525
18057909,2007-11-30T00:00:00,Phonation,G09.772.770.680
17370345,2007-12-01T00:00:00,Adolescent,M01.060.057
17370345,2007-12-01T00:00:00,Adult,M01.060.116
17370345,2007-12-01T00:00:00,Brain Mapping,E01.370.350.086
17370345,2007-12-01T00:00:00,Brain Mapping,E01.370.376.149
17370345,2007-12-01T00:00:00,Brain Mapping,E05.132
17370345,2007-12-01T00:00:00,Electroencephalography,E01.370.376.300
17370345,2007-12-01T00:00:00,Electroencephalography,E01.370.405.245
17370345,2007-12-01T00:00:00,"Epilepsy, Temporal Lobe",C10.228.140.490.360.290
17370345,2007-12-01T00:00:00,Hippocampus,A08.186.211.464.405
17370345,2007-12-01T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
17370345,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17370345,2007-12-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
17370345,2007-12-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17370345,2007-12-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17370345,2007-12-01T00:00:00,Mental Recall,F02.463.425.540.641
17370345,2007-12-01T00:00:00,Middle Aged,M01.060.116.630
17370345,2007-12-01T00:00:00,Neuropsychological Tests,F04.711.513
17370345,2007-12-01T00:00:00,Psychomotor Performance,F02.808
17370345,2007-12-01T00:00:00,Psychomotor Performance,G11.427.700
17370345,2007-12-01T00:00:00,Psychomotor Performance,G11.561.623
17370345,2007-12-01T00:00:00,Regression Analysis,E05.318.740.750
17370345,2007-12-01T00:00:00,Regression Analysis,N05.715.360.750.695
17370345,2007-12-01T00:00:00,Regression Analysis,N06.850.520.830.750
17370345,2007-12-01T00:00:00,Temporal Lobe,A08.186.211.730.885.287.500.863
17621259,2007-12-01T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
17621259,2007-12-01T00:00:00,Endothelial Cells,A11.436.275
17621259,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17621259,2007-12-01T00:00:00,Intercellular Adhesion Molecule-1,D12.776.395.550.200.450
17621259,2007-12-01T00:00:00,Intercellular Adhesion Molecule-1,D12.776.543.550.200.450
17621259,2007-12-01T00:00:00,Intercellular Adhesion Molecule-1,D23.050.301.264.035.400
17621259,2007-12-01T00:00:00,Intercellular Adhesion Molecule-1,D23.050.301.350.450
17621259,2007-12-01T00:00:00,Intercellular Adhesion Molecule-1,D23.101.100.110.400
17621259,2007-12-01T00:00:00,Mutation,G05.365.590
17621259,2007-12-01T00:00:00,NF-kappa B,D12.776.260.600
17621259,2007-12-01T00:00:00,NF-kappa B,D12.776.660.600
17621259,2007-12-01T00:00:00,NF-kappa B,D12.776.930.600
17621259,2007-12-01T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
17621259,2007-12-01T00:00:00,Signal Transduction,G02.111.087.800
17621259,2007-12-01T00:00:00,Signal Transduction,G02.149.115.800
17621259,2007-12-01T00:00:00,Signal Transduction,G04.299.880
17621259,2007-12-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
17621259,2007-12-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
17621259,2007-12-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
17621259,2007-12-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
17621259,2007-12-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
17621259,2007-12-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
17621259,2007-12-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
17621259,2007-12-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
17621259,2007-12-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
17621259,2007-12-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
17621259,2007-12-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
17659637,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17659637,2007-12-01T00:00:00,Parkinson Disease,C10.228.140.079.862.500
17659637,2007-12-01T00:00:00,Parkinson Disease,C10.228.662.600.400
17659637,2007-12-01T00:00:00,Parkinson Disease,C10.574.812
17940999,2007-12-01T00:00:00,"Adaptor Proteins, Signal Transducing",D12.644.360.024
17940999,2007-12-01T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.157.057
17940999,2007-12-01T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.476.024
17940999,2007-12-01T00:00:00,Animals,B01.050
17940999,2007-12-01T00:00:00,Bone Resorption,C05.116.264
17940999,2007-12-01T00:00:00,Bone Resorption,G11.427.590.195.150
17940999,2007-12-01T00:00:00,Bone and Bones,A02.835.232
17940999,2007-12-01T00:00:00,Bone and Bones,A10.165.265
17940999,2007-12-01T00:00:00,Cell Differentiation,G04.299.151
17940999,2007-12-01T00:00:00,Osteoblasts,A11.329.629
17940999,2007-12-01T00:00:00,Osteoclasts,A11.329.372.700
17940999,2007-12-01T00:00:00,Osteoclasts,A11.627.482.700
17940999,2007-12-01T00:00:00,Osteopetrosis,C05.116.099.708.702.678
17940999,2007-12-01T00:00:00,Phenotype,G05.695
17940999,2007-12-01T00:00:00,Signal Transduction,G02.111.087.800
17940999,2007-12-01T00:00:00,Signal Transduction,G02.149.115.800
17940999,2007-12-01T00:00:00,Signal Transduction,G04.299.880
17940999,2007-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17940999,2007-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17940999,2007-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17940999,2007-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17940999,2007-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17940999,2007-12-01T00:00:00,Transcription Factors,D12.776.930
17982366,2007-12-01T00:00:00,Adolescent,M01.060.057
17982366,2007-12-01T00:00:00,Adult,M01.060.116
17982366,2007-12-01T00:00:00,"Hearing Loss, Sensorineural",C09.218.458.341.887
17982366,2007-12-01T00:00:00,"Hearing Loss, Sensorineural",C10.597.751.418.341.887
17982366,2007-12-01T00:00:00,"Hearing Loss, Sensorineural",C23.888.592.763.393.341.887
17982366,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17982366,2007-12-01T00:00:00,"Otoacoustic Emissions, Spontaneous",G11.561.600.810.263.570
17982366,2007-12-01T00:00:00,Pressure,G01.374.715
17982366,2007-12-01T00:00:00,Research Design,E05.581.500
17982366,2007-12-01T00:00:00,Research Design,H01.770.644.728
17989513,2007-12-01T00:00:00,Animals,B01.050
17989513,2007-12-01T00:00:00,Cocaine,D02.145.074.722.388
17989513,2007-12-01T00:00:00,Cocaine,D03.132.889.354
17989513,2007-12-01T00:00:00,Cocaine,D03.605.869.388
17989513,2007-12-01T00:00:00,Cocaine,D04.075.080.875.099.722.388
17989513,2007-12-01T00:00:00,Discrimination Learning,F02.463.425.280
17989513,2007-12-01T00:00:00,Methamphetamine,D02.092.471.683.152.619
17989513,2007-12-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17989513,2007-12-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17993368,2007-12-01T00:00:00,Biomedical Research,H01.770.644.145
17993368,2007-12-01T00:00:00,Cardiopulmonary Resuscitation,E02.365.647.110
17993368,2007-12-01T00:00:00,Emergency Medical Services,N02.421.297
17993368,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17993368,2007-12-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
17993368,2007-12-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
17993368,2007-12-01T00:00:00,Stroke,C10.228.140.300.775
17993368,2007-12-01T00:00:00,Stroke,C14.907.253.855
18022486,2007-12-01T00:00:00,Adolescent,M01.060.057
18022486,2007-12-01T00:00:00,Adult,M01.060.116
18022486,2007-12-01T00:00:00,"Diagnosis, Differential",E01.171
18022486,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18024452,2007-12-01T00:00:00,Animals,B01.050
18024452,2007-12-01T00:00:00,Arterial Occlusive Diseases,C14.907.137
18024452,2007-12-01T00:00:00,Carotid Stenosis,C10.228.140.300.200.360
18024452,2007-12-01T00:00:00,Carotid Stenosis,C14.907.137.230
18024452,2007-12-01T00:00:00,Carotid Stenosis,C14.907.253.123.360
18024452,2007-12-01T00:00:00,"Constriction, Pathologic",C23.300.287
18024452,2007-12-01T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
18024452,2007-12-01T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
18024452,2007-12-01T00:00:00,Magnetic Resonance Angiography,E01.370.350.500.500
18024452,2007-12-01T00:00:00,Magnetic Resonance Angiography,E01.370.350.825.500.500
18024452,2007-12-01T00:00:00,Magnetic Resonance Angiography,E01.370.370.050.500
18024452,2007-12-01T00:00:00,Pressure,G01.374.715
18024452,2007-12-01T00:00:00,Swine,B01.050.150.900.649.077.880
18025232,2007-12-01T00:00:00,Animals,B01.050
18025232,2007-12-01T00:00:00,"Arthritis, Experimental",C05.550.114.015
18025232,2007-12-01T00:00:00,"Arthritis, Experimental",E05.598.500.249
18025232,2007-12-01T00:00:00,Binding Sites,G02.111.570.120
18025232,2007-12-01T00:00:00,Collagen,D05.750.078.280
18025232,2007-12-01T00:00:00,Collagen,D12.776.860.300.250
18025232,2007-12-01T00:00:00,Complement Activation,G12.425.255
18025232,2007-12-01T00:00:00,Complement C3,D12.776.124.050.140
18025232,2007-12-01T00:00:00,Complement C3,D12.776.124.486.274.250
18025232,2007-12-01T00:00:00,"Disease Models, Animal",C22.232
18025232,2007-12-01T00:00:00,"Disease Models, Animal",E05.598.500
18025232,2007-12-01T00:00:00,"Disease Models, Animal",E05.599.395.080
18025232,2007-12-01T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
18025232,2007-12-01T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
18025232,2007-12-01T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
18025232,2007-12-01T00:00:00,Inflammation,C23.550.470
18025232,2007-12-01T00:00:00,"Mice, Inbred DBA",B01.050.050.157.520.460
18025232,2007-12-01T00:00:00,"Mice, Inbred DBA",B01.050.050.199.520.520.460
18025232,2007-12-01T00:00:00,"Mice, Inbred DBA",B01.050.150.900.649.865.635.505.500.400.460
18025232,2007-12-01T00:00:00,Molecular Sequence Data,L01.453.245.667
18029813,2007-12-01T00:00:00,Animals,B01.050
18029813,2007-12-01T00:00:00,Cattle,B01.050.150.900.649.077.380.271
18029813,2007-12-01T00:00:00,Chickens,B01.050.150.900.248.350.150
18029813,2007-12-01T00:00:00,Chickens,B01.050.150.900.248.617.192
18029813,2007-12-01T00:00:00,Liver,A03.620
18029813,2007-12-01T00:00:00,Rabbits,B01.050.150.900.649.521.700
18033836,2007-12-01T00:00:00,Animals,B01.050
18033836,2007-12-01T00:00:00,Cattle,B01.050.150.900.649.077.380.271
18033836,2007-12-01T00:00:00,Ehrlichiosis,C01.252.400.054.160
18033836,2007-12-01T00:00:00,Ehrlichiosis,C01.252.400.825.200
18033836,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18033836,2007-12-01T00:00:00,"Models, Animal",E05.598
18033836,2007-12-01T00:00:00,Polymerase Chain Reaction,E05.393.620.500
18034607,2007-12-01T00:00:00,Aged,M01.060.116.100
18034607,2007-12-01T00:00:00,Algorithms,G17.035
18034607,2007-12-01T00:00:00,Algorithms,L01.224.050
18034607,2007-12-01T00:00:00,Blood Glucose,D09.546.359.448.500
18034607,2007-12-01T00:00:00,"Hospitals, University",N02.278.020.300.310
18034607,2007-12-01T00:00:00,"Hospitals, University",N02.278.421.639.725
18034607,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18034607,2007-12-01T00:00:00,Hypoglycemic Agents,D27.505.696.422
18034607,2007-12-01T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
18034607,2007-12-01T00:00:00,Insulin,D06.472.699.587.740.625
18034607,2007-12-01T00:00:00,Insulin,D12.644.548.586.740.625
18034607,2007-12-01T00:00:00,Internet,L01.224.230.110.500
18034607,2007-12-01T00:00:00,Middle Aged,M01.060.116.630
18036496,2007-12-01T00:00:00,Clinical Competence,I02.399.630.210
18036496,2007-12-01T00:00:00,Clinical Competence,N04.761.210
18036496,2007-12-01T00:00:00,Evidence-Based Medicine,H02.249.750
18036496,2007-12-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
18036496,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18036496,2007-12-01T00:00:00,Skin Temperature,G07.110.753
18036496,2007-12-01T00:00:00,Skin Temperature,G13.750.844
18036496,2007-12-01T00:00:00,Wounds and Injuries,C21.866
18042099,2007-12-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
18042099,2007-12-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
18042099,2007-12-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
18042099,2007-12-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
18042099,2007-12-01T00:00:00,Gastrostomy,E04.210.496
18042099,2007-12-01T00:00:00,Gastrostomy,E04.579.408
18042099,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18043106,2007-12-01T00:00:00,Adult,M01.060.116
18043106,2007-12-01T00:00:00,Aged,M01.060.116.100
18043106,2007-12-01T00:00:00,Bariatric Surgery,E02.065.062
18043106,2007-12-01T00:00:00,Bariatric Surgery,E04.062
18043106,2007-12-01T00:00:00,Cause of Death,E05.318.308.985.550.250
18043106,2007-12-01T00:00:00,Cause of Death,L01.280.975.550.250
18043106,2007-12-01T00:00:00,Cause of Death,N01.224.935.698.100
18043106,2007-12-01T00:00:00,Cause of Death,N06.850.505.400.975.550.250
18043106,2007-12-01T00:00:00,Cause of Death,N06.850.520.308.985.550.250
18043106,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18043106,2007-12-01T00:00:00,Laparoscopy,E01.370.388.250.520
18043106,2007-12-01T00:00:00,Laparoscopy,E04.800.250.520
18043106,2007-12-01T00:00:00,Middle Aged,M01.060.116.630
18043106,2007-12-01T00:00:00,"Obesity, Morbid",C18.654.726.500.700
18043106,2007-12-01T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
18043106,2007-12-01T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
18043106,2007-12-01T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
18043106,2007-12-01T00:00:00,Weight Loss,C23.888.144.243.963
18043106,2007-12-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
18047911,2007-12-01T00:00:00,Adolescent,M01.060.057
18047911,2007-12-01T00:00:00,African Americans,M01.686.508.100.100
18047911,2007-12-01T00:00:00,African Americans,M01.686.754.100
18047911,2007-12-01T00:00:00,Birth Weight,C23.888.144.186
18047911,2007-12-01T00:00:00,Birth Weight,E01.370.600.115.100.160.120.186
18047911,2007-12-01T00:00:00,Birth Weight,E05.041.124.160.750.149
18047911,2007-12-01T00:00:00,Birth Weight,G07.100.100.160.120.186
18047911,2007-12-01T00:00:00,Birth Weight,G07.700.320.249.314.120.186
18047911,2007-12-01T00:00:00,Blood Pressure,E01.370.600.875.249
18047911,2007-12-01T00:00:00,Blood Pressure,G09.330.380.076
18047911,2007-12-01T00:00:00,Child,M01.060.406
18047911,2007-12-01T00:00:00,"Child, Preschool",M01.060.406.448
18047911,2007-12-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
18047911,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18048628,2007-12-01T00:00:00,Adult,M01.060.116
18048628,2007-12-01T00:00:00,Delivery of Health Care,N04.590.374
18048628,2007-12-01T00:00:00,Delivery of Health Care,N05.300
18048628,2007-12-01T00:00:00,Health Promotion,N02.370
18048628,2007-12-01T00:00:00,Health Promotion,N02.421.726.507
18048628,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18048628,2007-12-01T00:00:00,Middle Aged,M01.060.116.630
18048628,2007-12-01T00:00:00,New York,Z01.107.567.875.075.437
18048628,2007-12-01T00:00:00,New York,Z01.107.567.875.350.530
18048628,2007-12-01T00:00:00,New York,Z01.107.567.875.500.530
18048628,2007-12-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
18048628,2007-12-01T00:00:00,Sex Factors,N05.715.350.675
18048628,2007-12-01T00:00:00,Sex Factors,N06.850.490.875
18048628,2007-12-01T00:00:00,Smoking,F01.145.466.753
18048628,2007-12-01T00:00:00,Smoking Cessation,F01.145.940.700
18053844,2007-12-01T00:00:00,"Anastomosis, Surgical",E04.035
18053844,2007-12-01T00:00:00,Drainage,E02.309
18053844,2007-12-01T00:00:00,Drainage,E04.237
18053844,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18053844,2007-12-01T00:00:00,Pleural Effusion,C08.528.652
18053844,2007-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18053844,2007-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18053844,2007-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18053844,2007-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18053844,2007-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18054747,2007-12-01T00:00:00,Aged,M01.060.116.100
18054747,2007-12-01T00:00:00,Dementia,C10.228.140.380
18054747,2007-12-01T00:00:00,Dementia,F03.087.400
18054747,2007-12-01T00:00:00,Endoscopy,E01.370.388.250
18054747,2007-12-01T00:00:00,Endoscopy,E04.800.250
18054747,2007-12-01T00:00:00,Enteral Nutrition,E02.421.360
18054747,2007-12-01T00:00:00,Enteral Nutrition,E02.642.500.360
18054747,2007-12-01T00:00:00,Gastrostomy,E04.210.496
18054747,2007-12-01T00:00:00,Gastrostomy,E04.579.408
18054747,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18054747,2007-12-01T00:00:00,United States,Z01.107.567.875
18059378,2007-12-01T00:00:00,Apoptosis,G04.299.139.160
18059378,2007-12-01T00:00:00,Arabidopsis,B01.650.388.100.157.100
18059378,2007-12-01T00:00:00,"Genome, Plant",G05.360.340.365
18059378,2007-12-01T00:00:00,Mutation,G05.365.590
18059378,2007-12-01T00:00:00,Phosphorylation,G02.111.087.677
18059378,2007-12-01T00:00:00,Phosphorylation,G02.149.115.677
18059378,2007-12-01T00:00:00,Phosphorylation,G02.149.465.700
18059378,2007-12-01T00:00:00,Phosphorylation,G02.607.750.700
18059378,2007-12-01T00:00:00,Phosphorylation,G03.495.790
18059378,2007-12-01T00:00:00,Reactive Oxygen Species,D01.339.431
18059378,2007-12-01T00:00:00,Reactive Oxygen Species,D01.650.775
18059378,2007-12-01T00:00:00,Signal Transduction,G02.111.087.800
18059378,2007-12-01T00:00:00,Signal Transduction,G02.149.115.800
18059378,2007-12-01T00:00:00,Signal Transduction,G04.299.880
18059378,2007-12-01T00:00:00,Sphingolipids,D10.570.877
18059378,2007-12-01T00:00:00,Sphingolipids,D10.808
18059378,2007-12-01T00:00:00,Sphingosine,D02.033.100.700
18059378,2007-12-01T00:00:00,Sphingosine,D02.033.455.843
18059378,2007-12-01T00:00:00,Sphingosine,D02.092.063.700
18071048,2007-12-01T00:00:00,Combined Modality Therapy,E02.186
18071048,2007-12-01T00:00:00,Disease Progression,C23.550.291.656
18071048,2007-12-01T00:00:00,Eye Diseases,C11
18071048,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18071048,2007-12-01T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
18071048,2007-12-01T00:00:00,Myasthenia Gravis,C10.114.656
18071048,2007-12-01T00:00:00,Myasthenia Gravis,C10.668.758.725
18071048,2007-12-01T00:00:00,Myasthenia Gravis,C20.111.258.500
18071048,2007-12-01T00:00:00,Prednisone,D04.808.745.432.719.702
18071048,2007-12-01T00:00:00,Thymectomy,E04.928.770
18085930,2007-12-01T00:00:00,Adult,M01.060.116
18085930,2007-12-01T00:00:00,Anxiety Disorders,F03.080
18085930,2007-12-01T00:00:00,Cognition,F02.463.188
18085930,2007-12-01T00:00:00,Depressive Disorder,F03.600.300
18085930,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18085930,2007-12-01T00:00:00,Personality Inventory,F04.711.647.513
18085930,2007-12-01T00:00:00,Psychiatric Status Rating Scales,F04.586
18085930,2007-12-01T00:00:00,Psychometrics,F04.711.780
18085930,2007-12-01T00:00:00,Questionnaires,E05.318.308.750
18085930,2007-12-01T00:00:00,Questionnaires,L01.280.800
18085930,2007-12-01T00:00:00,Questionnaires,N05.715.360.300.695
18085930,2007-12-01T00:00:00,Questionnaires,N06.850.520.308.750
18085930,2007-12-01T00:00:00,Somatoform Disorders,F03.875
18085930,2007-12-01T00:00:00,Students,I02.233.748
18085930,2007-12-01T00:00:00,Students,I02.851
18085930,2007-12-01T00:00:00,Students,M01.848
18090697,2007-12-01T00:00:00,Adolescent,M01.060.057
18090697,2007-12-01T00:00:00,Adult,M01.060.116
18090697,2007-12-01T00:00:00,Aged,M01.060.116.100
18090697,2007-12-01T00:00:00,Antidepressive Agents,D27.505.954.427.700.122
18090697,2007-12-01T00:00:00,Bias (Epidemiology),N05.715.350.150
18090697,2007-12-01T00:00:00,Bias (Epidemiology),N06.850.490.500
18090697,2007-12-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
18090697,2007-12-01T00:00:00,Electroconvulsive Therapy,F04.570.200.583
18090697,2007-12-01T00:00:00,Electroconvulsive Therapy,F04.669.224.300
18090697,2007-12-01T00:00:00,Electroencephalography,E01.370.376.300
18090697,2007-12-01T00:00:00,Electroencephalography,E01.370.405.245
18090697,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18090697,2007-12-01T00:00:00,"Interview, Psychological",F04.669.599
18090697,2007-12-01T00:00:00,Middle Aged,M01.060.116.630
18090697,2007-12-01T00:00:00,Neuropsychological Tests,F04.711.513
18090697,2007-12-01T00:00:00,Nortriptyline,D02.455.426.559.847.181.384.535
18090697,2007-12-01T00:00:00,Nortriptyline,D04.615.181.384.535
18090697,2007-12-01T00:00:00,Outcome and Process Assessment (Health Care),N04.761.559
18090697,2007-12-01T00:00:00,Outcome and Process Assessment (Health Care),N05.715.360.575
18090697,2007-12-01T00:00:00,Quality of Life,I01.800
18090697,2007-12-01T00:00:00,Quality of Life,K01.752.400.750
18090697,2007-12-01T00:00:00,Research Design,E05.581.500
18090697,2007-12-01T00:00:00,Research Design,H01.770.644.728
18090962,2007-12-01T00:00:00,Algorithms,G17.035
18090962,2007-12-01T00:00:00,Algorithms,L01.224.050
18090962,2007-12-01T00:00:00,Anemia,C15.378.071
18090962,2007-12-01T00:00:00,Diabetic Nephropathies,C12.777.419.192
18090962,2007-12-01T00:00:00,Diabetic Nephropathies,C13.351.968.419.192
18090962,2007-12-01T00:00:00,Diabetic Nephropathies,C19.246.099.875
18090962,2007-12-01T00:00:00,Disease Progression,C23.550.291.656
18090962,2007-12-01T00:00:00,Ferritins,D12.776.157.427.249
18090962,2007-12-01T00:00:00,Ferritins,D12.776.556.579.249
18090962,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18090962,2007-12-01T00:00:00,Hypertension,C14.907.489
18090962,2007-12-01T00:00:00,Kidney Diseases,C12.777.419
18090962,2007-12-01T00:00:00,Kidney Diseases,C13.351.968.419
18090962,2007-12-01T00:00:00,Oxidative Stress,G03.495.710
18090962,2007-12-01T00:00:00,Oxidative Stress,G07.700.830.750
18090962,2007-12-01T00:00:00,Primary Health Care,N04.590.233.727
18090962,2007-12-01T00:00:00,Quality of Life,I01.800
18090962,2007-12-01T00:00:00,Quality of Life,K01.752.400.750
18090962,2007-12-01T00:00:00,Recombinant Proteins,D12.776.828
18090962,2007-12-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18090962,2007-12-01T00:00:00,Risk Factors,N05.715.350.200.700
18090962,2007-12-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18090962,2007-12-01T00:00:00,Risk Factors,N06.850.490.625.750
18090962,2007-12-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18090966,2007-12-01T00:00:00,Adult,M01.060.116
18090966,2007-12-01T00:00:00,Exanthema,C17.800.257
18090966,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18090966,2007-12-01T00:00:00,Skin,A17.815
18090966,2007-12-01T00:00:00,"Syphilis, Cutaneous",C01.252.400.840.744.800
18090966,2007-12-01T00:00:00,"Syphilis, Cutaneous",C01.252.825.790
18090966,2007-12-01T00:00:00,"Syphilis, Cutaneous",C01.252.847.840.744.800
18090966,2007-12-01T00:00:00,"Syphilis, Cutaneous",C01.539.800.720.790
18090966,2007-12-01T00:00:00,"Syphilis, Cutaneous",C17.800.838.765.790
18091050,2007-12-01T00:00:00,Adult,M01.060.116
18091050,2007-12-01T00:00:00,Aged,M01.060.116.100
18091050,2007-12-01T00:00:00,"Biopsy, Needle",E01.370.388.100.100
18091050,2007-12-01T00:00:00,"Biopsy, Needle",E01.450.230.100.100
18091050,2007-12-01T00:00:00,"Biopsy, Needle",E01.450.865.100.100
18091050,2007-12-01T00:00:00,"Biopsy, Needle",E01.450.865.632.100
18091050,2007-12-01T00:00:00,"Biopsy, Needle",E04.074.119
18091050,2007-12-01T00:00:00,Brachytherapy,E02.815.150
18091050,2007-12-01T00:00:00,Breast Neoplasms,C04.588.180
18091050,2007-12-01T00:00:00,Breast Neoplasms,C17.800.090.500
18091050,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18091050,2007-12-01T00:00:00,Mammography,E01.370.350.700.500
18091050,2007-12-01T00:00:00,Middle Aged,M01.060.116.630
18091050,2007-12-01T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
18091050,2007-12-01T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
18091050,2007-12-01T00:00:00,Treatment Outcome,E01.789.800
18091050,2007-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18091050,2007-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18091391,2007-12-01T00:00:00,Coloring Agents,D27.720.233
18091391,2007-12-01T00:00:00,Coloring Agents,D27.720.470.330
18091391,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18091391,2007-12-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
18091391,2007-12-01T00:00:00,Software,L01.224.900
18091391,2007-12-01T00:00:00,"Tumor Markers, Biological",D23.101.840
18091391,2007-12-01T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
18091391,2007-12-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
18091391,2007-12-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
18091391,2007-12-01T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
18157883,2007-12-01T00:00:00,Adult,M01.060.116
18157883,2007-12-01T00:00:00,Crime Victims,M01.135
18157883,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18157883,2007-12-01T00:00:00,"Interview, Psychological",F04.669.599
18157883,2007-12-01T00:00:00,Sexual Partners,M01.778
18157883,2007-12-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
18157883,2007-12-01T00:00:00,United States,Z01.107.567.875
18157883,2007-12-01T00:00:00,Violence,I01.198.240.856
18157883,2007-12-01T00:00:00,Violence,I01.880.735.900
18157883,2007-12-01T00:00:00,Wounds and Injuries,C21.866
18158058,2007-12-01T00:00:00,Aged,M01.060.116.100
18158058,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18158058,2007-12-01T00:00:00,Laparoscopy,E01.370.388.250.520
18158058,2007-12-01T00:00:00,Laparoscopy,E04.800.250.520
18158058,2007-12-01T00:00:00,Prostatectomy,E04.950.774.860.625
18158058,2007-12-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
18158058,2007-12-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
18158058,2007-12-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
18158058,2007-12-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
18163938,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18163938,2007-12-01T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
18163938,2007-12-01T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
18163938,2007-12-01T00:00:00,Prostate-Specific Antigen,D08.811.277.656.300.760.442.750
18163938,2007-12-01T00:00:00,Prostate-Specific Antigen,D08.811.277.656.959.350.442.750
18163938,2007-12-01T00:00:00,Prostate-Specific Antigen,D12.776.866.249.500
18163938,2007-12-01T00:00:00,Prostate-Specific Antigen,D23.050.285.625
18163938,2007-12-01T00:00:00,Prostate-Specific Antigen,D23.101.840.625
18163938,2007-12-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
18163938,2007-12-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
18163938,2007-12-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
18163938,2007-12-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
18163938,2007-12-01T00:00:00,Salvage Therapy,E02.186.800
18163938,2007-12-01T00:00:00,Salvage Therapy,E02.895
18163938,2007-12-01T00:00:00,Treatment Outcome,E01.789.800
18163938,2007-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18163938,2007-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18163938,2007-12-01T00:00:00,"Tumor Markers, Biological",D23.101.840
18163939,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18163939,2007-12-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
18163939,2007-12-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
18163939,2007-12-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
18163939,2007-12-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
18163939,2007-12-01T00:00:00,Treatment Outcome,E01.789.800
18163939,2007-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18163939,2007-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18163941,2007-12-01T00:00:00,Aged,M01.060.116.100
18163941,2007-12-01T00:00:00,Algorithms,G17.035
18163941,2007-12-01T00:00:00,Algorithms,L01.224.050
18163941,2007-12-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
18163941,2007-12-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
18163941,2007-12-01T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
18163941,2007-12-01T00:00:00,Cryosurgery,E04.014.180
18163941,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18163941,2007-12-01T00:00:00,Middle Aged,M01.060.116.630
18163941,2007-12-01T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
18163941,2007-12-01T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
18163941,2007-12-01T00:00:00,Neoplasm Staging,E01.370.550
18163941,2007-12-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
18163941,2007-12-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
18163941,2007-12-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
18163941,2007-12-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
18163941,2007-12-01T00:00:00,Salvage Therapy,E02.186.800
18163941,2007-12-01T00:00:00,Salvage Therapy,E02.895
18163941,2007-12-01T00:00:00,Treatment Outcome,E01.789.800
18163941,2007-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18163941,2007-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18163942,2007-12-01T00:00:00,Brachytherapy,E02.815.150
18163942,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18163942,2007-12-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
18163942,2007-12-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
18163942,2007-12-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
18163942,2007-12-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
18163942,2007-12-01T00:00:00,"Radiotherapy Planning, Computer-Assisted",E02.950.825
18163942,2007-12-01T00:00:00,"Radiotherapy Planning, Computer-Assisted",L01.700.508.100.710.600.608
18163942,2007-12-01T00:00:00,Treatment Outcome,E01.789.800
18163942,2007-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18163942,2007-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18165617,2007-12-01T00:00:00,Antineoplastic Agents,D27.505.954.248
18165617,2007-12-01T00:00:00,"Carcinoma, Renal Cell",C04.557.470.200.025.390
18165617,2007-12-01T00:00:00,"Carcinoma, Renal Cell",C04.588.945.947.535.160
18165617,2007-12-01T00:00:00,"Carcinoma, Renal Cell",C12.758.820.750.160
18165617,2007-12-01T00:00:00,"Carcinoma, Renal Cell",C12.777.419.473.160
18165617,2007-12-01T00:00:00,"Carcinoma, Renal Cell",C13.351.937.820.535.160
18165617,2007-12-01T00:00:00,"Carcinoma, Renal Cell",C13.351.968.419.473.160
18165617,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18165617,2007-12-01T00:00:00,Kidney Neoplasms,C04.588.945.947.535
18165617,2007-12-01T00:00:00,Kidney Neoplasms,C12.758.820.750
18165617,2007-12-01T00:00:00,Kidney Neoplasms,C12.777.419.473
18165617,2007-12-01T00:00:00,Kidney Neoplasms,C13.351.937.820.535
18165617,2007-12-01T00:00:00,Kidney Neoplasms,C13.351.968.419.473
18165617,2007-12-01T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
18165617,2007-12-01T00:00:00,Protein Kinases,D08.811.913.696.620.682
18165617,2007-12-01T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
18165617,2007-12-01T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
18165617,2007-12-01T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
18186386,2007-12-01T00:00:00,Adult,M01.060.116
18186386,2007-12-01T00:00:00,Aged,M01.060.116.100
18186386,2007-12-01T00:00:00,Enteral Nutrition,E02.421.360
18186386,2007-12-01T00:00:00,Enteral Nutrition,E02.642.500.360
18186386,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18186386,2007-12-01T00:00:00,"Intubation, Gastrointestinal",E05.497.412
18186386,2007-12-01T00:00:00,Length of Stay,E02.760.400.480
18186386,2007-12-01T00:00:00,Length of Stay,N02.421.585.400.480
18186386,2007-12-01T00:00:00,Middle Aged,M01.060.116.630
18186386,2007-12-01T00:00:00,Pancreaticoduodenectomy,E04.210.760
18186386,2007-12-01T00:00:00,"Pancreatitis, Chronic",C06.689.750.830
18186386,2007-12-01T00:00:00,Treatment Outcome,E01.789.800
18186386,2007-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18186386,2007-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18199853,2007-12-01T00:00:00,Amino Acid Sequence,G02.111.570.060
18199853,2007-12-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
18199853,2007-12-01T00:00:00,Animals,B01.050
18199853,2007-12-01T00:00:00,Apoptosis,G04.299.139.160
18199853,2007-12-01T00:00:00,Endoplasmic Reticulum,A11.284.430.214.190.875.248
18199853,2007-12-01T00:00:00,Glutathione,D12.644.456.448
18199853,2007-12-01T00:00:00,Glutathione Transferase,D08.811.913.225.500
18199853,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18199853,2007-12-01T00:00:00,"Models, Biological",E05.599.395
18199853,2007-12-01T00:00:00,Molecular Sequence Data,L01.453.245.667
18199853,2007-12-01T00:00:00,Oxidative Stress,G03.495.710
18199853,2007-12-01T00:00:00,Oxidative Stress,G07.700.830.750
18199853,2007-12-01T00:00:00,Phosphorylation,G02.111.087.677
18199853,2007-12-01T00:00:00,Phosphorylation,G02.149.115.677
18199853,2007-12-01T00:00:00,Phosphorylation,G02.149.465.700
18199853,2007-12-01T00:00:00,Phosphorylation,G02.607.750.700
18199853,2007-12-01T00:00:00,Phosphorylation,G03.495.790
18199853,2007-12-01T00:00:00,Protein Disulfide-Isomerases,D08.811.399.475.800.550
18199853,2007-12-01T00:00:00,Protein Folding,G01.154.100.640
18199853,2007-12-01T00:00:00,Protein Folding,G01.595.100.640
18199853,2007-12-01T00:00:00,Protein Folding,G02.111.087.690
18199853,2007-12-01T00:00:00,Protein Folding,G02.149.115.690
18199853,2007-12-01T00:00:00,Protein Kinases,D08.811.913.696.620.682
18199853,2007-12-01T00:00:00,"Protein Processing, Post-Translational",G02.111.087.675.871.790.600
18199853,2007-12-01T00:00:00,"Protein Processing, Post-Translational",G02.111.087.693.600
18199853,2007-12-01T00:00:00,"Protein Processing, Post-Translational",G02.149.115.675.871.790.600
18199853,2007-12-01T00:00:00,"Protein Processing, Post-Translational",G02.149.115.693.600
18199853,2007-12-01T00:00:00,"Protein Processing, Post-Translational",G03.495.770.871.790.600
18199853,2007-12-01T00:00:00,"Protein Processing, Post-Translational",G05.355.315.670.600
18199853,2007-12-01T00:00:00,Signal Transduction,G02.111.087.800
18199853,2007-12-01T00:00:00,Signal Transduction,G02.149.115.800
18199853,2007-12-01T00:00:00,Signal Transduction,G04.299.880
18221619,2007-12-01T00:00:00,Cardiomyopathies,C14.280.238
18221619,2007-12-01T00:00:00,Heart Failure,C14.280.434
18221619,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18221619,2007-12-01T00:00:00,"Hypertrophy, Left Ventricular",C14.280.195.400
18221619,2007-12-01T00:00:00,"Hypertrophy, Left Ventricular",C23.300.775.250.400
18221619,2007-12-01T00:00:00,Obesity,C18.654.726.500
18221619,2007-12-01T00:00:00,Obesity,C23.888.144.699.500
18221619,2007-12-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
18221619,2007-12-01T00:00:00,Obesity,G07.100.100.160.120.699.500
18221619,2007-12-01T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
18221619,2007-12-01T00:00:00,Weight Loss,C23.888.144.243.963
18221619,2007-12-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
18274222,2007-12-01T00:00:00,Child,M01.060.406
18274222,2007-12-01T00:00:00,Cognition,F02.463.188
18274222,2007-12-01T00:00:00,Exercise,G11.427.590.237
18274222,2007-12-01T00:00:00,Exercise,I03.350
18274222,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18274222,2007-12-01T00:00:00,Overweight,C23.888.144.699
18274222,2007-12-01T00:00:00,Overweight,E01.370.600.115.100.160.120.699
18274222,2007-12-01T00:00:00,Overweight,G07.100.100.160.120.699
18274222,2007-12-01T00:00:00,Questionnaires,E05.318.308.750
18274222,2007-12-01T00:00:00,Questionnaires,L01.280.800
18274222,2007-12-01T00:00:00,Questionnaires,N05.715.360.300.695
18274222,2007-12-01T00:00:00,Questionnaires,N06.850.520.308.750
18290720,2007-12-01T00:00:00,Cholecalciferol,D04.808.247.222.159
18290720,2007-12-01T00:00:00,Cholecalciferol,D04.808.247.808.146
18290720,2007-12-01T00:00:00,Cholecalciferol,D04.808.812.768.196
18290720,2007-12-01T00:00:00,Cholecalciferol,D10.570.938.146
18290720,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18290720,2007-12-01T00:00:00,Lactation,G08.686.702.500
18290720,2007-12-01T00:00:00,Lactation,G08.686.785.420
18290720,2007-12-01T00:00:00,"Milk, Human",A12.200.467
18290720,2007-12-01T00:00:00,"Milk, Human",J02.200.700.500
18290720,2007-12-01T00:00:00,"Milk, Human",J02.500.350.525.500
18290720,2007-12-01T00:00:00,Pregnancy,G08.686.785.760.769
18290720,2007-12-01T00:00:00,Vitamin D,D04.808.812.768
18367015,2007-12-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
18367015,2007-12-01T00:00:00,Blood Pressure,E01.370.600.875.249
18367015,2007-12-01T00:00:00,Blood Pressure,G09.330.380.076
18367015,2007-12-01T00:00:00,Brain Ischemia,C10.228.140.300.150
18367015,2007-12-01T00:00:00,Brain Ischemia,C14.907.253.092
18367015,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18367015,2007-12-01T00:00:00,Hypertension,C14.907.489
18367015,2007-12-01T00:00:00,Stroke,C10.228.140.300.775
18367015,2007-12-01T00:00:00,Stroke,C14.907.253.855
18377793,2007-12-01T00:00:00,Gastric Acid,A12.200.307.603
18377793,2007-12-01T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
18377793,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18377793,2007-12-01T00:00:00,Proton Pump Inhibitors,D27.505.519.389.848
19124400,2007-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19124400,2007-12-01T00:00:00,Hypertension,C14.907.489
19124400,2007-12-01T00:00:00,Risk Factors,E05.318.740.600.800.725
19124400,2007-12-01T00:00:00,Risk Factors,N05.715.350.200.700
19124400,2007-12-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
19124400,2007-12-01T00:00:00,Risk Factors,N06.850.490.625.750
19124400,2007-12-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
19124400,2007-12-01T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
18053191,2007-12-03T00:00:00,Aged,M01.060.116.100
18053191,2007-12-03T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
18053191,2007-12-03T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
18053191,2007-12-03T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
18053191,2007-12-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18053191,2007-12-03T00:00:00,Middle Aged,M01.060.116.630
18053191,2007-12-03T00:00:00,Neoplasms,C04
18053191,2007-12-03T00:00:00,Pyrazoles,D03.383.129.539
18054326,2007-12-03T00:00:00,Animals,B01.050
18054326,2007-12-03T00:00:00,Calpain,D08.811.277.656.262.500.120
18054326,2007-12-03T00:00:00,Calpain,D08.811.277.656.300.200.120
18054326,2007-12-03T00:00:00,Gene Expression,G05.355.310
18054326,2007-12-03T00:00:00,Kidney,A05.810.453
18054326,2007-12-03T00:00:00,Mitochondria,A11.284.430.214.190.875.564
18054326,2007-12-03T00:00:00,Mitochondria,A11.284.835.626
18054326,2007-12-03T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18061594,2007-12-03T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
18061594,2007-12-03T00:00:00,Antibiotic Prophylaxis,E02.319.162.150
18061594,2007-12-03T00:00:00,Antibiotic Prophylaxis,E02.319.703.150
18061594,2007-12-03T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
18061594,2007-12-03T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
18061594,2007-12-03T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
18061594,2007-12-03T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
18061594,2007-12-03T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
18061594,2007-12-03T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
18061594,2007-12-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18061594,2007-12-03T00:00:00,Incidence,E05.318.308.985.525.375
18061594,2007-12-03T00:00:00,Incidence,L01.280.975.525.375
18061594,2007-12-03T00:00:00,Incidence,N01.224.935.597.500
18061594,2007-12-03T00:00:00,Incidence,N06.850.505.400.975.525.375
18061594,2007-12-03T00:00:00,Incidence,N06.850.520.308.985.525.375
18061594,2007-12-03T00:00:00,Patient Selection,E05.581.500.653
18061594,2007-12-03T00:00:00,Patient Selection,N04.590.731
18061594,2007-12-03T00:00:00,Risk Factors,E05.318.740.600.800.725
18061594,2007-12-03T00:00:00,Risk Factors,N05.715.350.200.700
18061594,2007-12-03T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18061594,2007-12-03T00:00:00,Risk Factors,N06.850.490.625.750
18061594,2007-12-03T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18061594,2007-12-03T00:00:00,Surgical Wound Infection,C01.539.947.692
18061594,2007-12-03T00:00:00,Surgical Wound Infection,C23.550.767.925
18061594,2007-12-03T00:00:00,Time Factors,G01.910.857
18061594,2007-12-03T00:00:00,Treatment Outcome,E01.789.800
18061594,2007-12-03T00:00:00,Treatment Outcome,N04.761.559.590.800
18061594,2007-12-03T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20633365,2007-12-03T00:00:00,Biomedical Research,H01.770.644.145
20633365,2007-12-03T00:00:00,Brain,A08.186.211
20633365,2007-12-03T00:00:00,Electric Stimulation,E05.723.402
20633365,2007-12-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20633365,2007-12-03T00:00:00,Periodicals as Topic,L01.178.682.829.678
18155648,2007-12-04T00:00:00,Adult,M01.060.116
18155648,2007-12-04T00:00:00,Gas Chromatography-Mass Spectrometry,E05.196.181.349.500
18155648,2007-12-04T00:00:00,Gas Chromatography-Mass Spectrometry,E05.196.566.500
18155648,2007-12-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18155648,2007-12-04T00:00:00,Methylphenidate,D02.241.223.601.600
18155648,2007-12-04T00:00:00,Methylphenidate,D03.383.621.460
18155648,2007-12-04T00:00:00,Phenotype,G05.695
18178178,2007-12-05T00:00:00,Age Factors,N05.715.350.075
18178178,2007-12-05T00:00:00,Age Factors,N06.850.490.250
18178178,2007-12-05T00:00:00,Animals,B01.050
18178178,2007-12-05T00:00:00,"Animals, Newborn",B01.050.050.282
18178178,2007-12-05T00:00:00,"Behavior, Animal",F01.145.113
18178178,2007-12-05T00:00:00,Cocaine,D02.145.074.722.388
18178178,2007-12-05T00:00:00,Cocaine,D03.132.889.354
18178178,2007-12-05T00:00:00,Cocaine,D03.605.869.388
18178178,2007-12-05T00:00:00,Cocaine,D04.075.080.875.099.722.388
18178178,2007-12-05T00:00:00,Dopamine,D02.092.211.215.311.342
18178178,2007-12-05T00:00:00,Dopamine,D02.092.311.342
18178178,2007-12-05T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
18178178,2007-12-05T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
18178178,2007-12-05T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
18178178,2007-12-05T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
18178178,2007-12-05T00:00:00,Glutamic Acid,D12.125.067.750
18178178,2007-12-05T00:00:00,Glutamic Acid,D12.125.119.450
18178178,2007-12-05T00:00:00,Glutamic Acid,D12.125.427.300
18178178,2007-12-05T00:00:00,"Mice, Inbred DBA",B01.050.050.157.520.460
18178178,2007-12-05T00:00:00,"Mice, Inbred DBA",B01.050.050.199.520.520.460
18178178,2007-12-05T00:00:00,"Mice, Inbred DBA",B01.050.150.900.649.865.635.505.500.400.460
18178178,2007-12-05T00:00:00,Motor Activity,F01.145.632
18178178,2007-12-05T00:00:00,Motor Activity,G11.427.590.530.698
18178178,2007-12-05T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
18313597,2007-12-05T00:00:00,Aged,M01.060.116.100
18313597,2007-12-05T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
18313597,2007-12-05T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
18313597,2007-12-05T00:00:00,"Defibrillators, Implantable",E07.695.175
18313597,2007-12-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18313597,2007-12-05T00:00:00,"Vena Cava, Superior",A07.231.908.949.815
18313597,2007-12-05T00:00:00,Ventricular Fibrillation,C14.280.067.922
18313597,2007-12-05T00:00:00,Ventricular Fibrillation,C23.550.073.922
18065523,2007-12-07T00:00:00,Animals,B01.050
18065523,2007-12-07T00:00:00,Fluorescent Dyes,D27.720.233.348
18065523,2007-12-07T00:00:00,Fluorescent Dyes,D27.720.470.330.348
18065523,2007-12-07T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
18065523,2007-12-07T00:00:00,Matrix Metalloproteinase 14,D08.811.277.656.300.480.525.300.500
18065523,2007-12-07T00:00:00,Matrix Metalloproteinase 14,D08.811.277.656.675.374.525.300.500
18065523,2007-12-07T00:00:00,Phosphorylation,G02.111.087.677
18065523,2007-12-07T00:00:00,Phosphorylation,G02.149.115.677
18065523,2007-12-07T00:00:00,Phosphorylation,G02.149.465.700
18065523,2007-12-07T00:00:00,Phosphorylation,G02.607.750.700
18065523,2007-12-07T00:00:00,Phosphorylation,G03.495.790
18065523,2007-12-07T00:00:00,Protein Kinase C,D08.811.913.696.620.682.700.725
18065523,2007-12-07T00:00:00,Signal Transduction,G02.111.087.800
18065523,2007-12-07T00:00:00,Signal Transduction,G02.149.115.800
18065523,2007-12-07T00:00:00,Signal Transduction,G04.299.880
18065523,2007-12-07T00:00:00,Stroke Volume,E01.370.370.380.150.700
18065523,2007-12-07T00:00:00,Stroke Volume,G09.330.380.124.882
18065523,2007-12-07T00:00:00,Swine,B01.050.150.900.649.077.880
18065523,2007-12-07T00:00:00,Threonine,D12.125.142.815
18065523,2007-12-07T00:00:00,Threonine,D12.125.154.900
18065523,2007-12-07T00:00:00,Threonine,D12.125.901
18070251,2007-12-07T00:00:00,Animals,B01.050
18070251,2007-12-07T00:00:00,"Behavior, Animal",F01.145.113
18070251,2007-12-07T00:00:00,Central Nervous System Depressants,D27.505.696.277
18070251,2007-12-07T00:00:00,Central Nervous System Depressants,D27.505.954.427.210
18070251,2007-12-07T00:00:00,Ethanol,D02.033.375
18066533,2007-12-08T00:00:00,Amygdala,A08.186.211.464.090
18066533,2007-12-08T00:00:00,Amygdala,A08.186.211.730.885.287.249.152
18066533,2007-12-08T00:00:00,Animals,B01.050
18066533,2007-12-08T00:00:00,"Behavior, Animal",F01.145.113
18066533,2007-12-08T00:00:00,Cocaine-Related Disorders,C21.739.300
18066533,2007-12-08T00:00:00,Cocaine-Related Disorders,F03.900.300
18066533,2007-12-08T00:00:00,Cues,F02.463.425.234
18066533,2007-12-08T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
18066533,2007-12-08T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18066533,2007-12-08T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18066533,2007-12-08T00:00:00,Self Administration,E02.319.890
18066533,2007-12-08T00:00:00,Self Administration,E02.900.890
18066063,2007-12-09T00:00:00,Animals,B01.050
18066063,2007-12-09T00:00:00,Breast Neoplasms,C04.588.180
18066063,2007-12-09T00:00:00,Breast Neoplasms,C17.800.090.500
18066063,2007-12-09T00:00:00,DNA Repair,G02.111.087.219
18066063,2007-12-09T00:00:00,DNA Repair,G02.149.115.219
18066063,2007-12-09T00:00:00,DNA Repair,G05.355.195
18066063,2007-12-09T00:00:00,"Genes, BRCA1",G05.360.340.024.340.375.249.100
18066063,2007-12-09T00:00:00,"Genes, BRCA1",G05.360.340.024.340.415.400.100
18066063,2007-12-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18066063,2007-12-09T00:00:00,"Mammary Neoplasms, Animal",C04.588.531
18066063,2007-12-09T00:00:00,"Mammary Neoplasms, Animal",C22.520
18066063,2007-12-09T00:00:00,Mutation,G05.365.590
18066063,2007-12-09T00:00:00,PTEN Phosphohydrolase,D08.811.277.352.650.850
18066063,2007-12-09T00:00:00,PTEN Phosphohydrolase,D12.776.476.590
18066063,2007-12-09T00:00:00,PTEN Phosphohydrolase,D12.776.624.776.695
18070977,2007-12-10T00:00:00,Antifungal Agents,D27.505.954.122.136
18070977,2007-12-10T00:00:00,Cryptococcosis,C01.703.248
18070977,2007-12-10T00:00:00,Cryptococcus neoformans,B01.300.381.258.366
18070977,2007-12-10T00:00:00,Cryptococcus neoformans,B01.300.930.316.366
18070977,2007-12-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18070977,2007-12-10T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
18070977,2007-12-10T00:00:00,Microbial Sensitivity Tests,E05.200.875.595
18070977,2007-12-10T00:00:00,Microbial Sensitivity Tests,E05.337.550.400
18070977,2007-12-10T00:00:00,Organ Transplantation,E04.936.450
18070977,2007-12-10T00:00:00,Treatment Outcome,E01.789.800
18070977,2007-12-10T00:00:00,Treatment Outcome,N04.761.559.590.800
18070977,2007-12-10T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18067883,2007-12-11T00:00:00,Animals,B01.050
18067883,2007-12-11T00:00:00,Antigen Presentation,G12.425.107
18067883,2007-12-11T00:00:00,Antigen Presentation,G12.450.050.400.070
18067883,2007-12-11T00:00:00,Antigen-Presenting Cells,A11.066
18067883,2007-12-11T00:00:00,Antigen-Presenting Cells,A15.382.066
18067883,2007-12-11T00:00:00,CD4-Positive T-Lymphocytes,A11.118.637.555.567.569.200
18067883,2007-12-11T00:00:00,CD4-Positive T-Lymphocytes,A15.145.229.637.555.567.569.200
18067883,2007-12-11T00:00:00,CD4-Positive T-Lymphocytes,A15.382.490.555.567.569.200
18067883,2007-12-11T00:00:00,Endocytosis,G04.299.482
18067883,2007-12-11T00:00:00,Fibroblasts,A11.329.228
18067883,2007-12-11T00:00:00,Fibroblasts,A11.872.228
18067883,2007-12-11T00:00:00,Histocompatibility Antigens Class II,D23.050.301.500.410
18067883,2007-12-11T00:00:00,Histocompatibility Antigens Class II,D23.050.705.552.410
18067883,2007-12-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18067883,2007-12-11T00:00:00,Molecular Chaperones,D12.776.580
18067883,2007-12-11T00:00:00,Peptides,D12.644
18074223,2007-12-12T00:00:00,Breast Neoplasms,C04.588.180
18074223,2007-12-12T00:00:00,Breast Neoplasms,C17.800.090.500
18074223,2007-12-12T00:00:00,Cell Proliferation,G04.299.233.750
18074223,2007-12-12T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18074223,2007-12-12T00:00:00,Collagen,D05.750.078.280
18074223,2007-12-12T00:00:00,Collagen,D12.776.860.300.250
18074223,2007-12-12T00:00:00,Enzyme Inhibitors,D27.505.519.389
18074223,2007-12-12T00:00:00,Epithelial Cells,A11.436
18074223,2007-12-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18074223,2007-12-12T00:00:00,Lentivirus,B04.820.650.589
18074223,2007-12-12T00:00:00,Lentivirus,B04.909.777.731.589
18074223,2007-12-12T00:00:00,Mutation,G05.365.590
18077482,2007-12-12T00:00:00,Adult,M01.060.116
18077482,2007-12-12T00:00:00,Aged,M01.060.116.100
18077482,2007-12-12T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
18077482,2007-12-12T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
18077482,2007-12-12T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
18077482,2007-12-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18077482,2007-12-12T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.150.477.200.450
18077482,2007-12-12T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.510.200.387
18077482,2007-12-12T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.775.200.200.450
18077482,2007-12-12T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.092.477.200.450
18077482,2007-12-12T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.560.200.387
18077482,2007-12-12T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.855.200.200.450
18077482,2007-12-12T00:00:00,Magnetic Resonance Angiography,E01.370.350.500.500
18077482,2007-12-12T00:00:00,Magnetic Resonance Angiography,E01.370.350.825.500.500
18077482,2007-12-12T00:00:00,Magnetic Resonance Angiography,E01.370.370.050.500
18077482,2007-12-12T00:00:00,Middle Aged,M01.060.116.630
18077482,2007-12-12T00:00:00,Reperfusion Injury,C14.907.725
18077482,2007-12-12T00:00:00,Reperfusion Injury,C23.550.767.877
18077482,2007-12-12T00:00:00,Thrombectomy,E04.100.814.842
18077482,2007-12-12T00:00:00,Treatment Outcome,E01.789.800
18077482,2007-12-12T00:00:00,Treatment Outcome,N04.761.559.590.800
18077482,2007-12-12T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18077684,2007-12-12T00:00:00,Animals,B01.050
18077684,2007-12-12T00:00:00,Bone Marrow,A15.382.216
18077684,2007-12-12T00:00:00,"Disease Models, Animal",C22.232
18077684,2007-12-12T00:00:00,"Disease Models, Animal",E05.598.500
18077684,2007-12-12T00:00:00,"Disease Models, Animal",E05.599.395.080
18077684,2007-12-12T00:00:00,Disease Progression,C23.550.291.656
18077684,2007-12-12T00:00:00,Hematopoietic Stem Cell Transplantation,E04.936.225.687.500
18077684,2007-12-12T00:00:00,"Leukocytes, Mononuclear",A11.118.637.555
18077684,2007-12-12T00:00:00,"Leukocytes, Mononuclear",A15.145.229.637.555
18077684,2007-12-12T00:00:00,"Leukocytes, Mononuclear",A15.382.490.555
18077684,2007-12-12T00:00:00,"Leukodystrophy, Globoid Cell",C10.228.140.163.100.435.825.590
18077684,2007-12-12T00:00:00,"Leukodystrophy, Globoid Cell",C10.314.400.500
18077684,2007-12-12T00:00:00,"Leukodystrophy, Globoid Cell",C16.320.565.189.435.825.590
18077684,2007-12-12T00:00:00,"Leukodystrophy, Globoid Cell",C16.320.565.398.641.803.585
18077684,2007-12-12T00:00:00,"Leukodystrophy, Globoid Cell",C16.320.565.595.554.825.590
18077684,2007-12-12T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.132.100.435.825.590
18077684,2007-12-12T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.584.687.803.585
18077684,2007-12-12T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.648.189.435.825.590
18077684,2007-12-12T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.648.398.641.803.585
18077684,2007-12-12T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.648.595.554.825.590
18077684,2007-12-12T00:00:00,Psychosine,D02.033.100.700.700
18077684,2007-12-12T00:00:00,Psychosine,D02.092.063.700.700
18077684,2007-12-12T00:00:00,Psychosine,D09.400.410.420.806
18077684,2007-12-12T00:00:00,Psychosine,D10.390.470.806
18077684,2007-12-12T00:00:00,Psychosine,D10.570.877.360.806
18077684,2007-12-12T00:00:00,Spleen,A10.549.700
18077684,2007-12-12T00:00:00,Spleen,A15.382.520.604.700
18077684,2007-12-12T00:00:00,Thymus Gland,A10.549.750
18077684,2007-12-12T00:00:00,Thymus Gland,A15.382.520.604.750
18080121,2007-12-12T00:00:00,Biofilms,G06.120
18080121,2007-12-12T00:00:00,Cellulose,D05.750.078.562.180
18080121,2007-12-12T00:00:00,Cellulose,D09.698.365.180
18080121,2007-12-12T00:00:00,Cellulose,D25.720.099.500
18080121,2007-12-12T00:00:00,Cellulose,J01.637.051.720.099.500
18080121,2007-12-12T00:00:00,Electrodes,E07.305.250
18080121,2007-12-12T00:00:00,Geologic Sediments,G01.311.500
18080121,2007-12-12T00:00:00,Geologic Sediments,G16.500.320
18080121,2007-12-12T00:00:00,Graphite,D01.268.150.300
18080121,2007-12-12T00:00:00,Graphite,D01.578.300
18080121,2007-12-12T00:00:00,Hot Temperature,G01.906.595.543
18080121,2007-12-12T00:00:00,Hot Temperature,G16.500.275.063.725.710.380
18080121,2007-12-12T00:00:00,Hot Temperature,G16.500.750.775.710.380
18080121,2007-12-12T00:00:00,Hot Temperature,N06.230.300.100.725.232
18080121,2007-12-12T00:00:00,Hot Temperature,N06.230.300.100.725.710.380
18080121,2007-12-12T00:00:00,Molecular Sequence Data,L01.453.245.667
18080121,2007-12-12T00:00:00,"Sequence Analysis, DNA",E05.393.760.700
18080121,2007-12-12T00:00:00,South Carolina,Z01.107.567.875.075.662
18080121,2007-12-12T00:00:00,South Carolina,Z01.107.567.875.750.700
18080741,2007-12-13T00:00:00,Community Mental Health Services,F04.408.307
18080741,2007-12-13T00:00:00,Community Mental Health Services,N02.421.143.183
18080741,2007-12-13T00:00:00,Community Mental Health Services,N02.421.461.232
18080741,2007-12-13T00:00:00,Diffusion of Innovation,L01.143.320
18080741,2007-12-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18080741,2007-12-13T00:00:00,Interviews as Topic,E05.318.308.420
18080741,2007-12-13T00:00:00,Interviews as Topic,L01.280.520
18080741,2007-12-13T00:00:00,Interviews as Topic,N05.715.360.300.400
18080741,2007-12-13T00:00:00,Interviews as Topic,N06.850.520.308.420
18086148,2007-12-13T00:00:00,Animals,B01.050
18086148,2007-12-13T00:00:00,Apoptosis,G04.299.139.160
18086148,2007-12-13T00:00:00,Calcium,D01.268.552.100
18086148,2007-12-13T00:00:00,Calcium,D01.552.539.288
18086148,2007-12-13T00:00:00,Calcium,D23.119.100
18086148,2007-12-13T00:00:00,Calpain,D08.811.277.656.262.500.120
18086148,2007-12-13T00:00:00,Calpain,D08.811.277.656.300.200.120
18086148,2007-12-13T00:00:00,Central Nervous System Depressants,D27.505.696.277
18086148,2007-12-13T00:00:00,Central Nervous System Depressants,D27.505.954.427.210
18086148,2007-12-13T00:00:00,Inflammation,C23.550.470
18086148,2007-12-13T00:00:00,Neuroprotective Agents,D27.505.696.706.548
18086148,2007-12-13T00:00:00,Neuroprotective Agents,D27.505.954.427.575
18086148,2007-12-13T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18086148,2007-12-13T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18086148,2007-12-13T00:00:00,Spinal Cord Injuries,C10.228.854.770
18086148,2007-12-13T00:00:00,Spinal Cord Injuries,C10.900.850
18086148,2007-12-13T00:00:00,Spinal Cord Injuries,C21.866.819
18086148,2007-12-13T00:00:00,Time Factors,G01.910.857
18056355,2007-12-15T00:00:00,Antibodies,D12.776.124.486.485.114
18056355,2007-12-15T00:00:00,Antibodies,D12.776.124.790.651.114
18056355,2007-12-15T00:00:00,Antibodies,D12.776.377.715.548.114
18056355,2007-12-15T00:00:00,Antigen Presentation,G12.425.107
18056355,2007-12-15T00:00:00,Antigen Presentation,G12.450.050.400.070
18056355,2007-12-15T00:00:00,Cell Differentiation,G04.299.151
18056355,2007-12-15T00:00:00,Cytokines,D12.644.276.374
18056355,2007-12-15T00:00:00,Cytokines,D12.776.467.374
18056355,2007-12-15T00:00:00,Cytokines,D23.529.374
18056355,2007-12-15T00:00:00,Dendritic Cells,A11.066.270
18056355,2007-12-15T00:00:00,Dendritic Cells,A11.436.270
18056355,2007-12-15T00:00:00,Dendritic Cells,A15.382.066.270
18056355,2007-12-15T00:00:00,Dendritic Cells,A15.382.812.260
18056355,2007-12-15T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D12.644.276.374.410.240.375
18056355,2007-12-15T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D12.776.395.240.300
18056355,2007-12-15T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D12.776.467.374.410.240.375
18056355,2007-12-15T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D23.529.374.410.240.375
18056355,2007-12-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18056355,2007-12-15T00:00:00,Lymphocyte Activation,E01.450.495.482
18056355,2007-12-15T00:00:00,Lymphocyte Activation,E05.478.594.530
18056355,2007-12-15T00:00:00,Lymphocyte Activation,G12.425.747
18056355,2007-12-15T00:00:00,Lymphocyte Activation,G12.450.050.400.545
18056355,2007-12-15T00:00:00,Monocytes,A11.118.637.555.652
18056355,2007-12-15T00:00:00,Monocytes,A11.148.580
18056355,2007-12-15T00:00:00,Monocytes,A11.627.624
18056355,2007-12-15T00:00:00,Monocytes,A11.733.547
18056355,2007-12-15T00:00:00,Monocytes,A15.145.229.637.555.652
18056355,2007-12-15T00:00:00,Monocytes,A15.378.316.580
18056355,2007-12-15T00:00:00,Monocytes,A15.382.490.555.652
18056355,2007-12-15T00:00:00,Monocytes,A15.382.680.547
18056355,2007-12-15T00:00:00,Monocytes,A15.382.812.547
18056355,2007-12-15T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
18056355,2007-12-15T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
18056355,2007-12-15T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
18080726,2007-12-15T00:00:00,Adolescent,M01.060.057
18080726,2007-12-15T00:00:00,Adult,M01.060.116
18080726,2007-12-15T00:00:00,African Americans,M01.686.508.100.100
18080726,2007-12-15T00:00:00,African Americans,M01.686.754.100
18080726,2007-12-15T00:00:00,Aged,M01.060.116.100
18080726,2007-12-15T00:00:00,European Continental Ancestry Group,M01.686.508.400
18080726,2007-12-15T00:00:00,Gastric Bypass,E02.065.062.249
18080726,2007-12-15T00:00:00,Gastric Bypass,E04.035.398.385
18080726,2007-12-15T00:00:00,Gastric Bypass,E04.062.249
18080726,2007-12-15T00:00:00,Gastric Bypass,E04.210.457.430
18080726,2007-12-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18080726,2007-12-15T00:00:00,Middle Aged,M01.060.116.630
18080726,2007-12-15T00:00:00,"Obesity, Morbid",C18.654.726.500.700
18080726,2007-12-15T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
18080726,2007-12-15T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
18080726,2007-12-15T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
18080726,2007-12-15T00:00:00,Treatment Outcome,E01.789.800
18080726,2007-12-15T00:00:00,Treatment Outcome,N04.761.559.590.800
18080726,2007-12-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18080726,2007-12-15T00:00:00,Weight Loss,C23.888.144.243.963
18080726,2007-12-15T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
18081321,2007-12-15T00:00:00,Amino Acid Sequence,G02.111.570.060
18081321,2007-12-15T00:00:00,Amino Acid Sequence,L01.453.245.667.060
18081321,2007-12-15T00:00:00,Calmodulin,D12.644.360.381.249
18081321,2007-12-15T00:00:00,Calmodulin,D12.776.157.125.412.249
18081321,2007-12-15T00:00:00,Calmodulin,D12.776.476.387.249
18081321,2007-12-15T00:00:00,Eye Proteins,D12.776.306
18081321,2007-12-15T00:00:00,Membrane Glycoproteins,D12.776.395.550
18081321,2007-12-15T00:00:00,Membrane Glycoproteins,D12.776.543.550
18081321,2007-12-15T00:00:00,"Models, Molecular",E05.599.595
18081321,2007-12-15T00:00:00,Molecular Sequence Data,L01.453.245.667
18081321,2007-12-15T00:00:00,Phosphorylation,G02.111.087.677
18081321,2007-12-15T00:00:00,Phosphorylation,G02.149.115.677
18081321,2007-12-15T00:00:00,Phosphorylation,G02.149.465.700
18081321,2007-12-15T00:00:00,Phosphorylation,G02.607.750.700
18081321,2007-12-15T00:00:00,Phosphorylation,G03.495.790
18081321,2007-12-15T00:00:00,"Protein Structure, Secondary",G02.111.570.790.709.600
18081321,2007-12-15T00:00:00,"Sequence Homology, Amino Acid",G02.111.810.200
18081321,2007-12-15T00:00:00,"Sequence Homology, Amino Acid",G05.810.200
18081321,2007-12-15T00:00:00,"Spectrometry, Fluorescence",E05.196.712.516.600.676
18081321,2007-12-15T00:00:00,"Spectrometry, Fluorescence",E05.196.867.726
18081321,2007-12-15T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
18086675,2007-12-17T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
18086675,2007-12-17T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
18086675,2007-12-17T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
18086675,2007-12-17T00:00:00,Animals,B01.050
18086675,2007-12-17T00:00:00,Fatty Liver,C06.552.241
18086675,2007-12-17T00:00:00,Mitochondrial Proteins,D12.776.575
18086675,2007-12-17T00:00:00,Phenotype,G05.695
18086675,2007-12-17T00:00:00,Reperfusion Injury,C14.907.725
18086675,2007-12-17T00:00:00,Reperfusion Injury,C23.550.767.877
18085434,2007-12-18T00:00:00,Adult,M01.060.116
18085434,2007-12-18T00:00:00,Attitude of Health Personnel,F01.100.050
18085434,2007-12-18T00:00:00,Attitude of Health Personnel,N05.300.100
18085434,2007-12-18T00:00:00,Diffusion of Innovation,L01.143.320
18085434,2007-12-18T00:00:00,Evidence-Based Medicine,H02.249.750
18085434,2007-12-18T00:00:00,Evidence-Based Medicine,H02.403.200.400
18085434,2007-12-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18085434,2007-12-18T00:00:00,Mental Health Services,F04.408
18085434,2007-12-18T00:00:00,Mental Health Services,N02.421.461
18085434,2007-12-18T00:00:00,Middle Aged,M01.060.116.630
18085434,2007-12-18T00:00:00,Questionnaires,E05.318.308.750
18085434,2007-12-18T00:00:00,Questionnaires,L01.280.800
18085434,2007-12-18T00:00:00,Questionnaires,N05.715.360.300.695
18085434,2007-12-18T00:00:00,Questionnaires,N06.850.520.308.750
18085434,2007-12-18T00:00:00,United States,Z01.107.567.875
18094145,2007-12-19T00:00:00,Animals,B01.050
18094145,2007-12-19T00:00:00,Calcium,D01.268.552.100
18094145,2007-12-19T00:00:00,Calcium,D01.552.539.288
18094145,2007-12-19T00:00:00,Calcium,D23.119.100
18094145,2007-12-19T00:00:00,Calpain,D08.811.277.656.262.500.120
18094145,2007-12-19T00:00:00,Calpain,D08.811.277.656.300.200.120
18094145,2007-12-19T00:00:00,Endoplasmic Reticulum,A11.284.430.214.190.875.248
18094145,2007-12-19T00:00:00,Energy Metabolism,G03.495.335
18094145,2007-12-19T00:00:00,Mitochondria,A11.284.430.214.190.875.564
18094145,2007-12-19T00:00:00,Mitochondria,A11.284.835.626
18094145,2007-12-19T00:00:00,Molecular Chaperones,D12.776.580
18094145,2007-12-19T00:00:00,Protein Transport,G03.495.166.700
18094145,2007-12-19T00:00:00,Proteins,D12.776
18094145,2007-12-19T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18094145,2007-12-19T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18094243,2007-12-19T00:00:00,Animals,B01.050
18094243,2007-12-19T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
18094243,2007-12-19T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
18094243,2007-12-19T00:00:00,Neurons,A08.663
18094243,2007-12-19T00:00:00,Neurons,A11.671
18094243,2007-12-19T00:00:00,Neuropeptides,D12.644.400
18094243,2007-12-19T00:00:00,Neuropeptides,D12.776.641.650
18094243,2007-12-19T00:00:00,Periodicity,G01.910.645
18094243,2007-12-19T00:00:00,Periodicity,G07.180.562
18094243,2007-12-19T00:00:00,Plant Proteins,D12.776.765
18094243,2007-12-19T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18094243,2007-12-19T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18094243,2007-12-19T00:00:00,Sleep,F02.830.855
18094243,2007-12-19T00:00:00,Sleep,G11.561.600.815
18094243,2007-12-19T00:00:00,Wakefulness,F02.830.104.821
18094243,2007-12-19T00:00:00,Wakefulness,G11.561.600.042.738
18094340,2007-12-19T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
18094340,2007-12-19T00:00:00,Graft Rejection,G12.425.901.545.328
18094340,2007-12-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18094340,2007-12-19T00:00:00,Hypertension,C14.907.489
18094340,2007-12-19T00:00:00,"Hypertrophy, Left Ventricular",C14.280.195.400
18094340,2007-12-19T00:00:00,"Hypertrophy, Left Ventricular",C23.300.775.250.400
18094340,2007-12-19T00:00:00,Kidney Transplantation,E02.870.500
18094340,2007-12-19T00:00:00,Kidney Transplantation,E04.936.450.485
18094340,2007-12-19T00:00:00,Kidney Transplantation,E04.950.774.400
18094340,2007-12-19T00:00:00,Proteinuria,C12.777.934.734
18094340,2007-12-19T00:00:00,Proteinuria,C13.351.968.934.734
18094340,2007-12-19T00:00:00,Proteinuria,C23.888.942.750
18094340,2007-12-19T00:00:00,Renin-Angiotensin System,G03.495.805
18094340,2007-12-19T00:00:00,Renin-Angiotensin System,G09.330.190.400.750
18094340,2007-12-19T00:00:00,Time Factors,G01.910.857
18097146,2007-12-19T00:00:00,Acetylglucosamine,D09.067.342.531.050
18097146,2007-12-19T00:00:00,Cell Movement,G04.299.283
18097146,2007-12-19T00:00:00,Cell Movement,G07.700.560.500.180
18097146,2007-12-19T00:00:00,Endothelial Cells,A11.436.275
18097146,2007-12-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18097146,2007-12-19T00:00:00,Integrins,D12.776.543.750.705.408
18097146,2007-12-19T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567
18097146,2007-12-19T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750
18097146,2007-12-19T00:00:00,Mitogen-Activated Protein Kinases,D12.644.360.450
18097146,2007-12-19T00:00:00,Mitogen-Activated Protein Kinases,D12.776.476.450
18097146,2007-12-19T00:00:00,Nanostructures,J01.637.512
18097146,2007-12-19T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
18097146,2007-12-19T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.260.665.100
18097146,2007-12-19T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.624.664.700.175.100
18097146,2007-12-19T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.930.635.100
18097146,2007-12-19T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
18097146,2007-12-19T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
18097146,2007-12-19T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
18165671,2007-12-19T00:00:00,"Ethics, Medical",K01.316.333.132.750
18165671,2007-12-19T00:00:00,"Ethics, Medical",N05.350.340.162.500
18165671,2007-12-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18165671,2007-12-19T00:00:00,State Government,I01.409.775
18165671,2007-12-19T00:00:00,State Government,N03.540.348.875
18165671,2007-12-19T00:00:00,United States,Z01.107.567.875
18096059,2007-12-20T00:00:00,Aged,M01.060.116.100
18096059,2007-12-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18096059,2007-12-20T00:00:00,Lung Neoplasms,C04.588.894.797.520
18096059,2007-12-20T00:00:00,Lung Neoplasms,C08.381.540
18096059,2007-12-20T00:00:00,Lung Neoplasms,C08.785.520
18096059,2007-12-20T00:00:00,Middle Aged,M01.060.116.630
18096059,2007-12-20T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
18096059,2007-12-20T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
18157693,2007-12-20T00:00:00,Adult,M01.060.116
18157693,2007-12-20T00:00:00,Cognitive Therapy,F04.754.137.428
18157693,2007-12-20T00:00:00,Diffusion of Innovation,L01.143.320
18157693,2007-12-20T00:00:00,Education,I02
18157693,2007-12-20T00:00:00,Health Personnel,M01.526.485
18157693,2007-12-20T00:00:00,Health Personnel,N02.360
18157693,2007-12-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18157693,2007-12-20T00:00:00,Middle Aged,M01.060.116.630
18157693,2007-12-20T00:00:00,Program Evaluation,E05.337.820
18157693,2007-12-20T00:00:00,Program Evaluation,N04.761.685
18157693,2007-12-20T00:00:00,Program Evaluation,N05.715.360.650
18157693,2007-12-20T00:00:00,Wounds and Injuries,C21.866
18083585,2007-12-21T00:00:00,Age Factors,N05.715.350.075
18083585,2007-12-21T00:00:00,Age Factors,N06.850.490.250
18083585,2007-12-21T00:00:00,Child,M01.060.406
18083585,2007-12-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18083585,2007-12-21T00:00:00,Infant,M01.060.703
18083585,2007-12-21T00:00:00,"Infant, Newborn",M01.060.703.520
18083585,2007-12-21T00:00:00,Oculomotor Muscles,A02.633.567.700
18083585,2007-12-21T00:00:00,Oculomotor Muscles,A09.371.613
18083585,2007-12-21T00:00:00,Ophthalmologic Surgical Procedures,E04.540
18083585,2007-12-21T00:00:00,Reoperation,E04.690
18083585,2007-12-21T00:00:00,Time Factors,G01.910.857
18156197,2007-12-21T00:00:00,Animals,B01.050
18156197,2007-12-21T00:00:00,Circadian Rhythm,G07.180.562.190
18156197,2007-12-21T00:00:00,DNA,D13.444.308
18156197,2007-12-21T00:00:00,Echocardiography,E01.370.350.850.220
18156197,2007-12-21T00:00:00,Echocardiography,E01.370.370.380.220
18156197,2007-12-21T00:00:00,Gene Expression,G05.355.310
18156197,2007-12-21T00:00:00,"Mitochondria, Heart",A11.284.430.214.190.875.564.627.603
18156197,2007-12-21T00:00:00,"Mitochondria, Heart",A11.284.835.626.627.603
18156197,2007-12-21T00:00:00,Myocardial Contraction,G09.330.190.541
18156197,2007-12-21T00:00:00,Myocardial Contraction,G11.427.590.540.570
18156197,2007-12-21T00:00:00,Myocardium,A02.633.580
18156197,2007-12-21T00:00:00,Myocardium,A07.541.704
18156197,2007-12-21T00:00:00,Myocardium,A10.690.552.750
18156197,2007-12-21T00:00:00,"Myocytes, Cardiac",A07.541.704.570
18156197,2007-12-21T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
18156197,2007-12-21T00:00:00,"Myocytes, Cardiac",A11.620.500
18156197,2007-12-21T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
18156197,2007-12-21T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
18156197,2007-12-21T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
18156197,2007-12-21T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
18156197,2007-12-21T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
18156197,2007-12-21T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
18156197,2007-12-21T00:00:00,Perfusion,E05.680
18156197,2007-12-21T00:00:00,Signal Transduction,G02.111.087.800
18156197,2007-12-21T00:00:00,Signal Transduction,G02.149.115.800
18156197,2007-12-21T00:00:00,Signal Transduction,G04.299.880
18237587,2007-12-21T00:00:00,Aged,M01.060.116.100
18237587,2007-12-21T00:00:00,Coronary Restenosis,C14.280.647.250.285.200
18237587,2007-12-21T00:00:00,Coronary Restenosis,C14.907.585.250.285.200
18237587,2007-12-21T00:00:00,Drug-Eluting Stents,E07.695.750.500
18237587,2007-12-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18237587,2007-12-21T00:00:00,Middle Aged,M01.060.116.630
18237587,2007-12-21T00:00:00,Myocardial Infarction,C14.280.647.500
18237587,2007-12-21T00:00:00,Myocardial Infarction,C14.907.585.500
18237587,2007-12-21T00:00:00,Prosthesis Design,E05.320.550
18237587,2007-12-21T00:00:00,Prosthesis Design,E07.695.680
18237587,2007-12-21T00:00:00,United States,Z01.107.567.875
18308023,2007-12-21T00:00:00,Cardiotonic Agents,D27.505.954.411.222
18308023,2007-12-21T00:00:00,Cardiotonic Agents,D27.720.799.080
18308023,2007-12-21T00:00:00,"Child, Preschool",M01.060.406.448
18308023,2007-12-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18308023,2007-12-21T00:00:00,Infant,M01.060.703
18308023,2007-12-21T00:00:00,"Infant, Newborn",M01.060.703.520
18308023,2007-12-21T00:00:00,Intensive Care Units,N02.278.388.493
18308023,2007-12-21T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
18308023,2007-12-21T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
18308023,2007-12-21T00:00:00,Postoperative Care,E02.760.722.700
18308023,2007-12-21T00:00:00,Postoperative Care,E04.624
18308023,2007-12-21T00:00:00,Postoperative Care,N02.421.585.722.700
18308023,2007-12-21T00:00:00,Premedication,E02.319.703
18308023,2007-12-21T00:00:00,Tetralogy of Fallot,C14.240.400.849
18308023,2007-12-21T00:00:00,Tetralogy of Fallot,C14.280.400.849
18308023,2007-12-21T00:00:00,Tetralogy of Fallot,C16.131.240.400.849
18291369,2007-12-23T00:00:00,Acetylcysteine,D02.886.030.230.259
18291369,2007-12-23T00:00:00,Acetylcysteine,D12.125.166.230.259
18291369,2007-12-23T00:00:00,Animals,B01.050
18291369,2007-12-23T00:00:00,Brain Injuries,C10.228.140.199
18291369,2007-12-23T00:00:00,Brain Injuries,C10.900.300.087
18291369,2007-12-23T00:00:00,Brain Injuries,C21.866.260.118
18291369,2007-12-23T00:00:00,Brain Injuries,C21.866.915.300.200
18291369,2007-12-23T00:00:00,Case-Control Studies,E05.318.760.500.500
18291369,2007-12-23T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18291369,2007-12-23T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18291369,2007-12-23T00:00:00,"Child, Preschool",M01.060.406.448
18291369,2007-12-23T00:00:00,Drug Interactions,G07.690.812.240
18291369,2007-12-23T00:00:00,Drug Interactions,G07.700.680.240
18291369,2007-12-23T00:00:00,Fetus,A16.378
18291369,2007-12-23T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
18291369,2007-12-23T00:00:00,Flow Cytometry,E05.200.500.386.350
18291369,2007-12-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18291369,2007-12-23T00:00:00,Infant,M01.060.703
18291369,2007-12-23T00:00:00,Lipopolysaccharides,D09.400.500
18291369,2007-12-23T00:00:00,Lipopolysaccharides,D09.698.718.450
18291369,2007-12-23T00:00:00,Lipopolysaccharides,D10.494
18291369,2007-12-23T00:00:00,Lipopolysaccharides,D23.050.161.616.525
18291369,2007-12-23T00:00:00,Lipopolysaccharides,D23.946.123.329.500
18291369,2007-12-23T00:00:00,Neuroglia,A08.637
18291369,2007-12-23T00:00:00,Neuroglia,A11.650
18291369,2007-12-23T00:00:00,Peroxisomes,A11.284.430.214.190.500.585.600
18291369,2007-12-23T00:00:00,Peroxisomes,A11.284.430.214.190.875.190.190.755.600
18291369,2007-12-23T00:00:00,Pregnancy,G08.686.785.760.769
18291369,2007-12-23T00:00:00,Prenatal Exposure Delayed Effects,C13.703.824.500
18291369,2007-12-23T00:00:00,Reactive Oxygen Species,D01.339.431
18291369,2007-12-23T00:00:00,Reactive Oxygen Species,D01.650.775
18291369,2007-12-23T00:00:00,Time Factors,G01.910.857
18085405,2007-12-25T00:00:00,Aged,M01.060.116.100
18085405,2007-12-25T00:00:00,Contrast Media,D27.720.259
18085405,2007-12-25T00:00:00,Gadolinium DTPA,D01.632.400
18085405,2007-12-25T00:00:00,Gadolinium DTPA,D02.092.782.590.401
18085405,2007-12-25T00:00:00,Gadolinium DTPA,D02.241.081.038.694.400
18085405,2007-12-25T00:00:00,Gadolinium DTPA,D02.691.400
18085405,2007-12-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18085405,2007-12-25T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18085405,2007-12-25T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18085405,2007-12-25T00:00:00,Radiotherapy Dosage,E02.815.639
18085405,2007-12-25T00:00:00,Uterine Neoplasms,C04.588.945.418.948
18085405,2007-12-25T00:00:00,Uterine Neoplasms,C13.351.500.852.762
18085405,2007-12-25T00:00:00,Uterine Neoplasms,C13.351.937.418.875
18155204,2007-12-26T00:00:00,"Biopsy, Needle",E01.370.388.100.100
18155204,2007-12-26T00:00:00,"Biopsy, Needle",E01.450.230.100.100
18155204,2007-12-26T00:00:00,"Biopsy, Needle",E01.450.865.100.100
18155204,2007-12-26T00:00:00,"Biopsy, Needle",E01.450.865.632.100
18155204,2007-12-26T00:00:00,"Biopsy, Needle",E04.074.119
18155204,2007-12-26T00:00:00,Colonoscopy,E01.370.372.250.250.200
18155204,2007-12-26T00:00:00,Colonoscopy,E01.370.388.250.250.250.160
18155204,2007-12-26T00:00:00,Colonoscopy,E04.210.240.250.160
18155204,2007-12-26T00:00:00,Colonoscopy,E04.800.250.250.250.160
18155204,2007-12-26T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
18155204,2007-12-26T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
18155204,2007-12-26T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
18155204,2007-12-26T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
18155204,2007-12-26T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
18155204,2007-12-26T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
18155204,2007-12-26T00:00:00,"Education, Medical, Continuing",I02.358.212.350
18155204,2007-12-26T00:00:00,"Education, Medical, Continuing",I02.358.399.250
18155204,2007-12-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18155204,2007-12-26T00:00:00,Mass Screening,E01.370.500
18155204,2007-12-26T00:00:00,Mass Screening,E05.318.308.250.580
18155204,2007-12-26T00:00:00,Mass Screening,N02.421.143.827.233.443
18155204,2007-12-26T00:00:00,Mass Screening,N02.421.726.233.443
18155204,2007-12-26T00:00:00,Mass Screening,N05.715.360.300.375.500
18155204,2007-12-26T00:00:00,Mass Screening,N06.850.520.308.250.580
18155204,2007-12-26T00:00:00,Mass Screening,N06.850.780.500
18158246,2007-12-26T00:00:00,Energy Metabolism,G03.495.335
18158246,2007-12-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18158246,2007-12-26T00:00:00,"Models, Statistical",E05.318.740.500
18158246,2007-12-26T00:00:00,"Models, Statistical",E05.599.835
18158246,2007-12-26T00:00:00,"Models, Statistical",N05.715.360.750.530
18158246,2007-12-26T00:00:00,"Models, Statistical",N06.850.520.830.500
18158246,2007-12-26T00:00:00,"Muscle, Skeletal",A02.633.567
18158246,2007-12-26T00:00:00,"Muscle, Skeletal",A10.690.552.500
18158246,2007-12-26T00:00:00,Walking,G11.427.590.530.568.900
18158246,2007-12-26T00:00:00,Walking,G11.427.590.530.698.940
18158246,2007-12-26T00:00:00,Walking,I03.450.642.845.940
18160673,2007-12-26T00:00:00,Adolescent,M01.060.057
18160673,2007-12-26T00:00:00,Adult,M01.060.116
18160673,2007-12-26T00:00:00,Aged,M01.060.116.100
18160673,2007-12-26T00:00:00,Biological Markers,D23.101
18160673,2007-12-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18160673,2007-12-26T00:00:00,Lipids,D10
18160673,2007-12-26T00:00:00,Middle Aged,M01.060.116.630
18160673,2007-12-26T00:00:00,Risk Factors,E05.318.740.600.800.725
18160673,2007-12-26T00:00:00,Risk Factors,N05.715.350.200.700
18160673,2007-12-26T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18160673,2007-12-26T00:00:00,Risk Factors,N06.850.490.625.750
18160673,2007-12-26T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18160673,2007-12-26T00:00:00,Stroke,C10.228.140.300.775
18160673,2007-12-26T00:00:00,Stroke,C14.907.253.855
18160998,2007-12-27T00:00:00,"Cholesterol, HDL",D10.532.432.400
18160998,2007-12-27T00:00:00,"Cholesterol, HDL",D10.570.938.208.270
18160998,2007-12-27T00:00:00,"Cholesterol, HDL",D12.776.521.479.470
18160998,2007-12-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18160998,2007-12-27T00:00:00,Lipoproteins,D10.532
18160998,2007-12-27T00:00:00,Lipoproteins,D12.776.521
18160998,2007-12-27T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
18162533,2007-12-27T00:00:00,Antineoplastic Agents,D27.505.954.248
18162533,2007-12-27T00:00:00,Breast Neoplasms,C04.588.180
18162533,2007-12-27T00:00:00,Breast Neoplasms,C17.800.090.500
18162533,2007-12-27T00:00:00,Cell Proliferation,G04.299.233.750
18162533,2007-12-27T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18162533,2007-12-27T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.644.360.225.500
18162533,2007-12-27T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.776.167.187.500
18162533,2007-12-27T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.776.476.225.500
18162533,2007-12-27T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.776.624.776.355.500
18162533,2007-12-27T00:00:00,DNA Methylation,G02.111.087.029.538.161
18162533,2007-12-27T00:00:00,DNA Methylation,G02.111.087.218
18162533,2007-12-27T00:00:00,DNA Methylation,G02.149.115.029.538.161
18162533,2007-12-27T00:00:00,DNA Methylation,G02.149.115.218
18162533,2007-12-27T00:00:00,DNA Methylation,G03.495.130.538.161
18162533,2007-12-27T00:00:00,DNA Methylation,G05.355.190
18162533,2007-12-27T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
18162533,2007-12-27T00:00:00,Estrogen Receptor alpha,D12.776.260.698.750.350.174
18162533,2007-12-27T00:00:00,Estrogen Receptor alpha,D12.776.826.750.350.174
18162533,2007-12-27T00:00:00,Estrogen Receptor alpha,D12.776.930.669.750.350.174
18162533,2007-12-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18162533,2007-12-27T00:00:00,Middle Aged,M01.060.116.630
18162533,2007-12-27T00:00:00,Treatment Outcome,E01.789.800
18162533,2007-12-27T00:00:00,Treatment Outcome,N04.761.559.590.800
18162533,2007-12-27T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18162626,2007-12-27T00:00:00,Aged,M01.060.116.100
18162626,2007-12-27T00:00:00,Brain Ischemia,C10.228.140.300.150
18162626,2007-12-27T00:00:00,Brain Ischemia,C14.907.253.092
18162626,2007-12-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18162626,2007-12-27T00:00:00,Lymphocytes,A11.118.637.555.567
18162626,2007-12-27T00:00:00,Lymphocytes,A15.145.229.637.555.567
18162626,2007-12-27T00:00:00,Lymphocytes,A15.382.490.555.567
18162626,2007-12-27T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18162626,2007-12-27T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18162626,2007-12-27T00:00:00,Middle Aged,M01.060.116.630
18162626,2007-12-27T00:00:00,Neutrophils,A11.118.637.415.583
18162626,2007-12-27T00:00:00,Neutrophils,A11.627.340.583
18162626,2007-12-27T00:00:00,Neutrophils,A11.733.689
18162626,2007-12-27T00:00:00,Neutrophils,A15.145.229.637.415.583
18162626,2007-12-27T00:00:00,Neutrophils,A15.382.490.315.583
18162626,2007-12-27T00:00:00,Neutrophils,A15.382.680.689
18162626,2007-12-27T00:00:00,Stroke,C10.228.140.300.775
18162626,2007-12-27T00:00:00,Stroke,C14.907.253.855
18164594,2007-12-31T00:00:00,Adult,M01.060.116
18164594,2007-12-31T00:00:00,Case-Control Studies,E05.318.760.500.500
18164594,2007-12-31T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18164594,2007-12-31T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18164594,2007-12-31T00:00:00,Cognition Disorders,F03.087.250
18164594,2007-12-31T00:00:00,Frontal Lobe,A08.186.211.730.885.287.500.270
18164594,2007-12-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18164594,2007-12-31T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18164594,2007-12-31T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18164594,2007-12-31T00:00:00,Middle Aged,M01.060.116.630
18164594,2007-12-31T00:00:00,Neuropsychological Tests,F04.711.513
18164594,2007-12-31T00:00:00,Regression Analysis,E05.318.740.750
18164594,2007-12-31T00:00:00,Regression Analysis,N05.715.360.750.695
18164594,2007-12-31T00:00:00,Regression Analysis,N06.850.520.830.750
18164594,2007-12-31T00:00:00,Schizophrenia,F03.700.750
18164797,2007-12-31T00:00:00,Animals,B01.050
18164797,2007-12-31T00:00:00,Echocardiography,E01.370.350.850.220
18164797,2007-12-31T00:00:00,Echocardiography,E01.370.370.380.220
18164797,2007-12-31T00:00:00,Heart Arrest,C14.280.383
18164797,2007-12-31T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18164797,2007-12-31T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
18164797,2007-12-31T00:00:00,Time Factors,G01.910.857
18261719,2007-12-31T00:00:00,Animals,B01.050
18261719,2007-12-31T00:00:00,Avian Proteins,D12.776.093
18261719,2007-12-31T00:00:00,Bone Morphogenetic Protein 2,D12.644.276.954.200.200
18261719,2007-12-31T00:00:00,Bone Morphogenetic Protein 2,D12.776.467.942.200.200
18261719,2007-12-31T00:00:00,Bone Morphogenetic Protein 2,D23.529.942.200.200
18261719,2007-12-31T00:00:00,"Bone Morphogenetic Protein Receptors, Type I",D08.811.913.696.620.682.700.109.500
18261719,2007-12-31T00:00:00,"Bone Morphogenetic Protein Receptors, Type I",D12.776.543.750.750.400.049.500
18261719,2007-12-31T00:00:00,Bone Morphogenetic Proteins,D12.644.276.954.200
18261719,2007-12-31T00:00:00,Bone Morphogenetic Proteins,D12.776.467.942.200
18261719,2007-12-31T00:00:00,Bone Morphogenetic Proteins,D23.529.942.200
18261719,2007-12-31T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
18261719,2007-12-31T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
18261719,2007-12-31T00:00:00,Cell Adhesion Molecules,D23.050.301.350
18261719,2007-12-31T00:00:00,Cell Differentiation,G04.299.151
18261719,2007-12-31T00:00:00,Cell Movement,G04.299.283
18261719,2007-12-31T00:00:00,Cell Movement,G07.700.560.500.180
18261719,2007-12-31T00:00:00,Chick Embryo,A13.350.150
18261719,2007-12-31T00:00:00,Chick Embryo,A16.331.200
18261719,2007-12-31T00:00:00,"Models, Biological",E05.599.395
18261719,2007-12-31T00:00:00,"RNA, Messenger",D13.444.735.544
18261719,2007-12-31T00:00:00,Signal Transduction,G02.111.087.800
18261719,2007-12-31T00:00:00,Signal Transduction,G02.149.115.800
18261719,2007-12-31T00:00:00,Signal Transduction,G04.299.880
18261719,2007-12-31T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
18261719,2007-12-31T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
18261719,2007-12-31T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
18261719,2007-12-31T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
18261719,2007-12-31T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
18261719,2007-12-31T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
18261719,2007-12-31T00:00:00,Transforming Growth Factor beta,D23.529.374.687
18261719,2007-12-31T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
18261719,2007-12-31T00:00:00,Transforming Growth Factor beta,D23.529.960.720
17457853,2008-01-01T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
17457853,2008-01-01T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
17457853,2008-01-01T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
17457853,2008-01-01T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
17457853,2008-01-01T00:00:00,"Biopsy, Needle",E01.370.388.100.100
17457853,2008-01-01T00:00:00,"Biopsy, Needle",E01.450.230.100.100
17457853,2008-01-01T00:00:00,"Biopsy, Needle",E01.450.865.100.100
17457853,2008-01-01T00:00:00,"Biopsy, Needle",E01.450.865.632.100
17457853,2008-01-01T00:00:00,"Biopsy, Needle",E04.074.119
17457853,2008-01-01T00:00:00,Blood Transfusion,E02.095.135
17457853,2008-01-01T00:00:00,Child,M01.060.406
17457853,2008-01-01T00:00:00,Ferritins,D12.776.157.427.249
17457853,2008-01-01T00:00:00,Ferritins,D12.776.556.579.249
17457853,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17457853,2008-01-01T00:00:00,Iron,D01.268.556.412
17457853,2008-01-01T00:00:00,Iron,D01.268.956.287
17457853,2008-01-01T00:00:00,Iron,D01.552.544.412
17457853,2008-01-01T00:00:00,Liver,A03.620
17724705,2008-01-01T00:00:00,Androgens,D27.505.696.399.472.161
17724705,2008-01-01T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
17724705,2008-01-01T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
17724705,2008-01-01T00:00:00,Cell Adhesion Molecules,D23.050.301.350
17724705,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17724705,2008-01-01T00:00:00,Neoplasm Staging,E01.370.550
17724705,2008-01-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
17724705,2008-01-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
17724705,2008-01-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
17724705,2008-01-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
17906981,2008-01-01T00:00:00,Adolescent,M01.060.057
17906981,2008-01-01T00:00:00,Adult,M01.060.116
17906981,2008-01-01T00:00:00,Aged,M01.060.116.100
17906981,2008-01-01T00:00:00,Child,M01.060.406
17906981,2008-01-01T00:00:00,"Child, Preschool",M01.060.406.448
17906981,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17906981,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
17906981,2008-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17906981,2008-01-01T00:00:00,Risk Factors,N05.715.350.200.700
17906981,2008-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17906981,2008-01-01T00:00:00,Risk Factors,N06.850.490.625.750
17906981,2008-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17906981,2008-01-01T00:00:00,Syndrome,C23.550.288.500
17932962,2008-01-01T00:00:00,Adolescent,M01.060.057
17932962,2008-01-01T00:00:00,Adult,M01.060.116
17932962,2008-01-01T00:00:00,Brain,A08.186.211
17932962,2008-01-01T00:00:00,Child,M01.060.406
17932962,2008-01-01T00:00:00,Child Behavior Disorders,F03.550.300
17932962,2008-01-01T00:00:00,"Child, Preschool",M01.060.406.448
17932962,2008-01-01T00:00:00,Cognition Disorders,F03.087.250
17932962,2008-01-01T00:00:00,Fragile X Syndrome,C10.597.606.643.455.500
17932962,2008-01-01T00:00:00,Fragile X Syndrome,C16.131.260.800.300
17932962,2008-01-01T00:00:00,Fragile X Syndrome,C16.320.180.800.300
17932962,2008-01-01T00:00:00,Fragile X Syndrome,C16.320.322.500.500
17932962,2008-01-01T00:00:00,Fragile X Syndrome,C16.320.400.525.500
17932962,2008-01-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17932962,2008-01-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
17932962,2008-01-01T00:00:00,Genetic Testing,E01.370.427
17932962,2008-01-01T00:00:00,Genetic Testing,E05.393.435
17932962,2008-01-01T00:00:00,Genetic Testing,N02.421.143.827.233.221
17932962,2008-01-01T00:00:00,Genetic Testing,N02.421.308.430
17932962,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17932962,2008-01-01T00:00:00,Infant,M01.060.703
17932962,2008-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17932962,2008-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17932962,2008-01-01T00:00:00,Mutation,G05.365.590
17932962,2008-01-01T00:00:00,Neuropsychological Tests,F04.711.513
17932962,2008-01-01T00:00:00,Sex Factors,N05.715.350.675
17932962,2008-01-01T00:00:00,Sex Factors,N06.850.490.875
17968520,2008-01-01T00:00:00,Adult,M01.060.116
17968520,2008-01-01T00:00:00,Aged,M01.060.116.100
17968520,2008-01-01T00:00:00,Brain,A08.186.211
17968520,2008-01-01T00:00:00,Brain Ischemia,C10.228.140.300.150
17968520,2008-01-01T00:00:00,Brain Ischemia,C14.907.253.092
17968520,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17968520,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
17968520,2008-01-01T00:00:00,Subarachnoid Hemorrhage,C10.228.140.300.535.800
17968520,2008-01-01T00:00:00,Subarachnoid Hemorrhage,C14.907.253.573.800
17968520,2008-01-01T00:00:00,Subarachnoid Hemorrhage,C23.550.414.913.850
17968520,2008-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17968520,2008-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17968520,2008-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17968520,2008-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17968520,2008-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17968520,2008-01-01T00:00:00,Treatment Outcome,E01.789.800
17968520,2008-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17968520,2008-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17968520,2008-01-01T00:00:00,Vasodilator Agents,D27.505.954.411.918
17981711,2008-01-01T00:00:00,Animals,B01.050
17981711,2008-01-01T00:00:00,Antineoplastic Agents,D27.505.954.248
17981711,2008-01-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
17981711,2008-01-01T00:00:00,Fas Ligand Protein,D12.644.276.374.750.249
17981711,2008-01-01T00:00:00,Fas Ligand Protein,D12.644.276.972.249
17981711,2008-01-01T00:00:00,Fas Ligand Protein,D12.776.395.550.312
17981711,2008-01-01T00:00:00,Fas Ligand Protein,D12.776.467.374.750.249
17981711,2008-01-01T00:00:00,Fas Ligand Protein,D12.776.467.972.249
17981711,2008-01-01T00:00:00,Fas Ligand Protein,D12.776.543.550.312
17981711,2008-01-01T00:00:00,Fas Ligand Protein,D23.050.301.264.035.283
17981711,2008-01-01T00:00:00,Fas Ligand Protein,D23.101.100.110.282
17981711,2008-01-01T00:00:00,Fas Ligand Protein,D23.529.374.750.249
17981711,2008-01-01T00:00:00,Fas Ligand Protein,D23.529.972.249
17981711,2008-01-01T00:00:00,Galactosylgalactosylglucosylceramidase,D08.811.277.450.410.150
17981711,2008-01-01T00:00:00,Genetic Vectors,G05.360.337
17981711,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17981711,2008-01-01T00:00:00,Neoplasms,C04
18023036,2008-01-01T00:00:00,Animals,B01.050
18023036,2008-01-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
18023036,2008-01-01T00:00:00,Apoptosis,G04.299.139.160
18023036,2008-01-01T00:00:00,Calcium,D01.268.552.100
18023036,2008-01-01T00:00:00,Calcium,D01.552.539.288
18023036,2008-01-01T00:00:00,Calcium,D23.119.100
18023036,2008-01-01T00:00:00,Cyclosporine,D04.345.566.235.300
18023036,2008-01-01T00:00:00,Cyclosporine,D12.644.641.235.300
18023036,2008-01-01T00:00:00,Graft Survival,G12.425.901.545.340
18023036,2008-01-01T00:00:00,Liver,A03.620
18023036,2008-01-01T00:00:00,Liver Transplantation,E04.210.650
18023036,2008-01-01T00:00:00,Liver Transplantation,E04.936.450.490
18023036,2008-01-01T00:00:00,Liver Transplantation,E04.936.580.490
18023036,2008-01-01T00:00:00,Mitochondria,A11.284.430.214.190.875.564
18023036,2008-01-01T00:00:00,Mitochondria,A11.284.835.626
18023036,2008-01-01T00:00:00,Mitochondrial Diseases,C18.452.660
18023036,2008-01-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
18023036,2008-01-01T00:00:00,Reperfusion Injury,C14.907.725
18023036,2008-01-01T00:00:00,Reperfusion Injury,C23.550.767.877
18027844,2008-01-01T00:00:00,Adolescent,M01.060.057
18027844,2008-01-01T00:00:00,Adult,M01.060.116
18027844,2008-01-01T00:00:00,Aged,M01.060.116.100
18027844,2008-01-01T00:00:00,Anxiety Disorders,F03.080
18027844,2008-01-01T00:00:00,Depressive Disorder,F03.600.300
18027844,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18027844,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18027844,2008-01-01T00:00:00,"Models, Psychological",E05.599.695
18027844,2008-01-01T00:00:00,Personality Inventory,F04.711.647.513
18027844,2008-01-01T00:00:00,Psychometrics,F04.711.780
18028586,2008-01-01T00:00:00,Aged,M01.060.116.100
18028586,2008-01-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
18028586,2008-01-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
18028586,2008-01-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
18028586,2008-01-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
18028586,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18028586,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18028586,2008-01-01T00:00:00,Physicians,M01.526.485.810
18028586,2008-01-01T00:00:00,Physicians,N02.360.810
18028586,2008-01-01T00:00:00,Venous Thromboembolism,C14.907.355.590.700
18028586,2008-01-01T00:00:00,Venous Thromboembolism,C14.907.355.830.850.700
18028586,2008-01-01T00:00:00,Venous Thrombosis,C14.907.355.830.925
18043497,2008-01-01T00:00:00,Aged,M01.060.116.100
18043497,2008-01-01T00:00:00,Algorithms,G17.035
18043497,2008-01-01T00:00:00,Algorithms,L01.224.050
18043497,2008-01-01T00:00:00,Biological Markers,D23.101
18043497,2008-01-01T00:00:00,Blood Proteins,D12.776.124
18043497,2008-01-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
18043497,2008-01-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
18043497,2008-01-01T00:00:00,Case-Control Studies,E05.318.760.500.500
18043497,2008-01-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18043497,2008-01-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18043497,2008-01-01T00:00:00,Gene Expression Profiling,E05.393.332
18043497,2008-01-01T00:00:00,Head and Neck Neoplasms,C04.588.443
18043497,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18043497,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18043497,2008-01-01T00:00:00,"Pattern Recognition, Automated",L01.725
18043497,2008-01-01T00:00:00,Smoking,F01.145.466.753
18043497,2008-01-01T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
18043497,2008-01-01T00:00:00,"Tumor Markers, Biological",D23.101.840
18058768,2008-01-01T00:00:00,Microfluidic Analytical Techniques,E05.196.630.465
18058768,2008-01-01T00:00:00,Microfluidic Analytical Techniques,E05.588.465
18058768,2008-01-01T00:00:00,Temperature,G01.906.595
18058768,2008-01-01T00:00:00,Temperature,G16.500.275.063.725.710
18058768,2008-01-01T00:00:00,Temperature,G16.500.750.775.710
18058768,2008-01-01T00:00:00,Temperature,N06.230.150.450
18058768,2008-01-01T00:00:00,Temperature,N06.230.300.100.725.710
18076342,2008-01-01T00:00:00,Cholecalciferol,D04.808.247.222.159
18076342,2008-01-01T00:00:00,Cholecalciferol,D04.808.247.808.146
18076342,2008-01-01T00:00:00,Cholecalciferol,D04.808.812.768.196
18076342,2008-01-01T00:00:00,Cholecalciferol,D10.570.938.146
18076342,2008-01-01T00:00:00,Dietary Supplements,J02.500.456
18076342,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18076342,2008-01-01T00:00:00,Skin Neoplasms,C04.588.805
18076342,2008-01-01T00:00:00,Skin Neoplasms,C17.800.882
18076342,2008-01-01T00:00:00,Vitamin D,D04.808.812.768
18076342,2008-01-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
18080059,2008-01-01T00:00:00,Adult,M01.060.116
18080059,2008-01-01T00:00:00,Aged,M01.060.116.100
18080059,2008-01-01T00:00:00,Alcohol Deterrents,D27.505.954.427.020
18080059,2008-01-01T00:00:00,Alcoholism,C21.739.100.250
18080059,2008-01-01T00:00:00,Alcoholism,F03.900.100.350
18080059,2008-01-01T00:00:00,Cognitive Therapy,F04.754.137.428
18080059,2008-01-01T00:00:00,Combined Modality Therapy,E02.186
18080059,2008-01-01T00:00:00,Double-Blind Method,E05.318.780.300
18080059,2008-01-01T00:00:00,Double-Blind Method,E05.581.500.300
18080059,2008-01-01T00:00:00,Double-Blind Method,N05.715.360.780.320
18080059,2008-01-01T00:00:00,Double-Blind Method,N06.850.520.445.300
18080059,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18080059,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18080059,2008-01-01T00:00:00,Taurine,D02.455.326.146.100.850
18080059,2008-01-01T00:00:00,Taurine,D02.886.645.600.055.850
18080059,2008-01-01T00:00:00,Treatment Outcome,E01.789.800
18080059,2008-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18080059,2008-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18090350,2008-01-01T00:00:00,Adult,M01.060.116
18090350,2008-01-01T00:00:00,Biological Markers,D23.101
18090350,2008-01-01T00:00:00,Hand,A01.378.800.667
18090350,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18090350,2008-01-01T00:00:00,"Muscle, Skeletal",A02.633.567
18090350,2008-01-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
18090350,2008-01-01T00:00:00,Oxygen,D01.268.185.550
18090350,2008-01-01T00:00:00,Oxygen,D01.362.670
18095881,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18095881,2008-01-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
18095881,2008-01-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
18095881,2008-01-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
18095881,2008-01-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
18095881,2008-01-01T00:00:00,Proto-Oncogene Proteins c-ets,D12.776.260.665
18095881,2008-01-01T00:00:00,Proto-Oncogene Proteins c-ets,D12.776.624.664.700.175
18095881,2008-01-01T00:00:00,Proto-Oncogene Proteins c-ets,D12.776.930.635
18098292,2008-01-01T00:00:00,Animals,B01.050
18098292,2008-01-01T00:00:00,Cattle,B01.050.150.900.649.077.380.271
18098292,2008-01-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
18098292,2008-01-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
18098292,2008-01-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
18098292,2008-01-01T00:00:00,"Stress, Mechanical",G01.374.676.830
18098292,2008-01-01T00:00:00,"Stress, Mechanical",G01.595.540.830
18098292,2008-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18098292,2008-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18098292,2008-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18098292,2008-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18098292,2008-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18154465,2008-01-01T00:00:00,Biotechnology,H01.158.550
18154465,2008-01-01T00:00:00,Biotechnology,J01.897.120
18154465,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18154465,2008-01-01T00:00:00,Robotics,H01.671.293.643
18154465,2008-01-01T00:00:00,Robotics,J01.897.104.834
18154465,2008-01-01T00:00:00,Robotics,L01.224.065.630
18154465,2008-01-01T00:00:00,Tissue Engineering,E05.200.249.750
18154815,2008-01-01T00:00:00,Academic Medical Centers,N02.278.020
18154815,2008-01-01T00:00:00,Adult,M01.060.116
18154815,2008-01-01T00:00:00,Aged,M01.060.116.100
18154815,2008-01-01T00:00:00,"Biopsy, Fine-Needle",E01.370.388.100.100.500
18154815,2008-01-01T00:00:00,"Biopsy, Fine-Needle",E01.450.230.100.100.500
18154815,2008-01-01T00:00:00,"Biopsy, Fine-Needle",E01.450.865.100.100.500
18154815,2008-01-01T00:00:00,"Biopsy, Fine-Needle",E04.074.119.500
18154815,2008-01-01T00:00:00,Endosonography,E01.370.350.850.280
18154815,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18154815,2008-01-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
18154815,2008-01-01T00:00:00,Lung Neoplasms,C08.381.540
18154815,2008-01-01T00:00:00,Lung Neoplasms,C08.785.520
18154815,2008-01-01T00:00:00,Lymph Nodes,A10.549.400
18154815,2008-01-01T00:00:00,Lymph Nodes,A15.382.520.604.412
18154815,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18154815,2008-01-01T00:00:00,Neoplasm Staging,E01.370.550
18154815,2008-01-01T00:00:00,Preoperative Care,E02.760.795
18154815,2008-01-01T00:00:00,Preoperative Care,E04.641
18154815,2008-01-01T00:00:00,Preoperative Care,N02.421.585.795
18154815,2008-01-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18154815,2008-01-01T00:00:00,Risk Assessment,N04.452.871.715
18154815,2008-01-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18154815,2008-01-01T00:00:00,Risk Assessment,N06.850.505.715
18154815,2008-01-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18156521,2008-01-01T00:00:00,Aged,M01.060.116.100
18156521,2008-01-01T00:00:00,Caregivers,M01.085
18156521,2008-01-01T00:00:00,Caregivers,M01.526.485.200
18156521,2008-01-01T00:00:00,Caregivers,N02.360.200
18156521,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18156521,2008-01-01T00:00:00,Informed Consent,I01.880.604.473.650.718
18156521,2008-01-01T00:00:00,Informed Consent,I01.880.604.583.427
18156521,2008-01-01T00:00:00,Informed Consent,N03.706.437.650.312
18156521,2008-01-01T00:00:00,Informed Consent,N03.706.535.489
18156521,2008-01-01T00:00:00,Mental Recall,F02.463.425.540.641
18156521,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18156521,2008-01-01T00:00:00,Parkinson Disease,C10.228.140.079.862.500
18156521,2008-01-01T00:00:00,Parkinson Disease,C10.228.662.600.400
18156521,2008-01-01T00:00:00,Parkinson Disease,C10.574.812
18156521,2008-01-01T00:00:00,Social Support,I01.880.656.600
18156940,2008-01-01T00:00:00,Digestive System Surgical Procedures,E04.210
18156940,2008-01-01T00:00:00,"History, 19th Century",K01.400.504.937
18156940,2008-01-01T00:00:00,"History, 20th Century",K01.400.504.968
18156940,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18157006,2008-01-01T00:00:00,Animals,B01.050
18157006,2008-01-01T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
18157006,2008-01-01T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
18157006,2008-01-01T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
18157006,2008-01-01T00:00:00,Genetic Vectors,G05.360.337
18157006,2008-01-01T00:00:00,"Immunotherapy, Adoptive",E02.095.465.425.400.330.050.400
18157006,2008-01-01T00:00:00,"Immunotherapy, Adoptive",E05.478.550.520.050.400
18157006,2008-01-01T00:00:00,Interferon-gamma,D12.644.276.374.440.893
18157006,2008-01-01T00:00:00,Interferon-gamma,D12.644.276.374.480.350
18157006,2008-01-01T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
18157006,2008-01-01T00:00:00,Interferon-gamma,D12.644.276.718.550
18157006,2008-01-01T00:00:00,Interferon-gamma,D12.776.467.374.440.893
18157006,2008-01-01T00:00:00,Interferon-gamma,D12.776.467.374.480.350
18157006,2008-01-01T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
18157006,2008-01-01T00:00:00,Interferon-gamma,D12.776.467.718.550
18157006,2008-01-01T00:00:00,Interferon-gamma,D23.529.374.440.893
18157006,2008-01-01T00:00:00,Interferon-gamma,D23.529.374.480.350
18157006,2008-01-01T00:00:00,Interferon-gamma,D23.529.374.480.615.350
18157006,2008-01-01T00:00:00,Interferon-gamma,D23.529.718.550
18157006,2008-01-01T00:00:00,Lymphocyte Activation,E01.450.495.482
18157006,2008-01-01T00:00:00,Lymphocyte Activation,E05.478.594.530
18157006,2008-01-01T00:00:00,Lymphocyte Activation,G12.425.747
18157006,2008-01-01T00:00:00,Lymphocyte Activation,G12.450.050.400.545
18157006,2008-01-01T00:00:00,Lymphocytes,A11.118.637.555.567
18157006,2008-01-01T00:00:00,Lymphocytes,A15.145.229.637.555.567
18157006,2008-01-01T00:00:00,Lymphocytes,A15.382.490.555.567
18157006,2008-01-01T00:00:00,Membrane Glycoproteins,D12.776.395.550
18157006,2008-01-01T00:00:00,Membrane Glycoproteins,D12.776.543.550
18157006,2008-01-01T00:00:00,Spleen,A10.549.700
18157006,2008-01-01T00:00:00,Spleen,A15.382.520.604.700
18161643,2008-01-01T00:00:00,Adolescent,M01.060.057
18161643,2008-01-01T00:00:00,Adult,M01.060.116
18161643,2008-01-01T00:00:00,Ambulatory Care,E02.760.106
18161643,2008-01-01T00:00:00,Ambulatory Care,N02.421.585.106
18161643,2008-01-01T00:00:00,Counseling,F02.784.176
18161643,2008-01-01T00:00:00,Counseling,F04.408.413
18161643,2008-01-01T00:00:00,Counseling,N02.421.143.303
18161643,2008-01-01T00:00:00,Counseling,N02.421.461.363
18161643,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18161643,2008-01-01T00:00:00,Patient Compliance,F01.145.488.500
18161643,2008-01-01T00:00:00,Patient Compliance,N05.300.150.600.600
18161643,2008-01-01T00:00:00,Patient Discharge,E02.760.400.610
18161643,2008-01-01T00:00:00,Patient Discharge,N02.421.585.400.610
18161643,2008-01-01T00:00:00,Sex Factors,N05.715.350.675
18161643,2008-01-01T00:00:00,Sex Factors,N06.850.490.875
18161643,2008-01-01T00:00:00,Substance Abuse Treatment Centers,N02.278.035.128.800
18161643,2008-01-01T00:00:00,Substance Abuse Treatment Centers,N02.278.808.930
18161643,2008-01-01T00:00:00,Substance-Related Disorders,C21.739
18161643,2008-01-01T00:00:00,Substance-Related Disorders,F03.900
18161643,2008-01-01T00:00:00,Treatment Outcome,E01.789.800
18161643,2008-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18161643,2008-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18163495,2008-01-01T00:00:00,Adult,M01.060.116
18163495,2008-01-01T00:00:00,Biological Markers,D23.101
18163495,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18163495,2008-01-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
18163495,2008-01-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
18163495,2008-01-01T00:00:00,Lupus Nephritis,C12.777.419.570.363.680
18163495,2008-01-01T00:00:00,Lupus Nephritis,C13.351.968.419.570.363.680
18163495,2008-01-01T00:00:00,Lupus Nephritis,C17.300.480.680
18163495,2008-01-01T00:00:00,Lupus Nephritis,C20.111.590.560
18164991,2008-01-01T00:00:00,Adolescent,M01.060.057
18164991,2008-01-01T00:00:00,Adult,M01.060.116
18164991,2008-01-01T00:00:00,Aged,M01.060.116.100
18164991,2008-01-01T00:00:00,Child,M01.060.406
18164991,2008-01-01T00:00:00,"Child, Preschool",M01.060.406.448
18164991,2008-01-01T00:00:00,"Diagnosis, Differential",E01.171
18164991,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18164991,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18164991,2008-01-01T00:00:00,Sinusitis,C08.460.692.752
18164991,2008-01-01T00:00:00,Sinusitis,C08.730.749
18164991,2008-01-01T00:00:00,Sinusitis,C09.603.692.752
18164991,2008-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18164991,2008-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18165099,2008-01-01T00:00:00,Cataract,C11.510.245
18165099,2008-01-01T00:00:00,Cataract Extraction,E04.540.825.249
18165099,2008-01-01T00:00:00,Child,M01.060.406
18165099,2008-01-01T00:00:00,Eye Diseases,C11
18165099,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18165099,2008-01-01T00:00:00,Infant,M01.060.703
18165099,2008-01-01T00:00:00,Intraoperative Complications,C23.550.505
18166300,2008-01-01T00:00:00,Adolescent,M01.060.057
18166300,2008-01-01T00:00:00,Adult,M01.060.116
18166300,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18166300,2008-01-01T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
18166300,2008-01-01T00:00:00,Pain Measurement,E01.370.376.550.600
18166300,2008-01-01T00:00:00,Pelvic Inflammatory Disease,C01.539.635.500
18166300,2008-01-01T00:00:00,Pelvic Inflammatory Disease,C13.351.500.056.750
18166300,2008-01-01T00:00:00,Probability,E05.318.740.600
18166300,2008-01-01T00:00:00,Probability,G17.680
18166300,2008-01-01T00:00:00,Probability,N05.715.360.750.625
18166300,2008-01-01T00:00:00,Probability,N06.850.520.830.600
18166300,2008-01-01T00:00:00,Time Factors,G01.910.857
18166300,2008-01-01T00:00:00,Treatment Outcome,E01.789.800
18166300,2008-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18166300,2008-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18166342,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18166342,2008-01-01T00:00:00,"Hypertension, Portal",C06.552.494
18166342,2008-01-01T00:00:00,Liver Cirrhosis,C06.552.630
18166342,2008-01-01T00:00:00,Sex Factors,N05.715.350.675
18166342,2008-01-01T00:00:00,Sex Factors,N06.850.490.875
18166564,2008-01-01T00:00:00,Adolescent,M01.060.057
18166564,2008-01-01T00:00:00,Adult,M01.060.116
18166564,2008-01-01T00:00:00,African Americans,M01.686.508.100.100
18166564,2008-01-01T00:00:00,African Americans,M01.686.754.100
18166564,2008-01-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
18166564,2008-01-01T00:00:00,Body Mass Index,E05.041.124.125
18166564,2008-01-01T00:00:00,Body Mass Index,G07.100.100.125
18166564,2008-01-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
18166564,2008-01-01T00:00:00,Body Weight,C23.888.144
18166564,2008-01-01T00:00:00,Body Weight,E01.370.600.115.100.160.120
18166564,2008-01-01T00:00:00,Body Weight,E05.041.124.160.750
18166564,2008-01-01T00:00:00,Body Weight,G07.100.100.160.120
18166564,2008-01-01T00:00:00,Body Weight,G07.700.320.249.314.120
18166564,2008-01-01T00:00:00,Cardiovascular Diseases,C14
18166564,2008-01-01T00:00:00,Case-Control Studies,E05.318.760.500.500
18166564,2008-01-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18166564,2008-01-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18166564,2008-01-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
18166564,2008-01-01T00:00:00,Hemodynamics,G09.330.190.400
18166564,2008-01-01T00:00:00,Hemodynamics,G09.330.380
18166564,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18166564,2008-01-01T00:00:00,Hypertension,C14.907.489
18166564,2008-01-01T00:00:00,Incidence,E05.318.308.985.525.375
18166564,2008-01-01T00:00:00,Incidence,L01.280.975.525.375
18166564,2008-01-01T00:00:00,Incidence,N01.224.935.597.500
18166564,2008-01-01T00:00:00,Incidence,N06.850.505.400.975.525.375
18166564,2008-01-01T00:00:00,Incidence,N06.850.520.308.985.525.375
18166564,2008-01-01T00:00:00,Overweight,C23.888.144.699
18166564,2008-01-01T00:00:00,Overweight,E01.370.600.115.100.160.120.699
18166564,2008-01-01T00:00:00,Overweight,G07.100.100.160.120.699
18166564,2008-01-01T00:00:00,Phenotype,G05.695
18166564,2008-01-01T00:00:00,Probability,E05.318.740.600
18166564,2008-01-01T00:00:00,Probability,G17.680
18166564,2008-01-01T00:00:00,Probability,N05.715.360.750.625
18166564,2008-01-01T00:00:00,Probability,N06.850.520.830.600
18166564,2008-01-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18166564,2008-01-01T00:00:00,Risk Assessment,N04.452.871.715
18166564,2008-01-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18166564,2008-01-01T00:00:00,Risk Assessment,N06.850.505.715
18166564,2008-01-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18166758,2008-01-01T00:00:00,Adult,M01.060.116
18166758,2008-01-01T00:00:00,Aged,M01.060.116.100
18166758,2008-01-01T00:00:00,Computer Simulation,L01.224.160
18166758,2008-01-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
18166758,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18166758,2008-01-01T00:00:00,Mammography,E01.370.350.700.500
18166758,2008-01-01T00:00:00,Mass Screening,E01.370.500
18166758,2008-01-01T00:00:00,Mass Screening,E05.318.308.250.580
18166758,2008-01-01T00:00:00,Mass Screening,N02.421.143.827.233.443
18166758,2008-01-01T00:00:00,Mass Screening,N02.421.726.233.443
18166758,2008-01-01T00:00:00,Mass Screening,N05.715.360.300.375.500
18166758,2008-01-01T00:00:00,Mass Screening,N06.850.520.308.250.580
18166758,2008-01-01T00:00:00,Mass Screening,N06.850.780.500
18166758,2008-01-01T00:00:00,Medicare,N03.219.521.346.506.564.663
18166758,2008-01-01T00:00:00,Medicare,N03.219.521.576.343.840
18166758,2008-01-01T00:00:00,Medicare,N03.706.615.696
18166758,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18166758,2008-01-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
18166758,2008-01-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
18166758,2008-01-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
18166758,2008-01-01T00:00:00,United States,Z01.107.567.875
18167088,2008-01-01T00:00:00,Animals,B01.050
18167088,2008-01-01T00:00:00,Dogs,B01.050.150.900.649.147.153.200
18167088,2008-01-01T00:00:00,Estradiol,D04.808.365.415.248
18167088,2008-01-01T00:00:00,Estradiol,D06.472.334.851.437.500
18167088,2008-01-01T00:00:00,Estrogens,D27.505.696.399.472.277
18167088,2008-01-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18167088,2008-01-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
18167088,2008-01-01T00:00:00,Hip Joint,A02.835.583.411
18167088,2008-01-01T00:00:00,Lactation,G08.686.702.500
18167088,2008-01-01T00:00:00,Lactation,G08.686.785.420
18167088,2008-01-01T00:00:00,Ligaments,A02.513
18167088,2008-01-01T00:00:00,Relaxin,D06.472.334.734.769
18167088,2008-01-01T00:00:00,Relaxin,D06.472.699.715
18167088,2008-01-01T00:00:00,Relaxin,D12.644.548.762
18172258,2008-01-01T00:00:00,Adult,M01.060.116
18172258,2008-01-01T00:00:00,Aged,M01.060.116.100
18172258,2008-01-01T00:00:00,Body Fluids,A12.207
18172258,2008-01-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
18172258,2008-01-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
18172258,2008-01-01T00:00:00,DNA Methylation,G02.111.087.029.538.161
18172258,2008-01-01T00:00:00,DNA Methylation,G02.111.087.218
18172258,2008-01-01T00:00:00,DNA Methylation,G02.149.115.029.538.161
18172258,2008-01-01T00:00:00,DNA Methylation,G02.149.115.218
18172258,2008-01-01T00:00:00,DNA Methylation,G03.495.130.538.161
18172258,2008-01-01T00:00:00,DNA Methylation,G05.355.190
18172258,2008-01-01T00:00:00,Head and Neck Neoplasms,C04.588.443
18172258,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18172258,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18172258,2008-01-01T00:00:00,Polymerase Chain Reaction,E05.393.620.500
18172258,2008-01-01T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
18172258,2008-01-01T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
18172258,2008-01-01T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
18172258,2008-01-01T00:00:00,Saliva,A12.200.666
18172798,2008-01-01T00:00:00,Adolescent,M01.060.057
18172798,2008-01-01T00:00:00,Adult,M01.060.116
18172798,2008-01-01T00:00:00,African Americans,M01.686.508.100.100
18172798,2008-01-01T00:00:00,African Americans,M01.686.754.100
18172798,2008-01-01T00:00:00,Attitude to Health,F01.100.150
18172798,2008-01-01T00:00:00,Attitude to Health,N05.300.150
18172798,2008-01-01T00:00:00,Biomedical Research,H01.770.644.145
18172798,2008-01-01T00:00:00,Data Collection,E05.318.308
18172798,2008-01-01T00:00:00,Data Collection,L01.280
18172798,2008-01-01T00:00:00,Data Collection,N05.715.360.300
18172798,2008-01-01T00:00:00,Data Collection,N06.850.520.308
18172798,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18172798,2008-01-01T00:00:00,Questionnaires,E05.318.308.750
18172798,2008-01-01T00:00:00,Questionnaires,L01.280.800
18172798,2008-01-01T00:00:00,Questionnaires,N05.715.360.300.695
18172798,2008-01-01T00:00:00,Questionnaires,N06.850.520.308.750
18172798,2008-01-01T00:00:00,Research Design,E05.581.500
18172798,2008-01-01T00:00:00,Research Design,H01.770.644.728
18172798,2008-01-01T00:00:00,Sex Factors,N05.715.350.675
18172798,2008-01-01T00:00:00,Sex Factors,N06.850.490.875
18172798,2008-01-01T00:00:00,Students,I02.233.748
18172798,2008-01-01T00:00:00,Students,I02.851
18172798,2008-01-01T00:00:00,Students,M01.848
18174777,2008-01-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
18174777,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18174777,2008-01-01T00:00:00,Hypertension,C14.907.489
18176190,2008-01-01T00:00:00,Bone Diseases,C05.116
18176190,2008-01-01T00:00:00,"Histiocytosis, Langerhans-Cell",C08.381.483.375
18176190,2008-01-01T00:00:00,"Histiocytosis, Langerhans-Cell",C15.604.250.400
18176190,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18176190,2008-01-01T00:00:00,"Infant, Newborn",M01.060.703.520
18176190,2008-01-01T00:00:00,"Remission, Spontaneous",C23.550.291.656.700
18176190,2008-01-01T00:00:00,"Remission, Spontaneous",G16.100.870
18176190,2008-01-01T00:00:00,Skin Diseases,C17.800
18177174,2008-01-01T00:00:00,Aged,M01.060.116.100
18177174,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18177174,2008-01-01T00:00:00,Progesterone,D04.808.745.745.654.829
18177174,2008-01-01T00:00:00,Progesterone,D06.472.334.734.623
18177174,2008-01-01T00:00:00,Progesterone,D06.472.334.851.687.750
18177174,2008-01-01T00:00:00,Speech Perception,F02.463.593.071.875
18180316,2008-01-01T00:00:00,Cell Membrane,A11.284.149
18180316,2008-01-01T00:00:00,DNA,D13.444.308
18180316,2008-01-01T00:00:00,Glucose,D09.546.359.448
18180316,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18180316,2008-01-01T00:00:00,Lipopolysaccharides,D09.400.500
18180316,2008-01-01T00:00:00,Lipopolysaccharides,D09.698.718.450
18180316,2008-01-01T00:00:00,Lipopolysaccharides,D10.494
18180316,2008-01-01T00:00:00,Lipopolysaccharides,D23.050.161.616.525
18180316,2008-01-01T00:00:00,Lipopolysaccharides,D23.946.123.329.500
18180316,2008-01-01T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.205.351
18180316,2008-01-01T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.525.700.100
18180316,2008-01-01T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.205.351
18180316,2008-01-01T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.525.700.100
18180316,2008-01-01T00:00:00,Monocytes,A11.118.637.555.652
18180316,2008-01-01T00:00:00,Monocytes,A11.148.580
18180316,2008-01-01T00:00:00,Monocytes,A11.627.624
18180316,2008-01-01T00:00:00,Monocytes,A11.733.547
18180316,2008-01-01T00:00:00,Monocytes,A15.145.229.637.555.652
18180316,2008-01-01T00:00:00,Monocytes,A15.378.316.580
18180316,2008-01-01T00:00:00,Monocytes,A15.382.490.555.652
18180316,2008-01-01T00:00:00,Monocytes,A15.382.680.547
18180316,2008-01-01T00:00:00,Monocytes,A15.382.812.547
18180316,2008-01-01T00:00:00,NF-kappa B,D12.776.260.600
18180316,2008-01-01T00:00:00,NF-kappa B,D12.776.660.600
18180316,2008-01-01T00:00:00,NF-kappa B,D12.776.930.600
18180316,2008-01-01T00:00:00,"RNA, Messenger",D13.444.735.544
18181849,2008-01-01T00:00:00,Attitude of Health Personnel,F01.100.050
18181849,2008-01-01T00:00:00,Attitude of Health Personnel,N05.300.100
18181849,2008-01-01T00:00:00,Clinical Competence,I02.399.630.210
18181849,2008-01-01T00:00:00,Clinical Competence,N04.761.210
18181849,2008-01-01T00:00:00,"Education, Medical, Graduate",I02.358.337.350
18181849,2008-01-01T00:00:00,"Education, Medical, Graduate",I02.358.399.350
18181849,2008-01-01T00:00:00,Family Practice,H02.403.280
18181849,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18181849,2008-01-01T00:00:00,Perception,F02.463.593
18181849,2008-01-01T00:00:00,Workplace,N01.824.245.925
18181849,2008-01-01T00:00:00,Workplace,N04.452.677.975
18184946,2008-01-01T00:00:00,"Child, Preschool",M01.060.406.448
18184946,2008-01-01T00:00:00,Developmental Disabilities,F03.550.362
18184946,2008-01-01T00:00:00,Gene Silencing,G05.355.315.203.374
18184946,2008-01-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
18184946,2008-01-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
18184946,2008-01-01T00:00:00,Growth Disorders,C23.550.393
18184946,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18184946,2008-01-01T00:00:00,Mutation,G05.365.590
18184946,2008-01-01T00:00:00,Phenotype,G05.695
18184946,2008-01-01T00:00:00,"Polymorphism, Genetic",G05.365.795
18185033,2008-01-01T00:00:00,Adolescent,M01.060.057
18185033,2008-01-01T00:00:00,Adult,M01.060.116
18185033,2008-01-01T00:00:00,Apolipoproteins E,D10.532.091.500
18185033,2008-01-01T00:00:00,Apolipoproteins E,D12.776.070.400.500
18185033,2008-01-01T00:00:00,Apolipoproteins E,D12.776.521.120.500
18185033,2008-01-01T00:00:00,Brain Concussion,C10.228.140.199.250
18185033,2008-01-01T00:00:00,Brain Concussion,C10.900.300.087.125
18185033,2008-01-01T00:00:00,Brain Concussion,C10.900.300.350.300
18185033,2008-01-01T00:00:00,Brain Concussion,C21.866.260.118.150
18185033,2008-01-01T00:00:00,Brain Concussion,C21.866.915.300.200.150
18185033,2008-01-01T00:00:00,Brain Concussion,C21.866.974.150
18185033,2008-01-01T00:00:00,Brain Concussion,C21.866.974.382.200
18185033,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18185033,2008-01-01T00:00:00,Point Mutation,G05.365.590.675
18185033,2008-01-01T00:00:00,"Polymorphism, Genetic",G05.365.795
18185033,2008-01-01T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
18185033,2008-01-01T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
18185033,2008-01-01T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
18185033,2008-01-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18185033,2008-01-01T00:00:00,Risk Assessment,N04.452.871.715
18185033,2008-01-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18185033,2008-01-01T00:00:00,Risk Assessment,N06.850.505.715
18185033,2008-01-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18185033,2008-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18185033,2008-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18185033,2008-01-01T00:00:00,tau Proteins,D12.776.220.600.450.510
18185033,2008-01-01T00:00:00,tau Proteins,D12.776.641.560.510
18186872,2008-01-01T00:00:00,Adult,M01.060.116
18186872,2008-01-01T00:00:00,Brachiocephalic Veins,A07.231.908.130
18186872,2008-01-01T00:00:00,Breast Neoplasms,C04.588.180
18186872,2008-01-01T00:00:00,Breast Neoplasms,C17.800.090.500
18186872,2008-01-01T00:00:00,"Constriction, Pathologic",C23.300.287
18186872,2008-01-01T00:00:00,"Diagnosis, Differential",E01.171
18186872,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18186872,2008-01-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
18186872,2008-01-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
18186872,2008-01-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
18186872,2008-01-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
18186872,2008-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18186872,2008-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18186872,2008-01-01T00:00:00,Renal Dialysis,E02.870.300
18186872,2008-01-01T00:00:00,Renal Dialysis,E02.912.800
18187589,2008-01-01T00:00:00,Adult,M01.060.116
18187589,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18187589,2008-01-01T00:00:00,"Medical Records Systems, Computerized",E05.318.308.940.968.625
18187589,2008-01-01T00:00:00,"Medical Records Systems, Computerized",L01.280.900.968.775
18187589,2008-01-01T00:00:00,"Medical Records Systems, Computerized",L01.700.508.300.695
18187589,2008-01-01T00:00:00,"Medical Records Systems, Computerized",N04.452.859.564.650
18187589,2008-01-01T00:00:00,"Medical Records Systems, Computerized",N05.715.360.300.715.500.530
18187589,2008-01-01T00:00:00,"Medical Records Systems, Computerized",N06.850.520.308.940.968.625
18187589,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18187589,2008-01-01T00:00:00,Pilot Projects,E05.318.760.750
18187589,2008-01-01T00:00:00,Pilot Projects,E05.337.737
18187589,2008-01-01T00:00:00,Pilot Projects,N05.715.360.775.625
18187589,2008-01-01T00:00:00,Pilot Projects,N06.850.520.450.720
18187589,2008-01-01T00:00:00,Primary Health Care,N04.590.233.727
18187589,2008-01-01T00:00:00,Publishing,L01.737
18187589,2008-01-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
18187589,2008-01-01T00:00:00,"Quality Assurance, Health Care",N05.700
18187589,2008-01-01T00:00:00,"Quality Indicators, Health Care",N04.761.789
18187589,2008-01-01T00:00:00,United States,Z01.107.567.875
18187758,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18187758,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18187758,2008-01-01T00:00:00,Pain,C10.597.617
18187758,2008-01-01T00:00:00,Pain,C23.888.592.612
18187758,2008-01-01T00:00:00,Pain,C23.888.646
18187758,2008-01-01T00:00:00,Pain,F02.830.816.444
18187758,2008-01-01T00:00:00,Pain,G11.561.600.810.444
18187758,2008-01-01T00:00:00,Peripheral Nervous System Diseases,C10.668.829
18188095,2008-01-01T00:00:00,Adolescent,M01.060.057
18188095,2008-01-01T00:00:00,Adult,M01.060.116
18188095,2008-01-01T00:00:00,Aged,M01.060.116.100
18188095,2008-01-01T00:00:00,Blood Glucose,D09.546.359.448.500
18188095,2008-01-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
18188095,2008-01-01T00:00:00,Body Mass Index,E05.041.124.125
18188095,2008-01-01T00:00:00,Body Mass Index,G07.100.100.125
18188095,2008-01-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
18188095,2008-01-01T00:00:00,Diabetes Mellitus,C18.452.394.750
18188095,2008-01-01T00:00:00,Diabetes Mellitus,C19.246
18188095,2008-01-01T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
18188095,2008-01-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
18188095,2008-01-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
18188095,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18188095,2008-01-01T00:00:00,Hyperglycemia,C18.452.394.952
18188095,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18188095,2008-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18188095,2008-01-01T00:00:00,Risk Factors,N05.715.350.200.700
18188095,2008-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18188095,2008-01-01T00:00:00,Risk Factors,N06.850.490.625.750
18188095,2008-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18188095,2008-01-01T00:00:00,Wounds and Injuries,C21.866
18190499,2008-01-01T00:00:00,Aged,M01.060.116.100
18190499,2008-01-01T00:00:00,Brain Infarction,C10.228.140.300.150.477
18190499,2008-01-01T00:00:00,Brain Infarction,C10.228.140.300.775.200
18190499,2008-01-01T00:00:00,Brain Infarction,C14.907.253.092.477
18190499,2008-01-01T00:00:00,Brain Infarction,C14.907.253.855.200
18190499,2008-01-01T00:00:00,"Diagnosis, Differential",E01.171
18190499,2008-01-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
18190499,2008-01-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
18190499,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18190499,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18190499,2008-01-01T00:00:00,Time Factors,G01.910.857
18190499,2008-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18190499,2008-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18190499,2008-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18190499,2008-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18190499,2008-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18190814,2008-01-01T00:00:00,Adult,M01.060.116
18190814,2008-01-01T00:00:00,Aged,M01.060.116.100
18190814,2008-01-01T00:00:00,Brain Ischemia,C10.228.140.300.150
18190814,2008-01-01T00:00:00,Brain Ischemia,C14.907.253.092
18190814,2008-01-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
18190814,2008-01-01T00:00:00,Clinical Trials as Topic,E05.337.250
18190814,2008-01-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
18190814,2008-01-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
18190814,2008-01-01T00:00:00,Hospitalization,E02.760.400
18190814,2008-01-01T00:00:00,Hospitalization,N02.421.585.400
18190814,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18190814,2008-01-01T00:00:00,Incidence,E05.318.308.985.525.375
18190814,2008-01-01T00:00:00,Incidence,L01.280.975.525.375
18190814,2008-01-01T00:00:00,Incidence,N01.224.935.597.500
18190814,2008-01-01T00:00:00,Incidence,N06.850.505.400.975.525.375
18190814,2008-01-01T00:00:00,Incidence,N06.850.520.308.985.525.375
18190814,2008-01-01T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
18190814,2008-01-01T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
18190814,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18190814,2008-01-01T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
18190814,2008-01-01T00:00:00,Multicenter Studies as Topic,E05.337.250.500
18190814,2008-01-01T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
18190814,2008-01-01T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
18190814,2008-01-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
18190814,2008-01-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
18190814,2008-01-01T00:00:00,Patient Discharge,E02.760.400.610
18190814,2008-01-01T00:00:00,Patient Discharge,N02.421.585.400.610
18190814,2008-01-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
18190814,2008-01-01T00:00:00,"Quality Assurance, Health Care",N05.700
18190814,2008-01-01T00:00:00,Quality of Health Care,N04.761
18190814,2008-01-01T00:00:00,Quality of Health Care,N05.715
18190814,2008-01-01T00:00:00,Stroke,C10.228.140.300.775
18190814,2008-01-01T00:00:00,Stroke,C14.907.253.855
18190814,2008-01-01T00:00:00,Treatment Outcome,E01.789.800
18190814,2008-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18190814,2008-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18190835,2008-01-01T00:00:00,Drug Delivery Systems,E02.319.300
18190835,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18190835,2008-01-01T00:00:00,Nanotechnology,H01.603
18190835,2008-01-01T00:00:00,Nanotechnology,J01.897.520.600
18191594,2008-01-01T00:00:00,Actins,D05.750.078.730.250
18191594,2008-01-01T00:00:00,Actins,D12.776.210.500.100
18191594,2008-01-01T00:00:00,Actins,D12.776.220.525.255
18191594,2008-01-01T00:00:00,Animals,B01.050
18191594,2008-01-01T00:00:00,Antigen Presentation,G12.425.107
18191594,2008-01-01T00:00:00,Antigen Presentation,G12.450.050.400.070
18191594,2008-01-01T00:00:00,B-Lymphocytes,A11.063.438
18191594,2008-01-01T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
18191594,2008-01-01T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
18191594,2008-01-01T00:00:00,B-Lymphocytes,A15.382.032.438
18191594,2008-01-01T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
18191594,2008-01-01T00:00:00,Cell Line,A11.251.210
18191594,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18191594,2008-01-01T00:00:00,Lymphocyte Activation,E01.450.495.482
18191594,2008-01-01T00:00:00,Lymphocyte Activation,E05.478.594.530
18191594,2008-01-01T00:00:00,Lymphocyte Activation,G12.425.747
18191594,2008-01-01T00:00:00,Lymphocyte Activation,G12.450.050.400.545
18191594,2008-01-01T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
18191594,2008-01-01T00:00:00,"Microscopy, Confocal",E05.595.395
18191594,2008-01-01T00:00:00,Signal Transduction,G02.111.087.800
18191594,2008-01-01T00:00:00,Signal Transduction,G02.149.115.800
18191594,2008-01-01T00:00:00,Signal Transduction,G04.299.880
18195216,2008-01-01T00:00:00,Adolescent,M01.060.057
18195216,2008-01-01T00:00:00,Age Factors,N05.715.350.075
18195216,2008-01-01T00:00:00,Age Factors,N06.850.490.250
18195216,2008-01-01T00:00:00,Cataract,C11.510.245
18195216,2008-01-01T00:00:00,Cataract Extraction,E04.540.825.249
18195216,2008-01-01T00:00:00,Child,M01.060.406
18195216,2008-01-01T00:00:00,"Child, Preschool",M01.060.406.448
18195216,2008-01-01T00:00:00,Cornea,A09.371.060.217
18195216,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18195216,2008-01-01T00:00:00,Infant,M01.060.703
18195216,2008-01-01T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
18195216,2008-01-01T00:00:00,"Refraction, Ocular",E01.370.380.850.700
18195216,2008-01-01T00:00:00,"Refraction, Ocular",G01.590.770.760
18195216,2008-01-01T00:00:00,"Refraction, Ocular",G01.595.640.760
18195216,2008-01-01T00:00:00,"Refraction, Ocular",G14.760
18195216,2008-01-01T00:00:00,Sex Factors,N05.715.350.675
18195216,2008-01-01T00:00:00,Sex Factors,N06.850.490.875
18195216,2008-01-01T00:00:00,Visual Acuity,E01.370.380.850.950
18195216,2008-01-01T00:00:00,Visual Acuity,F02.463.593.932.901
18195216,2008-01-01T00:00:00,Visual Acuity,G14.940
18195301,2008-01-01T00:00:00,Adult,M01.060.116
18195301,2008-01-01T00:00:00,Aged,M01.060.116.100
18195301,2008-01-01T00:00:00,Attitude to Health,F01.100.150
18195301,2008-01-01T00:00:00,Attitude to Health,N05.300.150
18195301,2008-01-01T00:00:00,Complementary Therapies,E02.190
18195301,2008-01-01T00:00:00,Constipation,C23.888.821.150
18195301,2008-01-01T00:00:00,Diarrhea,C23.888.821.214
18195301,2008-01-01T00:00:00,Health Behavior,F01.145.488
18195301,2008-01-01T00:00:00,Hispanic Americans,M01.686.754.441
18195301,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18195301,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18195301,2008-01-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
18195301,2008-01-01T00:00:00,Patient Satisfaction,N04.452.822.360.600
18195301,2008-01-01T00:00:00,Patient Satisfaction,N05.300.150.600.630
18195301,2008-01-01T00:00:00,Patient Satisfaction,N05.715.360.600
18195301,2008-01-01T00:00:00,Pregnancy,G08.686.785.760.769
18195301,2008-01-01T00:00:00,Pregnancy Complications,C13.703
18195301,2008-01-01T00:00:00,Primary Health Care,N04.590.233.727
18195301,2008-01-01T00:00:00,Questionnaires,E05.318.308.750
18195301,2008-01-01T00:00:00,Questionnaires,L01.280.800
18195301,2008-01-01T00:00:00,Questionnaires,N05.715.360.300.695
18195301,2008-01-01T00:00:00,Questionnaires,N06.850.520.308.750
18195301,2008-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18195301,2008-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18195304,2008-01-01T00:00:00,Adult,M01.060.116
18195304,2008-01-01T00:00:00,Family Practice,H02.403.280
18195304,2008-01-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
18195304,2008-01-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
18195304,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18195304,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18195304,2008-01-01T00:00:00,Patient Education as Topic,I02.233.332.500
18195304,2008-01-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
18195304,2008-01-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
18195304,2008-01-01T00:00:00,Professional-Patient Relations,F01.829.401.650
18195304,2008-01-01T00:00:00,Professional-Patient Relations,N05.300.660
18195304,2008-01-01T00:00:00,Questionnaires,E05.318.308.750
18195304,2008-01-01T00:00:00,Questionnaires,L01.280.800
18195304,2008-01-01T00:00:00,Questionnaires,N05.715.360.300.695
18195304,2008-01-01T00:00:00,Questionnaires,N06.850.520.308.750
18195583,2008-01-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
18195583,2008-01-01T00:00:00,Clinical Trials as Topic,E05.337.250
18195583,2008-01-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
18195583,2008-01-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
18195583,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18195583,2008-01-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
18195583,2008-01-01T00:00:00,Lung Neoplasms,C08.381.540
18195583,2008-01-01T00:00:00,Lung Neoplasms,C08.785.520
18195583,2008-01-01T00:00:00,Mass Screening,E01.370.500
18195583,2008-01-01T00:00:00,Mass Screening,E05.318.308.250.580
18195583,2008-01-01T00:00:00,Mass Screening,N02.421.143.827.233.443
18195583,2008-01-01T00:00:00,Mass Screening,N02.421.726.233.443
18195583,2008-01-01T00:00:00,Mass Screening,N05.715.360.300.375.500
18195583,2008-01-01T00:00:00,Mass Screening,N06.850.520.308.250.580
18195583,2008-01-01T00:00:00,Mass Screening,N06.850.780.500
18195583,2008-01-01T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
18195583,2008-01-01T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
18195583,2008-01-01T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
18195583,2008-01-01T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
18195583,2008-01-01T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
18195583,2008-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
18195583,2008-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
18195583,2008-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
18195583,2008-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
18195583,2008-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
18195584,2008-01-01T00:00:00,Adolescent,M01.060.057
18195584,2008-01-01T00:00:00,Adult,M01.060.116
18195584,2008-01-01T00:00:00,Bronchiectasis,C08.127.384
18195584,2008-01-01T00:00:00,Cystic Fibrosis,C06.689.202
18195584,2008-01-01T00:00:00,Cystic Fibrosis,C08.381.187
18195584,2008-01-01T00:00:00,Cystic Fibrosis,C16.320.190
18195584,2008-01-01T00:00:00,Cystic Fibrosis,C16.614.213
18195584,2008-01-01T00:00:00,Cystic Fibrosis Transmembrane Conductance Regulator,D12.776.157.530.400.175.125
18195584,2008-01-01T00:00:00,Cystic Fibrosis Transmembrane Conductance Regulator,D12.776.543.550.425.175.125
18195584,2008-01-01T00:00:00,Cystic Fibrosis Transmembrane Conductance Regulator,D12.776.543.585.400.175.125
18195584,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18195584,2008-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18195584,2008-01-01T00:00:00,Risk Factors,N05.715.350.200.700
18195584,2008-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18195584,2008-01-01T00:00:00,Risk Factors,N06.850.490.625.750
18195584,2008-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18195585,2008-01-01T00:00:00,Cystic Fibrosis,C06.689.202
18195585,2008-01-01T00:00:00,Cystic Fibrosis,C08.381.187
18195585,2008-01-01T00:00:00,Cystic Fibrosis,C16.320.190
18195585,2008-01-01T00:00:00,Cystic Fibrosis,C16.614.213
18195585,2008-01-01T00:00:00,Hemoptysis,C08.381.348
18195585,2008-01-01T00:00:00,Hemoptysis,C23.550.414.896
18195585,2008-01-01T00:00:00,Hemoptysis,C23.888.852.430
18195585,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18195585,2008-01-01T00:00:00,Pneumothorax,C08.528.778
18195585,2008-01-01T00:00:00,Respiratory Insufficiency,C08.618.846
18195587,2008-01-01T00:00:00,Critical Illness,C23.550.291.625
18195587,2008-01-01T00:00:00,Epilepsy,C10.228.140.490
18195587,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18195587,2008-01-01T00:00:00,Hypertension,C14.907.489
18195587,2008-01-01T00:00:00,Pregnancy,G08.686.785.760.769
18195587,2008-01-01T00:00:00,Pregnancy Complications,C13.703
18195587,2008-01-01T00:00:00,"Pregnancy Complications, Infectious",C01.539.674
18195587,2008-01-01T00:00:00,"Pregnancy Complications, Infectious",C13.703.700
18195587,2008-01-01T00:00:00,Sepsis,C01.539.757
18195587,2008-01-01T00:00:00,Sepsis,C23.550.470.790.500
18195587,2008-01-01T00:00:00,Venous Thromboembolism,C14.907.355.590.700
18195587,2008-01-01T00:00:00,Venous Thromboembolism,C14.907.355.830.850.700
18195588,2008-01-01T00:00:00,Aircraft,J01.937.285.100
18195588,2008-01-01T00:00:00,Altitude,G16.500.275.058
18195588,2008-01-01T00:00:00,Altitude,N06.230.058
18195588,2008-01-01T00:00:00,Anoxia,C23.888.852.079
18195588,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18195588,2008-01-01T00:00:00,"Hypertension, Pulmonary",C08.381.423
18195588,2008-01-01T00:00:00,Lung Diseases,C08.381
18195588,2008-01-01T00:00:00,"Lung Diseases, Interstitial",C08.381.483
18195588,2008-01-01T00:00:00,Oxygen,D01.268.185.550
18195588,2008-01-01T00:00:00,Oxygen,D01.362.670
18195588,2008-01-01T00:00:00,Pneumothorax,C08.528.778
18195588,2008-01-01T00:00:00,Respiratory Insufficiency,C08.618.846
18195588,2008-01-01T00:00:00,Travel,I03.883
18197744,2008-01-01T00:00:00,Adult,M01.060.116
18197744,2008-01-01T00:00:00,Cost of Illness,I01.137
18197744,2008-01-01T00:00:00,Cost of Illness,N03.219.151.165
18197744,2008-01-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
18197744,2008-01-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
18197744,2008-01-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
18197744,2008-01-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
18197744,2008-01-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
18197744,2008-01-01T00:00:00,Health Services Accessibility,N04.590.374.350
18197744,2008-01-01T00:00:00,Health Services Accessibility,N05.300.430
18197744,2008-01-01T00:00:00,"Hospitals, University",N02.278.020.300.310
18197744,2008-01-01T00:00:00,"Hospitals, University",N02.278.421.639.725
18197744,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18197744,2008-01-01T00:00:00,Medicare,N03.219.521.346.506.564.663
18197744,2008-01-01T00:00:00,Medicare,N03.219.521.576.343.840
18197744,2008-01-01T00:00:00,Medicare,N03.706.615.696
18197744,2008-01-01T00:00:00,Outcome and Process Assessment (Health Care),N04.761.559
18197744,2008-01-01T00:00:00,Outcome and Process Assessment (Health Care),N05.715.360.575
18197744,2008-01-01T00:00:00,"Outpatient Clinics, Hospital",N02.278.035.380
18197744,2008-01-01T00:00:00,"Outpatient Clinics, Hospital",N02.278.354.422.527
18197744,2008-01-01T00:00:00,"Outpatient Clinics, Hospital",N04.452.442.422.527
18197744,2008-01-01T00:00:00,Primary Health Care,N04.590.233.727
18197744,2008-01-01T00:00:00,Program Evaluation,E05.337.820
18197744,2008-01-01T00:00:00,Program Evaluation,N04.761.685
18197744,2008-01-01T00:00:00,Program Evaluation,N05.715.360.650
18197744,2008-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18197744,2008-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18197744,2008-01-01T00:00:00,United States,Z01.107.567.875
18197917,2008-01-01T00:00:00,Adult,M01.060.116
18197917,2008-01-01T00:00:00,Glucocorticoids,D06.472.040.543
18197917,2008-01-01T00:00:00,Glucocorticoids,D27.505.696.399.472.488
18197917,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18197917,2008-01-01T00:00:00,Mass Chest X-Ray,E01.370.350.700.730.500
18197917,2008-01-01T00:00:00,Mass Chest X-Ray,E01.370.386.500
18197917,2008-01-01T00:00:00,Mass Chest X-Ray,E01.370.500.500
18197917,2008-01-01T00:00:00,Mass Chest X-Ray,E05.318.308.250.580.510
18197917,2008-01-01T00:00:00,Mass Chest X-Ray,N02.421.143.827.233.443.443
18197917,2008-01-01T00:00:00,Mass Chest X-Ray,N02.421.726.233.443.443
18197917,2008-01-01T00:00:00,Mass Chest X-Ray,N05.715.360.300.375.500.500
18197917,2008-01-01T00:00:00,Mass Chest X-Ray,N06.850.520.308.250.580.510
18197917,2008-01-01T00:00:00,Mass Chest X-Ray,N06.850.780.500.500
18197917,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18197917,2008-01-01T00:00:00,"Sarcoidosis, Pulmonary",C08.381.483.725
18197917,2008-01-01T00:00:00,"Sarcoidosis, Pulmonary",C15.604.515.827.725
18197939,2008-01-01T00:00:00,Adult,M01.060.116
18197939,2008-01-01T00:00:00,Deglutition,G10.261.326.215
18197939,2008-01-01T00:00:00,Esophagus,A03.556.875.500
18197939,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18197939,2008-01-01T00:00:00,Manometry,E05.559
18197939,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18199996,2008-01-01T00:00:00,Anticholesteremic Agents,D27.505.519.186.071.202
18199996,2008-01-01T00:00:00,Anticholesteremic Agents,D27.505.954.230.202
18199996,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18199996,2008-01-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
18199996,2008-01-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
18199996,2008-01-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
18199996,2008-01-01T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
18199996,2008-01-01T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
18199996,2008-01-01T00:00:00,"Lipoproteins, HDL",D10.532.432
18199996,2008-01-01T00:00:00,"Lipoproteins, HDL",D12.776.521.479
18199996,2008-01-01T00:00:00,"Lipoproteins, LDL",D10.532.515
18199996,2008-01-01T00:00:00,"Lipoproteins, LDL",D12.776.521.550
18199996,2008-01-01T00:00:00,Stroke,C10.228.140.300.775
18199996,2008-01-01T00:00:00,Stroke,C14.907.253.855
18199996,2008-01-01T00:00:00,Treatment Outcome,E01.789.800
18199996,2008-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18199996,2008-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18206634,2008-01-01T00:00:00,Aged,M01.060.116.100
18206634,2008-01-01T00:00:00,Cardiovascular Agents,D27.505.954.411
18206634,2008-01-01T00:00:00,Cardiovascular Diseases,C14
18206634,2008-01-01T00:00:00,Drug-Eluting Stents,E07.695.750.500
18206634,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18206634,2008-01-01T00:00:00,Metals,D01.552
18206634,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18206634,2008-01-01T00:00:00,Myocardial Infarction,C14.280.647.500
18206634,2008-01-01T00:00:00,Myocardial Infarction,C14.907.585.500
18206634,2008-01-01T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
18206634,2008-01-01T00:00:00,Prosthesis Design,E05.320.550
18206634,2008-01-01T00:00:00,Prosthesis Design,E07.695.680
18206634,2008-01-01T00:00:00,Stents,E07.695.750
18206634,2008-01-01T00:00:00,Thrombosis,C14.907.355.830
18206634,2008-01-01T00:00:00,Time Factors,G01.910.857
18206634,2008-01-01T00:00:00,Treatment Outcome,E01.789.800
18206634,2008-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18206634,2008-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18209131,2008-01-01T00:00:00,Adenoidectomy,E04.580.068
18209131,2008-01-01T00:00:00,Child,M01.060.406
18209131,2008-01-01T00:00:00,"Child, Preschool",M01.060.406.448
18209131,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18209131,2008-01-01T00:00:00,"Pain, Postoperative",C23.550.767.700
18209131,2008-01-01T00:00:00,"Pain, Postoperative",C23.888.646.530
18209131,2008-01-01T00:00:00,Tonsillectomy,E04.580.848
18209150,2008-01-01T00:00:00,Aged,M01.060.116.100
18209150,2008-01-01T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
18209150,2008-01-01T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
18209150,2008-01-01T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
18209150,2008-01-01T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
18209150,2008-01-01T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
18209150,2008-01-01T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
18209150,2008-01-01T00:00:00,Hepatectomy,E04.210.556
18209150,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18209150,2008-01-01T00:00:00,Liver Neoplasms,C04.588.274.623
18209150,2008-01-01T00:00:00,Liver Neoplasms,C06.301.623
18209150,2008-01-01T00:00:00,Liver Neoplasms,C06.552.697
18209150,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18209150,2008-01-01T00:00:00,Probability,E05.318.740.600
18209150,2008-01-01T00:00:00,Probability,G17.680
18209150,2008-01-01T00:00:00,Probability,N05.715.360.750.625
18209150,2008-01-01T00:00:00,Probability,N06.850.520.830.600
18209150,2008-01-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18209150,2008-01-01T00:00:00,Risk Assessment,N04.452.871.715
18209150,2008-01-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18209150,2008-01-01T00:00:00,Risk Assessment,N06.850.505.715
18209150,2008-01-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18209150,2008-01-01T00:00:00,Treatment Outcome,E01.789.800
18209150,2008-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18209150,2008-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18209150,2008-01-01T00:00:00,"Ultrasonography, Interventional",E01.370.350.850.855
18214721,2008-01-01T00:00:00,Drug Therapy,E02.319
18214721,2008-01-01T00:00:00,Ethnic Groups,M01.686.754
18214721,2008-01-01T00:00:00,Ethnic Groups,N01.224.317
18214721,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18214721,2008-01-01T00:00:00,Mental Health Services,F04.408
18214721,2008-01-01T00:00:00,Mental Health Services,N02.421.461
18214721,2008-01-01T00:00:00,Substance-Related Disorders,C21.739
18214721,2008-01-01T00:00:00,Substance-Related Disorders,F03.900
18214721,2008-01-01T00:00:00,United States,Z01.107.567.875
18224562,2008-01-01T00:00:00,Adult,M01.060.116
18224562,2008-01-01T00:00:00,Aged,M01.060.116.100
18224562,2008-01-01T00:00:00,Deglutition,G10.261.326.215
18224562,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18224562,2008-01-01T00:00:00,Manometry,E05.559
18224562,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18224562,2008-01-01T00:00:00,Pressure,G01.374.715
18231883,2008-01-01T00:00:00,Adult,M01.060.116
18231883,2008-01-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
18231883,2008-01-01T00:00:00,Body Mass Index,E05.041.124.125
18231883,2008-01-01T00:00:00,Body Mass Index,G07.100.100.125
18231883,2008-01-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
18231883,2008-01-01T00:00:00,Cesarean Section,E04.520.252.500
18231883,2008-01-01T00:00:00,"Fetal Membranes, Premature Rupture",C13.703.420.339
18231883,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18231883,2008-01-01T00:00:00,Pregnancy,G08.686.785.760.769
18246782,2008-01-01T00:00:00,Famous Persons,K01.517.211.506
18246782,2008-01-01T00:00:00,Famous Persons,M01.228
18246782,2008-01-01T00:00:00,"History, 19th Century",K01.400.504.937
18246782,2008-01-01T00:00:00,"History, 20th Century",K01.400.504.968
18246782,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18246782,2008-01-01T00:00:00,"Scleroderma, Systemic",C17.300.799
18246782,2008-01-01T00:00:00,"Scleroderma, Systemic",C17.800.784
18254433,2008-01-01T00:00:00,Aged,M01.060.116.100
18254433,2008-01-01T00:00:00,Health Surveys,E05.318.308.250
18254433,2008-01-01T00:00:00,Health Surveys,N05.715.360.300.375
18254433,2008-01-01T00:00:00,Health Surveys,N06.850.520.308.250
18254433,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18254433,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18254433,2008-01-01T00:00:00,Patient Satisfaction,N04.452.822.360.600
18254433,2008-01-01T00:00:00,Patient Satisfaction,N05.300.150.600.630
18254433,2008-01-01T00:00:00,Patient Satisfaction,N05.715.360.600
18254433,2008-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18254433,2008-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18283076,2008-01-01T00:00:00,Anticoagulants,D27.505.954.502.119
18283076,2008-01-01T00:00:00,"Data Interpretation, Statistical",E05.245.380
18283076,2008-01-01T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
18283076,2008-01-01T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
18283076,2008-01-01T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
18283076,2008-01-01T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
18283076,2008-01-01T00:00:00,Double-Blind Method,E05.318.780.300
18283076,2008-01-01T00:00:00,Double-Blind Method,E05.581.500.300
18283076,2008-01-01T00:00:00,Double-Blind Method,N05.715.360.780.320
18283076,2008-01-01T00:00:00,Double-Blind Method,N06.850.520.445.300
18283076,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18283076,2008-01-01T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
18283076,2008-01-01T00:00:00,Multicenter Studies as Topic,E05.337.250.500
18283076,2008-01-01T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
18283076,2008-01-01T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
18283076,2008-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
18283076,2008-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
18283076,2008-01-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
18283076,2008-01-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
18283076,2008-01-01T00:00:00,Research Design,E05.581.500
18283076,2008-01-01T00:00:00,Research Design,H01.770.644.728
18283076,2008-01-01T00:00:00,Stroke,C10.228.140.300.775
18283076,2008-01-01T00:00:00,Stroke,C14.907.253.855
18283076,2008-01-01T00:00:00,Warfarin,D03.438.150.446.520.914
18283076,2008-01-01T00:00:00,Warfarin,D03.830.219.446.520.914
18297500,2008-01-01T00:00:00,"Diagnosis, Computer-Assisted",E01.158
18297500,2008-01-01T00:00:00,"Diagnosis, Computer-Assisted",L01.700.508.100.158
18297500,2008-01-01T00:00:00,Disability Evaluation,E01.370.400
18297500,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18297500,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18297500,2008-01-01T00:00:00,"Models, Statistical",E05.318.740.500
18297500,2008-01-01T00:00:00,"Models, Statistical",E05.599.835
18297500,2008-01-01T00:00:00,"Models, Statistical",N05.715.360.750.530
18297500,2008-01-01T00:00:00,"Models, Statistical",N06.850.520.830.500
18297500,2008-01-01T00:00:00,Movement,G07.700.560
18297500,2008-01-01T00:00:00,Movement,G11.427.590.530
18297500,2008-01-01T00:00:00,Psychometrics,F04.711.780
18297500,2008-01-01T00:00:00,Self Disclosure,F01.752.747.792.662
18297500,2008-01-01T00:00:00,Software,L01.224.900
18297500,2008-01-01T00:00:00,Walking,G11.427.590.530.568.900
18297500,2008-01-01T00:00:00,Walking,G11.427.590.530.698.940
18297500,2008-01-01T00:00:00,Walking,I03.450.642.845.940
18300666,2008-01-01T00:00:00,Adolescent,M01.060.057
18300666,2008-01-01T00:00:00,Adult,M01.060.116
18300666,2008-01-01T00:00:00,Aged,M01.060.116.100
18300666,2008-01-01T00:00:00,Arthroscopy,E01.370.388.250.070
18300666,2008-01-01T00:00:00,Arthroscopy,E04.555.113
18300666,2008-01-01T00:00:00,Arthroscopy,E04.800.250.070
18300666,2008-01-01T00:00:00,Cryotherapy,E02.258
18300666,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18300666,2008-01-01T00:00:00,Knee Joint,A02.835.583.475
18300666,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18300666,2008-01-01T00:00:00,"Pain, Postoperative",C23.550.767.700
18300666,2008-01-01T00:00:00,"Pain, Postoperative",C23.888.646.530
18315756,2008-01-01T00:00:00,Adult,M01.060.116
18315756,2008-01-01T00:00:00,Child,M01.060.406
18315756,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18348474,2008-01-01T00:00:00,Consumer Participation,N02.421.143.262
18348474,2008-01-01T00:00:00,Consumer Participation,N03.540.245.360
18348474,2008-01-01T00:00:00,"Ethics, Medical",K01.316.333.132.750
18348474,2008-01-01T00:00:00,"Ethics, Medical",N05.350.340.162.500
18348474,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18348474,2008-01-01T00:00:00,Patient Isolation,E02.770
18348474,2008-01-01T00:00:00,Patient Isolation,N06.850.780.200.450.650
18348474,2008-01-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18348474,2008-01-01T00:00:00,Risk Assessment,N04.452.871.715
18348474,2008-01-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18348474,2008-01-01T00:00:00,Risk Assessment,N06.850.505.715
18348474,2008-01-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18391367,2008-01-01T00:00:00,Adult,M01.060.116
18391367,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18391367,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18391367,2008-01-01T00:00:00,Military Personnel,M01.526.625
18391367,2008-01-01T00:00:00,"Monitoring, Physiologic",E01.370.520
18391367,2008-01-01T00:00:00,Occupational Exposure,N06.850.460.350.600
18391367,2008-01-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
18391367,2008-01-01T00:00:00,United States,Z01.107.567.875
18391367,2008-01-01T00:00:00,User-Computer Interface,L01.224.900.910
18391367,2008-01-01T00:00:00,War,I01.880.735.944
18397454,2008-01-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
18397454,2008-01-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
18397454,2008-01-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
18397454,2008-01-01T00:00:00,Health Manpower,N02.350
18397454,2008-01-01T00:00:00,Health Manpower,N05.300.420.400
18397454,2008-01-01T00:00:00,Healthcare Disparities,N04.590.374.380
18397454,2008-01-01T00:00:00,Healthcare Disparities,N05.300.493
18397454,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18397454,2008-01-01T00:00:00,Medicare,N03.219.521.346.506.564.663
18397454,2008-01-01T00:00:00,Medicare,N03.219.521.576.343.840
18397454,2008-01-01T00:00:00,Medicare,N03.706.615.696
18397454,2008-01-01T00:00:00,Physicians,M01.526.485.810
18397454,2008-01-01T00:00:00,Physicians,N02.360.810
18397454,2008-01-01T00:00:00,Rural Health Services,N02.421.816
18397454,2008-01-01T00:00:00,United States,Z01.107.567.875
18399613,2008-01-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
18399613,2008-01-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
18399613,2008-01-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
18399613,2008-01-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
18399613,2008-01-01T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
18399613,2008-01-01T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
18399613,2008-01-01T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
18399613,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18399613,2008-01-01T00:00:00,Postoperative Complications,C23.550.767
18399613,2008-01-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
18399613,2008-01-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
18399613,2008-01-01T00:00:00,Venous Thromboembolism,C14.907.355.590.700
18399613,2008-01-01T00:00:00,Venous Thromboembolism,C14.907.355.830.850.700
18401161,2008-01-01T00:00:00,Biological Markers,D23.101
18401161,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18401161,2008-01-01T00:00:00,Proteomics,H01.158.201.843
18401161,2008-01-01T00:00:00,Proteomics,H01.158.273.180.350.700
18401161,2008-01-01T00:00:00,Proteomics,H01.158.273.343.350.700
18401161,2008-01-01T00:00:00,Proteomics,H01.181.122.738
18407715,2008-01-01T00:00:00,Aged,M01.060.116.100
18407715,2008-01-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
18407715,2008-01-01T00:00:00,Alzheimer Disease,C10.574.945.249
18407715,2008-01-01T00:00:00,Alzheimer Disease,F03.087.400.100
18407715,2008-01-01T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
18407715,2008-01-01T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
18407715,2008-01-01T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
18407715,2008-01-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
18407715,2008-01-01T00:00:00,Ethnic Groups,M01.686.754
18407715,2008-01-01T00:00:00,Ethnic Groups,N01.224.317
18407715,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18407715,2008-01-01T00:00:00,Markov Chains,E05.318.740.600.500
18407715,2008-01-01T00:00:00,Markov Chains,E05.318.740.996.500
18407715,2008-01-01T00:00:00,Markov Chains,G17.830.500
18407715,2008-01-01T00:00:00,Markov Chains,N05.715.360.750.625.500
18407715,2008-01-01T00:00:00,Markov Chains,N05.715.360.750.770.500
18407715,2008-01-01T00:00:00,Markov Chains,N06.850.520.830.600.500
18407715,2008-01-01T00:00:00,Markov Chains,N06.850.520.830.996.500
18407715,2008-01-01T00:00:00,Psychomotor Agitation,C10.597.350.600
18407715,2008-01-01T00:00:00,Psychomotor Agitation,C10.597.606.881.700
18407715,2008-01-01T00:00:00,Psychomotor Agitation,C23.888.592.350.600
18407715,2008-01-01T00:00:00,Psychomotor Agitation,C23.888.592.604.882.700
18407715,2008-01-01T00:00:00,Psychomotor Agitation,F01.700.875.700
18407715,2008-01-01T00:00:00,Psychotic Disorders,F03.700.675
18407715,2008-01-01T00:00:00,Treatment Outcome,E01.789.800
18407715,2008-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
18407715,2008-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18407715,2008-01-01T00:00:00,United States,Z01.107.567.875
18425249,2008-01-01T00:00:00,Adult,M01.060.116
18425249,2008-01-01T00:00:00,"Arthritis, Rheumatoid",C05.550.114.154
18425249,2008-01-01T00:00:00,"Arthritis, Rheumatoid",C05.799.114
18425249,2008-01-01T00:00:00,"Arthritis, Rheumatoid",C17.300.775.099
18425249,2008-01-01T00:00:00,"Arthritis, Rheumatoid",C20.111.199
18425249,2008-01-01T00:00:00,Case-Control Studies,E05.318.760.500.500
18425249,2008-01-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18425249,2008-01-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18425249,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18425249,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18425249,2008-01-01T00:00:00,Oral Health,N01.400.535
18425249,2008-01-01T00:00:00,Periodontal Diseases,C07.465.714
18425249,2008-01-01T00:00:00,Periodontitis,C07.465.714.533
18437629,2008-01-01T00:00:00,Animals,B01.050
18437629,2008-01-01T00:00:00,Arrestins,D12.776.306.090
18437629,2008-01-01T00:00:00,Arrestins,D12.776.543.090
18437629,2008-01-01T00:00:00,Heterotrimeric GTP-Binding Proteins,D08.811.277.040.330.300.200
18437629,2008-01-01T00:00:00,Heterotrimeric GTP-Binding Proteins,D12.644.360.375
18437629,2008-01-01T00:00:00,Heterotrimeric GTP-Binding Proteins,D12.776.157.325.332
18437629,2008-01-01T00:00:00,Heterotrimeric GTP-Binding Proteins,D12.776.476.375
18437629,2008-01-01T00:00:00,Heterotrimeric GTP-Binding Proteins,D12.776.543.325
18437629,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18437629,2008-01-01T00:00:00,"Models, Biological",E05.599.395
18437629,2008-01-01T00:00:00,Mutation,G05.365.590
18437629,2008-01-01T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
18437629,2008-01-01T00:00:00,Signal Transduction,G02.111.087.800
18437629,2008-01-01T00:00:00,Signal Transduction,G02.149.115.800
18437629,2008-01-01T00:00:00,Signal Transduction,G04.299.880
18439079,2008-01-01T00:00:00,Adult,M01.060.116
18439079,2008-01-01T00:00:00,Aged,M01.060.116.100
18439079,2008-01-01T00:00:00,Ethnic Groups,M01.686.754
18439079,2008-01-01T00:00:00,Ethnic Groups,N01.224.317
18439079,2008-01-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
18439079,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18439079,2008-01-01T00:00:00,Interleukin-4,D12.644.276.374.465.504
18439079,2008-01-01T00:00:00,Interleukin-4,D12.776.467.374.465.504
18439079,2008-01-01T00:00:00,Interleukin-4,D23.529.374.465.504
18439079,2008-01-01T00:00:00,Interleukin-6,D12.644.276.374.465.506
18439079,2008-01-01T00:00:00,Interleukin-6,D12.776.467.374.465.506
18439079,2008-01-01T00:00:00,Interleukin-6,D23.529.374.465.506
18439079,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18439079,2008-01-01T00:00:00,"Polymorphism, Genetic",G05.365.795
18444160,2008-01-01T00:00:00,Androgens,D27.505.696.399.472.161
18444160,2008-01-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.250
18444160,2008-01-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.402.250
18444160,2008-01-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.230
18444160,2008-01-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.319.450
18444160,2008-01-01T00:00:00,Gene Expression Profiling,E05.393.332
18444160,2008-01-01T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
18444160,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18444160,2008-01-01T00:00:00,Mass Spectrometry,E05.196.566
18444160,2008-01-01T00:00:00,Neoplasm Proteins,D12.776.624
18444160,2008-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
18444160,2008-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
18444160,2008-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
18444160,2008-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
18444160,2008-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
18444160,2008-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
18444160,2008-01-01T00:00:00,Organoselenium Compounds,D02.712
18444160,2008-01-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
18444160,2008-01-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
18444160,2008-01-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
18444160,2008-01-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
18444160,2008-01-01T00:00:00,"RNA, Messenger",D13.444.735.544
18444160,2008-01-01T00:00:00,"Receptors, Androgen",D12.776.260.698.750.150
18444160,2008-01-01T00:00:00,"Receptors, Androgen",D12.776.826.750.150
18444160,2008-01-01T00:00:00,"Receptors, Androgen",D12.776.930.669.750.150
18444435,2008-01-01T00:00:00,Adolescent,M01.060.057
18444435,2008-01-01T00:00:00,Adolescent Behavior,F01.145.022
18444435,2008-01-01T00:00:00,African Americans,M01.686.508.100.100
18444435,2008-01-01T00:00:00,African Americans,M01.686.754.100
18444435,2008-01-01T00:00:00,Age Factors,N05.715.350.075
18444435,2008-01-01T00:00:00,Age Factors,N06.850.490.250
18444435,2008-01-01T00:00:00,Child,M01.060.406
18444435,2008-01-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
18444435,2008-01-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
18444435,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18444435,2008-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18444435,2008-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18444724,2008-01-01T00:00:00,Adult,M01.060.116
18444724,2008-01-01T00:00:00,Aggression,F01.145.126.125
18444724,2008-01-01T00:00:00,Aggression,F01.145.813.045
18444724,2008-01-01T00:00:00,Crime,I01.198.240
18444724,2008-01-01T00:00:00,Crime,I01.880.735.191
18444724,2008-01-01T00:00:00,Health Status,I01.240.425
18444724,2008-01-01T00:00:00,Health Status,N01.224.425
18444724,2008-01-01T00:00:00,Health Status,N06.850.505.400.425
18444724,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18444724,2008-01-01T00:00:00,Juvenile Delinquency,I01.880.735.479
18444724,2008-01-01T00:00:00,Mental Disorders,F03
18444724,2008-01-01T00:00:00,Substance-Related Disorders,C21.739
18444724,2008-01-01T00:00:00,Substance-Related Disorders,F03.900
18444724,2008-01-01T00:00:00,Time Factors,G01.910.857
18447091,2008-01-01T00:00:00,Adolescent,M01.060.057
18447091,2008-01-01T00:00:00,African Americans,M01.686.508.100.100
18447091,2008-01-01T00:00:00,African Americans,M01.686.754.100
18447091,2008-01-01T00:00:00,Awareness,F02.463.188.150
18447091,2008-01-01T00:00:00,Blood Pressure,E01.370.600.875.249
18447091,2008-01-01T00:00:00,Blood Pressure,G09.330.380.076
18447091,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18447091,2008-01-01T00:00:00,Hypertension,C14.907.489
18447091,2008-01-01T00:00:00,Meditation,E02.190.525.374
18447091,2008-01-01T00:00:00,Meditation,E02.190.901.455
18447091,2008-01-01T00:00:00,Meditation,F04.754.137.750.500
18447091,2008-01-01T00:00:00,Sodium,D01.268.549.750
18447091,2008-01-01T00:00:00,Sodium,D01.552.528.850
18447105,2008-01-01T00:00:00,Adolescent,M01.060.057
18447105,2008-01-01T00:00:00,Adult,M01.060.116
18447105,2008-01-01T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.370.140.100
18447105,2008-01-01T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.520.500.100
18447105,2008-01-01T00:00:00,Health Education,I02.233.332
18447105,2008-01-01T00:00:00,Health Education,N02.421.143.827.407
18447105,2008-01-01T00:00:00,Health Education,N02.421.726.407
18447105,2008-01-01T00:00:00,Hispanic Americans,M01.686.754.441
18447105,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18447105,2008-01-01T00:00:00,Hypertension,C14.907.489
18447105,2008-01-01T00:00:00,Mass Screening,E01.370.500
18447105,2008-01-01T00:00:00,Mass Screening,E05.318.308.250.580
18447105,2008-01-01T00:00:00,Mass Screening,N02.421.143.827.233.443
18447105,2008-01-01T00:00:00,Mass Screening,N02.421.726.233.443
18447105,2008-01-01T00:00:00,Mass Screening,N05.715.360.300.375.500
18447105,2008-01-01T00:00:00,Mass Screening,N06.850.520.308.250.580
18447105,2008-01-01T00:00:00,Mass Screening,N06.850.780.500
18447105,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18447105,2008-01-01T00:00:00,Students,I02.233.748
18447105,2008-01-01T00:00:00,Students,I02.851
18447105,2008-01-01T00:00:00,Students,M01.848
18470742,2008-01-01T00:00:00,Adult,M01.060.116
18470742,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18470742,2008-01-01T00:00:00,Panic Disorder,F03.080.700
18470742,2008-01-01T00:00:00,Psychotherapy,F04.754
18470742,2008-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18470742,2008-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18470742,2008-01-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
18507262,2008-01-01T00:00:00,African Americans,M01.686.508.100.100
18507262,2008-01-01T00:00:00,African Americans,M01.686.754.100
18507262,2008-01-01T00:00:00,Aged,M01.060.116.100
18507262,2008-01-01T00:00:00,Cardiovascular Diseases,C14
18507262,2008-01-01T00:00:00,"Databases, Factual",L01.470.750.750
18507262,2008-01-01T00:00:00,"Databases, Factual",L01.700.508.300.188.400
18507262,2008-01-01T00:00:00,Diabetes Complications,C19.246.099
18507262,2008-01-01T00:00:00,Diabetes Mellitus,C18.452.394.750
18507262,2008-01-01T00:00:00,Diabetes Mellitus,C19.246
18507262,2008-01-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
18507262,2008-01-01T00:00:00,Healthcare Disparities,N04.590.374.380
18507262,2008-01-01T00:00:00,Healthcare Disparities,N05.300.493
18507262,2008-01-01T00:00:00,Hospitalization,E02.760.400
18507262,2008-01-01T00:00:00,Hospitalization,N02.421.585.400
18507262,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18507262,2008-01-01T00:00:00,Length of Stay,E02.760.400.480
18507262,2008-01-01T00:00:00,Length of Stay,N02.421.585.400.480
18507262,2008-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18507262,2008-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18507274,2008-01-01T00:00:00,Adolescent,M01.060.057
18507274,2008-01-01T00:00:00,Adult,M01.060.116
18507274,2008-01-01T00:00:00,Aged,M01.060.116.100
18507274,2008-01-01T00:00:00,Awareness,F02.463.188.150
18507274,2008-01-01T00:00:00,Dizziness,C10.597.751.237
18507274,2008-01-01T00:00:00,Dizziness,C23.888.592.763.237
18507274,2008-01-01T00:00:00,Emergency Medical Service Communication Systems,N02.421.297.058
18507274,2008-01-01T00:00:00,Ethnic Groups,M01.686.754
18507274,2008-01-01T00:00:00,Ethnic Groups,N01.224.317
18507274,2008-01-01T00:00:00,Headache,C10.597.617.470
18507274,2008-01-01T00:00:00,Headache,C23.888.592.612.441
18507274,2008-01-01T00:00:00,Headache,C23.888.646.487
18507274,2008-01-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
18507274,2008-01-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
18507274,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18507274,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18507274,2008-01-01T00:00:00,Stroke,C10.228.140.300.775
18507274,2008-01-01T00:00:00,Stroke,C14.907.253.855
18507274,2008-01-01T00:00:00,United States,Z01.107.567.875
18507274,2008-01-01T00:00:00,Veterans,M01.930
18507274,2008-01-01T00:00:00,Vision Disorders,C10.597.751.941
18507274,2008-01-01T00:00:00,Vision Disorders,C11.966
18507274,2008-01-01T00:00:00,Vision Disorders,C23.888.592.763.941
18507282,2008-01-01T00:00:00,Adolescent,M01.060.057
18507282,2008-01-01T00:00:00,Adult,M01.060.116
18507282,2008-01-01T00:00:00,Aged,M01.060.116.100
18507282,2008-01-01T00:00:00,Awareness,F02.463.188.150
18507282,2008-01-01T00:00:00,Dizziness,C10.597.751.237
18507282,2008-01-01T00:00:00,Dizziness,C23.888.592.763.237
18507282,2008-01-01T00:00:00,Emergency Medical Service Communication Systems,N02.421.297.058
18507282,2008-01-01T00:00:00,Ethnic Groups,M01.686.754
18507282,2008-01-01T00:00:00,Ethnic Groups,N01.224.317
18507282,2008-01-01T00:00:00,Headache,C10.597.617.470
18507282,2008-01-01T00:00:00,Headache,C23.888.592.612.441
18507282,2008-01-01T00:00:00,Headache,C23.888.646.487
18507282,2008-01-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
18507282,2008-01-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
18507282,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18507282,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18507282,2008-01-01T00:00:00,Stroke,C10.228.140.300.775
18507282,2008-01-01T00:00:00,Stroke,C14.907.253.855
18507282,2008-01-01T00:00:00,United States,Z01.107.567.875
18507282,2008-01-01T00:00:00,Veterans,M01.930
18507282,2008-01-01T00:00:00,Vision Disorders,C10.597.751.941
18507282,2008-01-01T00:00:00,Vision Disorders,C11.966
18507282,2008-01-01T00:00:00,Vision Disorders,C23.888.592.763.941
18552054,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18552054,2008-01-01T00:00:00,Informed Consent,I01.880.604.473.650.718
18552054,2008-01-01T00:00:00,Informed Consent,I01.880.604.583.427
18552054,2008-01-01T00:00:00,Informed Consent,N03.706.437.650.312
18552054,2008-01-01T00:00:00,Informed Consent,N03.706.535.489
18552054,2008-01-01T00:00:00,Physician-Patient Relations,F01.829.401.650.675
18552054,2008-01-01T00:00:00,Physician-Patient Relations,N05.300.660.625
18552054,2008-01-01T00:00:00,Truth Disclosure,F01.145.209.259.800
18552054,2008-01-01T00:00:00,United States,Z01.107.567.875
18563368,2008-01-01T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
18563368,2008-01-01T00:00:00,Nucleic Acid Conformation,G02.111.570.790.486
18563368,2008-01-01T00:00:00,Nucleic Acid Conformation,G05.360.580
18563368,2008-01-01T00:00:00,RNA,D13.444.735
18563368,2008-01-01T00:00:00,"Transcription, Genetic",G02.111.087.847
18563368,2008-01-01T00:00:00,"Transcription, Genetic",G02.149.115.847
18563368,2008-01-01T00:00:00,"Transcription, Genetic",G05.355.310.700
18563368,2008-01-01T00:00:00,Viral Proteins,D12.776.964
18566921,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18566921,2008-01-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
18566921,2008-01-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
18566921,2008-01-01T00:00:00,Quality of Life,I01.800
18566921,2008-01-01T00:00:00,Quality of Life,K01.752.400.750
18566921,2008-01-01T00:00:00,Recovery of Function,G16.757
18566921,2008-01-01T00:00:00,United States,Z01.107.567.875
18566921,2008-01-01T00:00:00,United States Department of Veterans Affairs,I01.409.137.500.700
18566921,2008-01-01T00:00:00,United States Department of Veterans Affairs,N03.540.348.500.500.700
18566921,2008-01-01T00:00:00,Veterans,M01.930
18566921,2008-01-01T00:00:00,Walking,G11.427.590.530.568.900
18566921,2008-01-01T00:00:00,Walking,G11.427.590.530.698.940
18566921,2008-01-01T00:00:00,Walking,I03.450.642.845.940
18581666,2008-01-01T00:00:00,Adult,M01.060.116
18581666,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18581666,2008-01-01T00:00:00,Leg,A01.378.610.500
18581666,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18581666,2008-01-01T00:00:00,Motor Activity,F01.145.632
18581666,2008-01-01T00:00:00,Motor Activity,G11.427.590.530.698
18581666,2008-01-01T00:00:00,Muscle Contraction,G11.427.590.540
18581666,2008-01-01T00:00:00,"Muscle, Skeletal",A02.633.567
18581666,2008-01-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
18581666,2008-01-01T00:00:00,Physical Therapy Modalities,E02.779
18581666,2008-01-01T00:00:00,Recovery of Function,G16.757
18581666,2008-01-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
18581666,2008-01-01T00:00:00,Spinal Cord Injuries,C10.900.850
18581666,2008-01-01T00:00:00,Spinal Cord Injuries,C21.866.819
18581666,2008-01-01T00:00:00,Teaching,I02.903
18584568,2008-01-01T00:00:00,Adolescent,M01.060.057
18584568,2008-01-01T00:00:00,Adult,M01.060.116
18584568,2008-01-01T00:00:00,Age Factors,N05.715.350.075
18584568,2008-01-01T00:00:00,Age Factors,N06.850.490.250
18584568,2008-01-01T00:00:00,Child,M01.060.406
18584568,2008-01-01T00:00:00,Cocaine-Related Disorders,C21.739.300
18584568,2008-01-01T00:00:00,Cocaine-Related Disorders,F03.900.300
18584568,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18584568,2008-01-01T00:00:00,Life Change Events,F01.829.458.410
18584568,2008-01-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
18605441,2008-01-01T00:00:00,Adolescent,M01.060.057
18605441,2008-01-01T00:00:00,Adult,M01.060.116
18605441,2008-01-01T00:00:00,Affective Symptoms,F01.145.126.100
18605441,2008-01-01T00:00:00,Antisocial Personality Disorder,F03.675.050
18605441,2008-01-01T00:00:00,Community Mental Health Services,F04.408.307
18605441,2008-01-01T00:00:00,Community Mental Health Services,N02.421.143.183
18605441,2008-01-01T00:00:00,Community Mental Health Services,N02.421.461.232
18605441,2008-01-01T00:00:00,Education,I02
18605441,2008-01-01T00:00:00,Evidence-Based Medicine,H02.249.750
18605441,2008-01-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
18605441,2008-01-01T00:00:00,Family Therapy,F04.754.864.581.273
18605441,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18605441,2008-01-01T00:00:00,Social Environment,I01.880.656
18605441,2008-01-01T00:00:00,Socialization,I01.880.813
18605441,2008-01-01T00:00:00,Substance-Related Disorders,C21.739
18605441,2008-01-01T00:00:00,Substance-Related Disorders,F03.900
18608875,2008-01-01T00:00:00,Adolescent,M01.060.057
18608875,2008-01-01T00:00:00,Adult,M01.060.116
18608875,2008-01-01T00:00:00,Aged,M01.060.116.100
18608875,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18608875,2008-01-01T00:00:00,Laryngoscopy,E01.370.386.460
18608875,2008-01-01T00:00:00,Laryngoscopy,E01.370.388.250.525
18608875,2008-01-01T00:00:00,Laryngoscopy,E04.580.373
18608875,2008-01-01T00:00:00,Laryngoscopy,E04.800.250.525
18608875,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18608875,2008-01-01T00:00:00,Stroboscopy,E01.370.350.755
18608875,2008-01-01T00:00:00,Vocal Cords,A04.329.364.737
18608875,2008-01-01T00:00:00,Young Adult,M01.060.116.815
18624021,2008-01-01T00:00:00,Adolescent,M01.060.057
18624021,2008-01-01T00:00:00,Adult,M01.060.116
18624021,2008-01-01T00:00:00,Age Factors,N05.715.350.075
18624021,2008-01-01T00:00:00,Age Factors,N06.850.490.250
18624021,2008-01-01T00:00:00,Aged,M01.060.116.100
18624021,2008-01-01T00:00:00,Ambulatory Care,E02.760.106
18624021,2008-01-01T00:00:00,Ambulatory Care,N02.421.585.106
18624021,2008-01-01T00:00:00,Anxiety Disorders,F03.080
18624021,2008-01-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
18624021,2008-01-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
18624021,2008-01-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
18624021,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18624021,2008-01-01T00:00:00,Hypertension,C14.907.489
18624021,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18624021,2008-01-01T00:00:00,"Outpatient Clinics, Hospital",N02.278.035.380
18624021,2008-01-01T00:00:00,"Outpatient Clinics, Hospital",N02.278.354.422.527
18624021,2008-01-01T00:00:00,"Outpatient Clinics, Hospital",N04.452.442.422.527
18624021,2008-01-01T00:00:00,United States,Z01.107.567.875
18629746,2008-01-01T00:00:00,Age Factors,N05.715.350.075
18629746,2008-01-01T00:00:00,Age Factors,N06.850.490.250
18629746,2008-01-01T00:00:00,Aged,M01.060.116.100
18629746,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18629746,2008-01-01T00:00:00,Interviews as Topic,E05.318.308.420
18629746,2008-01-01T00:00:00,Interviews as Topic,L01.280.520
18629746,2008-01-01T00:00:00,Interviews as Topic,N05.715.360.300.400
18629746,2008-01-01T00:00:00,Interviews as Topic,N06.850.520.308.420
18629746,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
18629746,2008-01-01T00:00:00,Pain Measurement,E01.370.376.550.600
18629746,2008-01-01T00:00:00,Primary Health Care,N04.590.233.727
18629746,2008-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18629746,2008-01-01T00:00:00,Risk Factors,N05.715.350.200.700
18629746,2008-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18629746,2008-01-01T00:00:00,Risk Factors,N06.850.490.625.750
18629746,2008-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18629746,2008-01-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
18629746,2008-01-01T00:00:00,United States,Z01.107.567.875
18629746,2008-01-01T00:00:00,United States Department of Veterans Affairs,I01.409.137.500.700
18629746,2008-01-01T00:00:00,United States Department of Veterans Affairs,N03.540.348.500.500.700
18661347,2008-01-01T00:00:00,Animals,B01.050
18661347,2008-01-01T00:00:00,"Antigens, CD44",D12.776.395.550.200.625.144
18661347,2008-01-01T00:00:00,"Antigens, CD44",D12.776.543.550.200.625.144
18661347,2008-01-01T00:00:00,"Antigens, CD44",D12.776.543.750.705.877.144
18661347,2008-01-01T00:00:00,"Antigens, CD44",D23.050.301.264.035.850.144
18661347,2008-01-01T00:00:00,"Antigens, CD44",D23.050.301.350.625.144
18661347,2008-01-01T00:00:00,"Antigens, CD44",D23.101.100.110.850.144
18661347,2008-01-01T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
18661347,2008-01-01T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
18661347,2008-01-01T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
18661347,2008-01-01T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
18661347,2008-01-01T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
18661347,2008-01-01T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
18661347,2008-01-01T00:00:00,Disease Progression,C23.550.291.656
18661347,2008-01-01T00:00:00,Extracellular Matrix,A11.284.295.310
18661347,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18661347,2008-01-01T00:00:00,Hyaluronic Acid,D09.698.373.475
18661357,2008-01-01T00:00:00,Animals,B01.050
18661357,2008-01-01T00:00:00,"Antigens, CD44",D12.776.395.550.200.625.144
18661357,2008-01-01T00:00:00,"Antigens, CD44",D12.776.543.550.200.625.144
18661357,2008-01-01T00:00:00,"Antigens, CD44",D12.776.543.750.705.877.144
18661357,2008-01-01T00:00:00,"Antigens, CD44",D23.050.301.264.035.850.144
18661357,2008-01-01T00:00:00,"Antigens, CD44",D23.050.301.350.625.144
18661357,2008-01-01T00:00:00,"Antigens, CD44",D23.101.100.110.850.144
18661357,2008-01-01T00:00:00,Breast Neoplasms,C04.588.180
18661357,2008-01-01T00:00:00,Breast Neoplasms,C17.800.090.500
18661357,2008-01-01T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
18661357,2008-01-01T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
18661357,2008-01-01T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
18661357,2008-01-01T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
18661357,2008-01-01T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
18661357,2008-01-01T00:00:00,Gene Transfer Techniques,E05.393.350
18661357,2008-01-01T00:00:00,Genetic Vectors,G05.360.337
18661357,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18661357,2008-01-01T00:00:00,Hyaluronic Acid,D09.698.373.475
18661357,2008-01-01T00:00:00,Integrases,D08.811.739.500
18661357,2008-01-01T00:00:00,Nanoparticles,J01.637.512.600
18661357,2008-01-01T00:00:00,Neoplasms,C04
18661357,2008-01-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
18661357,2008-01-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
18661357,2008-01-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
18661357,2008-01-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
18661357,2008-01-01T00:00:00,RNA Interference,G05.355.315.203.374.790
18668213,2008-01-01T00:00:00,Animals,B01.050
18668213,2008-01-01T00:00:00,Cell Aging,G04.299.119
18668213,2008-01-01T00:00:00,Homeostasis,G07.700.360
18686760,2008-01-01T00:00:00,Aged,M01.060.116.100
18686760,2008-01-01T00:00:00,Geriatric Assessment,E05.318.308.225
18686760,2008-01-01T00:00:00,Geriatric Assessment,I01.240.425.350
18686760,2008-01-01T00:00:00,Geriatric Assessment,L01.280.360
18686760,2008-01-01T00:00:00,Geriatric Assessment,N01.224.425.350
18686760,2008-01-01T00:00:00,Geriatric Assessment,N05.715.360.300.360
18686760,2008-01-01T00:00:00,Geriatric Assessment,N06.850.505.400.425.350
18686760,2008-01-01T00:00:00,Geriatric Assessment,N06.850.520.308.225
18686760,2008-01-01T00:00:00,Health Surveys,E05.318.308.250
18686760,2008-01-01T00:00:00,Health Surveys,N05.715.360.300.375
18686760,2008-01-01T00:00:00,Health Surveys,N06.850.520.308.250
18686760,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18686760,2008-01-01T00:00:00,Polypharmacy,E02.319.698
18715858,2008-01-01T00:00:00,Adult,M01.060.116
18715858,2008-01-01T00:00:00,Anticoagulants,D27.505.954.502.119
18715858,2008-01-01T00:00:00,Blood Coagulation,G09.188.124.560.150
18715858,2008-01-01T00:00:00,Heparin,D09.698.373.400
18715858,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18715858,2008-01-01T00:00:00,Liver,A03.620
18715858,2008-01-01T00:00:00,Liver Transplantation,E04.210.650
18715858,2008-01-01T00:00:00,Liver Transplantation,E04.936.450.490
18715858,2008-01-01T00:00:00,Liver Transplantation,E04.936.580.490
18715858,2008-01-01T00:00:00,Peptide Fragments,D12.644.541
18715858,2008-01-01T00:00:00,Recombinant Proteins,D12.776.828
18715858,2008-01-01T00:00:00,Thrombocytopenia,C15.378.140.855
18715858,2008-01-01T00:00:00,Thrombosis,C14.907.355.830
18724565,2008-01-01T00:00:00,Asperger Syndrome,F03.550.325.100
18724565,2008-01-01T00:00:00,Autistic Disorder,F03.550.325.125
18724565,2008-01-01T00:00:00,Child,M01.060.406
18724565,2008-01-01T00:00:00,"Child Development Disorders, Pervasive",F03.550.325
18724565,2008-01-01T00:00:00,"Child, Preschool",M01.060.406.448
18724565,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18724565,2008-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18724565,2008-01-01T00:00:00,Risk Factors,N05.715.350.200.700
18724565,2008-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18724565,2008-01-01T00:00:00,Risk Factors,N06.850.490.625.750
18724565,2008-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18724569,2008-01-01T00:00:00,Adolescent,M01.060.057
18724569,2008-01-01T00:00:00,Alcoholism,C21.739.100.250
18724569,2008-01-01T00:00:00,Alcoholism,F03.900.100.350
18724569,2008-01-01T00:00:00,Attention Deficit and Disruptive Behavior Disorders,F03.550.150
18724569,2008-01-01T00:00:00,"Diagnosis, Differential",E01.171
18724569,2008-01-01T00:00:00,Edema,C23.888.277
18724569,2008-01-01T00:00:00,Hemorrhage,C23.550.414
18724569,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18724569,2008-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18724569,2008-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18724569,2008-01-01T00:00:00,Marijuana Abuse,C21.739.635
18724569,2008-01-01T00:00:00,Marijuana Abuse,F03.900.635
18724569,2008-01-01T00:00:00,Paresis,C10.597.636
18724569,2008-01-01T00:00:00,Paresis,C23.888.592.643
18724569,2008-01-01T00:00:00,Patient Care Team,N04.590.715
18724569,2008-01-01T00:00:00,Spinal Cord,A08.186.854
18724569,2008-01-01T00:00:00,Tobacco Use Disorder,C21.739.912
18724569,2008-01-01T00:00:00,Tobacco Use Disorder,F03.900.912
18785453,2008-01-01T00:00:00,Ethnic Groups,M01.686.754
18785453,2008-01-01T00:00:00,Ethnic Groups,N01.224.317
18785453,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18785453,2008-01-01T00:00:00,Occupational Therapy,E02.831.489
18785453,2008-01-01T00:00:00,Occupational Therapy,H02.010.500
18785453,2008-01-01T00:00:00,Physical Therapy Modalities,E02.779
18785453,2008-01-01T00:00:00,Stroke,C10.228.140.300.775
18785453,2008-01-01T00:00:00,Stroke,C14.907.253.855
18838951,2008-01-01T00:00:00,Angioplasty,E02.148.050
18838951,2008-01-01T00:00:00,Angioplasty,E04.100.814.050
18838951,2008-01-01T00:00:00,Brain,A08.186.211
18838951,2008-01-01T00:00:00,Carotid Arteries,A07.231.114.186
18838951,2008-01-01T00:00:00,"Constriction, Pathologic",C23.300.287
18838951,2008-01-01T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
18838951,2008-01-01T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
18838951,2008-01-01T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
18838951,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18838951,2008-01-01T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
18838951,2008-01-01T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
18838951,2008-01-01T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
18838951,2008-01-01T00:00:00,Stents,E07.695.750
18838951,2008-01-01T00:00:00,Stroke,C10.228.140.300.775
18838951,2008-01-01T00:00:00,Stroke,C14.907.253.855
18838951,2008-01-01T00:00:00,Vertebral Artery,A07.231.114.955
18853562,2008-01-01T00:00:00,"Accidents, Traffic",N06.850.135.392
18853562,2008-01-01T00:00:00,Adolescent,M01.060.057
18853562,2008-01-01T00:00:00,Automobile Driving,I03.125
18853562,2008-01-01T00:00:00,Discrimination (Psychology),F02.463.593.257
18853562,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18853562,2008-01-01T00:00:00,Reaction Time,F02.830.650
18853562,2008-01-01T00:00:00,Reaction Time,F04.669.817
18853562,2008-01-01T00:00:00,Reaction Time,G11.561.677
18853562,2008-01-01T00:00:00,Visual Acuity,E01.370.380.850.950
18853562,2008-01-01T00:00:00,Visual Acuity,F02.463.593.932.901
18853562,2008-01-01T00:00:00,Visual Acuity,G14.940
18853562,2008-01-01T00:00:00,Walking,G11.427.590.530.568.900
18853562,2008-01-01T00:00:00,Walking,G11.427.590.530.698.940
18853562,2008-01-01T00:00:00,Walking,I03.450.642.845.940
18853562,2008-01-01T00:00:00,Young Adult,M01.060.116.815
18949448,2008-01-01T00:00:00,Animals,B01.050
18949448,2008-01-01T00:00:00,Antigen-Presenting Cells,A11.066
18949448,2008-01-01T00:00:00,Antigen-Presenting Cells,A15.382.066
18949448,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18949448,2008-01-01T00:00:00,"Immunotherapy, Adoptive",E02.095.465.425.400.330.050.400
18949448,2008-01-01T00:00:00,"Immunotherapy, Adoptive",E05.478.550.520.050.400
18949448,2008-01-01T00:00:00,Lymphocyte Activation,E01.450.495.482
18949448,2008-01-01T00:00:00,Lymphocyte Activation,E05.478.594.530
18949448,2008-01-01T00:00:00,Lymphocyte Activation,G12.425.747
18949448,2008-01-01T00:00:00,Lymphocyte Activation,G12.450.050.400.545
18949448,2008-01-01T00:00:00,Neoplasms,C04
18949448,2008-01-01T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.550.500
18949448,2008-01-01T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.569.500
18949448,2008-01-01T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.550.500
18949448,2008-01-01T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.569.500
18949448,2008-01-01T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.550.500
18949448,2008-01-01T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.569.500
18949448,2008-01-01T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
18949448,2008-01-01T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
18949448,2008-01-01T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
19005910,2008-01-01T00:00:00,Brain,A08.186.211
19005910,2008-01-01T00:00:00,Brain Mapping,E01.370.350.086
19005910,2008-01-01T00:00:00,Brain Mapping,E01.370.376.149
19005910,2008-01-01T00:00:00,Brain Mapping,E05.132
19005910,2008-01-01T00:00:00,Functional Laterality,F02.830.297.425
19005910,2008-01-01T00:00:00,Functional Laterality,G11.561.225.425
19005910,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19005910,2008-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19005910,2008-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19007396,2008-01-01T00:00:00,Adolescent,M01.060.057
19007396,2008-01-01T00:00:00,Child,M01.060.406
19007396,2008-01-01T00:00:00,Data Collection,E05.318.308
19007396,2008-01-01T00:00:00,Data Collection,L01.280
19007396,2008-01-01T00:00:00,Data Collection,N05.715.360.300
19007396,2008-01-01T00:00:00,Data Collection,N06.850.520.308
19007396,2008-01-01T00:00:00,Exercise,G11.427.590.237
19007396,2008-01-01T00:00:00,Exercise,I03.350
19007396,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19007396,2008-01-01T00:00:00,Life Style,F01.829.458
19007396,2008-01-01T00:00:00,Overweight,C23.888.144.699
19007396,2008-01-01T00:00:00,Overweight,E01.370.600.115.100.160.120.699
19007396,2008-01-01T00:00:00,Overweight,G07.100.100.160.120.699
19007396,2008-01-01T00:00:00,Rural Population,N01.600.725
19007396,2008-01-01T00:00:00,Social Environment,I01.880.656
19007396,2008-01-01T00:00:00,Urban Population,N01.600.900
19023744,2008-01-01T00:00:00,Adult,M01.060.116
19023744,2008-01-01T00:00:00,Aged,M01.060.116.100
19023744,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19023744,2008-01-01T00:00:00,Language,F01.145.209.399
19023744,2008-01-01T00:00:00,Language,L01.143.506
19023744,2008-01-01T00:00:00,Mental Processes,F02.463
19023744,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
19023744,2008-01-01T00:00:00,Neuropsychological Tests,F04.711.513
19023744,2008-01-01T00:00:00,Psychometrics,F04.711.780
19072751,2008-01-01T00:00:00,Attention Deficit Disorder with Hyperactivity,F03.550.150.150
19072751,2008-01-01T00:00:00,Cues,F02.463.425.234
19072751,2008-01-01T00:00:00,Forecasting,I01.320
19072751,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19072751,2008-01-01T00:00:00,Psychology,F04.096.628
19082961,2008-01-01T00:00:00,Lipids,D10
19082961,2008-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
19082961,2008-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
19082961,2008-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
19082961,2008-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
19082961,2008-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
19082961,2008-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
19082961,2008-01-01T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
19082961,2008-01-01T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
19082961,2008-01-01T00:00:00,Sphingolipids,D10.570.877
19082961,2008-01-01T00:00:00,Sphingolipids,D10.808
19082961,2008-01-01T00:00:00,"Stress, Physiological",G07.700.830
19082961,2008-01-01T00:00:00,"Transcription, Genetic",G02.111.087.847
19082961,2008-01-01T00:00:00,"Transcription, Genetic",G02.149.115.847
19082961,2008-01-01T00:00:00,"Transcription, Genetic",G05.355.310.700
19142236,2008-01-01T00:00:00,Brain,A08.186.211
19142236,2008-01-01T00:00:00,Electric Stimulation,E05.723.402
19142236,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19142236,2008-01-01T00:00:00,Periodicals as Topic,L01.178.682.829.678
19147010,2008-01-01T00:00:00,Animals,B01.050
19147010,2008-01-01T00:00:00,Bone Development,G07.700.320.500.325.377.625.100
19147010,2008-01-01T00:00:00,Bone Development,G11.427.590.560.100
19147010,2008-01-01T00:00:00,Cilia,A11.284.180.165
19152280,2008-01-01T00:00:00,Crime Victims,M01.135
19152280,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19152280,2008-01-01T00:00:00,Patient Education as Topic,I02.233.332.500
19152280,2008-01-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
19152280,2008-01-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
19152280,2008-01-01T00:00:00,Psychotherapy,F04.754
19152280,2008-01-01T00:00:00,Rape,I01.198.240.748.640
19152280,2008-01-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19162637,2008-01-01T00:00:00,Animals,B01.050
19162637,2008-01-01T00:00:00,Catheter Ablation,E01.370.370.380.410.200
19162637,2008-01-01T00:00:00,Catheter Ablation,E02.148.110
19162637,2008-01-01T00:00:00,Catheter Ablation,E02.148.442.110
19162637,2008-01-01T00:00:00,Catheter Ablation,E02.154.402.110
19162637,2008-01-01T00:00:00,Catheter Ablation,E04.014.170.402.110
19162637,2008-01-01T00:00:00,Computer Simulation,L01.224.160
19162637,2008-01-01T00:00:00,"Hyperthermia, Induced",E02.565
19162637,2008-01-01T00:00:00,"Hyperthermia, Induced",E02.779.496
19162637,2008-01-01T00:00:00,Liver,A03.620
19162637,2008-01-01T00:00:00,Liver Neoplasms,C04.588.274.623
19162637,2008-01-01T00:00:00,Liver Neoplasms,C06.301.623
19162637,2008-01-01T00:00:00,Liver Neoplasms,C06.552.697
19162637,2008-01-01T00:00:00,"Models, Biological",E05.599.395
19162637,2008-01-01T00:00:00,Radiation Dosage,E05.799.513
19162637,2008-01-01T00:00:00,Radiation Dosage,G01.201.875.740
19162637,2008-01-01T00:00:00,Radiation Dosage,N06.850.810.250
19162637,2008-01-01T00:00:00,Swine,B01.050.150.900.649.077.880
19165695,2008-01-01T00:00:00,Activities of Daily Living,E02.831.067
19165695,2008-01-01T00:00:00,Activities of Daily Living,I03.050
19165695,2008-01-01T00:00:00,Activities of Daily Living,N02.421.784.110
19165695,2008-01-01T00:00:00,Algorithms,G17.035
19165695,2008-01-01T00:00:00,Algorithms,L01.224.050
19165695,2008-01-01T00:00:00,Disability Evaluation,E01.370.400
19165695,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19165695,2008-01-01T00:00:00,Medical Records,E05.318.308.940.968
19165695,2008-01-01T00:00:00,Medical Records,L01.280.900.968
19165695,2008-01-01T00:00:00,Medical Records,N04.452.859.564
19165695,2008-01-01T00:00:00,Medical Records,N05.715.360.300.715.500
19165695,2008-01-01T00:00:00,Medical Records,N06.850.520.308.940.968
19165695,2008-01-01T00:00:00,United States,Z01.107.567.875
19165695,2008-01-01T00:00:00,United States Department of Veterans Affairs,I01.409.137.500.700
19165695,2008-01-01T00:00:00,United States Department of Veterans Affairs,N03.540.348.500.500.700
19319762,2008-01-01T00:00:00,Activities of Daily Living,E02.831.067
19319762,2008-01-01T00:00:00,Activities of Daily Living,I03.050
19319762,2008-01-01T00:00:00,Activities of Daily Living,N02.421.784.110
19319762,2008-01-01T00:00:00,Aged,M01.060.116.100
19319762,2008-01-01T00:00:00,Cognition Disorders,F03.087.250
19319762,2008-01-01T00:00:00,Geriatric Assessment,E05.318.308.225
19319762,2008-01-01T00:00:00,Geriatric Assessment,I01.240.425.350
19319762,2008-01-01T00:00:00,Geriatric Assessment,L01.280.360
19319762,2008-01-01T00:00:00,Geriatric Assessment,N01.224.425.350
19319762,2008-01-01T00:00:00,Geriatric Assessment,N05.715.360.300.360
19319762,2008-01-01T00:00:00,Geriatric Assessment,N06.850.505.400.425.350
19319762,2008-01-01T00:00:00,Geriatric Assessment,N06.850.520.308.225
19319762,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19319762,2008-01-01T00:00:00,Psychiatric Status Rating Scales,F04.586
19319762,2008-01-01T00:00:00,Psychometrics,F04.711.780
19319762,2008-01-01T00:00:00,United States,Z01.107.567.875
19319762,2008-01-01T00:00:00,United States Department of Veterans Affairs,I01.409.137.500.700
19319762,2008-01-01T00:00:00,United States Department of Veterans Affairs,N03.540.348.500.500.700
19424444,2008-01-01T00:00:00,Adult,M01.060.116
19424444,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19424444,2008-01-01T00:00:00,"Models, Neurological",E05.599.395.642
19424444,2008-01-01T00:00:00,Pain,C10.597.617
19424444,2008-01-01T00:00:00,Pain,C23.888.592.612
19424444,2008-01-01T00:00:00,Pain,C23.888.646
19424444,2008-01-01T00:00:00,Pain,F02.830.816.444
19424444,2008-01-01T00:00:00,Pain,G11.561.600.810.444
19424444,2008-01-01T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
19424444,2008-01-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
19424444,2008-01-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
19424459,2008-01-01T00:00:00,Adult,M01.060.116
19424459,2008-01-01T00:00:00,Electric Stimulation,E05.723.402
19424459,2008-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19424459,2008-01-01T00:00:00,Middle Aged,M01.060.116.630
19424459,2008-01-01T00:00:00,Pain,C10.597.617
19424459,2008-01-01T00:00:00,Pain,C23.888.592.612
19424459,2008-01-01T00:00:00,Pain,C23.888.646
19424459,2008-01-01T00:00:00,Pain,F02.830.816.444
19424459,2008-01-01T00:00:00,Pain,G11.561.600.810.444
19424459,2008-01-01T00:00:00,Pain Measurement,E01.370.376.550.600
19424459,2008-01-01T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
19424459,2008-01-01T00:00:00,Skin,A17.815
19424459,2008-01-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
19424459,2008-01-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
19424459,2008-01-01T00:00:00,Young Adult,M01.060.116.815
19753389,2008-01-01T00:00:00,Allied Health Occupations,H02.010
19753389,2008-01-01T00:00:00,Faculty,I02.463
19753389,2008-01-01T00:00:00,Faculty,M01.526.339
19753389,2008-01-01T00:00:00,Publishing,L01.737
19753389,2008-01-01T00:00:00,Research,H01.770.644
19753389,2008-01-01T00:00:00,Teaching,I02.903
